Citrus Sinensis ID: 005898
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | 2.2.26 [Sep-21-2011] | |||||||
| Q8LFN2 | 802 | Probable inactive leucine | no | no | 0.880 | 0.736 | 0.433 | 1e-133 | |
| Q9M9S4 | 728 | Probable LRR receptor-lik | no | no | 0.824 | 0.759 | 0.339 | 6e-85 | |
| C0LGJ9 | 742 | Probable LRR receptor-lik | no | no | 0.822 | 0.743 | 0.335 | 4e-78 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.816 | 0.459 | 0.293 | 1e-56 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.739 | 0.396 | 0.301 | 4e-55 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.718 | 0.385 | 0.299 | 2e-54 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.782 | 0.434 | 0.281 | 2e-47 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.780 | 0.434 | 0.284 | 2e-47 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.739 | 0.422 | 0.301 | 2e-46 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.733 | 0.437 | 0.295 | 2e-45 |
| >sp|Q8LFN2|Y3037_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At3g03770 OS=Arabidopsis thaliana GN=At3g03770 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 474 bits (1220), Expect = e-133, Method: Compositional matrix adjust.
Identities = 267/616 (43%), Positives = 397/616 (64%), Gaps = 25/616 (4%)
Query: 43 YPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLS 102
YPK L W N+ DFC S + + C ++ +T+L IIGD +++ L
Sbjct: 43 YPKVLNSWNNY-TDFCNSEPSPSLTVVCYEDSVTQLHIIGDNGTHM------------LP 89
Query: 103 ENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI 162
++FSI+SFVTTL +L ++VL+ VSLG+WG LP KI+RL SLE L++SSNFLFG +P ++
Sbjct: 90 KSFSINSFVTTLVKLPDVKVLTFVSLGLWGWLPQKINRLSSLEILNVSSNFLFGPIPHEL 149
Query: 163 STMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222
S++ LQTLILD+N F+ +P+W DSLPSL LS+R N L G PSS+ +S L L L+
Sbjct: 150 SSLATLQTLILDENMFSGELPDWIDSLPSLAVLSLRKNVLNGSLPSSLSSLSGLRVLALA 209
Query: 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI-PKQYGQL 281
N +G+LPDLS L +L VL+L N P+L LV LS N F + ++ L
Sbjct: 210 NNRFNGALPDLSHLTNLQVLDLEGNSFGPLFPRLSNKLVTLILSKNKFRSAVSAEEVSSL 269
Query: 282 NQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNK 341
QLQ LD+S+N G P ++ SLP I+ LN++ NK +G L NL+C +L+F D+S+N
Sbjct: 270 YQLQHLDLSYNTFVGPFPTSLMSLPAITYLNISHNKLTGRLSANLSCNSQLMFVDMSSNL 329
Query: 342 LTGGLPSCLSNES-DKRVVKFRGNCLSSNVQNQHPESYC------FEVRTERNQAGSKNV 394
LTG LP+CL S R V + NCL++ ++Q P S+C + +R SK V
Sbjct: 330 LTGSLPTCLKPSSGTSRDVVYASNCLATTNEDQRPVSFCSNEALAVGILPQRRNKVSK-V 388
Query: 395 GKLVGIIVGVLVIMVLLAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNAR 454
G +G+ +L +++L F+V+ R + ++ + +++N++ G++S++L++AR
Sbjct: 389 GIALGVTASILGVLLLAGALFVVLRRLNAKKTVTKSS--PRLIRENASMGYTSKLLSDAR 446
Query: 455 YVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRC 514
Y+S+ KLG GLPA R+F+LEEL+ ATNNF+ SA MGEGS G++Y+GRL++G+ VAIRC
Sbjct: 447 YISQTMKLGGLGLPAYRTFSLEELEYATNNFESSAFMGEGSQGQIYRGRLKDGSFVAIRC 506
Query: 515 LPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNF 574
L K + +NL ++L+AKLRH HLV +LGHC + DD V+++F V+E++ NG
Sbjct: 507 LKMKKSCSTQNLMHHIELIAKLRHRHLVSVLGHCFE-CYLDDSTVSRMFFVFEYVPNGEL 565
Query: 575 RTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634
RT IS+ G++L W +R++V IGVAK +QFLHTG++PG ++N +K +ILL+ + AKL
Sbjct: 566 RTWISDGHMGRLLTWEQRISVAIGVAKGIQFLHTGIVPGVYDNNLKMTDILLDNNLAAKL 625
Query: 635 SDYGLSIVSEDINSVG 650
S Y L ++ E + VG
Sbjct: 626 SSYNLPLLVEGLGKVG 641
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9S4|Y1143_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g14390 OS=Arabidopsis thaliana GN=At1g14390 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 218/643 (33%), Positives = 330/643 (51%), Gaps = 90/643 (13%)
Query: 25 QLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDK 84
QL SS+++ LL+++KHL+YP L W N +FCY+ SS I C + +TEL + G++
Sbjct: 28 QLISSESRTLLEIQKHLQYPPTLRSWSNW-TNFCYLPSSPSFKILCFNGHVTELTVTGNR 86
Query: 85 PSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSL 144
L FS DS T L +L++L+ LSLVSLGI
Sbjct: 87 -------------TVKLPGRFSSDSLFTVLTKLSNLKTLSLVSLGI-------------- 119
Query: 145 EYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG 204
G +P +I + + + F ++G
Sbjct: 120 ----------SGPLPSQIIRLSSSLQSLNLSSNF-----------------------ISG 146
Query: 205 PFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNL-PKLPRGLVMA 263
P I + L L L+ N +GS+PDL L +L LNL NKL + P L L+
Sbjct: 147 NIPKEISSLKNLRSLVLANNLFNGSVPDLRGLSNLQELNLGGNKLGPEVVPSLASNLITI 206
Query: 264 FLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP 323
L NNSF +IP+Q +LN+LQ LD+S N G P + SLP++ +L+LA N SGSLP
Sbjct: 207 SLKNNSFGSKIPEQIKKLNKLQSLDLSSNKFTGSIPRFLLSLPSLQNLSLAQNLLSGSLP 266
Query: 324 KNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN----VQNQHPESYC 379
+ C KL D+S N LTG LPSC S++ + V+ F NCLS N + Q P ++C
Sbjct: 267 NSSLCNSKLRILDVSRNLLTGKLPSCFSSK-KQTVLLFTFNCLSINGSPSAKYQRPVTFC 325
Query: 380 ------------FEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRYCPRCT 427
+ + + + + + I + + VI+V LV+ R R
Sbjct: 326 ENEAKQAVAAVKSDTKDKERKEEDTGIELGLVIGIIIGVILVSAVLAGLVLVRMRKSRSK 385
Query: 428 SE----QHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEATN 483
E ++ +V N+ +S+ + + R V + + GL R F+LEEL+EATN
Sbjct: 386 EEPLEANNVDQVTVCSNTTRSTTSKTVPDLRRVPQTMRSAVIGLSPYRVFSLEELEEATN 445
Query: 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVC 543
NFD + GE +LYKG L G +V +RC+ +K + +NL ++++L+KLRH HLV
Sbjct: 446 NFDAENLCGE----QLYKGCLREGIAVTVRCIKLKQKNSTQNLAQQMEVLSKLRHMHLVS 501
Query: 544 LLGHCIDGGGRDD--YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
+LGHCI G +D YA + +F+V E++SNG+ R ++++ +VL W +R+++ IGVA+
Sbjct: 502 VLGHCI-GTYQDHHPYAGSTIFIVQEYISNGSLRDYLTDWRKKEVLKWPQRMSIAIGVAR 560
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644
+QFLHTGV PG F N ++ N+LL+E KLS Y + + S+
Sbjct: 561 GIQFLHTGVAPGIFGNNLEIENVLLDETLTVKLSGYSIPLPSK 603
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGJ9|Y2278_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g02780 OS=Arabidopsis thaliana GN=At2g02780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 218/649 (33%), Positives = 330/649 (50%), Gaps = 97/649 (14%)
Query: 25 QLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDK 84
Q+ SS++Q LL+++K L+YP+ L+ W + +FC+I S + I C +TEL + G++
Sbjct: 28 QVASSESQTLLEIQKQLQYPQVLQSWTD-TTNFCHIRPSPSLRIICLHGHVTELTVTGNR 86
Query: 85 PSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSL-PDKIHRLY- 142
S + S T L +L+SL+ LSL SLGI GSL P I +L
Sbjct: 87 TSKLSG---------------SFHKLFTLLTQLSSLKTLSLTSLGISGSLSPKIITKLSP 131
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
SLE L+LSSN F + IP SL +L L +R+N
Sbjct: 132 SLESLNLSSN------------------------FISGKIPEEIVSLKNLKSLVLRDNMF 167
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVM 262
G +SD DL L +L L+L NKL +P LP L
Sbjct: 168 WG----------FVSD-------------DLRGLSNLQELDLGGNKLGPEVPSLPSKLTT 204
Query: 263 AFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSL 322
L NNSF +IP+Q +LN LQ LD+S N G P +FS+P++ L+L N SGSL
Sbjct: 205 VSLKNNSFRSKIPEQIKKLNNLQSLDLSSNEFTGSIPEFLFSIPSLQILSLDQNLLSGSL 264
Query: 323 PKNLNCGGKLVFFDISNNKLTGGLPSCLSNES-DKRVVKFRGNCLS----SNVQNQHPES 377
P + K++ D+S+N LTG LPSC S++S + V F NCLS N + Q P S
Sbjct: 265 PNSSCTSSKIITLDVSHNLLTGKLPSCYSSKSFSNQTVLFSFNCLSLIGTPNAKYQRPLS 324
Query: 378 YC------------FEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRYCP- 424
+C +++ A K ++ II +++ +L+ + + RR
Sbjct: 325 FCQNQASKAIAVEPIPKAKDKDSARIKLGLVILIIIGVIILAAILVLLVLIALKRRRSRS 384
Query: 425 --------RCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLE 476
+E+H K V S T SS+ L ++R V + + GLP R F+LE
Sbjct: 385 EDDPFEVNNSNNERHASDK-VSVCSTTTASSKSLPDSRRVPQTMRSAVIGLPPYRVFSLE 443
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL 536
EL+EATN+FD +++ E +LY+G L G V +R + +K ++L ++++L+KL
Sbjct: 444 ELEEATNDFDAASLFCE----QLYRGCLREGIPVTVRVIKLKQKSLPQSLAQQMEVLSKL 499
Query: 537 RHPHLVCLLGHCI-DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
RH HLV +LGH I + +A + +F+V E++S+G+ R ++ +VL W +R+A+
Sbjct: 500 RHMHLVSVLGHSIASNQDHNQHAGHTIFIVQEYISSGSLRDFLTNCRKKEVLKWPQRMAI 559
Query: 596 LIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644
IGVA+ +QFLH GV PG F N +K NI+L+E K+S Y + + S+
Sbjct: 560 AIGVARGIQFLHMGVAPGIFGNNLKIENIMLDETLTVKISGYTIPLPSK 608
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 182/621 (29%), Positives = 309/621 (49%), Gaps = 73/621 (11%)
Query: 79 KIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKI 138
++ G P+ +GN LS+N + +LTSL VL+L + G +P ++
Sbjct: 459 RLEGYLPAEIGNAASLK--RLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVEL 516
Query: 139 HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPN----WFD--SLPSL 192
SL LDL SN L G +P KI+ + +LQ L+L N + +IP+ +F +P L
Sbjct: 517 GDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDL 576
Query: 193 TFLS------MRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLS 245
+FL + N+L+GP P + L ++ LS N +SG +P LS L +L +L+LS
Sbjct: 577 SFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLS 636
Query: 246 DNKLDSNLPK-LPRGLVMAFL--SNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
N L ++PK + L + L +NN +G IP+ +G L L +L+++ N L G P ++
Sbjct: 637 GNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASL 696
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362
+L ++ ++L+ N SG L L+ KLV I NK TG +PS L N + +
Sbjct: 697 GNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVS 756
Query: 363 GNCLS--------------------SNVQNQHPESYCFEVRTERNQAGSKNV-GKLVGI- 400
N LS +N++ + P + ++ +G+K + G++VG
Sbjct: 757 ENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSD 816
Query: 401 -------------IVGVLVIMVLLAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATGFSS 447
I G+++ ++ F F+ RR+ +Q + ++++ GF
Sbjct: 817 CKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVD 876
Query: 448 E---VLTNARY---VSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYK 501
+ L+ +R +S + + L R L ++ EAT++F I+G+G +G +YK
Sbjct: 877 QNLYFLSGSRSREPLSINIAMFEQPLLKVR---LGDIVEATDHFSKKNIIGDGGFGTVYK 933
Query: 502 GRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561
L +VA++ L +K R ++ L K++HP+LV LLG+C ++ K
Sbjct: 934 ACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYC-------SFSEEK 986
Query: 562 VFLVYEFMSNGNFRTHISENTPG--KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV 619
+ LVYE+M NG+ H N G +VL+WS+RL + +G A+ + FLH G IP + +
Sbjct: 987 L-LVYEYMVNGSL-DHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDI 1044
Query: 620 KTNNILLNEHRIAKLSDYGLS 640
K +NILL+ K++D+GL+
Sbjct: 1045 KASNILLDGDFEPKVADFGLA 1065
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 163/541 (30%), Positives = 265/541 (48%), Gaps = 45/541 (8%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L + T+L L L G +P ++ L LD+S N L G +P ++ KL + L
Sbjct: 596 LGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDL 655
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-D 232
++N+ + IP W LP L L + +NK G P+ I ++ + L L N+++GS+P +
Sbjct: 656 NNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQE 715
Query: 233 LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF---LSNNSFSGEIPKQYGQLNQLQQ-LD 288
+ +L +LN LNL +N+L LP L F LS N+ +GEIP + GQL LQ LD
Sbjct: 716 IGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALD 775
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPS 348
+S+N G P I +LP + L+L+ N+ G +P + L + ++S N L G L
Sbjct: 776 LSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK 835
Query: 349 CLSNESDKRVVKFRGNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKL---VGIIVGVL 405
S V G C S P S+C N+AGSKN L +I+ +
Sbjct: 836 QFSRWQADAFVGNAGLCGS-------PLSHC-------NRAGSKNQRSLSPKTVVIISAI 881
Query: 406 VIMVLLAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSE 465
+ +A LV+ + + H L K V+ ++ S+ + A S
Sbjct: 882 SSLAAIALMVLVIILFF-----KQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGG----- 931
Query: 466 GLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAI-RCLPSSKKYTVR 524
A +++ EAT+ + ++G G GK+YK L+NG ++A+ + L + +
Sbjct: 932 ---AKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNK 988
Query: 525 NLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT--HISENT 582
+ + L +RH HLV L+G+C A L+YE+M+NG+ H +ENT
Sbjct: 989 SFNREVKTLGTIRHRHLVKLMGYC------SSKADGLNLLIYEYMANGSVWDWLHANENT 1042
Query: 583 PGK-VLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641
K VL W RL + +G+A+ V++LH +P + +K++N+LL+ + A L D+GL+
Sbjct: 1043 KKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAK 1102
Query: 642 V 642
+
Sbjct: 1103 I 1103
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (544), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 157/525 (29%), Positives = 263/525 (50%), Gaps = 43/525 (8%)
Query: 132 GSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPS 191
G +P + ++ L LD+SSN L G++P ++ KL + L++NF + IP W L
Sbjct: 613 GKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQ 672
Query: 192 LTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLD 250
L L + +N+ P+ + + L L L N+++GS+P ++ +LG+LNVLNL N+
Sbjct: 673 LGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFS 732
Query: 251 SNLPKLPRGLVMAF---LSNNSFSGEIPKQYGQLNQLQQ-LDMSFNALRGMPPPAIFSLP 306
+LP+ L + LS NS +GEIP + GQL LQ LD+S+N G P I +L
Sbjct: 733 GSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLS 792
Query: 307 NISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCL 366
+ L+L+ N+ +G +P ++ L + ++S N L G L S + G C
Sbjct: 793 KLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCG 852
Query: 367 SSNVQNQHPESYCFEVRTERNQAG--SKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRYCP 424
S P S C VR+ Q G +++V +I+ + + + LV+ +
Sbjct: 853 S-------PLSRCNRVRSNNKQQGLSARSV-----VIISAISALTAIGLMILVIALFF-- 898
Query: 425 RCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRS-FTLEELKEATN 483
++H K V G S T++ S+A A +S E++ EAT+
Sbjct: 899 ---KQRHDFFKKV------GHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATH 949
Query: 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIR-CLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
N ++G G GK+YK LENG +VA++ L + ++ + L ++RH HLV
Sbjct: 950 NLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLV 1009
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-----GKVLNWSERLAVLI 597
L+G+C +N L+YE+M NG+ + E+ P K+L+W RL + +
Sbjct: 1010 KLMGYC----SSKSEGLN--LLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAV 1063
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642
G+A+ V++LH +P + +K++N+LL+ + A L D+GL+ V
Sbjct: 1064 GLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKV 1108
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 167/594 (28%), Positives = 272/594 (45%), Gaps = 69/594 (11%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPP 160
LS N+ S ++L L+ L+ L L + G +P ++ L +LE L L N L G +P
Sbjct: 458 LSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDLTGPIPA 517
Query: 161 KISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLD 220
+S KL + L +N + IP L +L L + NN ++G P+ + +L LD
Sbjct: 518 SLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLD 577
Query: 221 LSKNAISGSLP---------------------------DLSSLGSLNVLN---LSDNKLD 250
L+ N ++GS+P G+ N+L + +LD
Sbjct: 578 LNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLD 637
Query: 251 S-------NLPKLPRGLV---------MAFL--SNNSFSGEIPKQYGQLNQLQQLDMSFN 292
N ++ RG+ M FL S N G IPK+ G + L L++ N
Sbjct: 638 RISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHN 697
Query: 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
L GM P + L N++ L+L+ N+F+G++P +L L D+SNN L+G +P
Sbjct: 698 DLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPF 757
Query: 353 ES--DKRVVKFRGNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVL 410
++ D R F N L P S + ++Q + L G + L+ +
Sbjct: 758 DTFPDYR---FANNSLCG-YPLPIPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLF 813
Query: 411 LAFGFLVVCRRYCPRCTSEQHLLHKSV--QDNSATGFSSEVLTNARYVSEAAKLGSEGLP 468
FG ++V R ++ L + +SAT S+ T+AR EA +
Sbjct: 814 CIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAR---EALSINLAAFE 870
Query: 469 A-CRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLK 527
R T +L EATN F +++G G +G +YK +L++G+ VAI+ L R
Sbjct: 871 KPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFT 930
Query: 528 LRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-GKV 586
++ + K++H +LV LLG+C G R LVYE+M G+ + + G
Sbjct: 931 AEMETIGKIKHRNLVPLLGYCKVGEER--------LLVYEYMKYGSLEDVLHDRKKIGIK 982
Query: 587 LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
LNW R + IG A+ + FLH IP + +K++N+LL+E+ A++SD+G++
Sbjct: 983 LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMA 1036
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 169/595 (28%), Positives = 273/595 (45%), Gaps = 71/595 (11%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPP 160
LS N+ S ++L L+ L+ L L + G +P ++ L +LE L L N L G +P
Sbjct: 458 LSFNYLTGSIPSSLGSLSKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDLTGPIPA 517
Query: 161 KISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLD 220
+S KL + L +N + IP L +L L + NN ++G P+ + +L LD
Sbjct: 518 SLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLD 577
Query: 221 LSKNAISGSLP---------------------------DLSSLGSLNVLN---LSDNKLD 250
L+ N ++GS+P G+ N+L + +LD
Sbjct: 578 LNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLD 637
Query: 251 S-------NLPKLPRGLV---------MAFL--SNNSFSGEIPKQYGQLNQLQQLDMSFN 292
N ++ RG+ M FL S N G IPK+ G + L L++ N
Sbjct: 638 RISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHN 697
Query: 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
L GM P + L N++ L+L+ N+F+G++P +L L D+SNN L+G +P
Sbjct: 698 DLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPF 757
Query: 353 ES--DKRVVKFRGNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVL 410
++ D R F N L P S + ++Q + L G + L+ +
Sbjct: 758 DTFPDYR---FANNSLCG-YPLPLPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLF 813
Query: 411 LAFGFLVVCRRYCPRCTSEQHLLHKSV--QDNSATGFSSEVLTNARYVSEAAKLGSEGLP 468
FG ++V R ++ L + +SAT S+ T+AR EA +
Sbjct: 814 CIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAR---EALSINLAAFE 870
Query: 469 -ACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLK 527
R T +L EATN F +++G G +G +YK +L++G+ VAI+ L R
Sbjct: 871 KPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFT 930
Query: 528 LRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT--HISENTPGK 585
++ + K++H +LV LLG+C G R LVYE+M G+ H + T G
Sbjct: 931 AEMETIGKIKHRNLVPLLGYCKVGEER--------LLVYEYMKYGSLEDVLHDRKKT-GI 981
Query: 586 VLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
LNW R + IG A+ + FLH IP + +K++N+LL+E+ A++SD+G++
Sbjct: 982 KLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMA 1036
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 165/548 (30%), Positives = 269/548 (49%), Gaps = 52/548 (9%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
+ L L +L L S G G +P ++ L L+ L + SN L G +P ++ M L L L
Sbjct: 499 IGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDL 558
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD- 232
+N F+ IP F L SLT+LS++ NK G P+S++ +S L+ D+S N ++G++P
Sbjct: 559 SNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGE 618
Query: 233 -LSSLGSLNV-LNLSDNKLDSNLPKLPRGLVMAF---LSNNSFSGEIPKQYGQLNQLQQL 287
L+SL ++ + LN S+N L +PK L M LSNN FSG IP+ + L
Sbjct: 619 LLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTL 678
Query: 288 DMSFNALRGMPPPAIFS-LPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGL 346
D S N L G P +F + I LNL+ N FSG +P++ LV D+S+N LTG +
Sbjct: 679 DFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEI 738
Query: 347 PSCLSNESDKRVVKFRGNCLSSNVQNQHPESYCF------EVRTERNQAGSKNVGKLVGI 400
P L+N S + +K N L +V PES F ++ + GSK K I
Sbjct: 739 PESLANLSTLKHLKLASNNLKGHV----PESGVFKNINASDLMGNTDLCGSKKPLKPCTI 794
Query: 401 IVG-------VLVIMVLLAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNA 453
VI+++L ++ + K ++++S +
Sbjct: 795 KQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPD------ 848
Query: 454 RYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIR 513
+ A KL + F +EL++AT++F+ + I+G S +YKG+LE+GT +A++
Sbjct: 849 --LDSALKL--------KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVK 898
Query: 514 CLPSSKKYTVRNLK---LRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMS 570
L + K+++ + K L++L+H +LV +LG + G LV FM
Sbjct: 899 VL-NLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKA-------LVLPFME 950
Query: 571 NGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630
NGN I + + + E++ + + +A + +LH+G + +K NILL+ R
Sbjct: 951 NGNLEDTI-HGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDR 1009
Query: 631 IAKLSDYG 638
+A +SD+G
Sbjct: 1010 VAHVSDFG 1017
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (467), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 161/545 (29%), Positives = 258/545 (47%), Gaps = 53/545 (9%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDD 175
R SL L +V + G P ++ +L +L ++L N G +PP+I T KLQ L L
Sbjct: 467 RCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAA 526
Query: 176 NFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL-PDLS 234
N F++ +PN L +L ++ +N L GP PS I L LDLS+N+ GSL P+L
Sbjct: 527 NQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELG 586
Query: 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAF---LSNNSFSGEIPKQYGQLNQLQ-QLDMS 290
SL L +L LS+N+ N+P L + N FSG IP Q G L+ LQ +++S
Sbjct: 587 SLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLS 646
Query: 291 FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLP--S 348
+N G PP I +L + L+L +N SG +P L+ + S N LTG LP
Sbjct: 647 YNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQ 706
Query: 349 CLSNESDKRVVKFRGNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIM 408
N + + +G C ++++ P S+ +AGS G+++ I+ V+ +
Sbjct: 707 IFQNMTLTSFLGNKGLC-GGHLRSCDP-SHSSWPHISSLKAGSARRGRIIIIVSSVIGGI 764
Query: 409 VLLAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEG-- 466
LL +V H L V+ A YV + E
Sbjct: 765 SLLLIAIVV-------------HFLRNPVE------------PTAPYVHDKEPFFQESDI 799
Query: 467 --LPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLP-------S 517
+P R FT++++ EAT F S I+G G+ G +YK + +G ++A++ L +
Sbjct: 800 YFVPKER-FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNN 858
Query: 518 SKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH 577
+ T + + + L K+RH ++V L C G N L+YE+MS G+
Sbjct: 859 NSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGS------NSNLLLYEYMSRGSL-GE 911
Query: 578 ISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637
+ ++W R A+ +G A+ + +LH P + +K+NNIL++E+ A + D+
Sbjct: 912 LLHGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDF 971
Query: 638 GLSIV 642
GL+ V
Sbjct: 972 GLAKV 976
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | ||||||
| 225456272 | 770 | PREDICTED: probable inactive leucine-ric | 0.949 | 0.827 | 0.708 | 0.0 | |
| 224133902 | 737 | predicted protein [Populus trichocarpa] | 0.964 | 0.877 | 0.700 | 0.0 | |
| 255540293 | 802 | leucine-rich repeat protein, putative [R | 0.913 | 0.764 | 0.691 | 0.0 | |
| 147788411 | 773 | hypothetical protein VITISV_008739 [Viti | 0.968 | 0.840 | 0.633 | 0.0 | |
| 356518897 | 763 | PREDICTED: probable inactive leucine-ric | 0.962 | 0.846 | 0.632 | 0.0 | |
| 449469629 | 780 | PREDICTED: probable inactive leucine-ric | 0.955 | 0.821 | 0.641 | 0.0 | |
| 255536961 | 769 | leucine-rich repeat protein, putative [R | 0.970 | 0.846 | 0.614 | 0.0 | |
| 356507347 | 743 | PREDICTED: probable inactive leucine-ric | 0.932 | 0.842 | 0.623 | 0.0 | |
| 357463601 | 755 | Receptor protein kinase-like protein [Me | 0.956 | 0.850 | 0.627 | 0.0 | |
| 449441678 | 767 | PREDICTED: probable inactive leucine-ric | 0.958 | 0.838 | 0.584 | 0.0 |
| >gi|225456272|ref|XP_002279697.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 920 bits (2379), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/637 (70%), Positives = 521/637 (81%)
Query: 16 WSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFI 75
W+ F LGTHQLQSSQTQVLLQLRK LEYP QLEIW +H DFCY+SSSTQVNITCQD+F+
Sbjct: 14 WNFFILGTHQLQSSQTQVLLQLRKQLEYPVQLEIWKDHTLDFCYLSSSTQVNITCQDSFV 73
Query: 76 TELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLP 135
T +KI+GDK NFDGFA +LS FS+DSFVTTLARLTSLRVLSLVSLGIWG LP
Sbjct: 74 TGIKIMGDKTVKDSNFDGFAIPTVTLSGAFSMDSFVTTLARLTSLRVLSLVSLGIWGPLP 133
Query: 136 DKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195
DKIHRL SLEYLDLSSNFLFGSVPPKI TMVKLQ L LD N+FN T+P+ DSL +LT L
Sbjct: 134 DKIHRLSSLEYLDLSSNFLFGSVPPKICTMVKLQALSLDGNYFNGTVPDCLDSLSNLTVL 193
Query: 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPK 255
S+ NN+L GPFP+SIQRI+TLSDLD S N ISG LPDLS L SL++L++S NKLDS LP
Sbjct: 194 SLGNNRLNGPFPASIQRIATLSDLDFSGNEISGKLPDLSRLTSLHLLDMSKNKLDSKLPA 253
Query: 256 LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLAS 315
LP+G+ MAFLSNNSF GEIP+QY +L QLQ LD+SFN L G PP A+FSLPNIS LNLAS
Sbjct: 254 LPKGVAMAFLSNNSFMGEIPQQYSRLVQLQHLDLSFNFLTGTPPEALFSLPNISYLNLAS 313
Query: 316 NKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQNQHP 375
N SGSL +++C +L F DISNNKLTGGLPSCLS DKRVV GNCLS Q+QHP
Sbjct: 314 NTLSGSLSNHIHCSSELSFVDISNNKLTGGLPSCLSTALDKRVVNSDGNCLSIGFQHQHP 373
Query: 376 ESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRYCPRCTSEQHLLHK 435
+SYC V ++ ++ SK++G LV +I GV V +LL FG VC+R C R SEQHLLHK
Sbjct: 374 DSYCMAVPVKKKESRSKDMGILVAVIGGVFVATLLLVFGCFFVCKRCCSRSISEQHLLHK 433
Query: 436 SVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGS 495
+VQ+NS TG SSE+LTNAR++ + AKLG+EG+P CR F+LEEL+EATNNFD S MG+GS
Sbjct: 434 TVQENSTTGLSSELLTNARFIPQVAKLGTEGVPVCRVFSLEELREATNNFDRSTFMGDGS 493
Query: 496 YGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555
GKLYKGRLENGT VAIRCLP SKKYT+RNLKLRLDL+A+LRH HLVCLLGH ID GGRD
Sbjct: 494 NGKLYKGRLENGTQVAIRCLPLSKKYTIRNLKLRLDLIARLRHTHLVCLLGHGIDTGGRD 553
Query: 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFF 615
D +V KVFL+YE++ NGNFR+H+SEN P K L WSERL+VLIGVAKA+ FLHTGVIPGFF
Sbjct: 554 DSSVYKVFLIYEYLPNGNFRSHLSENGPEKALKWSERLSVLIGVAKALHFLHTGVIPGFF 613
Query: 616 NNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVR 652
NNR+KTNNILLNEH +AKLSDYGLSI+SE+ + G +
Sbjct: 614 NNRLKTNNILLNEHGMAKLSDYGLSIISEENDKHGEK 650
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133902|ref|XP_002321688.1| predicted protein [Populus trichocarpa] gi|222868684|gb|EEF05815.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2358), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/652 (70%), Positives = 531/652 (81%), Gaps = 5/652 (0%)
Query: 3 MGQGNLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISS 62
MG +L LL CL W GTHQLQSSQTQVLLQ+RKHLEYP QLEIW NHG D CY+S
Sbjct: 1 MGHCSLFLLSCLLWGFLITGTHQLQSSQTQVLLQIRKHLEYPSQLEIWNNHGMDLCYLSP 60
Query: 63 STQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRV 122
STQVN+TCQ+N +TEL+I+GDKP+ V NF GFA N +LS +FS+DSFVTTL+RLTSLRV
Sbjct: 61 STQVNMTCQNNVVTELRIVGDKPAKVNNFVGFAIPNQTLSGSFSMDSFVTTLSRLTSLRV 120
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
LSLVSLGIWG LPDKIHRL SLEYLDLSSN LFGS+PPKISTMVKLQTL LDDNFFN T+
Sbjct: 121 LSLVSLGIWGPLPDKIHRLSSLEYLDLSSNNLFGSIPPKISTMVKLQTLNLDDNFFNGTV 180
Query: 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVL 242
PNWFDSL +LT LS+RNN+L G FPSSIQR++TL DL LS N +SG LP+L L LNVL
Sbjct: 181 PNWFDSLSNLTILSIRNNQLKGAFPSSIQRVTTLVDLILSGNDLSGKLPNLDRLSKLNVL 240
Query: 243 NLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
+LS N LDS+LP +P+GLVMAFLSNNS SGE+P +Y QL+QLQ DMSFN L G P ++
Sbjct: 241 DLSGNSLDSDLPSMPKGLVMAFLSNNSLSGEVPGKYSQLSQLQHFDMSFNKLSGKLPASL 300
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362
SLPNIS LNLASN SGSLP +LNCG KL DISNN+LTGGLP CLS ES RVVK
Sbjct: 301 LSLPNISYLNLASNMLSGSLPDHLNCGSKLQLVDISNNRLTGGLPYCLSTESGNRVVKLG 360
Query: 363 GNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRY 422
GNCLS ++++QH ES C +V +R +G K + LVG+I G+ VI+VLLAFG L+VC+RY
Sbjct: 361 GNCLSVDLRHQHAESSCIDVPVKRKPSGEKKIVVLVGVIAGIFVIIVLLAFGLLMVCKRY 420
Query: 423 CPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEAT 482
CP SEQHLLHK+ Q+ S TGFSSE+L+NA ++SEAA LG +G PACRSFT+EELKEAT
Sbjct: 421 CPLGISEQHLLHKAAQEKSVTGFSSEILSNASFISEAANLGIQGRPACRSFTIEELKEAT 480
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
NNF+ SAI+G+GS+GKLY+G LENGT VAIR +PSSKKY++RNLKLRLDLLAKLRHPHLV
Sbjct: 481 NNFNNSAILGDGSHGKLYRGTLENGTQVAIRRIPSSKKYSMRNLKLRLDLLAKLRHPHLV 540
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
CLLGHCID GG DY VNKVFLVYE++SNGNF ++SE+ PGKVLNWSERLAVLI VAKA
Sbjct: 541 CLLGHCID-GGEQDYTVNKVFLVYEYVSNGNFGAYLSEDNPGKVLNWSERLAVLISVAKA 599
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLL 654
+ FLHTGVIPGFFNNR+K NNILL+E+ IAK L + +D+ S G LL
Sbjct: 600 IHFLHTGVIPGFFNNRLKANNILLDEYGIAK----QLERLEDDVCSFGFILL 647
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540293|ref|XP_002511211.1| leucine-rich repeat protein, putative [Ricinus communis] gi|223550326|gb|EEF51813.1| leucine-rich repeat protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/645 (69%), Positives = 520/645 (80%), Gaps = 32/645 (4%)
Query: 3 MGQGNLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISS 62
MG + LLLLCL WS LGT QLQSSQTQVLLQLRKHLEYP QLEIW +H DFCY+SS
Sbjct: 81 MGYCSWLLLLCLVWSSLILGTLQLQSSQTQVLLQLRKHLEYPYQLEIWNDHTIDFCYLSS 140
Query: 63 STQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRV 122
+TQVN+TCQDNF+TEL+I+GDKP+ V +F GFA +LSENFSIDSFV TLARL SL+V
Sbjct: 141 TTQVNVTCQDNFVTELRILGDKPTQVNSFVGFAIPTITLSENFSIDSFVVTLARLNSLKV 200
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
LSLVSLGIWG LPDKIHRL SLEYL+LSSN+LFGSVPPKISTMVKLQTLILDDNFFN+T+
Sbjct: 201 LSLVSLGIWGPLPDKIHRLSSLEYLELSSNYLFGSVPPKISTMVKLQTLILDDNFFNHTV 260
Query: 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVL 242
PNWFDSL +LT L +RNNKL GPFPSSIQ+++TL+D+ LS N ISG LP+L +L +L++L
Sbjct: 261 PNWFDSLSNLTILRLRNNKLKGPFPSSIQKLATLTDVILSGNEISGKLPNLEALHNLHLL 320
Query: 243 NLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
+LS+N LDSNLP +P+GL MAFLSNNSFSGEIP+QY QL++LQ LD+SFN L G PP +
Sbjct: 321 DLSENNLDSNLPSMPKGLAMAFLSNNSFSGEIPQQYSQLSELQHLDVSFNVLSGKPPATL 380
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362
FSLPNIS LNLASN SGSLP +L+CG KL F DISNN TGGLP CLS ES R VKF
Sbjct: 381 FSLPNISYLNLASNMLSGSLPNHLSCGSKLQFVDISNNSFTGGLPYCLSIESGDRAVKFD 440
Query: 363 GNCLSSNVQNQHPESYCFEV--RTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCR 420
GNCLS + +Q ES C V +R Q+G KNV LVG+I +L+++VLLA GFL+VCR
Sbjct: 441 GNCLSIELHHQRAESSCVNVPMAVKRKQSGGKNVALLVGVITVILIVVVLLAIGFLIVCR 500
Query: 421 RYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKE 480
RYCPR SEQHLLHK+VQ+NSATGFSSE+LTNAR++S+AAKLG++GLP CR FTLEELKE
Sbjct: 501 RYCPRGVSEQHLLHKAVQENSATGFSSEILTNARWISQAAKLGTQGLPVCRPFTLEELKE 560
Query: 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
AT NFD + I+GEG YGK+ SK + K RHPH
Sbjct: 561 ATRNFDNAIILGEGFYGKVL-----------------SKTF-------------KTRHPH 590
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
LVCLLGHCIDGGG+DDY VNKVFL+YE++SNGN R H+ E++PGKVLNWSERL VLIGVA
Sbjct: 591 LVCLLGHCIDGGGQDDYRVNKVFLIYEYISNGNLRAHLCEDSPGKVLNWSERLTVLIGVA 650
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
KAV FLHTGVIPGFFNN++KTNNILL+EH +AKLSDYGLSIVS++
Sbjct: 651 KAVHFLHTGVIPGFFNNQLKTNNILLSEHGVAKLSDYGLSIVSDE 695
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788411|emb|CAN69961.1| hypothetical protein VITISV_008739 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2127), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/653 (63%), Positives = 503/653 (77%), Gaps = 3/653 (0%)
Query: 3 MGQGNLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISS 62
MG NL+ L L W F THQ+QSSQTQ LLQLRKHLEYP LEIW N+ DFC ++S
Sbjct: 1 MGLLNLVFLAFLFWVFFISHTHQMQSSQTQALLQLRKHLEYPXALEIWENYSGDFCNLAS 60
Query: 63 STQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRV 122
+ + ITCQDN ++ELKI+GDK V +F GFA N +LS+ FSIDSFVTTL+RL+ LRV
Sbjct: 61 TPHMAITCQDNSVSELKIMGDKHVKVSDFSGFAVPNETLSDGFSIDSFVTTLSRLSGLRV 120
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
LSLVSLGIWG LPDKIHRL LE LDLSSNF+FGS+PPK+ST+VKLQTL LD NFFN+++
Sbjct: 121 LSLVSLGIWGPLPDKIHRLALLEVLDLSSNFMFGSIPPKVSTLVKLQTLTLDANFFNDSV 180
Query: 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVL 242
P+W DSL +L+ LS+RNN+ G FP SI RI+TL+D+ LS N +SG LPDLSSL +L+VL
Sbjct: 181 PDWMDSLSNLSSLSLRNNRFKGQFPPSISRIATLTDVALSHNELSGKLPDLSSLTNLHVL 240
Query: 243 NLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
+L DN LDS LP +P+GLV A LS NSFSGEIP Q G+L QLQ LD+SFN+L G PP A+
Sbjct: 241 DLRDNHLDSELPIMPKGLVTALLSENSFSGEIPAQLGELAQLQHLDLSFNSLTGTPPSAL 300
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362
FS+ NIS LNLASN SGSLP L+CG +L F DIS+NKL G LPSCLS SD+RVVKF
Sbjct: 301 FSMANISYLNLASNMLSGSLPDGLSCGDELGFVDISSNKLMGVLPSCLSIASDRRVVKFG 360
Query: 363 GNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRR- 421
GNC S + Q+QH ESYC + Q+ K +G L+G I G ++I+ LAF ++CRR
Sbjct: 361 GNCFSIDAQHQHQESYCKAAHIKGKQSKGKEIGVLLGAIAGAVIIVAFLAFVLFILCRRC 420
Query: 422 --YCPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELK 479
Y R + EQ + K Q+NS+TG S E+L NAR++S+AAKLG++G P R F+LEELK
Sbjct: 421 RKYPSRGSFEQPAMPKLAQENSSTGISPELLANARFISQAAKLGTQGSPTYRLFSLEELK 480
Query: 480 EATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHP 539
+ATNNFD +GEGS GKLYKG+LENG V IR + +KY++RNLKLRLDLL+KLRHP
Sbjct: 481 DATNNFDPMTFLGEGSIGKLYKGKLENGAYVGIRTITLYRKYSIRNLKLRLDLLSKLRHP 540
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
HLV LLGHCIDGGG+DD V++ FL+YE+M NGN+ TH+SEN P KVL WS+RLAVLIGV
Sbjct: 541 HLVSLLGHCIDGGGQDDSNVDRFFLIYEYMPNGNYHTHLSENCPAKVLKWSDRLAVLIGV 600
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVR 652
AKAV FLHTGVIPG FNNR+KTNNILL+EHRIAKLSDYG+SI+ E+ V +
Sbjct: 601 AKAVHFLHTGVIPGSFNNRLKTNNILLDEHRIAKLSDYGMSIIMEENEKVDAK 653
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518897|ref|XP_003528113.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2124), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/656 (63%), Positives = 515/656 (78%), Gaps = 10/656 (1%)
Query: 3 MGQGNLLLLLCLSWSLFPLGT--HQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYI 60
MG +L+LL C +W +F +G+ QLQSSQTQVLLQL+KHLEYPKQLEIW + D C I
Sbjct: 1 MGFHDLVLLFCSAWCVFYVGSCSAQLQSSQTQVLLQLKKHLEYPKQLEIWRDRWTDLCSI 60
Query: 61 SSSTQVNITCQDNFITELKIIGD-KPSNVG-NFDGFASANASLSENFSIDSFVTTLARLT 118
SS QVN+TC+DNF+TEL I+GD KP+ G +FDGFA N +LSE+FS+DS V TLARLT
Sbjct: 61 SSPGQVNVTCKDNFVTELTILGDDKPTTKGRDFDGFAIPNQTLSESFSMDSLVATLARLT 120
Query: 119 SLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFF 178
SLRVL+LVSLG+WG LPD+IHRLY+LE+LDLSSN+L+GS+PPKI TM LQTL L DNFF
Sbjct: 121 SLRVLNLVSLGMWGPLPDRIHRLYALEHLDLSSNYLYGSIPPKICTMENLQTLRLVDNFF 180
Query: 179 NNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGS 238
N TIP+ F+S LT LS+++N+L GPFP SI ++TL+++D+S N ISGSL DLS L S
Sbjct: 181 NGTIPSLFNSSSHLTVLSLKSNRLKGPFPPSILSVTTLTEIDMSSNQISGSLEDLSVLSS 240
Query: 239 LNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP 298
L L+L +N+L+S LP +P+GL+ +LS NSFSGEIPK YGQLN+L++LD+SFN+L G
Sbjct: 241 LEELDLRENRLESKLPAMPKGLISLYLSRNSFSGEIPKHYGQLNRLEKLDVSFNSLTGTA 300
Query: 299 PPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCL-SNESDKR 357
P +FSLPNIS LNLASN +G L +L C +L F DIS N+ GGLPS L + +S+K
Sbjct: 301 PSELFSLPNISYLNLASNMLNGPLQNHLRCSSQLRFVDISYNRFVGGLPSSLNTTKSEKI 360
Query: 358 VVKFRGNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLV 417
VVK GNCLS +VQ+QH SYC E ++ S VG VG+IVG+L I+V+LA ++
Sbjct: 361 VVKSDGNCLSGSVQHQHAVSYCTEAHVKKK---SYRVGIFVGLIVGILFIIVVLALTIII 417
Query: 418 VCRRYCPRCTSEQHLLHKSVQDNS-ATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLE 476
C+RY P SEQHLLHK+VQD+S A G SSE++TNARYVSEA KLG E LP CRS++LE
Sbjct: 418 TCKRYFPWGVSEQHLLHKTVQDSSYAAGLSSELVTNARYVSEAEKLGREDLPTCRSYSLE 477
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL 536
ELKEATNNFD S MGE YGKLY+G+LE+G V IR LP SKKY++RN KLRLDLLAKL
Sbjct: 478 ELKEATNNFDNSTFMGENIYGKLYRGKLESGIQVVIRSLPLSKKYSIRNFKLRLDLLAKL 537
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
RHPHLV LLGHCIDG ++ N VFL+YE++SNG F+T++S ++PGKV NWSERL+VL
Sbjct: 538 RHPHLVSLLGHCIDGVVGENNEAN-VFLIYEYVSNGTFQTYLSGDSPGKVFNWSERLSVL 596
Query: 597 IGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVR 652
I VAKAV FLHTG+IPGFF NR+KTNNILLNE+ +AKLSDYGLSI+SE+ ++ GV+
Sbjct: 597 INVAKAVHFLHTGMIPGFFKNRLKTNNILLNENWMAKLSDYGLSIISEETDACGVK 652
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469629|ref|XP_004152521.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Cucumis sativus] gi|449530901|ref|XP_004172430.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/656 (64%), Positives = 517/656 (78%), Gaps = 15/656 (2%)
Query: 3 MGQGNLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISS 62
MG+ +LLLLLC +W+ +QLQ+SQ QVLLQLRKHLEYPKQLE W +H DFC +S
Sbjct: 1 MGKCDLLLLLCFAWTFLFAEAYQLQASQAQVLLQLRKHLEYPKQLESWTDHRVDFCTLSF 60
Query: 63 STQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRV 122
VN+TCQD+ +TEL+I GD V F GFA N +LSE FS+DSF+TTL RL SLRV
Sbjct: 61 LPLVNVTCQDSVVTELRIAGDTKDKVDEFIGFAIPNQTLSEGFSLDSFITTLTRLNSLRV 120
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
LSLVSLGIWG LPDKIHRL SLEYLDLSSN+LFGS+PPKIST+VKLQTL LDDNFFN+T+
Sbjct: 121 LSLVSLGIWGPLPDKIHRLSSLEYLDLSSNYLFGSIPPKISTLVKLQTLKLDDNFFNDTV 180
Query: 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVL 242
PNWFDSL SLT LS++NNK+ FPSSI ISTL++L +S N ISG LPDLS L L VL
Sbjct: 181 PNWFDSLSSLTVLSLKNNKIKDSFPSSIVSISTLTELVMSGNEISGELPDLSPLHGLTVL 240
Query: 243 NLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
+LS NKLDS+LP LP+ L+ A L NSFSGEIP+QYG+L+QLQQLD+SFNAL G+PP +I
Sbjct: 241 DLSWNKLDSSLPPLPKSLITASLGKNSFSGEIPQQYGELSQLQQLDISFNALAGIPPASI 300
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362
FSLPNIS LNL+SNK GSL +L CG L F DISNN LTG LPSCL ESD R +K
Sbjct: 301 FSLPNISHLNLSSNKLFGSLSTHLRCGNMLQFVDISNNMLTGALPSCLGIESDNRTLKVD 360
Query: 363 GNCLSSNVQNQHPESYC----FEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVV 418
GNCLS ++ QH +SYC + + Q+ +KN G ++G+++G+ + ++LL+ ++
Sbjct: 361 GNCLSVSIGKQHSKSYCDIDHIQQHQHQEQSKAKNAGAVMGLLLGIFLSVLLLSIVVVLF 420
Query: 419 CRRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEEL 478
RR PR SEQHLL KSVQD+SA GFSSE+LT+AR+VS+AAK+G +GLP CR+F+LEE+
Sbjct: 421 -RRCWPRGMSEQHLLQKSVQDSSAAGFSSELLTSARFVSQAAKIGIQGLPLCRTFSLEEI 479
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRH 538
+EAT+NF S I+G+GSYGKLY+GRLENGT VAIR L SKK+++RNLKLRLD+L KLRH
Sbjct: 480 REATSNFHDSTIIGDGSYGKLYRGRLENGTQVAIRSLVVSKKFSIRNLKLRLDMLGKLRH 539
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP---------GKVLNW 589
P+LVCLLGHCIDG G+D + + KVFL++E++SNG+FRTH+S+ KVLNW
Sbjct: 540 PNLVCLLGHCIDGEGQDYHDI-KVFLIFEYVSNGSFRTHLSDVFSFVLQIIVLVEKVLNW 598
Query: 590 SERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
SERLA+LI VAKAV FLHTGVIPGFF+N++K NNIL++EH +AKLSDYGLSIVSE+
Sbjct: 599 SERLAILISVAKAVHFLHTGVIPGFFDNQLKINNILIDEHNVAKLSDYGLSIVSEE 654
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255536961|ref|XP_002509547.1| leucine-rich repeat protein, putative [Ricinus communis] gi|223549446|gb|EEF50934.1| leucine-rich repeat protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 814 bits (2103), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/651 (61%), Positives = 500/651 (76%)
Query: 3 MGQGNLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISS 62
MG N L+L LSW+ TH+LQ+ Q Q+LLQ+RKHLEYP QL+IW ++ + C + S
Sbjct: 1 MGLVNWFLILFLSWAFLIPRTHELQTYQYQLLLQVRKHLEYPSQLDIWGSYSGEPCNLPS 60
Query: 63 STQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRV 122
+ ++I C+DN ITELKI GDK V +F+GFA +LS++FSIDS VTTLARLTSLRV
Sbjct: 61 TLYMSIICKDNVITELKIKGDKIVKVSDFNGFAIPGPTLSQSFSIDSLVTTLARLTSLRV 120
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
+SLVSLGIWG LPDKIHRLYSLE+LDLSSNFLFGSVPP+I+ +VKL +L+LD N+FN +I
Sbjct: 121 VSLVSLGIWGPLPDKIHRLYSLEFLDLSSNFLFGSVPPQIARLVKLNSLVLDGNYFNGSI 180
Query: 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVL 242
P+W DSL +LT LS++NN+ G FPSSI RISTL+D+ N ++G+LPDLS+L SL+VL
Sbjct: 181 PDWLDSLSNLTVLSLKNNRFKGQFPSSICRISTLTDIAFCHNQLTGTLPDLSALTSLHVL 240
Query: 243 NLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
+L +N LDS+LP +P+GL+ LSNNSFSG+I Q+ QL+QLQ LD+S N L G PP ++
Sbjct: 241 DLRENNLDSDLPTMPKGLITILLSNNSFSGKIRAQFDQLSQLQHLDLSLNRLSGTPPSSL 300
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362
FSLPNI LNLASN SGSLP +L+CG L F DIS NK GGLPSCL + S+KR +KF
Sbjct: 301 FSLPNIRYLNLASNMLSGSLPDHLSCGSNLGFVDISTNKFIGGLPSCLGSMSNKRAIKFG 360
Query: 363 GNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRY 422
GNCLS N Q QH E YC E E Q+ + VG LV +I G +++MVL+A G L CRRY
Sbjct: 361 GNCLSINGQYQHQEPYCEEANIEAKQSRGRAVGTLVAVIGGAVLVMVLVALGVLFFCRRY 420
Query: 423 CPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEAT 482
R T EQ++ K+VQDN+ T SSEVL NAR++S+ AKLG++G P R F+ EEL EAT
Sbjct: 421 SSRRTFEQNIFAKAVQDNAPTAVSSEVLANARFISQTAKLGTQGAPVHRVFSFEELTEAT 480
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
NNFD S MGEGS GK+Y+GRLENGT+VAIR L KK +++NLK+RLDLL+KL HPHLV
Sbjct: 481 NNFDSSTFMGEGSIGKIYRGRLENGTNVAIRSLTLLKKNSIQNLKVRLDLLSKLHHPHLV 540
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
LLG+CID G DD + KVFL+YE++SNGN+R H+SE P KVL WS RLA+LIGVAKA
Sbjct: 541 GLLGYCIDSCGLDDLSGIKVFLIYEYVSNGNYRAHLSETCPEKVLKWSHRLAILIGVAKA 600
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRL 653
V FLHTGVIPG NNR+KTNNILL+EHRIAKLSDYG+++++E+I + V L
Sbjct: 601 VHFLHTGVIPGTLNNRLKTNNILLDEHRIAKLSDYGMAVMTEEIEKLEVFL 651
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507347|ref|XP_003522429.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2070), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/653 (62%), Positives = 504/653 (77%), Gaps = 27/653 (4%)
Query: 3 MGQGNLLLLLCLSWSLFPLGT--HQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYI 60
MG +L+LL C +W +F +G+ QLQSSQTQVLLQL+KHLEYPKQLEIW + D C I
Sbjct: 1 MGFHDLVLLFCSAWCVFYVGSCSAQLQSSQTQVLLQLKKHLEYPKQLEIWRDRWTDLCSI 60
Query: 61 SSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSL 120
SSS QVN+TC+DNF+TEL I+GDKP+ +FDGFA+ N +LSE+FS++SFV TLARLTSL
Sbjct: 61 SSSGQVNVTCKDNFVTELTILGDKPTKGRDFDGFANPNQTLSESFSMESFVATLARLTSL 120
Query: 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNN 180
RVLSLVSLG+WG LPD+IHRLY+LE+LDLSSN+L+GS+PPKI TMV LQTL L DNFFN
Sbjct: 121 RVLSLVSLGMWGPLPDRIHRLYALEHLDLSSNYLYGSIPPKICTMVNLQTLRLGDNFFNG 180
Query: 181 TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLN 240
TI + F S +LT LS+++N+L GPFP SI + TL+++D+S N ISG L DL+ L SL
Sbjct: 181 TISSLFSSSNNLTVLSLKSNRLKGPFPLSIPSVITLTEIDMSCNQISGRLQDLTDLSSLE 240
Query: 241 VLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPP 300
L+L +N+LDS LP +P+GL+ FLS NSFSGEIP+ YGQL++LQ+LD+SFN+L G P
Sbjct: 241 QLDLRENRLDSKLPAMPKGLISLFLSRNSFSGEIPEHYGQLDRLQKLDVSFNSLTGTAPA 300
Query: 301 AIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVK 360
+FSLPNIS LNLASN +G L +L C +L F DIS N+L G LPS LS +S+ RVVK
Sbjct: 301 ELFSLPNISYLNLASNMLNGPLHNHLRCSSQLRFVDISYNRLVGDLPSSLSTKSENRVVK 360
Query: 361 FRGNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCR 420
GNCLS V VG VG+IVG+L I+V+LA ++ C+
Sbjct: 361 SDGNCLSGRV-----------------------VGIFVGLIVGILAIIVVLALTIVITCK 397
Query: 421 RYCPRCTSEQHLLHKSVQDNS-ATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELK 479
RY P SEQHLLHK+VQD+S A G SSE+LTNARYVSEAAKLG E LP CRS++LEELK
Sbjct: 398 RYFPWGVSEQHLLHKTVQDSSYAAGISSELLTNARYVSEAAKLGREDLPTCRSYSLEELK 457
Query: 480 EATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHP 539
EATNNFD S MGE YGKLY+G+LE+G V IR LP SKKY++RN KLRLDLLAKLRHP
Sbjct: 458 EATNNFDNSTFMGENIYGKLYRGKLESGIQVVIRSLPLSKKYSIRNFKLRLDLLAKLRHP 517
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
HLV LLGHC+DG ++ N VFL+YE++SNG F+T++S ++PGKV NWSERL+VLI +
Sbjct: 518 HLVSLLGHCMDGAVGENNEAN-VFLIYEYVSNGTFQTYLSGDSPGKVFNWSERLSVLINI 576
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVR 652
AKAV FLHTG+IPGFF NR+KTNNILLNE+ +AKLSDYGLS++SE+ ++ GV+
Sbjct: 577 AKAVHFLHTGMIPGFFKNRLKTNNILLNENWMAKLSDYGLSVISEETDASGVK 629
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463601|ref|XP_003602082.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355491130|gb|AES72333.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2044), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/653 (62%), Positives = 502/653 (76%), Gaps = 11/653 (1%)
Query: 3 MGQGNLLLLLCLSWSLFPLGT--HQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYI 60
MG +L+LL C W +F +G+ QLQSSQ QVLLQL+KHLEYP QLEIW + + C+I
Sbjct: 1 MGFYDLVLLFCYVWYVFYVGSCIAQLQSSQIQVLLQLQKHLEYPTQLEIWKDRRTELCFI 60
Query: 61 SSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSL 120
S TQV ++C+DNF+ EL I GDKP+ FDGFA N +LS++FS+DSFV TLARLTSL
Sbjct: 61 PS-TQVKVSCKDNFVIELSIFGDKPNKGRGFDGFAIPNQTLSQSFSMDSFVATLARLTSL 119
Query: 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNN 180
RVL LVSLGIWG PD+IHRL+SLE LDLSSN+L+GS+PPKISTMV LQ L+L DNFFN
Sbjct: 120 RVLHLVSLGIWGPFPDRIHRLFSLEQLDLSSNYLYGSIPPKISTMVSLQILMLGDNFFNG 179
Query: 181 TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLN 240
TIPN FDS +LT S++NNKL GPFP SI I+TL+++D+S+N ISGSL D + L SL
Sbjct: 180 TIPNLFDSSSNLTVFSLKNNKLKGPFPFSILSITTLTNIDMSRNQISGSLQDFTGLSSLE 239
Query: 241 VLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPP 300
L+L +N+LDS+LP LP+GL+ FL+ NSFSG+IPK YGQLN LQ LD+SFN L G P
Sbjct: 240 HLDLRENELDSDLPALPKGLISLFLNRNSFSGQIPKSYGQLNSLQHLDISFNTLTGATPS 299
Query: 301 AIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVK 360
+FSLPNI LNL SN SG+L +L CG L F DISNN+L G LP LSN S+ R V+
Sbjct: 300 ELFSLPNIIYLNLGSNMLSGTLQNSLRCGRNLSFVDISNNRLIGALPYSLSNVSENRAVE 359
Query: 361 FRGNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCR 420
GNCLS +Q+QH SYC E ++ S VG VG+IVG+LVI+VL +V+C+
Sbjct: 360 SDGNCLSGTLQHQHAVSYCAEAPDKKK---SNRVGIFVGVIVGILVIIVLFGLCIVVICK 416
Query: 421 RYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKE 480
RY R +EQHLLHKSVQD+ + GFS E++ NARYVSEAAKLG E LP+CRS++LEEL E
Sbjct: 417 RYYSRGIAEQHLLHKSVQDSYSAGFSCELIANARYVSEAAKLGREDLPSCRSYSLEELME 476
Query: 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
ATNNFD S +GE YGKLYKG+LENG V IRC+P SKKY++RN KLRLDLLAKLRH H
Sbjct: 477 ATNNFDNSTFLGENIYGKLYKGKLENGIPVVIRCIPLSKKYSIRNFKLRLDLLAKLRHTH 536
Query: 541 LVCLLGHCIDG--GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
L+ LLGHCIDG G R+D +KVFL+YE +SNGNF+T++S ++ GK+ NWSERL+VLI
Sbjct: 537 LISLLGHCIDGILGERND---SKVFLIYECVSNGNFQTYLSGDSCGKIFNWSERLSVLIS 593
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGV 651
VAKA+ FLHTG+IPGFF NR+KTNNIL NE+ +AKLSDYGLSIVSE+ ++ GV
Sbjct: 594 VAKAIHFLHTGMIPGFFRNRLKTNNILFNENWMAKLSDYGLSIVSEETDASGV 646
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441678|ref|XP_004138609.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At3g03770-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/643 (58%), Positives = 486/643 (75%)
Query: 3 MGQGNLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISS 62
MG L++ LSW LF THQLQ+SQTQ+LLQ+RKHLE+P LE+ D C +S
Sbjct: 1 MGSLRFFLIISLSWILFLPFTHQLQTSQTQILLQIRKHLEFPSSLEVMDAFDGDLCNVSP 60
Query: 63 STQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRV 122
S + I CQDN +TEL I GDKP + F+G N +LSE FS+DSFVTTL+RL+SLRV
Sbjct: 61 SRNMTIACQDNVVTELIIKGDKPFDFKGFNGLPILNQTLSERFSMDSFVTTLSRLSSLRV 120
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
L L+SLGIWG LPDKIHRL SLE+LDLSSN+++G +PPKISTMV+L +L+LD NFFN+T+
Sbjct: 121 LGLISLGIWGQLPDKIHRLSSLEFLDLSSNYIYGQIPPKISTMVQLYSLVLDANFFNDTV 180
Query: 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVL 242
P+W DSL +LTFLS+++N+L G FPSS+ +I TL+D+ LS N ISG LPDLS+L +L+VL
Sbjct: 181 PDWIDSLTNLTFLSLKSNRLKGQFPSSLCKIRTLADVYLSHNEISGELPDLSALANLHVL 240
Query: 243 NLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
++ +NKL+S LP +P+GLV LS N+ SGEIPK +GQ++QLQ LD+S N L G PPP +
Sbjct: 241 DIRENKLNSVLPVMPKGLVTLLLSKNALSGEIPKHFGQMDQLQHLDLSSNRLTGSPPPFL 300
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362
F+LPNI+ LNL+SN SG+L L+C KL DIS+NKLTG LPSCL + SDKR+VKF
Sbjct: 301 FNLPNITYLNLSSNLMSGTLQNPLSCSAKLGDVDISDNKLTGTLPSCLGSSSDKRMVKFS 360
Query: 363 GNCLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRY 422
GNC ++N+Q+QH S C E ++ K +V I G ++++VLLA G + RR
Sbjct: 361 GNCFATNLQHQHEASLCAESLAGTGESRRKEKLLIVAFISGAIIVIVLLALGVFFLYRRL 420
Query: 423 CPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEAT 482
C R EQ + K VQ++S SE+L NAR +S+A KLG++ +P CRSF+ +EL+EAT
Sbjct: 421 CKRTVQEQPVPPKVVQESSPATVPSELLANARLISQAMKLGAQTVPVCRSFSFQELREAT 480
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
NFD S ++GEGS GKLY+G+LENGT VAIRCL SKKY+V+NLK+RLD+L+KL HPHLV
Sbjct: 481 KNFDKSMLLGEGSIGKLYRGKLENGTLVAIRCLVLSKKYSVQNLKVRLDVLSKLHHPHLV 540
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L GHC++G G D+ VN+V LVYE++SN N+RT +SE P KVL WS+RL +LIGVAKA
Sbjct: 541 GLFGHCMEGDGHDNSNVNQVLLVYEYVSNRNYRTLLSETFPEKVLKWSDRLTILIGVAKA 600
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ FLHTGVIPG FNN +KTNNILL+EHRI KLSDYG+SI++E+
Sbjct: 601 IHFLHTGVIPGSFNNGLKTNNILLDEHRIPKLSDYGMSIITEE 643
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | ||||||
| TAIR|locus:2079339 | 802 | AT3G03770 [Arabidopsis thalian | 0.883 | 0.739 | 0.385 | 1.6e-109 | |
| TAIR|locus:2167326 | 680 | AT5G63410 [Arabidopsis thalian | 0.675 | 0.666 | 0.463 | 4.9e-101 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.257 | 0.178 | 0.366 | 1.3e-39 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.295 | 0.207 | 0.314 | 3.1e-39 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.356 | 0.200 | 0.290 | 5e-39 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.250 | 0.179 | 0.367 | 7.8e-39 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.266 | 0.189 | 0.335 | 1.1e-38 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.737 | 0.395 | 0.270 | 1.4e-38 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.549 | 0.295 | 0.271 | 1.6e-38 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.241 | 0.125 | 0.335 | 1.6e-38 |
| TAIR|locus:2079339 AT3G03770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
Identities = 238/618 (38%), Positives = 348/618 (56%)
Query: 41 LEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANAS 100
L YPK L W N+ DFC S + + C ++ +T+L IIGD +++
Sbjct: 41 LYYPKVLNSWNNY-TDFCNSEPSPSLTVVCYEDSVTQLHIIGDNGTHM------------ 87
Query: 101 LSENFSIDSFXXXXXXXXXXXXXXXXXXGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPP 160
L ++FSI+SF G+WG LP KI+RL SLE L++SSNFLFG +P
Sbjct: 88 LPKSFSINSFVTTLVKLPDVKVLTFVSLGLWGWLPQKINRLSSLEILNVSSNFLFGPIPH 147
Query: 161 KISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLD 220
++S++ LQTLILD+N F+ +P+W DSLPSL LS+R N L G PSS+ +S L L
Sbjct: 148 ELSSLATLQTLILDENMFSGELPDWIDSLPSLAVLSLRKNVLNGSLPSSLSSLSGLRVLA 207
Query: 221 LSKNAIXXXXXXXXXXXXXXXXXXXXXXXXXXXPKLPRGLVMAFLSNNSFSGEIP-KQYG 279
L+ N P+L LV LS N F + ++
Sbjct: 208 LANNRFNGALPDLSHLTNLQVLDLEGNSFGPLFPRLSNKLVTLILSKNKFRSAVSAEEVS 267
Query: 280 QLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISN 339
L QLQ LD+S+N G P ++ SLP I+ LN++ NK +G L NL+C +L+F D+S+
Sbjct: 268 SLYQLQHLDLSYNTFVGPFPTSLMSLPAITYLNISHNKLTGRLSANLSCNSQLMFVDMSS 327
Query: 340 NKLTGGLPSCLSNESD-KRVVKFRGNCLSSNVQNQHPESYCFE------VRTERNQAGSK 392
N LTG LP+CL S R V + NCL++ ++Q P S+C + +R SK
Sbjct: 328 NLLTGSLPTCLKPSSGTSRDVVYASNCLATTNEDQRPVSFCSNEALAVGILPQRRNKVSK 387
Query: 393 NXXXXXXXXXXXXXXXXXXAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTN 452
A VV RR + T + + +++N++ G++S++L++
Sbjct: 388 VGIALGVTASILGVLLLAGAL--FVVLRRLNAKKTVTKSS-PRLIRENASMGYTSKLLSD 444
Query: 453 ARYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAI 512
ARY+S+ KLG GLPA R+F+LEEL+ ATNNF+ SA MGEGS G++Y+GRL++G+ VAI
Sbjct: 445 ARYISQTMKLGGLGLPAYRTFSLEELEYATNNFESSAFMGEGSQGQIYRGRLKDGSFVAI 504
Query: 513 RCLPSSKKYTVRNXXXXXXXXXXXXHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG 572
RCL K + +N H HLV +LGHC + DD V+++F V+E++ NG
Sbjct: 505 RCLKMKKSCSTQNLMHHIELIAKLRHRHLVSVLGHCFECY-LDDSTVSRMFFVFEYVPNG 563
Query: 573 NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632
RT IS+ G++L W +R++V IGVAK +QFLHTG++PG ++N +K +ILL+ + A
Sbjct: 564 ELRTWISDGHMGRLLTWEQRISVAIGVAKGIQFLHTGIVPGVYDNNLKMTDILLDNNLAA 623
Query: 633 KLSDYGLSIVSEDINSVG 650
KLS Y L ++ E + VG
Sbjct: 624 KLSSYNLPLLVEGLGKVG 641
|
|
| TAIR|locus:2167326 AT5G63410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
Identities = 228/492 (46%), Positives = 296/492 (60%)
Query: 168 LQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAIX 227
+ + L D F + L SL L++ + + G P + R+S+L LDLS N +
Sbjct: 95 ISNVTLSDGFSIESFVTTLSRLKSLRVLTLASLGIWGRLPEKLHRLSSLEYLDLSNNFLF 154
Query: 228 XXXXXXXXXXXXXXXXXXXXXXXXXXPKLPRGLVM-AF-LSNNSFSGEIPKQYGQLNQLQ 285
PKL + + F +N F+G +P + L+
Sbjct: 155 GSVP----------------------PKLSTMVKLETFRFDHNFFNGTLPSWFDSYWYLK 192
Query: 286 QLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGG 345
L N L G ++ SL I ++L +N SGSLP +L CG KL F DIS+NKLTG
Sbjct: 193 VLSFKSNKLSGELHSSLLSLSTIEYIDLRANSLSGSLPDDLKCGSKLWFIDISDNKLTGK 252
Query: 346 LPSCLSNESDKRVVKFRGNCLSSNVQNQHPESYCF-EVRTE-----RNQAGSKNXXXXXX 399
LP CLS++ D ++F GNCLS Q QHPES+C EVR + +A + N
Sbjct: 253 LPRCLSSKQDI-ALRFNGNCLSLEKQ-QHPESFCVKEVRAAAKAEAKAEAEAANESGKRK 310
Query: 400 -XXXXXXXXXXXXAFGFLV-VCRRYC---PRCTSEQHLLHKSVQDNS-ATGFSSEVLTNA 453
+ LV VC + + +++H+ H +VQDN TGFSSE+L+NA
Sbjct: 311 WKKGALIGLIVGISMSVLVLVCCVFILLRRKGVTKKHVHHNTVQDNHPTTGFSSEILSNA 370
Query: 454 RYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGS-YGKLYKGRLENGTSVAI 512
RY+SE +K GSE LP CR F+LEE+ +AT NFD + I+GE S YG LYKG LENGT VAI
Sbjct: 371 RYISETSKFGSEDLPVCRQFSLEEIVKATKNFDKTMILGESSLYGTLYKGNLENGTKVAI 430
Query: 513 RCLPSSKKYTVRNXXXXXXXXXXXXHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG 572
RCLPSSKKY++RN HP+LVCLLGHCID GG+DDY+V KVFL+YE++ NG
Sbjct: 431 RCLPSSKKYSIRNLKLRLDLLAKLRHPNLVCLLGHCIDCGGKDDYSVEKVFLIYEYIPNG 490
Query: 573 NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632
NF++ +S+N+ GK +NWSERL VL GVAKAV FLHTGVIPGFF+NR+KTNN+LLN+HR A
Sbjct: 491 NFQSCLSDNSSGKGMNWSERLNVLTGVAKAVHFLHTGVIPGFFSNRLKTNNVLLNQHRFA 550
Query: 633 KLSDYGLSIVSE 644
KLSDYGLSIVSE
Sbjct: 551 KLSDYGLSIVSE 562
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 282 (104.3 bits), Expect = 1.3e-39, Sum P(2) = 1.3e-39
Identities = 67/183 (36%), Positives = 101/183 (55%)
Query: 463 GSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYT 522
G+ L R F+ EELK+ TNNF +S+ +G G YGK+YKG L++G VAI+
Sbjct: 616 GAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQG 675
Query: 523 VRNXXXXXXXXXXXXHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT 582
H +LV L+G C + G + LVYE+MSNG+ + ++ +
Sbjct: 676 GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ--------ILVYEYMSNGSLKDSLTGRS 727
Query: 583 PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-I 641
G L+W RL V +G A+ + +LH P + VK+ NILL+E+ AK++D+GLS +
Sbjct: 728 -GITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKL 786
Query: 642 VSE 644
VS+
Sbjct: 787 VSD 789
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 271 (100.5 bits), Expect = 3.1e-39, Sum P(2) = 3.1e-39
Identities = 66/210 (31%), Positives = 110/210 (52%)
Query: 431 HLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAI 490
+ L + + ATG ++ A++ + + + + L ++FT EELK+ T+NF +
Sbjct: 580 YALRQKKRAERATGQNNPF---AKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEAND 636
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNXXXXXXXXXXXXHPHLVCLLGHCID 550
+G G YGK+Y+G L NG +AI+ H ++V LLG C D
Sbjct: 637 VGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFD 696
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV 610
N+ LVYE++SNG+ + +S + G L+W+ RL + +G K + +LH
Sbjct: 697 R--------NEQMLVYEYISNGSLKDSLSGKS-GIRLDWTRRLKIALGSGKGLAYLHELA 747
Query: 611 IPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
P + +K+NNILL+E+ AK++D+GLS
Sbjct: 748 DPPIIHRDIKSNNILLDENLTAKVADFGLS 777
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 254 (94.5 bits), Expect = 5.0e-39, Sum P(2) = 5.0e-39
Identities = 74/255 (29%), Positives = 118/255 (46%)
Query: 132 GSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPN----WFD 187
G +P ++ SL LDL SN L G +P KI+ + +LQ L+L N + +IP+ +F
Sbjct: 510 GKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFH 569
Query: 188 SL--PSLTFLS------MRNNKLAGPFPSSIQRISTLSDLDLSKNAIXXXX-XXXXXXXX 238
+ P L+FL + N+L+GP P + L ++ LS N +
Sbjct: 570 QIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTN 629
Query: 239 XXXXXXXXXXXXXXXPK-LPRGLVMAFLS--NNSFSGEIPKQYGQLNQLQQLDMSFNALR 295
PK + L + L+ NN +G IP+ +G L L +L+++ N L
Sbjct: 630 LTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLD 689
Query: 296 GMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESD 355
G P ++ +L ++ ++L+ N SG L L+ KLV I NK TG +PS L N +
Sbjct: 690 GPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQ 749
Query: 356 KRVVKFRGNCLSSNV 370
+ N LS +
Sbjct: 750 LEYLDVSENLLSGEI 764
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 271 (100.5 bits), Expect = 7.8e-39, Sum P(2) = 7.8e-39
Identities = 65/177 (36%), Positives = 95/177 (53%)
Query: 464 SEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTV 523
S + + F+ EL +ATN FD S ++G GSYGK+YKG L N T VAI+ + +
Sbjct: 593 SREIKGVKKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSE 652
Query: 524 RNXXXXXXXXXXXXHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP 583
+ H +LV L+G+ D + + LVYE+M NGN R +S N
Sbjct: 653 KEFLNEIDLLSRLHHRNLVSLIGYSSD--------IGEQMLVYEYMPNGNVRDWLSANA- 703
Query: 584 GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
L++S R V +G AK + +LHT P + +KT+NILL+ AK++D+GLS
Sbjct: 704 ADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLS 760
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 268 (99.4 bits), Expect = 1.1e-38, Sum P(2) = 1.1e-38
Identities = 63/188 (33%), Positives = 97/188 (51%)
Query: 453 ARYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAI 512
A++ + ++ + L ++FT EEL + TNNF + +G G YG++YKG L NG +AI
Sbjct: 602 AKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAI 661
Query: 513 RCLPSSKKYTVRNXXXXXXXXXXXXHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG 572
+ H ++V LLG C D + LVYE++ NG
Sbjct: 662 KRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQ--------KEQMLVYEYIPNG 713
Query: 573 NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632
+ R +S G L+W+ RL + +G K + +LH P + VK+NNILL+EH A
Sbjct: 714 SLRDGLSGKN-GVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTA 772
Query: 633 KLSDYGLS 640
K++D+GLS
Sbjct: 773 KVADFGLS 780
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 425 (154.7 bits), Expect = 1.4e-38, P = 1.4e-38
Identities = 144/532 (27%), Positives = 237/532 (44%)
Query: 129 GIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDS 188
G G +P ++ + +L+ L L N G +P + +L L + N + IP
Sbjct: 587 GFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGL 646
Query: 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAIXXXXXXXXXXXXXXXXXXXXXX 248
LT + + NN L+G P+ + ++ L +L LS N
Sbjct: 647 CKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGN 706
Query: 249 XXXXXPKLPRGLVMAF----LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFS 304
G + A L N SG +P G+L++L +L +S NAL G P I
Sbjct: 707 SLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQ 766
Query: 305 LPNI-SDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRG 363
L ++ S L+L+ N F+G +P ++ KL D+S+N+L G +P + + +
Sbjct: 767 LQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSY 826
Query: 364 NCLSSNVQNQ----HPESY------CFEVRTERNQAGSKNXXXXXXXXXXXXXXXXXXAF 413
N L ++ Q +++ C + N+AGSKN A
Sbjct: 827 NNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAA 886
Query: 414 GFLVVCRRYCPRCTSEQHLLHKSVQD-NSATGFSSEVLTNARYVSEAAKLGSEGLPACRS 472
L+V + H L K V+ NSA FSS N+ S A L S G A
Sbjct: 887 IALMVL--VIILFFKQNHDLFKKVRGGNSA--FSS----NSS--SSQAPLFSNG-GAKSD 935
Query: 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIR-CLPSSKKYTVRNXXXXXX 531
+++ EAT+ + ++G G GK+YK L+NG ++A++ L + ++
Sbjct: 936 IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVK 995
Query: 532 XXXXXXHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT--HISENTPGK-VLN 588
H HLV L+G+C + D +N L+YE+M+NG+ H +ENT K VL
Sbjct: 996 TLGTIRHRHLVKLMGYC---SSKAD-GLN--LLIYEYMANGSVWDWLHANENTKKKEVLG 1049
Query: 589 WSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
W RL + +G+A+ V++LH +P + +K++N+LL+ + A L D+GL+
Sbjct: 1050 WETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLA 1101
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 360 (131.8 bits), Expect = 1.6e-38, Sum P(2) = 1.6e-38
Identities = 110/405 (27%), Positives = 193/405 (47%)
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNI-SDLNLASNKFSGSLP 323
L N FSG +P+ G+L++L +L +S N+L G P I L ++ S L+L+ N F+G +P
Sbjct: 726 LDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIP 785
Query: 324 KNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQNQH---P-ESY- 378
+ KL D+S+N+LTG +P + + + N L ++ Q P +S+
Sbjct: 786 STIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFL 845
Query: 379 -----CFEV--RTERNQAGSKNXXXXXXXXXXXXXXXXXXAFGFLVVCRRYCPRCTSEQH 431
C R R ++ +K A G +++ ++H
Sbjct: 846 GNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILV---IALFFKQRH 902
Query: 432 LLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRS-FTLEELKEATNNFDMSAI 490
K V S SS + A + L G A +S E++ EAT+N +
Sbjct: 903 DFFKKVGHGSTAYTSSSSSSQATH----KPLFRNG--ASKSDIRWEDIMEATHNLSEEFM 956
Query: 491 MGEGSYGKLYKGRLENGTSVAIR-CLPSSKKYTVRNXXXXXXXXXXXXHPHLVCLLGHCI 549
+G G GK+YK LENG +VA++ L + ++ H HLV L+G+C
Sbjct: 957 IGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYC- 1015
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-----GKVLNWSERLAVLIGVAKAVQ 604
+ + +N L+YE+M NG+ + E+ P K+L+W RL + +G+A+ V+
Sbjct: 1016 --SSKSE-GLN--LLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVE 1070
Query: 605 FLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-IVSEDINS 648
+LH +P + +K++N+LL+ + A L D+GL+ +++E+ ++
Sbjct: 1071 YLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 256 (95.2 bits), Expect = 1.6e-38, Sum P(2) = 1.6e-38
Identities = 58/173 (33%), Positives = 94/173 (54%)
Query: 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTV-RNXXXXXXX 532
T +++ +AT NF I+G+G +G +YK L G VAI+ L ++ R
Sbjct: 991 TADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMET 1050
Query: 533 XXXXXHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG-KVLNWSE 591
HP+LV LLG+C+ G R FL+YE+M NG+ + + L W +
Sbjct: 1051 IGKVKHPNLVPLLGYCVCGDER--------FLIYEYMENGSLEMWLRNRADALEALGWPD 1102
Query: 592 RLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-IVS 643
RL + +G A+ + FLH G +P + +K++NILL+E+ ++SD+GL+ I+S
Sbjct: 1103 RLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIIS 1155
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XV000279 | hypothetical protein (737 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 671 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-29 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-20 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-18 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-09 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-05 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 8e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-04 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.001 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 0.001 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.001 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.002 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 0.002 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.002 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 0.002 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.002 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 0.003 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.003 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.003 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.003 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.004 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.004 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-33
Identities = 142/528 (26%), Positives = 225/528 (42%), Gaps = 76/528 (14%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L + +L VL L + + G +P+ + +L L L SN L G +P + L+ + L
Sbjct: 352 LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
DN F+ +P+ F LP + FL + NN L G S + +L L L++N G LPD
Sbjct: 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471
Query: 234 SSLGSLNVLNLSDNKLDSNLPKLPRGL--VMAF-LSNNSFSGEIPKQYGQLNQLQQLDMS 290
L L+LS N+ +P+ L +M LS N SGEIP + +L LD+S
Sbjct: 472 FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531
Query: 291 FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCL 350
N L G P + +P +S L+L+ N+ SG +PKNL LV +IS+N L G LPS
Sbjct: 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591
Query: 351 S----NESDKRVVKFRGN---CLSSNVQNQHPESYCFEVRTERNQAGSKNVGKLVGIIVG 403
+ N S GN C P C VR + + + +G
Sbjct: 592 AFLAINAS-----AVAGNIDLCGGDTTSGLPP---CKRVRK------TPSWWFYITCTLG 637
Query: 404 VLVIMVLLAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATG----FSSEVLTNARYVSEA 459
+++ L+AFGF+ + R +L K V++ T F S+V
Sbjct: 638 AFLVLALVAFGFVFIRGR--------NNLELKRVENEDGTWELQFFDSKVS--------- 680
Query: 460 AKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK 519
+S T+ ++ + ++ G G YKG+ + +
Sbjct: 681 -----------KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV--VKEIN 724
Query: 520 KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHIS 579
D + KL+HP++V L+G C G +L++E++ N +S
Sbjct: 725 DVNSIPSSEIAD-MGKLQHPNIVKLIGLCRSEKG--------AYLIHEYIEGKN----LS 771
Query: 580 ENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627
E L+W R + IG+AKA++FLH P + I+++
Sbjct: 772 EVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-33
Identities = 92/267 (34%), Positives = 139/267 (52%), Gaps = 6/267 (2%)
Query: 92 DGFASANASLSENFSIDSFVTTLAR--LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDL 149
D F ++++ N S ++F ++ R + +L L L + + G +P+ I SL+ LDL
Sbjct: 112 DIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171
Query: 150 SSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSS 209
N L G +P ++ + L+ L L N IP + SL ++ + N L+G P
Sbjct: 172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231
Query: 210 IQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKLP---RGLVMAFL 265
I +++L+ LDL N ++G +P L +L +L L L NKL +P + L+ L
Sbjct: 232 IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291
Query: 266 SNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKN 325
S+NS SGEIP+ QL L+ L + N G P A+ SLP + L L SNKFSG +PKN
Sbjct: 292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
Query: 326 LNCGGKLVFFDISNNKLTGGLPSCLSN 352
L L D+S N LTG +P L +
Sbjct: 352 LGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 96/272 (35%), Positives = 142/272 (52%), Gaps = 8/272 (2%)
Query: 82 GDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRL 141
G+ P+++G+F + L N + +L LTSL L+L S + G +P ++ ++
Sbjct: 154 GEIPNDIGSFSSLKVLD--LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 142 YSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNK 201
SL+++ L N L G +P +I + L L L N IP+ +L +L +L + NK
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271
Query: 202 LAGPFPSSIQRISTLSDLDLSKNAISGSLPDL-SSLGSLNVLNLSDNKLDSNLP----KL 256
L+GP P SI + L LDLS N++SG +P+L L +L +L+L N +P L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 257 PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
PR V+ SN FSGEIPK G+ N L LD+S N L G P + S N+ L L SN
Sbjct: 332 PRLQVLQLWSNK-FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 317 KFSGSLPKNLNCGGKLVFFDISNNKLTGGLPS 348
G +PK+L L + +N +G LPS
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-30
Identities = 90/268 (33%), Positives = 137/268 (51%), Gaps = 27/268 (10%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
++L L +L+ L L + G +P I L L LDLS N L G +P + + L+ L
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
L N F IP SLP L L + +NK +G P ++ + + L+ LDLS N ++G +P
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
Query: 232 D-LSSLGSLNVLNLSDNKLDSNLPK---LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQL 287
+ L S G+L L L N L+ +PK R L L +NSFSGE+P ++ +L + L
Sbjct: 374 EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433
Query: 288 DMSFNALRG--------MPP---------------PAIFSLPNISDLNLASNKFSGSLPK 324
D+S N L+G MP P F + +L+L+ N+FSG++P+
Sbjct: 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPR 493
Query: 325 NLNCGGKLVFFDISNNKLTGGLPSCLSN 352
L +L+ +S NKL+G +P LS+
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPDELSS 521
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 7e-29
Identities = 84/241 (34%), Positives = 129/241 (53%), Gaps = 10/241 (4%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMV-KLQT 170
+R+ S+ L I G + I RL ++ ++LS+N L G +P I T L+
Sbjct: 66 NNSSRVVSI---DLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L L +N F +IP S+P+L L + NN L+G P+ I S+L LDL N + G +
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 231 P-DLSSLGSLNVLNLSDNKLDSNLPK---LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ 286
P L++L SL L L+ N+L +P+ + L +L N+ SGEIP + G L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGL 346
LD+ +N L G P ++ +L N+ L L NK SG +P ++ KL+ D+S+N L+G +
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 347 P 347
P
Sbjct: 301 P 301
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 9e-22
Identities = 49/162 (30%), Positives = 83/162 (51%), Gaps = 20/162 (12%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHCI 549
GEG +G +Y R + G VAI+ + ++ LR +++L KL HP++V L G
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH-T 608
D N ++LV E+ G+ + + EN L+ E L +L+ + + +++LH
Sbjct: 62 DE--------NHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSN 111
Query: 609 GVIPGFFNNR-VKTNNILLNE-HRIAKLSDYGLSIVSEDINS 648
G+I +R +K NILL+ + KL+D+GLS + S
Sbjct: 112 GII-----HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 32/165 (19%)
Query: 492 GEGSYGKLYKGRLENG----TSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLG 546
GEG++G++YKG+L+ T VA++ L R L+ ++ KL HP++V LLG
Sbjct: 4 GEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP------GKVLNWSERLAVLIGVA 600
C + ++LV E+M G+ ++ ++ P L+ + L+ I +A
Sbjct: 64 VCTEEE--------PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 601 KAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
K +++L + + N L+ E + K+SD+GLS
Sbjct: 116 KGMEYLA--------SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 22/157 (14%)
Query: 492 GEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLL 545
GEG++G++YKG L VA++ L LR ++ KL HP++V LL
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
G C + + +V E+M G+ ++ +N P K L+ S+ L+ + +A+ +++
Sbjct: 68 GVCTEEEP--------LMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEY 118
Query: 606 LHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
L + I +R + N L+ E+ + K+SD+GLS
Sbjct: 119 LESKNFI-----HRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 24/155 (15%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHCI 549
GEGS+GK+Y R + G VAI+ + K R LR + +L KL+HP++V L
Sbjct: 8 GEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFE 67
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG--VAKAVQFLH 607
D +K++LV E+ G+ + + SE A + A+++LH
Sbjct: 68 DE--------DKLYLVMEYCEGGDLFDLLKKRGR-----LSEDEARFYLRQILSALEYLH 114
Query: 608 T-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ G++ +R +K NILL+E KL+D+GL+
Sbjct: 115 SKGIV-----HRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 23/157 (14%)
Query: 492 GEGSYGKLYKGRLE-----NGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLL 545
GEG++G++YKG+L+ VA++ L LR ++ KL HP++V LL
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
G C + +++V E+M G+ +++ +N L+ S+ L+ + +A+ +++
Sbjct: 68 GVCTEEE--------PLYIVMEYMEGGDLLSYLRKN--RPKLSLSDLLSFALQIARGMEY 117
Query: 606 LHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
L + I +R + N L+ E+ + K+SD+GLS
Sbjct: 118 LESKNFI-----HRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 43/160 (26%), Positives = 81/160 (50%), Gaps = 27/160 (16%)
Query: 492 GEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLK--LR-LDLLAKLRHPHLVC 543
GEG++G++YKG L T VA++ L + + + L ++ KL HP++V
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLK--EGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
LLG C G +++V E+M G+ + ++ G+ L + L + + +AK +
Sbjct: 66 LLGVCTQGE--------PLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGM 115
Query: 604 QFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSI 641
++L + + +R + N L+ E+ + K+SD+GLS
Sbjct: 116 EYLESKNFV-----HRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 21/156 (13%)
Query: 490 IMGEGSYGKLYKGRLEN-GTSVAIRCLP-SSKKYTVRNLKLR-LDLLAKLRHPHLVCLLG 546
+G GS+G +YK + + G VA++ L S+K R + +L +L HP++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL 606
D + ++LV E+ G+ ++S P L+ E + + + + +++L
Sbjct: 66 AFEDK--------DHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYL 114
Query: 607 HT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
H+ G+I +R +K NILL+E+ + K++D+GL+
Sbjct: 115 HSNGII-----HRDLKPENILLDENGVVKIADFGLA 145
|
Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 49/177 (27%), Positives = 88/177 (49%), Gaps = 33/177 (18%)
Query: 491 MGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRN-LKLRLDLLAKLRHPHLVC 543
+GEG++GK+YKG L + TSVAI+ L + + V+ + +L++ L+HP++VC
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWS 590
LLG C +++E++++G+ + N+P L+ S
Sbjct: 73 LLGVCTKE--------QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 591 ERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS--IVSED 645
+ L + I +A +++L + F + + N L+ E K+SD+GLS I S D
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 39/159 (24%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ A +G+G +G + G G VA++CL + ++ LRHP+LV
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLV 63
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGK-VLNWSERLAVLIGVAK 601
LLG + G +++V E+M+ G+ ++ + G+ V+ +++L + V +
Sbjct: 64 QLLGVVLQGNP--------LYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCE 113
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+++L F + + N+L++E +AK+SD+GL+
Sbjct: 114 GMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
G+G +G++YK R G VAI+ + K + + +L K +HP++V G +
Sbjct: 9 GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK 68
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-G 609
++++V EF S G+ + + ++T L S+ V + K +++LH+ G
Sbjct: 69 KD--------ELWIVMEFCSGGSLKD-LLKSTNQT-LTESQIAYVCKELLKGLEYLHSNG 118
Query: 610 VIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSI 641
+I +R +K NILL KL D+GLS
Sbjct: 119 II-----HRDIKAANILLTSDGEVKLIDFGLSA 146
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVC 543
FD+ +GEGSYG +YK E G VAI+ +P + ++ + + +L + P++V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
G +++V E+ G+ + K L E A+L K +
Sbjct: 63 YYGSYFKN--------TDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGL 112
Query: 604 QFLHTGVIPGFFNNR-----VKTNNILLNEHRIAKLSDYGLS 640
++LH +N+ +K NILLNE AKL+D+G+S
Sbjct: 113 EYLH--------SNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 54/181 (29%), Positives = 91/181 (50%), Gaps = 37/181 (20%)
Query: 484 NFDMSAIMGEGSYGKLYKG-RLENGTSVAIRCLPSSKKYT--VRNLKLRLDLLAKLRHPH 540
N+ + ++G G++G +YKG LE G VAI+ + K ++++ +DLL L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA------ 594
+V +G + ++++ E+ NG+ R I + P + E L
Sbjct: 61 IVKYIGSIETS--------DSLYIILEYAENGSLRQIIKKFGP-----FPESLVAVYVYQ 107
Query: 595 VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYG----LSIVSEDINS 648
VL G+A +LH GVI +R +K NIL + + KL+D+G L+ VS+D S
Sbjct: 108 VLQGLA----YLHEQGVI-----HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158
Query: 649 V 649
V
Sbjct: 159 V 159
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 42/168 (25%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 485 FDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCL 544
F + +G G +G++++G +N VAI+ L S ++ + + L +LRH HL+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-GKVLNWSERLAVLIGVAKAV 603
C G V+++ E M G+ +P G+VL + + + VA+ +
Sbjct: 68 FAVCSVG--------EPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 604 QFLHTGVIPGFFNNRVKTN----NILLNEHRIAKLSDYGLS-IVSEDI 646
+L N + + NIL+ E + K++D+GL+ ++ ED+
Sbjct: 118 AYLEE-------QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 30/88 (34%), Positives = 52/88 (59%)
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
L L + G+ G +P+ I +L L+ ++LS N + G++PP + ++ L+ L L N FN +I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSI 210
P L SL L++ N L+G P+++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 34/176 (19%)
Query: 487 MSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSKKYTVRNLKLRLDLLA------KL 536
+ ++G G +G++ +GRL + VAI+ L + + K RLD L +
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSD---KQRLDFLTEASIMGQF 62
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNK---VFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
HP+++ L G V K V ++ E+M NG+ + EN GK + +
Sbjct: 63 DHPNIIRLEG-----------VVTKSRPVMIITEYMENGSLDKFLREND-GK-FTVGQLV 109
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSV 649
+L G+A +++L + + + NIL+N + + K+SD+GLS ED +
Sbjct: 110 GMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 31/185 (16%)
Query: 491 MGEGSYGKLYKGRLEN------GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCL 544
+GEG++GK++ N VA++ L + + ++ + +LL L+H H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGN----FRTH--------ISENTPGKVLNWSER 592
G C +G + +V+E+M +G+ R+H E+ L +
Sbjct: 73 YGVCTEG--------RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 593 LAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS--IVSEDINSVG 650
LA+ +A + +L + F + + T N L+ + + K+ D+G+S I S D VG
Sbjct: 125 LAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 651 VRLLI 655
R ++
Sbjct: 182 GRTML 186
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 42/186 (22%), Positives = 81/186 (43%), Gaps = 43/186 (23%)
Query: 491 MGEGSYGKLYKGRLENG------TSVAIRCLPSSKKYTVRNLKL----RLDLLAKLRHPH 540
+GEG++GK++ G + VA++ L K+ + + +LL +H +
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL---KETASNDARKDFEREAELLTNFQHEN 69
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN----FRTH-------ISENTPGKVLNW 589
+V G C +G +V+E+M +G+ R+H S ++P L
Sbjct: 70 IVKFYGVCTEGD--------PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 590 SERLAVLIGVAKAVQFL---HTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS--IVSE 644
S+ L + + +A + +L H F + + T N L+ + K+ D+G+S + +
Sbjct: 122 SQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175
Query: 645 DINSVG 650
D VG
Sbjct: 176 DYYRVG 181
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 41/129 (31%), Positives = 63/129 (48%), Gaps = 25/129 (19%)
Query: 178 FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLG 237
F++T WF + L + N L G P+ I ++ L ++LS N+I G++P SLG
Sbjct: 411 FDSTKGKWF-----IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP--PSLG 463
Query: 238 SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM 297
S+ L + D LS NSF+G IP+ GQL L+ L+++ N+L G
Sbjct: 464 SITSLEVLD------------------LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 298 PPPAIFSLP 306
P A+
Sbjct: 506 VPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 41/183 (22%), Positives = 88/183 (48%), Gaps = 31/183 (16%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRC--LPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG 546
++G GS+G +Y + G +A++ L + + L+ + +L+ L+HP++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA------VLIGVA 600
D + +N +FL E++S G+ + + + GK+ E + +L G+
Sbjct: 67 SERD---EEKNTLN-IFL--EYVSGGSLSSLLKKF--GKL---PEPVIRKYTRQILEGL- 114
Query: 601 KAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLILMS 658
+LH+ G++ +R +K NIL++ + KL+D+G + DI + + +
Sbjct: 115 ---AYLHSNGIV-----HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 659 FFF 661
++
Sbjct: 167 PYW 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 44/186 (23%), Positives = 85/186 (45%), Gaps = 29/186 (15%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLEN------GTSVAIRCLPSSKKYTVRNLKLRLDLLAKL 536
+N + +GEG++GK++ N VA++ L + ++ +LL L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN----FRTH------ISENTPGKV 586
+H H+V G C++G + + +V+E+M +G+ R H ++E
Sbjct: 65 QHEHIVKFYGVCVEG--------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116
Query: 587 LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS--IVSE 644
L S+ L + +A + +L + F + + T N L+ E+ + K+ D+G+S + S
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173
Query: 645 DINSVG 650
D VG
Sbjct: 174 DYYRVG 179
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 38/157 (24%), Positives = 73/157 (46%), Gaps = 14/157 (8%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
+G G +G++++G N T VA++ L L ++ KLRHP L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA-EAQIMKKLRHPKLIQLYAVCTL 72
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV 610
+++V E M G+ ++ G+ L + + + VA + +L
Sbjct: 73 E--------EPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA-- 121
Query: 611 IPGFFNNRVKTNNILLNEHRIAKLSDYGLS-IVSEDI 646
+ + + N+L+ E+ I K++D+GL+ ++ EDI
Sbjct: 122 -QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 6/116 (5%)
Query: 136 DKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195
D + ++ L L + L G +P IS + LQ++ L N IP S+ SL L
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471
Query: 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSL----NVLNLSDN 247
+ N G P S+ ++++L L+L+ N++SG +P ++LG N +DN
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP--AALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (143), Expect = 2e-09
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 43/165 (26%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLK-------LR-LDLLAKLRHPHLV 542
GEG+YG +YK R + G VA+ KK + N + LR + LL +L+HP++V
Sbjct: 8 GEGTYGVVYKARDKKTGEIVAL------KKIRLDNEEEGIPSTALREISLLKELKHPNIV 61
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VLIGVA 600
LL + K++LV+E+ + + ++ + N + + +L G+A
Sbjct: 62 KLLDVI--------HTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 601 KAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ H+ +R+ K NIL+N + KL+D+GL+
Sbjct: 113 ----YCHS--------HRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 34/161 (21%)
Query: 492 GEGSYGKLYKGRLEN-GTSVAIRCLPSSKKYTVRN-----LKLRLDLLAKLRHPHLVCLL 545
G+GS+GK+ R ++ G A++ L KK ++ ++L+++ HP +V L
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVL--KKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 546 GHCIDGGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG--VA 600
YA K++LV E+ G +H+S K +SE A +
Sbjct: 60 -----------YAFQTEEKLYLVLEYAPGGELFSHLS-----KEGRFSEERARFYAAEIV 103
Query: 601 KAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
A+++LH+ G+I +K NILL+ KL+D+GL+
Sbjct: 104 LALEYLHSLGIIYRD----LKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 38/166 (22%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 491 MGEGSYGKLYKGRLEN-----GTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHLVCL 544
+GEG +GK+ R + G VA++ L S ++ + + +++L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP----GKVLNWSERLAVLIGVA 600
G C GGR + L+ E++ +G+ R ++ + ++L +S + +
Sbjct: 72 KGVCEKPGGRS------LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------IC 119
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-IVSED 645
K + +L + + + + NIL+ + K+SD+GL+ ++ ED
Sbjct: 120 KGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 27/175 (15%)
Query: 478 LKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL 536
L + T F++ ++GEG+YGK+YK R + G VAI+ + + +K ++L K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKY 59
Query: 537 -RHPHLVCLLGHCI--DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT--PGKVLNWSE 591
HP++ G I + G DD +++LV E G+ T + + GK L E
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDD----QLWLVMELCGGGSV-TDLVKGLRKKGKRLK-EE 113
Query: 592 RLAVLI-GVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+A ++ + + +LH N+V K NILL ++ KL D+G+S
Sbjct: 114 WIAYILRETLRGLAYLH--------ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 59.0 bits (141), Expect = 4e-09
Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 20/171 (11%)
Query: 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLD---LLAKLRHPH 540
++ + +GEGS+G++Y R VA++ L + + ++ L +LA L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 541 LVC-LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
+ L D ++LV E++ G+ + + L+ SE L +L +
Sbjct: 59 NIVKLYDFFQDE--------GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110
Query: 600 AKAVQFLHT-GVIPGFFNNRVKTNNILLNEH-RIAKLSDYGLSIVSEDINS 648
A+++LH+ G+I +K NILL+ R+ KL D+GL+ + D S
Sbjct: 111 LSALEYLHSKGIIHRD----IKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
|
Length = 384 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 33/163 (20%)
Query: 489 AIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKY------TVRNLKLRLDLLAKLRHPHL 541
A +GEG+YG++YK R + G VA++ + + +R +KL L KLRHP++
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKL----LQKLRHPNI 60
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMS---NGNFRTHISENTPGKVLNWSERLAVLIG 598
V L +++V+E+M G + + T ++ + ++L
Sbjct: 61 VRLKEIVTS------KGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---- 110
Query: 599 VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGL 639
+ +Q+LH+ G++ +R +K +NIL+N + KL+D+GL
Sbjct: 111 --EGLQYLHSNGIL-----HRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 21/154 (13%)
Query: 491 MGEGSYGKLYKGR-LENGTSVAI-RCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGH 547
+GEG+YG +YK R G VAI + + + LR + LL +L HP+++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL--AVLIGVAKAVQF 605
G ++LV+EFM T + + + E L + L + + + F
Sbjct: 67 FRHKG--------DLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113
Query: 606 LHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
H+ G + +K N+L+N + KL+D+GL
Sbjct: 114 CHSH---GILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 43/192 (22%)
Query: 491 MGEGSYGKLYKGRL-----ENGTSVAIRCLP---SSKKYTVRNLKLRLDLLAKLRHPHLV 542
+GE ++GK+YKG L ++ VAI+ L + +++ + L+A+L HP++V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG--EFQQEASLMAELHHPNIV 70
Query: 543 CLLGHCIDGGGRDDYAVNK---VFLVYEFMSNGNFRTHISENTP-----------GKV-- 586
CLLG V + V +++E+++ G+ + +P G V
Sbjct: 71 CLLG-----------VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 587 -LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS--IVS 643
L+ + L + I +A +++L + F + + NIL+ E K+SD GLS I S
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 644 EDINSVGVRLLI 655
D V + L+
Sbjct: 177 ADYYRVQPKSLL 188
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 34/172 (19%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRC---------LPSSKKYTVRNLKLRLDLLA 534
++ A +GEG+YG +YK R L G VA++ +P S T+R + L L L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIAL-LKQLE 56
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
HP++V LL C G K+ LV+E + + T++S P L E +
Sbjct: 57 SFEHPNIVRLLDVCH---GPRTDRELKLTLVFEHVDQ-DLATYLS-KCPKPGLP-PETIK 110
Query: 595 VLIG-VAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
L+ + + V FLH+ +R+ K NIL+ K++D+GL+
Sbjct: 111 DLMRQLLRGVDFLHS--------HRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 45/168 (26%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSS------KKYTVRNLKLRLDLLAKLRHPHLVCL 544
G+GS+GK+Y R +G ++ + S ++ + +K+ L KL HP+++
Sbjct: 9 GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKI----LKKLNHPNIIKY 64
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISE-NTPGK------VLNWSERLAVLI 597
+ G K+ +V E+ G+ I + GK +L+W +
Sbjct: 65 YESFEEKG--------KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FV 110
Query: 598 GVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ A+++LH+ ++ K NI L + + KL D+G+S
Sbjct: 111 QLCLALKYLHS--------RKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 6/89 (6%)
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK 324
L N G IP +L LQ +++S N++RG PP++ S+ ++ L+L+ N F+GS+P+
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 325 NLNCGGKLVFFDISN---NKLTGGLPSCL 350
+L G+L I N N L+G +P+ L
Sbjct: 485 SL---GQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 21/163 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAI-RCLPSSKKYTVRNLKLR-LDLLAKLRHP 539
++ ++GEGSYG + K + E G VAI + L S V+ + +R + +L +LRH
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHIS--ENTPGKVLNWSERLAVLI 597
+LV L+ +++LV+EF+ + T + E P L+ S L
Sbjct: 61 NLVNLIEVF--------RRKKRLYLVFEFVDH----TVLDDLEKYPNG-LDESRVRKYLF 107
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + ++F H+ I + +K NIL+++ + KL D+G +
Sbjct: 108 QILRGIEFCHSHNI---IHRDIKPENILVSQSGVVKLCDFGFA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 37/158 (23%), Positives = 72/158 (45%), Gaps = 23/158 (14%)
Query: 490 IMGEGSYGK--LYKGRLENGTSVAIR-----CLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
++G+G++G+ LY+ R E+ + V + L ++ N + +L+ L+HP+++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQHPNII 62
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
H +D N + + E+ + G I G++ L L + A
Sbjct: 63 AYYNHFMDD--------NTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSA 113
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
V ++H G + +KT NI L + + KL D+G+S
Sbjct: 114 VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 27/169 (15%)
Query: 484 NFDMSAIMGEGSYGKLYK-GRLENGTSVAIRCLPSSKKYTVRNL--KLRLD------LLA 534
+F + +G+GSYG +YK RL + A+ K+ + ++ K R D +LA
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYAL------KEVDLGSMSQKEREDAVNEIRILA 54
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-GKVLNWSERL 593
+ HP+++ +DG NK+ +V E+ G+ IS+ K++ E
Sbjct: 55 SVNHPNIISYKEAFLDG--------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW 106
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642
+ I + + +Q LH I + +K+ NILL + + K+ D G+S V
Sbjct: 107 RIFIQLLRGLQALHEQKI---LHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 43/172 (25%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKY-------TVRNLKLR-LDLL 533
N +++ ++GEG+YG + K R G VAI KK+ V+ LR + +L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAI------KKFKESEDDEDVKKTALREVKVL 54
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG------KVL 587
+LRH ++V L G +++LV+E++ + + G +
Sbjct: 55 RQLRHENIVNLKEAFRRKG--------RLYLVFEYVER-TLLELLEASPGGLPPDAVRSY 105
Query: 588 NWSERLAVLIGVAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638
W + +A+ + H+ +I + +K NIL++E + KL D+G
Sbjct: 106 IWQ--------LLQAIAYCHSHNII----HRDIKPENILVSESGVLKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 44/163 (26%), Positives = 70/163 (42%), Gaps = 31/163 (19%)
Query: 213 ISTLSDLDLSKNAISGSL-PDLSSLGSLNVLNLSDNKLDSNLP----KLPRGLVMAFLSN 267
S + +DLS ISG + + L + +NLS+N+L +P L LSN
Sbjct: 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 268 NSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327
N+F+G IP RG S+PN+ L+L++N SG +P ++
Sbjct: 128 NNFTGSIP-------------------RG-------SIPNLETLDLSNNMLSGEIPNDIG 161
Query: 328 CGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370
L D+ N L G +P+ L+N + + N L +
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 39/152 (25%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 490 IMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
+G+G +G + G G VA++C+ + T + ++ +LRH +LV LLG +
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGK-VLNWSERLAVLIGVAKAVQFLHT 608
+ G +++V E+M+ G+ ++ + G+ VL L + V +A+++L
Sbjct: 70 EEKG-------GLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 609 GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
F + + N+L++E +AK+SD+GL+
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 13/170 (7%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLL 533
L L++ F++ ++G G+YG++YKGR ++ G AI+ + ++ +KL +++L
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINML 66
Query: 534 AKL-RHPHLVCLLGHCIDGG--GRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWS 590
K H ++ G I G DD +++LV EF G+ T + +NT G L
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDD----QLWLVMEFCGAGSV-TDLVKNTKGNALKED 121
Query: 591 ERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + + + LH + + +K N+LL E+ KL D+G+S
Sbjct: 122 WIAYICREILRGLAHLHAHKV---IHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 48/188 (25%)
Query: 468 PACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNL 526
CRS T F+ +GEG+YG +Y+ R +G VA+ KK + N
Sbjct: 1 GRCRSVT---------EFEKLNRIGEGTYGIVYRARDTTSGEIVAL------KKVRMDNE 45
Query: 527 K-------LR-LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG------ 572
+ LR + LL LRHP++V L + G ++ +FLV E+
Sbjct: 46 RDGIPISSLREITLLLNLRHPNIVELK-EVVVGK-----HLDSIFLVMEYCEQDLASLLD 99
Query: 573 NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632
N T SE S+ +++ + + +Q+LH I + +K +N+LL +
Sbjct: 100 NMPTPFSE---------SQVKCLMLQLLRGLQYLHENFI---IHRDLKVSNLLLTDKGCL 147
Query: 633 KLSDYGLS 640
K++D+GL+
Sbjct: 148 KIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 32/181 (17%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLD------LLAKLRHPHLVCL 544
+GEG++GK++ N + + L + K L R D LL L+H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV-------------LNWSE 591
G C DG + + +V+E+M +G+ + + P + L S+
Sbjct: 73 YGVCGDG--------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 592 RLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS--IVSEDINSV 649
L + +A + +L + F + + T N L+ + + K+ D+G+S + S D V
Sbjct: 125 MLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 650 G 650
G
Sbjct: 182 G 182
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
+G G +G+++ G T VA++ L L+ ++ KLRH LV L C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ-EAQIMKKLRHDKLVQLYAVCSE 72
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG----VAKAVQFL 606
+++V E+MS G+ + GK L RL L+ +A+ + +L
Sbjct: 73 E--------EPIYIVTEYMSKGSLLDFLKSGE-GKKL----RLPQLVDMAAQIAEGMAYL 119
Query: 607 HTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ + + + NIL+ E+ + K++D+GL+ + ED
Sbjct: 120 ES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 36/109 (33%), Positives = 60/109 (55%), Gaps = 3/109 (2%)
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLP-NISDLNLASNKFSGSLP 323
LS + SG+I +L +Q +++S N L G P IF+ ++ LNL++N F+GS+P
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
Query: 324 KNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQN 372
+ L D+SNN L+G +P+ + + S +V+ GN L + N
Sbjct: 136 RGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
|
Length = 968 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 33/174 (18%)
Query: 481 ATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLK-------LR-LD 531
++++ +GEG++G++YK R ++ G VA+ KK + N K LR +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVAL------KKILMHNEKDGFPITALREIK 59
Query: 532 LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSN------GNFRTHISENTPGK 585
+L KL+HP++V L+ ++ + V++V +M + N + T +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL---TESQ 116
Query: 586 VLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
+ + +L L G+ +LH + +K NIL++ I K++D+GL
Sbjct: 117 IKCYMLQL--LEGI----NYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/155 (26%), Positives = 84/155 (54%), Gaps = 19/155 (12%)
Query: 491 MGEGSYGKLYKGR-LENGTSVA---IRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLL 545
+GEG+YG +YKGR + G VA IR S++ V + +R + LL +L+HP++VCL
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL--ESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
+ ++++L++EF+S + + ++ G+ ++ + L + + + F
Sbjct: 66 -DVL-------MQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 606 LHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
H+ + + +K N+L++ + KL+D+GL+
Sbjct: 117 CHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 41/176 (23%), Positives = 83/176 (47%), Gaps = 25/176 (14%)
Query: 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHP 539
+F++ ++G+G++GK+ + + A++ + K K +VRN+ +L +L HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
LV L D ++LV + + G+ R H+S+ +SE
Sbjct: 61 FLVNLWYSFQDE--------ENMYLVVDLLLGGDLRYHLSQKVK-----FSEEQVKFWIC 107
Query: 600 --AKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-IVSEDINSVGV 651
A+++LH+ G+I + +K +NILL+E ++D+ ++ V+ D +
Sbjct: 108 EIVLALEYLHSKGII----HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTV----RNLKLRLDLLAKL-R 537
N+ ++GEG++G++ K R++ + K+Y R+ L++L KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNF-----RTHISENTPG-------- 584
HP+++ LLG C G ++L E+ +GN ++ + E P
Sbjct: 67 HPNIINLLGACEHRG--------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS---- 640
L+ + L VA+ + +L F + + NIL+ E+ +AK++D+GLS
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175
Query: 641 -IVSEDINSVGVRLLILMSFFFGSMTSCS 668
V + + + VR + + S + T+ S
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNS 204
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
+G+G +G+++ G T VAI+ L L+ ++ KLRH LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ-EAQIMKKLRHDKLVPL------ 66
Query: 551 GGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
YAV +++V EFM G+ + E GK L + + + +A + ++
Sbjct: 67 ------YAVVSEEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE 119
Query: 608 TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ + ++ NIL+ ++ + K++D+GL+ + ED
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 40/161 (24%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 491 MGEGSYGKL----YKGRLEN-GTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHLVCL 544
+GEG +GK+ Y +N G VA++ L P S + +LK +++L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQ 604
G C + GG N + L+ EF+ +G+ + ++ N +N ++L + + K +
Sbjct: 72 KGICTEDGG------NGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMD 123
Query: 605 FLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+L + + + + N+L+ K+ D+GL+ E
Sbjct: 124 YLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 491 MGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
+G+G++GK+YK + E G A + + + + + + + +++LA HP++V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF- 78
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG 609
Y K++++ EF G + E G L + + + +A+Q+LH+
Sbjct: 79 -------YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHSM 129
Query: 610 VIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
I + +K N+LL KL+D+G+S
Sbjct: 130 KI---IHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 41/177 (23%), Positives = 82/177 (46%), Gaps = 31/177 (17%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRL-----DLLAKL 536
++F I+GEGS+ + + E AI+ L K+ ++ K++ ++L +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 537 -RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
HP ++ L +D+ ++ V E+ NG +I K + E+
Sbjct: 59 NGHPGIIKLYYTF-----QDE---ENLYFVLEYAPNGELLQYIR-----KYGSLDEKCTR 105
Query: 596 LIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ A+++LH+ G+I +R +K NILL++ K++D+G + V + +S
Sbjct: 106 FYAAEILLALEYLHSKGII-----HRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 35/160 (21%), Positives = 80/160 (50%), Gaps = 20/160 (12%)
Query: 490 IMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRL----DLLAKLRHPHLVCLL 545
++G+G++G+++KG L++ T VA++ + K+ + LK++ +L + HP++V L+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
G C +++V E + G+F + + + L + + + A + +
Sbjct: 59 GVCTQR--------QPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAY 108
Query: 606 LHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
L + + + N L+ E+ + K+SD+G+S +D
Sbjct: 109 LES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 34/171 (19%)
Query: 490 IMGEGSYGKLYKGRL-------ENGTSVAIRCLPSSKKYTVRNLKLRL----DLLAKLRH 538
+G G++G++Y+G VA++ L +K K L++ H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI----SENTPGKVLNWSERLA 594
P++V LLG C+ +++ E M G+ +++ E +L E L
Sbjct: 59 PNIVKLLGVCLLN--------EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-----RIAKLSDYGLS 640
+ + VAK +L F + + N L++E R+ K+ D+GL+
Sbjct: 111 ICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 478 LKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL 536
L++ F++ ++G G+YG++YKGR ++ G AI+ + + +K +++L K
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59
Query: 537 -RHPHLVCLLGHCIDGG--GRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
H ++ G I G DD +++LV EF G+ T + +NT G L
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDD----QLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIA 114
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + + + LH + + +K N+LL E+ KL D+G+S
Sbjct: 115 YICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPS---SKKYTVRNLKLRLDLLAKLRHPHLVCLLGH 547
+G G +G ++ G+ VAI+ + S+ + K+ + KL HP+LV L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKV----MMKLSHPNLVQLYGV 67
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
C +F+V E+M+NG ++ E L L + V +A+++L
Sbjct: 68 CTKQR--------PIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLE 117
Query: 608 TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ GF + + N L+ E + K+SD+GL+
Sbjct: 118 SN---GFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 20/154 (12%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRN--LKLR-LDLLAKL-RHPHLVCLLG 546
G+G++G +Y R E G VAI+ + KK+ + LR + L KL HP++V L
Sbjct: 8 GDGTFGSVYLARNKETGELVAIKKM--KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL 606
+ ++++ V+E+M GN + + GK + S +++ + + + +
Sbjct: 66 VFREN--------DELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHI 115
Query: 607 HTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
H GFF+ +K N+L++ + K++D+GL+
Sbjct: 116 HKH---GFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 79/270 (29%), Positives = 115/270 (42%), Gaps = 19/270 (7%)
Query: 72 DNFITELKIIGDKPSNVGNFDGFASANASLSEN-FSIDSFVTTLARLTSLRVLSLVSLGI 130
+ I+ L SL N + S ++ L LT+L L L + I
Sbjct: 77 PSGISSLDGS--------ENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNI 128
Query: 131 WGSLPDKIHRLYS-LEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSL 189
+P I L S L+ LDLS N + S+P + + L+ L L N + +P +L
Sbjct: 129 T-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNL 185
Query: 190 PSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKL 249
+L L + NK++ P I+ +S L +LDLS N+I L LS+L +L+ L LS+NKL
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKL 244
Query: 250 --DSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN 307
L LSNN S I G L L++LD+S N+L P I L
Sbjct: 245 EDLPESIGNLSNLETLDLSNNQIS-SISSL-GSLTNLRELDLSGNSLSN-ALPLIALLLL 301
Query: 308 ISDLNLASNKFSGSLPKNLNCGGKLVFFDI 337
+ +L L +L LN
Sbjct: 302 LLELLLNLLLTLKALELKLNSILLNNNILS 331
|
Length = 394 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 38/160 (23%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 487 MSAIMGEGSYGK--LYKGRLEN---GTSVAIRCLPSSKKYTVRN-LKLRLDLLAKLRHPH 540
++GEG +GK LY N G VA++ L + K +++L L H +
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V G C + GG+ + L+ E++ G+ R ++ ++ LN ++ L +
Sbjct: 68 IVKYKGCCSEQGGK------GLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQIC 117
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + +LH+ + + + N+LL+ R+ K+ D+GL+
Sbjct: 118 EGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 25/167 (14%)
Query: 487 MSAIMGEGSYGKLYKGRLEN-GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLL 545
M +G G YG++Y+G + +VA++ L V ++ +++HP+LV LL
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI-----GVA 600
G C R+ +++ EFM+ GN ++ E N E AV++ ++
Sbjct: 69 GVCT----REP----PFYIITEFMTYGNLLDYLREC------NRQEVNAVVLLYMATQIS 114
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-IVSEDI 646
A+++L F + + N L+ E+ + K++D+GLS +++ D
Sbjct: 115 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 8e-07
Identities = 43/172 (25%), Positives = 82/172 (47%), Gaps = 38/172 (22%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKY---------TVRNLKLRLDLL 533
++ +GEG+Y +YK R E G VAI+ + ++ +R +K LL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK----LL 56
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----TPGKVLNW 589
+L+HP+++ LL D G + LV+EFM + I + TP + ++
Sbjct: 57 QELKHPNIIGLL----DVFGHKSN----INLVFEFME-TDLEKVIKDKSIVLTPADIKSY 107
Query: 590 SERLAVLIGVAKAVQFLHTGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
++ + +++LH+ + +R +K NN+L+ + KL+D+GL+
Sbjct: 108 ------MLMTLRGLEYLHS----NWILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 35/154 (22%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRL----DLLAKLRHPHLVCLLG 546
+G+G++G +YKG L+ T VA++ + + +LK + ++L + HP++V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL 606
C+ +++V E + G+ T + L + L + + A +++L
Sbjct: 60 VCVQK--------QPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 607 HTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + + N L+ E+ + K+SD+G+S
Sbjct: 110 ES---KNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 33/159 (20%)
Query: 491 MGEGSYGKLYKGR-LENGTSVAI-RCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGH 547
+GEGSYG ++K R E G VAI + + S ++ + LR + +L +L+HP+LV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-- 66
Query: 548 CIDGGGRDDYAVNKVF-------LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+VF LV+E+ + + E P V + ++
Sbjct: 67 -------------EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIK-KIIWQTL 110
Query: 601 KAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638
+AV F H I + VK NIL+ + KL D+G
Sbjct: 111 QAVNFCHKHNCI----HRDVKPENILITKQGQIKLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG 546
+ I+GEG +G + +G G VA++ + T + ++ KL H +LV LLG
Sbjct: 10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL-NWSERLAVLIGVAKAVQF 605
+ G +++V E MS GN + T G+ L + + L + VA+ +++
Sbjct: 67 VILHNG---------LYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 606 LHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642
L + + + NIL++E +AK+SD+GL+ V
Sbjct: 116 LES---KKLVHRDLAARNILVSEDGVAKVSDFGLARV 149
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 43/185 (23%), Positives = 81/185 (43%), Gaps = 39/185 (21%)
Query: 484 NFDMSAIMGEGSYGKLYKGR------LENGTSVAIRCLP-SSKKYTVRNLKLRLDLLAKL 536
N + +GEG +GK+ K T+VA++ L ++ +R+L +LL ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT---PGKVLNWSERL 593
HPH++ L G C G + L+ E+ G+ R+ + E+ P + + R
Sbjct: 61 NHPHVIKLYGACSQDG--------PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 594 ----------AVLIG--------VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635
A+ +G +++ +Q+L + + N+L+ E R K+S
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKIS 169
Query: 636 DYGLS 640
D+GLS
Sbjct: 170 DFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 23/173 (13%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRC--LPSSKK----YTVRNLKLRLD 531
K + FD+ +GEG+YG++YK R + G VA++ L + K+ +R +K
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK---- 58
Query: 532 LLAKLRHPHLVCLLGHCIDGGGRDDYAVNK--VFLVYEFMSNGNFRTHISENTPGKVLNW 589
+L +L H ++V L D D+ +K +LV+E+M + S ++++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GLVHF 113
Query: 590 SER--LAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
SE + + + + + + H F + +K +NILLN KL+D+GL+
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
+G+G +G+++ G T VAI+ L L+ ++ KLRH LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQL------ 66
Query: 551 GGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
YAV +++V E+MS G+ + GK L + + + +A + ++
Sbjct: 67 ------YAVVSEEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE 119
Query: 608 TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ + ++ NIL+ E+ + K++D+GL+ + ED
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 40/164 (24%), Positives = 78/164 (47%), Gaps = 25/164 (15%)
Query: 491 MGEGSYGKLYKG--RLENGTS----VAIRCLP-SSKKYTVRNLKLRLDLLAKLRHPHLVC 543
+G G++G++Y+G R +G + VA++ LP S + + + +++K H ++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV----LNWSERLAVLIGV 599
L+G + R F++ E M+ G+ ++ + EN P L + L V
Sbjct: 74 LIGVSFERLPR--------FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLN---EHRIAKLSDYGLS 640
AK ++L F + + N LL R+AK++D+G++
Sbjct: 126 AKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 34/169 (20%)
Query: 490 IMGEGSYGKLYKGR----LENGTSVAIRCLPSSKKYT--VRN---LKLRLDLLAKLRHPH 540
++G+GS+GK++ R + G A++ L KK T VR+ K+ D+LA++ HP
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 541 LVCLLGHCIDGGGRDDYAVN---KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV-L 596
+V L YA K++L+ +F+ G+ T +S+ +V+ E + L
Sbjct: 60 IVKL-----------HYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYL 104
Query: 597 IGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+A A+ LH+ G +K NILL+E KL+D+GLS S D
Sbjct: 105 AELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYK-GRLENGTSVAIRCLPSSKKYTVRNLKLRLDLL 533
LE L + T+ +++ +G+G+YGK+YK ++G+ A++ L ++ ++L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 534 AKL-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
L HP++V G D +++LV E + G+ ++E G +L +R
Sbjct: 73 QSLPNHPNVVKFYGMFYKA---DKLVGGQLWLVLELCNGGS----VTELVKG-LLICGQR 124
Query: 593 LA------VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
L +L G +Q LH I + VK NNILL KL D+G+S
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRI---IHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 40/178 (22%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 485 FDMSAIMGEGSYGKLYKGRL--ENGTS--VAIRCLPSSKKYTVRNLKLRLDLLAKLR--- 537
+ I+GEG +G + +G+L ++G+ VA++ + +T ++ L A ++
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFD 59
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI--------SENTPGKVLNW 589
HP+++ L+G C + V L FM +G+ + + E P + L
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVIL--PFMKHGDLHSFLLYSRLGGLPEKLPLQTL-- 115
Query: 590 SERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS--IVSED 645
L ++ +A +++L F + + N +L E ++D+GLS I S D
Sbjct: 116 ---LKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 40/165 (24%), Positives = 80/165 (48%), Gaps = 33/165 (20%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
+G G +G+++ G N T VA++ L P + +V+ +L+ L+H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRL----- 66
Query: 550 DGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVL-----NWSERLAVLIGVA 600
YAV ++++ E+M+ G+ + + GKVL ++S ++A +
Sbjct: 67 -------YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ ++H ++ N+L++E + K++D+GL+ V ED
Sbjct: 120 ERKNYIH---------RDLRAANVLVSESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 490 IMGEGSYGKLYKGRLE----NGTSVAIRCLPSSKKYT---VRNLKLRLDLLAKLRHPHLV 542
++G G +G++ GRL+ VAI+ L + YT R+ ++ + HP+++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNII 68
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L G V +V E+M NG+ + ++ G+ + + +L G+A
Sbjct: 69 HLEGVVTKS--------KPVMIVTEYMENGSLDAFLRKHD-GQ-FTVIQLVGMLRGIASG 118
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+++L G+ + + NIL+N + + K+SD+GLS V ED
Sbjct: 119 MKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 34/156 (21%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
+G G +G ++ G VAI+ + + + ++ KL HP LV L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV 610
+ + LV+EFM +G ++ + L + + V + + +L +
Sbjct: 71 R--------SPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESS- 119
Query: 611 IPGFFNNRVKTNNILLNEHRIAKLSDYGLS-IVSED 645
+ + N L+ E+++ K+SD+G++ V +D
Sbjct: 120 --NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 45/220 (20%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRN-LKLRLDLLAK 535
NN + +G+G++G++++ R E T VA++ L ++ + L+A+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV--------- 586
HP++V LLG C G + L++E+M+ G+ + +P
Sbjct: 65 FDHPNIVKLLGVCAVG--------KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 587 ----------LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636
L+ +E+L + VA + +L F + + T N L+ E+ + K++D
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 173
Query: 637 YGLS--IVSEDI------NSVGVRLLILMSFFFGSMTSCS 668
+GLS I S D +++ +R + S F+ T+ S
Sbjct: 174 FGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES 213
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 38/169 (22%), Positives = 83/169 (49%), Gaps = 22/169 (13%)
Query: 484 NFDMSAIMGEGSYGKLY--KGRLENGTSV----AIRCLPSSKKYTVRNLKLRLDLLAKLR 537
+++ +GEGS+GK+Y K + ++ V + +P +K + + LLAK++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMK 57
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
HP++V + G ++F+V E+ G+ I+ G + + + L+ +
Sbjct: 58 HPNIVTFFASFQENG--------RLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFV 108
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGLSIVSED 645
++ ++ +H I + +K+ NI L+++ +AKL D+G++ D
Sbjct: 109 QISLGLKHIHDRKI---LHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 21/160 (13%)
Query: 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRL----DLLAKLRHPHLVCLL 545
+G G++G+++ GRL + T VA++ S ++ +LK + +L + HP++V L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
G C +++V E + G+F T + T G L E + ++ A +++
Sbjct: 60 GVCTQK--------QPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEY 109
Query: 606 LHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
L + + + N L+ E + K+SD+G+S ED
Sbjct: 110 LESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEED 146
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 42/173 (24%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD----------- 531
NF +GEG+YG +YK R G VA++ K+RLD
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALK-------------KIRLDTETEGVPSTAI 47
Query: 532 ----LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
LL +L HP++V LL + NK++LV+EF+ + + + + + +P +
Sbjct: 48 REISLLKELNHPNIVKLLDVI--------HTENKLYLVFEFL-HQDLKKFM-DASPLSGI 97
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ L + + + F H+ + + +K N+L+N KL+D+GL+
Sbjct: 98 PLPLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 45/202 (22%), Positives = 91/202 (45%), Gaps = 34/202 (16%)
Query: 490 IMGEGSYGKLYKGRLE---NGTSVAIRCLPS-SKKYTVRNLKLRLDLLAKL-RHPHLVCL 544
++GEG++G++ + ++ + AI+ L + + R+ L++L KL HP+++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNF-----RTHISENTPG--------KVLNWSE 591
LG C + G +++ E+ GN ++ + E P L +
Sbjct: 69 LGACENRG--------YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 592 RLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-----IVSEDI 646
L VA +Q+L F + + N+L+ E+ +K++D+GLS V + +
Sbjct: 121 LLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177
Query: 647 NSVGVRLLILMSFFFGSMTSCS 668
+ VR + + S + T+ S
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKS 199
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 22/162 (13%)
Query: 489 AIMGEGSYGKLYKGR-LENGTSVAIRC---------LPSSKKYTVRNLKLRLDLLAKLRH 538
A +G G+YG +YK R +G VA++ LP S TVR + L L L H
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS---TVREVAL-LKRLEAFDH 61
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
P++V L+ C R D KV LV+E + + RT++ + P L ++
Sbjct: 62 PNIVRLMDVC--ATSRTDRET-KVTLVFEHVDQ-DLRTYL-DKVPPPGLPAETIKDLMRQ 116
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + FLH I + +K NIL+ KL+D+GL+
Sbjct: 117 FLRGLDFLHANCI---VHRDLKPENILVTSGGQVKLADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 38/180 (21%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKG--RLENGT---SVAIRCL-----PSSKKYTVR 524
L LKE + ++G G++G +YKG E VAI+ L P + K +
Sbjct: 1 LRILKET--ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD 58
Query: 525 NLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-- 582
+ +A + HPH+V LLG C+ ++V L+ + M G ++ +
Sbjct: 59 EAYV----MASVDHPHVVRLLGICLS---------SQVQLITQLMPLGCLLDYVRNHKDN 105
Query: 583 --PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+LNW + +AK + +L + + N+L+ + K++D+GL+
Sbjct: 106 IGSQYLLNWCVQ------IAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 29/167 (17%)
Query: 491 MGEGSYGKLYKG-RLENG-------TSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+G+G++ K++KG R E G T V ++ L S + + ++++L H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
G C+ G + +V E++ G+ T++ +N ++N S +L V +A A
Sbjct: 63 LNYGVCVCGD--------ESIMVQEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWA 112
Query: 603 VQFLHTGVIPGFFNNRVKTNNILL--NEHRIA------KLSDYGLSI 641
+ FL + + V N+LL E R KLSD G+SI
Sbjct: 113 LHFLEDKGLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 40/184 (21%), Positives = 82/184 (44%), Gaps = 45/184 (24%)
Query: 491 MGEGSYGKLYKGRLEN---------------GTS--VAIRCLPSSKKYTVRNLKLR-LDL 532
+GEG +G+++ + N G VA++ L RN L+ + +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHIS------------- 579
L++L+ P+++ LLG C+D +D + ++ E+M NG+ +S
Sbjct: 73 LSRLKDPNIIRLLGVCVD----ED----PLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 580 ---ENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636
+++S L V + +A +++L + F + + T N L+ E+ K++D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIAD 181
Query: 637 YGLS 640
+G+S
Sbjct: 182 FGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 28/159 (17%)
Query: 490 IMGEGSYGKLYKGRLENGTSVAIR--------CLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
++G+G+YG +Y G G +A++ L + K+Y L+ +DLL L+H ++
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY--EKLQEEVDLLKSLKHVNI 64
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISE--NTPGKVLNWSERLAVLIGV 599
V LG C+D N + + EF+ G+ + ++ P V + +L GV
Sbjct: 65 VQYLGTCLDD--------NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGV 115
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638
A +LH + + +K NN++L + I KL D+G
Sbjct: 116 A----YLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFG 147
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYT-VRNLKLRLDLLAKLRHPHLVCLLGHCI 549
G G+ +Y L N VAI+ + K T V L+ + +++ HP++V +
Sbjct: 10 GVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV 69
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG 609
G ++++LV ++S G+ + + P L+ + VL V K +++LH+
Sbjct: 70 VG--------DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 610 VIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
G + +K NILL E K++D+G+S
Sbjct: 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 28/169 (16%)
Query: 490 IMGEGSYGKLYKGRLE----NGTSVAIRCLPSSKKYTVRNLKLRL---DLLAKLRHPHLV 542
++G G +G++ +GRL+ VAI+ L S YT + + L ++ + HP+++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNII 68
Query: 543 CLLGHCIDGGGRDDYAVNK---VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
L G V K V ++ EFM NG + + +N G+ + + +L G+
Sbjct: 69 HLEG-----------VVTKSRPVMIITEFMENGALDSFLRQND-GQ-FTVIQLVGMLRGI 115
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
A +++L + + + NIL+N + + K+SD+GLS ED S
Sbjct: 116 AAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 41/179 (22%), Positives = 85/179 (47%), Gaps = 33/179 (18%)
Query: 510 VAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEF 568
VA++ L + T RN L+ + ++++L++P+++ LLG C+ DD + ++ E+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV----SDD----PLCMITEY 98
Query: 569 MSNGNFRTHISE-----------NTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN 617
M NG+ +S+ N P ++ + L + + +A +++L + F +
Sbjct: 99 MENGDLNQFLSQREIESTFTHANNIPS--VSIANLLYMAVQIASGMKYLAS---LNFVHR 153
Query: 618 RVKTNNILLNEHRIAKLSDYGLS--IVSEDINSVG------VRLLILMSFFFGSMTSCS 668
+ T N L+ H K++D+G+S + S D + +R + S G T+ S
Sbjct: 154 DLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS 212
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 34/178 (19%)
Query: 490 IMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLR-------------LDLLAKL 536
++G+GSYG++ +R K+Y ++ L LR LL++L
Sbjct: 7 VVGKGSYGEV----------SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL 56
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
+HP++V G +++V F G+ + E GK+L ++ +
Sbjct: 57 KHPNIVAYRESWEGEDG-------LLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWF 108
Query: 597 IGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLL 654
+ +A A+Q+LH I + +KT N+ L I K+ D G++ V E+ + L+
Sbjct: 109 VQIAMALQYLHEKHI---LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 491 MGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
+G+G++GK+YK + E G A + + + + + + + +D+LA HP++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG 609
Y N ++++ EF + G + E + L + V +A+ +LH
Sbjct: 72 -------YYENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 610 VIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
I + +K NIL KL+D+G+S
Sbjct: 123 KI---IHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 43/170 (25%), Positives = 85/170 (50%), Gaps = 29/170 (17%)
Query: 490 IMGEGSYGKLYKG-RLENGTSVAIRC--LP--------SSKKYTVRNLKLRLDLLAKLRH 538
++G+G+YG++Y + G +A++ LP S +K V+ L+ ++ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VL 596
++V LG + ++ FL E++ G+ + + T G+ + E+L
Sbjct: 68 LNIVQYLGF---ETTEEYLSI---FL--EYVPGGSIGSCL--RTYGR---FEEQLVRFFT 114
Query: 597 IGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDI 646
V + + +LH+ G + +K +N+L++ I K+SD+G+S S+DI
Sbjct: 115 EQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 22/71 (30%), Positives = 39/71 (54%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLI 172
+++L L+ ++L I G++P + + SLE LDLS N GS+P + + L+ L
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496
Query: 173 LDDNFFNNTIP 183
L+ N + +P
Sbjct: 497 LNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 41/172 (23%), Positives = 73/172 (42%), Gaps = 27/172 (15%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPH 540
++ + ++G+GS G +YK R G A++ + R LR L L P+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER-LA-VLIG 598
+V G G ++ +V E+M G+ + KV E LA +
Sbjct: 61 VVKCYGAFYKEG--------EISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQ 107
Query: 599 VAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSEDI 646
+ K + +LHT + + K +N+L+N K++D+G+S V E+
Sbjct: 108 ILKGLDYLHTK------RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 43/171 (25%), Positives = 79/171 (46%), Gaps = 56/171 (32%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD---------------LLAK 535
GEG+YG +YK R G VA++ K+RL+ LL +
Sbjct: 8 GEGTYGVVYKARDKLTGEIVALK-------------KIRLETEDEGVPSTAIREISLLKE 54
Query: 536 LRHPHLVCLLGHCIDGGGRDD--YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
L HP++V LL D ++ NK++LV+EF+ + + + ++ +++P L+
Sbjct: 55 LNHPNIVRLL----------DVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIK 102
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGL 639
+ L + + + + H+ +RV K N+L++ KL+D+GL
Sbjct: 103 SYLYQLLQGIAYCHS--------HRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 23/169 (13%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPS---SKKYTVRNLKLRLDLLAKLRHPHLVCLLGH 547
+G G +G + G+ VAI+ + S+ + K+ + KL H LV L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKV----MMKLSHEKLVQLYGV 67
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
C +++V E+MSNG ++ E+ GK S+ L + V + + +L
Sbjct: 68 CTKQ--------RPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 608 TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS---IVSEDINSVGVRL 653
+ F + + N L+++ K+SD+GLS + E +SVG +
Sbjct: 118 S---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 38/166 (22%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G G +G+++ G T VAI+ L L +L+ +L+HP LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA-EANLMKQLQHPRLV 64
Query: 543 CLLGHCIDGGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
L YAV ++++ E+M NG+ + + G L ++ + + +
Sbjct: 65 RL------------YAVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQI 111
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
A+ + F+ + + ++ NIL++E K++D+GL+ + ED
Sbjct: 112 AEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 37/160 (23%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
+ +++ +G+G++GK+YK + E G A + + + + + + +D+L++ +HP+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V L + NK++++ EF G + + E + L + V +
Sbjct: 64 IVGLYEAY--------FYENKLWILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQML 113
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+A+ FLH+ + + +K NILL KL+D+G+S
Sbjct: 114 EALNFLHSHKV---IHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVC 543
+++ +G G+YG +YK R + G VAI+ + ++ + +L + RHP++V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG--VAK 601
G + +K+++V E+ G+ I + T G + SE + K
Sbjct: 65 YFGSYLRR--------DKLWIVMEYCGGGSL-QDIYQVTRGPL---SELQIAYVCRETLK 112
Query: 602 AVQFLH-TGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ +LH TG I +R +K NILL E KL+D+G+S
Sbjct: 113 GLAYLHETGKI-----HRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 37/155 (23%), Positives = 80/155 (51%), Gaps = 26/155 (16%)
Query: 494 GSYGKLYKGRLEN-GTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
G+YG+++ + ++ G AI+ + + +K V + D+L++ + P++V L +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI--GVAKAVQFLH 607
G ++LV E++ G+ + + V + E +A + + A+++LH
Sbjct: 63 QG-------KKNLYLVMEYLPGGDLASLLE-----NVGSLDEDVARIYIAEIVLALEYLH 110
Query: 608 T-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ G+I +R +K +NIL++ + KL+D+GLS
Sbjct: 111 SNGII-----HRDLKPDNILIDSNGHLKLTDFGLS 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 37/158 (23%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
+G G +G+++ G T VA++ L L+ ++ KLRH LV L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE-EAQIMKKLRHDKLVQL------ 66
Query: 551 GGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
YAV +++V E+MS G+ + + G+ L + + VA + ++
Sbjct: 67 ------YAVVSEEPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE 119
Query: 608 TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ + +++ NIL+ + + K++D+GL+ + ED
Sbjct: 120 R---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPH 540
++ + +G G+ G + K G +A++ + ++ LR LD+L K P+
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNF-------RTHISENTPGKVLNWSERL 593
+V G + + + E+M G+ + I E GK+
Sbjct: 61 IVGFYGAFYNN--------GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV----- 107
Query: 594 AVLIGVAKAVQFLHT--GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVG 650
V K + +LH +I + VK +NIL+N KL D+G+S + +NS+
Sbjct: 108 ----AVLKGLTYLHEKHKII----HRDVKPSNILVNSRGQIKLCDFGVS--GQLVNSLA 156
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 50/231 (21%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRI--- 213
+P +I+T LILD+N + N ++ +L S + + P +IQ +
Sbjct: 196 CIPEQITT------LILDNNELKSLPENLQGNIKTLYANSNQLTSIPATLPDTIQEMELS 249
Query: 214 ------------STLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLV 261
S L LDL N IS LP+ L L++ DN + + LP G+
Sbjct: 250 INRITELPERLPSALQSLDLFHNKIS-CLPENLPEE-LRYLSVYDNSIRTLPAHLPSGIT 307
Query: 262 MAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP---PPAIFSL------------- 305
+ +NS + +P+ L+ L+ NAL +P PP + L
Sbjct: 308 HLNVQSNSLTA-LPETLPP--GLKTLEAGENALTSLPASLPPELQVLDVSKNQITVLPET 364
Query: 306 --PNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN---KLTGGLPSCLS 351
P I+ L+++ N + +LP+NL L S N +L LP
Sbjct: 365 LPPTITTLDVSRNALT-NLPENLPAA--LQIMQASRNNLVRLPESLPHFRG 412
|
Length = 754 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 37/159 (23%), Positives = 81/159 (50%), Gaps = 26/159 (16%)
Query: 491 MGEGSYGKLYKG-RLENGTSVAIRCLP-----SSKKYTVRNLKLRLDLLAKLRHPHLVCL 544
+G GS+G +Y+G L++G A++ + + + V+ L+ + LL+KL+HP++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGK---VLNWSERLAVLIGVAK 601
L G R++ + +FL E + G+ + + + ++ ++ L+G+
Sbjct: 68 L-----GTEREEDNLY-IFL--ELVPGGSLAKLLKKYGSFPEPVIRLYTRQI--LLGLE- 116
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+LH + +K NIL++ + + KL+D+G++
Sbjct: 117 ---YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 44/170 (25%), Positives = 67/170 (39%), Gaps = 38/170 (22%)
Query: 485 FDMSAIMGEGSYGKL----YKGRLENGTSVAIRCLPSSKK---------YTVRNLKLRLD 531
F A++G G +GK+ YK G AI+ L KK ++ K +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKAL---KKGDIIARDEVESLMCEKRIFE 54
Query: 532 LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
RHP LV L C + V V E+ + G+ HI + +SE
Sbjct: 55 TANSERHPFLVNLFA-CFQ-------TEDHVCFVMEYAAGGDLMMHIHTDV------FSE 100
Query: 592 RLAVLIG--VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
AV V +Q+LH +K +N+LL+ K++D+GL
Sbjct: 101 PRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 39/160 (24%), Positives = 82/160 (51%), Gaps = 28/160 (17%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRCLP-SSKKYTVRNLKLRLDLLAKLRH---PHLVCL 544
++G G+YG +Y+G+ + G VA++ + + V +++ + LL++LR P++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI--GVAKA 602
G + G +++++ E+ G+ RT + G + +E+ +I V A
Sbjct: 68 YGSYLKG--------PRLWIIMEYAEGGSVRTLMK---AGPI---AEKYISVIIREVLVA 113
Query: 603 VQFLH-TGVIPGFFNNRVKTNNILL-NEHRIAKLSDYGLS 640
++++H GVI + +K NIL+ N + KL D+G++
Sbjct: 114 LKYIHKVGVI----HRDIKAANILVTNTGNV-KLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 33/182 (18%), Positives = 86/182 (47%), Gaps = 37/182 (20%)
Query: 491 MGEGSYGKLY--------KGRLENGTSVAIRCLP-SSKKYTVRNLKLRLDLLAKL-RHPH 540
+GEG +G++ K + + +VA++ L + + + +L ++++ + +H +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV-------------L 587
++ LLG C G ++++ E+ S GN R ++ P + +
Sbjct: 83 IINLLGACTQDG--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDIN 647
+ + ++ VA+ +++L + + + N+L+ E+ + K++D+GL + D+N
Sbjct: 135 TFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGL---ARDVN 188
Query: 648 SV 649
++
Sbjct: 189 NI 190
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
+G G +G ++ G+ VAI+ + + ++ KL HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV 610
+++V EFM NG ++ + GK L+ L++ V + +++L
Sbjct: 71 Q--------KPLYIVTEFMENGCLLNYLRQRQ-GK-LSKDMLLSMCQDVCEGMEYLERN- 119
Query: 611 IPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
F + + N L++ + K+SD+G++
Sbjct: 120 --SFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 37/179 (20%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLK-------LR- 529
+ + ++ A +G+G++G+++K R + VA+ KK + N K LR
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVAL------KKVLMENEKEGFPITALRE 61
Query: 530 LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEF--------MSNGNFRTHISEN 581
+ +L L+H ++V L+ C + +LV+EF +SN N +
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK------ 115
Query: 582 TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
SE V+ + + ++H I + +K NIL+ + I KL+D+GL+
Sbjct: 116 -----FTLSEIKKVMKMLLNGLYYIHRNKI---LHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 26/84 (30%), Positives = 39/84 (46%)
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGL 346
L + LRG P I L ++ +NL+ N G++P +L L D+S N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 347 PSCLSNESDKRVVKFRGNCLSSNV 370
P L + R++ GN LS V
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 38/170 (22%), Positives = 72/170 (42%), Gaps = 31/170 (18%)
Query: 487 MSAIMGEGSYGKLYKGRLEN----GTSVAIRCLPSSKKYTVRNLKLRLDLLAK-LRHPHL 541
+ +GEG +G +Y+G + +VA++ + +VR L+ + + HPH+
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV-- 599
V L+G + N V++V E G R+++ N L + +
Sbjct: 70 VKLIGVITE---------NPVWIVMELAPLGELRSYLQVN--------KYSLDLASLILY 112
Query: 600 ----AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ A+ +L + F + + N+L++ KL D+GLS ED
Sbjct: 113 SYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 35/161 (21%)
Query: 492 GEGSYGKLYKG-RLENGTSVA---IRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG- 546
G G++GK+Y L+ G +A IR + K T++ + + +L L+HP+LV G
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-TIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 547 --HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL----IGVA 600
H R+ KV++ E+ S G + E+ G++L+ V+ + +
Sbjct: 68 EVH------RE-----KVYIFMEYCSGGTL-EELLEH--GRILD----EHVIRVYTLQLL 109
Query: 601 KAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + +LH+ G++ + +K NI L+ + + KL D+G +
Sbjct: 110 EGLAYLHSHGIV----HRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 42/173 (24%)
Query: 490 IMGEGSYGKLYKGRLE----NGTSVAIRCLPSSKKYTVRNLKLRLDLLA------KLRHP 539
++G G +G++++G L+ +VAI+ L YT K R D L+ + H
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTE---KQRQDFLSEASIMGQFSHH 66
Query: 540 HLVCLLGHCIDGGGRDDYAVNK---VFLVYEFMSNGNF----RTHISENTPGKVLNWSER 592
+++ L G V K ++ E+M NG R H E + +++
Sbjct: 67 NIIRLEG-----------VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV----- 110
Query: 593 LAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+L G+A +++L + + + NIL+N + K+SD+GLS V ED
Sbjct: 111 -GMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 43/169 (25%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRCLPSSK------KYTVRNLKLRLDLLAKLRHPHLV 542
I+G G +G++Y R + G A++CL + + N ++ L L++ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 543 CLLGHCIDGGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
C+ YA +K+ + + M+ G+ H+S++ +SE
Sbjct: 61 CM-----------TYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-----FSE-------- 96
Query: 600 AKAVQFLHTGVIPGF--FNNR------VKTNNILLNEHRIAKLSDYGLS 640
K ++F T +I G +NR +K NILL+EH ++SD GL+
Sbjct: 97 -KEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 40/155 (25%), Positives = 80/155 (51%), Gaps = 25/155 (16%)
Query: 493 EGSYGKLYKGR-LENGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCL---- 544
EG+YG +Y+ R + G VA++ L K+ + + +L+ +++L KL+HP++V +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVV 73
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQ 604
+G +D K+++V E++ + + ++ + SE +++ + V
Sbjct: 74 VGSNLD----------KIYMVMEYVEH-DLKSLMETMKQP--FLQSEVKCLMLQLLSGVA 120
Query: 605 FLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
LH I + +KT+N+LLN I K+ D+GL
Sbjct: 121 HLHDNWI---LHRDLKTSNLLLNNRGILKICDFGL 152
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 39/172 (22%), Positives = 77/172 (44%), Gaps = 37/172 (21%)
Query: 491 MGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRN-LKLRLDLLAKLRHPHLVC 543
+GE +GK+YKG L E +VAI+ L + +R K + ++L+HP++VC
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 544 LLGHCIDGGGRDDYAVNK---VFLVYEFMSNGNFRTHISENTP-------------GKVL 587
LLG V K + +++ + S+ + + +P L
Sbjct: 73 LLG-----------VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
++ + ++ +A ++FL + + + + T N+L+ + K+SD GL
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 30/166 (18%)
Query: 490 IMGEGSYGKLYKG-RLENGTSV----AIRCL--PSSKKYTVRNLKLRLDLLAKLRHPHLV 542
++G G++G +YKG + G +V AI+ L + K V + L ++A + HPHLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMASMDHPHLV 72
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG----KVLNWSERLAVLIG 598
LLG C+ + LV + M +G ++ E+ +LNW +
Sbjct: 73 RLLGVCLS---------PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQ 117
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644
+AK + +L + + + N+L+ K++D+GL+ + E
Sbjct: 118 IAKGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLE 160
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 37/158 (23%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+F++ +G G+YG +YK R + G AI+ + ++ + ++ +H ++V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
G + RD K+++ EF G+ + P L+ S+ V +
Sbjct: 70 AYFGSYLR---RD-----KLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQG 118
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ +LH+ G + +K NILL ++ KL+D+G+S
Sbjct: 119 LYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 484 NFDMSAIMGEGSYGKLY----KGRLENGTSVAIRCLPSS----KKYTVRNLKLRLDLLAK 535
NF++ ++G G+YGK++ G + G A++ L + K T + + +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 536 LRH-PHLVCLLGHCIDGGGRDDYAVN---KVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
+R P LV L H YA K+ L+ ++++ G TH+ +
Sbjct: 61 VRRCPFLVTL--H---------YAFQTDTKLHLILDYVNGGELFTHLYQREHFT----ES 105
Query: 592 RLAVLIG-VAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ V I + A+ LH G+I +K NILL+ L+D+GLS
Sbjct: 106 EVRVYIAEIVLALDHLHQLGII----YRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 40/205 (19%)
Query: 490 IMGEGSYGKLYKGRLENG---TSVAIRCLPSSKKYTV----RNLKLRLDLLAKL-RHPHL 541
++GEG++G++ K R++ AI+ + K+Y R+ L++L KL HP++
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNF-----RTHISENTPG--------KVLN 588
+ LLG C G ++L E+ +GN ++ + E P L+
Sbjct: 59 INLLGACEHRG--------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110
Query: 589 WSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS-----IVS 643
+ L VA+ + +L F + + NIL+ E+ +AK++D+GLS V
Sbjct: 111 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 167
Query: 644 EDINSVGVRLLILMSFFFGSMTSCS 668
+ + + VR + + S + T+ S
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNS 192
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 66/310 (21%), Positives = 102/310 (32%), Gaps = 65/310 (20%)
Query: 122 VLSLVSLGIWGS---------LPDKIHRLYSLEYLDLSSNFL------FGSVPPKISTMV 166
+L L L + G+ L + SL+ L LS N S+ ++
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 167 KLQTLILDDNFFNNTIPNWFDSL---PSLTFLSMRNNKLAGPFPSSIQR-----ISTLSD 218
LQ L L DN +SL SL L + NN L + + L
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 219 LDLSKNAISGSLPD-----LSSLGSLNVLNLSDNKL-DSNLPKLPRGLVMAFLSNNSFSG 272
L L +N + G+ + L + L LNL++N + D+ + L GL
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKA---------- 191
Query: 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIF------SLPNISDLNLASNKFSGS----- 321
L+ LD++ N L A SL ++ LNL N + +
Sbjct: 192 --------NCNLEVLDLNNNGL--TDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241
Query: 322 LPKNLNCGGKLVFFDISNNKLT--GGLPSC--LSNESDKRVVKFRGNCLSSNVQNQHPES 377
L+ L+ +S N +T G L+ + + RGN ES
Sbjct: 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301
Query: 378 -YCFEVRTER 386
E
Sbjct: 302 LLEPGNELES 311
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 40/167 (23%)
Query: 490 IMGEGSYGKLYKGRLENGTS----VAIRCLPSSKKYTVRNLK------LRLDLLAKLRHP 539
++G+G YGK+++ R G A++ L K VRN K ++L ++HP
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVL--KKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHIS------ENTPGKVLNWSERL 593
+V L+ + GG K++L+ E++S G H+ E+T L SE
Sbjct: 61 FIVDLI-YAFQTGG-------KLYLILEYLSGGELFMHLEREGIFMEDTACFYL--SE-- 108
Query: 594 AVLIGVAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
++ A++ LH G+I +K NILL+ KL+D+GL
Sbjct: 109 -----ISLALEHLHQQGII----YRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 36/186 (19%), Positives = 76/186 (40%), Gaps = 45/186 (24%)
Query: 490 IMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL------- 536
+GEG++G++ K ++VA++ L K DL++++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-----ATEKDLSDLVSEMEMMKMIG 73
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
+H +++ LLG C G +++V E+ ++GN R + P +
Sbjct: 74 KHKNIINLLGVCTQEG--------PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 597 IG-------------VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643
VA+ ++FL + + + N+L+ E + K++D+GL +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKC---IHRDLAARNVLVTEDHVMKIADFGL---A 179
Query: 644 EDINSV 649
DI+ +
Sbjct: 180 RDIHHI 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYK------GRLENGTSVAIRCLPSSKKYTVRN-LKLRLDLLAK 535
NN +G G++GK+ + + + VA++ L + + R L L +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 536 L-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
L H ++V LLG C GG + ++ E+ G+ + L + L+
Sbjct: 95 LGNHENIVNLLGACTIGG--------PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLS 145
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
VAK + FL + + + N+LL +I K+ D+GL+
Sbjct: 146 FSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 32/161 (19%)
Query: 491 MGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHC 548
+GEG+Y +YKGR G VA++ + + + +R + L+ +L+H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 549 IDGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQ 604
+ V NK+ LV+E+M + + ++ + L+ + + + K +
Sbjct: 64 --------HDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 605 FLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
F H NRV K N+L+N+ KL+D+GL+
Sbjct: 115 FCH--------ENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 32/170 (18%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP-----SSKKYTVRNLKLRLDLLAKL 536
N+ ++G+G++G++Y ++ G +A++ +P K V L+ + LL L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI------SENTPGKVLNWS 590
+H +V G C+ RDD + + E+M G+ + + +E K
Sbjct: 62 QHERIVQYYG-CL----RDD---ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-- 111
Query: 591 ERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+L GV +LH+ +I + +K NIL + KL D+G S
Sbjct: 112 ---QILEGVE----YLHSNMI---VHRDIKGANILRDSAGNVKLGDFGAS 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 37/186 (19%), Positives = 73/186 (39%), Gaps = 53/186 (28%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLEN------GTSVAIRCL---PSSKKYTVRNLKLRLDLL 533
+ +G+GS+G +Y+G + T VAI+ + S ++ R++ L
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE--------RIEFL 57
Query: 534 A------KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI------SEN 581
+ H+V LLG G +V E M+ G+ ++++ +EN
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTG--------QPTLVVMELMAKGDLKSYLRSRRPEAEN 109
Query: 582 TPG-------KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634
PG K + + +A + A +F+H + N ++ E K+
Sbjct: 110 NPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH---------RDLAARNCMVAEDLTVKI 160
Query: 635 SDYGLS 640
D+G++
Sbjct: 161 GDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 28/161 (17%)
Query: 490 IMGEGSYGKLYKG-RLENGTS----VAIRCLPS-SKKYTVRNLKLRLDLLAKLRHPHLVC 543
++G G +G ++KG + G S VAI+ + S + T + + + + L H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----TPGKVLNWSERLAVLIGV 599
LLG C + LV + G+ H+ ++ P ++LNW + +
Sbjct: 74 LLGICPGA---------SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC------VQI 118
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
AK + +L + + NILL I +++D+G++
Sbjct: 119 AKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 34/169 (20%)
Query: 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHP 539
+F+M +G GS+G++ + + G AI+CL K V+++ +L +L HP
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
+V ++ +D+ N+V+ + EF+ G TH+ G+ N V
Sbjct: 79 FIVNMMC-----SFQDE---NRVYFLLEFVVGGELFTHL--RKAGRFPN---------DV 119
Query: 600 AKAVQFLHTGVIPGF--FNNR------VKTNNILLNEHRIAKLSDYGLS 640
AK F H ++ F +++ +K N+LL+ K++D+G +
Sbjct: 120 AK---FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA 165
|
Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 34/153 (22%), Positives = 80/153 (52%), Gaps = 19/153 (12%)
Query: 491 MGEGSYGKLYKGRLENGTS--VAIRCLP-SSKKYTVRNLKLRLDLLAKLRHPHLVCLLGH 547
+G+GS+G+++KG ++N T VAI+ + + + +++ + +L++ P++ G
Sbjct: 12 IGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
+ K++++ E++ G + + PG L+ ++ +L + K + +LH
Sbjct: 71 YLKD--------TKLWIIMEYLGGG---SALDLLEPGP-LDETQIATILREILKGLDYLH 118
Query: 608 TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + +K N+LL+EH KL+D+G++
Sbjct: 119 S---EKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 40/164 (24%), Positives = 84/164 (51%), Gaps = 28/164 (17%)
Query: 489 AIMGEGSYGKLYKGR-LENGTSVAI------RCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+G G++ Y+ R ++ GT +A+ R S ++ V L+ + L+A+L HPH+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGK---VLNWSERLAVLIG 598
+ +L G +D N +F+ E+M+ G+ +S+ K ++N++E+ +L G
Sbjct: 66 IRML-----GATCEDSHFN-LFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQ--LLRG 115
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGLSI 641
++ +LH I + VK N+L++ + +++D+G +
Sbjct: 116 LS----YLHENQI---IHRDVKGANLLIDSTGQRLRIADFGAAA 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLEN-GTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRH 538
+F + +G+G YG+++ + ++ G VA++ + S K VR++ D+L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 539 PHLVCLLGHCIDGGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
LV LL YA ++L E++ G+FRT ++ VL+
Sbjct: 61 EWLVKLL-----------YAFQDDEYLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFY 106
Query: 596 LIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + +AV LH G+ + +K N L++ KL+D+GLS
Sbjct: 107 MAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 35/173 (20%), Positives = 81/173 (46%), Gaps = 34/173 (19%)
Query: 491 MGEGSYGK--------LYKGRLENGTSVAIRCLPS-SKKYTVRNLKLRLDLLAKL-RHPH 540
+GEG +G+ L K + T VA++ L S + + + +L ++++ + +H +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHIS-------------ENTPGKVL 587
++ LLG C G ++++ E+ S GN R ++ P + L
Sbjct: 86 IINLLGACTQDG--------PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
++ + ++ VA+ +++L + + + N+L+ E + K++D+GL+
Sbjct: 138 SFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 37/164 (22%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 484 NFDMSAIMGEGSYGKLYKG-RLENGTSVAIRCLPSSKKYTV-RNLKLR-LDLLAKLRHPH 540
+F++ +G+GS+G ++K R + A++ + SK R + +LAKL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN----WSERLAVL 596
++ +D G K+ +V E+ NG+ + G+ L W + +L
Sbjct: 61 IIRYYESFLDKG--------KLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQIL 111
Query: 597 IGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+G+A LH+ I + +K+ N+ L+ + K+ D G++
Sbjct: 112 LGLA----HLHSKKI---LHRDIKSLNLFLDAYDNVKIGDLGVA 148
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 31/170 (18%)
Query: 484 NFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSS----KKYTVRNLKLRLDLLAK 535
NF++ ++G G+YGK++ R ++G A++ L + K T + + +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 536 LRH-PHLVCLLGHCIDGGGRDDYAVN---KVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
+R P LV L YA K+ L+ ++++ G TH+S+ K +
Sbjct: 61 IRQSPFLVTL-----------HYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQ 105
Query: 592 RLAVLIG-VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + G + A++ LH G +K NILL+ + L+D+GLS
Sbjct: 106 EVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 39/166 (23%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHC 548
++G+G+YG +Y R L +AI+ +P V+ L + L + L+H ++V LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN------W---SERLAVLIGV 599
+ G F + FM E PG L+ W + +I
Sbjct: 75 SENG---------FFKI--FM----------EQVPGGSLSALLRSKWGPLKDNEQTIIFY 113
Query: 600 AKAV----QFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGLS 640
K + ++LH I + +K +N+L+N + + K+SD+G S
Sbjct: 114 TKQILEGLKYLHDNQI---VHRDIKGDNVLVNTYSGVVKISDFGTS 156
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 33/151 (21%), Positives = 77/151 (50%), Gaps = 18/151 (11%)
Query: 491 MGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
+G+G+ G ++ + G VAI+ + K+ + + ++ +L++P++V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFL---- 82
Query: 550 DGGGRDDYAV-NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT 608
D + V +++F+V E+++ G+ ++E ++ ++ AV +A++FLH
Sbjct: 83 -----DSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHA 133
Query: 609 GVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
+ + +K++N+LL KL+D+G
Sbjct: 134 NQV---IHRDIKSDNVLLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 46/176 (26%)
Query: 486 DMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTV---RNLKLRLDLLAKLRHPHL 541
D+ I G GS+G +Y R + VAI+ + S K + +++ + L +LRHP+
Sbjct: 19 DLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT 77
Query: 542 V----CLLG---------HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN 588
+ C L +C+ G D V+K K L
Sbjct: 78 IEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-----------------------KPLQ 113
Query: 589 WSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG-LSIVS 643
E A+ G + + +LH+ + +K NILL E KL+D+G S+VS
Sbjct: 114 EVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 18/60 (30%), Positives = 27/60 (45%)
Query: 167 KLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAI 226
L++L L +N F LP+L L + N L P + + +L LDLS N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 40/154 (25%), Positives = 77/154 (50%), Gaps = 23/154 (14%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRC--LPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHC 548
G+GS+G++YK VAI+ L ++ + +++ + L++ R P++ G
Sbjct: 10 GKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-EIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT 608
+ G +K++++ E+ G+ + PGK L+ + +L V +++LH
Sbjct: 69 LKG--------SKLWIIMEYCGGGSCLDLLK---PGK-LDETYIAFILREVLLGLEYLHE 116
Query: 609 -GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
G I +R +K NILL+E KL+D+G+S
Sbjct: 117 EGKI-----HRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 35/153 (22%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 491 MGEGSYGKLYKGRLENGTS--VAIRCLP-SSKKYTVRNLKLRLDLLAKLRHPHLVCLLGH 547
+G+GS+G++YKG ++N T VAI+ + + + +++ + +L++ P++ G
Sbjct: 12 IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
+ G K++++ E++ G + + PG L + +L + K + +LH
Sbjct: 71 YLKG--------TKLWIIMEYLGGG---SALDLLKPGP-LEETYIATILREILKGLDYLH 118
Query: 608 TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + +K N+LL+E KL+D+G++
Sbjct: 119 S---ERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 45/186 (24%), Positives = 71/186 (38%), Gaps = 46/186 (24%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCL-----PSSKKYTVRNLKLRLDLLAKL 536
+ +GEG+ G + K RL G A++ + P +K +R L++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEI----NKSC 56
Query: 537 RHPHLVCLLGHCID-------------GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP 583
+ P++V G +D GG D KV G I E
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV------KKRGG---RIGEKVL 107
Query: 584 GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643
GK+ V K + +LH+ I + +K +NILL KL D+G+S
Sbjct: 108 GKIAE---------SVLKGLSYLHSRKI---IHRDIKPSNILLTRKGQVKLCDFGVS--G 153
Query: 644 EDINSV 649
E +NS+
Sbjct: 154 ELVNSL 159
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 33/171 (19%)
Query: 484 NFDMSAIMGEGSYGKLYKGRLENG--------TSVAIRCLPSSKKYTVRNLKLRLDLLAK 535
NF++ ++G G+YGK++ R G V + K TV + + ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 536 LRH-PHLVCLLGHCIDGGGRDDYAVN---KVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
+R P LV L YA K+ L+ +++S G TH+ + N+SE
Sbjct: 61 VRQSPFLVTL-----------HYAFQTEAKLHLILDYVSGGEMFTHLYQRD-----NFSE 104
Query: 592 -RLAVLIG-VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ G + A++ LH G +K NILL+ L+D+GLS
Sbjct: 105 DEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 20/165 (12%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP----SSKKYTVRNLKLRLDLLAKL 536
NF + +G+G + +YK L +G VA++ + K LK +DLL +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL--A 594
HP+++ L I+ N++ +V E G+ I K L ER
Sbjct: 60 DHPNVIKYLASFIEN--------NELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWK 110
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
+ + A++ +H+ I + +K N+ + + KL D GL
Sbjct: 111 YFVQLCSALEHMHSKRI---MHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 32/160 (20%), Positives = 66/160 (41%), Gaps = 28/160 (17%)
Query: 491 MGEGSYGKLYKGRLENGTS----VAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLL 545
+G+GS+G + +G VA++CL S K + + ++ L H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL-----NWSERLAVLIGVA 600
G + + + +V E G+ + ++ G L +++ + +A
Sbjct: 63 GVVLT---------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IA 107
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+++L + F + + NILL K+ D+GL
Sbjct: 108 NGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 40/155 (25%), Positives = 78/155 (50%), Gaps = 26/155 (16%)
Query: 491 MGEGSYGKLYKG-RLENGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLG 546
+G+G+ G +Y + G VAI+ + KK + N L ++ + +HP++V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL---VMRENKHPNIVNYL- 82
Query: 547 HCIDGGGRDDYAV-NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
D Y V +++++V E+++ G+ ++E ++ + AV +A++F
Sbjct: 83 --------DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEF 130
Query: 606 LHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
LH+ VI + +K++NILL KL+D+G
Sbjct: 131 LHSNQVI----HRDIKSDNILLGMDGSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 23/62 (37%), Positives = 34/62 (54%)
Query: 98 NASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGS 157
+ +LS N + +L +TSL VL L GS+P+ + +L SL L+L+ N L G
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 158 VP 159
VP
Sbjct: 506 VP 507
|
Length = 623 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 30/166 (18%)
Query: 490 IMGEGSYGKLYK-GRLENGTSVAIRCLPSSKKYTVRNLKLR--------LDLLAKLRHPH 540
+G+GS+G + K R +G + K+ N+ + +++L +L+HP+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVW------KEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-GKVLNWSERLAVLIGV 599
+V ID + +++V E+ G+ I + K + +L +
Sbjct: 61 IVRYYDRIID------RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 600 AKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
A+ H PG N V K NI L+ + KL D+GL+
Sbjct: 115 LLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAI-RCLPSSKKYTVRNLKLR-LDLLAKLRH-PHLVCLL 545
+GEG+YGK+YK R G VA+ + + + LR + LL L ++V LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 546 G--HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN--TPGKVLNWSERLAVLIGVAK 601
H + G+ ++LV+E++ + + + + N PG+ L + + + K
Sbjct: 68 DVEHVEEKNGK-----PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 602 AVQFLHT-GVIPGFFNNRVKTNNILLNEHR-IAKLSDYGLS 640
V H GV+ + +K N+L+++ + + K++D GL
Sbjct: 122 GVAHCHKHGVM----HRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 45/170 (26%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVR-------NLKLRLDLLAKLRHPHL 541
I+G G +G++Y R + G A++CL K+ ++ N ++ L L++ P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 542 VCLLGHCIDGGGRDDYAV---NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
VC+ YA +K+ + + M+ G+ H+S++ +SE
Sbjct: 60 VCM-----------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSE------- 96
Query: 599 VAKAVQFLHTGVIPGF--FNNR------VKTNNILLNEHRIAKLSDYGLS 640
++F +I G +NR +K NILL+EH ++SD GL+
Sbjct: 97 --AEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 32/173 (18%), Positives = 78/173 (45%), Gaps = 34/173 (19%)
Query: 491 MGEGSYGKLY--------KGRLENGTSVAIRCLPS-SKKYTVRNLKLRLDLLAKL-RHPH 540
+GEG +G++ K + +VA++ L + + +L ++++ + +H +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISE-------------NTPGKVL 587
++ LLG C G ++++ E+ S GN R ++ P + L
Sbjct: 80 IINLLGACTQDG--------PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + ++ VA+ +++L + + + N+L+ E + K++D+GL+
Sbjct: 132 TFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 34/178 (19%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRL----EN-GTSVAIRCLPSSKKYTVRNLKLR 529
L LKE F ++G G++G +YKG E VAI+ L + K
Sbjct: 1 LRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEI 56
Query: 530 LD---LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG-- 584
LD ++A + +PH+ LLG C+ + V L+ + M G ++ E+
Sbjct: 57 LDEAYVMASVDNPHVCRLLGICL---------TSTVQLITQLMPFGCLLDYVREHKDNIG 107
Query: 585 --KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+LNW + +AK + +L + + + N+L+ + K++D+GL+
Sbjct: 108 SQYLLNWC------VQIAKGMNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 23/167 (13%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTS-VAIR---------CLPSSKKYTVRNLKLRLDLL 533
++ A +GEG+YGK++K R L+NG VA++ +P S T+R + + L L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAV-LRHL 58
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
HP++V L C R D K+ LV+E + + T++ + P +
Sbjct: 59 ETFEHPNVVRLFDVCT--VSRTDRE-TKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIK 113
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
++ + + + FLH+ + + +K NIL+ KL+D+GL+
Sbjct: 114 DMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 36/166 (21%), Positives = 73/166 (43%), Gaps = 29/166 (17%)
Query: 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRL-------DLLAK------LR 537
+GEG +G + +G+L S+ K V+ +K+ + D L++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSIL--------KVAVKTMKIAICTRSEMEDFLSEAVCMKEFD 58
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV---LNWSERLA 594
HP+++ L+G C+ + Y V L FM +G+ + + + G L +
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVIL--PFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK 116
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ +A +++L + F + + N +LNE+ ++D+GLS
Sbjct: 117 FMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 28/167 (16%)
Query: 491 MGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYT---VRNLKLRLDLLAKLRHPHLV---- 542
+G GS+G +Y R + N VAI+ + S K + +++ + L KLRHP+ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEF-MSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
C L + +LV E+ + + + + + K L E AV G +
Sbjct: 83 CYLRE------------HTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQ 126
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ +LH+ + VK NILL+E + KL D+G + + N
Sbjct: 127 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.98 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.98 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.94 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.93 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.93 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.93 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.93 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.92 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.92 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.92 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.92 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.92 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.92 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.92 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.92 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.92 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.92 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.91 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.91 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.91 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.91 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.91 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.91 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.91 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.91 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.91 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.9 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.9 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.9 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.9 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.9 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.9 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.9 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.9 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.9 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.9 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.9 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.89 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.89 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.89 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.89 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.89 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.89 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.88 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.88 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.88 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.88 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.88 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.87 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.87 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.87 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.87 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.87 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.87 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.86 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.86 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.85 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.84 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.83 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.83 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.81 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.81 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.79 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.79 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.79 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.77 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.77 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.76 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.75 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.65 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.58 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.52 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.41 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.29 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.29 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.21 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.14 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.05 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.98 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.94 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.86 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.85 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.84 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.83 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.74 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.71 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.71 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.67 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.59 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.57 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.57 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.3 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.18 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.17 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.16 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.1 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.09 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.05 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-66 Score=626.59 Aligned_cols=585 Identities=28% Similarity=0.459 Sum_probs=344.3
Q ss_pred CChHHHHHHHHHHhcCCCC-CCCCCccCCCCCCCCCCCCCccceEeC-CCCEeEEEecCCCCCCC---------------
Q 005898 26 LQSSQTQVLLQLRKHLEYP-KQLEIWINHGADFCYISSSTQVNITCQ-DNFITELKIIGDKPSNV--------------- 88 (671)
Q Consensus 26 ~~~~~~~~Ll~~k~~~~~~-~~l~~W~~~~~~~C~~~~~~~~~v~C~-~~~v~~l~l~~~~~~~~--------------- 88 (671)
..+.|++||++||+++.+| ..+.+|+.. .|||.|. ||+|+ ..+|+.+++.+....+.
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~-----gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQ-----GITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCc-----ceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 4568999999999999877 467899764 7899986 69996 46899999876543221
Q ss_pred ---CCCCCc------------cc--------------------ccccCCCccCCCcchhcccCCCCCCEEeccccccccc
Q 005898 89 ---GNFDGF------------AS--------------------ANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGS 133 (671)
Q Consensus 89 ---~~~~~~------------~~--------------------~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~ 133 (671)
+.+.+. .. ..++++.|...+.+|..++++++|++|+|++|.+.+.
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence 001000 00 0011122222334566667777777777777777666
Q ss_pred CCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCc------
Q 005898 134 LPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFP------ 207 (671)
Q Consensus 134 ~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p------ 207 (671)
+|..++++++|++|+|++|++++.+|..++++++|++|+|++|.+++.+|..++++++|++|++++|++++.+|
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 259 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259 (968)
T ss_pred CChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCC
Confidence 77666667777777766666666666666666666666666666655555555555555555555555544444
Q ss_pred ------------------ccccCCCCCCEEEeccCccccccCC-CCCCCC------------------------CCEEEC
Q 005898 208 ------------------SSIQRISTLSDLDLSKNAISGSLPD-LSSLGS------------------------LNVLNL 244 (671)
Q Consensus 208 ------------------~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~------------------------L~~L~L 244 (671)
..+.++++|+.|++++|.+++.+|. +..+++ |+.|++
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 4444455555555555555444332 122223 333333
Q ss_pred CCCCCCCCCCCC---CC------------------------------------------------C--------------
Q 005898 245 SDNKLDSNLPKL---PR------------------------------------------------G-------------- 259 (671)
Q Consensus 245 s~N~l~~~~p~~---~~------------------------------------------------~-------------- 259 (671)
++|.+++.+|.. .. +
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~ 419 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence 333322222110 00 0
Q ss_pred ---------------------------------------------------------ccEEEcCCCCCCCCchhhhcCCc
Q 005898 260 ---------------------------------------------------------LVMAFLSNNSFSGEIPKQYGQLN 282 (671)
Q Consensus 260 ---------------------------------------------------------L~~l~l~~N~l~~~~p~~~~~l~ 282 (671)
|+.+++++|++++.+|..+..++
T Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~ 499 (968)
T PLN00113 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499 (968)
T ss_pred CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhh
Confidence 11222333333333333444444
Q ss_pred ccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccC
Q 005898 283 QLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362 (671)
Q Consensus 283 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~ 362 (671)
+|+.|++++|++++.+|..+..+++|+.|+|++|.++|.+|..+..+++|+.|||++|+++|.+|..+..++.++.++++
T Consensus 500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls 579 (968)
T PLN00113 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579 (968)
T ss_pred ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence 45555555555555555555566666666666666666666666666666666666666666666666666666666666
Q ss_pred CCcCCCCcCCCCC------------CCcchhcccc-----ccccCCCCccceeeeehhhHHHHHHHHHHhheeeeeccCC
Q 005898 363 GNCLSSNVQNQHP------------ESYCFEVRTE-----RNQAGSKNVGKLVGIIVGVLVIMVLLAFGFLVVCRRYCPR 425 (671)
Q Consensus 363 ~N~l~~~~~~~~~------------~~~~~~~~~~-----~~~~~~~~~~~~igiivg~~v~l~l~~~~~~~~~rr~~~~ 425 (671)
+|.+++..|.... ...|...... ..........+++++++++++++++++++++ ++||++..
T Consensus 580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 658 (968)
T PLN00113 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFV-FIRGRNNL 658 (968)
T ss_pred CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHH-HHHhhhcc
Confidence 6666654442110 0112111000 0000001111222222222222222222222 22221111
Q ss_pred CccccccccccccCCCCCCCchhhhhhhhhhhhhhhcCCCCCCCccccCHHHHHHHhcCCCcCceeccCCceEEEEEEE-
Q 005898 426 CTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRL- 504 (671)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~- 504 (671)
..++. .... +. .+ .........+.++++++. ..++..++||+|+||.||+|+.
T Consensus 659 ~~~~~-------~~~~--~~-~~-------------~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~ 712 (968)
T PLN00113 659 ELKRV-------ENED--GT-WE-------------LQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSI 712 (968)
T ss_pred ccccc-------cccc--cc-cc-------------ccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEEC
Confidence 00000 0000 00 00 000000011224455544 3577788999999999999996
Q ss_pred cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCC
Q 005898 505 ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG 584 (671)
Q Consensus 505 ~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~ 584 (671)
.+|..||||++...... ..+|++.|++++|||||+++|+|.+.+ ..++|||||++|+|.++++.
T Consensus 713 ~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~--------~~~lv~Ey~~~g~L~~~l~~---- 776 (968)
T PLN00113 713 KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK--------GAYLIHEYIEGKNLSEVLRN---- 776 (968)
T ss_pred CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC--------CCEEEEeCCCCCcHHHHHhc----
Confidence 57899999998754322 234688899999999999999998753 57999999999999999963
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc----------------------
Q 005898 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV---------------------- 642 (671)
Q Consensus 585 ~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~---------------------- 642 (671)
++|.++.+++.|||+|++|||+.+.++|+||||||+||++++++.+++. ||.+..
T Consensus 777 --l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 853 (968)
T PLN00113 777 --LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETK 853 (968)
T ss_pred --CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCC
Confidence 8999999999999999999998877899999999999999999888774 443311
Q ss_pred ----cccccccceeeeeeehhhhc
Q 005898 643 ----SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 643 ----~~d~~s~g~~l~~~~~~~~~ 662 (671)
..|+||+||++|||+++...
T Consensus 854 ~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 854 DITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred CCCcccchhhHHHHHHHHHhCCCC
Confidence 12999999999999998654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.34 Aligned_cols=184 Identities=42% Similarity=0.744 Sum_probs=165.7
Q ss_pred ccccCHHHHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceee
Q 005898 470 CRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549 (671)
Q Consensus 470 ~~~~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 549 (671)
.+.|+++++..||++|...++||+|+||.||+|.+++|..||||++........++|.+|++++++++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 46799999999999999999999999999999999999999999987654321567999999999999999999999999
Q ss_pred cCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 550 ~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
+.++ +.+||||||++|+|+++|+..... +++|.+|++||.++|+||+|||+.+.|+||||||||+|||||++
T Consensus 142 e~~~-------~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 142 EGGE-------HRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred cCCc-------eEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 7641 379999999999999999976533 79999999999999999999999999999999999999999999
Q ss_pred CcEEEcccCCcccc-----------c--------------------cccccceeeeeeehhhh
Q 005898 630 RIAKLSDYGLSIVS-----------E--------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 630 ~~~ki~DfGla~~~-----------~--------------------d~~s~g~~l~~~~~~~~ 661 (671)
++|||+|||+|+.. . |+||+|++|.|++||-.
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCc
Confidence 99999999997543 1 99999999999988764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=300.10 Aligned_cols=167 Identities=29% Similarity=0.503 Sum_probs=149.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..+|...+.||+|+||+||+|+.+ ++.+||||++.+. .....+.+..|+++|++++|||||+|++++++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~------ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD------ 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC------
Confidence 356777788999999999999965 6899999999766 4556777899999999999999999999998874
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC------CcE
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH------RIA 632 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~------~~~ 632 (671)
.+|||||||.+|||..|++.++ .++......++.|+|.||++||++ +||||||||.||||+.. -.+
T Consensus 83 --~i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 83 --FIYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred --eEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 8999999999999999999765 389999999999999999999998 79999999999999764 568
Q ss_pred EEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 633 KLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 633 ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+|||+|+... |+||+|+++|+|++|...
T Consensus 155 KIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 155 KIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred EecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC
Confidence 999999998765 999999999999998544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.86 Aligned_cols=168 Identities=24% Similarity=0.486 Sum_probs=149.8
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
.++..+.||+|.||.||.|+++....||||.++... ...++|.+|+++|.+++|+|||+++|+|..++ .+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--------piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--------PIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC--------ceE
Confidence 344568899999999999999877799999998753 34578999999999999999999999998753 589
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
||||||+.|+|.+||+.. .+..+.-.+-+.++.|||+|++||+++ .+|||||.++|||++++..+||+|||+|+..
T Consensus 278 IVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999973 245688999999999999999999998 7999999999999999999999999999964
Q ss_pred c-------------------------------cccccceeeeeeehhhhccc
Q 005898 644 E-------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 644 ~-------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
. ||||+||+||||.|....++
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC
Confidence 3 99999999999999866663
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=280.69 Aligned_cols=169 Identities=25% Similarity=0.440 Sum_probs=145.1
Q ss_pred hcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchh-------hHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKY-------TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
.+.|...+.+|+|+||.|-+|. -.+|+.||||++.+.... ......+|+++|.+++|||||++++++..++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d- 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD- 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence 3456778999999999999998 458999999999654311 1234579999999999999999999998764
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC---C
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH---R 630 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~---~ 630 (671)
..|||||||++|+|.+.+-... .+.......++.|+..|+.|||+. +|+||||||+|||+..+ .
T Consensus 250 -------s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 250 -------SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred -------ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcce
Confidence 5799999999999999887543 377777889999999999999998 89999999999999755 8
Q ss_pred cEEEcccCCccccc--------------------------------cccccceeeeeeehhhhccc
Q 005898 631 IAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 631 ~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
.+||+|||+|+... |+||+||++|.++||+++..
T Consensus 317 llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS 382 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFS 382 (475)
T ss_pred EEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcc
Confidence 89999999998763 99999999999999987643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.24 Aligned_cols=167 Identities=25% Similarity=0.450 Sum_probs=145.2
Q ss_pred cCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.|+..++||+|.||.||||+ ..+|+.||+|++.... .....-..+||.+|++++|||||+|.+...+...
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~------ 190 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS------ 190 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC------
Confidence 457778899999999999998 6789999999997544 3334556899999999999999999998877521
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..+|||+|||++ ||.-++.. ++-.++..+...++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+||||
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred ceEEEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence 368999999998 88877764 334599999999999999999999998 899999999999999999999999999
Q ss_pred ccccc--------------------------------cccccceeeeeeehhhh
Q 005898 640 SIVSE--------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~~--------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|++++ |+||+||||+||..|-.
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence 99654 99999999999988754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=290.85 Aligned_cols=167 Identities=24% Similarity=0.431 Sum_probs=151.1
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..|+..+.||+|||..||.++. ++|+.||+|++.+. +..+.+...+||++-++++|||||+++++|++.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~------ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN------ 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC------
Confidence 4588889999999999999996 88999999999763 3455778999999999999999999999999874
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
++|+|.|+|++|+|.+++..+ +++++.....+..||+.||.|||+. +|||||||..|+++++++++||+|||
T Consensus 92 --nVYivLELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 92 --NVYIVLELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred --ceEEEEEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 899999999999999988743 4599999999999999999999998 79999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
||..++ |+||+||+||.|+.|.+..
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPF 218 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPF 218 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCc
Confidence 997654 9999999999999876654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=288.67 Aligned_cols=164 Identities=26% Similarity=0.515 Sum_probs=141.6
Q ss_pred cCceeccCCceEEEEEEEcCCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
..+.||+|+||+||+|.++....||||++..... ...++|.+|+.+|.+++|||||+++|+|.++. ....+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-------~~~~i 117 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-------GSLCI 117 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-------CceEE
Confidence 3456999999999999998544599999975432 22668999999999999999999999998753 14799
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEcccCCcccc
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGLSIVS 643 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~DfGla~~~ 643 (671)
|||||++|+|.++++.. ....++|..++++|.|||+||.|||++.. ||||||||+|||++.++ ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999999999999874 34569999999999999999999999732 99999999999999998 9999999999431
Q ss_pred c--------------------------------cccccceeeeeeehhh
Q 005898 644 E--------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 644 ~--------------------------------d~~s~g~~l~~~~~~~ 660 (671)
. |+||+|+++|||+|+-
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~ 243 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGE 243 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCC
Confidence 1 9999999999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=296.59 Aligned_cols=178 Identities=26% Similarity=0.502 Sum_probs=154.9
Q ss_pred ccccCHHHHHHHhcCC---------CcCceeccCCceEEEEEEEc-C---CcEEEEEEccCCc-hhhHHHHHHHHHHHhc
Q 005898 470 CRSFTLEELKEATNNF---------DMSAIMGEGSYGKLYKGRLE-N---GTSVAIRCLPSSK-KYTVRNLKLRLDLLAK 535 (671)
Q Consensus 470 ~~~~~~~~~~~~~~~f---------~~~~~iG~G~~g~Vy~~~~~-~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~ 535 (671)
.++++|||.-+|...| ++.++||.|.||.||+|+++ . ...||||.++... ..++++|..|+.+|++
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3456777665555544 56789999999999999975 2 3589999998764 4567899999999999
Q ss_pred CCCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCcc
Q 005898 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFF 615 (671)
Q Consensus 536 l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii 615 (671)
++||||++|.|+..... .+|+|+|||+||+|+.||+... ..++|.+...+.++||.|+.||.+. ++|
T Consensus 687 FdHPNIIrLEGVVTks~--------PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YV 753 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSK--------PVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYV 753 (996)
T ss_pred CCCCcEEEEEEEEecCc--------eeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cch
Confidence 99999999999987653 7899999999999999998754 3499999999999999999999987 899
Q ss_pred ccCCCCCceeecCCCcEEEcccCCccccc---------------------------------cccccceeeeeeehhh
Q 005898 616 NNRVKTNNILLNEHRIAKLSDYGLSIVSE---------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 616 HrDlk~~NiLl~~~~~~ki~DfGla~~~~---------------------------------d~~s~g~~l~~~~~~~ 660 (671)
||||.++|||++.+..+||+|||+++.++ |+||.|++|||.|++.
T Consensus 754 HRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG 831 (996)
T KOG0196|consen 754 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 831 (996)
T ss_pred hhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence 99999999999999999999999998764 9999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-33 Score=267.99 Aligned_cols=168 Identities=24% Similarity=0.317 Sum_probs=141.9
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.|+...++|+|+||+|||++.+ +|+.||||++.+... .-.+-..+||++|++++|+|+|.|+++|....
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-------- 74 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-------- 74 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--------
Confidence 4666778999999999999965 799999999976543 23455789999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
.++||+||++..-|++.=+.. .-++.....++..|+++|+.|+|.+ .+|||||||+|||+..++.+|++|||+|
T Consensus 75 klhLVFE~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 75 KLHLVFEYCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred eeEEEeeecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhh
Confidence 789999999985444332222 2378888899999999999999998 7999999999999999999999999999
Q ss_pred cccc-------------------------------cccccceeeeeeehhhhcccc
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+.+. |+|++||++.||++|.+=-|+
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 8744 999999999999998765443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=262.02 Aligned_cols=167 Identities=25% Similarity=0.406 Sum_probs=145.5
Q ss_pred CCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchh--hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKY--TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.|...+++|+|.||+||+|+ ..+|+.||||+++..+.. -.....+||..|+.++|+||+.|+++|.+.+
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-------- 74 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-------- 74 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC--------
Confidence 35567889999999999999 458999999999765322 2456889999999999999999999997654
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
.+-||+|||+. ||+..+++.. ..+...+...++.++.+|++|||.+ -|+||||||.|+|++++|.+||+|||+|
T Consensus 75 ~l~lVfEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 75 NLSLVFEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred ceEEEEEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccch
Confidence 68899999987 9999998753 4589999999999999999999997 7999999999999999999999999999
Q ss_pred cccc-------------------------------cccccceeeeeeehhhhccc
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
+.+. |+||+|||++||+-+.+=.+
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp 203 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP 203 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC
Confidence 8654 99999999999987655433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=300.53 Aligned_cols=171 Identities=27% Similarity=0.506 Sum_probs=149.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
.+.+.+..+.||+|+||+||+|+.. +...||||.+++.... ..++|++|+++|+.++|||||+|+|+|.+++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~- 562 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD- 562 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-
Confidence 3455566788999999999999842 3468999999887655 7889999999999999999999999999875
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCC
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTP-----------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTN 622 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~ 622 (671)
..+||+|||..|||.+||+...+ ..+|+-.+.+.||.|||.||+||-++ .+|||||..+
T Consensus 563 -------P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATR 632 (774)
T KOG1026|consen 563 -------PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATR 632 (774)
T ss_pred -------eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhh
Confidence 68999999999999999975332 12388999999999999999999987 7899999999
Q ss_pred ceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehhhhc
Q 005898 623 NILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 623 NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+|+.++..+||+|||+++.+. ||||+||+|||+.|+..-
T Consensus 633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~Q 704 (774)
T KOG1026|consen 633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQ 704 (774)
T ss_pred hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccC
Confidence 9999999999999999997532 999999999999886543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=269.43 Aligned_cols=171 Identities=22% Similarity=0.378 Sum_probs=147.3
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeec
Q 005898 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 550 (671)
++.+|++. .+.||+|..|+|||++.+ +++.+|+|.+... +....++..+|++++.+++||+||.++|.|+.
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45555554 578999999999999975 7999999999533 34456889999999999999999999999987
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
.. +.+.++||||.+|+|+.++...+ .+++...-+|+.+|.+||.|||+. .+||||||||+|||++..|
T Consensus 149 ~~-------~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskG 216 (364)
T KOG0581|consen 149 NG-------EEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKG 216 (364)
T ss_pred CC-------ceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCC
Confidence 64 14899999999999999987643 388899999999999999999964 2799999999999999999
Q ss_pred cEEEcccCCccccc----------------------------cccccceeeeeeehhhhc
Q 005898 631 IAKLSDYGLSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 631 ~~ki~DfGla~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++||+|||.++.+. |+||+|.++.|++.|-+.
T Consensus 217 eVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP 276 (364)
T KOG0581|consen 217 EVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFP 276 (364)
T ss_pred CEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCC
Confidence 99999999997533 999999999999998443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=271.47 Aligned_cols=169 Identities=27% Similarity=0.471 Sum_probs=148.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
-++|+..++||+|+||+||.++- ++++.+|+|++++.. ....+....|..+|.+++||.||+++-.|++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~----- 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE----- 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-----
Confidence 35789999999999999999984 579999999997653 334677899999999999999999998888764
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.+|||+||+.||+|..+|.+.+. ++.....-++..|+.||.|||+. +||||||||+|||||++|+++++||
T Consensus 99 ---kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 99 ---KLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred ---eEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence 79999999999999999986543 77777777788999999999997 8999999999999999999999999
Q ss_pred CCccccc------------------------------cccccceeeeeeehhhhccc
Q 005898 638 GLSIVSE------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 638 Gla~~~~------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|+++... |-||+|+++|+|++|.+...
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 9997421 99999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=317.66 Aligned_cols=253 Identities=34% Similarity=0.530 Sum_probs=167.0
Q ss_pred CCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
++++|++|+|++|++.|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|
T Consensus 116 ~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 193 (968)
T PLN00113 116 TSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFL 193 (968)
T ss_pred cCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCee
Confidence 444455555555544444443 335555555555555555566666666666666666666666666666666666666
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCC---CCCccEEEcCCCCCC
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLSNNSFS 271 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~~N~l~ 271 (671)
+|++|++++.+|..++++++|+.|+|++|.+++.+|. ++.+++|++|++++|++++.+|.. ..+|+.+++++|.++
T Consensus 194 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 273 (968)
T PLN00113 194 TLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273 (968)
T ss_pred eccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeee
Confidence 6666666666666666666666666666666665553 566666666666666666666543 245666777777777
Q ss_pred CCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCC
Q 005898 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLS 351 (671)
Q Consensus 272 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~ 351 (671)
+.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..++
T Consensus 274 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 353 (968)
T PLN00113 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353 (968)
T ss_pred ccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHh
Confidence 77777777777777777777777777776677777777777777777777777777777777777777777777777777
Q ss_pred CCCCCceeccCCCcCCCCc
Q 005898 352 NESDKRVVKFRGNCLSSNV 370 (671)
Q Consensus 352 ~~~~l~~l~l~~N~l~~~~ 370 (671)
.+++++.+++++|.+++..
T Consensus 354 ~~~~L~~L~Ls~n~l~~~~ 372 (968)
T PLN00113 354 KHNNLTVLDLSTNNLTGEI 372 (968)
T ss_pred CCCCCcEEECCCCeeEeeC
Confidence 7777777777777766543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=265.76 Aligned_cols=169 Identities=22% Similarity=0.386 Sum_probs=144.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhh--HHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYT--VRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.|++|.||+||+|+.. +++.||+|+++...... ----.+||.+|.+++|||||.+..+.....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~------ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN------ 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc------
Confidence 345777899999999999999964 78999999997654221 123478999999999999999999887643
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+.+|||||||+. ||...++... +++...+...++.|+.+|++|||++ -|+|||||++|+|+.+.|..||+|||
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence 3479999999998 9999998643 4588889999999999999999998 79999999999999999999999999
Q ss_pred Cccccc-------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|+.+. |+||+|||++||++.-+=
T Consensus 223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence 998654 999999999999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=261.84 Aligned_cols=170 Identities=24% Similarity=0.438 Sum_probs=144.2
Q ss_pred cCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccce-eecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGH-CIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~~~~~~ 558 (671)
.+|+..++||+|+||.|||+. +.+|..||.|.+.-. +....++...|+.+|++++|||||+.++. +.+..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~------ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN------ 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc------
Confidence 346677899999999999998 678999999998632 33456789999999999999999999883 33321
Q ss_pred cceEEEEEecCCCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCC--ccccCCCCCceeecCCCcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISE-NTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPG--FFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~--iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
+.+++||||+..|||...+.. +..++.++.....++..|.++||..+|. ..|. |+||||||.||+++.+|.+|++
T Consensus 93 -evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~-~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 93 -EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHS-KIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred -hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhc-cccccceeeccCcchheEEcCCCceeec
Confidence 248999999999999998865 3345668999999999999999999998 2345 9999999999999999999999
Q ss_pred ccCCccccc------------------------------cccccceeeeeeehhh
Q 005898 636 DYGLSIVSE------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 636 DfGla~~~~------------------------------d~~s~g~~l~~~~~~~ 660 (671)
|||+++.++ |+||+||++|||+.-.
T Consensus 171 DfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~ 225 (375)
T KOG0591|consen 171 DFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ 225 (375)
T ss_pred cchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence 999998765 9999999999987643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=267.15 Aligned_cols=172 Identities=29% Similarity=0.472 Sum_probs=145.6
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--------------hhHHHHHHHHHHHhcCCCCCcccc
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--------------YTVRNLKLRLDLLAKLRHPHLVCL 544 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l 544 (671)
...++|++...||+|.||+|-+|+.. +++.||||++.+... ...+..++||++|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45678999999999999999999965 799999999964321 123578999999999999999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCc
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV-LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNN 623 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~N 623 (671)
+++..++. .+.+|||+|||..|.+.. .. ..++ ++..+..++..++..||+|||.+ +||||||||+|
T Consensus 174 iEvLDDP~------s~~~YlVley~s~G~v~w-~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN 240 (576)
T KOG0585|consen 174 IEVLDDPE------SDKLYLVLEYCSKGEVKW-CP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN 240 (576)
T ss_pred EEeecCcc------cCceEEEEEeccCCcccc-CC---CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence 99887654 357999999999998743 22 2233 89999999999999999999997 89999999999
Q ss_pred eeecCCCcEEEcccCCccccc---------------------------------------cccccceeeeeeehhhhccc
Q 005898 624 ILLNEHRIAKLSDYGLSIVSE---------------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 624 iLl~~~~~~ki~DfGla~~~~---------------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
+|+++++++||+|||.+.... |+||+|||+|.|+-|-+..+
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 999999999999999986441 99999999999887766554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=267.19 Aligned_cols=171 Identities=24% Similarity=0.370 Sum_probs=140.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
.|...+++|.|+||.||+|++. +++.||||+.-..++. --+|+++|++++|||||+|+-+|....+.| .-..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d---~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESD---EVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCc---hhHH
Confidence 3556789999999999999964 6799999998655432 246889999999999999998888765332 1245
Q ss_pred EEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEEEcccCCc
Q 005898 563 FLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGLS 640 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~ki~DfGla 640 (671)
-+||||||. +|.+.++.. ..+..++-....-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 689999998 999888742 1223466667778899999999999995 89999999999999976 99999999999
Q ss_pred cccc------------------------------cccccceeeeeeehhhhcccc
Q 005898 641 IVSE------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 641 ~~~~------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+... |+||.||+++||+.|..=.+|
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 8754 999999999999998765554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=274.31 Aligned_cols=165 Identities=27% Similarity=0.448 Sum_probs=146.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|...+.||+|+||.||||+-+ +.+.||+|.+.+.. +...+.+.+|++++++++|||||.++++|.+..
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~------- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA------- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc-------
Confidence 45777789999999999999854 78999999997654 345678999999999999999999999998764
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
++++|+||+.+ +|+++|.... .+.+.+...|+.+...||.|||+. .|+|||+||.|||+++.+++|++|||+
T Consensus 75 -~~~vVte~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 75 -HLWVVTEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred -eEEEEehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 78999999977 9999998653 489999999999999999999998 899999999999999999999999999
Q ss_pred ccccc------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+... |.||+||++|||++|.+.
T Consensus 147 Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PP 199 (808)
T KOG0597|consen 147 ARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPP 199 (808)
T ss_pred hhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCC
Confidence 97533 999999999998876543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=269.89 Aligned_cols=147 Identities=24% Similarity=0.462 Sum_probs=131.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
..++|+...+||+|+||.||.|+- ++|..+|+|++++.. ..+.+..+.|-.+|...++|+||+|+..|.+.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~---- 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE---- 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC----
Confidence 567899999999999999999985 579999999998764 345678899999999999999999998888764
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
.+||||||+||||+.+.|.... .|+......++.+..-|++-+|.. ++|||||||+|+|||..|++|++|
T Consensus 215 ----~LYLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 215 ----YLYLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred ----eeEEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 8999999999999999998654 388887778888888999999997 899999999999999999999999
Q ss_pred cCCcc
Q 005898 637 YGLSI 641 (671)
Q Consensus 637 fGla~ 641 (671)
|||++
T Consensus 285 FGLs~ 289 (550)
T KOG0605|consen 285 FGLST 289 (550)
T ss_pred ccccc
Confidence 99984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=274.06 Aligned_cols=175 Identities=23% Similarity=0.438 Sum_probs=151.1
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEEcC--C--cE-EEEEEccC---CchhhHHHHHHHHHHHhcCCCCCcccc
Q 005898 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRLEN--G--TS-VAIRCLPS---SKKYTVRNLKLRLDLLAKLRHPHLVCL 544 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~--g--~~-vAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l 544 (671)
+..+.++...++....++||+|+||.||+|++.. + .. ||||..+. ......++|.+|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 4445555566677778999999999999998653 2 23 89999874 335667899999999999999999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
+|++.... ..|+|||+|+||+|.++|+.... .++..+++.++.++|+||+|||+. .+|||||.++|+
T Consensus 227 yGVa~~~~--------Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNc 293 (474)
T KOG0194|consen 227 YGVAVLEE--------PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNC 293 (474)
T ss_pred EEEEcCCC--------ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHh
Confidence 99998764 68999999999999999987532 599999999999999999999997 789999999999
Q ss_pred eecCCCcEEEcccCCccccc------------------------------cccccceeeeeeehhh
Q 005898 625 LLNEHRIAKLSDYGLSIVSE------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~~------------------------------d~~s~g~~l~~~~~~~ 660 (671)
|++.+..+||+|||+++..+ |+||+||++||..+--
T Consensus 294 L~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 294 LYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred eecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccC
Confidence 99999999999999996542 9999999999998843
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=259.29 Aligned_cols=167 Identities=27% Similarity=0.496 Sum_probs=147.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..|+..+.+|+|.||+|-+|+- ..|+.||||.+++.+. ++.-..++||++|+.++||||++++.+|...+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd------ 126 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD------ 126 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc------
Confidence 3466778899999999999984 5799999999976543 34556789999999999999999999998654
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+.+||||..+|+|++|+.+++. |+......+..||..|+.|+|.+ .++|||||.+|||+|.++++||+|||
T Consensus 127 --KIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 127 --KIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred --eEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence 78999999999999999998654 99999999999999999999998 78999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhccccc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
++-++. |.||+|+.+|.+ +|||+.|
T Consensus 199 LSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtL---VyGtMPF 253 (668)
T KOG0611|consen 199 LSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTL---VYGTMPF 253 (668)
T ss_pred hhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHH---hhccccc
Confidence 996543 999999999874 5677665
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=272.98 Aligned_cols=172 Identities=23% Similarity=0.479 Sum_probs=151.0
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
+.+++...-+.+.+.+.||+|+||+||||+|.. .||||.+.... ....+.|+.|+.++++.||.||+=+.|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 446666666777788999999999999999863 49999997653 44678999999999999999999999999876
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
. .++|+-+|++-+|+.++|-.. ..++-.+.+.||.|||+|+.|||.. .|||||||+.||++.++++
T Consensus 461 ~---------~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 461 P---------LAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred c---------eeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCc
Confidence 3 599999999999999999653 4588899999999999999999997 7999999999999999999
Q ss_pred EEEcccCCccccc-----------------------------------cccccceeeeeeehhhh
Q 005898 632 AKLSDYGLSIVSE-----------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
+||+|||++..-. ||||+|+++|||+|+-.
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l 591 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL 591 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence 9999999985421 99999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=268.32 Aligned_cols=165 Identities=24% Similarity=0.454 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHH--HHHHHHHhcCC-CCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNL--KLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 558 (671)
+.|...++||.|.||.||+|+ .++|..||||++++.-. ..++. .||+.-|+++. |||||+|.+++.+.+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~------ 82 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND------ 82 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC------
Confidence 456677899999999999998 56899999999976432 23333 57999999998 999999999998764
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..+|+|||||+. +|++.+.++ .+.++..+...|+.||.+||+|+|.+ ++.|||+||+|||+.....+||+|||
T Consensus 83 -~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 83 -RILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred -ceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence 278999999977 999999876 56799999999999999999999998 89999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhh
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
+|+.+. |+|++||+++|+.+--+
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP 208 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP 208 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc
Confidence 998755 99999999999877433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=247.56 Aligned_cols=169 Identities=21% Similarity=0.364 Sum_probs=151.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+.+|.|+||.|...+.+ +|.-+|+|+++..+ ..+.+...+|..+|+.++||.+++|.+.|.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~----- 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS----- 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-----
Confidence 346777899999999999999965 68899999997654 345677889999999999999999999998764
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.+||||||.++|.|..+++..++ ++.+...-+|.+|+.|++|||+. .|++|||||+|||+|.+|..||+||
T Consensus 118 ---~lymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 ---NLYMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred ---eEEEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 79999999999999999997654 88999999999999999999997 7999999999999999999999999
Q ss_pred CCccccc---------------------------cccccceeeeeeehhhhccc
Q 005898 638 GLSIVSE---------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 638 Gla~~~~---------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|+|+.+. |-|++||..|||+.|....+
T Consensus 189 GFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 189 GFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred cceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 9998754 99999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=266.82 Aligned_cols=170 Identities=24% Similarity=0.399 Sum_probs=147.4
Q ss_pred HHhcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
+..++|.-.+.||+|+|++||+|+ .++++++|||++.+.- ..-.+-..+|-..|.++ .||.||+|+--|.+..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-- 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-- 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc--
Confidence 345678889999999999999998 4579999999986532 11234466788888888 8999999998887753
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
.+|+|+||+++|+|-++++..+. ++......+|.+|..|++|||.+ +||||||||+|||+|++|.+||
T Consensus 148 ------sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikI 215 (604)
T KOG0592|consen 148 ------SLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKI 215 (604)
T ss_pred ------ceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEE
Confidence 78999999999999999987654 88888899999999999999998 8999999999999999999999
Q ss_pred cccCCccccc-------------------------------------------cccccceeeeeeehhhhcc
Q 005898 635 SDYGLSIVSE-------------------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 635 ~DfGla~~~~-------------------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|||-|+++. |+|++|||+|-|+.|.+..
T Consensus 216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF 287 (604)
T KOG0592|consen 216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF 287 (604)
T ss_pred eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC
Confidence 9999998754 9999999999999987643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=254.67 Aligned_cols=167 Identities=23% Similarity=0.385 Sum_probs=143.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++...+.||+|+||.||++... +|...|||..........+.+.+|+++|.+++|||||+.+|....... ...
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~------~~~ 91 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN------DEY 91 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC------eee
Confidence 3555788999999999999965 599999999876543336779999999999999999999997544321 258
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEcccCCcc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLSDYGLSI 641 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~DfGla~ 641 (671)
++.|||+++|+|.+++...+. .++......+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 999999999999999987542 599999999999999999999987 8999999999999999 7999999999875
Q ss_pred ccc----------------------------------cccccceeeeeeehhhh
Q 005898 642 VSE----------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~~----------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
... |+||+||++.||+||.+
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 211 99999999999999843
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=255.06 Aligned_cols=177 Identities=22% Similarity=0.361 Sum_probs=145.4
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCC-cccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPH-LVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~~~~ 559 (671)
.|+..++||+|+||+||+|+. .+|+.||+|++.-... ..-....+|+.++++++|+| ||+|.+++.+... ....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~--~~~~ 89 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN--HRGI 89 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc--cccc
Confidence 455567799999999999994 5899999999965432 22345689999999999999 9999999987541 1112
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPG-KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
...+|||||+.. +|.+++...... +.++-.....++.|+.+||+|||++ +|+||||||.|||++++|..|++|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 368899999987 999999864421 3466678899999999999999998 89999999999999999999999999
Q ss_pred Cccccc-------------------------------cccccceeeeeeehhhhccccc
Q 005898 639 LSIVSE-------------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 639 la~~~~-------------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
+|+... |+||+|||++||.+...=.++.
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~ 224 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD 224 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence 997533 9999999999999965554443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=253.75 Aligned_cols=174 Identities=24% Similarity=0.365 Sum_probs=148.5
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccC--CchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPS--SKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
...|...+.||+|+||.|++|+. ++|+.||||++.. ......+...+|+.+++.++|+||+.+++.+..+. . ..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~-~--~~ 97 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS-R--DK 97 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc-c--cc
Confidence 34566678899999999999985 4799999999974 34455778899999999999999999999887632 1 13
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+.+|+|+|+|+. ||...++... .|+......+..|+.+||.|+|+. +++||||||+|++++.+...||+|||
T Consensus 98 f~DvYiV~elMet-DL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 4689999999955 8999988643 388889999999999999999997 79999999999999999999999999
Q ss_pred Ccccc-----c----------------------------cccccceeeeeeehhhhcccc
Q 005898 639 LSIVS-----E----------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 639 la~~~-----~----------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+|+.. + |+||+|||++||+++-.-.+|
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 99887 2 999999999999998665554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=256.88 Aligned_cols=165 Identities=21% Similarity=0.426 Sum_probs=143.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhc--CCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAK--LRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.+...+.+.||+|.||.||+|+++ |+.||||++.... .+.+.+|.++... +||+||+.+++.-..+. ..+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~----gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDN----GSW 281 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCC----Cce
Confidence 456778899999999999999997 7899999997654 3568888888776 49999999998755432 356
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC-----CCCCCccccCCCCCceeecCCCcEEE
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-----GVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
.++|||+||.++|||++||.+. .++-...++++..+|.||++||. ...|.|+|||||+.|||+.+++++.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 7899999999999999999863 38999999999999999999995 35689999999999999999999999
Q ss_pred cccCCccccc----------------------------------------cccccceeeeeeeh
Q 005898 635 SDYGLSIVSE----------------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 635 ~DfGla~~~~----------------------------------------d~~s~g~~l~~~~~ 658 (671)
+|+|||...+ |+||+|.++||++.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999995432 99999999999865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=265.08 Aligned_cols=169 Identities=29% Similarity=0.462 Sum_probs=147.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC----ch-hhHHHHHHHHHHHhcCC-CCCcccccceeecCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS----KK-YTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGG 553 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 553 (671)
..+.|...+.||+|+||+||.|+. .+|+.||||.+... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~- 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT- 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence 346788899999999999999985 47899999976543 11 23456778999999999 999999999998764
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcE
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIA 632 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~ 632 (671)
..|+||||+.+|+|.+++.+.. .+......+++.|++.|++|+|+. +|+|||||++|||+|++ +++
T Consensus 94 -------~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 94 -------KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred -------eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCE
Confidence 6899999999999999998743 378889999999999999999997 89999999999999999 999
Q ss_pred EEcccCCcccc-c-------------------------------cccccceeeeeeehhhhcc
Q 005898 633 KLSDYGLSIVS-E-------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 633 ki~DfGla~~~-~-------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
||+|||++... . |+||+||++|.|++|....
T Consensus 161 Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF 223 (370)
T KOG0583|consen 161 KLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF 223 (370)
T ss_pred EEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence 99999999866 1 9999999999999987653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=253.39 Aligned_cols=164 Identities=21% Similarity=0.465 Sum_probs=139.1
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHh--cCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLA--KLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
...+..++||+|+||.||||++.+ +.||||++... ..+.|..|-++.+ .++|+||++++++=...... ..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~----~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD----RM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc----cc
Confidence 345567889999999999999964 89999999754 3456777766654 57999999999875544321 23
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCC------CCCCccccCCCCCceeecCCCcEEE
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG------VIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
+.+||+||.++|+|.+||... .++|....+|+..+|+||+|||+. ..|+|+|||||++|||+..|+++.|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 689999999999999999854 489999999999999999999974 4589999999999999999999999
Q ss_pred cccCCccccc--------------------------------------cccccceeeeeeeh
Q 005898 635 SDYGLSIVSE--------------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 635 ~DfGla~~~~--------------------------------------d~~s~g~~l~~~~~ 658 (671)
+|||+|..++ |+||+|.+||||++
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence 9999997654 99999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=238.75 Aligned_cols=171 Identities=22% Similarity=0.409 Sum_probs=149.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+.++|+..+.+|+|.||.||.|+.+ ++-.||+|++.+.. ....+++++|+++=+.++||||+++++|+.+..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~---- 95 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK---- 95 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc----
Confidence 3467889999999999999999965 68899999996543 234578999999999999999999999998864
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
.+||++||.++|++...|++.. ...++....-.++.|+|.|+.|+|.. .+|||||||+|+|++..+..|++|
T Consensus 96 ----riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 96 ----RIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ----eeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence 7999999999999999998543 34578888889999999999999986 789999999999999999999999
Q ss_pred cCCccccc----------------------------cccccceeeeeeehhhhcc
Q 005898 637 YGLSIVSE----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~~----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
||.+.... |+|++|+..||++.|.++.
T Consensus 168 fGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppF 222 (281)
T KOG0580|consen 168 FGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPF 222 (281)
T ss_pred CCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCch
Confidence 99986642 9999999999988876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-29 Score=281.38 Aligned_cols=172 Identities=28% Similarity=0.573 Sum_probs=148.7
Q ss_pred cCCCcCceeccCCceEEEEEEEcC--Cc----EEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN--GT----SVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~--g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
.+.+..+.||+|+||.||+|++.+ |. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~--- 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG--- 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC---
Confidence 345667899999999999998653 43 4999999765 4556789999999999999999999999999854
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTP----GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
..++++|||++|||..||++.++ ...++-.+-+.++.|||+|+.||++. ++|||||.++|+||++...
T Consensus 769 -----~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 769 -----PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred -----CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCc
Confidence 57999999999999999997532 34588899999999999999999997 7899999999999999999
Q ss_pred EEEcccCCcccc-c-------------------------------cccccceeeeeeehhhhcccc
Q 005898 632 AKLSDYGLSIVS-E-------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 632 ~ki~DfGla~~~-~-------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+||+|||+|+.. + |+||+||++||++|-...|++
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999832 1 999999999999996555544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=260.47 Aligned_cols=167 Identities=22% Similarity=0.448 Sum_probs=145.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.......++||+|.||.|..+....+..||||+++... .....+|.+||++|.+++|||||+|+|+|..++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De------- 608 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD------- 608 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-------
Confidence 344456678999999999999999888999999998654 445689999999999999999999999999764
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...+|+|||++|+|.+|+....... ++-....+|+.|||.|++||.+. .+||||+.++|+|+|.++++||+|||+
T Consensus 609 -PicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 609 -PLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred -chHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence 6789999999999999998754322 45566788999999999999986 799999999999999999999999999
Q ss_pred cccc--------------------------------ccccccceeeeeeehh
Q 005898 640 SIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 640 a~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
++-+ .|+|++|+|+||+++.
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~ 735 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFML 735 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHH
Confidence 9832 1999999999998763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=260.76 Aligned_cols=167 Identities=24% Similarity=0.458 Sum_probs=141.2
Q ss_pred hcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 553 (671)
.++|+..++||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +|||||+++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN- 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC-
Confidence 45688889999999999999974 235689999997543 23356789999999999 8999999999987543
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCC--------------------------------------------------
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------------------------------------------- 583 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------------------------------------------- 583 (671)
...++||||+++|+|.+++.....
T Consensus 85 ------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 85 ------GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred ------CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 257999999999999998864211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-----------
Q 005898 584 ---------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS----------- 643 (671)
Q Consensus 584 ---------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~----------- 643 (671)
...+++.+...++.||++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 13488899999999999999999986 8999999999999999999999999988531
Q ss_pred ---------------------ccccccceeeeeeeh
Q 005898 644 ---------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 644 ---------------------~d~~s~g~~l~~~~~ 658 (671)
.|+||+||++|||++
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 199999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=260.75 Aligned_cols=145 Identities=23% Similarity=0.422 Sum_probs=127.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~------ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL------ 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC------
Confidence 36888899999999999999854 68999999996532 223456888999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++++||+|||
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 75 --NLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred --eEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 6899999999999999997643 489999999999999999999987 89999999999999999999999999
Q ss_pred Ccc
Q 005898 639 LSI 641 (671)
Q Consensus 639 la~ 641 (671)
+++
T Consensus 147 la~ 149 (363)
T cd05628 147 LCT 149 (363)
T ss_pred Ccc
Confidence 874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=253.08 Aligned_cols=166 Identities=17% Similarity=0.306 Sum_probs=144.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR------ 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC------
Confidence 36778899999999999999965 68999999986432 223567889999999999999999999887643
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 75 --~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 75 --FLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred --eEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 6899999999999999997643 488999999999999999999987 89999999999999999999999999
Q ss_pred Ccccc---------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|+++...
T Consensus 147 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~p 197 (291)
T cd05612 147 FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197 (291)
T ss_pred cchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 87532 2999999999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=253.68 Aligned_cols=160 Identities=23% Similarity=0.336 Sum_probs=139.1
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
++||+|+||.||+++.. +|+.||||+++... ......+.+|++++++++||||+++++++.+.+ ..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--------~~~l 72 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--------RLCF 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--------EEEE
Confidence 46999999999999864 78999999987532 223456788999999999999999999887653 7899
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS- 643 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~- 643 (671)
||||+++|+|.+++.... .+++.+...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 73 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 73 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999999987543 489999999999999999999987 8999999999999999999999999987531
Q ss_pred -----------------------------ccccccceeeeeeehhhhc
Q 005898 644 -----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 -----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|||++|...
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 194 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCC
Confidence 1999999999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=256.56 Aligned_cols=167 Identities=22% Similarity=0.357 Sum_probs=144.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-C-CcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-N-GTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~-g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|+.. + +..||||++.... ....+.+.+|+++++.++|||||++++++.+.+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----- 104 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES----- 104 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC-----
Confidence 46888899999999999999854 3 3689999986432 233567889999999999999999999997653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++++||+||
T Consensus 105 ---~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 105 ---YLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred ---EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence 6899999999999999997643 488999999999999999999987 8999999999999999999999999
Q ss_pred CCcccc---------------------------ccccccceeeeeeehhhhcc
Q 005898 638 GLSIVS---------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~---------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|+++.. .|+||+||++|+|++|....
T Consensus 176 G~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf 228 (340)
T PTZ00426 176 GFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228 (340)
T ss_pred CCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCC
Confidence 998542 19999999999999976543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=259.22 Aligned_cols=145 Identities=26% Similarity=0.432 Sum_probs=126.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~------ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ------ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC------
Confidence 36778899999999999999854 78999999986432 223567889999999999999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++|||
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 75 --YLYLIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred --eeEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 6899999999999999987543 478888889999999999999987 89999999999999999999999999
Q ss_pred Ccc
Q 005898 639 LSI 641 (671)
Q Consensus 639 la~ 641 (671)
+++
T Consensus 147 la~ 149 (377)
T cd05629 147 LST 149 (377)
T ss_pred ccc
Confidence 874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=259.82 Aligned_cols=145 Identities=24% Similarity=0.438 Sum_probs=128.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++..++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~------ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN------ 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC------
Confidence 36888899999999999999965 68999999996432 233456889999999999999999999988753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 --~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 75 --YLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred --eEEEEECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 7899999999999999987643 489999999999999999999987 79999999999999999999999999
Q ss_pred Ccc
Q 005898 639 LSI 641 (671)
Q Consensus 639 la~ 641 (671)
+++
T Consensus 147 ~~~ 149 (364)
T cd05599 147 LCT 149 (364)
T ss_pred cce
Confidence 874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=256.21 Aligned_cols=166 Identities=23% Similarity=0.432 Sum_probs=144.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++.+++||||+++++++.+.+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 91 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN------ 91 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC------
Confidence 46788899999999999999975 68999999986432 223467889999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 92 --~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 92 --RVYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred --EEEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence 7899999999999999997643 378888899999999999999987 79999999999999999999999999
Q ss_pred Ccccc---------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|++|...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 214 (329)
T PTZ00263 164 FAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214 (329)
T ss_pred CceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCC
Confidence 98632 2999999999999997654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=254.75 Aligned_cols=165 Identities=27% Similarity=0.414 Sum_probs=144.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+|+..+.||+|+||.||+|+.. +++.||||+++... ....+++.+|++++..++||||+++++++.+.+
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~------- 74 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE------- 74 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-------
Confidence 5788899999999999999975 68999999986432 223567889999999999999999999987653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... .+++.+...++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 75 -YLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred -EEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcC
Confidence 7899999999999999997543 488999999999999999999987 799999999999999999999999998
Q ss_pred cccc---------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++.. .|+||+||++|+|++|...
T Consensus 148 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 197 (333)
T cd05600 148 SKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197 (333)
T ss_pred CcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCC
Confidence 8632 1999999999999997653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=260.39 Aligned_cols=143 Identities=21% Similarity=0.352 Sum_probs=126.1
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++.+++|||||++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~------- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD------- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-------
Confidence 577889999999999999985 478999999996532 233567899999999999999999999998653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||.. +|+||||||+||+++.++.+||+|||+
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 75 -NLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred -EEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 7899999999999999987543 388888889999999999999987 899999999999999999999999998
Q ss_pred c
Q 005898 640 S 640 (671)
Q Consensus 640 a 640 (671)
+
T Consensus 148 ~ 148 (381)
T cd05626 148 C 148 (381)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=257.12 Aligned_cols=153 Identities=25% Similarity=0.421 Sum_probs=134.1
Q ss_pred cCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
..+.+|+|+.|.||+|+++ +++||||+.++.+ ..+|+.|++++||||+.+.|+|.+.. ...+||
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP--------cyCIiM 191 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP--------CYCIIM 191 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc--------eeEEee
Confidence 3578999999999999997 5889999976433 34678899999999999999998764 678999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccccc--
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE-- 644 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~-- 644 (671)
|||+.|-|.+.|+..+ ++.......+..+||.|+.|||.+ .|||||||+-||||..+-.+||+|||-++...
T Consensus 192 EfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999998654 477777788899999999999998 79999999999999999999999999886532
Q ss_pred ---------------------------cccccceeeeeeehhhh
Q 005898 645 ---------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 645 ---------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|+||+||+||||+|+-+
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~Ei 309 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEI 309 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCC
Confidence 99999999999999744
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=230.94 Aligned_cols=175 Identities=20% Similarity=0.372 Sum_probs=154.0
Q ss_pred hcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.+.|...+.+|+|||..||.++ +.+++.+|+|++......+.+...+|++.-++++|||++++++++..+.. + ..+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~--D-~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK--D-GKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc--c-Cce
Confidence 3567788999999999999998 77899999999998887788899999999999999999999998876431 1 235
Q ss_pred eEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
+.|+++.|...|+|.+.+.... .+..++..+.+.|+.+|++||++||+. .|+++||||||.|||+.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 7899999999999999987643 345799999999999999999999985 46899999999999999999999999999
Q ss_pred ccccc------------------------------------------cccccceeeeeeehhh
Q 005898 640 SIVSE------------------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 640 a~~~~------------------------------------------d~~s~g~~l~~~~~~~ 660 (671)
+..++ |+||+||++|+||-+.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~ 238 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGE 238 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcC
Confidence 87654 9999999999988654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=257.61 Aligned_cols=143 Identities=20% Similarity=0.355 Sum_probs=125.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+|+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++.+.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~------- 74 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD------- 74 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-------
Confidence 6888899999999999999854 68999999986432 223466889999999999999999999987653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... .++......++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 75 -~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 75 -NLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred -EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 7899999999999999997643 478888888999999999999987 899999999999999999999999998
Q ss_pred c
Q 005898 640 S 640 (671)
Q Consensus 640 a 640 (671)
|
T Consensus 148 a 148 (376)
T cd05598 148 C 148 (376)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=267.05 Aligned_cols=177 Identities=21% Similarity=0.407 Sum_probs=147.0
Q ss_pred cCCCcCceeccCCceEEEEEEEcCC-cEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccce-eecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENG-TSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGH-CIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~~~~~~~~~~ 559 (671)
.+.+..+.|.+|||+.||.|+...+ ..+|+|++-.......+...+||++|++++ |+|||.+++. .....+.. ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~--~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN--GV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC--ce
Confidence 4456678999999999999997654 999999998777778899999999999997 9999999983 22221111 12
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
-+++|.||||++|.|-+++..+...+ |+..+.++|+.|+++|+++||. +.|+|||||||.+||||..+++-|+||||-
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 37899999999999999998654333 9999999999999999999997 467899999999999999999999999998
Q ss_pred ccccc------------------------------------------cccccceeeeeeehhhhccc
Q 005898 640 SIVSE------------------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 640 a~~~~------------------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|..-- |+|++||++|- +|++.-||
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYk-LCy~t~PF 258 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYK-LCYFTTPF 258 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHH-HHHhCCCc
Confidence 84311 99999999998 55555444
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=258.04 Aligned_cols=177 Identities=24% Similarity=0.457 Sum_probs=155.2
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 476 EELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 476 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
++++....++.+.+++|-|.||.||.|.|+ -...||||.++++. ...++|..|+++|+.++|||+|+|+|+|....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-- 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-- 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC--
Confidence 556656667888899999999999999987 47799999998764 45789999999999999999999999998653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..|+|+|||.+|+|-+||++... ..+.-.-.+++|.||+.|++||... ++|||||.++|+|+.++..+||
T Consensus 337 ------PFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 337 ------PFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred ------CeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence 68999999999999999998642 3466667789999999999999987 7899999999999999999999
Q ss_pred cccCCccccc-------------------------------cccccceeeeeeehhhhcccc
Q 005898 635 SDYGLSIVSE-------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 635 ~DfGla~~~~-------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+|||+++++. |+|++||+|||+.|+.-+|+.
T Consensus 407 ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred eccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 9999998754 999999999999997766653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=248.61 Aligned_cols=161 Identities=22% Similarity=0.329 Sum_probs=138.0
Q ss_pred ceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 489 AIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
+.||+|+||.||+++. .+|+.||+|.+.... .....++.+|++++..++||||+++++++.+.+ ..++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~--------~~~l 72 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--------RLCF 72 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC--------EEEE
Confidence 4689999999999985 478999999996532 233456788999999999999999999887653 7899
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS- 643 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~- 643 (671)
||||+++|+|..++.... .+++.++..++.|++.||+|||+. .+|+||||||+||++++++.+||+|||+++..
T Consensus 73 v~E~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 73 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 999999999998887543 489999999999999999999973 17999999999999999999999999987531
Q ss_pred -----------------------------ccccccceeeeeeehhhhc
Q 005898 644 -----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 -----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~P 195 (325)
T cd05594 148 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195 (325)
T ss_pred CCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCC
Confidence 1999999999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=258.95 Aligned_cols=143 Identities=22% Similarity=0.377 Sum_probs=125.8
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.|+..++||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~------- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD------- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-------
Confidence 477889999999999999986 468899999986532 233567889999999999999999999988653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 75 -~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 75 -NLYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred -EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 6899999999999999987543 378888889999999999999987 799999999999999999999999998
Q ss_pred c
Q 005898 640 S 640 (671)
Q Consensus 640 a 640 (671)
+
T Consensus 148 a 148 (382)
T cd05625 148 C 148 (382)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=249.18 Aligned_cols=166 Identities=24% Similarity=0.469 Sum_probs=140.5
Q ss_pred cCCCcCceeccCCceEEEEEEEcC-----------------CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN-----------------GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCL 544 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 544 (671)
+.|...++||+|+||.||+|+.++ +..||||.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 457778899999999999997532 3479999987543 3345679999999999999999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHhcC
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT----------------PGKVLNWSERLAVLIGVAKAVQFLHT 608 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~yLH~ 608 (671)
++++.+.+ ..++||||+++|+|.+++.... ....++|.+..+++.|+++||+|||+
T Consensus 85 ~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 85 LGVCVDED--------PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred EEEEecCC--------ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99998653 5799999999999999886421 11357899999999999999999998
Q ss_pred CCCCCccccCCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeee
Q 005898 609 GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLIL 656 (671)
Q Consensus 609 ~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~ 656 (671)
. +|+||||||+||++++++.+||+|||+++.. .|+||+|+++|+|
T Consensus 157 ~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 L---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred C---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 7 7999999999999999999999999988521 1999999999998
Q ss_pred ehh
Q 005898 657 MSF 659 (671)
Q Consensus 657 ~~~ 659 (671)
+++
T Consensus 234 ~~~ 236 (304)
T cd05096 234 LML 236 (304)
T ss_pred HHc
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=245.96 Aligned_cols=176 Identities=19% Similarity=0.280 Sum_probs=144.7
Q ss_pred cccCHHHHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchh---hHHHHHHHHHHHhcCCCCCcccccce
Q 005898 471 RSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY---TVRNLKLRLDLLAKLRHPHLVCLLGH 547 (671)
Q Consensus 471 ~~~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~ 547 (671)
+.++.+++. ......||+|++|.||+|++ +|+.||||+++..... ..+.|.+|+++|.+++|||||+++|+
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 345566652 23346799999999999998 5889999999754322 24678899999999999999999999
Q ss_pred eecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 548 ~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
+.+..+ .....++||||+++|+|.+++.... .++|..+.+++.+++.|++|||... +++||||||+||+++
T Consensus 87 ~~~~~~----~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~ 157 (283)
T PHA02988 87 IIDIVD----DLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVT 157 (283)
T ss_pred EEeccc----CCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEEC
Confidence 876210 0135799999999999999997643 4899999999999999999999742 567999999999999
Q ss_pred CCCcEEEcccCCccc-----------------------------cccccccceeeeeeehhhh
Q 005898 628 EHRIAKLSDYGLSIV-----------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 628 ~~~~~ki~DfGla~~-----------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
+++.+||+|||+++. ..|+||+||++|||+++..
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~ 220 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220 (283)
T ss_pred CCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence 999999999999763 1199999999999999654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=257.53 Aligned_cols=169 Identities=22% Similarity=0.302 Sum_probs=145.4
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
...++|+..+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--- 116 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK--- 116 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC---
Confidence 34567889999999999999999965 68899999986422 223456889999999999999999999887653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..++||||+++|+|.+++... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 117 -----~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 117 -----YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred -----EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence 789999999999999998643 378888999999999999999987 89999999999999999999999
Q ss_pred ccCCcccc-----------------------------------ccccccceeeeeeehhhhcc
Q 005898 636 DYGLSIVS-----------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 636 DfGla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|||+++.. .|+||+||++|+|++|....
T Consensus 185 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred ecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 99987431 29999999999999976543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=246.75 Aligned_cols=166 Identities=17% Similarity=0.242 Sum_probs=142.1
Q ss_pred CCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|+..+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|++++++++|+||+++++++.+.+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-------- 73 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-------- 73 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--------
Confidence 66778999999999999986 479999999986432 223446789999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|..++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 6899999999999988876432 23589999999999999999999987 8999999999999999999999999998
Q ss_pred ccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|++|...
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence 532 1999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=250.41 Aligned_cols=160 Identities=23% Similarity=0.363 Sum_probs=139.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
++||+|+||.||+++.. +|+.||||++.... ....+++.+|++++++++||||+++++++.+.+ ..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--------~~~l 72 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD--------RLCF 72 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC--------EEEE
Confidence 46899999999999864 78999999996532 234567889999999999999999999887653 6899
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS- 643 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~- 643 (671)
||||+++|+|..++.... .+++.+...++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 v~Ey~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 73 VMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999998887543 489999999999999999999987 8999999999999999999999999987531
Q ss_pred -----------------------------ccccccceeeeeeehhhhc
Q 005898 644 -----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 -----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~P 194 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCC
Confidence 1999999999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=249.23 Aligned_cols=158 Identities=23% Similarity=0.321 Sum_probs=138.1
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+ ..++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~ 72 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--------KLYLVL 72 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--------eEEEEE
Confidence 699999999999865 68899999986432 234567889999999999999999999887653 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 73 AFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999999997543 489999999999999999999987 7999999999999999999999999988631
Q ss_pred ---------------------------ccccccceeeeeeehhhhc
Q 005898 644 ---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~p 192 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCC
Confidence 1999999999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=235.02 Aligned_cols=176 Identities=24% Similarity=0.415 Sum_probs=154.8
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecC
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDG 551 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 551 (671)
+++|+-+-|+ +++|+|+|+.|-.++ +.+|.++|||++.+...+......+|++++.+.+ |+||++|+++|.+.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677777764 789999999999987 6789999999998887777888999999999996 99999999999876
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC--
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-- 629 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-- 629 (671)
. ..|||||-|.+|.|-.+++++. .++....-+++.+||.||+|||.. +|.|||+||+|||-.+.
T Consensus 149 ~--------~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~ 214 (463)
T KOG0607|consen 149 T--------RFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNK 214 (463)
T ss_pred c--------eEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCC
Confidence 4 7899999999999999998653 488889999999999999999997 89999999999998643
Q ss_pred -CcEEEcccCCccccc------------------------------------------cccccceeeeeeehhhhccccc
Q 005898 630 -RIAKLSDYGLSIVSE------------------------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 630 -~~~ki~DfGla~~~~------------------------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
.-+||+||.+..-.. |.||+|+++|.|++|+....|.
T Consensus 215 vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 215 VSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred cCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 468999997763211 9999999999999999999999
Q ss_pred cc
Q 005898 667 CS 668 (671)
Q Consensus 667 ~~ 668 (671)
|-
T Consensus 295 Cg 296 (463)
T KOG0607|consen 295 CG 296 (463)
T ss_pred cC
Confidence 94
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=256.53 Aligned_cols=166 Identities=20% Similarity=0.383 Sum_probs=146.4
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..|++.+.+|.|+-|.|-.|+. .+|+.+|||++....+ .......+||.+|+-+.|||+++|++++.+.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~------- 84 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK------- 84 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-------
Confidence 4577888999999999999994 6899999999976532 2245688999999999999999999998865
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.++|+|.||+++|.|++++..+++ +...+..++..||..|+.|+|+. +|+|||+||+|+|||+++++||+|||
T Consensus 85 -~~lylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 85 -QHLYLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred -ceEEEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence 379999999999999999987654 88899999999999999999997 79999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|.+-. |+||+|||+|.++||...
T Consensus 158 MAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP 211 (786)
T KOG0588|consen 158 MASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP 211 (786)
T ss_pred eeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC
Confidence 996411 999999999999998654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=250.49 Aligned_cols=160 Identities=23% Similarity=0.344 Sum_probs=138.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
+.||+|+||.||+++.. +|+.||+|++.... ......+.+|++++++++||||+++++++...+ ..++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--------~~~l 72 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--------RLCF 72 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--------EEEE
Confidence 46899999999999864 78999999986532 233456788999999999999999999887653 6899
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS- 643 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~- 643 (671)
||||+++|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 v~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 73 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999998887543 489999999999999999999987 8999999999999999999999999986431
Q ss_pred -----------------------------ccccccceeeeeeehhhhc
Q 005898 644 -----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 -----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~P 194 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCC
Confidence 1999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=251.97 Aligned_cols=145 Identities=23% Similarity=0.428 Sum_probs=127.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++.+.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~------ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR------ 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC------
Confidence 36788899999999999999865 68999999986432 223467888999999999999999999887653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 75 --NLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred --EEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 7899999999999999987543 388999999999999999999987 89999999999999999999999999
Q ss_pred Ccc
Q 005898 639 LSI 641 (671)
Q Consensus 639 la~ 641 (671)
+++
T Consensus 147 ~~~ 149 (360)
T cd05627 147 LCT 149 (360)
T ss_pred CCc
Confidence 864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-28 Score=260.62 Aligned_cols=165 Identities=26% Similarity=0.422 Sum_probs=144.3
Q ss_pred CCcCceeccCCceEEEEEEE-cCC----cEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRL-ENG----TSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~-~~g----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++...+||+|+||+||||.+ +.| .+||||.+.... .+..+++.+|+-+|++++|||+++|+|+|..+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------- 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------- 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc-------
Confidence 34568999999999999985 444 378999986543 44567899999999999999999999999875
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+.||++|||.|.|.+|++..+ ..+.-...+.+..|||+||.|||.+ .++||||.++|||+.+-..+||.|||
T Consensus 771 --~~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 771 --TLQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred --hHHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 4789999999999999998754 3488899999999999999999987 79999999999999999999999999
Q ss_pred Cccccc--------------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE--------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~--------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+... ||||+||+.||+||+..-|
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~P 900 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKP 900 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCc
Confidence 998754 9999999999999975444
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=254.74 Aligned_cols=167 Identities=27% Similarity=0.462 Sum_probs=141.3
Q ss_pred hcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 553 (671)
.++|+..+.||+|+||.||+|+. +++..||||+++... ....+.+.+|++++..+ +|||||+++++|.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 44678889999999999999963 246689999997543 23456788999999999 8999999999998764
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCC--------------------------------------------------
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------------------------------------------- 583 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------------------------------------------- 583 (671)
..++||||+++|+|.++++....
T Consensus 113 -------~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 113 -------PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred -------cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 67999999999999998864210
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 584 ----------------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 584 ----------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
...++|..+.+++.||++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~ 262 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 262 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccce
Confidence 12588999999999999999999986 89999999999999999999999999874
Q ss_pred cc--------------------------------ccccccceeeeeeehh
Q 005898 642 VS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 642 ~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
.. .|+||+||++|+|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~ 312 (375)
T cd05104 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 312 (375)
T ss_pred eccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhc
Confidence 21 2999999999999983
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=255.12 Aligned_cols=167 Identities=23% Similarity=0.294 Sum_probs=143.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~---- 116 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK---- 116 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 4567888999999999999999865 68999999986432 223456788999999999999999998887653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++... .++......++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 117 ----~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 117 ----YLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred ----EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 689999999999999998753 377788888999999999999987 899999999999999999999999
Q ss_pred cCCcccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 637 YGLSIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+++.. .|+||+||++|||++|...
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 246 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence 9987321 2999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=245.97 Aligned_cols=167 Identities=21% Similarity=0.312 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~------ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD------ 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC------
Confidence 36788899999999999999864 78999999997532 223566889999999999999999999887643
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 75 --~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 75 --NLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred --eEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 6899999999999999997642 3489999999999999999999987 89999999999999999999999999
Q ss_pred Ccccc-------------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS-------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~-------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++... .|+||+||++|+|++|...
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~P 208 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCC
Confidence 87421 2999999999999987654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=247.36 Aligned_cols=167 Identities=23% Similarity=0.305 Sum_probs=145.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+++.. +|..||+|.+.... ....+++.+|+++|++++||||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 76 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-------- 76 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--------
Confidence 57888899999999999999965 68899999987542 334567999999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... .+++.....++.+++.||+|||+.. +|+||||||+||++++++.+||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 6899999999999999997643 3889999999999999999999752 5999999999999999999999999988
Q ss_pred ccc----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. .|+||+||++|+|++|...
T Consensus 152 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 201 (331)
T cd06649 152 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201 (331)
T ss_pred ccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 532 1999999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=244.37 Aligned_cols=160 Identities=29% Similarity=0.462 Sum_probs=138.0
Q ss_pred ceeccCCceEEEEEEE----cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 489 AIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+.||+|+||.||+++. .+|+.||||++.... ......+.+|++++++++||||+++++++.+.+ ..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--------KL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--------EE
Confidence 5799999999999874 368899999997532 223456778999999999999999999987653 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
|+||||+++|+|.+++.... .+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 74 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999999987543 489999999999999999999987 799999999999999999999999998753
Q ss_pred c------------------------------ccccccceeeeeeehhhhc
Q 005898 643 S------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 643 ~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
. .|+||+||++|+|++|...
T Consensus 148 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 197 (318)
T cd05582 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197 (318)
T ss_pred cCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCC
Confidence 1 1999999999999997543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=252.67 Aligned_cols=172 Identities=22% Similarity=0.306 Sum_probs=146.5
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 476 EELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 476 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
.++....++|+..+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455678999999999999999999965 68899999986422 22345678899999999999999999988765
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
+ ..++||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+||+++++++
T Consensus 116 ~--------~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 116 R--------YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred C--------EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence 3 789999999999999998753 377888889999999999999987 8999999999999999999
Q ss_pred EEEcccCCcccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++.. .|+||+||++|+|++|...
T Consensus 181 ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 246 (371)
T cd05622 181 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (371)
T ss_pred EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence 999999987421 2999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=246.40 Aligned_cols=160 Identities=26% Similarity=0.461 Sum_probs=137.3
Q ss_pred ceeccCCceEEEEEEE----cCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 489 AIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.||+|+||.||+++. .+++.||||.++... ......+.+|+++|+.++||||+++++++.+.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-------- 73 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-------- 73 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC--------
Confidence 5799999999999985 357899999986532 123456788999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... .+.+.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (323)
T cd05584 74 KLYLILEYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC 147 (323)
T ss_pred eEEEEEeCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence 6899999999999999987543 377888889999999999999987 7999999999999999999999999987
Q ss_pred ccc------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. .|+||+||++|||++|...
T Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred eecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCC
Confidence 521 1999999999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=243.42 Aligned_cols=166 Identities=20% Similarity=0.337 Sum_probs=141.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 76 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-------- 76 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--------
Confidence 45788899999999999999865 68999999986432 223456789999999999999999999987643
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++ +|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 77 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 77 CLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred eEEEEEeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence 68999999985 9998886542 3478999999999999999999987 8999999999999999999999999987
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. .|+||+||++|+|++|...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p 203 (288)
T cd07871 151 RAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM 203 (288)
T ss_pred eeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 421 1999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=246.06 Aligned_cols=162 Identities=25% Similarity=0.449 Sum_probs=140.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc----EEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT----SVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.+|+..+.||+|+||.||+|++. +|+ .||||.++... ....+++.+|+.+++.++||||++++|+|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 35888999999999999999854 444 38999987543 34457899999999999999999999999764
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++|+||+++|+|.+++.... ..+++...+.++.||++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 82 ----~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 82 ----TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred ----CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 3589999999999999987643 2488999999999999999999987 799999999999999999999999
Q ss_pred cCCccccc--------------------------------cccccceeeeeeeh
Q 005898 637 YGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
||+++... |+||+||++|||++
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t 206 (316)
T cd05108 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206 (316)
T ss_pred ccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 99986321 99999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=254.25 Aligned_cols=177 Identities=27% Similarity=0.380 Sum_probs=146.0
Q ss_pred CCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 485 FDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+...+.+|+|+||.||+|+. .+|+.||||.+.... ....+..-+|+++|++++|+|||++.+.=.+.. ........
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~--~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF--LGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc--cCcccccc
Confidence 44567899999999999994 589999999997532 344667789999999999999999987643321 01112356
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec--CCC--cEEEcccC
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN--EHR--IAKLSDYG 638 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~--~~~--~~ki~DfG 638 (671)
.+|||||++|||+..|.+.....-|...+.+.+..+++.||.|||++ +|+||||||.||++- ++| --|++|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999998765556699999999999999999999987 899999999999984 233 35999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhccccc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
.|+-.+ |.||+||++|+.+||..+...+
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 998755 9999999999999998776544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=246.71 Aligned_cols=167 Identities=23% Similarity=0.319 Sum_probs=145.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+.. ++..||+|.+... .....+++.+|++++.+++|||||+++++|.+.+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 76 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-------- 76 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--------
Confidence 57888999999999999999975 6889999988654 2334567999999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... .+++.....++.+++.|++|||+.. +|+||||||+||++++++.+||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 7899999999999999997543 3888999999999999999999742 6999999999999999999999999988
Q ss_pred ccc----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|+++...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 201 (333)
T cd06650 152 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201 (333)
T ss_pred hhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 531 1999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=246.23 Aligned_cols=167 Identities=17% Similarity=0.263 Sum_probs=143.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++..++|+||+++++++.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~------ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN------ 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC------
Confidence 36788899999999999999965 68899999986432 223456888999999999999999999887653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 75 --~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 75 --YLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred --EEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 7899999999999999997632 2488999999999999999999986 89999999999999999999999999
Q ss_pred Ccccc------------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|++|...
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 86321 1999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=238.67 Aligned_cols=163 Identities=24% Similarity=0.429 Sum_probs=140.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN----- 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC-----
Confidence 45778899999999999999753 35689999997643 334567999999999999999999999987653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ..++|.+++.++.|++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 80 ---~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~df 151 (266)
T cd05064 80 ---TMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGF 151 (266)
T ss_pred ---CcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCC
Confidence 6899999999999999997542 3589999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc-------------------------------ccccccceeeeeeeh
Q 005898 638 GLSIVS-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 638 Gla~~~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
|.+... .|+||+||++||+++
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~ 203 (266)
T cd05064 152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203 (266)
T ss_pred cccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhc
Confidence 975321 299999999999776
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=252.22 Aligned_cols=170 Identities=26% Similarity=0.401 Sum_probs=147.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 555 (671)
..++|....++|+|+||+|+++.+. +++.+|||++++.. +.+.+....|.+++.-. +||.+++|+..+++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~--- 442 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE--- 442 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC---
Confidence 4567999999999999999999976 68899999998764 34567788888887666 5999999999888763
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
.++.||||..+||+..+.+. ..++.....-+|..|+.||+|||++ +||+||||..|||||.+|.+||+
T Consensus 443 -----~l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 443 -----HLFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred -----eEEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 89999999999996655553 2488899999999999999999998 89999999999999999999999
Q ss_pred ccCCccccc------------------------------cccccceeeeeeehhhhcccc
Q 005898 636 DYGLSIVSE------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 636 DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
|||+++... |-|++||.|||||.|-+..++
T Consensus 511 DFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 511 DFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred ccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999997532 999999999999999887664
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=245.21 Aligned_cols=165 Identities=27% Similarity=0.394 Sum_probs=140.8
Q ss_pred CCCcCceeccCCceEEEEEEE----cCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 554 (671)
+|+..+.||+|+||+||+++. .+++.||+|++.... ....+.+.+|++++.+++ ||||+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-- 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence 467789999999999999874 368899999986432 223456888999999995 999999998887543
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++|+|.+++.... .+++.+...++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 79 ------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 79 ------KLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred ------EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 6899999999999999987543 488999999999999999999987 7999999999999999999999
Q ss_pred cccCCcccc--------------------------------ccccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVS--------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++.. .|+||+||++|+|++|...
T Consensus 147 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 206 (332)
T cd05614 147 TDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206 (332)
T ss_pred eeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence 999987531 1999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=239.66 Aligned_cols=167 Identities=25% Similarity=0.477 Sum_probs=144.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-----CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-----NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..|+..+.||+|+||.||+|+.+ +++.||||++........+++.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---- 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC----
Confidence 35777899999999999999742 578999999987666667789999999999999999999998865431
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++.... ..++|.++..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 80 --~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 80 --RNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred --CceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence 25799999999999999997532 2489999999999999999999987 8999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehhh
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
|+++.. .|+||+||++|||+++.
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 208 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcC
Confidence 987631 19999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-28 Score=233.87 Aligned_cols=168 Identities=23% Similarity=0.392 Sum_probs=141.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc---C--CcEEEEEEccCCchh--hHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE---N--GTSVAIRCLPSSKKY--TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~---~--g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
...|+....||+|.||.||||+-. + .+.+|||+++..++. -.....+|+.+++.++|||||.|..++...+
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d-- 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD-- 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC--
Confidence 456888899999999999999632 2 237999999865432 2456789999999999999999999887643
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC---
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISEN--TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH--- 629 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~--- 629 (671)
..++|++||.+. ||.+.++.. ...+.+.-.....|..||..|+.|||++ =|+||||||+||++..+
T Consensus 101 -----~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 101 -----KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred -----ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCc
Confidence 379999999998 899888643 2335688889999999999999999997 68999999999999877
Q ss_pred -CcEEEcccCCccccc----------------------------------cccccceeeeeeehhh
Q 005898 630 -RIAKLSDYGLSIVSE----------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 630 -~~~ki~DfGla~~~~----------------------------------d~~s~g~~l~~~~~~~ 660 (671)
|.+||+|+|+|+++. |+|++|||++||++--
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~ 237 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLE 237 (438)
T ss_pred cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccC
Confidence 999999999998754 9999999999999843
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=245.22 Aligned_cols=160 Identities=23% Similarity=0.364 Sum_probs=137.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. +++.||+|.++... ....+.+.+|+.++.++ +||||+++++++.+.+ ..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~--------~~~ 72 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES--------RLF 72 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC--------EEE
Confidence 46999999999999965 68899999997532 23345678898888776 7999999999887653 789
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 73 lv~E~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999998886543 489999999999999999999987 7999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P 195 (329)
T cd05618 147 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred cCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCC
Confidence 1999999999999998553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=243.30 Aligned_cols=166 Identities=22% Similarity=0.367 Sum_probs=141.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 76 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-------- 76 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--------
Confidence 57888999999999999999965 789999999865432 22346788999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++ |+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 6899999996 68888876532 3488899999999999999999987 7999999999999999999999999987
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. .|+||+||++|+|++|...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 203 (303)
T cd07869 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203 (303)
T ss_pred eeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 421 1999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=243.27 Aligned_cols=160 Identities=23% Similarity=0.375 Sum_probs=134.5
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHH-HHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLD-LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|.. +++.++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~--------~~~ 72 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE--------KLY 72 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC--------EEE
Confidence 46899999999999854 78999999986432 223345555654 577899999999999887653 789
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++.+...++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 73 FVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred EEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999998887543 488999999999999999999987 8999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~p 195 (325)
T cd05604 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred CCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCC
Confidence 1999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=213.64 Aligned_cols=161 Identities=24% Similarity=0.376 Sum_probs=136.3
Q ss_pred CCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..++||+|.||+||||+ .++++.||+|+..-.. ..--....+||.+++.++|+|||+++++.... .
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd--------k 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD--------K 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--------c
Confidence 34556889999999999999 4579999999985432 22245678999999999999999999987654 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..-||+|||.. +|.+|..... ..++-.....++.|..+||.|+|++ .+.|||+||.|.|++.+|+.|++|||+|
T Consensus 75 kltlvfe~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 75 KLTLVFEFCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred eeEEeHHHhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 68899999977 8888876543 2488888999999999999999998 6899999999999999999999999999
Q ss_pred cccc-------------------------------cccccceeeeeeeh
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~ 658 (671)
+-.. |+||.|||++|+.-
T Consensus 149 rafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelan 197 (292)
T KOG0662|consen 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_pred hhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhh
Confidence 6533 99999999999754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=251.94 Aligned_cols=170 Identities=27% Similarity=0.465 Sum_probs=142.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
..++|+..+.||+|+||.||+|+. +++..||||+++... ....+.+.+|+++++.+ +|+|||+++++|.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345788899999999999999873 234589999997543 33356788999999999 8999999999998753
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCC--------------------------------------------------
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENT-------------------------------------------------- 582 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------------------------------------------- 582 (671)
..++||||+++|+|.++++...
T Consensus 116 --------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 116 --------PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred --------CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 6899999999999999885321
Q ss_pred -----------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc--
Q 005898 583 -----------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS-- 643 (671)
Q Consensus 583 -----------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~-- 643 (671)
....++|.+..+++.||++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 113478899999999999999999986 8999999999999999999999999987421
Q ss_pred ------------------------------ccccccceeeeeeeh-hhh
Q 005898 644 ------------------------------EDINSVGVRLLILMS-FFF 661 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~-~~~ 661 (671)
.|+||+||++|+|++ |..
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~ 313 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 199999999999997 443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=247.37 Aligned_cols=164 Identities=23% Similarity=0.423 Sum_probs=143.8
Q ss_pred hcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
...|..-.+||+|+.|.||.|+ ..+++.||||++........+-..+|+.+|+..+|+|||++++.|.-.+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-------- 343 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-------- 343 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc--------
Confidence 4456677889999999999998 5578999999997665555566889999999999999999999877653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
+.|.|||||++|+|-+.+... .+++.+...|+.++.+||+|||.. +|+|||||+.|||++.++.+||+|||+.
T Consensus 344 eLWVVMEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeee
Confidence 789999999999998877643 389999999999999999999998 8999999999999999999999999998
Q ss_pred cccc------------------------------cccccceeeeeeehhh
Q 005898 641 IVSE------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 641 ~~~~------------------------------d~~s~g~~l~~~~~~~ 660 (671)
..+. |+||+|+...||.-|-
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 5543 9999999999988654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=245.18 Aligned_cols=167 Identities=19% Similarity=0.314 Sum_probs=143.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+++.. +++.||||++.... ....+.+.+|+.++..++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN------ 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC------
Confidence 36788899999999999999965 68999999986422 223456889999999999999999999887653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... ..+++.....++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 75 --~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 75 --NLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred --eEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 7899999999999999997532 2488899999999999999999987 79999999999999999999999999
Q ss_pred Cccc------------------------------------cccccccceeeeeeehhhhc
Q 005898 639 LSIV------------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~------------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
++.. ..|+||+||++|+|++|...
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 8632 02999999999999987543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=244.62 Aligned_cols=160 Identities=24% Similarity=0.364 Sum_probs=138.1
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. +++.||||.++... ....+.+.+|+.++.++ +||||+++++++.+.+ ..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~--------~~~ 72 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES--------RLF 72 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC--------EEE
Confidence 46999999999999865 68999999997532 22345688899999988 6999999999987653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~e~~~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999998886543 489999999999999999999987 8999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~P 195 (329)
T cd05588 147 IRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195 (329)
T ss_pred ccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCC
Confidence 1999999999999997554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=242.39 Aligned_cols=160 Identities=24% Similarity=0.380 Sum_probs=134.0
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHH-HHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLD-LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. +++.||||++.... ....+++.+|+. +++.++||||+++++++.+.+ ..+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--------~~~ 72 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--------KLY 72 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--------EEE
Confidence 46999999999999965 68999999986432 122344555554 678899999999999887653 789
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+...+...++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 73 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 73 FVLDYVNGGELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred EEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999999998886532 378888889999999999999986 7999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCC
Confidence 1999999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=242.34 Aligned_cols=160 Identities=23% Similarity=0.378 Sum_probs=134.5
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHH-HHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLD-LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|.. +++.++||||+++++++.+.+ ..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--------~~~ 72 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--------KLY 72 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--------EEE
Confidence 46999999999999965 78999999986432 122344555544 568899999999999887653 789
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 73 FVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred EEEcCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999999987543 488999999999999999999987 8999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|+++...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 195 (323)
T cd05575 147 IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195 (323)
T ss_pred ccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCC
Confidence 1999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=243.90 Aligned_cols=165 Identities=21% Similarity=0.331 Sum_probs=139.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+|+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+..|.+++..+ +|++|+++.+++.+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD------ 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC------
Confidence 4677899999999999999865 67899999987532 22344567788888777 5889999988887653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|..++.... .+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 75 --~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 75 --RLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred --EEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 6899999999999999887543 388999999999999999999987 89999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|||++|...
T Consensus 147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~P 200 (323)
T cd05616 147 MCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200 (323)
T ss_pred CceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCC
Confidence 88631 1999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=244.65 Aligned_cols=163 Identities=25% Similarity=0.387 Sum_probs=137.2
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHH---HhcCCCCCcccccceeecCCCCCCc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDL---LAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+++ +++++||||+++++++.+.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~----- 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED----- 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence 456789999999999999865 68999999996432 2223456666555 46778999999999987653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|..+++.. .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 76 ---~~~lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 ---HVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred ---EEEEEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 689999999999999888642 489999999999999999999987 8999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+||++|+|++|...
T Consensus 146 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~p 200 (324)
T cd05589 146 GLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200 (324)
T ss_pred cCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 987531 1999999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=245.58 Aligned_cols=169 Identities=25% Similarity=0.405 Sum_probs=141.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.|+..+.||+|+||.||+|+.. +|+.||||++... ......++.+|++++++++||||+++++++...... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~---~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR---EFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC---CCc
Confidence 3677889999999999999854 7899999998643 223345788999999999999999999988654311 123
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++|||||+ ++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 5799999996 68988887543 489999999999999999999987 7999999999999999999999999987
Q ss_pred ccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. .|+||+||++|+|++|...
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~p 207 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCC
Confidence 521 1999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=243.42 Aligned_cols=160 Identities=25% Similarity=0.365 Sum_probs=136.7
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..+ +||||+++++++.+.+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~--------~~~ 72 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD--------RLF 72 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--------eEE
Confidence 46899999999999865 68899999986532 23345677888888866 7999999999987653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999998887543 488999999999999999999987 7999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 195 (321)
T cd05591 147 ILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195 (321)
T ss_pred ccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCC
Confidence 1999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=239.89 Aligned_cols=164 Identities=23% Similarity=0.341 Sum_probs=140.2
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 73 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-------- 73 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--------
Confidence 5788899999999999999975 68899999986532 233567889999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred EEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 689999999998776554322 3488999999999999999999986 7999999999999999999999999987
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+.. .|+||+||++|+|++|..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 531 199999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=246.46 Aligned_cols=144 Identities=24% Similarity=0.462 Sum_probs=127.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++..++||||+++++++.+.+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------- 74 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE------- 74 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-------
Confidence 5788899999999999999965 78999999986432 234567889999999999999999999887653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 75 -HLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred -eEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCC
Confidence 689999999999999999764 3488999999999999999999986 899999999999999999999999998
Q ss_pred cc
Q 005898 640 SI 641 (671)
Q Consensus 640 a~ 641 (671)
++
T Consensus 148 ~~ 149 (350)
T cd05573 148 CK 149 (350)
T ss_pred Cc
Confidence 74
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=243.85 Aligned_cols=165 Identities=21% Similarity=0.333 Sum_probs=139.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCC-CcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHP-HLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~~~ 558 (671)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++|+ +|+++++++.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD------ 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC------
Confidence 4677899999999999999865 67899999986432 23456788899999999765 5777877776543
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+++|+|..++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 75 --~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 75 --RLYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred --EEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 6899999999999999887543 388999999999999999999987 89999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (324)
T cd05587 147 MCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200 (324)
T ss_pred cceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 87521 1999999999999997553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.44 Aligned_cols=160 Identities=24% Similarity=0.371 Sum_probs=134.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhc-CCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAK-LRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||+||+|+.. +++.||||.++... ....+.+..|..++.. .+||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--------~~~ 72 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--------HLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--------EEE
Confidence 46999999999999965 68899999986432 2234455667777665 48999999999887653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++.+...++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 73 lv~e~~~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999999887543 388899999999999999999987 8999999999999999999999999988531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 147 MNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred CCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCC
Confidence 1999999999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=243.02 Aligned_cols=160 Identities=25% Similarity=0.401 Sum_probs=136.8
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||+||+|+.. +++.||||++.... ....+.+..|+.++..+ +||||+++++++.+.+ ..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~--------~~~ 72 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD--------RLF 72 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC--------EEE
Confidence 46999999999999965 68999999986432 22345677888888876 6999999999887653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 iv~Ey~~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred EEEcCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999999999999887543 488999999999999999999987 7999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P 195 (320)
T cd05590 147 IFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195 (320)
T ss_pred CcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCC
Confidence 1999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=244.07 Aligned_cols=167 Identities=19% Similarity=0.285 Sum_probs=142.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..++||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++..++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN------ 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC------
Confidence 36788899999999999999975 57899999986422 223445888999999999999999999887653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 75 --~~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 75 --NLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred --EEEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 6899999999999999997532 2488999999999999999999987 89999999999999999999999999
Q ss_pred Cccc------------------------------------cccccccceeeeeeehhhhc
Q 005898 639 LSIV------------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~------------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
+++. ..|+||+||++|||++|...
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 8632 12999999999999997554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=234.83 Aligned_cols=170 Identities=24% Similarity=0.411 Sum_probs=145.5
Q ss_pred hcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.+.|++.++||.|.-++||+|+ .+.++.||||++.-.+ ....+++++|+..|+.++|||||+.+..|..+.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~------- 97 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS------- 97 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-------
Confidence 3568889999999999999998 5678999999996433 334688999999999999999999988777653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
.+|+||.||.+|++.+.+...-+ .-+++.....|..++.+||.|||++ +-||||||+.|||||++|++|++|||.
T Consensus 98 -~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 98 -ELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred -eeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 79999999999999998876432 2288889999999999999999998 789999999999999999999999987
Q ss_pred cccc------------------------------------ccccccceeeeeeehhhhcc
Q 005898 640 SIVS------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
+..+ .|+||+|++-.|+.+|....
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 6321 19999999999999887544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=247.78 Aligned_cols=161 Identities=22% Similarity=0.373 Sum_probs=136.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..+.||+|+||.||+|+.. +++.||||.+.... ....+++.+|++++++++|+||+++++++.+.+ .
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~ 146 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG--------E 146 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--------e
Confidence 3445688999999999999865 78999999986543 334567899999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.... ...+.....++.||++||+|||+. +|+|||||++||++++++.+||+|||+++
T Consensus 147 ~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 89999999999986532 256777889999999999999987 79999999999999999999999999874
Q ss_pred c-----------------------------------cccccccceeeeeeehhhhc
Q 005898 642 V-----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~-----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
. ..|+||+||++|||+++...
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p 272 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence 2 12999999999999987543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=248.82 Aligned_cols=167 Identities=25% Similarity=0.453 Sum_probs=140.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCC-CCCcccccceeecCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGG 552 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 552 (671)
..+.|...+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|++++++++ |||||+++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888899999999999999742 23479999997543 334567999999999996 999999999997653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCC--------------------------------------------------
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENT-------------------------------------------------- 582 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------------------------------------------- 582 (671)
..++||||+++|+|.++++...
T Consensus 115 --------~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 115 --------PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred --------ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 6899999999999999886421
Q ss_pred -------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCC
Q 005898 583 -------------------------------------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV 619 (671)
Q Consensus 583 -------------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 619 (671)
....++|.++..++.|+++||+|||+. +|+||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~di 263 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDL 263 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCC
Confidence 012478899999999999999999986 7999999
Q ss_pred CCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 620 KTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 620 k~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+||++++++.+|++|||+++.. .|+||+||++|+|++
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999987521 199999999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=255.89 Aligned_cols=166 Identities=19% Similarity=0.273 Sum_probs=143.6
Q ss_pred CCcCceeccCCceEEEEEEEc-C-CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-N-GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
|...+.||+|+||.||+|... + +..||+|.+..........+.+|+++++.++|||||+++++|.+.+ ..
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~--------~~ 140 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD--------KL 140 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC--------EE
Confidence 778899999999999999743 4 6788999876555555567889999999999999999999998753 78
Q ss_pred EEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 563 FLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
++||||+++|+|.+++... ....++++.....++.|++.||+|+|+. +|+||||||+||++++++.+||+|||+++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 9999999999999988643 2234588999999999999999999987 89999999999999999999999999985
Q ss_pred ccc--------------------------------cccccceeeeeeehhhh
Q 005898 642 VSE--------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~~--------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
... |+||+||++|+|+++..
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 269 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 321 99999999999999754
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=236.73 Aligned_cols=163 Identities=31% Similarity=0.565 Sum_probs=139.0
Q ss_pred cCceeccCCceEEEEEEEc-----CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 487 MSAIMGEGSYGKLYKGRLE-----NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
..+.||+|+||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-------- 74 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-------- 74 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--------
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc--------
Confidence 3578999999999999976 25689999996543 334788999999999999999999999999543
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.++++... ...++|.++..++.|||+||+|||+. +++|+||+++||++++++.+||+|||++
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred cccccccccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 5899999999999999998752 23589999999999999999999987 7999999999999999999999999998
Q ss_pred cccc--------------------------------cccccceeeeeeehhhh
Q 005898 641 IVSE--------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~~--------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
+... |+||+|+++||+++...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~ 203 (259)
T PF07714_consen 151 RPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGK 203 (259)
T ss_dssp EETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 7651 99999999999999543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=233.99 Aligned_cols=164 Identities=20% Similarity=0.469 Sum_probs=143.6
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~ 76 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEE--------PI 76 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--------Cc
Confidence 46788899999999999999988888999999865432 3578999999999999999999998887643 57
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.++++... ...+++.++..++.++++||+|||+. +++||||||+||++++++.+|++|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred EEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCcccee
Confidence 99999999999999987542 34588999999999999999999986 799999999999999999999999999853
Q ss_pred c-------------------------------ccccccceeeeeeehh
Q 005898 643 S-------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~~ 659 (671)
. .|+||+||++|+|+++
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence 1 1999999999999983
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=242.34 Aligned_cols=165 Identities=21% Similarity=0.326 Sum_probs=139.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 558 (671)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+..|++++..+. |++|+++.+++.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~------ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD------ 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC------
Confidence 3667789999999999999864 78999999986432 223456788899998886 567777887776543
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|..++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 75 --~~~lv~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 75 --RLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred --EEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 6899999999999999987543 389999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p 200 (323)
T cd05615 147 MCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200 (323)
T ss_pred cccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCC
Confidence 87531 1999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=241.37 Aligned_cols=159 Identities=25% Similarity=0.385 Sum_probs=135.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhc-CCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAK-LRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||+||+|+.. +++.||||.++... ....+.+..|..++.. .+||||+++++++.+.+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~--------~~~ 72 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE--------NLF 72 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC--------EEE
Confidence 46999999999999965 68899999987532 2234556677788776 48999999999987653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++.+...++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999999987542 488999999999999999999987 8999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhh
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.|+||+||++|+|++|..
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~ 194 (316)
T cd05619 147 MLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred CCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 199999999999998765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=243.10 Aligned_cols=169 Identities=25% Similarity=0.408 Sum_probs=147.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
....|.+...||+|.|++|..|+.. +|..||||.+.+.. ....+.+.+|+++|..++|||||+++.+...+.
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~----- 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA----- 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-----
Confidence 4567888999999999999999954 79999999997653 233456899999999999999999999998764
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.+|+||||..+|.+++|+..... +.......+..|+.+|++|+|++ .|+|||||++||+||.++++||+||
T Consensus 129 ---~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 129 ---TLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred ---eeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence 79999999999999999987544 44467778889999999999998 6899999999999999999999999
Q ss_pred CCccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 638 GLSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|++..++ |+|++|+++|.|++|....
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF 255 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF 255 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc
Confidence 9997755 9999999999999876543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-27 Score=226.67 Aligned_cols=167 Identities=21% Similarity=0.347 Sum_probs=143.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--------hhhHHHHHHHHHHHhcC-CCCCcccccceeec
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--------KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCID 550 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 550 (671)
.-++|...+++|+|..++|.++.. ++|++.|+|++.... ..-.+.-.+|+.+|+++ .||+|+.+.++|.+
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 345677889999999999998875 478999999985322 12245677899999998 59999999999987
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
+. .+++|+|.|+.|.|.++|... ..++.....+|+.++.+|++|||.. .||||||||+|||+|++.
T Consensus 95 ~s--------F~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 95 DA--------FVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNM 160 (411)
T ss_pred cc--------hhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecccc
Confidence 64 789999999999999999864 3488899999999999999999998 799999999999999999
Q ss_pred cEEEcccCCccccc-----------------------------------cccccceeeeeeehhhh
Q 005898 631 IAKLSDYGLSIVSE-----------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 631 ~~ki~DfGla~~~~-----------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
++||+|||+|+.++ |.|++|||||.++.|-+
T Consensus 161 ~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 99999999997654 99999999999887643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=237.21 Aligned_cols=166 Identities=18% Similarity=0.250 Sum_probs=142.2
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|+..++||+|+||+||+++.. +++.||||++.... ......+.+|++++++++||||+++++.+.+.+
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 73 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-------- 73 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--------
Confidence 677889999999999999864 78999999986532 122355788999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|..++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 6899999999999998886532 23589999999999999999999987 7999999999999999999999999987
Q ss_pred ccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|++|...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence 532 2999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=232.98 Aligned_cols=162 Identities=23% Similarity=0.431 Sum_probs=141.7
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+|+..+.||+|+||.||+|++.++..+|+|.+.... ...+++.+|++++++++||||++++++|.+.+ ..+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~ 75 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK--------PLY 75 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC--------CEE
Confidence 467778999999999999998888899999986443 23467899999999999999999999987653 679
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|.++++... ..++|..+..++.+++.||+|||+. +|+||||||+||++++++.+|++|||+++..
T Consensus 76 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 9999999999999987532 2489999999999999999999987 7999999999999999999999999977521
Q ss_pred -------------------------------ccccccceeeeeeehh
Q 005898 644 -------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 644 -------------------------------~d~~s~g~~l~~~~~~ 659 (671)
.|+||+|+++|+|++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~ 197 (256)
T cd05114 151 LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197 (256)
T ss_pred CCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcC
Confidence 2999999999999983
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=248.60 Aligned_cols=158 Identities=19% Similarity=0.269 Sum_probs=138.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|+..+.||+|+||.||+++. .+++.||||... .+.+.+|++++++++|||||++++++.... .
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--------~ 157 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK--------F 157 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC--------e
Confidence 5699999999999999999985 478999999753 235688999999999999999999987643 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|+||+. ++|..++.... .+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 799999995 68988886543 388999999999999999999987 79999999999999999999999999985
Q ss_pred cc-------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+||+||++|||++|..
T Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred ccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 31 199999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=236.83 Aligned_cols=161 Identities=20% Similarity=0.281 Sum_probs=136.9
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||+||+++.. +|+.||||++..... ...+.+..|++++++++||||+++.+++.+.. ..++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--------~~~lv~ 72 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT--------DLCLVM 72 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC--------eEEEEE
Confidence 699999999999864 789999999864322 23456788999999999999999998887643 689999
Q ss_pred ecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc--
Q 005898 567 EFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS-- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~-- 643 (671)
|||++|+|..++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 73 TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred eCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999998875422 234589999999999999999999987 8999999999999999999999999988531
Q ss_pred ----------------------------ccccccceeeeeeehhhhc
Q 005898 644 ----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|+++...
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p 196 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 2999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=240.71 Aligned_cols=160 Identities=24% Similarity=0.382 Sum_probs=135.8
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. +|+.||||+++... ....+.+..|+.++... +||||+++++++.+.+ ..+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--------~~~ 72 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--------HLF 72 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--------EEE
Confidence 46999999999999965 68999999997532 12345567788887754 8999999999987653 789
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++.+...++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred EEECCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999999887543 388999999999999999999987 8999999999999999999999999987521
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~P 195 (316)
T cd05620 147 VFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred ccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 1999999999999997553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=241.08 Aligned_cols=161 Identities=24% Similarity=0.361 Sum_probs=138.3
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.++ +||||+++++++.+.+ ..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--------~~~ 72 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS--------RLF 72 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC--------EEE
Confidence 46999999999999965 68899999997542 22345688999999888 6999999999887653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999998886543 489999999999999999999997 7999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhcc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
.|+||+||++|+|++|....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf 196 (327)
T cd05617 147 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196 (327)
T ss_pred cCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCC
Confidence 19999999999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=239.73 Aligned_cols=160 Identities=23% Similarity=0.345 Sum_probs=132.9
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHH-HHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRL-DLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||+||+|+.. +++.||+|++.... .....++.+|. .+++.++||||+++++++.+.+ ..+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~--------~~~ 72 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--------KLY 72 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC--------eEE
Confidence 46999999999999965 67899999986432 12233444444 4578899999999999887653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+...+...++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 73 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999999987543 377788888999999999999987 8999999999999999999999999987531
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 195 (325)
T cd05602 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195 (325)
T ss_pred ccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCC
Confidence 1999999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=235.99 Aligned_cols=165 Identities=30% Similarity=0.526 Sum_probs=140.8
Q ss_pred cCCCcCceeccCCceEEEEEEE-----cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..+.||+|+||+||+|+. +++..||+|.+.... ....+++.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ---- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence 3567788999999999999984 246789999997533 334567899999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCC
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTP--------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTN 622 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~ 622 (671)
..++||||+++|+|.+++....+ ...+++.+.+.++.+++.||+|||+. +++||||||+
T Consensus 81 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 153 (283)
T cd05090 81 ----PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAAR 153 (283)
T ss_pred ----ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhccccc
Confidence 67999999999999999863221 23488999999999999999999987 7999999999
Q ss_pred ceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 623 NILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 623 NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||++++++.+|++|||+++.. .|+||+|+++|||++
T Consensus 154 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 221 (283)
T cd05090 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221 (283)
T ss_pred eEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 999999999999999988531 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=242.87 Aligned_cols=169 Identities=24% Similarity=0.409 Sum_probs=145.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|...+++|+|+||.++..+.+ +++.+++|.+...+ ....+...+|+.++++++|||||..++.+...+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~------- 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG------- 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-------
Confidence 45777899999999999988754 67899999986443 334557889999999999999999999888754
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||++||++.+.+.+.. +..+...+...+..|+..|+.|||+. .|+|||||++||++.++..+|++|||+
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 23899999999999999988654 45678888899999999999999976 799999999999999999999999999
Q ss_pred ccccc------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+... |+||+||.+|||++--.+
T Consensus 153 aK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~a 205 (426)
T KOG0589|consen 153 AKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPA 205 (426)
T ss_pred hhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccc
Confidence 98754 999999999999885444
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=243.67 Aligned_cols=166 Identities=24% Similarity=0.461 Sum_probs=140.3
Q ss_pred cCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
+.|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++.++ +|+||++++++|...+
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~-- 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG-- 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC--
Confidence 4688889999999999999963 235789999997543 23345688899999999 8999999999887643
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCC---------------------------------------------------
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTP--------------------------------------------------- 583 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~--------------------------------------------------- 583 (671)
...++||||+++|+|.+++.....
T Consensus 85 -----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 85 -----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred -----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 368999999999999988853211
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-------------
Q 005898 584 -------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS------------- 643 (671)
Q Consensus 584 -------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~------------- 643 (671)
...++|..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 12589999999999999999999987 8999999999999999999999999988532
Q ss_pred -------------------ccccccceeeeeeeh
Q 005898 644 -------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 644 -------------------~d~~s~g~~l~~~~~ 658 (671)
.|+||+||++|||++
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t 270 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHH
Confidence 299999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=235.33 Aligned_cols=169 Identities=21% Similarity=0.383 Sum_probs=142.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
.+++|+..+.||+|+||+||+|+.. ++..||||++.... .....++.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 4567888999999999999999742 35689999986432 234567899999999999999999999987543
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTP-------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL 626 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl 626 (671)
..++||||+++|+|.++++.... ...++|.++..++.+++.|++|||+. +++||||||+||++
T Consensus 83 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~ 152 (277)
T cd05062 83 -------PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 152 (277)
T ss_pred -------CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEE
Confidence 67999999999999999875321 23478899999999999999999986 79999999999999
Q ss_pred cCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehhh
Q 005898 627 NEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 627 ~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
++++.+|++|||+++.. .|+||+||++|+|+++.
T Consensus 153 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 218 (277)
T cd05062 153 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218 (277)
T ss_pred cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCC
Confidence 99999999999987421 19999999999999843
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=238.56 Aligned_cols=158 Identities=22% Similarity=0.335 Sum_probs=132.4
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcC---CCCCcccccceeecCCCCCCcccceEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKL---RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++.+.+ ..+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~--------~~~ 72 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS--------DLY 72 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC--------eEE
Confidence 699999999999864 689999999864321 2233455666666655 6999999999887653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++.....++.||++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 73 LVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred EEEcCCCCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999999887543 488999999999999999999987 8999999999999999999999999987531
Q ss_pred -------------------------------ccccccceeeeeeehhhhc
Q 005898 644 -------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 -------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~P 196 (330)
T cd05586 147 LTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196 (330)
T ss_pred CCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCC
Confidence 1999999999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=254.01 Aligned_cols=180 Identities=22% Similarity=0.330 Sum_probs=148.2
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 479 KEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 479 ~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
....++|...+.||+|+||+||+|+. .+|+.||||++... .......+.+|+..+..++|+||+++.+.+...+...
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999985 57999999998643 2334567889999999999999999988765543221
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
.......++||||+++|+|.+++.... ....+++.....++.|++.||+|+|+. +|+||||||+||++++++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 111224789999999999999987532 234688999999999999999999987 8999999999999999999999
Q ss_pred cccCCcccc--------------------------------ccccccceeeeeeehhhh
Q 005898 635 SDYGLSIVS--------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 635 ~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+|||+++.. .|+||+||++|||+++..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~ 243 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999987531 199999999999999754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=244.36 Aligned_cols=168 Identities=21% Similarity=0.380 Sum_probs=141.4
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+. .+|+.||||++... .....+++.+|+++++.++||||+++++++.+.+. ....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI---DPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc---cccc
Confidence 477889999999999999986 47999999998643 22345678899999999999999999999876431 1123
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..|+|+||+. ++|.+++... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 6899999997 5888877643 3489999999999999999999987 7999999999999999999999999987
Q ss_pred ccc--------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS--------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~--------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+.. .|+||+||++|||++|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 203 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence 521 199999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=232.12 Aligned_cols=165 Identities=21% Similarity=0.380 Sum_probs=144.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++||||+++++++...+ .
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--------~ 80 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--------K 80 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--------E
Confidence 4678889999999999999996 578999999987554444567889999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.++++... .+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence 899999999999999987543 489999999999999999999986 89999999999999999999999999764
Q ss_pred cc---------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS---------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~---------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+||+||++|||+++..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~ 207 (267)
T cd06646 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred eecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 21 299999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=242.19 Aligned_cols=169 Identities=27% Similarity=0.449 Sum_probs=148.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh---hHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY---TVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~ 556 (671)
...|+..+.||+|.||+||+++.. +|+.+|+|.+.+.... ..+.+.+|+++|+++. |||||.+.+++.+..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~---- 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD---- 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC----
Confidence 456778899999999999999965 5999999999765443 3468999999999998 999999999998764
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC----CcE
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH----RIA 632 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~----~~~ 632 (671)
.+++|||++.+|+|.+.+... .++..+...++.+|+.++.|||+. +|+||||||+|+|+... +.+
T Consensus 110 ----~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 110 ----SVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred ----eEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence 789999999999999998765 288999999999999999999996 89999999999999643 579
Q ss_pred EEcccCCccccc-----------------------------cccccceeeeeeehhhhcccc
Q 005898 633 KLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 633 ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
|++|||+|+... |+||+||++|.|++|.....+
T Consensus 179 k~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred EEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 999999997643 999999999999998776544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-27 Score=247.73 Aligned_cols=166 Identities=25% Similarity=0.462 Sum_probs=144.2
Q ss_pred CCcCceeccCCceEEEEEEEc--CCc--EEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE--NGT--SVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~--~g~--~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.+..++||+|.||+|++|.|. .|+ .||||++...... ...+|.+|+.+|-+|+|||+|+|||+..+.
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q-------- 183 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ-------- 183 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc--------
Confidence 345688999999999999975 454 6899999876543 578999999999999999999999999864
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..+||||.++.|+|.+.|+. .....+-......++.|||.||+||... +.|||||.++|+|+...-.+||+||||
T Consensus 184 -p~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 184 -PAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred -hhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence 57999999999999999987 3334566777889999999999999987 789999999999999999999999999
Q ss_pred ccccc---------------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE---------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~---------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
.+-+. |+|..|||+|||.|+.-.+
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP 315 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP 315 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC
Confidence 97543 9999999999999975444
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=231.10 Aligned_cols=161 Identities=25% Similarity=0.430 Sum_probs=140.8
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+|+..+.||+|+||+||+|+..++..||||.+.... ...+++.+|++++.+++||||++++++|.+.+ ..+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~ 75 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR--------PIY 75 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC--------CcE
Confidence 466778899999999999998777789999987543 23567999999999999999999999987653 579
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|.+++.... ..++|.++..++.+|+.||+|||+. +++||||||+||++++++.+|++|||.++..
T Consensus 76 lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceec
Confidence 9999999999999987532 2489999999999999999999987 8999999999999999999999999987521
Q ss_pred -------------------------------ccccccceeeeeeeh
Q 005898 644 -------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 644 -------------------------------~d~~s~g~~l~~~~~ 658 (671)
.|+||+|+++|+|++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~ 196 (256)
T cd05113 151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196 (256)
T ss_pred CCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhc
Confidence 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=233.58 Aligned_cols=162 Identities=20% Similarity=0.307 Sum_probs=137.3
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||.||+++.. +|+.||+|++.... ....+.+..|++++++++||||+++.+++.+.. ..++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--------~~~lv~ 72 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--------HLCLVM 72 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--------eEEEEE
Confidence 699999999999864 69999999986432 122345667999999999999999998887643 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++|+|..++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 73 e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 73 SLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred ecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999998886432 23489999999999999999999986 8999999999999999999999999987431
Q ss_pred --------------------------ccccccceeeeeeehhhhccc
Q 005898 644 --------------------------EDINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 644 --------------------------~d~~s~g~~l~~~~~~~~~~~ 664 (671)
.|+||+||++|+|++|.....
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 199999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=232.00 Aligned_cols=169 Identities=19% Similarity=0.406 Sum_probs=138.6
Q ss_pred CcCceeccCCceEEEEEEEcC-Cc--EEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 486 DMSAIMGEGSYGKLYKGRLEN-GT--SVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 486 ~~~~~iG~G~~g~Vy~~~~~~-g~--~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
...++||+|+||.||+|+..+ +. .||||.++.. .....+++.+|++++++++||||++++++|......+ ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~--~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE--GYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc--CCC
Confidence 456889999999999999753 33 5899988653 2344678899999999999999999999886532111 112
Q ss_pred eEEEEEecCCCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHISENT---PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|..++.... ....++|.....++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 4689999999999998874321 234589999999999999999999986 8999999999999999999999999
Q ss_pred CCcccc--------------------------------ccccccceeeeeeehh
Q 005898 638 GLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 638 Gla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|+++.. .|+||+||++|+|+++
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcC
Confidence 997531 2999999999999883
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=259.79 Aligned_cols=169 Identities=20% Similarity=0.392 Sum_probs=144.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..++||+|+||.||+|+.. +|+.||||++.... ....+++.+|++++++++|||||++++++.+.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~------ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD------ 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC------
Confidence 46788899999999999999865 68999999986432 233567999999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENT--------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
..++||||+++|+|.+++.... ....+++.+.++++.||++||+|||+. +|+||||||+||+++.++
T Consensus 76 --~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 76 --PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFG 150 (932)
T ss_pred --EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCC
Confidence 6899999999999999886421 123467888999999999999999987 899999999999999999
Q ss_pred cEEEcccCCcccc------------------------------------------------ccccccceeeeeeehhhhc
Q 005898 631 IAKLSDYGLSIVS------------------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 631 ~~ki~DfGla~~~------------------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.+||+|||+++.. .|+||+||++|||++|...
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 9999999988543 1999999999999998643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=238.74 Aligned_cols=160 Identities=23% Similarity=0.367 Sum_probs=137.2
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||+||+|+.. +++.||||.++... ....+.+.+|++++..+ +||||+++++++.+.+ ..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--------~~~ 72 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--------RLF 72 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--------EEE
Confidence 46999999999999865 68899999997532 22345677888888887 6999999999887653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|..++.... .+++.+...++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred EEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999998887543 489999999999999999999987 8999999999999999999999999987431
Q ss_pred ------------------------------ccccccceeeeeeehhhhc
Q 005898 644 ------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 147 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~p 195 (318)
T cd05570 147 ILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195 (318)
T ss_pred CcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCC
Confidence 1999999999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=250.71 Aligned_cols=174 Identities=17% Similarity=0.252 Sum_probs=138.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
...+|+..++||+|+||.||+|+. .+++.||||++.... ....+|+.+|++++|||||++++++....-......
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345789999999999999999986 468999999985432 234579999999999999999998754321000011
Q ss_pred ceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEEEccc
Q 005898 560 NKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDY 637 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~ki~Df 637 (671)
...++||||+++ ++.+++... .....+++.....++.|+++||+|||+. +|+||||||+||+++.+ +.+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 777766532 2234589999999999999999999987 79999999999999965 47999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+|+.. .|+||+||++|||++|...
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~p 270 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 998531 1999999999999998643
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-26 Score=231.62 Aligned_cols=164 Identities=24% Similarity=0.505 Sum_probs=144.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.+.|+..+.||+|+||.||+|...+++.||||.++... ...+++.+|++++++++||||+++++++...+ .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--------P 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC--------C
Confidence 35678889999999999999998778899999987543 23567999999999999999999999887653 5
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ...++|.++..++.+++.|+.|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred eeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 799999999999999997543 34589999999999999999999986 79999999999999999999999999874
Q ss_pred cc-------------------------------ccccccceeeeeeeh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
.. .|+||+|+++|+|++
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 199 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199 (261)
T ss_pred EccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHh
Confidence 21 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=233.10 Aligned_cols=167 Identities=25% Similarity=0.516 Sum_probs=147.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+..+|+..++||+|+||.||+|+..+++.||+|.+........+++.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 75 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-------- 75 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC--------
Confidence 345677889999999999999998889999999998765555678999999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.++++... ...++|.++..++.+++.|++|||+. +|+||||||+||++++++.+|++|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccch
Confidence 6799999999999999997643 34589999999999999999999986 7999999999999999999999999987
Q ss_pred ccc------------------------------ccccccceeeeeeehh
Q 005898 641 IVS------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 641 ~~~------------------------------~d~~s~g~~l~~~~~~ 659 (671)
... .|+||+|+++|+|+++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~ 200 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 421 2999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=236.11 Aligned_cols=167 Identities=22% Similarity=0.296 Sum_probs=144.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+++.. ++..||+|.+... .....+++.+|++++.+++||||++++++|.+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-------- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--------
Confidence 36888899999999999999864 6889999998654 2333567889999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++... ..+++.....++.|+++||+|||+.+ +++||||||+||++++++.+|++|||++
T Consensus 73 ~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 73 EISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred EEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence 789999999999999999764 34889999999999999999999742 6999999999999999999999999987
Q ss_pred ccc----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+|+++|+|+++...
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 197 (308)
T cd06615 148 GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197 (308)
T ss_pred ccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 531 2999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=228.56 Aligned_cols=158 Identities=24% Similarity=0.478 Sum_probs=137.3
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||++++++|.+.. ..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~ 72 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ--------PIYIVM 72 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--------CeEEEE
Confidence 46899999999999964 78999999886543 334567999999999999999999999987653 679999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++|+|.++++... ..++|.++..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++...
T Consensus 73 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 73 ELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred eeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9999999999997542 3489999999999999999999987 7999999999999999999999999986420
Q ss_pred -----------------------------ccccccceeeeeeehh
Q 005898 644 -----------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 644 -----------------------------~d~~s~g~~l~~~~~~ 659 (671)
.|+||+||++|+|+++
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~ 192 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSL 192 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 1999999999999973
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=233.95 Aligned_cols=170 Identities=24% Similarity=0.369 Sum_probs=136.5
Q ss_pred CCCcCceeccCCceEEEEEEE-c-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcC---CCCCcccccceeecCCCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-E-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKL---RHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~~ 556 (671)
+|+..+.||+|+||+||+|+. . +++.||||++.... ......+.+|+++++.+ +||||++++++|......
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~-- 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD-- 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC--
Confidence 577889999999999999985 3 47889999986432 22234566677766655 799999999998643211
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
.....++||||++ |+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+|++|
T Consensus 80 -~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 80 -RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred -CCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 1135899999997 59999887532 23489999999999999999999987 799999999999999999999999
Q ss_pred cCCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 637 YGLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 637 fGla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
||+++.. .|+||+||++|||+++..
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCC
Confidence 9987532 199999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=233.34 Aligned_cols=156 Identities=26% Similarity=0.411 Sum_probs=130.7
Q ss_pred eeccCCceEEEEEEEcC-------------------------CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccc
Q 005898 490 IMGEGSYGKLYKGRLEN-------------------------GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCL 544 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 544 (671)
.||+|+||.||+|++.. ...||||.+........++|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13589999876544445678999999999999999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
+++|.+.. ..++||||+++|+|..++.... ..+++..++.++.|+++||+|||+. +|+||||||+||
T Consensus 82 ~~~~~~~~--------~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVRGS--------ENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEeCC--------ceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 99998753 5799999999999999987532 3488999999999999999999986 799999999999
Q ss_pred eecCCC-------cEEEcccCCcccc---------------------------ccccccceeeeeeeh
Q 005898 625 LLNEHR-------IAKLSDYGLSIVS---------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 625 Ll~~~~-------~~ki~DfGla~~~---------------------------~d~~s~g~~l~~~~~ 658 (671)
++++.+ .+|++|||++... .|+||+||++|||+.
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 998643 3799999976321 299999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=229.52 Aligned_cols=163 Identities=25% Similarity=0.494 Sum_probs=141.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||+||+|++. +...||||.++... ....++|.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR----- 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC-----
Confidence 46888899999999999999874 24589999987543 334567999999999999999999999887653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ..++|.++.+++.|++.|++|||+. +|+||||||+||++++++.+|++||
T Consensus 79 ---~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 79 ---PVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred ---ceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence 6799999999999999997543 2589999999999999999999986 7999999999999999999999999
Q ss_pred CCcccc--------------------------------ccccccceeeeeeeh
Q 005898 638 GLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 638 Gla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
|+++.. .|+||+|+++|+|++
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHc
Confidence 987532 199999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=237.25 Aligned_cols=165 Identities=21% Similarity=0.359 Sum_probs=140.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|...+.||+|+||.||+|+.. +++.||||.++... ......+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 77 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-------- 77 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC--------
Confidence 45778899999999999999865 68899999986443 223446788999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++ +|.+++.... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred eEEEEEeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 68999999985 8888876542 3478999999999999999999987 8999999999999999999999999987
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+.. .|+||+||++|+|++|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 152 RAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred eecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 431 199999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=232.59 Aligned_cols=162 Identities=24% Similarity=0.426 Sum_probs=137.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc----EEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT----SVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..+.||+|+||+||+|++. +++ .||+|.+.... ....+++..|+..+++++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~----- 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA----- 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-----
Confidence 35677889999999999999863 454 47788875432 23346788889999999999999999987542
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++|+||+++|+|.+++.... ..++|..+..++.||++||+|||+. +++||||||+||++++++.+|++|
T Consensus 82 ----~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 82 ----SLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred ----ccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 4689999999999999997542 3489999999999999999999986 799999999999999999999999
Q ss_pred cCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 637 YGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+++.. .|+||+|+++|||++
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t 206 (279)
T cd05111 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206 (279)
T ss_pred CccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHc
Confidence 9988531 199999999999998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=234.60 Aligned_cols=165 Identities=30% Similarity=0.566 Sum_probs=139.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc--EEEEEEccCC-chhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT--SVAIRCLPSS-KKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||+||+|+.. ++. .+|+|+++.. .....+++.+|++++.++ +||||+++++++.+.+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~----- 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-----
Confidence 46778899999999999999864 454 4688887643 233456889999999999 8999999999987653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..|+||||+++|+|.++++... ....+++.+++.++.|++.|++|||+. +|+||||||+||
T Consensus 82 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Ni 155 (303)
T cd05088 82 ---YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 155 (303)
T ss_pred ---CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheE
Confidence 6799999999999999997532 123588999999999999999999986 899999999999
Q ss_pred eecCCCcEEEcccCCccc-----------------------------cccccccceeeeeeeh
Q 005898 625 LLNEHRIAKLSDYGLSIV-----------------------------SEDINSVGVRLLILMS 658 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~-----------------------------~~d~~s~g~~l~~~~~ 658 (671)
++++++.+||+|||+++. ..|+||+||++|+|+|
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred EecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence 999999999999998741 1299999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=230.39 Aligned_cols=162 Identities=26% Similarity=0.501 Sum_probs=141.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+|+..+.||+|+||.||+|... +++.||+|.+.... ...+++.+|++++++++||||++++++|.+.+ ..
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~ 77 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--------PF 77 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC--------Cc
Confidence 4667789999999999999865 68899999987543 34567999999999999999999999987653 57
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ...++|..++.++.|+++||+|||.. +++||||||+||++++++.+|++|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999987543 23589999999999999999999987 799999999999999999999999997643
Q ss_pred c-------------------------------ccccccceeeeeeeh
Q 005898 643 S-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
. .|+||+||++|+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 200 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 1 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.05 Aligned_cols=165 Identities=25% Similarity=0.473 Sum_probs=140.8
Q ss_pred CCCcCceeccCCceEEEEEEE-----cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
+|+..+.||+|+||+||+++. .+++.||+|.+.... ....+.+.+|++++++++||||++++++|...+.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 80 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG---- 80 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC----
Confidence 347788999999999988653 357899999987543 2345678899999999999999999998875431
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++... .++|.++..++.|++.|++|||+. +|+||||||+||++++++.+|++||
T Consensus 81 --~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df 151 (283)
T cd05080 81 --KGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDF 151 (283)
T ss_pred --ceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeec
Confidence 3579999999999999998753 389999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+|+++|+|+++..
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~ 208 (283)
T cd05080 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208 (283)
T ss_pred ccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCC
Confidence 987521 299999999999999743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=232.63 Aligned_cols=165 Identities=24% Similarity=0.491 Sum_probs=142.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
+.|...+.||+|+||.||+|+.. +++.||||.++..... ..+++.+|++++++++|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--- 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC---
Confidence 34667789999999999999863 3478999999765433 4578999999999999999999999988653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENT-----------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..++||||+++|+|.+++.... ....+++.+...++.+++.|++|||.. +++||||||+||
T Consensus 82 -----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~ni 153 (280)
T cd05049 82 -----PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNC 153 (280)
T ss_pred -----CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceE
Confidence 6899999999999999997532 124588999999999999999999987 799999999999
Q ss_pred eecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 625 LLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
++++++.+|++|||+++.. .|+||+||++|+|++
T Consensus 154 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~ 219 (280)
T cd05049 154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219 (280)
T ss_pred EEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHh
Confidence 9999999999999987521 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=230.67 Aligned_cols=159 Identities=24% Similarity=0.393 Sum_probs=133.9
Q ss_pred eeccCCceEEEEEEEcC---CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEE
Q 005898 490 IMGEGSYGKLYKGRLEN---GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLV 565 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv 565 (671)
.||+|+||+||+|+..+ ...+|+|.+.... ....+++.+|+++++.++||||++++++|.+.. ..++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~--------~~~lv 73 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI--------PYLLV 73 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC--------ceEEE
Confidence 58999999999997543 3478888876443 334567889999999999999999999987653 68999
Q ss_pred EecCCCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc-
Q 005898 566 YEFMSNGNFRTHISENTP--GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV- 642 (671)
Q Consensus 566 ~Ey~~~GsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~- 642 (671)
|||+++|+|.+++..... ....++.....++.|++.|++|||+. +|+||||||+||++++++++||+|||+++.
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence 999999999999976432 23357888899999999999999987 799999999999999999999999998742
Q ss_pred --------------------------------------cccccccceeeeeeehh
Q 005898 643 --------------------------------------SEDINSVGVRLLILMSF 659 (671)
Q Consensus 643 --------------------------------------~~d~~s~g~~l~~~~~~ 659 (671)
..|+||+||++|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhC
Confidence 12899999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.83 Aligned_cols=163 Identities=25% Similarity=0.456 Sum_probs=140.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCc----EEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGT----SVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..++||+|+||+||+|++ ++|+ .||||.+.... ....+++.+|+.++..++||||++++++|...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----- 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----- 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-----
Confidence 4677889999999999999985 3555 48999986543 33456789999999999999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..+++|||+++|+|.++++... ..+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 82 ----~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 82 ----TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred ----CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECC
Confidence 4689999999999999987532 3489999999999999999999987 799999999999999999999999
Q ss_pred cCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 637 YGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 637 fGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
||+++.. .|+||+||++|||+++
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~ 207 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTF 207 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcC
Confidence 9987532 1999999999999883
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=229.85 Aligned_cols=170 Identities=19% Similarity=0.423 Sum_probs=140.7
Q ss_pred CCcCceeccCCceEEEEEEEc-C---CcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-N---GTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~---g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
|+..+.||+|+||.||+|+.. + +..||||+++... ....+++.+|++.+++++||||+++++++.+.+.. ..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL--QK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc--cc
Confidence 456789999999999999864 2 3689999987532 33456899999999999999999999988764311 01
Q ss_pred cceEEEEEecCCCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENT---PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
....++|+||+++|+|..++.... ....+++.+...++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 124699999999999999885432 224589999999999999999999986 79999999999999999999999
Q ss_pred ccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 636 DYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 636 DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||+++.. .|+||+||++|||+++
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence 99997531 2999999999999883
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=232.97 Aligned_cols=165 Identities=25% Similarity=0.509 Sum_probs=143.0
Q ss_pred cCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|...+.||+|+||+||+++. .++..+|||.+........+.+.+|++++++++||||++++++|.+.+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 4677889999999999999974 234679999997766556678999999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENT----------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL 626 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl 626 (671)
..++||||+++|+|.+++.... ....++|.++..++.|++.||+|||+. +++||||||+||++
T Consensus 81 ----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili 153 (288)
T cd05093 81 ----PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLV 153 (288)
T ss_pred ----ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 6799999999999999987432 123489999999999999999999986 79999999999999
Q ss_pred cCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 627 NEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 627 ~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
++++.+|++|||+++.. .|+||+||++|+|++
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999987521 199999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=232.97 Aligned_cols=165 Identities=24% Similarity=0.475 Sum_probs=142.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|...+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD---- 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence 34677889999999999999742 35679999997766555678999999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNN 623 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~N 623 (671)
..++||||+++|+|.+++.... ....++|.++..++.+++.|++|||+. +|+||||||+|
T Consensus 81 ----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 153 (291)
T cd05094 81 ----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRN 153 (291)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcce
Confidence 6799999999999999987532 123589999999999999999999987 79999999999
Q ss_pred eeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 624 ILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 624 iLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
|++++++.+|++|||+++.. .|+||+||++|+|++
T Consensus 154 il~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 220 (291)
T cd05094 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220 (291)
T ss_pred EEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999987421 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=233.00 Aligned_cols=165 Identities=27% Similarity=0.528 Sum_probs=139.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc--EEEEEEccCC-chhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT--SVAIRCLPSS-KKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..++||+|+||.||+|+.. ++. .+|+|.++.. .....+++.+|++++.++ +||||+++++++.+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG----- 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence 46778899999999999999875 343 5788888753 333456799999999999 7999999999987643
Q ss_pred ccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..++|+||+++|+|.++++... ....+++.++..++.|++.|++|||+. +|+||||||+||
T Consensus 77 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Ni 150 (297)
T cd05089 77 ---YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNV 150 (297)
T ss_pred ---cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceE
Confidence 5799999999999999987532 113588999999999999999999986 899999999999
Q ss_pred eecCCCcEEEcccCCcccc-----------------------------ccccccceeeeeeeh
Q 005898 625 LLNEHRIAKLSDYGLSIVS-----------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~-----------------------------~d~~s~g~~l~~~~~ 658 (671)
++++++.+||+|||++... .|+||+||++|+|++
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t 213 (297)
T cd05089 151 LVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213 (297)
T ss_pred EECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 9999999999999987321 199999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=239.80 Aligned_cols=166 Identities=27% Similarity=0.474 Sum_probs=139.9
Q ss_pred cCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
++|+..+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++.++ +|||||+++++|...+
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC--
Confidence 4688899999999999999973 357899999997543 23356788999999999 6899999999887543
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCC---------------------------------------------------
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTP--------------------------------------------------- 583 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~--------------------------------------------------- 583 (671)
...++||||+++|+|.++++....
T Consensus 85 -----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 85 -----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred -----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 257999999999999998864210
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-------
Q 005898 584 -------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS------- 643 (671)
Q Consensus 584 -------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~------- 643 (671)
...++|.++..++.|+++||+|||+. +|+||||||+||++++++++|++|||+++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence 12478899999999999999999987 8999999999999999999999999987531
Q ss_pred -------------------------ccccccceeeeeeeh
Q 005898 644 -------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 644 -------------------------~d~~s~g~~l~~~~~ 658 (671)
.|+||+|+++|+|++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 276 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 199999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=230.20 Aligned_cols=165 Identities=25% Similarity=0.523 Sum_probs=141.4
Q ss_pred CCCcCceeccCCceEEEEEEE-----cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.|+..+.||+|+||.||+++. .++..||+|.++... ....+.+.+|++++++++||||+++.+++.+.+.
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 80 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---- 80 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC----
Confidence 467788999999999999974 257889999987543 3345679999999999999999999999876421
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++.... ..++|.++..++.+++.||+|||+. +++||||||+||++++++.+|++||
T Consensus 81 --~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 81 --NGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred --CceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCC
Confidence 25799999999999999986532 2489999999999999999999987 8999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehh
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|+++.. .|+||+||++|+|+++
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~ 208 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcC
Confidence 987421 2999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=243.97 Aligned_cols=167 Identities=23% Similarity=0.481 Sum_probs=140.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCC-CCCcccccceeecCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGG 552 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 552 (671)
..++|...+.||+|+||.||+|++. .++.||||+++... ....+.+.+|+++|.++. |||||+++++|.+.+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3445777899999999999999853 34689999997543 233457889999999997 999999999997653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCC--------------------------------------------------
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENT-------------------------------------------------- 582 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------------------------------------------- 582 (671)
..++||||+++|+|.++++...
T Consensus 115 --------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 115 --------PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred --------CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 5799999999999999986421
Q ss_pred ---------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCcccc
Q 005898 583 ---------------------------------------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN 617 (671)
Q Consensus 583 ---------------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr 617 (671)
....++|.+..+++.++++||+|||+. +|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcc
Confidence 112478888999999999999999986 79999
Q ss_pred CCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 618 RVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 618 Dlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||||+||++++++.+|++|||+++.. .|+||+|+++|||++
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 99999999999999999999997531 199999999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=229.52 Aligned_cols=163 Identities=23% Similarity=0.460 Sum_probs=140.8
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
..|+..+.||+|+||.||+|+..++..||||++..... ..+++.+|++++++++||||+++++++.+. ..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---------~~ 75 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---------PI 75 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCC---------Cc
Confidence 45778899999999999999987667899999975332 346789999999999999999999877432 46
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ...++|..+..++.++++||+|+|+. +++||||||+||++++++.+|++|||.++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred EEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceee
Confidence 89999999999999997532 23589999999999999999999986 799999999999999999999999998742
Q ss_pred c-------------------------------ccccccceeeeeeehh
Q 005898 643 S-------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~~ 659 (671)
. .|+||+|+++|+|+++
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~ 199 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcC
Confidence 1 2999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=229.59 Aligned_cols=174 Identities=21% Similarity=0.305 Sum_probs=147.0
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 478 LKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 478 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 78 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG---- 78 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC----
Confidence 3456777777889999999999999854 67899999987766666778999999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLS 635 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~ 635 (671)
..++|+||+++++|.++++........++..+..++.|+++|++|||+. +|+||||||+||+++. ++.+||+
T Consensus 79 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 79 ----FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred ----EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence 6899999999999999997542211127888899999999999999986 8999999999999986 6799999
Q ss_pred ccCCcccc--------------------------------ccccccceeeeeeehhhhc
Q 005898 636 DYGLSIVS--------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 636 DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|||++... .|+||+|+++|+|+++...
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p 210 (268)
T cd06624 152 DFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210 (268)
T ss_pred cchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence 99976321 1999999999999987543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.80 Aligned_cols=169 Identities=21% Similarity=0.370 Sum_probs=141.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
..++|+..+.||+|+||.||+|+.. .+..||||.+.... .....++.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 3567888999999999999999743 24589999986543 233456889999999999999999999987653
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTP-------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL 626 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl 626 (671)
..++||||+++|+|.+++..... ....++.....++.|++.||+|||+. +|+||||||+||++
T Consensus 83 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili 152 (288)
T cd05061 83 -------PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMV 152 (288)
T ss_pred -------CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEE
Confidence 57999999999999999975221 23467888899999999999999986 79999999999999
Q ss_pred cCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehhh
Q 005898 627 NEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 627 ~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
++++.+|++|||+++.. .|+||+||++|||+++.
T Consensus 153 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~ 218 (288)
T cd05061 153 AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 218 (288)
T ss_pred cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCC
Confidence 99999999999987521 19999999999999843
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=230.27 Aligned_cols=161 Identities=24% Similarity=0.402 Sum_probs=135.4
Q ss_pred CceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 488 SAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
.+++|+|.||+||-|+.+ +|+.||||.+.+.+ +.+..++++|+++|.+++||.||.|.--|.+++ .++.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--------rvFV 640 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE--------RVFV 640 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc--------eEEE
Confidence 578999999999999965 79999999997643 334578999999999999999999988887664 7999
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC---CcEEEcccCCcc
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH---RIAKLSDYGLSI 641 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~---~~~ki~DfGla~ 641 (671)
|||-+.+.-|+-.|.... ..|......-++.||..||.|||.. +|+|+||||+|||+.+. -++|++|||+|+
T Consensus 641 VMEKl~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EehhhcchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 999996655555565432 2377777788899999999999987 89999999999999643 579999999998
Q ss_pred ccc-----------------------------cccccceeeeeeehhhh
Q 005898 642 VSE-----------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~~-----------------------------d~~s~g~~l~~~~~~~~ 661 (671)
++. |+||+|||+|.-++|..
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTF 764 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTF 764 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccc
Confidence 865 99999999999887643
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=228.75 Aligned_cols=158 Identities=26% Similarity=0.383 Sum_probs=133.0
Q ss_pred ceeccCCceEEEEEEEcC-------------CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 489 AIMGEGSYGKLYKGRLEN-------------GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
+.||+|+||.||+|++.+ ...||+|.+..........|.+|+.+++.++||||++++++|.+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 368999999999998532 2258999887655545567889999999999999999999998653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc----
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI---- 631 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~---- 631 (671)
..++||||+++|+|..+++... ..+++..+.+++.||++|++|||+. +|+||||||+||+++.++.
T Consensus 78 -----~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 78 -----ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred -----CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 5689999999999998887532 3489999999999999999999986 7999999999999987664
Q ss_pred ---EEEcccCCcccc---------------------------ccccccceeeeeeehh
Q 005898 632 ---AKLSDYGLSIVS---------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 632 ---~ki~DfGla~~~---------------------------~d~~s~g~~l~~~~~~ 659 (671)
+|++|||++... .|+||+||++|+|+++
T Consensus 148 ~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 148 GPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 899999987421 1999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=228.07 Aligned_cols=162 Identities=27% Similarity=0.461 Sum_probs=140.6
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+|+..+.||+|+||.||+|+..++..+|||.+..... ..+++.+|++++++++||||+++++++.+.+ ..+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~~~ 75 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR--------PIF 75 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--------ceE
Confidence 3667788999999999999987777899999864332 3457889999999999999999999887653 679
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc-
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV- 642 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~- 642 (671)
+||||+++++|.+++.... ..++|..+..++.+++.|++|||+. +|+||||||+||++++++.+|++|||+++.
T Consensus 76 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 76 IVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred EEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceec
Confidence 9999999999999987543 2589999999999999999999987 799999999999999999999999997742
Q ss_pred ------------------------------cccccccceeeeeeehh
Q 005898 643 ------------------------------SEDINSVGVRLLILMSF 659 (671)
Q Consensus 643 ------------------------------~~d~~s~g~~l~~~~~~ 659 (671)
..|+||+|+++|+|+++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 151 LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred ccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 12999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=232.42 Aligned_cols=166 Identities=22% Similarity=0.467 Sum_probs=141.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-----------------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-----------------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCL 544 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 544 (671)
++|+..+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 24479999997543 3345789999999999999999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccc
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP--------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFN 616 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH 616 (671)
++++.+.+ ..++||||+++|+|.+++..... ...++|.+...++.|++.|++|||+. +|+|
T Consensus 85 ~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H 153 (296)
T cd05095 85 LAVCITSD--------PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVH 153 (296)
T ss_pred EEEEecCC--------ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 99987653 57999999999999999875321 23488899999999999999999987 7999
Q ss_pred cCCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 617 NRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 617 rDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||||+||++++++.+|++|||+++.. .|+||+||++|||+++
T Consensus 154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred ccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 999999999999999999999997531 2999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=231.85 Aligned_cols=167 Identities=23% Similarity=0.513 Sum_probs=142.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
..++|+..+.||+|+||.||+|... ....||+|.+.... .....++.+|++++.++ +|+||++++++|.+.+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456788899999999999999853 23689999987542 33456788999999999 8999999999987653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCC
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISEN-------------TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV 619 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 619 (671)
..++||||+++|+|..+++.. .....++|..+++++.|++.||+|||+. +|+||||
T Consensus 90 --------~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dl 158 (293)
T cd05053 90 --------PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDL 158 (293)
T ss_pred --------CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence 689999999999999998643 2235689999999999999999999986 8999999
Q ss_pred CCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 620 KTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 620 k~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+||++++++.+|++|||+++.. .|+||+||++|+|++
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhc
Confidence 999999999999999999987521 199999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=230.57 Aligned_cols=166 Identities=19% Similarity=0.247 Sum_probs=141.4
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|+..+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+++|.+++|+||+++.+++.+.+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-------- 73 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-------- 73 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--------
Confidence 556688999999999999864 78999999986432 223455788999999999999999998887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|..++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 6899999999999998886532 23589999999999999999999986 7999999999999999999999999987
Q ss_pred ccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|+++...
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P 200 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 421 2999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=230.00 Aligned_cols=167 Identities=31% Similarity=0.580 Sum_probs=141.4
Q ss_pred cCCCcCceeccCCceEEEEEEEcC-C-----cEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN-G-----TSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~-g-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
++|+..+.||+|+||.||+|.... + ..||+|.+.... ....++|.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--- 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence 357778899999999999998532 2 579999987543 334567999999999999999999999987643
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCC
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTN 622 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~ 622 (671)
..+++|||+++|+|.+++....+ ...+++.+...++.|++.||+|||+. +++||||||+
T Consensus 82 -----~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~ 153 (283)
T cd05048 82 -----PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAAR 153 (283)
T ss_pred -----ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccccc
Confidence 57999999999999999875321 14588999999999999999999987 7999999999
Q ss_pred ceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh-hh
Q 005898 623 NILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS-FF 660 (671)
Q Consensus 623 NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~-~~ 660 (671)
||++++++.+||+|||+++.. .|+||+||++|||++ +.
T Consensus 154 Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~ 224 (283)
T cd05048 154 NCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224 (283)
T ss_pred eEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCC
Confidence 999999999999999987531 299999999999997 44
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=225.76 Aligned_cols=162 Identities=26% Similarity=0.527 Sum_probs=140.5
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||.||+|+.+ |..||+|.++... ..+.+.+|+.++++++|+|++++++++...+ +..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------~~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-------GGL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-------Cce
Confidence 35777899999999999999865 7889999986543 3467899999999999999999999876433 257
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.++++... ...++|..+..++.+++.||+|||+. +++||||||+||++++++.+|++|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcccee
Confidence 99999999999999987543 23489999999999999999999987 799999999999999999999999998763
Q ss_pred c---------------------------ccccccceeeeeeeh
Q 005898 643 S---------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 643 ~---------------------------~d~~s~g~~l~~~~~ 658 (671)
. .|+||+||++|+|++
T Consensus 152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 152 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred ccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh
Confidence 2 299999999999997
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=224.14 Aligned_cols=158 Identities=23% Similarity=0.480 Sum_probs=137.8
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEe
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYE 567 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~E 567 (671)
++||+|+||.||+|..+++..||+|.+.... ......+.+|++++++++||||++++++|...+ ..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ--------PIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC--------ccEEEEE
Confidence 3689999999999998888999999987543 233457889999999999999999999987653 5799999
Q ss_pred cCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc----
Q 005898 568 FMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS---- 643 (671)
Q Consensus 568 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~---- 643 (671)
|+++|+|.+++.... ..++|..+..++.+++.||.|+|.. +++||||||+||++++++.+|++|||++...
T Consensus 73 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 73 LVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred CCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 999999999987543 2489999999999999999999986 7999999999999999999999999987421
Q ss_pred ---------------------------ccccccceeeeeeehh
Q 005898 644 ---------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 644 ---------------------------~d~~s~g~~l~~~~~~ 659 (671)
.|+||+|+++|+|++.
T Consensus 148 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~ 190 (250)
T cd05085 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSL 190 (250)
T ss_pred cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcC
Confidence 2999999999999883
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=232.76 Aligned_cols=167 Identities=20% Similarity=0.510 Sum_probs=141.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEc--------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE--------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
.++|+..+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 345777899999999999999741 24579999987532 34457799999999999 899999999998765
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
. ..++||||+++|+|.+++....+ ...++|.++..++.|+++||+|||+. +++|||
T Consensus 94 ~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~d 162 (304)
T cd05101 94 G--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRD 162 (304)
T ss_pred C--------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence 3 67999999999999999875321 23588999999999999999999987 899999
Q ss_pred CCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||+||++++++.+|++|||+++.. .|+||+|+++|+|+++
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 9999999999999999999987521 1999999999999884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=236.63 Aligned_cols=172 Identities=21% Similarity=0.322 Sum_probs=142.6
Q ss_pred HHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+..+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++......
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI-- 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc--
Confidence 3456788899999999999999985 478899999986532 22345678899999999999999999988643211
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
......++++||+ +++|..++.. ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 1124579999998 7799887753 2489999999999999999999987 899999999999999999999999
Q ss_pred cCCcccc----------------------------ccccccceeeeeeehhhh
Q 005898 637 YGLSIVS----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 637 fGla~~~----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
||+++.. .|+||+||++|+|+++..
T Consensus 162 fg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (343)
T cd07878 162 FGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214 (343)
T ss_pred CccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCC
Confidence 9987531 299999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=227.01 Aligned_cols=168 Identities=22% Similarity=0.336 Sum_probs=142.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.+|+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.++.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME--- 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---
Confidence 46888899999999999999864 68999999875321 2235678899999999999999999998765421
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...++||||+++|+|.+++.... .+++....+++.+++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 79 ---~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 ---RTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ---ceEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 25789999999999999987543 378889999999999999999987 799999999999999999999999
Q ss_pred cCCcccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 637 YGLSIVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+++.. .|+||+||++|+|+++...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 208 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence 9977421 1999999999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=231.79 Aligned_cols=166 Identities=22% Similarity=0.463 Sum_probs=139.6
Q ss_pred cCCCcCceeccCCceEEEEEEEcC---------------CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN---------------GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLG 546 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~---------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g 546 (671)
++|+..+.||+|+||.||+++... ...||||.+.... ....+.|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467788999999999999987532 2358999987542 334567999999999999999999999
Q ss_pred eeecCCCCCCcccceEEEEEecCCCCChhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCcccc
Q 005898 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT---------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN 617 (671)
Q Consensus 547 ~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr 617 (671)
++...+ ..++||||+++|+|.+++.... ....++|.+++.++.++++|++|||+. +++||
T Consensus 85 ~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~ 153 (295)
T cd05097 85 VCVSDD--------PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHR 153 (295)
T ss_pred EEcCCC--------ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecc
Confidence 987653 6799999999999999986432 112478999999999999999999987 79999
Q ss_pred CCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 618 RVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 618 Dlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
||||+||++++++.+|++|||++... .|+||+||++|+|++.
T Consensus 154 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 154 DLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred ccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999987421 2999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=227.33 Aligned_cols=163 Identities=23% Similarity=0.449 Sum_probs=140.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc---EEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT---SVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~---~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|+.. ++. .||||+++... ....+++.+|++++++++||||+++.+++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK----- 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-----
Confidence 46777899999999999999864 333 79999987542 334577999999999999999999999987653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ..++|.++..++.+++.|++|||+. +++||||||+||++++++.+|++||
T Consensus 80 ---~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 151 (268)
T cd05063 80 ---PAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF 151 (268)
T ss_pred ---CcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence 6799999999999999997542 3489999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeeh
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~ 658 (671)
|++... .|+||+||++|+|++
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~ 205 (268)
T cd05063 152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205 (268)
T ss_pred ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHh
Confidence 987421 199999999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=226.20 Aligned_cols=156 Identities=28% Similarity=0.418 Sum_probs=134.0
Q ss_pred ceeccCCceEEEEEEEcC-C----------cEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 489 AIMGEGSYGKLYKGRLEN-G----------TSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~-g----------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
+.||+|+||.||+|+..+ + ..|++|.+...... .+.|.+|+.++++++||||++++++|.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----- 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D----- 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----
Confidence 468999999999999753 3 25788887654433 6789999999999999999999999876 2
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-------
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR------- 630 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~------- 630 (671)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 74 ---~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ---ENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred ---CcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 46899999999999999976432 589999999999999999999986 899999999999999887
Q ss_pred cEEEcccCCcccc----------------------------ccccccceeeeeeehh
Q 005898 631 IAKLSDYGLSIVS----------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 631 ~~ki~DfGla~~~----------------------------~d~~s~g~~l~~~~~~ 659 (671)
.+|++|||++... .|+||+||++|+|+++
T Consensus 146 ~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~ 202 (259)
T cd05037 146 FIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202 (259)
T ss_pred eEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhC
Confidence 7999999987641 2999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=225.98 Aligned_cols=161 Identities=25% Similarity=0.431 Sum_probs=135.4
Q ss_pred ceeccCCceEEEEEEEc----CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE----NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++.++||||++++++|...+ ...+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------~~~~ 73 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-------GSPL 73 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-------CCcE
Confidence 46899999999999853 2457999998643 2344678889999999999999999999886543 2468
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+|+||+++|+|.+++.... ..+.+..++.++.+++.|++|||+. +++||||||+||++++++.+|++|||+++..
T Consensus 74 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 9999999999999997542 2368888999999999999999986 7999999999999999999999999987421
Q ss_pred ----------------------------------ccccccceeeeeeehhhh
Q 005898 644 ----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 ----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.|+||+||++|||+++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 200 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 200 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCC
Confidence 199999999999998543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=225.48 Aligned_cols=162 Identities=27% Similarity=0.575 Sum_probs=142.6
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||.||+|... |+.||||.+..... ..+++.+|+.++++++|+||+++++++.+.+ ..
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~~ 75 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN--------PL 75 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC--------Ce
Confidence 46777899999999999999865 78999999976544 5678999999999999999999999987643 67
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ...++|..+..++.|++.|+.|||+. +++||||||+||++++++.+|++|||+++.
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred EEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccc
Confidence 99999999999999997643 23589999999999999999999987 799999999999999999999999997653
Q ss_pred c---------------------------ccccccceeeeeeeh
Q 005898 643 S---------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 643 ~---------------------------~d~~s~g~~l~~~~~ 658 (671)
. .|+||+|+++|+|++
T Consensus 152 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~ 194 (256)
T cd05039 152 ASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred cccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHh
Confidence 1 299999999999987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=231.00 Aligned_cols=163 Identities=25% Similarity=0.417 Sum_probs=138.0
Q ss_pred CCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
|+..+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----- 81 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ----- 81 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-----
Confidence 455678999999999999853 2578999999754432 3467889999999999999999999997654
Q ss_pred ccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..++++||+++++|.+++.... ....+++..+..++.|+++||+|+|+. +|+||||||+||
T Consensus 82 ---~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Ni 155 (283)
T cd05091 82 ---PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNV 155 (283)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhhe
Confidence 5799999999999999985321 123588999999999999999999987 799999999999
Q ss_pred eecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 625 LLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
++++++.+|++|||+++.. .|+||+||++|||++
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 221 (283)
T cd05091 156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221 (283)
T ss_pred EecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 9999999999999986421 199999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=225.76 Aligned_cols=154 Identities=25% Similarity=0.459 Sum_probs=133.1
Q ss_pred eccCCceEEEEEEEc---CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE---NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||.||+|++. ++..||||.+.... ....+++.+|++++++++||||++++++|... ..++||
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~---------~~~lv~ 73 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---------ALMLVM 73 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC---------CeEEEE
Confidence 899999999999764 35679999997553 33456799999999999999999999988542 479999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++|+|.+++.... ..+++.++.+++.|+++|++|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 74 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 74 EMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EeCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999999999987532 3589999999999999999999987 7999999999999999999999999987421
Q ss_pred ------------------------------ccccccceeeeeeeh
Q 005898 644 ------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 644 ------------------------------~d~~s~g~~l~~~~~ 658 (671)
.|+||+||++|++++
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 193 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhc
Confidence 299999999999986
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=231.75 Aligned_cols=165 Identities=22% Similarity=0.378 Sum_probs=144.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++.... .
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--------~ 91 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--------E 91 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--------E
Confidence 4677788999999999999985 478999999987655445677899999999999999999999887653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred EEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 89999999999999998642 378999999999999999999987 79999999999999999999999999864
Q ss_pred cc------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+||++|+|++|...
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~p 215 (296)
T cd06654 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (296)
T ss_pred hccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 21 1999999999999997754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=232.95 Aligned_cols=166 Identities=23% Similarity=0.503 Sum_probs=141.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc--------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE--------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|++++.++ +||||++++++|.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46788899999999999999742 23579999997542 33456788999999999 7999999999987653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCC
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV 619 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 619 (671)
..++||||+++|+|.+++....+ ...++|.++++++.|++.||+|||+. +++||||
T Consensus 98 --------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dl 166 (307)
T cd05098 98 --------PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDL 166 (307)
T ss_pred --------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence 67999999999999999975421 23589999999999999999999986 8999999
Q ss_pred CCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 620 KTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 620 k~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
||+||++++++.+|++|||+++.. .|+||+||++|+|+++
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 999999999999999999987421 1999999999999883
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=226.64 Aligned_cols=162 Identities=22% Similarity=0.474 Sum_probs=141.7
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+.|+..++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+. ..
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---------~~ 75 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQE---------PI 75 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccC---------Cc
Confidence 46778899999999999999988899999999875433 356799999999999999999999886432 57
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ...+++.++..++.+++.||+|||+. +++||||||+||++++++.++++|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceee
Confidence 99999999999999987533 34589999999999999999999986 799999999999999999999999998742
Q ss_pred c-------------------------------ccccccceeeeeeeh
Q 005898 643 S-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
. .|+||+|+++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~ 198 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHh
Confidence 1 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=230.10 Aligned_cols=169 Identities=22% Similarity=0.385 Sum_probs=144.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..+.||+|+||.||+++.. +|+.||+|.+... .....+++.+|++++.+++||||+++++++...+ .
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--------~ 73 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--------A 73 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--------e
Confidence 5677889999999999999975 7899999988653 2334567899999999999999999999887653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++++|..+++.......+++..+..++.+++.|++|||+.+ +|+||||||+||+++.++.+|++|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 8999999999999998876433345899999999999999999999642 79999999999999999999999999774
Q ss_pred c----------------------------------cccccccceeeeeeehhhhc
Q 005898 642 V----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
. ..|+||+||++|+|+++...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 206 (286)
T cd06622 152 NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206 (286)
T ss_pred cccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCC
Confidence 2 13999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=228.83 Aligned_cols=176 Identities=23% Similarity=0.399 Sum_probs=146.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
.+++.|+..+.||+|+||.||+|+.. +++.||||++.... ....++.+|+.++.++ +||||+++++++...+.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~--~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP--G 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC--C
Confidence 35667888889999999999999865 68899999986543 2346788999999998 699999999998764311 0
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+++|+|.+++.... ...++|.....++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 1236899999999999999987532 24589999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+||++|+|++|...
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p 215 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 997421 3999999999999998653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=229.64 Aligned_cols=166 Identities=19% Similarity=0.272 Sum_probs=141.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|+..++||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++|+||+++++.+.+.+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-------- 73 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-------- 73 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--------
Confidence 566788999999999999865 78999999986432 222345778999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.++++|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 6899999999999999886432 23488999999999999999999986 8999999999999999999999999987
Q ss_pred ccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|++|...
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 431 2999999999999997554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=228.48 Aligned_cols=167 Identities=25% Similarity=0.454 Sum_probs=144.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEcC-----CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLEN-----GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
.++|+..++||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--- 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG--- 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC---
Confidence 4567888999999999999998754 6889999987543 344677899999999999999999999987642
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPG-----KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
...++++||+++|+|..++...... ..+++.++..++.+++.||+|||+. +++||||||+||++++++
T Consensus 82 ----~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~ 154 (280)
T cd05043 82 ----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL 154 (280)
T ss_pred ----CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCC
Confidence 2579999999999999998754322 4689999999999999999999986 799999999999999999
Q ss_pred cEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 631 IAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 631 ~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
.+||+|||+++.. .|+||+||++|++++
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~ 214 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhc
Confidence 9999999998632 199999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=229.14 Aligned_cols=166 Identities=25% Similarity=0.498 Sum_probs=142.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++++..++||+|+||.||+++.. ++..||+|.+........+++.+|++++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR---- 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----
Confidence 35667889999999999999632 35689999988766666778999999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTP------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..++||||+++|+|.++++...+ ...++|.++..++.|++.|++|||+. +++||||||+||
T Consensus 81 ----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~ni 153 (280)
T cd05092 81 ----PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNC 153 (280)
T ss_pred ----ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhE
Confidence 57999999999999999875322 13589999999999999999999986 799999999999
Q ss_pred eecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 625 LLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
++++++.+||+|||+++.. .|+||+||++|+|+++
T Consensus 154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 220 (280)
T cd05092 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220 (280)
T ss_pred EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 9999999999999987421 1999999999999883
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=226.12 Aligned_cols=163 Identities=22% Similarity=0.472 Sum_probs=141.2
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||.||+|...++..||+|.+..... ..+++.+|+.++++++|+|++++++++.+. ..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---------~~ 75 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEE---------PI 75 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCC---------Cc
Confidence 35677889999999999999988888899999875433 346799999999999999999999887432 46
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.++++... ...+++.++..++.+++.||+|||+. +|+||||||+||++++++.+|++|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred EEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeee
Confidence 89999999999999987532 23589999999999999999999987 799999999999999999999999998742
Q ss_pred c-------------------------------ccccccceeeeeeehh
Q 005898 643 S-------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~~ 659 (671)
. .|+||+|+++|+|+++
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 1 2999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=223.27 Aligned_cols=167 Identities=20% Similarity=0.329 Sum_probs=144.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|++++++++||||+++++++.+.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-------- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--------
Confidence 3667789999999999999865 6899999998643 3345678999999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++++|.++++... ...+++.++..++.+++.|+.|||+. +|+||||||+||++++++.+|++|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 6899999999999999997642 34589999999999999999999986 8999999999999999999999999976
Q ss_pred ccc------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. .|+||+|+++|+|+++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 200 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 531 2999999999999997543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=228.48 Aligned_cols=161 Identities=22% Similarity=0.354 Sum_probs=139.1
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..++||+|+||.||+|+. .+++.||||.+... .....+++.+|++++++++||||++++++|...+ .
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~ 73 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--------R 73 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC--------E
Confidence 567788999999999999985 47899999998643 2334567999999999999999999999998753 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|..+. .+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 74 ISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred EEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 78999999999997553 267888899999999999999987 89999999999999999999999999885
Q ss_pred cc----------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+||++|+|++|...
T Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~p 192 (279)
T cd06619 144 QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192 (279)
T ss_pred ecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 21 1999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=226.22 Aligned_cols=168 Identities=25% Similarity=0.470 Sum_probs=144.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-----CCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-----NGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.|+..+.||+|+||.||+|+++ +++.||||.+...... ..++|.+|++++++++||||+++++++...++
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~---- 80 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG---- 80 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCC----
Confidence 4666789999999999999864 3679999999755442 46789999999999999999999998876331
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++..... .++|.++..++.+++.||+|||+. +++||||||+||+++.++.+|++||
T Consensus 81 --~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 81 --RSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred --CceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccc
Confidence 357999999999999999976432 489999999999999999999986 7999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|||+++...
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p 211 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCC
Confidence 987431 2999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=237.31 Aligned_cols=170 Identities=22% Similarity=0.295 Sum_probs=140.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..++|+..+.||+|+||.||+++.. +|+.||||++... .....+++.+|+.+++.++||||+++++++...... .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL--E 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc--c
Confidence 3467888999999999999999864 6899999998643 223456788999999999999999999988654311 1
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+++ ++...++. .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 12357999999975 56666642 278888999999999999999997 8999999999999999999999999
Q ss_pred CCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+||++|+|++|..
T Consensus 168 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 168 GLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220 (359)
T ss_pred CCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 988531 199999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=226.56 Aligned_cols=163 Identities=26% Similarity=0.508 Sum_probs=139.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-C---CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-N---GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|+.. + +..||+|.++... ....+++.+|+.++.+++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK----- 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----
Confidence 35777899999999999999853 2 3479999987543 334568999999999999999999999987653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 79 ---~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 79 ---PVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred ---ccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence 6799999999999999997543 3489999999999999999999986 7999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeeh
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~ 658 (671)
|++... .|+||+||++|++++
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204 (267)
T ss_pred CcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence 977421 199999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=226.14 Aligned_cols=159 Identities=23% Similarity=0.338 Sum_probs=134.4
Q ss_pred ceeccCCceEEEEEEEcC---CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 489 AIMGEGSYGKLYKGRLEN---GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
+.||+|+||.||+|+..+ +..+|+|.++... .....++.+|+.++++++||||+++++++.+.. ..++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~l 72 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT--------PYLL 72 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC--------CcEE
Confidence 358999999999998643 4579999987543 233457889999999999999999999987653 5799
Q ss_pred EEecCCCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 565 VYEFMSNGNFRTHISENT--PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
||||+++|+|.++++... .....++..+..++.|+++|++|||+. +++||||||+||++++++++|++|||+++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccc
Confidence 999999999999997532 223467888899999999999999987 799999999999999999999999997731
Q ss_pred ---------------------------------------cccccccceeeeeeeh
Q 005898 643 ---------------------------------------SEDINSVGVRLLILMS 658 (671)
Q Consensus 643 ---------------------------------------~~d~~s~g~~l~~~~~ 658 (671)
..|+||+|+++|||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 204 (269)
T cd05087 150 KYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE 204 (269)
T ss_pred ccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh
Confidence 1399999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=225.61 Aligned_cols=169 Identities=20% Similarity=0.367 Sum_probs=144.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..++||+|+||.||+|+.. +++.||||.+... .....+++.+|++++++++||||+++++++.+.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN------ 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC------
Confidence 46888899999999999999964 7899999987542 2334567899999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++|+||+++|+|.+++.... ....+++.....++.++++||+|||+. +++||||||+||+++.++.++++||
T Consensus 76 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 76 --ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred --eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcc
Confidence 6799999999999998886422 234578899999999999999999987 8999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|+|+++...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 205 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 976531 1999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=230.92 Aligned_cols=164 Identities=21% Similarity=0.375 Sum_probs=144.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++ .
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------~ 90 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--------E 90 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--------E
Confidence 5678889999999999999985 579999999997655445567889999999999999999999997653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.+. .+++.++..++.+++.||.|||+. +++||||||+||+++.++.+|++|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred EEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence 89999999999999998642 378999999999999999999986 79999999999999999999999999864
Q ss_pred cc------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+||+||++|+|+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 21 199999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=237.44 Aligned_cols=170 Identities=21% Similarity=0.294 Sum_probs=141.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..++|+..+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~ 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL--E 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc--c
Confidence 4568999999999999999999854 6889999998653 233356788999999999999999999988654311 1
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+++ ++...+.. .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 12357999999975 67666643 378899999999999999999987 8999999999999999999999999
Q ss_pred CCccccc-----------------------------cccccceeeeeeehhhh
Q 005898 638 GLSIVSE-----------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~~-----------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|+++... |+||+||++|+|+++..
T Consensus 164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred cccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9985421 99999999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=226.03 Aligned_cols=162 Identities=27% Similarity=0.517 Sum_probs=139.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CC---cEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NG---TSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.|+..+.||+|+||.||+|+.. ++ ..||||+++.. .....++|..|++++++++||||+++.+++.++.
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------ 78 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR------ 78 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC------
Confidence 3667889999999999999864 33 36999998754 3344678999999999999999999999887653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 79 --~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 79 --PVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred --ceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence 6799999999999999987542 3489999999999999999999986 89999999999999999999999999
Q ss_pred Ccccc-----------------------------------ccccccceeeeeeeh
Q 005898 639 LSIVS-----------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 639 la~~~-----------------------------------~d~~s~g~~l~~~~~ 658 (671)
++... .|+||+||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~ 206 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhc
Confidence 76421 299999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=244.15 Aligned_cols=158 Identities=22% Similarity=0.310 Sum_probs=136.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|...+.||+|+||.||+|+.. +++.||||... ...+.+|++++++++|+|||++++++...+ .
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--------~ 234 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG--------L 234 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC--------E
Confidence 46888899999999999999975 58899999643 234678999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+. |+|..++.... ..++|.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 799999995 78988886532 3599999999999999999999987 79999999999999999999999999985
Q ss_pred cc--------------------------------ccccccceeeeeeehhh
Q 005898 642 VS--------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 642 ~~--------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
.. .|+||+||++|||+++.
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence 32 19999999999998754
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=231.03 Aligned_cols=165 Identities=21% Similarity=0.351 Sum_probs=141.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-------- 77 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-------- 77 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--------
Confidence 45778899999999999999865 68899999986433 223456788999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++ ++|..++.... ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence 6899999997 58988887542 3488999999999999999999987 8999999999999999999999999987
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
... .|+||+||++|+|++|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 152 RAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred hccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 421 199999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=224.33 Aligned_cols=157 Identities=23% Similarity=0.425 Sum_probs=137.3
Q ss_pred ceeccCCceEEEEEEEcC--C--cEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLEN--G--TSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~--g--~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|++.+ + ..||||.+..... ...+++.+|++++++++||||+++++++.+ . ..+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~--------~~~ 71 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H--------PLM 71 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C--------eEE
Confidence 468999999999998643 3 3699999976654 556789999999999999999999998875 2 679
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|.+++..... ..++|.....++.|++.||+|||.. +++||||||+||++++++.+|++|||+++..
T Consensus 72 ~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 72 MVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999999976432 4589999999999999999999987 8999999999999999999999999976421
Q ss_pred ---------------------------------ccccccceeeeeeeh
Q 005898 644 ---------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 644 ---------------------------------~d~~s~g~~l~~~~~ 658 (671)
.|+||+||++|+|++
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t 195 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHh
Confidence 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=229.01 Aligned_cols=164 Identities=27% Similarity=0.514 Sum_probs=139.1
Q ss_pred CCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+|+..+.||+|+||.||+|+.. ....||+|.+.... ....+++.+|+.++++++||||+++++.|...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG---- 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence 4677889999999999999852 23578999886543 334567999999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENT---------------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFF 615 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii 615 (671)
..++|+||+++|+|.+++.... ....++|.+...++.|++.|++|||+. +|+
T Consensus 77 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~iv 149 (290)
T cd05045 77 ----PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLV 149 (290)
T ss_pred ----CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 5799999999999999886421 123588999999999999999999986 799
Q ss_pred ccCCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 616 NNRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 616 HrDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||||||+||++++++.+||+|||+++.. .|+||+|+++|+|++
T Consensus 150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence 9999999999999999999999998521 199999999999998
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=237.06 Aligned_cols=170 Identities=21% Similarity=0.271 Sum_probs=141.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..++|+..+.||+|+||.||+|+.. .++.||||++... .....+++.+|+.+++.++||||+++++++...+.. .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~--~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL--E 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc--c
Confidence 3467888999999999999999854 6889999998653 233456788999999999999999999987653211 0
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+++ ++..++.. .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 12357999999975 77777653 378899999999999999999987 8999999999999999999999999
Q ss_pred CCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+||++|+|++|..
T Consensus 171 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred CCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence 998532 199999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=224.65 Aligned_cols=154 Identities=24% Similarity=0.413 Sum_probs=133.8
Q ss_pred eeccCCceEEEEEEE---cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 490 IMGEGSYGKLYKGRL---ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~---~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
.||+|+||.||+|.+ .+++.||||+++... ....+++.+|+.++++++||||+++++++... ..++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---------~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE---------SWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---------CcEE
Confidence 589999999999975 357899999986443 23457899999999999999999999988532 4689
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS- 643 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~- 643 (671)
||||+++|+|.+++.... .+++..+..++.|++.|++|||.. +|+||||||+||++++++.+||+|||+++..
T Consensus 73 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 73 VMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999999997543 489999999999999999999986 7999999999999999999999999987421
Q ss_pred --------------------------------ccccccceeeeeeeh
Q 005898 644 --------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 644 --------------------------------~d~~s~g~~l~~~~~ 658 (671)
.|+||+||++|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence 299999999999998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=228.49 Aligned_cols=166 Identities=24% Similarity=0.462 Sum_probs=141.9
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-------- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC--------
Confidence 4667889999999999999965 68999999986432 223467889999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++ |+|.+++........+++.+...++.|+++||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 6899999997 68988887544445689999999999999999999987 7999999999999999999999999976
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
... .|+||+||++|+|+++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 149 RAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred eecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence 411 199999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=227.67 Aligned_cols=165 Identities=24% Similarity=0.412 Sum_probs=143.2
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||.||+|+. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+ .
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~--------~ 80 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD--------K 80 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--------E
Confidence 3566678899999999999985 468999999987655445567889999999999999999999887653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... .+++.+...++.+++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 899999999999999987543 489999999999999999999987 79999999999999999999999999863
Q ss_pred c---------------------------------cccccccceeeeeeehhhh
Q 005898 642 V---------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~---------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
. ..|+||+||++|+|+++..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~ 207 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 1 1299999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=229.49 Aligned_cols=167 Identities=27% Similarity=0.497 Sum_probs=142.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.++|+..+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|++++++++||||++++++|.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 456888899999999999999853 46789999987543 334567999999999999999999999987653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCcc
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENT-------------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFF 615 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii 615 (671)
..++||||+++|+|.+++.... ....+++.+++.++.+++.||+|||+. +++
T Consensus 82 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~ 152 (288)
T cd05050 82 ------PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFV 152 (288)
T ss_pred ------ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 5799999999999999987421 113478999999999999999999987 799
Q ss_pred ccCCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 616 NNRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 616 HrDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
||||||+||++++++.+|++|||++... .|+||+||++|+|++.
T Consensus 153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~ 228 (288)
T cd05050 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228 (288)
T ss_pred cccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999987421 2999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=228.64 Aligned_cols=168 Identities=24% Similarity=0.423 Sum_probs=146.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-------- 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC--------
Confidence 356777889999999999999975 68999999997665556678999999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... ..+++.....++.|++.|++|||+. +|+||||||+||+++.++.++++|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 6899999999999999987532 3489999999999999999999987 7999999999999999999999999976
Q ss_pred cc-----------------------------------cccccccceeeeeeehhhhc
Q 005898 641 IV-----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~-----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
.. -.|+||+|+++|+|+++...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p 207 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 31 13999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=226.65 Aligned_cols=163 Identities=20% Similarity=0.348 Sum_probs=134.0
Q ss_pred eeccCCceEEEEEEEcCC---cEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEE
Q 005898 490 IMGEGSYGKLYKGRLENG---TSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLV 565 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv 565 (671)
.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|.+.. ..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--------~~~lv 73 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI--------PYLLV 73 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC--------ccEEE
Confidence 589999999999985433 346677765433 334578999999999999999999999998653 67999
Q ss_pred EecCCCCChhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc--
Q 005898 566 YEFMSNGNFRTHISENTP-GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV-- 642 (671)
Q Consensus 566 ~Ey~~~GsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~-- 642 (671)
|||+++|+|.++++.... ....++.....++.||++||+|||+. +++||||||+||++++++.+|++|||++..
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 999999999999976422 23467777889999999999999986 799999999999999999999999998631
Q ss_pred -------------------------------------cccccccceeeeeeehhhhcc
Q 005898 643 -------------------------------------SEDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 643 -------------------------------------~~d~~s~g~~l~~~~~~~~~~ 663 (671)
..|+||+||++|||+++...+
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 208 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCC
Confidence 139999999999998754433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=226.95 Aligned_cols=165 Identities=23% Similarity=0.418 Sum_probs=143.3
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
|+..+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||++++++|.... ..+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--------~~~ 78 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--------NLW 78 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--------EEE
Confidence 455678999999999999965 58889999997665556678999999999999999999999987653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc-
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV- 642 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~- 642 (671)
+||||+++|+|..++.... ..++|..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++..
T Consensus 79 ~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 9999999999998876532 3589999999999999999999987 899999999999999999999999998732
Q ss_pred ----------------------------------cccccccceeeeeeehhhhc
Q 005898 643 ----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 643 ----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
..|+||+||++|+|+++...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 14999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=254.86 Aligned_cols=177 Identities=18% Similarity=0.315 Sum_probs=145.1
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
...+.|+..+.||+|+||+||+|+.. ++..||+|.+... .......|..|+.++.+++|||||++++++.+...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~--- 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN--- 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC---
Confidence 34567999999999999999999964 6789999998643 23345678999999999999999999998865431
Q ss_pred cccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCC----CCccccCCCCCceeecC---
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVI----PGFFNNRVKTNNILLNE--- 628 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~iiHrDlk~~NiLl~~--- 628 (671)
...|+||||+++|+|.+++.... ....+++.....|+.||+.||+|||.... .+||||||||+|||++.
T Consensus 87 ---~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 87 ---QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred ---CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 36899999999999999987532 22458999999999999999999998531 35999999999999964
Q ss_pred --------------CCcEEEcccCCcccc-------------------------------ccccccceeeeeeehhhhc
Q 005898 629 --------------HRIAKLSDYGLSIVS-------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 629 --------------~~~~ki~DfGla~~~-------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
...+||+|||+++.. .|+||+||++|+|+++...
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 345899999987532 1999999999999997653
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=227.46 Aligned_cols=167 Identities=25% Similarity=0.479 Sum_probs=141.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.++|+..+.||+|+||.||+|... .+..||+|...... .....+|.+|+.++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-- 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--
Confidence 456888899999999999999864 35689999986543 334567999999999999999999999887653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTP----GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
..++||||+++|+|.+++..... ...++|.++++++.+|+.|++|||+. +++||||||+||+++.++
T Consensus 83 ------~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 83 ------PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKG 153 (277)
T ss_pred ------CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccC
Confidence 56899999999999999875432 23589999999999999999999987 799999999999998654
Q ss_pred ---cEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 631 ---IAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 631 ---~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
.+|++|||+++.. .|+||+||++|+|++.
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~ 217 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcC
Confidence 6999999987521 2999999999999873
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=226.37 Aligned_cols=166 Identities=20% Similarity=0.375 Sum_probs=141.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
++|+..+.||+|+||.||+|... ++..||+|.+.... .....++.+|+.++..++||||+++++++.+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 82 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ--- 82 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC---
Confidence 46777899999999999999864 24689999986543 334567889999999999999999999987653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTP-------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE 628 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~ 628 (671)
..++||||+++|+|.+++....+ ...++|..+..++.|++.||.|||+. +|+||||||+||++++
T Consensus 83 -----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~ 154 (277)
T cd05032 83 -----PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAE 154 (277)
T ss_pred -----CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcC
Confidence 67999999999999999875322 23478999999999999999999986 8999999999999999
Q ss_pred CCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 629 HRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 629 ~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
++.+|++|||+++.. .|+||+||++|++++.
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 217 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhcc
Confidence 999999999986421 1999999999999983
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=226.15 Aligned_cols=166 Identities=22% Similarity=0.404 Sum_probs=142.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
++|+..+.||+|+||.||+|+.. +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--- 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence 46778899999999999999853 3467999998765433 4578999999999999999999999987643
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCC------CCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPG------KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
..++||||+++|+|.+++...... ..++|.++..++.|+++||+|||+. +|+||||||+||+++++
T Consensus 82 -----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~ 153 (275)
T cd05046 82 -----PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQ 153 (275)
T ss_pred -----cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCC
Confidence 579999999999999999754311 2589999999999999999999987 79999999999999999
Q ss_pred CcEEEcccCCcccc-------------------------------ccccccceeeeeeehh
Q 005898 630 RIAKLSDYGLSIVS-------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 630 ~~~ki~DfGla~~~-------------------------------~d~~s~g~~l~~~~~~ 659 (671)
+.++++|||+++.. .|+||+|+++|+|+++
T Consensus 154 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~ 214 (275)
T cd05046 154 REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ 214 (275)
T ss_pred CcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999987421 2999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=227.26 Aligned_cols=167 Identities=25% Similarity=0.433 Sum_probs=145.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+.|+..+.||+|+||.||+|+.. +++.||+|.+........+++.+|++++++++||||+++++++.... .
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~ 83 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--------K 83 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--------e
Confidence 45777889999999999999965 68999999997666556778999999999999999999999887643 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|..++.... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 899999999999988876432 3489999999999999999999986 79999999999999999999999999763
Q ss_pred c-----------------------------------cccccccceeeeeeehhhhc
Q 005898 642 V-----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~-----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
. ..|+||+||++|+|+++...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 214 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence 1 13999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=228.11 Aligned_cols=160 Identities=29% Similarity=0.417 Sum_probs=135.5
Q ss_pred ceeccCCceEEEEEEEc-C-------CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 489 AIMGEGSYGKLYKGRLE-N-------GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~-------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.||+|+||.||+|... . ...||+|.+........+++.+|+.+++.++||||+++++++..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-------- 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-------- 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--------
Confidence 46899999999999853 2 2358888887655555678899999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc--------E
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI--------A 632 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~--------~ 632 (671)
..++||||+++|+|.++++... ..++|..++.++.||+.|++|||+. +|+||||||+||+++.+++ +
T Consensus 73 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 73 ESIMVQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred CcEEEEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 5799999999999999997643 2589999999999999999999986 8999999999999987765 5
Q ss_pred EEcccCCccc---------------------------cccccccceeeeeeehhhh
Q 005898 633 KLSDYGLSIV---------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 633 ki~DfGla~~---------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
|++|||++.. ..|+||+||++|+|+++..
T Consensus 148 ~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 203 (258)
T cd05078 148 KLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203 (258)
T ss_pred EecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 9999998732 1299999999999999843
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=224.32 Aligned_cols=165 Identities=24% Similarity=0.410 Sum_probs=142.8
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
+|+..+.||+|+||.||+|...+|+.+|||.+.... ....+.+.+|++++++++|+||++++++|.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN----- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC-----
Confidence 366788999999999999998889999999886432 122456889999999999999999999998653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... .+++.....++.|++.|++|||+. +|+|+||||+||++++++.+|++||
T Consensus 76 ---~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 76 ---TISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred ---eEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccc
Confidence 6899999999999999997543 378999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc------------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|+|+++...
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 207 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCc
Confidence 986421 2999999999999997654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-27 Score=221.86 Aligned_cols=170 Identities=22% Similarity=0.407 Sum_probs=140.9
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+++|+..++||+|+|++||+... ++|+.+|+|.+...+ ..+.+++.+|+++.+.++|||||+|...+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~------- 82 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------- 82 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-------
Confidence 35567778999999999999874 579999998885432 33578899999999999999999998877654
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~ 635 (671)
...|||+|+|++|+|..-+-.+ ...+....-..+.||.++|.|+|.+ +|||||+||+|+++.. .-.+|++
T Consensus 83 -~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 83 -SFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred -ceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence 3789999999999997655432 2356677778899999999999998 8999999999999963 3468999
Q ss_pred ccCCccccc-----------------------------cccccceeeeeeehhhhcccc
Q 005898 636 DYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 636 DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
|||+|+.+. |+|+.||++|.++.|.....+
T Consensus 156 ~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 156 DFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred ccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 999997543 999999999999998876544
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=223.66 Aligned_cols=165 Identities=23% Similarity=0.507 Sum_probs=144.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++|...++||+|+||.||+|...+++.||||.+..... ..+++.+|+.++++++|+||+++++++.+.. .
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE--------P 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCC--------c
Confidence 457888899999999999999988788999999875432 3567999999999999999999999887643 5
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ...+++.++..++.+++.|++|||+. +++|+||||+||++++++.+|++|||+++
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred eEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccce
Confidence 799999999999999997642 24589999999999999999999987 79999999999999999999999999864
Q ss_pred cc-------------------------------ccccccceeeeeeehh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~~ 659 (671)
.. .|+||+|+++|+|+++
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhC
Confidence 31 2999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=223.94 Aligned_cols=165 Identities=23% Similarity=0.399 Sum_probs=143.1
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc-----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK-----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..+.||+|+||.||+|.. ++++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE---- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence 4688899999999999999985 468999999986432 123457889999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++++|.+++.... .+++.....++.+++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 78 ----~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 78 ----TLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred ----eEEEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 7899999999999999987543 388899999999999999999987 799999999999999999999999
Q ss_pred cCCccc---------------------------------cccccccceeeeeeehhhh
Q 005898 637 YGLSIV---------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 637 fGla~~---------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
||+++. ..|+||+|+++|+|++|..
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 998742 1299999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=228.91 Aligned_cols=164 Identities=26% Similarity=0.431 Sum_probs=141.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh-----hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY-----TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
+|+..+.||+|+||.||+|... +|+.||||.+...... ....+..|++++++++|+||+++++++.+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS----- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----
Confidence 3667789999999999999965 6899999999754322 2456778999999999999999999998743
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+ +|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ---~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 ---NINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred ---EEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 689999999 899999997543 2589999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc-------------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+||++|+|+++..
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~ 201 (298)
T cd07841 147 GLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201 (298)
T ss_pred eeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence 987421 299999999999999843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=235.83 Aligned_cols=161 Identities=19% Similarity=0.338 Sum_probs=137.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
...+|+..+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|||||++++++.+..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 130 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA------- 130 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-------
Confidence 3457999999999999999999965 5789999985432 2356899999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|+||+. |+|..++.... ..++|..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 131 -~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 131 -ITCMVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred -eeEEEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 6799999995 68888886532 3589999999999999999999987 799999999999999999999999999
Q ss_pred cccc-----------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++.. .|+||+||++|||+++..
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~ 254 (357)
T PHA03209 204 AQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS 254 (357)
T ss_pred ccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCC
Confidence 8531 199999999999998533
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=230.36 Aligned_cols=167 Identities=22% Similarity=0.337 Sum_probs=142.6
Q ss_pred cCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.-|++.+.||+|.|.+|-.|+ .-+|..||||++.+.+. ....++.+|++.|+-++|||||+||++..+.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-------- 89 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-------- 89 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc--------
Confidence 346677889999999999998 45899999999987653 3456788999999999999999999998765
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEcccC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLSDYG 638 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~DfG 638 (671)
..+|||+|.-.+|+|++|+-.... -++..-..++..||.+|+.|+|+- ++|||||||+||++-+ -|-+|+.|||
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 379999999999999999865432 288888899999999999999986 6899999999999864 5899999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++-.+. |+||+|||+|-++||...
T Consensus 165 FSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P 218 (864)
T KOG4717|consen 165 FSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP 218 (864)
T ss_pred ccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc
Confidence 985432 999999999988887643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=230.99 Aligned_cols=162 Identities=20% Similarity=0.365 Sum_probs=132.9
Q ss_pred CceeccCCceEEEEEEEc---CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 488 SAIMGEGSYGKLYKGRLE---NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
..+||+|+||+||+|+.. +++.||||.+..... ...+.+|++++++++||||+++++++.+..+ ...++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHAD------RKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCC------cEEEE
Confidence 468999999999999854 467899999865432 3457889999999999999999998865431 36899
Q ss_pred EEecCCCCChhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee----cCCCcEEE
Q 005898 565 VYEFMSNGNFRTHISENT------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL----NEHRIAKL 634 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl----~~~~~~ki 634 (671)
||||+.+ +|.+++.... ....+++.....++.|++.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 9999965 8887765321 123488889999999999999999987 79999999999999 45689999
Q ss_pred cccCCcccc----------------------------------ccccccceeeeeeehhhh
Q 005898 635 SDYGLSIVS----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 635 ~DfGla~~~----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+|||+++.. .|+||+||++|+|+++.+
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999988431 099999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=225.60 Aligned_cols=169 Identities=20% Similarity=0.371 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+. .+++.||||.+.... ....+++.+|+++++.++||||+++++++.+.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN------ 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC------
Confidence 4577788999999999999995 579999999886432 233567899999999999999999999988653
Q ss_pred cceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++... .....++|.++..++.+++.|++|||+. +++|+||||+||+++.++.++++||
T Consensus 76 --~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 76 --ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred --eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcc
Confidence 689999999999999988742 2234689999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|+|+++...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p 205 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 976421 2999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=223.49 Aligned_cols=166 Identities=21% Similarity=0.358 Sum_probs=141.6
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc-----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK-----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
+|+..+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+..+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 78 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---- 78 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC----
Confidence 678889999999999999986 468999999885321 2234578899999999999999999998865321
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++++||+++++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 79 --~~~~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~df 150 (266)
T cd06651 79 --KTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 150 (266)
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 36789999999999999997543 388999999999999999999986 7999999999999999999999999
Q ss_pred CCccc---------------------------------cccccccceeeeeeehhhh
Q 005898 638 GLSIV---------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~---------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
|+++. ..|+||+||++|+|++|..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~ 207 (266)
T cd06651 151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207 (266)
T ss_pred CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCC
Confidence 98742 1299999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=231.31 Aligned_cols=167 Identities=20% Similarity=0.505 Sum_probs=141.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEc--------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE--------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
.++|+..+.||+|+||.||+|+.. +...||+|+++... ....+++.+|+++++++ +||||++++++|.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 346778899999999999999741 24579999987543 33456789999999999 699999999998764
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
+ ..++||||+++|+|.+++.... ....++|.+.++++.|++.||+|||+. +|+|||
T Consensus 91 ~--------~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~d 159 (314)
T cd05099 91 G--------PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRD 159 (314)
T ss_pred C--------ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence 3 6799999999999999997532 124589999999999999999999986 899999
Q ss_pred CCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||+||++++++.+|++|||+++.. .|+||+|+++|+|+++
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 9999999999999999999998521 2999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=223.96 Aligned_cols=162 Identities=23% Similarity=0.487 Sum_probs=139.8
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+.|...+.||+|+||.||+|....+..||+|.+..... ..+.+.+|++++++++|||++++++++... ..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---------~~ 75 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSEE---------PI 75 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---------Cc
Confidence 34677789999999999999987777899999865432 346789999999999999999999887432 46
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.++++... ...++|..+..++.+++.||+|||+. +++||||||+||++++++.+|++|||++..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceE
Confidence 89999999999999997532 34589999999999999999999986 799999999999999999999999999853
Q ss_pred c-------------------------------ccccccceeeeeeeh
Q 005898 643 S-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
. .|+||+|+++|+|++
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHh
Confidence 1 199999999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=235.70 Aligned_cols=165 Identities=24% Similarity=0.479 Sum_probs=143.9
Q ss_pred cCCCcCceeccCCceEEEEEEEcC---C--cEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN---G--TSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~---g--~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+...+.++||+|.||.||+|.+.+ | ..||||..+... ....+.|..|.-+|++++|||||+|+|+|.+.
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~----- 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ----- 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-----
Confidence 345667899999999999998532 3 368999998743 44578899999999999999999999999874
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
.+|+|||.++-|.|..||+... ..|+......++.|++.||+|||+. .+|||||.++|||+...--+|++|
T Consensus 464 ----P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 464 ----PMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred ----ceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 6899999999999999998643 3488888999999999999999997 789999999999999999999999
Q ss_pred cCCccccc-------------------------------cccccceeeeeeehhhh
Q 005898 637 YGLSIVSE-------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 637 fGla~~~~-------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
||+++.++ |+|=+||-|||+++..-
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGv 590 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGV 590 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcC
Confidence 99998765 99999999999887443
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=227.55 Aligned_cols=167 Identities=22% Similarity=0.445 Sum_probs=142.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEcC-----------------CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLEN-----------------GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVC 543 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 543 (671)
..+|+..+.||+|+||.||+|+... +..||+|++.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3467888999999999999987532 2468999987543 344678999999999999999999
Q ss_pred ccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCcc
Q 005898 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT--------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFF 615 (671)
Q Consensus 544 l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii 615 (671)
++++|...+ ..++||||+++|+|..++.... ....+++.....++.|++.||+|||+. +|+
T Consensus 84 ~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~ 152 (296)
T cd05051 84 LLGVCTVDP--------PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFV 152 (296)
T ss_pred EEEEEecCC--------CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccc
Confidence 999987653 6799999999999999987543 123589999999999999999999987 799
Q ss_pred ccCCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 616 NNRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 616 HrDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
||||||+||++++++.++++|||+++.. .|+||+||++|+|++.
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred ccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 9999999999999999999999987631 1999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=229.86 Aligned_cols=164 Identities=26% Similarity=0.481 Sum_probs=141.1
Q ss_pred cCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
++|+..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+++++++ +||||++++++|...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-- 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG-- 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC--
Confidence 4688889999999999999973 135589999987543 33456789999999999 7999999999987653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++|+|.++++... ...+++.++..++.+++.|++|||+. +|+||||||+||++++++.+|+
T Consensus 113 ------~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 113 ------PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ------ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEE
Confidence 5799999999999999997533 23489999999999999999999986 7999999999999999999999
Q ss_pred cccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 635 SDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 635 ~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
+|||+++.. .|+||+||++|+|++
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t 238 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence 999987521 199999999999988
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=225.31 Aligned_cols=162 Identities=25% Similarity=0.464 Sum_probs=139.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc----EEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT----SVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.+|+..+.||+|+||+||+|... +|. .||+|.+.... ....+++.+|++++++++||||++++++|.+.
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSS----- 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 45677899999999999999864 343 68999987554 33457889999999999999999999999762
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++.... ..+++.....++.|+++|++|||+. +|+||||||+||++++++.+|++|
T Consensus 82 ----~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 82 ----QVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 5799999999999999997643 2389999999999999999999986 899999999999999999999999
Q ss_pred cCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 637 YGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+++.. .|+||+|+++||+++
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~ 206 (279)
T cd05057 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206 (279)
T ss_pred CcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhc
Confidence 9987521 199999999999998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.07 Aligned_cols=168 Identities=21% Similarity=0.380 Sum_probs=145.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++.+.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~------ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN------ 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC------
Confidence 56888899999999999999976 7999999988632 2233567899999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|..++... .....+++.++..++.++++|++|||+. +|+||||||+||++++++.++++||
T Consensus 76 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 76 --ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred --eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecc
Confidence 679999999999999988653 2234589999999999999999999987 8999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|++... .|+||+||++|+|+++..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~ 204 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCC
Confidence 986421 199999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.80 Aligned_cols=159 Identities=30% Similarity=0.567 Sum_probs=134.8
Q ss_pred ceeccCCceEEEEEEEc-CCc--EEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGT--SVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. ++. .+|+|.++... ....+.+.+|++++.++ +||||++++++|...+ ..+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--------~~~ 72 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG--------YLY 72 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC--------Cce
Confidence 46899999999999975 444 56889887532 34456889999999999 7999999999987653 579
Q ss_pred EEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 564 LVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
+||||+++|+|.++++... ....+++.++..++.+++.|++|||+. +++||||||+||++++++
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~ 149 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 149 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCC
Confidence 9999999999999987532 123488999999999999999999986 899999999999999999
Q ss_pred cEEEcccCCccc-----------------------------cccccccceeeeeeeh
Q 005898 631 IAKLSDYGLSIV-----------------------------SEDINSVGVRLLILMS 658 (671)
Q Consensus 631 ~~ki~DfGla~~-----------------------------~~d~~s~g~~l~~~~~ 658 (671)
.+|++|||++.. ..|+||+||++|+|++
T Consensus 150 ~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~ 206 (270)
T cd05047 150 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206 (270)
T ss_pred eEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHc
Confidence 999999998731 1299999999999997
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=218.66 Aligned_cols=167 Identities=23% Similarity=0.409 Sum_probs=143.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..+.||+|+||.||+++.. +++.||+|.+... .....+++.+|+.++++++|+||+++++++.+.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~ 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--------H 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--------E
Confidence 3667889999999999999864 7899999998643 2334567889999999999999999999987653 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ...+++.....++.++++|+.|||+. +|+|+||||+||++++++.++++|||++.
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 899999999999999886432 34578899999999999999999987 89999999999999999999999999874
Q ss_pred cc------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+|+++|+|+++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p 199 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCC
Confidence 22 2999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=228.62 Aligned_cols=183 Identities=26% Similarity=0.390 Sum_probs=151.6
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeec
Q 005898 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCID 550 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 550 (671)
++++++..++++|+..+.||+|+||.||++.. .+++.+|+|.+..... ..+++.+|+.++.++ +|||+++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34456666788999999999999999999986 4789999999865432 245678899999999 79999999999876
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
.+.. .....++||||+++|+|.++++... ....++|..+..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 91 ~~~~---~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~ 164 (291)
T cd06639 91 ADKL---VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164 (291)
T ss_pred cccc---CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence 4311 1236899999999999999886421 234589999999999999999999986 89999999999999999
Q ss_pred CcEEEcccCCccc-----------------------------------cccccccceeeeeeehhhhc
Q 005898 630 RIAKLSDYGLSIV-----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 630 ~~~ki~DfGla~~-----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
+.+||+|||+++. ..|+||+||++|+|++|...
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p 232 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232 (291)
T ss_pred CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCC
Confidence 9999999997642 12999999999999998644
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=236.59 Aligned_cols=168 Identities=25% Similarity=0.375 Sum_probs=142.7
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-C-----CCcccccceeecCCCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-H-----PHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~~ 556 (671)
.|+..++||+|.||.|-||.. .+++.||||+++..... .++...|+.+|..++ | -|+|++++++...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr----- 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR----- 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-----
Confidence 577889999999999999984 57999999999876543 456677899999887 4 4899999999865
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC--CCcEEE
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE--HRIAKL 634 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~--~~~~ki 634 (671)
+..+||+|.+.. +|++++.... ...++......++.||+.||.+||+. +|||+||||+||||.+ ...+||
T Consensus 261 ---~HlciVfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 261 ---NHLCIVFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ---cceeeeehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 378999999977 9999998643 23488899999999999999999987 8999999999999974 358999
Q ss_pred cccCCccccc---------------------------cccccceeeeeeehhhhcccc
Q 005898 635 SDYGLSIVSE---------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 635 ~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
.|||.|.... |+||+|||++||.+|.+=.||
T Consensus 333 IDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 333 IDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred EecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 9999997644 999999999999998654443
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=221.11 Aligned_cols=161 Identities=27% Similarity=0.428 Sum_probs=140.9
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
|+...++|+|+||.||||..+ +|+.||||...... +.++...|+.+|.+++.|++|+.||.|.... .+|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--------DLW 104 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--------DLW 104 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCC--------ceE
Confidence 555688999999999999864 79999999987543 4678999999999999999999999776542 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+|||||-.|+..+.++-+ .++|.....-.+..+..+||+|||.. .=||||||+.|||++.+|.+|++|||.|..+
T Consensus 105 IVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred eehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence 999999999999998764 35699999999999999999999986 4489999999999999999999999999543
Q ss_pred c------------------------------cccccceeeeeeehhh
Q 005898 644 E------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 644 ~------------------------------d~~s~g~~l~~~~~~~ 660 (671)
. |+||+|++-.||.-|-
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~ 226 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGR 226 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCC
Confidence 2 9999999999987653
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=228.11 Aligned_cols=165 Identities=22% Similarity=0.393 Sum_probs=144.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|+..+.||+|+||.||+|+. .+++.||||.+........+.+.+|+++++.++||||+++++++...+ .
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~ 90 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD--------E 90 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc--------e
Confidence 3577889999999999999985 578999999987654445677899999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|+||+++|+|..++... .++|.++..++.+++.|++|||+. +++||||||+||++++++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 89999999999999988642 389999999999999999999987 79999999999999999999999999764
Q ss_pred cc------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+||++|+|+++...
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 21 2999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=226.06 Aligned_cols=163 Identities=23% Similarity=0.396 Sum_probs=140.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
|+..+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.... ..
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~ 77 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT--------KL 77 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC--------ce
Confidence 445577999999999999864 68899999986433 334567899999999999999999999987643 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.. ..+++.....++.++++|++|||+. +++|+||||+||++++++.+|++|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccccc
Confidence 999999999999998864 2488999999999999999999986 799999999999999999999999998743
Q ss_pred c------------------------------ccccccceeeeeeehhhhc
Q 005898 643 S------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 643 ~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
. .|+||+||++|+|++|...
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred ccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence 1 1999999999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=220.47 Aligned_cols=160 Identities=30% Similarity=0.571 Sum_probs=139.8
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLEN----GTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||.||+|+... +..||||.+...... ..+++.+|++.+..++|+||+++++++.+.. ..+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--------~~~ 72 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE--------PLY 72 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC--------ceE
Confidence 468999999999999653 789999999765433 3678999999999999999999999988643 689
Q ss_pred EEEecCCCCChhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 564 LVYEFMSNGNFRTHISENTP------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
+||||+++|+|.+++..... ...+++.++..++.++++|++|||+. +++||||||+||++++++.+|++||
T Consensus 73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~df 149 (262)
T cd00192 73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDF 149 (262)
T ss_pred EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccc
Confidence 99999999999999986421 24589999999999999999999996 7999999999999999999999999
Q ss_pred CCcccc--------------------------------ccccccceeeeeeehh
Q 005898 638 GLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 638 Gla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|.+... .|+||+|+++|+|+++
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 203 (262)
T cd00192 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203 (262)
T ss_pred ccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhc
Confidence 988532 1999999999999985
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=225.71 Aligned_cols=165 Identities=24% Similarity=0.363 Sum_probs=141.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR------- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-------
Confidence 35777889999999999999976 68999999986432 223456889999999999999999999987653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||++++.|..+.... ..++|.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 74 -~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 74 -KLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred -EEEEEEeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 689999999999888776543 2489999999999999999999986 899999999999999999999999998
Q ss_pred cccc-------------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+... .|+||+|+++|+|+++..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~ 199 (286)
T cd07847 147 ARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199 (286)
T ss_pred ceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence 7521 199999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=221.27 Aligned_cols=156 Identities=26% Similarity=0.417 Sum_probs=135.0
Q ss_pred ceeccCCceEEEEEEEc--C--CcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE--N--GTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~--~--g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||.||+|+.. + +..||+|.+..... ...+++.+|++++++++|||||++++++... ..+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------~~~ 71 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE---------PLM 71 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---------ceE
Confidence 46999999999999753 2 26899999976543 3456799999999999999999999987532 479
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|.+++.... .++|..+..++.|++.|++|||.. +++||||||+||++++++.+|++|||+++..
T Consensus 72 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 72 LVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999999997643 489999999999999999999987 7999999999999999999999999987522
Q ss_pred ---------------------------------ccccccceeeeeeehh
Q 005898 644 ---------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 644 ---------------------------------~d~~s~g~~l~~~~~~ 659 (671)
.|+||+|+++|+|+++
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~ 194 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcC
Confidence 2999999999999983
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-26 Score=231.84 Aligned_cols=164 Identities=23% Similarity=0.405 Sum_probs=141.0
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.|...+.||+|+||.||||.. .+++.||||.+.-. .....++..+|+.++.+++|+||.+.+|.+..+. .
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~--------~ 85 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--------K 85 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--------c
Confidence 355568899999999999985 57999999999643 3445788999999999999999999999887653 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
++++||||.+|++.+.+.... .++.....-|..++..|+.|||.+ ..+|||||+.|||+..+|.+|++|||++.
T Consensus 86 LwiiMey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHHHHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceee
Confidence 899999999999999887543 346666677788999999999998 67999999999999999999999999985
Q ss_pred ccc------------------------------cccccceeeeeeehhhh
Q 005898 642 VSE------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~~------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
... |+||+|+|.+||++|-+
T Consensus 160 ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP 209 (467)
T KOG0201|consen 160 QLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP 209 (467)
T ss_pred eeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC
Confidence 433 99999999999998754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-25 Score=237.96 Aligned_cols=163 Identities=20% Similarity=0.296 Sum_probs=138.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc---CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE---NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
...|+..+.||+|+||.||++... .+..||||.+... +.+.+|++++++++|||||++++++....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~------ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS------ 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC------
Confidence 356888999999999999999753 3578999988643 23568999999999999999999887543
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+. ++|.+++... ..++|.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 160 --~~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 160 --TVCMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred --EEEEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 6899999996 6888888533 3489999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc--------------------------------ccccccceeeeeeehhhhccc
Q 005898 639 LSIVS--------------------------------EDINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 639 la~~~--------------------------------~d~~s~g~~l~~~~~~~~~~~ 664 (671)
+++.. .|+||+||++|||+++....+
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 87421 299999999999999766543
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=221.18 Aligned_cols=163 Identities=19% Similarity=0.460 Sum_probs=141.7
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+.|+..+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++.+++.+. ..
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------~~ 75 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKE---------PI 75 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCC---------Ce
Confidence 5677889999999999999998777889999987543 3456789999999999999999999887652 47
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
+++|||+++|+|.+++.... ...++|.++..++.+++.||+|||+. +++||||||+||+++.++.+|++|||.+..
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 151 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceee
Confidence 99999999999999997532 34589999999999999999999986 799999999999999999999999997642
Q ss_pred c-------------------------------ccccccceeeeeeehh
Q 005898 643 S-------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~~ 659 (671)
. .|+||+||++|+++++
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 1 2999999999999983
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-25 Score=234.86 Aligned_cols=159 Identities=27% Similarity=0.438 Sum_probs=134.6
Q ss_pred CCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchh---hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKY---TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|...+.||.|+||.||-|+ ..+.++||||++.-..++ -.+++..||..|.+++|||+|...|+|... .
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre--------~ 99 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE--------H 99 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc--------c
Confidence 5556789999999999999 457899999999754433 357889999999999999999999988754 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..|||||||-| +-.+.+.-. .+++.......|+.|+..||+|||+. ..||||||+.|||+.+.|.+|++|||.|
T Consensus 100 TaWLVMEYClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 100 TAWLVMEYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred hHHHHHHHHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 68999999965 666665422 24588889999999999999999997 7899999999999999999999999998
Q ss_pred cccc-----------------------------cccccceeeeeee
Q 005898 641 IVSE-----------------------------DINSVGVRLLILM 657 (671)
Q Consensus 641 ~~~~-----------------------------d~~s~g~~l~~~~ 657 (671)
.+.. |+||+|+|-.|+.
T Consensus 174 si~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELA 219 (948)
T KOG0577|consen 174 SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 219 (948)
T ss_pred hhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhh
Confidence 6644 9999999877754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=226.20 Aligned_cols=166 Identities=23% Similarity=0.415 Sum_probs=144.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS------ 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC------
Confidence 35778899999999999999965 68999999986432 223567889999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 75 --~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 75 --NLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred --eEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 6899999999999999987643 488999999999999999999986 89999999999999999999999999
Q ss_pred Ccccc---------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+|+++|+|+++...
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 147 FAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred CccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 88642 2999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-25 Score=228.47 Aligned_cols=162 Identities=26% Similarity=0.463 Sum_probs=137.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc----EEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT----SVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.+|+..+.||+|+||.||+|+.. +|. .||+|.+.... .....++.+|+.++++++||||++++|+|...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 45677889999999999999853 454 47899886543 23345788999999999999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 82 ----~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~D 152 (303)
T cd05110 82 ----TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITD 152 (303)
T ss_pred ----CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcc
Confidence 3579999999999999987542 2488999999999999999999987 799999999999999999999999
Q ss_pred cCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 637 YGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+++.. .|+||+|+++|||++
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred ccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 9988531 199999999999987
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=225.96 Aligned_cols=170 Identities=25% Similarity=0.381 Sum_probs=136.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcC---CCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKL---RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~~~ 557 (671)
+|+..+.||+|+||+||+|+.. +++.||+|.++.... .....+.+|++++..+ +||||+++++++.+....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~--- 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD--- 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC---
Confidence 3677889999999999999865 789999999864321 1233456677666554 799999999988754211
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+++ +|.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 12368999999985 8988887532 23489999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+||++|+|+++.+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205 (288)
T ss_pred CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCc
Confidence 987532 199999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=228.39 Aligned_cols=159 Identities=23% Similarity=0.378 Sum_probs=139.8
Q ss_pred CceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 488 SAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
...||+|+||.||++... ++..||||.+........+.+.+|+..+++++|+||+++++.+..++ ..++||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--------~~~lv~ 98 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD--------ELWVVM 98 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC--------eEEEEE
Confidence 466999999999999864 68899999987655555677899999999999999999999887653 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++++|.+++... .+++.+...++.+++.|++|||+. +|+||||||+||++++++.+|++|||++...
T Consensus 99 e~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 99 EFLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred eCCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999999988542 388999999999999999999987 7999999999999999999999999987421
Q ss_pred ---------------------------ccccccceeeeeeehhhh
Q 005898 644 ---------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 ---------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.|+||+|+++|||++|..
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~ 216 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 399999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=227.26 Aligned_cols=163 Identities=25% Similarity=0.400 Sum_probs=141.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 73 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-------- 73 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--------
Confidence 5777899999999999999975 689999999864322 23467889999999999999999999987643
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++++++..+..... .++|.++..++.|+++|++|||+. +++||||+|+||++++++.+|++|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred eEEEEEecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence 6899999999999988765432 389999999999999999999987 7999999999999999999999999986
Q ss_pred ccc-------------------------------ccccccceeeeeeehhh
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
... .|+||+|+++|+|++|.
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~ 198 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence 421 29999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=228.82 Aligned_cols=162 Identities=21% Similarity=0.369 Sum_probs=132.8
Q ss_pred CceeccCCceEEEEEEEc---CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEE
Q 005898 488 SAIMGEGSYGKLYKGRLE---NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
..+||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++..... ...++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSD------RKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCC------CeEEE
Confidence 467999999999999864 457899999865432 3467889999999999999999998865431 36799
Q ss_pred EEecCCCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee----cCCCcEEE
Q 005898 565 VYEFMSNGNFRTHISEN------TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL----NEHRIAKL 634 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl----~~~~~~ki 634 (671)
||||+++ +|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 9999975 777776421 1123588999999999999999999987 79999999999999 56689999
Q ss_pred cccCCcccc----------------------------------ccccccceeeeeeehhhh
Q 005898 635 SDYGLSIVS----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 635 ~DfGla~~~----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+|||+++.. .|+||+||++|||++|..
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~ 214 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCC
Confidence 999988531 199999999999999764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=230.37 Aligned_cols=164 Identities=22% Similarity=0.503 Sum_probs=139.8
Q ss_pred CCCcCceeccCCceEEEEEEEc--------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE--------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 553 (671)
.|+..+.||+|+||.||+|+.. .+..||+|.++... ....+++.+|++++.++ +||||++++++|.+.+
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 91 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG- 91 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC-
Confidence 5778899999999999999742 12379999987543 33467899999999999 7999999999987653
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCC
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVK 620 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 620 (671)
..++||||+++|+|.+++.... +...++|.+++.++.|++.||+|||.. +|+|||||
T Consensus 92 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlk 161 (334)
T cd05100 92 -------PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLA 161 (334)
T ss_pred -------ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccc
Confidence 6799999999999999987532 234589999999999999999999986 89999999
Q ss_pred CCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 621 TNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 621 ~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
|+||++++++.+||+|||+++.. .|+||+|+++|+|++
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999999999987521 299999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=222.97 Aligned_cols=161 Identities=22% Similarity=0.427 Sum_probs=138.5
Q ss_pred CCCcCceeccCCceEEEEEEEcC----CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLEN----GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||++++++|.+.
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------- 79 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------- 79 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-------
Confidence 46678899999999999998643 3478999986544 34466899999999999999999999988653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... ..++|.++..++.+++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 80 --~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 80 --PVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred --CcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence 4689999999999999997532 2489999999999999999999986 79999999999999999999999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeeh
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
+++.. .|+||+|+++|+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 203 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203 (270)
T ss_pred eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHH
Confidence 87531 199999999999886
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=226.52 Aligned_cols=166 Identities=19% Similarity=0.357 Sum_probs=143.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+++++.++||||+++++.+.+.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR------ 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC------
Confidence 36788899999999999999865 68899999986543 223457889999999999999999999887643
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+.+.....++.+++.|++|||+. +++||||||+||++++++++|++|||
T Consensus 75 --~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 75 --HLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred --EEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 6899999999999999997543 488999999999999999999987 79999999999999999999999999
Q ss_pred Cccc---------------------------------------------cccccccceeeeeeehhhhc
Q 005898 639 LSIV---------------------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~---------------------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
+++. ..|+||+||++|+|+++...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~p 215 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 8752 02999999999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=220.31 Aligned_cols=167 Identities=25% Similarity=0.423 Sum_probs=145.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|++++++++||||+++++++.+.. .
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------~ 74 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD--------K 74 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC--------E
Confidence 56888899999999999999864 67899999997665556678999999999999999999999887653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.+++|||+++++|.+++.... ..+++.+...++.|++.|++|||+. +|+|+||||+||++++++.+||+|||++.
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 899999999999999887542 3488999999999999999999987 79999999999999999999999999763
Q ss_pred cc---------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+|+++|+|+++...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p 203 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203 (262)
T ss_pred hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 20 1999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=219.39 Aligned_cols=160 Identities=25% Similarity=0.471 Sum_probs=139.1
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEe
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYE 567 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~E 567 (671)
++||+|+||.||+|...+++.||+|.+...... ..+++.+|++++++++|+||+++++++.+.. ..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ--------PIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--------CeEEEEE
Confidence 468999999999999777999999998754332 4578999999999999999999999987653 6799999
Q ss_pred cCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc----
Q 005898 568 FMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS---- 643 (671)
Q Consensus 568 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~---- 643 (671)
|+++++|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||++++++.+|++|||++...
T Consensus 73 ~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 73 LVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 999999999997532 2488999999999999999999987 7999999999999999999999999987521
Q ss_pred ----------------------------ccccccceeeeeeehhhh
Q 005898 644 ----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 ----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.|+||+||++|+|+++..
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~ 193 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGD 193 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccC
Confidence 199999999999998433
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=238.19 Aligned_cols=181 Identities=17% Similarity=0.310 Sum_probs=139.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-----------------cCCcEEEEEEccCCchhhHHHH--------------HHH
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-----------------ENGTSVAIRCLPSSKKYTVRNL--------------KLR 529 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~~~--------------~~E 529 (671)
..++|+..++||+|+||+||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356899999875433223333 346
Q ss_pred HHHHhcCCCCCc-----ccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCC---------------------C
Q 005898 530 LDLLAKLRHPHL-----VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT---------------------P 583 (671)
Q Consensus 530 ~~~l~~l~H~ni-----v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~---------------------~ 583 (671)
+.++.+++|.++ ++++++|..............+|||||+++|+|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877665 67888876532111112246899999999999999887421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc--------------------
Q 005898 584 GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS-------------------- 643 (671)
Q Consensus 584 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~-------------------- 643 (671)
...++|..+..++.++++||+|+|+. +|+||||||+||++++++.+||+|||+++..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12367888999999999999999987 7999999999999999999999999987321
Q ss_pred ---------------------------------ccccccceeeeeeehhhhccc
Q 005898 644 ---------------------------------EDINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 644 ---------------------------------~d~~s~g~~l~~~~~~~~~~~ 664 (671)
-|+||+||++|+|+++...++
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 199999999999998765444
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=219.74 Aligned_cols=166 Identities=23% Similarity=0.427 Sum_probs=143.4
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..++||+|+||.||.++. .+++.|++|.+... .....+++.+|++++++++|+||+++++++.+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-------- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-------- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--------
Confidence 367789999999999999985 46899999998643 2344567899999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... ...+++.++..++.++++|++|||+. +++||||||+||++++++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 6899999999999999987542 34589999999999999999999986 7899999999999999999999999977
Q ss_pred ccc------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
... .|+||+|+++|+|+++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 199 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCC
Confidence 431 299999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=225.82 Aligned_cols=183 Identities=22% Similarity=0.356 Sum_probs=150.2
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeec
Q 005898 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCID 550 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 550 (671)
+.++++..++++|+..+.||+|+||.||+++.. +++.+|+|.+..... ..+++.+|+.++.++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344566677889999999999999999999864 688999998865322 245788899999999 69999999998864
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
.+.. .....++||||+++|+|.++++... ....+++.....++.|+++|+.|||+. +|+||||||+||+++++
T Consensus 87 ~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~ 160 (286)
T cd06638 87 KDVK---NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE 160 (286)
T ss_pred cccC---CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence 3211 1236899999999999999876421 234588999999999999999999986 79999999999999999
Q ss_pred CcEEEcccCCccc-----------------------------------cccccccceeeeeeehhhhc
Q 005898 630 RIAKLSDYGLSIV-----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 630 ~~~ki~DfGla~~-----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
+.+|++|||+++. ..|+||+||++|+|+++...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p 228 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228 (286)
T ss_pred CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCC
Confidence 9999999998732 12999999999999987543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=225.75 Aligned_cols=167 Identities=20% Similarity=0.319 Sum_probs=143.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||+||+++.. +|+.||+|.+.... ....+++.+|+++++.++||||+++++++...+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 76 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-------- 76 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--------
Confidence 34666788999999999999864 68999999886433 334578999999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|..++.... .+++.....++.++++|+.|||+.. +++||||||+||++++++.++|+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 6899999999999999887643 4899999999999999999999742 6999999999999999999999999987
Q ss_pred ccc----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|+++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p 201 (284)
T cd06620 152 GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201 (284)
T ss_pred cchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCC
Confidence 421 2999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=228.87 Aligned_cols=164 Identities=23% Similarity=0.315 Sum_probs=137.7
Q ss_pred cCceeccC--CceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 487 MSAIMGEG--SYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 487 ~~~~iG~G--~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..++||+| +||+||+++. .+|+.||||++.... ....+.+.+|+++++.++|||||+++++|.+.+ .
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--------~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--------E 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--------E
Confidence 35789999 7899999986 479999999996542 233456778999999999999999999998753 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||...
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 899999999999999986432 23489999999999999999999986 79999999999999999999999986321
Q ss_pred ---------------------------------------ccccccccceeeeeeehhhhc
Q 005898 642 ---------------------------------------VSEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ---------------------------------------~~~d~~s~g~~l~~~~~~~~~ 662 (671)
...|+||+||++|+|+++...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 209 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 012999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=219.04 Aligned_cols=163 Identities=22% Similarity=0.408 Sum_probs=141.7
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
|+..+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------ 75 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED------ 75 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC------
Confidence 566788999999999999976 78999999985432 224567899999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++++|.+++.... .+++..+..++.++++|++|||+. +++|+||||+||++++++.+||+|||
T Consensus 76 --~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 76 --NLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred --eEEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence 6899999999999999997543 488999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++... .|+||+||++|+|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~ 200 (258)
T cd06632 148 MAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200 (258)
T ss_pred cceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 76421 299999999999998654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=225.51 Aligned_cols=167 Identities=21% Similarity=0.309 Sum_probs=140.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++.+|...+.||+|+||.||+|... +|+.||||.+..... .....+.+|++++++++|+||+++.+++.+.+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------ 76 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE------ 76 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC------
Confidence 3567888999999999999999864 689999999864432 22346788999999999999999999987643
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+. +++..++.... ..+.+.+...++.|++.||+|||+. +|+||||||+||+++.++++||+|||
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 77 --TLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred --eEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 6799999996 68877765432 2478888889999999999999987 79999999999999999999999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+++.. .|+||+||++|+|++|..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 149 LARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred cccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 77421 199999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=222.81 Aligned_cols=169 Identities=23% Similarity=0.412 Sum_probs=139.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHH-HhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDL-LAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +|+.||||+++... .....++..|+.. ++..+||||+++++++...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~------- 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG------- 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-------
Confidence 36778899999999999999965 79999999986542 2233455666665 66678999999999997653
Q ss_pred ceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 560 NKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||++ |+|.+++... .....+++.....++.|++.|++|||+++ +++||||||+||++++++.+||+|||
T Consensus 74 -~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 74 -DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred -cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence 6899999997 6888887652 23346899999999999999999999853 68999999999999999999999999
Q ss_pred Ccccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++... .|+||+||++|+|+++.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 150 ISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred cccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 87421 2999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=219.18 Aligned_cols=164 Identities=29% Similarity=0.466 Sum_probs=144.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||.||+|+.. +++.||+|.+..... .+++.+|++++++++||||+++++++.+.. .
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------~ 72 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT--------D 72 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC--------c
Confidence 56888899999999999999976 488999999875433 678999999999999999999999988653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++++||+++++|.+++.... ..++|.....++.+++.|+.|||+. +++||||+|+||++++++++|++|||++.
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 899999999999999987532 3589999999999999999999987 79999999999999999999999999865
Q ss_pred cc------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+||+|+++|+|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~ 197 (256)
T cd06612 148 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197 (256)
T ss_pred hcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCC
Confidence 31 299999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=220.12 Aligned_cols=161 Identities=28% Similarity=0.524 Sum_probs=139.1
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
.+|+..+.||+|+||.||+|+. +++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN---------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---------Cc
Confidence 3477789999999999999975 57889999986543 346789999999999999999999988643 36
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred EEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcccee
Confidence 89999999999999997543 23589999999999999999999986 899999999999999999999999998753
Q ss_pred c---------------------------ccccccceeeeeeehh
Q 005898 643 S---------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~---------------------------~d~~s~g~~l~~~~~~ 659 (671)
. .|+||+|+++|+|+++
T Consensus 150 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~ 193 (254)
T cd05083 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193 (254)
T ss_pred ccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhC
Confidence 1 1999999999999973
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=220.18 Aligned_cols=170 Identities=19% Similarity=0.419 Sum_probs=138.9
Q ss_pred CCcCceeccCCceEEEEEEEc----CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
|+..++||+|+||.||+|.+. +++.||||.+... .....+++.+|++++++++||||+++++++....... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~--~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG--R 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC--c
Confidence 456788999999999999853 3688999998653 2334567899999999999999999999887543111 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENT---PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
....++++||+++|+|..++.... ....+++....+++.|++.|++|||+. +|+||||||+||++++++.+|++
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 123578999999999998875321 123478999999999999999999986 79999999999999999999999
Q ss_pred ccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 636 DYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 636 DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||+++.. .|+||+||++|+|++.
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence 99987531 2999999999999883
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=220.34 Aligned_cols=164 Identities=21% Similarity=0.388 Sum_probs=140.9
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+|+..+.||+|+||.||+|+. .+++.||+|.+.... ....+++.+|++++++++|+||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS---- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence 467788999999999999985 578999999986432 123567899999999999999999999987653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLS 635 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~ 635 (671)
..++||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+|++
T Consensus 77 ----~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 77 ----HFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred ----eEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 6899999999999999997543 488999999999999999999987 899999999999998775 69999
Q ss_pred ccCCcccc----------------------------------ccccccceeeeeeehhhh
Q 005898 636 DYGLSIVS----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 636 DfGla~~~----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|||++... .|+|++|+++|+|+++..
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 206 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCC
Confidence 99986321 299999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-25 Score=222.71 Aligned_cols=163 Identities=29% Similarity=0.512 Sum_probs=140.9
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhh--HHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYT--VRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|+||+||+++.. +++.||+|.+....... .....+|+.++++++||||+++++++.+.. .
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN--------Y 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS--------E
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc--------c
Confidence 456789999999999999976 57799999998765332 234456999999999999999999998743 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+.
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 89999999999999999832 3489999999999999999999997 89999999999999999999999999986
Q ss_pred ccc-------------------------------cccccceeeeeeehhhh
Q 005898 642 VSE-------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~~-------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
... |+||+|+++|+|+++..
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 197 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKL 197 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 310 99999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=241.97 Aligned_cols=173 Identities=17% Similarity=0.295 Sum_probs=137.7
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCC------Cccccccee
Q 005898 476 EELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHP------HLVCLLGHC 548 (671)
Q Consensus 476 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~g~~ 548 (671)
+++...+++|+..++||+|+||+||+|+.. +++.||||+++.... ..+++..|++++.+++|. +++.+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455678999999999999999999864 688999999965322 234566677777776554 588888888
Q ss_pred ecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC
Q 005898 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE 628 (671)
Q Consensus 549 ~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~ 628 (671)
.... ...++|||++ +++|.+++.... .+++.....|+.||+.||+|||+. .+||||||||+|||++.
T Consensus 201 ~~~~-------~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 201 QNET-------GHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMET 267 (467)
T ss_pred EcCC-------ceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEec
Confidence 6543 3578999988 678988887543 489999999999999999999974 27999999999999987
Q ss_pred CC----------------cEEEcccCCcccc---------------------------ccccccceeeeeeehhhhc
Q 005898 629 HR----------------IAKLSDYGLSIVS---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 629 ~~----------------~~ki~DfGla~~~---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++ .+||+|||.+... .|+||+||++|||++|...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 65 4999999976421 1999999999999998654
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=224.63 Aligned_cols=165 Identities=22% Similarity=0.349 Sum_probs=140.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+.+ +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 76 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-------- 76 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC--------
Confidence 46778899999999999999965 689999999864322 22345778999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++ +|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+||++++++.+|++|||++
T Consensus 77 ~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 77 TLTLVFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred eEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence 68999999985 9999887543 2588999999999999999999987 7999999999999999999999999976
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+.. .|+||+|+++|+|+++..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 202 (291)
T cd07844 151 RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP 202 (291)
T ss_pred cccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 321 199999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-25 Score=234.30 Aligned_cols=166 Identities=20% Similarity=0.404 Sum_probs=139.4
Q ss_pred CcCceeccCCceEEEEEEEc-CCcEEE---EEEccC-CchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 486 DMSAIMGEGSYGKLYKGRLE-NGTSVA---IRCLPS-SKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 486 ~~~~~iG~G~~g~Vy~~~~~-~g~~vA---vK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+...+||+|+|=+||||... +|.+|| ||.=+. ......+.|..|+++|+.++|||||+++.++.+... .
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n------~ 116 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN------K 116 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC------c
Confidence 34578999999999999864 688887 322111 123345789999999999999999999998887542 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~ki~DfGl 639 (671)
..-+|+|.|+.|+|+.|+.+.+. ++.....+++.||.+||.|||++ .|||||||||..||+++.+ |.+||+|.||
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 57899999999999999987543 78888999999999999999986 4799999999999999864 8999999999
Q ss_pred ccccc---------------------------cccccceeeeeeehhhh
Q 005898 640 SIVSE---------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~~---------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|++.. |+||+|-=|.||+|+=|
T Consensus 193 Atl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eY 241 (632)
T KOG0584|consen 193 ATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEY 241 (632)
T ss_pred HHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccC
Confidence 97644 99999999999999765
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=221.69 Aligned_cols=164 Identities=21% Similarity=0.379 Sum_probs=142.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.|+..+.||+|+||.||+|+.. ++..||||.+.... ....+++.+|++++++++||||+++++++.+.. .
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~ 76 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--------K 76 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--------E
Confidence 3556788999999999999865 68899999986443 344678999999999999999999999988753 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++... .+++.+...++.+++.|++|+|+. +++|+||+|+||++++++.++++|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccce
Confidence 89999999999999998642 388899999999999999999987 79999999999999999999999999883
Q ss_pred cc------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+||++|+|++|...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCC
Confidence 21 1999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=226.89 Aligned_cols=159 Identities=25% Similarity=0.370 Sum_probs=138.9
Q ss_pred CceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 488 SAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
...||+|+||.||+|+.. +++.||||.+........+.+.+|+.+++.++||||+++++++..++ ..++||
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--------~~~iv~ 97 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE--------ELWVLM 97 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC--------eEEEEE
Confidence 457999999999999864 78999999986554445567889999999999999999999887653 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++|+|..++.. ..+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 98 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 98 EFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred ecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 99999999988754 2389999999999999999999987 7999999999999999999999999987421
Q ss_pred ---------------------------ccccccceeeeeeehhhh
Q 005898 644 ---------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 ---------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.|+||+||++|+|++|..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 215 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 299999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=219.60 Aligned_cols=167 Identities=23% Similarity=0.376 Sum_probs=141.9
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS-----KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.+|+..+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++|+||+++++++.+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--- 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE--- 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---
Confidence 3678889999999999999985 46899999987432 12335678899999999999999999998876431
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...++|+||+++++|.+++.... .+++.....++.+++.|++|||+. +++||||||+||++++++.++|+|
T Consensus 79 ---~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 ---KKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred ---CEEEEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 25789999999999999987543 378999999999999999999987 799999999999999999999999
Q ss_pred cCCcccc---------------------------------ccccccceeeeeeehhhh
Q 005898 637 YGLSIVS---------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 637 fGla~~~---------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
||+++.. .|+||+||++|+|++|..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 207 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9987421 199999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-26 Score=215.72 Aligned_cols=169 Identities=20% Similarity=0.295 Sum_probs=134.1
Q ss_pred CcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHH-HhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 486 DMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDL-LAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 486 ~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+....||.|+||+|+|-..+ .|+.+|||++.... ....+++..|.+. |+.-+.||||+++|++...+ ..
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG--------dc 138 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG--------DC 138 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC--------ce
Confidence 34567999999999998864 79999999997654 3556788888876 66668999999999987654 68
Q ss_pred EEEEecCCCCChhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 563 FLVYEFMSNGNFRTHIS---ENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~---~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
|+.||.|.- +++.+.. .. ....+.+.-.-.|..-+.+||.||-... .|||||+||+|||+|..|.+|++|||+
T Consensus 139 WiCMELMd~-SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 139 WICMELMDI-SLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred eeeHHHHhh-hHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccc
Confidence 999999965 7655432 21 1123666666677777789999998763 799999999999999999999999998
Q ss_pred ccccc-------------------------------cccccceeeeeeehhhhccccc
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
+..+. |+||+|+||||.+||.+.-..+
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 74321 9999999999999998865544
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=220.08 Aligned_cols=163 Identities=23% Similarity=0.406 Sum_probs=139.2
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch---------hhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
|.....||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD-- 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Confidence 556788999999999999854 688999998854321 12356889999999999999999999987653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++++|.+++.... .+++.....++.+++.|++|||+. +++||||||+||++++++.+||
T Consensus 80 ------~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 80 ------HLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred ------ccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEe
Confidence 6799999999999999997543 488999999999999999999986 7999999999999999999999
Q ss_pred cccCCcccc------------------------------------ccccccceeeeeeehhhh
Q 005898 635 SDYGLSIVS------------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 635 ~DfGla~~~------------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+|||+++.. .|+||+||++|+|+++..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 210 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCC
Confidence 999965311 399999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=224.44 Aligned_cols=164 Identities=21% Similarity=0.313 Sum_probs=139.3
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|+||.||+|+.. +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+.. .
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--------~ 73 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--------K 73 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC--------c
Confidence 667789999999999999964 789999999864322 22356788999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|+||++ |+|.+++.... ..+++.....++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 74 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 74 LTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred eEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 899999997 58888776432 3489999999999999999999987 79999999999999999999999999775
Q ss_pred cc-------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS-------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+||++|+|+++...
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p 199 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCC
Confidence 31 1999999999999987554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=248.62 Aligned_cols=174 Identities=21% Similarity=0.294 Sum_probs=148.0
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 476 EELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 476 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
.+++...++|+..++||+|+||.|...+.+ +++.+|.|++.+. +.....-|++|-.+|...+.+.||+|.-+|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455556678999999999999999999975 7899999999763 334456799999999999999999998888775
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
. ++|+|||||+||||-..+.... .++.....-++..|..||+-+|+. ++|||||||.|||||..|+
T Consensus 148 ~--------~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 148 R--------YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred c--------ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCc
Confidence 3 7999999999999999998654 377777777777888999999997 8999999999999999999
Q ss_pred EEEcccCCccccc------------------------------------cccccceeeeeeehhhhcc
Q 005898 632 AKLSDYGLSIVSE------------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 632 ~ki~DfGla~~~~------------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|++|||-...++ |-||+||.+|||+.|-.+.
T Consensus 214 ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 9999999763322 9999999999999875443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=228.62 Aligned_cols=163 Identities=24% Similarity=0.369 Sum_probs=138.7
Q ss_pred ceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEe
Q 005898 489 AIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYE 567 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~E 567 (671)
-++|+|.||+||-|+. ++...+|||-+........+-+-+||.+-++++|+|||+.+|.|.+.+ ..-+.||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG--------f~kIFME 652 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG--------FFKIFME 652 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC--------eEEEEee
Confidence 3689999999999995 456689999998877666777899999999999999999999987653 6789999
Q ss_pred cCCCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-CCCcEEEcccCCccccc-
Q 005898 568 FMSNGNFRTHISE-NTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-EHRIAKLSDYGLSIVSE- 644 (671)
Q Consensus 568 y~~~GsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-~~~~~ki~DfGla~~~~- 644 (671)
-+|||+|...|+. +++ -+=...+.-.+-.||.+||.|||++ .|||||||-.|||++ -.|.+||+|||-++-+.
T Consensus 653 qVPGGSLSsLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred cCCCCcHHHHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 9999999999975 333 1125667777788999999999998 799999999999997 47999999999875422
Q ss_pred -------------------------------cccccceeeeeeehhhhcc
Q 005898 645 -------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 645 -------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+||+||++.||.||-+..
T Consensus 729 inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF 778 (1226)
T KOG4279|consen 729 INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF 778 (1226)
T ss_pred CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence 9999999999999987654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=219.43 Aligned_cols=164 Identities=24% Similarity=0.408 Sum_probs=143.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+|+..++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE------- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC-------
Confidence 4677899999999999999965 68999999996432 234678999999999999999999999887643
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|+||+++++|..++... ..+++.+...++.++++||.|||+. +++|+||||+||++++++.++++|||+
T Consensus 74 -~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 74 -NMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred -eEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 689999999999999998754 2488999999999999999999986 799999999999999999999999998
Q ss_pred cccc-----------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+... .|+||+|+++|+|++|..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 197 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCC
Confidence 7431 199999999999998754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=222.48 Aligned_cols=166 Identities=25% Similarity=0.389 Sum_probs=142.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..+.||+|++|.||+|+.. +|+.||||.+..... ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~ 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN--------K 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--------c
Confidence 4777899999999999999975 689999999875432 23456788999999999999999999998753 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++ +|.+++........+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++|||++.
T Consensus 73 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 73 LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 7999999985 8988887654345689999999999999999999986 79999999999999999999999999774
Q ss_pred cc-------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+|++||++|+|+++..
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 149 AFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred hhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 21 199999999999999754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=220.48 Aligned_cols=164 Identities=24% Similarity=0.407 Sum_probs=143.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..+.||+|+||.||+|+.. +++.||+|.+.... .....++.+|++++++++|+||+++++++.+.. .
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~ 73 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--------K 73 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC--------e
Confidence 4677788999999999999965 68999999986543 334567889999999999999999999887653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|+||+++|+|.+++... .+++.....++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccce
Confidence 89999999999999998753 589999999999999999999986 79999999999999999999999999874
Q ss_pred cc------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+|+++|+|++|...
T Consensus 147 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p 197 (274)
T cd06609 147 QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197 (274)
T ss_pred eecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 31 2999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=222.40 Aligned_cols=165 Identities=25% Similarity=0.417 Sum_probs=140.9
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-------- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC--------
Confidence 4778899999999999999865 68999999986432 222357889999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++ ++|..++.... ...+++.+...++.++++|++|||+. +++||||||+||++++++.+|++|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 6899999996 68988887532 34589999999999999999999986 7999999999999999999999999976
Q ss_pred ccc-------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
... .|+||+|+++|+|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 199 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199 (284)
T ss_pred hhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 421 299999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=232.53 Aligned_cols=256 Identities=23% Similarity=0.233 Sum_probs=172.2
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
.+..=.++++|+|++|.|+..--+.|.+|.+|..|.|+.|+++...+..|.+|++|+.|+|..|++.-.---.|..|++|
T Consensus 168 sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl 247 (873)
T KOG4194|consen 168 SFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSL 247 (873)
T ss_pred CCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhh
Confidence 34444445555555555544444445555555555555555544333444445555555555555442222334555555
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCC---CCCCccEEEcCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPK---LPRGLVMAFLSNN 268 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~L~~l~l~~N 268 (671)
+.|.|..|.++-.-...|..|.+++.|+|+.|+++..-. .+.+|+.|+.|+||+|.+...-++ ..+.|..|+|++|
T Consensus 248 ~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N 327 (873)
T KOG4194|consen 248 QNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSN 327 (873)
T ss_pred hhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccc
Confidence 555555555554444456666777777777777764433 367788888888888887654433 3567888899999
Q ss_pred CCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCc---ccCCCCCccEEECcCCcCccc
Q 005898 269 SFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK---NLNCGGKLVFFDISNNKLTGG 345 (671)
Q Consensus 269 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~---~~~~~~~L~~l~ls~N~l~g~ 345 (671)
+++...|..|..+..|++|+|++|.++.+-...|..+++|+.|||++|.+++.|.+ .|..+.+|+.|+|.+|++.-.
T Consensus 328 ~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I 407 (873)
T KOG4194|consen 328 RITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSI 407 (873)
T ss_pred ccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeec
Confidence 88888888888888888899999988888888888888999999999998887765 356678888899999988744
Q ss_pred CCCCCCCCCCCceeccCCCcCCC
Q 005898 346 LPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 346 ~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
....+..+..|..|++.+|.+..
T Consensus 408 ~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 408 PKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred chhhhccCcccceecCCCCccee
Confidence 44567778888889998887653
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=219.89 Aligned_cols=164 Identities=22% Similarity=0.369 Sum_probs=140.0
Q ss_pred CCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch----------hhHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 485 FDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK----------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
|...+.||+|+||.||+|+. .+|+.||||.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE- 81 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC-
Confidence 56678999999999999985 4689999998753211 11346888999999999999999999987653
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEE
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAK 633 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~k 633 (671)
..++||||+++|+|.++++... .+++..+..++.+++.||.|||+. +++||||||+||++++++.+|
T Consensus 82 -------~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 82 -------YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICK 148 (272)
T ss_pred -------ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEE
Confidence 6899999999999999997643 489999999999999999999986 799999999999999999999
Q ss_pred EcccCCcccc----------------------------------ccccccceeeeeeehhhhc
Q 005898 634 LSDYGLSIVS----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 634 i~DfGla~~~----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++|||+++.. .|+||+|+++|+++++...
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 211 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCC
Confidence 9999977421 1999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=217.25 Aligned_cols=162 Identities=23% Similarity=0.454 Sum_probs=140.4
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+|+..+.||+|+||.||+|...++..+|+|.+.... ....+|.+|++++++++||||+++++++.... ..+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~~~ 75 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS--------PIC 75 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC--------ceE
Confidence 566778999999999999998778899999986543 23467999999999999999999999887643 679
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|.+++.... ..+.|..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 76 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeec
Confidence 9999999999999987532 2488999999999999999999987 7999999999999999999999999986421
Q ss_pred -------------------------------ccccccceeeeeeehh
Q 005898 644 -------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 644 -------------------------------~d~~s~g~~l~~~~~~ 659 (671)
.|+||+|+++|||++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~ 197 (256)
T cd05112 151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred ccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcC
Confidence 2999999999999883
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=222.48 Aligned_cols=164 Identities=22% Similarity=0.390 Sum_probs=143.4
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||++++++|...+ .
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--------~ 90 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD--------E 90 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--------c
Confidence 5677789999999999999985 468899999986554445677899999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|+||+++|+|.+++... .+++.++..++.++++|+.|||+. +++||||||+||++++++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 89999999999999998743 378999999999999999999987 79999999999999999999999999753
Q ss_pred c------------------------------cccccccceeeeeeehhhh
Q 005898 642 V------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
. ..|+||+||++|+++++..
T Consensus 164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~ 213 (293)
T cd06647 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (293)
T ss_pred cccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 1 1299999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=216.69 Aligned_cols=166 Identities=24% Similarity=0.365 Sum_probs=146.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|++|.||+|+.. +++.||||++..... ...+++.+|++.+.+++|+||+++++++..+.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-------- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC--------
Confidence 35778899999999999999976 599999999876543 44678999999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC-CCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||++++++.++++|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 689999999999999999754 348999999999999999999998 6 799999999999999999999999998
Q ss_pred cccc------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+... .|+|++|+++|+|+++.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p 199 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 7542 2999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=218.76 Aligned_cols=162 Identities=22% Similarity=0.408 Sum_probs=140.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
|+..+.||+|+||.||+|... +++.||||.+.... ....+++.+|+.++++++||||+++++++.+.. ..
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~ 77 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--------KL 77 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC--------eE
Confidence 566788999999999999864 68899999986433 334567899999999999999999999987653 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++... .+++.....++.+++.|+.|||+. +++|+||||+||+++.++.++++|||++..
T Consensus 78 ~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 78 WIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred EEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 9999999999999998642 489999999999999999999986 899999999999999999999999997742
Q ss_pred c------------------------------ccccccceeeeeeehhhh
Q 005898 643 S------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 643 ~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
. .|+||+||++|+|+++..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (277)
T cd06641 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred cccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 1 199999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=220.65 Aligned_cols=169 Identities=22% Similarity=0.334 Sum_probs=143.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||++++++|.+... ..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~ 75 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS------SS 75 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC------Ce
Confidence 5777899999999999999974 68899999987433 2345678999999999999999999999875431 35
Q ss_pred EEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 562 VFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
.++||||+++|+|.+++.... ....+++.....++.+++.||+|||+. +++|+||+|+||++++++.++++|||++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 799999999999998876421 234588899999999999999999986 7999999999999999999999999986
Q ss_pred ccc----------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
... .|+|++||++|+|++|..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 201 (287)
T cd06621 153 GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF 201 (287)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 421 299999999999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-24 Score=219.93 Aligned_cols=160 Identities=24% Similarity=0.358 Sum_probs=130.7
Q ss_pred eeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHH---HHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 490 IMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLD---LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+||+|+||.||+++.. +++.||||.+.... ....+.+.+|.. ++...+||||+.+++++.+.+ ..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--------~~ 72 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD--------KL 72 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC--------eE
Confidence 4899999999999864 68999999986432 111223344443 344457999999998887643 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... .++|.+...++.|++.||+|||+. +|+||||||+||++++++.+|++|||++..
T Consensus 73 ~lv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 73 CFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999999987543 489999999999999999999987 799999999999999999999999998742
Q ss_pred c-----------------------------ccccccceeeeeeehhhhcc
Q 005898 643 S-----------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 643 ~-----------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
. .|+||+||++|+|+++....
T Consensus 147 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 196 (279)
T cd05633 147 FSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196 (279)
T ss_pred ccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 1 19999999999999976643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=223.59 Aligned_cols=146 Identities=27% Similarity=0.428 Sum_probs=127.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+|+..+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++++.++||||+++++++.+..
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 74 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET------- 74 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-------
Confidence 5778899999999999999865 589999999965432 24567889999999999999999999987643
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++... ....+++..+..++.|+++||+|||.. +++||||||+||+++.++.++++|||+
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 75 -YLCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred -EEEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence 689999999999999998743 234689999999999999999999987 799999999999999999999999998
Q ss_pred cc
Q 005898 640 SI 641 (671)
Q Consensus 640 a~ 641 (671)
+.
T Consensus 150 ~~ 151 (316)
T cd05574 150 SK 151 (316)
T ss_pred hh
Confidence 64
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=215.42 Aligned_cols=167 Identities=23% Similarity=0.429 Sum_probs=142.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+|++++++.+...+ .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED-------G 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC-------C
Confidence 3677899999999999999865 67899999986432 334567889999999999999999988765432 2
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++++|.+++.... ...+++.++..++.+++.|++|||+. +|+||||||+||++++++.++++|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 5789999999999999987532 34589999999999999999999987 7999999999999999999999999987
Q ss_pred ccc------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
... .|+||+|+++|+|+++..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 432 299999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=215.83 Aligned_cols=167 Identities=20% Similarity=0.406 Sum_probs=143.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+++.. +|+.||||++... .....+++.+|+.++++++||||+++.+++.+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG-------- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--------
Confidence 3677899999999999999854 7899999998643 2334568899999999999999999999887643
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++|+||+|+||++++++.++++|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 6899999999999999887532 23478999999999999999999986 7999999999999999999999999987
Q ss_pred ccc------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|+++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~ 200 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCC
Confidence 432 2999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-24 Score=220.56 Aligned_cols=163 Identities=21% Similarity=0.376 Sum_probs=141.8
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-------- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-------- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--------
Confidence 3667889999999999999964 78999999987543 333567899999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+ +++|.+++.... ..+++.++..++.|+++||+|||+. +++|+||||+||++++++.++++|||++
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 689999999 999999987543 4589999999999999999999987 7999999999999999999999999976
Q ss_pred ccc--------------------------------ccccccceeeeeeehhh
Q 005898 641 IVS--------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 641 ~~~--------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
... .|+||+|+++|+|+++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred ccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 421 29999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-24 Score=219.46 Aligned_cols=159 Identities=24% Similarity=0.495 Sum_probs=134.6
Q ss_pred ceeccCCceEEEEEEEcC-------CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 489 AIMGEGSYGKLYKGRLEN-------GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.||+|+||.||+|+..+ ++.||||.+.... .....++.+|++++++++||||++++++|.+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-------- 72 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC--------
Confidence 368999999999998532 2579999886543 234567899999999999999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-----c
Q 005898 561 KVFLVYEFMSNGNFRTHISENT----PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-----I 631 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-----~ 631 (671)
..++||||+++|+|.++++... ....++|.+++.++.+++.|++|||+. +++|+||||+||+++++. .
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcc
Confidence 5799999999999999997532 223589999999999999999999986 799999999999999877 8
Q ss_pred EEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 632 AKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 632 ~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
+|++|||+++.. .|+||+||++|+|++
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 208 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHH
Confidence 999999987421 299999999999998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-24 Score=222.06 Aligned_cols=166 Identities=25% Similarity=0.355 Sum_probs=140.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|++++++++||||+++.++|.+.+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~------ 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH------ 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC------
Confidence 44777889999999999999865 68999999986432 233467889999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||++ |++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+|++|||
T Consensus 89 --~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 89 --TAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred --eEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 6799999997 57777665432 3489999999999999999999986 79999999999999999999999999
Q ss_pred Ccccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++... .|+||+|+++|+|++|...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p 213 (307)
T cd06607 161 SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213 (307)
T ss_pred cceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCC
Confidence 77421 2999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=220.68 Aligned_cols=164 Identities=26% Similarity=0.407 Sum_probs=139.5
Q ss_pred CCCcCceeccCCceEEEEEEE----cCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
+|+..+.||+|+||.||+++. ++|+.||+|++.... ....+++.+|++++.++ +|+||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT-- 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence 366788999999999999985 368999999986532 12346788999999999 5999999988876542
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++|+|.+++.... .+.+.....++.|+++||+|||+. +++||||||+||++++++.+||
T Consensus 79 ------~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 79 ------KLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred ------eEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 6799999999999999987543 478888889999999999999986 7999999999999999999999
Q ss_pred cccCCccc---------------------------------cccccccceeeeeeehhhh
Q 005898 635 SDYGLSIV---------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 635 ~DfGla~~---------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
+|||++.. ..|+||+|+++|+|+++..
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 206 (290)
T cd05613 147 TDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206 (290)
T ss_pred eeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence 99997632 1399999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=216.11 Aligned_cols=172 Identities=22% Similarity=0.360 Sum_probs=143.8
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++....+ .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~------~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN------Q 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC------C
Confidence 366778999999999999985 47889999998643 23345678899999999999999999998765331 3
Q ss_pred eEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCC--CCCccccCCCCCceeecCCCcEEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGV--IPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..+++|||+++|+|.+++... .....+++.....++.+++.|++|||..+ ..+++|+||||+||++++++.+|++||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 579999999999999998753 22356999999999999999999999432 348999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|++... .|+||+|+++|+|+++..
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 155 GLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred cccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 987542 299999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-26 Score=215.33 Aligned_cols=170 Identities=22% Similarity=0.404 Sum_probs=138.2
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccC--CchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPS--SKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+-..+||+|.||.||+|+.. +|+.||+|+.-. .+..--....+|+.++..++|+|++.+++.|.............
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 334567999999999999965 688899987632 12222345678999999999999999999998754221112245
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.||||++|+. ||+-.|.... ..++..+..+++.+...||.|+|.. .|+|||+|++|+|++.++..|++|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 8999999988 8988887643 3488889999999999999999997 79999999999999999999999999995
Q ss_pred ccc-----------------------------------cccccceeeeeeehhh
Q 005898 642 VSE-----------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 642 ~~~-----------------------------------d~~s~g~~l~~~~~~~ 660 (671)
.+. |+|..||+|+||-+..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs 226 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS 226 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC
Confidence 433 9999999999998754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=201.07 Aligned_cols=169 Identities=23% Similarity=0.408 Sum_probs=137.1
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC-chhhHHHHHHHHHH-HhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS-KKYTVRNLKLRLDL-LAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.......||+|+||+|-+-++ .+|+..|||++... ..+..+...+|+.+ ++....|.+|.++|.+....
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg------- 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG------- 118 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-------
Confidence 3444567799999999998885 47999999999754 34455678888887 55568999999999877653
Q ss_pred ceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 560 NKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+|+.||.|.- +|+.+-.+. ..+..+.+.-.=+||..|.+||.|||+.- .+||||+||+|||++.+|++|++|||
T Consensus 119 -dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 119 -DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred -cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 68999999976 887765431 12344777778899999999999999974 79999999999999999999999999
Q ss_pred Cccccc---------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE---------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~---------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++..+. |+||+|+++.||+++-+.
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P 251 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP 251 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence 986532 999999999999876443
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-24 Score=219.12 Aligned_cols=182 Identities=24% Similarity=0.431 Sum_probs=150.0
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
++.++..+.+.|+..+.||+|+||.||+|+. .+++.||+|.+.... ....++..|+.++.++ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778899999999999999999996 468899999986543 2346788899999998 699999999988643
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
... ......++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 86 ~~~--~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPP--GHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccc--CCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 210 11247899999999999999887532 23478888999999999999999987 7999999999999999999
Q ss_pred EEEcccCCccc-----------------------------------cccccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIV-----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~-----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
++|+|||++.. ..|+||+||++|+|+++...
T Consensus 160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p 225 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225 (282)
T ss_pred EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence 99999998631 13999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=214.43 Aligned_cols=164 Identities=29% Similarity=0.565 Sum_probs=140.8
Q ss_pred CCcCceeccCCceEEEEEEEcC-C----cEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLEN-G----TSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~~-g----~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
|+..+.||+|+||.||+++..+ + ..||+|++...... ..+.+.+|++++.+++|+||+++++++.+.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE------ 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC------
Confidence 3456889999999999998653 3 88999999765433 5678999999999999999999999988753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++..... ..+++.++..++.+++.|++|||+. +++||||||+||++++++.++++|||
T Consensus 75 --~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 75 --PLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred --eeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 68999999999999999875332 1289999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeehhh
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
+++.. .|+||+|+++|+|+++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCC
Confidence 88421 19999999999998743
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=218.18 Aligned_cols=163 Identities=23% Similarity=0.463 Sum_probs=140.9
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC-chhhHHHHHHHHHHHhcCC---CCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLR---HPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~~~ 558 (671)
.|+..+.||+|+||.||+|+. .+++.||||.+... .....+++.+|++++++++ |||+++++++|.+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~------ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP------ 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC------
Confidence 466778899999999999996 47899999998643 2334567889999999987 999999999987643
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++++|.++++.. .+++.....++.+++.||.|||+. +|+||||+|+||++++++.++++|||
T Consensus 76 --~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 76 --RLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred --EEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 689999999999999988643 489999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++... .|+||+||++|+|++|..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 200 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence 76321 299999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.45 Aligned_cols=168 Identities=25% Similarity=0.429 Sum_probs=145.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-------- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--------
Confidence 36788899999999999999854 68899999986433 235678999999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++|+||+++++|.++++...+...+++.....++.|++.|++|||+. +|+||||||+||++++++.+|++|||++
T Consensus 73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 6899999999999999997644334689999999999999999999987 7999999999999999999999999975
Q ss_pred cc-----------------------------------cccccccceeeeeeehhhh
Q 005898 641 IV-----------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~-----------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
.. ..|+||+||++|+|++|..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 205 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCC
Confidence 21 0299999999999999754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-24 Score=220.43 Aligned_cols=172 Identities=23% Similarity=0.337 Sum_probs=141.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++ ||||+++++++...+.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~---~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN---G 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC---C
Confidence 36788899999999999999965 68999999876432 223457888999999995 69999999988764311 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTP--GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~ 635 (671)
....|+||||+++ +|.+++..... ...+++.....++.||+.||+|||+. +|+||||||+||+++. ++.+|++
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEe
Confidence 1247999999985 89888865321 34689999999999999999999987 7999999999999998 8999999
Q ss_pred ccCCcccc-------------------------------ccccccceeeeeeehhhh
Q 005898 636 DYGLSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 636 DfGla~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|||+++.. .|+||+|+++|+|+++..
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 210 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence 99976421 199999999999999764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.19 Aligned_cols=164 Identities=23% Similarity=0.421 Sum_probs=142.9
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|+||.||+|+.. +++.||+|.++.... ...+++.+|++++++++|+||+++++++.+.+ .
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------~ 73 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE--------K 73 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--------E
Confidence 667789999999999999865 789999999875433 35678999999999999999999999887543 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|+||+++++|.++++... .+++..+..++.++++|++|||+. +|+|+||||+||++++++.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccccc
Confidence 899999999999999987542 378999999999999999999987 79999999999999999999999999764
Q ss_pred cc-------------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS-------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~-------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+|++|+++|+|+++...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p 205 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 21 2999999999999987543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=218.58 Aligned_cols=167 Identities=23% Similarity=0.388 Sum_probs=146.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++.|+..+.||+|+||.||+|+.+ ++..||+|.+..... ..+.+.+|++++++++|+||+++++++...+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 88 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD------- 88 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-------
Confidence 4566777889999999999999976 688999999976544 5677899999999999999999999988753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|+||+++++|.+++.... ..+++..+..++.+++.||+|||.. +|+|+||||+||+++.++.+||+|||+
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 89 -ELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred -EEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence 7899999999999999998643 3599999999999999999999986 899999999999999999999999996
Q ss_pred ccc------------------------------cccccccceeeeeeehhhh
Q 005898 640 SIV------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
+.. -.|+||+|+++|+|++|..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred hhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 532 1299999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-25 Score=231.02 Aligned_cols=162 Identities=26% Similarity=0.461 Sum_probs=140.3
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.+.-.+|.|+||.||||+.+ ++-..|-|.+........++|.-||++|+.++||+||+|++.|+.. +.+|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--------nkLw 105 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--------NKLW 105 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--------CceE
Confidence 444566899999999999865 4556678888877777788999999999999999999999977654 3789
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+..|||.||.++..+-+- +++|...+...++.+++.||.|||+. .|||||||+.|||++-+|.++++|||++...
T Consensus 106 iliEFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred EEEeecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence 999999999999887653 34699999999999999999999997 7999999999999999999999999998432
Q ss_pred c-----------------------------------cccccceeeeeeehh
Q 005898 644 E-----------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 644 ~-----------------------------------d~~s~g~~l~~~~~~ 659 (671)
. |+||+|+++.||.-.
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi 231 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI 231 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc
Confidence 1 999999999999753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=225.21 Aligned_cols=178 Identities=20% Similarity=0.308 Sum_probs=147.1
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeec
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 550 (671)
..+++...+++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 4456677889999999999999999999985 478999999986532 2335678899999999999999999998865
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
.... ......++++|++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||++++++
T Consensus 88 ~~~~--~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 88 ARSL--EEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccc--cccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 3210 0113468888887 77998877642 389999999999999999999987 799999999999999999
Q ss_pred cEEEcccCCcccc----------------------------ccccccceeeeeeehhhh
Q 005898 631 IAKLSDYGLSIVS----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 631 ~~ki~DfGla~~~----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.+|++|||+++.. .|+||+||++|+|++|..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 216 (345)
T cd07877 158 ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216 (345)
T ss_pred CEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999987421 299999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=217.55 Aligned_cols=160 Identities=19% Similarity=0.279 Sum_probs=136.6
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||+||++... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~~~lv~ 72 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD--------DLCLVM 72 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC--------eEEEEE
Confidence 699999999999854 78999999986432 223455778999999999999999999887643 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++|+|.+++..... ..+++.++..++.+++.|+.|||+. +++||||||+||++++++.+|++|||++...
T Consensus 73 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 73 TLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred ecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999999875432 3589999999999999999999987 7999999999999999999999999977431
Q ss_pred --------------------------ccccccceeeeeeehhhhc
Q 005898 644 --------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 --------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|++|...
T Consensus 149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 193 (277)
T cd05577 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193 (277)
T ss_pred CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCC
Confidence 2999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-26 Score=238.72 Aligned_cols=255 Identities=27% Similarity=0.343 Sum_probs=204.6
Q ss_pred CCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCC-CCCCccCCCCCccCEEEccCCcCCCCCCcc
Q 005898 107 IDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLF-GSVPPKISTMVKLQTLILDDNFFNNTIPNW 185 (671)
Q Consensus 107 ~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 185 (671)
...+|.+++.|.+|++|++++|++. .+-.+++.|+.|+.+++..|++. ..+|+.+..|..|+.|||++|++. ..|..
T Consensus 44 L~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~ 121 (1255)
T KOG0444|consen 44 LEQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTN 121 (1255)
T ss_pred hhhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchh
Confidence 4568899999999999999999885 34556888999999999999883 358888999999999999999998 78998
Q ss_pred cCCCCCcCEEEcccccCCCCCccc-ccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCC----CCCC-----
Q 005898 186 FDSLPSLTFLSMRNNKLAGPFPSS-IQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS----NLPK----- 255 (671)
Q Consensus 186 ~~~l~~L~~L~L~~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~----~~p~----- 255 (671)
+..-+++-.|+||+|++. .||.. +-+++.|-.||||+|++...+|.+..|..|++|+|++|.+.- .+|.
T Consensus 122 LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~ 200 (1255)
T KOG0444|consen 122 LEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLS 200 (1255)
T ss_pred hhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhh
Confidence 999999999999999998 56754 678999999999999999888888888899999999986531 2222
Q ss_pred ----------------C---CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccC
Q 005898 256 ----------------L---PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316 (671)
Q Consensus 256 ----------------~---~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 316 (671)
. ..+|..+++|.|++. .+|+.+-++.+|+.|+||+|+++..-- ....+.+|++|+||.|
T Consensus 201 vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~-~~~~W~~lEtLNlSrN 278 (1255)
T KOG0444|consen 201 VLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNM-TEGEWENLETLNLSRN 278 (1255)
T ss_pred hhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeec-cHHHHhhhhhhccccc
Confidence 1 124566778888876 677777788888888888888876543 3456677888888888
Q ss_pred cCcccCCcccCCCCCccEEECcCCcCc-ccCCCCCCCCCCCceeccCCCcCC
Q 005898 317 KFSGSLPKNLNCGGKLVFFDISNNKLT-GGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 317 ~l~g~~p~~~~~~~~L~~l~ls~N~l~-g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
+++ .+|+.++.+++|+.|.+.+|+++ ..||+.++.+..|.++..++|.+.
T Consensus 279 QLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE 329 (1255)
T KOG0444|consen 279 QLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE 329 (1255)
T ss_pred hhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc
Confidence 887 67888888888888888888775 247888888888888888888765
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=216.95 Aligned_cols=159 Identities=25% Similarity=0.379 Sum_probs=130.3
Q ss_pred eeccCCceEEEEEEE-cCCcEEEEEEccCCch---hhHHHHHHH---HHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 490 IMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK---YTVRNLKLR---LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E---~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+||+|+||.||+|+. .+++.||||.+..... .....+..| ++.++...||||+++++++.+.+ ..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--------~~ 72 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--------KL 72 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC--------EE
Confidence 489999999999985 4689999999864321 112223333 34455668999999998887653 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|..++... ..++|..+..++.|+++|++|||+. +|+||||||+||++++++.+|++|||+++.
T Consensus 73 ~~v~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 73 SFILDLMNGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 9999999999999888653 3489999999999999999999986 799999999999999999999999998642
Q ss_pred c-----------------------------ccccccceeeeeeehhhhc
Q 005898 643 S-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 643 ~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
. .|+||+|+++|+|++|...
T Consensus 147 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p 195 (278)
T cd05606 147 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195 (278)
T ss_pred cCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCC
Confidence 1 1999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.7e-24 Score=215.78 Aligned_cols=166 Identities=24% Similarity=0.361 Sum_probs=144.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+|+..+.||+|+||.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--------~ 73 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG--------D 73 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--------E
Confidence 5667788999999999999975 68999999987543 344567899999999999999999999987653 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC-CCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
.++|+||+++++|.+++.... ..++.....+++.+++.|++|||+ . +++||||||+||++++++.+|++|||.+
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 899999999999999987542 458889999999999999999998 5 7999999999999999999999999987
Q ss_pred ccc----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+|+++|+|+++...
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 198 (265)
T cd06605 149 GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198 (265)
T ss_pred hhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 531 2999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=227.58 Aligned_cols=272 Identities=20% Similarity=0.210 Sum_probs=175.2
Q ss_pred ccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcC
Q 005898 99 ASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFF 178 (671)
Q Consensus 99 ~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 178 (671)
+++++|...+.-+..|.++++|+.++|..|.+ ..||...+...+|+.|+|.+|.|+..-.+++..++.|+.|||+.|.+
T Consensus 83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~L-t~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~i 161 (873)
T KOG4194|consen 83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNEL-TRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLI 161 (873)
T ss_pred eeccccccccCcHHHHhcCCcceeeeeccchh-hhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchh
Confidence 34555555555556677777777777777766 34565555555566666666666555555566666666666666665
Q ss_pred CCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCC------
Q 005898 179 NNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDS------ 251 (671)
Q Consensus 179 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~------ 251 (671)
+..--..|..=.++++|+|++|+++..--..|..+.+|..|.|+.|+++..++. |.+|++|+.|+|..|++.-
T Consensus 162 s~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltF 241 (873)
T KOG4194|consen 162 SEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTF 241 (873)
T ss_pred hcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhh
Confidence 533223444445566666666666544444555555666666666666543332 4456666666666555431
Q ss_pred ------------------CCCCC---CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCe
Q 005898 252 ------------------NLPKL---PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISD 310 (671)
Q Consensus 252 ------------------~~p~~---~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 310 (671)
.-... ..++..++|..|+++..-..++-.++.|+.|+||+|.+..+-+..+.-+++|+.
T Consensus 242 qgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~ 321 (873)
T KOG4194|consen 242 QGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKE 321 (873)
T ss_pred cCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccccee
Confidence 11111 245667778888887666677777888888888888888887777777788888
Q ss_pred EecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCCcC
Q 005898 311 LNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQ 371 (671)
Q Consensus 311 L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~~~ 371 (671)
|+|++|+++...|.+|..+..|+.|+|++|.++-.-...+..+++|+.|+++.|.++..++
T Consensus 322 LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 322 LDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred EeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 8888888887777777778888888888888764434445567788889999998876554
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=216.46 Aligned_cols=162 Identities=25% Similarity=0.406 Sum_probs=140.7
Q ss_pred CCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 485 FDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~--------~~~ 92 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD--------ELW 92 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC--------eEE
Confidence 44457899999999999985 478899999987555445567889999999999999999999887653 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc-
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV- 642 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~- 642 (671)
+|+||+++++|.+++... .+++.++..++.+++.|++|||+. +|+||||||+||++++++.++++|||++..
T Consensus 93 ~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 93 VVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEeccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 999999999999998752 388999999999999999999987 799999999999999999999999997632
Q ss_pred -----------------------------cccccccceeeeeeehhhh
Q 005898 643 -----------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 643 -----------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
-.|+||+||++|+|+++..
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~ 213 (285)
T cd06648 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213 (285)
T ss_pred ccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 1299999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-24 Score=224.11 Aligned_cols=168 Identities=18% Similarity=0.339 Sum_probs=141.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++..... ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA----DF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC----CC
Confidence 67888899999999999999854 69999999986532 2335677889999999999999999998765431 12
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||+. |+|.+++.... .+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 36899999996 68988886532 389999999999999999999986 799999999999999999999999998
Q ss_pred cccc-----------------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS-----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~-----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++.. .|+||+||++|+|+++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence 7321 299999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=215.28 Aligned_cols=176 Identities=26% Similarity=0.416 Sum_probs=147.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++++|+..+.||+|+||.||+|+.. +++.+|+|.+..... ..+++.+|+++++++ +|+||+++++++.+.... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~--~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP--GN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC--Cc
Confidence 5678999999999999999999975 678999999875543 346799999999999 699999999998764310 01
Q ss_pred cceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
....++||||+++++|.+++.... ....+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 246899999999999999886532 234589999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|+|+++...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p 217 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence 976321 3999999999999987543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=219.43 Aligned_cols=164 Identities=24% Similarity=0.375 Sum_probs=138.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|+..+.||+|+||.||+|+.. ++..||+|++.... ....+++.+|++++++++|||+++++++|.+..
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 98 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-------- 98 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--------
Confidence 666788999999999999964 68999999986432 223457889999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++ |++.+.+... ...++|.++..++.+++.|+.|||+. +|+||||||+||++++++.+|++|||++
T Consensus 99 ~~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 99 TAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred eEEEEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCc
Confidence 6799999997 5787776543 23489999999999999999999987 7999999999999999999999999975
Q ss_pred ccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|+++...
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 223 (317)
T cd06635 173 SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223 (317)
T ss_pred cccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 321 1999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=213.72 Aligned_cols=145 Identities=25% Similarity=0.369 Sum_probs=125.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh---hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY---TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.|+..+.||+|.-|+||.++++ ++...|+|++.+.... -......|-++|+.++||.++.||+.+.++.
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~------- 150 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK------- 150 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-------
Confidence 4556788999999999999987 4689999999765322 2345667888999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..+||||||+||+|....+. ++++.++.....-+|..|.-||+|||-. +||.|||||+|||+.++|++-++||-|
T Consensus 151 -~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 151 -YSCLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred -eeEEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccc
Confidence 78999999999999887775 4566788888888999999999999986 899999999999999999999999987
Q ss_pred c
Q 005898 640 S 640 (671)
Q Consensus 640 a 640 (671)
+
T Consensus 226 S 226 (459)
T KOG0610|consen 226 S 226 (459)
T ss_pred c
Confidence 6
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-24 Score=219.66 Aligned_cols=167 Identities=25% Similarity=0.403 Sum_probs=140.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh--hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY--TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +++.||||.++..... ....+.+|++++.+++||||+++++++...+.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL------ 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC------
Confidence 46777899999999999999975 6889999999644322 23457789999999999999999999876521
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||++ ++|.+++.... ..+++.+...++.|++.||+|||+. +++||||||+||++++++.+|++|||+
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 36899999997 49988886532 2589999999999999999999987 799999999999999999999999997
Q ss_pred cccc-------------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++.. .|+||+|+++|+|+++..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (293)
T cd07843 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205 (293)
T ss_pred eeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCC
Confidence 6421 299999999999998743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=212.29 Aligned_cols=166 Identities=23% Similarity=0.404 Sum_probs=141.1
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||++.. .+++.+|||.+.... ....+.+.+|++++++++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-------- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-------- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--------
Confidence 467788999999999999986 478899999986432 334567899999999999999999999876543
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... ...+++..+.+++.++++|++|||+. +++||||||+||+++++ +.+|++|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 6899999999999999997643 34589999999999999999999987 89999999999999854 5689999998
Q ss_pred cccc-----------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+... .|+||+|+++|+|+++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 199 (256)
T cd08220 149 SKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199 (256)
T ss_pred ceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCC
Confidence 7521 299999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=222.74 Aligned_cols=168 Identities=22% Similarity=0.369 Sum_probs=140.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||.+... .....+.+.+|++++++++||||+++++++....- ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF---ESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc---ccc
Confidence 46788899999999999999985 47899999998643 22345668889999999999999999998765421 112
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++|+||+++ ++..++.. ..+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 357999999975 88777753 2489999999999999999999987 799999999999999999999999998
Q ss_pred cccc----------------------------------ccccccceeeeeeehhh
Q 005898 640 SIVS----------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 640 a~~~----------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
++.. .|+||+||++|+|++|.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~ 207 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 7321 19999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=236.95 Aligned_cols=171 Identities=18% Similarity=0.255 Sum_probs=131.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcC--CcEEEEEEc--------------c---CCchhhHHHHHHHHHHHhcCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLEN--GTSVAIRCL--------------P---SSKKYTVRNLKLRLDLLAKLRHPHL 541 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~--g~~vAvK~l--------------~---~~~~~~~~~~~~E~~~l~~l~H~ni 541 (671)
..++|+..+.||+|+||+||+++.+. +..+++|.+ . .......+.+.+|+++|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 222222211 0 0111234568899999999999999
Q ss_pred ccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCC
Q 005898 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP--GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV 619 (671)
Q Consensus 542 v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 619 (671)
|++++++.+.+ ..|+|+|++. +++..++..... .......+...++.|++.||+|||+. +|+||||
T Consensus 226 v~l~~~~~~~~--------~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDL 293 (501)
T PHA03210 226 LKIEEILRSEA--------NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDI 293 (501)
T ss_pred CcEeEEEEECC--------eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 99999998754 6799999985 477777654221 11233455678999999999999987 7999999
Q ss_pred CCCceeecCCCcEEEcccCCcccc-------------------------------ccccccceeeeeeehhhhcc
Q 005898 620 KTNNILLNEHRIAKLSDYGLSIVS-------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 620 k~~NiLl~~~~~~ki~DfGla~~~-------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||+|||+++++.+||+|||+++.. .|+||+||++|||+++.+.+
T Consensus 294 KP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 294 KLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999998532 19999999999999875433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-25 Score=210.39 Aligned_cols=164 Identities=21% Similarity=0.388 Sum_probs=137.6
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.+..+.||-|+||+||....+ +|+.||.|++...- ...-+.+.+|++++..++|.|++..++....+. ...+++
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph---~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN---PSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC---chHHHH
Confidence 456789999999999998854 89999999987532 334567889999999999999999998775432 113467
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
+|.|+|.|.. ||.+.+-.. ..++-....-+..||.+||.|||+. +|.||||||.|.|++.+...||+|||+|+
T Consensus 132 iYV~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 8999999976 888877643 3477777888899999999999997 89999999999999999999999999998
Q ss_pred ccc--------------------------------cccccceeeeeeeh
Q 005898 642 VSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 642 ~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
.-+ |+||+|||+.|++-
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence 754 99999999998764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=219.70 Aligned_cols=168 Identities=24% Similarity=0.412 Sum_probs=140.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +|+.||+|.++.... .....+.+|++++.+++|+||+++++++.+..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH------ 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC------
Confidence 467888999999999999999964 699999999864322 12335678999999999999999999887542
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+..++||||+++ +|.+++.... ..+++.++..++.|+++|++|||+. +++||||||+||++++++.+|++|||
T Consensus 80 ~~~~~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 80 LDSIFLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred CCeEEEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 1357999999975 8888876532 3589999999999999999999997 79999999999999999999999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++... .|+||+||++|+|+++..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence 77431 199999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=235.27 Aligned_cols=317 Identities=21% Similarity=0.328 Sum_probs=185.7
Q ss_pred cCCCChHHHHHHHHHHhcCCCCCCCCC----ccCCCCCCCCCCC-----------CCccceEeCCCCEeEEEecCCCCCC
Q 005898 23 THQLQSSQTQVLLQLRKHLEYPKQLEI----WINHGADFCYISS-----------STQVNITCQDNFITELKIIGDKPSN 87 (671)
Q Consensus 23 ~~~~~~~~~~~Ll~~k~~~~~~~~l~~----W~~~~~~~C~~~~-----------~~~~~v~C~~~~v~~l~l~~~~~~~ 87 (671)
++.+.++|.+.+++..+.+.-|+.+++ |... .|+|.-.. .+...|.|..+.||.+.+.|.....
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~-~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~ 135 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGA-DQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQAS 135 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCC-CcccccCCcchhhheeeecCCceEEecCCCcccccccccccccc
Confidence 344678999999999999988876555 8765 79998876 4567799999999999988754322
Q ss_pred CC--CCCCccc--------cc--------------------------ccCCCccCCCcchhcccCCCCCCEEeccccccc
Q 005898 88 VG--NFDGFAS--------AN--------------------------ASLSENFSIDSFVTTLARLTSLRVLSLVSLGIW 131 (671)
Q Consensus 88 ~~--~~~~~~~--------~~--------------------------~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~ 131 (671)
.. .-+.... .. ..+. +.....+|..+. +.|+.|+|++|.+.
T Consensus 136 ~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~-~~~LtsLP~~Ip--~~L~~L~Ls~N~Lt 212 (754)
T PRK15370 136 SASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLK-ILGLTTIPACIP--EQITTLILDNNELK 212 (754)
T ss_pred cCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeC-CCCcCcCCcccc--cCCcEEEecCCCCC
Confidence 11 0000000 00 0000 112223343332 35666666666665
Q ss_pred ccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCccccc
Q 005898 132 GSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQ 211 (671)
Q Consensus 132 g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~ 211 (671)
.+|..+. .+|++|+|++|+|+ .+|..+. .+|+.|+|++|.+. .+|..+. ++|+.|++++|+++ .+|..+.
T Consensus 213 -sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~ 282 (754)
T PRK15370 213 -SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP 282 (754)
T ss_pred -cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC
Confidence 3454433 36666666666665 3454443 35666666666665 4555443 35666666666666 4555443
Q ss_pred CCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeeccc
Q 005898 212 RISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSF 291 (671)
Q Consensus 212 ~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 291 (671)
++|+.|++++|+|++.++.+. ++|+.|++++|+++...+.++.+|+.|++++|.+++ +|..+. ++|+.|++++
T Consensus 283 --~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~ 355 (754)
T PRK15370 283 --EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTALPETLPPGLKTLEAGENALTS-LPASLP--PELQVLDVSK 355 (754)
T ss_pred --CCCcEEECCCCccccCcccch--hhHHHHHhcCCccccCCccccccceeccccCCcccc-CChhhc--CcccEEECCC
Confidence 366666666666664332222 356666666666665333345566677777777664 555443 5677777777
Q ss_pred ccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCC----CCCCCCceeccCCCcCC
Q 005898 292 NALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCL----SNESDKRVVKFRGNCLS 367 (671)
Q Consensus 292 N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~----~~~~~l~~l~l~~N~l~ 367 (671)
|+|+..|. .+ .++|+.|+|++|+|+ .+|..+. ..|+.|++++|+++ .+|..+ ...+.+..+++.+|.++
T Consensus 356 N~L~~LP~-~l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 356 NQITVLPE-TL--PPTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCCCcCCh-hh--cCCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 77765432 22 256777777777776 3454443 24667777777776 444433 33355666777777665
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=215.61 Aligned_cols=164 Identities=24% Similarity=0.390 Sum_probs=140.0
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|++|.||+|+.. +|..||||++.... ....+.+.+|++++++++|||++++++++.+.+ .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--------~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--------K 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC--------e
Confidence 456788999999999999864 79999999986432 223456889999999999999999999998653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||++ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++++|||++.
T Consensus 73 ~~iv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFLD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEEEEeccC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 899999995 68999887543 23589999999999999999999986 79999999999999999999999999864
Q ss_pred cc-------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+||+|+++|+|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 198 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 21 199999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-24 Score=208.93 Aligned_cols=170 Identities=21% Similarity=0.369 Sum_probs=139.2
Q ss_pred hcCCCc-CceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHH-HhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDM-SAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDL-LAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~-~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+++|.. .++||-|--|+|-.+..+ +++..|+|++.... ..++|+++ +..-.|||||+++++|...- ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~----~~ 130 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSY----QG 130 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhc----cC
Confidence 344443 367899999999998754 78999999987543 35778877 44457999999999886431 12
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~ 635 (671)
...+++|||+|++|+|...+++++ ...++..+.-.|+.+|+.|+.|||+. .|.||||||+|+|-.. +...|++
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 357889999999999999998764 35689999999999999999999997 7999999999999864 5678999
Q ss_pred ccCCccccc-----------------------------cccccceeeeeeehhhhccc
Q 005898 636 DYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 636 DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|||+|+.-. |.||+||+||.|+||++..+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999997633 99999999999999987654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=223.07 Aligned_cols=170 Identities=22% Similarity=0.305 Sum_probs=141.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..+.|+..+.||+|+||.||+|+.. +|+.||||.+... .....+++.+|+.++++++||||+++++++...... .
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL--E 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc--c
Confidence 3467888999999999999999854 7899999998643 233345678899999999999999999988654211 1
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+. |+|.+.+... +++.+...++.|+++||+|||+. +|+||||||+||++++++.+|++||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 1235799999996 4888877532 78889999999999999999987 8999999999999999999999999
Q ss_pred CCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+||++|+|++|..
T Consensus 163 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 163 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred ccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 998532 199999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=213.73 Aligned_cols=168 Identities=17% Similarity=0.400 Sum_probs=138.9
Q ss_pred CCCcCceeccCCceEEEEEEEcC--CcEEEEEEccCC----------chhhHHHHHHHHHHHhc-CCCCCcccccceeec
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLEN--GTSVAIRCLPSS----------KKYTVRNLKLRLDLLAK-LRHPHLVCLLGHCID 550 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~--g~~vAvK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 550 (671)
+|+..+.||+|+||.||+|+... ++.+|||.+... .....+++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677899999999999999754 788999987532 12234567788888875 799999999999876
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
.+ ..++||||+++++|.+++... .....+++..+.+++.|++.|++|||+.. +++||||||+||+++++
T Consensus 81 ~~--------~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 81 ND--------RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGED 150 (269)
T ss_pred CC--------eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCC
Confidence 53 689999999999999887542 22345899999999999999999999632 68999999999999999
Q ss_pred CcEEEcccCCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 630 RIAKLSDYGLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 630 ~~~ki~DfGla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+.+|++|||++... .|+||+|+++|+|+++..
T Consensus 151 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~ 211 (269)
T cd08528 151 DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211 (269)
T ss_pred CcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCC
Confidence 99999999987421 299999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=217.15 Aligned_cols=164 Identities=23% Similarity=0.381 Sum_probs=140.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+.. +++.||||.++... ....+.+.+|++++++++|+||+++++++.+.+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 73 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-------- 73 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--------
Confidence 5778899999999999999965 68899999986432 233567899999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++++.+..+.... ..+++.+...++.+++.|++|||+. +++||||||+||++++++.+|++|||++
T Consensus 74 ~~~iv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 74 RLYLVFEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred EEEEEEecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 689999999987776655432 2389999999999999999999987 7999999999999999999999999975
Q ss_pred cc--------------------------------cccccccceeeeeeehhhh
Q 005898 641 IV--------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~--------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
.. ..|+||+|+++|+|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 200 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 32 0299999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=212.35 Aligned_cols=158 Identities=20% Similarity=0.362 Sum_probs=137.3
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++.++. ..++||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~ 72 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK--------YIYMLM 72 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC--------ccEEEE
Confidence 699999999999975 58999999986432 233567999999999999999999999887653 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++|+|.+++.... .+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+|++|||+++..
T Consensus 73 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 73 EYCLGGELWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred ecCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999999999997643 388999999999999999999986 8999999999999999999999999987531
Q ss_pred --------------------------ccccccceeeeeeehhhhc
Q 005898 644 --------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 --------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+|++|+++|+|++|...
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence 1999999999999986543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=212.54 Aligned_cols=167 Identities=25% Similarity=0.493 Sum_probs=141.4
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+.+.+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-------- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-------- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC--------
Confidence 3677889999999999999965 68899999986432 223467889999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~DfGl 639 (671)
..++|+||+++++|.+++.... ...++|..+..++.++++|++|||+. +++|+||||+||++++++ .+|++|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 6899999999999999987532 23589999999999999999999987 799999999999999875 569999997
Q ss_pred cccc------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+... .|+||+|+++|+|+++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p 201 (257)
T cd08225 149 ARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201 (257)
T ss_pred chhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 7421 2999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-25 Score=233.32 Aligned_cols=252 Identities=27% Similarity=0.327 Sum_probs=180.5
Q ss_pred CcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCC-ccCCCCCccCEEEccCCcCCCCCCccc
Q 005898 108 DSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP-PKISTMVKLQTLILDDNFFNNTIPNWF 186 (671)
Q Consensus 108 ~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~ 186 (671)
..+|+.+.+|..|.+|||++|++ .+.|..+.+-+++-+|+||+|+|. .|| +-|.+|+.|-.|||++|++. .+|+.+
T Consensus 93 sGiP~diF~l~dLt~lDLShNqL-~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~ 169 (1255)
T KOG0444|consen 93 SGIPTDIFRLKDLTILDLSHNQL-REVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQI 169 (1255)
T ss_pred CCCCchhcccccceeeecchhhh-hhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHH
Confidence 34555555555555555555555 234444444445555555555543 233 23344444555555555444 344444
Q ss_pred CCCCCcCEEEcccccC------------------------C-CCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCE
Q 005898 187 DSLPSLTFLSMRNNKL------------------------A-GPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNV 241 (671)
Q Consensus 187 ~~l~~L~~L~L~~N~l------------------------~-g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~ 241 (671)
..|..|++|+|++|.+ + ..+|.++..+.+|+.+|+|.|++.-.+..+.++++|+.
T Consensus 170 RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~Lrr 249 (1255)
T KOG0444|consen 170 RRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRR 249 (1255)
T ss_pred HHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhhe
Confidence 4444444444444432 2 46888888999999999999999865556889999999
Q ss_pred EECCCCCCCCCCCC--CCCCccEEEcCCCCCCCCchhhhcCCcccceeeccccccc-CCCccccCCCCCcCeEecccCcC
Q 005898 242 LNLSDNKLDSNLPK--LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALR-GMPPPAIFSLPNISDLNLASNKF 318 (671)
Q Consensus 242 L~Ls~N~l~~~~p~--~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l 318 (671)
|+||+|+++..--. ...++..|+||.|+++ .+|+.+..++.|+.|.+.+|+++ .-+|..++.+.+|+.+..++|.+
T Consensus 250 LNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 250 LNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL 328 (1255)
T ss_pred eccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc
Confidence 99999998753221 2357888999999998 78999999999999999999875 23456789999999999999998
Q ss_pred cccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCc
Q 005898 319 SGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNC 365 (671)
Q Consensus 319 ~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~ 365 (671)
. .+|+.++.+.+|+.|.|+.|.+- .+|..+--++.+.+|+++.|.
T Consensus 329 E-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 329 E-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred c-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 7 88999999999999999999987 789998888999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=215.59 Aligned_cols=164 Identities=25% Similarity=0.439 Sum_probs=135.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|+||.||+|+.. +++.||||+++... ........+|+.++.++. |+||+++++++.+... +.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~------~~ 74 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKT------GR 74 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCC------Cc
Confidence 455788999999999999854 78999999986542 222334557888999885 9999999999986521 26
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||++ |++.+++.... ..++|.++..++.|++.||+|||+. +++||||||+||++++ +.+||+|||+++
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 75 LALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 799999997 58888876532 3589999999999999999999987 7999999999999999 999999999874
Q ss_pred cc------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+||+||++|||+++..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 32 199999999999998643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=213.27 Aligned_cols=157 Identities=23% Similarity=0.411 Sum_probs=137.0
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|++++.+++||||+++++.+.+.. ..++||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------~~~lv~ 72 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--------NLYLVM 72 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--------EEEEEE
Confidence 689999999999976 599999999865432 34567899999999999999999998887543 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc----
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV---- 642 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~---- 642 (671)
||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||++++++.+|++|||++..
T Consensus 73 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 73 EYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999999997643 489999999999999999999986 799999999999999999999999997632
Q ss_pred ----------------------------------cccccccceeeeeeehhhh
Q 005898 643 ----------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 643 ----------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
..|+||+|+++|+++++..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 1399999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=217.14 Aligned_cols=158 Identities=25% Similarity=0.390 Sum_probs=138.4
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEe
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYE 567 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~E 567 (671)
.+||+|+||.||+|... +++.||||++........+.+.+|+.++++++|+||+++++++...+ ..++|||
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e 97 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--------ELWVVME 97 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC--------EEEEEEe
Confidence 57999999999999864 78999999986555455667899999999999999999999987653 6899999
Q ss_pred cCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc----
Q 005898 568 FMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS---- 643 (671)
Q Consensus 568 y~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~---- 643 (671)
|+++++|.+++... .+++.....++.+++.|++|||+. +++||||||+||++++++.++++|||++...
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 98 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 99999999887532 378999999999999999999987 7999999999999999999999999976321
Q ss_pred --------------------------ccccccceeeeeeehhhh
Q 005898 644 --------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 --------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.|+||+|+++|+|+++..
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~ 214 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214 (292)
T ss_pred ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 299999999999998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=217.48 Aligned_cols=173 Identities=20% Similarity=0.346 Sum_probs=141.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||++++++|...+......
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888899999999999999865 78999999985432 222345678999999999999999999987654221112
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++||||+++ ++..++.... ..+++.+...++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 2457999999975 8888776532 3489999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc-----------------------------------ccccccceeeeeeehhh
Q 005898 639 LSIVS-----------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 639 la~~~-----------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
++... .|+||+|+++|+|+++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~ 221 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRS 221 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCC
Confidence 77311 29999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=222.09 Aligned_cols=167 Identities=25% Similarity=0.396 Sum_probs=141.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+.||+|+||.||+|... +|+.||||++... .......+.+|+++++++ +||||++++++|...++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---- 81 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---- 81 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC----
Confidence 456778899999999999999965 6889999998542 223345678899999999 99999999998865431
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||++ ++|..++... .++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 82 --~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~ 151 (337)
T cd07852 82 --KDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADF 151 (337)
T ss_pred --ceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence 25799999997 5998888653 488999999999999999999986 8999999999999999999999999
Q ss_pred CCcccc------------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+|+++|+|+++...
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p 212 (337)
T cd07852 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212 (337)
T ss_pred cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCC
Confidence 977411 2999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=218.95 Aligned_cols=167 Identities=22% Similarity=0.408 Sum_probs=138.4
Q ss_pred CCcCceeccCCceEEEEEEEc---CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE---NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
|+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++.+++||||+++++++.+..+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 76 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD----- 76 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC-----
Confidence 667788999999999999864 47899999997632 3334667889999999999999999999986521
Q ss_pred cceEEEEEecCCCCChhhhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC----CCcE
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENT--PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE----HRIA 632 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~----~~~~ 632 (671)
...++||||+++ ++..++.... ....++......++.|++.|++|||+. +|+||||||+||+++. ++.+
T Consensus 77 -~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 77 -KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred -ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence 368999999975 6777665322 123588889999999999999999987 7999999999999999 9999
Q ss_pred EEcccCCcccc----------------------------------ccccccceeeeeeehhhh
Q 005898 633 KLSDYGLSIVS----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 633 ki~DfGla~~~----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|++|||+++.. .|+||+||++|+|+++..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 214 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCC
Confidence 99999986531 199999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=216.90 Aligned_cols=175 Identities=24% Similarity=0.384 Sum_probs=142.7
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
...++|+..+.||+|+||.||+|... +|+.||||.++... ......+.+|++++++++||||+++++++.+..+...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888999999999999999975 68999999986432 2234567889999999999999999999876431000
Q ss_pred c--ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 557 Y--AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 557 ~--~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
. .....++|+||+++ ++...+... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 0 01268999999986 777766543 23589999999999999999999987 8999999999999999999999
Q ss_pred cccCCcccc--------------------------------ccccccceeeeeeehhh
Q 005898 635 SDYGLSIVS--------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 635 ~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
+|||++... .|+||+||++|+|+++.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999987421 19999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=208.23 Aligned_cols=164 Identities=26% Similarity=0.482 Sum_probs=143.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|++|.||+|+.. +++.||||.+..... ...+++.+|++++.+++|||++++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-------- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--------
Confidence 3667889999999999999865 688999999976543 45678999999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++++|.+++... ..+++..+..++.+++.|+.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 689999999999999998754 3489999999999999999999987 7999999999999999999999999977
Q ss_pred ccc------------------------------ccccccceeeeeeehhhh
Q 005898 641 IVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
... .|+|++|+++|+|+++..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~ 197 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 531 399999999999998764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=241.93 Aligned_cols=168 Identities=22% Similarity=0.395 Sum_probs=141.8
Q ss_pred HhcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.+-+++-...||.|.||.||-|. .++|+..|||-++-+ .........+|+.++..++|||+|+.+|+=.+.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR------ 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR------ 1306 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH------
Confidence 34456778889999999999998 678999999988533 233456788999999999999999999975543
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
+.+++.||||++|+|++.+...+ ..+.....-+..|++.|++|||++ +||||||||.||+||.+|.+|.+||
T Consensus 1307 --ekv~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1307 --EKVYIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred --HHHHHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecc
Confidence 47899999999999999987543 245555556677999999999998 8999999999999999999999999
Q ss_pred CCccccc-------------------------------------cccccceeeeeeehhhhc
Q 005898 638 GLSIVSE-------------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~~-------------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|-|+.+. |+||+||+..||+||-+.
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrP 1440 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRP 1440 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCc
Confidence 9997533 999999999999998764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=211.56 Aligned_cols=167 Identities=17% Similarity=0.243 Sum_probs=134.1
Q ss_pred HHHHHhcCCCcCcee--ccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 477 ELKEATNNFDMSAIM--GEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 477 ~~~~~~~~f~~~~~i--G~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
+.....++|+..+.+ |+|+||.||+++.. ++..+|+|.+........ |+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445566666666 99999999999854 688999999864322111 12111112 7999999999987653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-c
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-I 631 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~ 631 (671)
..++||||+++|+|.+++.... .++|.+...++.|+++|++|||+. +++||||||+||+++.++ .
T Consensus 83 --------~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 83 --------GHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred --------eeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCe
Confidence 6899999999999999997643 589999999999999999999987 799999999999999988 9
Q ss_pred EEEcccCCcccc--------------------------ccccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVS--------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~--------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++++|||+++.. .|+||+|+++|+|+++...
T Consensus 149 ~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 205 (267)
T PHA03390 149 IYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205 (267)
T ss_pred EEEecCccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999987431 1999999999999997643
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=207.26 Aligned_cols=165 Identities=28% Similarity=0.479 Sum_probs=145.0
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+|+..+.||+|++|.||++... +++.|++|++........+++.+|++++++++|+||+++++++.... ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD--------EL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC--------eE
Confidence 3667789999999999999975 68999999997665445678999999999999999999999887653 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++++||+++++|.+++.... ..+++..+..++.++++|++|||.. +++||||+|+||++++++.++|+|||.+..
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999999999999987642 3589999999999999999999986 799999999999999999999999997743
Q ss_pred c-----------------------------ccccccceeeeeeehhhh
Q 005898 643 S-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 643 ~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
. .|+||+|+++|+|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 195 (253)
T cd05122 148 LSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195 (253)
T ss_pred ccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 2 399999999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=210.26 Aligned_cols=160 Identities=23% Similarity=0.324 Sum_probs=132.5
Q ss_pred ceeccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHH-HhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDL-LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||.||+|+.. +|+.||||.+..... .....+..|..+ ....+|+|++++++++.+.+ ..+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--------~~~ 73 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--------YLY 73 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--------eEE
Confidence 46899999999999864 689999999865432 222344555544 44558999999999987643 689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+|+||+++|+|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+|++|||+++..
T Consensus 74 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 74 LVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred EEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999999997543 488999999999999999999986 7999999999999999999999999987431
Q ss_pred --------------------------ccccccceeeeeeehhhhc
Q 005898 644 --------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 --------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+|+++|+|++|...
T Consensus 148 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p 192 (260)
T cd05611 148 LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192 (260)
T ss_pred cccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCC
Confidence 2999999999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=214.34 Aligned_cols=166 Identities=20% Similarity=0.374 Sum_probs=138.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|++|.||+|+.. +|+.||||.+..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK------- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-------
Confidence 46788899999999999999965 789999999864322 23457889999999999999999999987653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEcccC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLSDYG 638 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~DfG 638 (671)
..++||||++ +++.+++.... ....++.....++.+++.||+|||+. +++||||||+||++++ ++.+||+|||
T Consensus 75 -~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 75 -RLYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred -eEEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 6899999996 58888776432 23367888889999999999999987 7999999999999985 5679999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++... .|+||+|+++|+|++|..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~ 202 (294)
T PLN00009 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202 (294)
T ss_pred cccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 87421 199999999999999753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=219.91 Aligned_cols=171 Identities=21% Similarity=0.324 Sum_probs=141.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..+.|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~ 90 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL--D 90 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc--c
Confidence 456788899999999999999985 47999999998542 222345688999999999999999999988754311 1
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+ +++|..++.. ..+++..+..++.|+++|++|||.. +|+||||||+||++++++.+|++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 123568999999 6799888763 2489999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc----------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|++... .|+||+|+++|++++|..
T Consensus 163 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~ 214 (343)
T cd07880 163 GLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214 (343)
T ss_pred ccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 987421 299999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=219.07 Aligned_cols=169 Identities=20% Similarity=0.328 Sum_probs=139.4
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG--DE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC--CC
Confidence 36788899999999999999985 478999999986432 22245688999999999999999999998754211 11
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++|+||+.. ++..+.. ..+++.....++.|+++||+|||.. +++||||||+||++++++.+|++|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 2356999999975 7766653 2388999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc----------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+++.. .|+||+||++|+|++|..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~ 213 (342)
T cd07879 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213 (342)
T ss_pred CCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCC
Confidence 87531 199999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=212.65 Aligned_cols=164 Identities=24% Similarity=0.446 Sum_probs=138.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-hhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|+||+||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++.+.+ .
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~--------~ 72 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND--------E 72 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC--------c
Confidence 456788999999999999975 588999999865422 22334567899999999 999999999987743 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+ +|+|.+++.... ...++|.++..++.|++.||+|||+. +++|+||||+||++++++.++++|||+++
T Consensus 73 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 73 LYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 89999999 889999887643 23589999999999999999999987 79999999999999999999999999774
Q ss_pred cc------------------------------ccccccceeeeeeehhhh
Q 005898 642 VS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 642 ~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.. .|+||+|+++++|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~ 197 (283)
T cd07830 148 EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197 (283)
T ss_pred eccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence 21 199999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-23 Score=219.34 Aligned_cols=169 Identities=22% Similarity=0.366 Sum_probs=141.2
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.|+..+.||+|+||+||+|+. .+++.||||.+... .......+.+|+.+++.++|+||+++++++..... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~---~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR---EAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc---ccc
Confidence 4688889999999999999985 47899999998643 22334567789999999999999999998875421 112
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||+. ++|.+++... ..+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 35799999996 6898888653 2489999999999999999999987 799999999999999999999999998
Q ss_pred cccc-------------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++.. .|+||+||++|+|+++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 7531 299999999999998754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-24 Score=207.90 Aligned_cols=168 Identities=24% Similarity=0.352 Sum_probs=142.3
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+++|+|.||+|..++- .+|+.+|+|++++.- +.....-..|-++|...+||.+..|.-.++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d----- 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD----- 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc-----
Confidence 35688889999999999999984 479999999997642 334456678899999999999999987777653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.+..||||..+|.|..+|.+.+ .++.....-+-..|..||.|||++ .||.||+|.+|.++|++|++||+||
T Consensus 242 ---rlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 ---RLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred ---eEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 7899999999999999997643 366666667778899999999997 7999999999999999999999999
Q ss_pred CCccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 638 GLSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+.+-.- |-|.+||+||||+||-...
T Consensus 313 GLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 313 GLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF 368 (516)
T ss_pred ccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc
Confidence 9986311 9999999999999986543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=213.36 Aligned_cols=164 Identities=28% Similarity=0.462 Sum_probs=139.9
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++|+|++++++++.+.+ ...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG------KGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC------CCc
Confidence 456788999999999999965 58999999997652 333567889999999999999999999987652 126
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++ +|.+++.... ..+++.++..++.++++|++|||+. +++|+||||+||++++++.+|++|||++.
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred EEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 8999999985 8988886542 3589999999999999999999987 79999999999999999999999999764
Q ss_pred cc--------------------------------ccccccceeeeeeehhh
Q 005898 642 VS--------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 642 ~~--------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
.. .|+||+|+++|+|+++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~ 199 (287)
T cd07840 149 PYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199 (287)
T ss_pred eccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCC
Confidence 21 19999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=214.26 Aligned_cols=165 Identities=27% Similarity=0.405 Sum_probs=138.9
Q ss_pred CCCcCceeccCCceEEEEEEE----cCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
+|+..+.||+|+||.||+++. .+++.||||.++... ....+.+.+|++++.++ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-- 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-- 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence 366778999999999999974 357899999986432 22345688999999999 5999999998876543
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++|+|.+++... ..+++.....++.|+++||+|||+. +++||||||+||++++++.+++
T Consensus 79 ------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 79 ------KLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred ------EEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 679999999999999998753 2488999999999999999999986 7999999999999999999999
Q ss_pred cccCCccc---------------------------------cccccccceeeeeeehhhhc
Q 005898 635 SDYGLSIV---------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~---------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++. ..|+||+|+++|+|+++...
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p 207 (288)
T cd05583 147 TDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207 (288)
T ss_pred EECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence 99997642 12999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-24 Score=217.11 Aligned_cols=172 Identities=20% Similarity=0.298 Sum_probs=147.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+.|..-++||+|+||.||-++.+ +|+.+|.|++.+.. ++...-...|-.++.+++.+.||.|--+|.+.+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd------ 258 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD------ 258 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC------
Confidence 55788899999999999999865 79999999985432 233445678899999999999999977777654
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+.||+..|.+|||.-+|...+. ..++.....-+|.+|+.||++||.. .||.||+||+|||+|++|+++|+|.|
T Consensus 259 --~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 259 --ALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred --ceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence 68999999999999998876542 3589999999999999999999998 79999999999999999999999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhccccc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
+|..+. |-|++||.+|||+.|....-.|
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 996432 9999999999999887654433
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=207.36 Aligned_cols=167 Identities=22% Similarity=0.374 Sum_probs=144.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|++|.||+|+.. +++.|++|.+..... ...+.+.+|++++++++||||+++++.+.+.. ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE------KN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC------CC
Confidence 3667789999999999999976 789999999865442 45678999999999999999999999887652 12
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++|+||+++++|.+++.... .++|.++..++.++++|++|||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 6899999999999999987643 589999999999999999999986 7999999999999999999999999976
Q ss_pred ccc--------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS--------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~--------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+|++|+++|+|++|...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 202 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 421 2999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=218.91 Aligned_cols=160 Identities=24% Similarity=0.372 Sum_probs=134.9
Q ss_pred cCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhh--------------HHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 487 MSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYT--------------VRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
..+.||+|+||+||+|+.. +++.||||.+....... ...+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999854 68999999986432111 12477899999999999999999998765
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
+ ..++||||++ |+|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 93 ~--------~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 93 D--------FINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred C--------cEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 3 6899999997 69998886532 388999999999999999999986 7999999999999999999
Q ss_pred EEEcccCCccc---------------------------------------------cccccccceeeeeeehhhh
Q 005898 632 AKLSDYGLSIV---------------------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 632 ~ki~DfGla~~---------------------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
+|++|||++.. ..|+||+||++|+|+++..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999997631 0299999999999999754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=218.34 Aligned_cols=169 Identities=23% Similarity=0.354 Sum_probs=142.2
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 478 LKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 478 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
+...+++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++.+++||||+++.+++....
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 82 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-- 82 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC--
Confidence 3456788999999999999999999854 7999999988542 2223567889999999999999999999886533
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
+..++|+||+ +++|.+++... .+++.....++.|+++||+|||+. +|+||||||+||++++++.+|+
T Consensus 83 -----~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 83 -----EDIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred -----CcEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEe
Confidence 2579999999 56898887642 378888889999999999999987 7999999999999999999999
Q ss_pred cccCCcccc----------------------------ccccccceeeeeeehhhh
Q 005898 635 SDYGLSIVS----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 635 ~DfGla~~~----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+|||++... .|+||+||++|+|++|..
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 150 CDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred CccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 999977421 199999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-23 Score=213.63 Aligned_cols=165 Identities=28% Similarity=0.397 Sum_probs=139.0
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|+..+.||+|+||.||+|+.. +++.||||.+... .....+++.+|++++++++|+|++++++++.+..
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 88 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-------- 88 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--------
Confidence 555678999999999999964 6889999998632 2233467889999999999999999999988653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+. |++.+++.... ..+++.++..++.+++.|+.|||+. +++||||||+||++++++.+|++|||++
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccc
Confidence 6799999997 68877775432 3488999999999999999999987 7999999999999999999999999976
Q ss_pred cc-----------------------------cccccccceeeeeeehhhhcc
Q 005898 641 IV-----------------------------SEDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 641 ~~-----------------------------~~d~~s~g~~l~~~~~~~~~~ 663 (671)
.. ..|+||+||++|+|++|....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 214 (308)
T cd06634 163 SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (308)
T ss_pred eeecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCC
Confidence 52 129999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-23 Score=207.28 Aligned_cols=166 Identities=26% Similarity=0.441 Sum_probs=142.6
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+++.. +++.+|||.+.... .....++.+|++++++++|+||+++.+++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN-------- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC--------
Confidence 3677889999999999999854 78899999986432 334567889999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++++|.+++.+.. ....+++.....++.++++|++|||+. +++||||+|+||++++++.+|++|||+
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccc
Confidence 6899999999999999987632 234589999999999999999999987 799999999999999999999999997
Q ss_pred cccc----------------------------ccccccceeeeeeehhh
Q 005898 640 SIVS----------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 640 a~~~----------------------------~d~~s~g~~l~~~~~~~ 660 (671)
+... .|+||+|+++|+|+++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~ 198 (256)
T cd08530 150 SKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198 (256)
T ss_pred hhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 7432 39999999999998865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-23 Score=216.04 Aligned_cols=162 Identities=22% Similarity=0.353 Sum_probs=135.4
Q ss_pred ceeccC--CceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEG--SYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G--~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
..||+| +||+||+|+. .+|+.||||++.... ....+.+.+|+.+++.++||||++++++|..++ ..+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--------~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS--------WLW 75 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC--------ceE
Confidence 456666 9999999986 479999999986432 233567899999999999999999999998753 679
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc--
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI-- 641 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~-- 641 (671)
+|+||+++|++.+++..... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+.
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999999999998875432 3488999999999999999999986 79999999999999999999999986210
Q ss_pred -------------------------------------ccccccccceeeeeeehhhhc
Q 005898 642 -------------------------------------VSEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 -------------------------------------~~~d~~s~g~~l~~~~~~~~~ 662 (671)
...|+||+||++|+|++|...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p 209 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 012999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=209.88 Aligned_cols=168 Identities=27% Similarity=0.374 Sum_probs=136.4
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcC---CCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKL---RHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~~~~ 558 (671)
|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++.++ +||||+++++++.+.+.. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~---~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD---R 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC---C
Confidence 456789999999999999976 589999999964322 2234566777766555 699999999999875411 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....+++|||+++ +|.+++.... ...++|.++..++.++++||+|||+. +++|+||||+||++++++.+|++|||
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred CceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 1248999999975 8988886532 23589999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc-----------------------------ccccccceeeeeeehhh
Q 005898 639 LSIVS-----------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 639 la~~~-----------------------------~d~~s~g~~l~~~~~~~ 660 (671)
++... .|+||+||++|+|+++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~ 203 (287)
T cd07838 153 LARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203 (287)
T ss_pred cceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCC
Confidence 87442 29999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=211.16 Aligned_cols=167 Identities=26% Similarity=0.405 Sum_probs=137.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +++.||||.++... .....++.+|+.++.+.. ||||++++++|.+..
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~------- 87 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS------- 87 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-------
Confidence 45777899999999999999976 48999999997543 233456777887777775 999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++ ++........ ..+++..+..++.++++|++|||+. ++|+||||||+||++++++.+||+|||+
T Consensus 88 -~~~~v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 88 -DVFICMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred -eEEEEeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 68999999864 7766655422 2589999999999999999999974 2799999999999999999999999998
Q ss_pred ccc---------------------------------cccccccceeeeeeehhhhc
Q 005898 640 SIV---------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~---------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. ..|+||+|+++|+|++|...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 217 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCC
Confidence 742 13999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=216.70 Aligned_cols=172 Identities=16% Similarity=0.297 Sum_probs=140.8
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC-----
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD----- 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~----- 556 (671)
.+|+..+.||+|+||.||+|+. .+|+.||+|++........+.+.+|++++++++||||+++++++........
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5688889999999999999986 4689999999876555556778999999999999999999987765431100
Q ss_pred -cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-CCCcEEE
Q 005898 557 -YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-EHRIAKL 634 (671)
Q Consensus 557 -~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-~~~~~ki 634 (671)
......++||||++ ++|.+++... .+.+.....++.|++.||+|||+. +|+||||||+||+++ +++.+|+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 00125789999997 5898887532 388999999999999999999987 799999999999998 4567899
Q ss_pred cccCCcccc----------------------------------ccccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVS----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++.. .|+||+||++|+|+++...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 218 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC
Confidence 999987421 1999999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=212.72 Aligned_cols=174 Identities=21% Similarity=0.401 Sum_probs=141.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..++||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+........
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467889999999999999999965 689999999854322 22346788999999999999999999876543210112
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++|+||+.. ++...+... ...+++.+...++.|+++||+|||+. +|+||||||+||++++++.+|++|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 2467999999975 677766543 23589999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc------------------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS------------------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~------------------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+++.. .|+||+||++|+|++|..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 77421 299999999999999753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=204.19 Aligned_cols=167 Identities=25% Similarity=0.461 Sum_probs=144.5
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|||++++.+.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~-------- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG-------- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC--------
Confidence 4677789999999999999965 689999999975432 45677899999999999999999999887653
Q ss_pred eEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|+||+++++|.+++.... ....+++.+...++.+++.|++|||+. +++|+||+|+||++++++.++++|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccc
Confidence 6899999999999999987642 235699999999999999999999987 899999999999999999999999998
Q ss_pred cccc------------------------------ccccccceeeeeeehhhh
Q 005898 640 SIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+... .|+|++|+++|+|+++..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 201 (258)
T cd08215 150 SKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201 (258)
T ss_pred eeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCC
Confidence 7431 299999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=210.90 Aligned_cols=164 Identities=24% Similarity=0.360 Sum_probs=138.3
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|...+.||+|+||+||+|+.. +++.||||++.... ....+++.+|++++++++|||++++++++.+..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-------- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--------
Confidence 455678999999999999864 68999999986432 233467889999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..|+||||++ |++.+++.... ..++|.++..++.+++.|++|||+. +++||||||+||++++++.+|++|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 6899999996 57777775432 3589999999999999999999987 7999999999999999999999999976
Q ss_pred ccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+||++|+|++|...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p 219 (313)
T cd06633 169 SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219 (313)
T ss_pred cccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 421 1999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=212.87 Aligned_cols=160 Identities=23% Similarity=0.293 Sum_probs=131.6
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
+.+|.|+++.||+++. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+ ..+++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~--------~~~~~~ 78 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS--------ELYVVS 78 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC--------eEEEEE
Confidence 3344555555555544 6899999998654 3345678999999999999999999999887653 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc----
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV---- 642 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~---- 642 (671)
||+++|+|.+++..... ..+++.....++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+..
T Consensus 79 e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 79 PLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred eccCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccc
Confidence 99999999999875422 3478889999999999999999987 799999999999999999999999996521
Q ss_pred -----------------------------------cccccccceeeeeeehhhh
Q 005898 643 -----------------------------------SEDINSVGVRLLILMSFFF 661 (671)
Q Consensus 643 -----------------------------------~~d~~s~g~~l~~~~~~~~ 661 (671)
..|+||+||++|+|+++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 1299999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=209.23 Aligned_cols=145 Identities=24% Similarity=0.449 Sum_probs=127.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++.+++ ||||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~----- 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE----- 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc-----
Confidence 36778899999999999999965 79999999986532 233467889999999998 999999999887653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... .+++.....++.+++.||+|||+. +++|+||||+||+++.++.++++||
T Consensus 76 ---~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 ---NLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred ---eEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 6899999999999999997643 499999999999999999999987 7999999999999999999999999
Q ss_pred CCcc
Q 005898 638 GLSI 641 (671)
Q Consensus 638 Gla~ 641 (671)
|++.
T Consensus 147 ~~~~ 150 (280)
T cd05581 147 GTAK 150 (280)
T ss_pred cccc
Confidence 9764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=217.76 Aligned_cols=146 Identities=21% Similarity=0.370 Sum_probs=123.0
Q ss_pred cCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.-|...+.||=|+||+|..++ .++...+|.|.+.+.+ +.+....+.|-.+|+..+.+.||+|+-.|.+.+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd------ 702 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD------ 702 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC------
Confidence 347778889999999999997 6677889999997654 345667889999999999999999998888764
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
.+|+||||+++||+-..|-+.+ .+.+.-..-++..++.|+++.|.. ++|||||||.|||||.+|++|++|||
T Consensus 703 --nLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 703 --NLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred --ceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence 7999999999999998876543 255554445556788999999986 89999999999999999999999999
Q ss_pred Cccc
Q 005898 639 LSIV 642 (671)
Q Consensus 639 la~~ 642 (671)
|..-
T Consensus 775 LCTG 778 (1034)
T KOG0608|consen 775 LCTG 778 (1034)
T ss_pred cccc
Confidence 9853
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=210.50 Aligned_cols=167 Identities=23% Similarity=0.350 Sum_probs=135.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+++.. +++.||||.+.... .....++.+|+.++.++. |+||+++++++..+.
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-------- 76 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-------- 76 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--------
Confidence 3445678999999999999864 68999999986543 234567889999999996 999999999887643
Q ss_pred eEEEEEecCCCCChhhhh---hcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHI---SENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..+++|||++. ++..+. ... ....+++.....++.+++.||+|||+.. +|+||||||+||+++.++.+||+||
T Consensus 77 ~~~~~~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 77 DCWICMELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred cEEEEEecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeec
Confidence 57999999874 554433 221 1245899999999999999999999752 6999999999999999999999999
Q ss_pred CCccc--------------------------------cccccccceeeeeeehhhhc
Q 005898 638 GLSIV--------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~--------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++. ..|+||+||++|+|++|...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 209 (288)
T cd06616 153 GISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209 (288)
T ss_pred chhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCC
Confidence 98731 13999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=209.60 Aligned_cols=162 Identities=19% Similarity=0.169 Sum_probs=124.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc--CCcEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE--NGTSVAIRCLPSS-----KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~--~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
..+.|...+.||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++++|+|+|+.+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 4567999999999999999999864 5778899987532 222356799999999999999999633211
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCC-CCCceeecCCCcE
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-KTNNILLNEHRIA 632 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-k~~NiLl~~~~~~ 632 (671)
...++||||+++++|... . + .. ...++.++++||+|||+. +|+|||| ||+||+++.++.+
T Consensus 91 ------~~~~LVmE~~~G~~L~~~-~---~---~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHLA-R---P---HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred ------CCcEEEEEccCCCCHHHh-C---c---cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence 146999999999999632 1 1 11 146778999999999987 8999999 9999999999999
Q ss_pred EEcccCCcccccccccccee-eeeeehhhhccccc
Q 005898 633 KLSDYGLSIVSEDINSVGVR-LLILMSFFFGSMTS 666 (671)
Q Consensus 633 ki~DfGla~~~~d~~s~g~~-l~~~~~~~~~~~~~ 666 (671)
||+|||+|+...+--..+-+ -++.+++..+++.|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~ 186 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRT 186 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCcc
Confidence 99999999988764333332 24555666666655
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=208.58 Aligned_cols=162 Identities=25% Similarity=0.423 Sum_probs=139.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+||+++++++.+.+ .
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--------~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--------K 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--------c
Confidence 445678999999999999965 69999999987543 223467888999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||++ ++|.+++.... ..+++.++..++.++++|++|||+. +|+||||+|+||++++++.+||+|||+++
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 899999998 59999997642 3489999999999999999999997 79999999999999999999999999864
Q ss_pred cc-------------------------------ccccccceeeeeeehhh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
.. .|+||+|+++|+|+++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 196 (282)
T cd07829 147 AFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196 (282)
T ss_pred ccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence 21 29999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=228.86 Aligned_cols=171 Identities=22% Similarity=0.467 Sum_probs=143.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc----C----CcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeec
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE----N----GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCID 550 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~----~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 550 (671)
..++++..+.+|+|.||.|++|... . ...||||.++... ..+.+.+..|+++|..+ +|+|||.++|+|.+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444555669999999999999742 1 4579999998653 34567899999999999 59999999999987
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCC-------C----C--CCCCHHHHHHHHHHHHHHHHHhcCCCCCCcccc
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-------P----G--KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN 617 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr 617 (671)
.+ ..++|+||+..|+|..+|+..+ . . ..++-.+.+.++.|||+|++||++. ++|||
T Consensus 374 ~~--------~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHR 442 (609)
T KOG0200|consen 374 DG--------PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHR 442 (609)
T ss_pred CC--------ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccch
Confidence 43 6899999999999999998654 0 1 2388899999999999999999997 78999
Q ss_pred CCCCCceeecCCCcEEEcccCCccccc---------------------------------cccccceeeeeeehhhhc
Q 005898 618 RVKTNNILLNEHRIAKLSDYGLSIVSE---------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 618 Dlk~~NiLl~~~~~~ki~DfGla~~~~---------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||.++|||+.++..+||+|||+|+... |+||+|+.|||+.|..-.
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 999999999999999999999997311 999999999998874433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-23 Score=208.58 Aligned_cols=149 Identities=20% Similarity=0.355 Sum_probs=123.5
Q ss_pred CCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCc---h----hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK---K----YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~---~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
|-+.+.+|+|||+.||||. +...+-||||+-...+ . .-.+...+|-++-+.++||.||++|+|+.-+.
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt---- 540 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT---- 540 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc----
Confidence 4556789999999999997 5667889999863221 1 11345678889999999999999999987542
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec---CCCcEE
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN---EHRIAK 633 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~---~~~~~k 633 (671)
+...-|+|||++-+|+.||... +.++......|+.||..||.||.+- .|||||-||||.|||+- ..|++|
T Consensus 541 ---dsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 541 ---DSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ---ccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 3568899999999999999764 3488999999999999999999874 57999999999999995 358899
Q ss_pred EcccCCccccc
Q 005898 634 LSDYGLSIVSE 644 (671)
Q Consensus 634 i~DfGla~~~~ 644 (671)
|+|||++++.+
T Consensus 614 ITDFGLSKIMd 624 (775)
T KOG1151|consen 614 ITDFGLSKIMD 624 (775)
T ss_pred eeecchhhhcc
Confidence 99999999866
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=207.84 Aligned_cols=162 Identities=30% Similarity=0.462 Sum_probs=138.7
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|+..+.||+|++|.||+|+.. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+++ .
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG--------D 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC--------C
Confidence 345678999999999999864 789999999865432 23567889999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++ ++.+++.... ..+++.++..++.+++.||+|||+. +|+|+||||+||++++++.+||+|||.+.
T Consensus 73 ~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 73 LYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 8999999975 8888887542 3589999999999999999999987 79999999999999999999999998763
Q ss_pred cc-------------------------------ccccccceeeeeeehhh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
.. .|+||+|+++|+|+++.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 196 (283)
T cd05118 147 SFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196 (283)
T ss_pred ecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 21 19999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-23 Score=231.56 Aligned_cols=158 Identities=22% Similarity=0.422 Sum_probs=123.1
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCC----
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG---- 553 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 553 (671)
+-..+|+..+.+|+||||.|||++.+ ||+.+|||++.-.. ........+|+..+++++|||||+++..+.+...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888999999999999999966 89999999996543 3335568899999999999999998765433100
Q ss_pred ------------------------------------------------C------------C------------------
Q 005898 554 ------------------------------------------------R------------D------------------ 555 (671)
Q Consensus 554 ------------------------------------------------~------------~------------------ 555 (671)
. +
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0
Q ss_pred --------------------C-ccc--------ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 005898 556 --------------------D-YAV--------NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL 606 (671)
Q Consensus 556 --------------------~-~~~--------~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL 606 (671)
+ ... ..+|+-||||+.-.+++++++..... .-....++..+|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 000 34688899999977777776532211 2344577899999999999
Q ss_pred cCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 607 HTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 607 H~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
|+. +||||||||.||++|++..+||+|||+|..
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchh
Confidence 997 799999999999999999999999999976
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=214.69 Aligned_cols=171 Identities=22% Similarity=0.344 Sum_probs=142.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++.+++...+.. .
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL--E 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc--c
Confidence 3567888899999999999999975 6889999998643 223346678899999999999999999877654310 0
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++|+||+ +++|.+++.. ..+++.++..++.++++|++|||+. +|+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 123479999999 5699988864 2489999999999999999999986 7999999999999999999999999
Q ss_pred CCcccc----------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|++... .|+||+|+++|+|++|..
T Consensus 163 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~ 214 (343)
T cd07851 163 GLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214 (343)
T ss_pred cccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 987531 299999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=208.74 Aligned_cols=169 Identities=13% Similarity=0.211 Sum_probs=125.2
Q ss_pred cCCCcCceeccCCceEEEEEEEcC----CcEEEEEEccCCchhh-----------HHHHHHHHHHHhcCCCCCcccccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN----GTSVAIRCLPSSKKYT-----------VRNLKLRLDLLAKLRHPHLVCLLGH 547 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~ 547 (671)
..|+..++||+|+||+||+|+..+ +..+|+|+........ ......+...+..++|+||+++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568889999999999999999653 4566776543221110 1112334455677899999999987
Q ss_pred eecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 548 ~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
+..... .....++++|++.. ++.+.+.... ..++.....++.|+++||+|||+. +|+||||||+|||++
T Consensus 92 ~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 92 GSFKRC----RMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred eeEecC----CceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 655321 11245778887754 5655554322 256788899999999999999986 799999999999999
Q ss_pred CCCcEEEcccCCcccc-------------------------------------ccccccceeeeeeehhhhc
Q 005898 628 EHRIAKLSDYGLSIVS-------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 628 ~~~~~ki~DfGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.+||+|||+|+.. .|+||+||++|||+++..+
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999998532 1999999999999987443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=212.82 Aligned_cols=169 Identities=24% Similarity=0.344 Sum_probs=142.7
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+. ....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP---EDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc---cccc
Confidence 3677889999999999999965 58999999987543 3345678999999999999999999999876531 1223
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++ +|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||++++++.++++|||++
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred ceEEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 67999999984 8988887543 599999999999999999999987 7999999999999999999999999977
Q ss_pred ccc----------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
... .|+||+|+++|+|+++...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p 206 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL 206 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence 421 2999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=211.70 Aligned_cols=167 Identities=23% Similarity=0.371 Sum_probs=136.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-C--CcEEEEEEccCC--chhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-N--GTSVAIRCLPSS--KKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~--g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
+|+..+.||+|+||.||+++.. + +..||||++... .....+.+.+|++++.++ +||||+++++++.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~---- 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG---- 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc----
Confidence 3667789999999999999964 4 789999998643 222345688899999999 59999999987653311
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++++||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 77 ~~~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 77 NFNELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cCCcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 1235789999986 5898888643 3489999999999999999999987 7999999999999999999999999
Q ss_pred CCcccc-----------------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS-----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~-----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+||++|+|+++..
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~ 208 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCc
Confidence 987410 199999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=218.01 Aligned_cols=179 Identities=25% Similarity=0.477 Sum_probs=151.4
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
.++.+...++.|+..++||.|.+|.|||++ .++|+.+|||++....+. .++.+.|.+++... .|||++.++|++...
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 345555677889999999999999999998 568999999998765443 45677788887776 699999999988765
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
+. ...+++|||||||.+|+.-+.+..-. +..+.|.....|+..+.+|+.+||.+ .++|||+|=.|||+++++.
T Consensus 89 ~~---~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 89 DP---GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred cC---CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence 42 23468999999999999988876543 55699999999999999999999998 6899999999999999999
Q ss_pred EEEcccCCccccc-----------------------------------cccccceeeeeeehhh
Q 005898 632 AKLSDYGLSIVSE-----------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------------d~~s~g~~l~~~~~~~ 660 (671)
+|+.|||++..++ |+||+|+|-.||.-|.
T Consensus 162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~ 225 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA 225 (953)
T ss_pred EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence 9999999996544 9999999999987654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-23 Score=196.83 Aligned_cols=165 Identities=25% Similarity=0.363 Sum_probs=133.5
Q ss_pred CceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccceEEE
Q 005898 488 SAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
...+|.|.-|+|++++++ +|..+|||.+.... ....+.....+.++.+-. .|.||+-+|||.... .+++
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--------dV~I 168 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--------DVFI 168 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--------hHHH
Confidence 456899999999999975 69999999997543 444566777788776664 899999999998753 5789
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc-
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS- 643 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~- 643 (671)
.||.|.. -++..+... ..++.+.-.=++...+..||.||.+.+ +|||||+||+|||+|+.|++|++|||++..+
T Consensus 169 cMelMs~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 9999964 566666542 233666666677888999999998764 7999999999999999999999999998432
Q ss_pred c-------------------------------cccccceeeeeeehhhhcccc
Q 005898 644 E-------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 644 ~-------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+ |+||+|++++|++|+.|.-.+
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 2 999999999999999886554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=200.84 Aligned_cols=158 Identities=27% Similarity=0.385 Sum_probs=137.0
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEE
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++.+.+.. ..++||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~~v~ 72 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE--------KLYLVL 72 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC--------eeEEEE
Confidence 699999999999965 589999999865432 24567899999999999999999999887543 689999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--- 643 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--- 643 (671)
||+++++|.+++.... .+++.....++.|+++|+.|+|+. +++|+||||+||++++++.++++|||++...
T Consensus 73 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 73 EYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999999997543 489999999999999999999986 7999999999999999999999999987421
Q ss_pred ---------------------------ccccccceeeeeeehhhhc
Q 005898 644 ---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+|++|+++|+++++...
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 192 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 2999999999999987643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=201.96 Aligned_cols=148 Identities=21% Similarity=0.213 Sum_probs=125.9
Q ss_pred CCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCCC
Q 005898 494 GSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG 572 (671)
Q Consensus 494 G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~G 572 (671)
|.||.||+++. .+++.||+|++.... ++.+|...+....||||+++++++.+.+ ..++||||+++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~--------~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED--------SVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC--------eEEEEEecCCCC
Confidence 88999999985 478999999987543 2344555556677999999999887653 689999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc----------
Q 005898 573 NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV---------- 642 (671)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~---------- 642 (671)
+|.+++.... .+++.....++.++++||+|||+. +|+||||||+||+++.++.++++|||.+..
T Consensus 71 ~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 144 (237)
T cd05576 71 KLWSHISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV 144 (237)
T ss_pred CHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCc
Confidence 9999987543 389999999999999999999986 799999999999999999999999996421
Q ss_pred -----------------cccccccceeeeeeehhh
Q 005898 643 -----------------SEDINSVGVRLLILMSFF 660 (671)
Q Consensus 643 -----------------~~d~~s~g~~l~~~~~~~ 660 (671)
..|+||+|+++|+|++|.
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~ 179 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGK 179 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCc
Confidence 129999999999999975
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=203.41 Aligned_cols=166 Identities=20% Similarity=0.373 Sum_probs=135.6
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-----KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
|...+.||+|+||.||+++.. .+..+++|.++.. ......++.+|+.++++++||||+++++++.+.+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 75 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD------ 75 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC------
Confidence 667789999999999999864 3555666665432 1223446778999999999999999999887653
Q ss_pred cceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++++|..+++.. .....+++.++..++.|++.|+.|||+. +++|+||||+||++++ ..+|++||
T Consensus 76 --~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 --AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred --ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 579999999999999988752 2234699999999999999999999986 8999999999999975 56999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+|+++|+|+++...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~ 204 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA 204 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 976431 2999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-23 Score=211.67 Aligned_cols=251 Identities=31% Similarity=0.419 Sum_probs=198.1
Q ss_pred cchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccC-
Q 005898 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFD- 187 (671)
Q Consensus 109 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 187 (671)
.+|+..-+++.|+.||.-+|-+ +.+|..++.+.+|+.|+|.+|++. .+| +|.+++.|++|+++.|++. .+|...+
T Consensus 174 ~l~~~~i~m~~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~ 249 (565)
T KOG0472|consen 174 ALPENHIAMKRLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLK 249 (565)
T ss_pred hCCHHHHHHHHHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhc
Confidence 4455555588888888877776 788999999999999999999985 566 8999999999999999988 6776655
Q ss_pred CCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCC----------------
Q 005898 188 SLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS---------------- 251 (671)
Q Consensus 188 ~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~---------------- 251 (671)
.+++|.+|||.+|+++ +.|.++..+.+|.+||+|+|.+++.+++++++ .|+.|.+.+|.+..
T Consensus 250 ~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKy 327 (565)
T KOG0472|consen 250 HLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKY 327 (565)
T ss_pred ccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHH
Confidence 8999999999999998 89999999999999999999999999999999 99999999996511
Q ss_pred ---------------------C-----CCC-------------------CC---------CCccEEEcCCCCCC------
Q 005898 252 ---------------------N-----LPK-------------------LP---------RGLVMAFLSNNSFS------ 271 (671)
Q Consensus 252 ---------------------~-----~p~-------------------~~---------~~L~~l~l~~N~l~------ 271 (671)
. .|. +| ...+..+++.|++.
T Consensus 328 Lrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L 407 (565)
T KOG0472|consen 328 LRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRL 407 (565)
T ss_pred HHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhh
Confidence 0 000 00 00223344444432
Q ss_pred -----------------CCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCc---------------
Q 005898 272 -----------------GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS--------------- 319 (671)
Q Consensus 272 -----------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------- 319 (671)
+.+|..+..+++|..|+|++|-+...| ..++.+..|+.||++.|+|.
T Consensus 408 ~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP-~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtl 486 (565)
T KOG0472|consen 408 VELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLP-EEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETL 486 (565)
T ss_pred HHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcc-hhhhhhhhhheecccccccccchHHHhhHHHHHHH
Confidence 356666777888888888888887665 46777878888888888874
Q ss_pred -------ccCCcc-cCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 320 -------GSLPKN-LNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 320 -------g~~p~~-~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
+.+|.+ +.++.+|..|||.+|.+. .+|+.++++++++.+.+.+|.|.
T Consensus 487 las~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 487 LASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 223333 667788899999999988 78889999999999999999887
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-22 Score=224.01 Aligned_cols=152 Identities=15% Similarity=0.207 Sum_probs=105.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-C----CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-N----GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
..++|+..+.||+|+||.||+|+.. + +..||||++..... .+.+..| .+....+.+++.++..+.....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~-- 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVS-- 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccc--
Confidence 4578999999999999999999965 5 78999999864322 1112211 1222333444443332221110
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPG-----------------KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
.......++||||+++|+|.+++...... ..........++.|+++||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 00124689999999999999988643210 0111233457899999999999986 899999
Q ss_pred CCCCceeecC-CCcEEEcccCCcc
Q 005898 619 VKTNNILLNE-HRIAKLSDYGLSI 641 (671)
Q Consensus 619 lk~~NiLl~~-~~~~ki~DfGla~ 641 (671)
|||+|||+++ ++.+||+|||+|+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~ 304 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAA 304 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcc
Confidence 9999999986 5899999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=223.94 Aligned_cols=147 Identities=26% Similarity=0.459 Sum_probs=129.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~------ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN------ 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC------
Confidence 56888899999999999999965 68999999986532 233467889999999999999999998887653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.++++... .+++.....++.||+.||+|||.. +|+||||||+|||++.++.+||+|||
T Consensus 78 --~~~lVmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 78 --NVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred --EEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 7899999999999999997543 388899999999999999999986 79999999999999999999999999
Q ss_pred Ccccc
Q 005898 639 LSIVS 643 (671)
Q Consensus 639 la~~~ 643 (671)
+++..
T Consensus 150 ls~~~ 154 (669)
T cd05610 150 LSKVT 154 (669)
T ss_pred CCccc
Confidence 99754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-22 Score=208.29 Aligned_cols=164 Identities=19% Similarity=0.283 Sum_probs=138.5
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEcc--CCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLP--SSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.|+..+.||+||.+.||++...+.+.+|+|+.. ..+.+....|.+|++.|.+++ |.+||+|++|=..+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-------- 432 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-------- 432 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--------
Confidence 4577789999999999999998888899998874 345566788999999999996 99999999986653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..+||||||-+- ||..+|..... ...+| .+..+..|+..|+.++|++ +|||.||||.|.|+-+ |.+|+.|||+
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGI 505 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGI 505 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeech
Confidence 389999998755 99999986542 23556 6778889999999999998 8999999999999864 8999999999
Q ss_pred ccccc-------------------------------------------cccccceeeeeeehhhh
Q 005898 640 SIVSE-------------------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 640 a~~~~-------------------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|.-+. |+||+|||+|+|+-+..
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgkt 570 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKT 570 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCC
Confidence 96533 99999999999876543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-24 Score=219.08 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=225.2
Q ss_pred cchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCC
Q 005898 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDS 188 (671)
Q Consensus 109 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 188 (671)
.+.+.+.++..|.+|++++|.+. .+|++++.+..++.|+.|+|+++ .+|+.++.+.+|..|+.++|.+. .+|+.++.
T Consensus 59 ~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~ 135 (565)
T KOG0472|consen 59 VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGR 135 (565)
T ss_pred hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHH
Confidence 44567889999999999999984 68888999999999999999996 79999999999999999999988 78889999
Q ss_pred CCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCC--CCCccEEEcC
Q 005898 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL--PRGLVMAFLS 266 (671)
Q Consensus 189 l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~l~l~ 266 (671)
+..|+.|+..+|+++ ..|+.++++.+|..|++.+|.+...+|+.-+++.|+.||...|-++...|.+ ..+|..++|.
T Consensus 136 ~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~ 214 (565)
T KOG0472|consen 136 LLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLR 214 (565)
T ss_pred Hhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhh
Confidence 999999999999998 7899999999999999999999988887666999999999999887766665 4678889999
Q ss_pred CCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccC
Q 005898 267 NNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGL 346 (671)
Q Consensus 267 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~ 346 (671)
.|++. .+| +|+.++.|.+|.++.|+++-.+......++++..|||..|+++ .+|+.+.-+.+|+.||+|+|.++ .+
T Consensus 215 ~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~L 290 (565)
T KOG0472|consen 215 RNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SL 290 (565)
T ss_pred hcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cC
Confidence 99997 677 8999999999999999999888777779999999999999998 78999999999999999999999 68
Q ss_pred CCCCCCCCCCceeccCCCcCC
Q 005898 347 PSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 347 p~~~~~~~~l~~l~l~~N~l~ 367 (671)
|.+++++ .++.+.+.||.+.
T Consensus 291 p~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 291 PYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred Ccccccc-eeeehhhcCCchH
Confidence 8899999 8999999999764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-23 Score=192.20 Aligned_cols=159 Identities=24% Similarity=0.479 Sum_probs=135.8
Q ss_pred hcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+++|+|.|+.||-|. ..+.+.++||+++..++ +...+|+.+|..++ ||||++|++...++.++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk----- 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESK----- 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCcccc-----
Confidence 3567778899999999999998 56778899999986543 56899999999998 99999999999887643
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEcccC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLSDYG 638 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~DfG 638 (671)
...||+||+.+.+....... ++-.+...+..++..||+|+|+. +|+|||+||.|+++|. .-..++.|+|
T Consensus 109 -tpaLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 109 -TPSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred -CchhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence 56899999999888766542 66777888899999999999997 8999999999999996 4689999999
Q ss_pred Cccccc------------------------------cccccceeeeeeeh
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~ 658 (671)
+|-+.. |+||+||.++.|..
T Consensus 179 LAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF 228 (338)
T KOG0668|consen 179 LAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228 (338)
T ss_pred hHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHh
Confidence 995532 99999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=203.62 Aligned_cols=161 Identities=21% Similarity=0.369 Sum_probs=135.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh---h-----HHHHHHHHHHHhcCC---CCCcccccceeec
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY---T-----VRNLKLRLDLLAKLR---HPHLVCLLGHCID 550 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~---~-----~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 550 (671)
.+|.....+|+|+||.|..|..+ +..+|+||.+.+.+-- . .--.-.||++|+.++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35778899999999999999865 5779999999654311 1 112457999999997 9999999999987
Q ss_pred CCCCCCcccceEEEEEecC-CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 551 GGGRDDYAVNKVFLVYEFM-SNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~-~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
.+ ..||+||-. ++-+|++++.... .+++.....|..||+-|+++||+. +|||||||-+||.+|.+
T Consensus 641 dd--------~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 641 DD--------YYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN 706 (772)
T ss_pred CC--------eeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC
Confidence 64 789999954 3448899987543 389999999999999999999997 89999999999999999
Q ss_pred CcEEEcccCCccccc-----------------------------cccccceeeeeee
Q 005898 630 RIAKLSDYGLSIVSE-----------------------------DINSVGVRLLILM 657 (671)
Q Consensus 630 ~~~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~ 657 (671)
|-+|+.|||.|.... |+|++|+.+|+..
T Consensus 707 g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv 763 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV 763 (772)
T ss_pred CeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE
Confidence 999999999985422 9999999999865
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=214.07 Aligned_cols=229 Identities=28% Similarity=0.383 Sum_probs=153.1
Q ss_pred CcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccC
Q 005898 108 DSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFD 187 (671)
Q Consensus 108 ~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 187 (671)
..+|..+. ++|+.|++.+|+++. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.++ .+|..+
T Consensus 214 tsLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp- 281 (788)
T PRK15387 214 TTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP- 281 (788)
T ss_pred CcCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch-
Confidence 35666554 367888888887753 554 2467888888888876 35543 245566666666555 233321
Q ss_pred CCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccc-------------------cCCCCCCCCCCEEECCCCC
Q 005898 188 SLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGS-------------------LPDLSSLGSLNVLNLSDNK 248 (671)
Q Consensus 188 ~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-------------------~p~~~~l~~L~~L~Ls~N~ 248 (671)
++|+.|++++|+++ .+|.. +++|+.|+|++|++++. +|.+ ..+|+.|+|++|+
T Consensus 282 --~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~l--p~~Lq~LdLS~N~ 353 (788)
T PRK15387 282 --SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTL--PSGLQELSVSDNQ 353 (788)
T ss_pred --hhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCCCcccccccccccCcccccccc--ccccceEecCCCc
Confidence 33444455555544 23321 23455555555554432 2221 1367788888888
Q ss_pred CCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCC
Q 005898 249 LDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNC 328 (671)
Q Consensus 249 l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 328 (671)
|++ +|..+.++..|++++|+++. +|.. ..+|+.|++++|+|++.++ . .++|+.|++++|+|++ +|...
T Consensus 354 Ls~-LP~lp~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~-l---~s~L~~LdLS~N~Lss-IP~l~-- 421 (788)
T PRK15387 354 LAS-LPTLPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPV-L---PSELKELMVSGNRLTS-LPMLP-- 421 (788)
T ss_pred cCC-CCCCCcccceehhhcccccc-Cccc---ccccceEEecCCcccCCCC-c---ccCCCEEEccCCcCCC-CCcch--
Confidence 875 56667777788888888874 6653 3578899999999987654 2 3678999999999984 67543
Q ss_pred CCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCCc
Q 005898 329 GGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370 (671)
Q Consensus 329 ~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~~ 370 (671)
.+|+.|++++|+++ .+|.++.+++.+..+++++|.+++..
T Consensus 422 -~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~ 461 (788)
T PRK15387 422 -SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERT 461 (788)
T ss_pred -hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchH
Confidence 46788999999998 78999999999999999999999754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-22 Score=207.37 Aligned_cols=166 Identities=18% Similarity=0.281 Sum_probs=142.9
Q ss_pred CCCcCceeccCCceEEEEEEEcC-CcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLEN-GTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+++....+|-|+||.|-..+... ...+|+|++++. +..+.+....|-.+|-+++.|.||+||--|.+..
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k------- 493 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK------- 493 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch-------
Confidence 34445668999999999988754 335888888653 3455678889999999999999999998887653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
.+|+.||-|-+|.+++.|++++. ++..+..-++..|.+|++|||.. +||.|||||+|.++|.+|-+|+.|||+
T Consensus 494 -yvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 494 -YVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred -hhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhh
Confidence 79999999999999999998754 78888888889999999999997 899999999999999999999999999
Q ss_pred ccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+.+. |+|++|+.+||+++|.+..
T Consensus 567 AKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPF 619 (732)
T KOG0614|consen 567 AKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPF 619 (732)
T ss_pred HHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCC
Confidence 98754 9999999999999986654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-21 Score=181.91 Aligned_cols=164 Identities=20% Similarity=0.395 Sum_probs=135.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|...+.+|+|.||.+-.++.+ +.+.+++|.+.... ...++|.+|...=-.+ .|.||+.-+++..+.. +
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-------d 95 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-------D 95 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcC-------c
Confidence 35677889999999999999976 57789999987543 2467899998775556 5999999887655432 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec--CCCcEEEcccC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN--EHRIAKLSDYG 638 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~--~~~~~ki~DfG 638 (671)
....++||+|.|||..-+...+ +......+++.|++.|++|+|+. .+||||||.+|||+- +...+|++|||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred eEEEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 6678999999999988776533 77888999999999999999997 799999999999993 44689999999
Q ss_pred Cccccc--------------------------------cccccceeeeeeehhhh
Q 005898 639 LSIVSE--------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~~--------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
..+..+ |+|.+|+++|..+||..
T Consensus 169 ~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~ 223 (378)
T KOG1345|consen 169 LTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF 223 (378)
T ss_pred cccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence 987644 99999999999999754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=185.59 Aligned_cols=164 Identities=30% Similarity=0.464 Sum_probs=142.0
Q ss_pred CCcCceeccCCceEEEEEEEcC-CcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLEN-GTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
|+..+.||+|++|.||+++..+ ++.+|||.+...... ..+.+.+|++.+.+++|+|++++++++.... ..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~--------~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE--------PL 72 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC--------ce
Confidence 4556889999999999999764 899999999765443 5678999999999999999999999887643 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++++||+++++|.+++..... .+++.+...++.++++++.|||.. +++|+|++++||+++.++.++++|||.+..
T Consensus 73 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 73 YLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 999999999999999876432 178999999999999999999987 899999999999999999999999997642
Q ss_pred c--------------------------------ccccccceeeeeeehhhh
Q 005898 643 S--------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 643 ~--------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
. .|+|++|+++++|+++..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 2 399999999999998543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=181.79 Aligned_cols=140 Identities=16% Similarity=0.215 Sum_probs=108.1
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchh--h-------H-----------------HHHHHHHHHHhcCCCCCc
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY--T-------V-----------------RNLKLRLDLLAKLRHPHL 541 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~H~ni 541 (671)
...||+|+||.||+|+..+|+.||||+++..... . . ....+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999878999999999643210 0 0 122349999999998887
Q ss_pred ccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-cCCCCCCccccCCC
Q 005898 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL-HTGVIPGFFNNRVK 620 (671)
Q Consensus 542 v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDlk 620 (671)
.....+... ..++||||++++++....... ..+++.+...++.+++.+|+|+ |+. +|+|||||
T Consensus 82 ~~p~~~~~~----------~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlk 145 (190)
T cd05147 82 PCPEPILLK----------SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLS 145 (190)
T ss_pred CCCcEEEec----------CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 554333221 238999999998776543222 2488899999999999999999 454 79999999
Q ss_pred CCceeecCCCcEEEcccCCccccc
Q 005898 621 TNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 621 ~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
|+||+++ ++.+++.|||+|...+
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccCC
Confidence 9999998 4789999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-21 Score=205.09 Aligned_cols=163 Identities=22% Similarity=0.316 Sum_probs=134.0
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++.|.....+|+|+|++|-++.. .+++..|||++.+.. .+-.+|+.++... +||||+++.+.|.+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~------- 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGK------- 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCc-------
Confidence 45666777799999999999874 578999999997652 2345566665555 6999999999998763
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee-cCCCcEEEcccC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL-NEHRIAKLSDYG 638 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl-~~~~~~ki~DfG 638 (671)
+.|+|||++.+|-+-+.+.... ..+ ..+..|+.+++.|++|||+. ++|||||||+|||+ ++.++++++|||
T Consensus 390 -~~~~v~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 390 -EIYLVMELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred -eeeeeehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence 7899999999988766665322 123 67778999999999999996 89999999999999 588999999999
Q ss_pred Cccccc---------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE---------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~---------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
.++..+ |+||+|++||+|++|....
T Consensus 462 ~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~ 513 (612)
T KOG0603|consen 462 FWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF 513 (612)
T ss_pred hhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence 997644 9999999999999997643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-21 Score=190.08 Aligned_cols=167 Identities=23% Similarity=0.281 Sum_probs=134.9
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
|.....+|.|.- .|.-|... .++.||+|++... .....+...+|..+|..+.|+||++++.++..... .....+
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~--l~~~~e 95 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT--LEEFQE 95 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc--HHHHHh
Confidence 444567888887 56555532 5889999998543 23345677889999999999999999998864321 112357
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.|+|||||.. +|...++.+ ++..+...|..|+..|+.|||+. +|+||||||+||++..+...||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILME-----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 8999999965 898888732 78889999999999999999997 89999999999999999999999999997
Q ss_pred ccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 642 VSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 642 ~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
..+ |+||+||+++||+++..=.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 543 9999999999999875433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=176.47 Aligned_cols=141 Identities=16% Similarity=0.199 Sum_probs=111.8
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchh--------------------------hHHHHHHHHHHHhcCCCCCc
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY--------------------------TVRNLKLRLDLLAKLRHPHL 541 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 541 (671)
...||+|+||.||+|+..+|+.||||++...... ....+.+|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998653210 01224678999999999998
Q ss_pred ccccceeecCCCCCCcccceEEEEEecCCCCChhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC-CCCCCccccCC
Q 005898 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH-ISENTPGKVLNWSERLAVLIGVAKAVQFLHT-GVIPGFFNNRV 619 (671)
Q Consensus 542 v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDl 619 (671)
.....+... ..+|||||++++++... +.. ..++..+..+++.+++.++.|+|+ . +|+||||
T Consensus 82 ~~p~~~~~~----------~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl 144 (190)
T cd05145 82 PVPEPILLK----------KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL 144 (190)
T ss_pred CCceEEEec----------CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence 655544332 23899999998865433 332 236778889999999999999998 6 8999999
Q ss_pred CCCceeecCCCcEEEcccCCccccccc
Q 005898 620 KTNNILLNEHRIAKLSDYGLSIVSEDI 646 (671)
Q Consensus 620 k~~NiLl~~~~~~ki~DfGla~~~~d~ 646 (671)
||+||+++ ++.+++.|||+++..+..
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecCCC
Confidence 99999999 789999999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-21 Score=193.17 Aligned_cols=167 Identities=22% Similarity=0.335 Sum_probs=136.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh---hHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY---TVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
.+|.-..+||+|+||+|..|.-+ +.+.+|||++++.-.. +.+--..|-++|+-- +-|.+|+|...+++-
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm------ 422 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM------ 422 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh------
Confidence 36788899999999999999855 5778999999765321 223334566666655 678899998777664
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
+.+|.||||+.+|+|--+++.-+. +..+...-+|..||-||-|||+. +||.||||..||++|.+|++||+||
T Consensus 423 --DRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 423 --DRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred --hheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence 379999999999999888876433 66677888999999999999998 8999999999999999999999999
Q ss_pred CCccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 638 GLSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+.+--- |-||.||++|||+.|....
T Consensus 495 GmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPF 550 (683)
T KOG0696|consen 495 GMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 550 (683)
T ss_pred ccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCC
Confidence 9986311 9999999999999987654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=206.03 Aligned_cols=208 Identities=29% Similarity=0.344 Sum_probs=146.4
Q ss_pred CCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCC-----------------CCCccCEEEccCCcCC
Q 005898 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKIS-----------------TMVKLQTLILDDNFFN 179 (671)
Q Consensus 117 l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~-----------------~l~~L~~L~L~~N~l~ 179 (671)
+++|++|+|++|+|+. +|.. .++|+.|+|++|.++ .+|..+. .+++|+.|+|++|+++
T Consensus 241 p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~lp~~L~~L~Ls~N~Lt~LP~~p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 241 PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 315 (788)
T ss_pred CCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhchhhcCEEECcCCccccccccccccceeECCCCccc
Confidence 4567777777777753 4432 234555555555543 2222110 1245566666666555
Q ss_pred CCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRG 259 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 259 (671)
+ +|... .+|+.|++++|++++ +|.. ..+|+.|+|++|+|++ +|.+ .++|..|++++|++++ +|..+.+
T Consensus 316 ~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l--p~~L~~L~Ls~N~L~~-LP~l~~~ 383 (788)
T PRK15387 316 S-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL--PSELYKLWAYNNRLTS-LPALPSG 383 (788)
T ss_pred c-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC--Ccccceehhhcccccc-Ccccccc
Confidence 3 33321 235555666666652 4431 2479999999999996 4443 3578889999999985 7888889
Q ss_pred ccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcC
Q 005898 260 LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISN 339 (671)
Q Consensus 260 L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~ 339 (671)
|..|++++|.|++ +|.. .++|+.|++++|+|+++|. . ..+|+.|++++|+++ .+|..+..+.+|+.++|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssIP~-l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSLPM-L---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCCCCc-c---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 9999999999985 6654 3679999999999998653 2 357889999999998 7899999999999999999
Q ss_pred CcCcccCCCCC
Q 005898 340 NKLTGGLPSCL 350 (671)
Q Consensus 340 N~l~g~~p~~~ 350 (671)
|+|+|..|..+
T Consensus 455 N~Ls~~~~~~L 465 (788)
T PRK15387 455 NPLSERTLQAL 465 (788)
T ss_pred CCCCchHHHHH
Confidence 99999887765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-20 Score=186.55 Aligned_cols=180 Identities=23% Similarity=0.356 Sum_probs=148.2
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEcC------CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccce
Q 005898 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRLEN------GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGH 547 (671)
Q Consensus 475 ~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~ 547 (671)
.+++......+....++-+|.||.||+|.|++ .+.|-||.++... ..+...+..|..++..+.|||+.+..++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 44555556668888889999999999997643 3456778876543 4456778999999999999999999999
Q ss_pred eecCCCCCCcccceEEEEEecCCCCChhhhhhc-----CCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCC
Q 005898 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISE-----NTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTN 622 (671)
Q Consensus 548 ~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~ 622 (671)
+.+.. +..+.+|.++.-|+|..||.. ....+.++-.+...+|.|++.|++|||.+ ++||.||.++
T Consensus 356 ~ie~~-------~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaR 425 (563)
T KOG1024|consen 356 SIEDY-------ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAAR 425 (563)
T ss_pred Eeecc-------CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhh
Confidence 98753 356899999999999999983 22234577778899999999999999997 8999999999
Q ss_pred ceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehhhhccc
Q 005898 623 NILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 623 NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~~~~~ 664 (671)
|+++|+...+|++|-.+++.+ .|+||+||+||||+|-..-|.
T Consensus 426 NCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py 499 (563)
T KOG1024|consen 426 NCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY 499 (563)
T ss_pred cceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc
Confidence 999999999999999998742 199999999999999654443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=182.24 Aligned_cols=152 Identities=30% Similarity=0.464 Sum_probs=134.0
Q ss_pred CceEEEEEEEc-CCcEEEEEEccCCchhh-HHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCCC
Q 005898 495 SYGKLYKGRLE-NGTSVAIRCLPSSKKYT-VRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG 572 (671)
Q Consensus 495 ~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~G 572 (671)
+||.||+|+.. +|+.||+|++....... .+.+.+|++.+++++|+||+++.+++.... ..+++|||++++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------~~~l~~e~~~~~ 72 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED--------KLYLVMEYCDGG 72 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC--------EEEEEEeCCCCC
Confidence 58999999976 58999999997654433 678999999999999999999999987653 689999999999
Q ss_pred ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---------
Q 005898 573 NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--------- 643 (671)
Q Consensus 573 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--------- 643 (671)
+|.+++..... +++.++..++.+++++++|||.. +++|+||+|+||++++++.++++|||.+...
T Consensus 73 ~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 73 DLFDLLKKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccc
Confidence 99999876432 88999999999999999999987 8999999999999999999999999987532
Q ss_pred --------------------ccccccceeeeeeehhh
Q 005898 644 --------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 644 --------------------~d~~s~g~~l~~~~~~~ 660 (671)
.|+|++|+++|+|+++.
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~ 183 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK 183 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 29999999999999864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-18 Score=210.60 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=166.0
Q ss_pred CcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccC
Q 005898 108 DSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFD 187 (671)
Q Consensus 108 ~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 187 (671)
..+|..+ .+.+|+.|+|.+|.+. .+|..+..+++|++|+|++|...+.+|. +..+++|++|+|++|.....+|..++
T Consensus 602 ~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~ 678 (1153)
T PLN03210 602 RCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQ 678 (1153)
T ss_pred CCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhh
Confidence 4445544 4567777777777663 4566667777777777776654455553 66677777777777666666777777
Q ss_pred CCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCC------------
Q 005898 188 SLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPK------------ 255 (671)
Q Consensus 188 ~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~------------ 255 (671)
++++|+.|++++|...+.+|..+ ++++|+.|++++|...+.+|.. .++|+.|++++|.+.. +|.
T Consensus 679 ~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l 754 (1153)
T PLN03210 679 YLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDETAIEE-FPSNLRLENLDELIL 754 (1153)
T ss_pred ccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc--cCCcCeeecCCCcccc-ccccccccccccccc
Confidence 77777777777765555666655 5667777777766544444432 2455666666665432 111
Q ss_pred ---------------------CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecc
Q 005898 256 ---------------------LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLA 314 (671)
Q Consensus 256 ---------------------~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 314 (671)
.+.+|+.|++++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|+|+
T Consensus 755 ~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls 833 (1153)
T PLN03210 755 CEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLS 833 (1153)
T ss_pred cccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECC
Confidence 12467778888887777888888888888888888865444444443 67888888888
Q ss_pred cCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCC-CcCC
Q 005898 315 SNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRG-NCLS 367 (671)
Q Consensus 315 ~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~-N~l~ 367 (671)
+|.....+|.. ..+|+.|+|++|.++ .+|.++..+++|+.+++++ |.+.
T Consensus 834 ~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~ 883 (1153)
T PLN03210 834 GCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ 883 (1153)
T ss_pred CCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC
Confidence 87665566653 356788888888887 6788888888888888887 3444
|
syringae 6; Provisional |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-20 Score=198.64 Aligned_cols=148 Identities=22% Similarity=0.455 Sum_probs=128.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..++|+....+|+|.||.||||+. .+++.+|||.++-.......-..+|+-+++..+|||||.++|.+...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-------- 84 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-------- 84 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh--------
Confidence 456788899999999999999994 57999999999866555566678899999999999999999987654
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
+..|++|||+.+|+|.+.-+--+ +++..+.-.+++...+|++|||+. +=+|||||=.||++.+.+.+|++|||.
T Consensus 85 dklwicMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCc
Confidence 36899999999999998777544 388888888999999999999997 448999999999999999999999999
Q ss_pred ccc
Q 005898 640 SIV 642 (671)
Q Consensus 640 a~~ 642 (671)
+..
T Consensus 159 saq 161 (829)
T KOG0576|consen 159 SAQ 161 (829)
T ss_pred hhh
Confidence 854
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=196.85 Aligned_cols=165 Identities=24% Similarity=0.357 Sum_probs=128.0
Q ss_pred CCcCceeccCCce-EEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceE
Q 005898 485 FDMSAIMGEGSYG-KLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 485 f~~~~~iG~G~~g-~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
|...+++|.|+-| .||+|.++ |++||||++-... ..-..+||..+..- +|||||+.+ |.+.+. ...
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~------qF~ 578 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYY--CSEQDR------QFL 578 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEE--eeccCC------ceE
Confidence 4556778888877 57999986 7899999985332 23457899999888 599999985 555432 489
Q ss_pred EEEEecCCCCChhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---C--CcEEEcc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKV-LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---H--RIAKLSD 636 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~--~~~ki~D 636 (671)
|+..|.|.- +|.+++........ ..-..-..+..|++.||++||+. +||||||||.||||+. + ..|+|+|
T Consensus 579 YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 579 YIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence 999999966 99999875311111 11134467788999999999995 8999999999999975 2 5799999
Q ss_pred cCCccccc---------------------------------cccccceeeeeeehhhhcccc
Q 005898 637 YGLSIVSE---------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 637 fGla~~~~---------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
||+++... |+.|+||++|+.+++..-|++
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99998654 999999999999998766665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-19 Score=171.09 Aligned_cols=153 Identities=33% Similarity=0.595 Sum_probs=132.3
Q ss_pred eccCCceEEEEEEEc-CCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEec
Q 005898 491 MGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEF 568 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey 568 (671)
||+|++|.||+++.. +++.++||++...... ..+.+.+|++.++.++|++|+++++++.... ..++++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--------~~~~~~e~ 72 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN--------HLYLVMEY 72 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--------eEEEEEec
Confidence 689999999999976 4899999999765432 3567999999999999999999999987643 68999999
Q ss_pred CCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEcccCCcccc----
Q 005898 569 MSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLSDYGLSIVS---- 643 (671)
Q Consensus 569 ~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~DfGla~~~---- 643 (671)
+++++|.+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. +..++++|||.+...
T Consensus 73 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 73 CEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99999999987542 2489999999999999999999987 8999999999999999 899999999987522
Q ss_pred ---------------------------ccccccceeeeee
Q 005898 644 ---------------------------EDINSVGVRLLIL 656 (671)
Q Consensus 644 ---------------------------~d~~s~g~~l~~~ 656 (671)
.|+|++|+++++|
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3888888888776
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.8e-19 Score=202.21 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=187.9
Q ss_pred EeCCCCEeEEEecCCCCCCCCC-CCCcccccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEE
Q 005898 69 TCQDNFITELKIIGDKPSNVGN-FDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYL 147 (671)
Q Consensus 69 ~C~~~~v~~l~l~~~~~~~~~~-~~~~~~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L 147 (671)
.|.....+.+++.+..+..... +. .....+.++.|. +..+|..+. .+|+.|+|++|.|. .+|..+. .+|+.|
T Consensus 174 ~Cl~~~~~~L~L~~~~LtsLP~~Ip-~~L~~L~Ls~N~-LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L 246 (754)
T PRK15370 174 DCLKNNKTELRLKILGLTTIPACIP-EQITTLILDNNE-LKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEM 246 (754)
T ss_pred hhcccCceEEEeCCCCcCcCCcccc-cCCcEEEecCCC-CCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEE
Confidence 4655556777776554332211 10 011122344443 345666654 58999999999997 5677654 479999
Q ss_pred EcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccc
Q 005898 148 DLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAIS 227 (671)
Q Consensus 148 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 227 (671)
+|++|++. .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|.++
T Consensus 247 ~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 247 ELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred ECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc
Confidence 99999997 6787765 58999999999999 5787664 58999999999999 4676553 57999999999999
Q ss_pred cccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCC
Q 005898 228 GSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN 307 (671)
Q Consensus 228 g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 307 (671)
..++.+ .++|+.|++++|.+++....++.+|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+..|+. +. .+
T Consensus 318 ~LP~~l--~~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP~~-l~--~s 389 (754)
T PRK15370 318 ALPETL--PPGLKTLEAGENALTSLPASLPPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPEN-LP--AA 389 (754)
T ss_pred cCCccc--cccceeccccCCccccCChhhcCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCCHh-HH--HH
Confidence 644333 368999999999998754456789999999999998 5777663 6899999999999987654 32 47
Q ss_pred cCeEecccCcCcccCCccc----CCCCCccEEECcCCcCc
Q 005898 308 ISDLNLASNKFSGSLPKNL----NCGGKLVFFDISNNKLT 343 (671)
Q Consensus 308 L~~L~L~~N~l~g~~p~~~----~~~~~L~~l~ls~N~l~ 343 (671)
|+.|++++|+|+ .+|..+ ..++.+..+++.+|.++
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 999999999998 566544 34578899999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=170.74 Aligned_cols=161 Identities=12% Similarity=0.144 Sum_probs=124.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhH---H------HHHHHHHHHhcCCCCCcccccceeecCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTV---R------NLKLRLDLLAKLRHPHLVCLLGHCIDGG 552 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~---~------~~~~E~~~l~~l~H~niv~l~g~~~~~~ 552 (671)
...|...+++|+|+||.||.+.. ++..+|||.+........ + .+.+|++.+.+++|++|..+..++....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 56799999999999999999655 567899999964322111 1 2689999999999999999988866432
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcE
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ 632 (671)
...-......+|||||+++.+|.++.. ++. ....+++.++..+|.. +++|||+||+||++++++ +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence 100001135799999999999977632 222 2455889999999997 899999999999999988 9
Q ss_pred EEcccCCccccc------------------cccccceeeeeeeh
Q 005898 633 KLSDYGLSIVSE------------------DINSVGVRLLILMS 658 (671)
Q Consensus 633 ki~DfGla~~~~------------------d~~s~g~~l~~~~~ 658 (671)
++.|||..+... |+|++|+++.....
T Consensus 174 ~liDfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhHHHHHHHhHhcccccccceeEeehHHHH
Confidence 999999876542 99999999876444
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=169.00 Aligned_cols=142 Identities=16% Similarity=0.191 Sum_probs=107.5
Q ss_pred CCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-----CCCCcccccceeecCCCCCCccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-----RHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+...+.||+|+||.||+ .++....+||++........+++.+|+.+++++ +||||++++|++.+..+.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~----- 76 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT----- 76 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC-----
Confidence 34568899999999996 333233479988655444567899999999999 679999999999875421
Q ss_pred ce-EEEEEec--CCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHhcCCCCCCccccCCCCCceeecC----CCc
Q 005898 560 NK-VFLVYEF--MSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV-QFLHTGVIPGFFNNRVKTNNILLNE----HRI 631 (671)
Q Consensus 560 ~~-~~Lv~Ey--~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~iiHrDlk~~NiLl~~----~~~ 631 (671)
.. ..+|+|| +++|+|.+++.+. .++.. ..++.++..++ +|||++ +|+||||||+||+++. +..
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 13 3478999 6689999999653 14444 35577778777 999997 8999999999999974 347
Q ss_pred EEEcc-cCCccc
Q 005898 632 AKLSD-YGLSIV 642 (671)
Q Consensus 632 ~ki~D-fGla~~ 642 (671)
++|+| ||....
T Consensus 148 ~~LiDg~G~~~~ 159 (210)
T PRK10345 148 PVVCDNIGESTF 159 (210)
T ss_pred EEEEECCCCcce
Confidence 99999 554444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.9e-18 Score=205.77 Aligned_cols=248 Identities=21% Similarity=0.247 Sum_probs=174.5
Q ss_pred chhcccCCC-CCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCC
Q 005898 110 FVTTLARLT-SLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDS 188 (671)
Q Consensus 110 ~~~~l~~l~-~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 188 (671)
+|..+..++ +|+.|++.++.+ ..+|..| .+.+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l-~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~ 655 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPL-RCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSM 655 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCC-CCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-ccc
Confidence 455555553 588888887766 5677766 5789999999999985 6888899999999999998876667775 888
Q ss_pred CCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCC
Q 005898 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNN 268 (671)
Q Consensus 189 l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N 268 (671)
+++|++|+|++|.....+|..++++++|+.|++++|.....+|...++++|+.|++++|...+.+|..+.+|..+++++|
T Consensus 656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n 735 (1153)
T PLN03210 656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET 735 (1153)
T ss_pred CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence 99999999999887789999999999999999999765566776558999999999999887888888889999999999
Q ss_pred CCCCCchhhhcCCcccce-------------------------------eecccccccCCCccccCCCCCcCeEecccCc
Q 005898 269 SFSGEIPKQYGQLNQLQQ-------------------------------LDMSFNALRGMPPPAIFSLPNISDLNLASNK 317 (671)
Q Consensus 269 ~l~~~~p~~~~~l~~L~~-------------------------------L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 317 (671)
.++ .+|..+ .+++|+. |+|++|...+.+|..+.++++|+.|++++|.
T Consensus 736 ~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 736 AIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred ccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 986 566543 3444444 4444444444444445555555555555443
Q ss_pred CcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 318 FSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 318 l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
..+.+|..+ ++++|+.|++++|.....+|.. ..+++.|++++|.++
T Consensus 814 ~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~ 859 (1153)
T PLN03210 814 NLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE 859 (1153)
T ss_pred CcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc
Confidence 333444433 3444555555544333333322 123445555555444
|
syringae 6; Provisional |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-19 Score=177.86 Aligned_cols=165 Identities=23% Similarity=0.383 Sum_probs=135.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 556 (671)
..+|.+.++||+|+|.+|..+++ ++.+.+|+|++++.- ..+.+=...|-.+..+. +||.+|.|...+.+..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes---- 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES---- 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc----
Confidence 46799999999999999999996 478999999986532 22222344565666665 6999999987776543
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
.++.|.||+++|+|--++++.+ ++......-+...|..||.|||++ +||.||||..|||+|..|.+|++|
T Consensus 325 ----rlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 325 ----RLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ----eEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 7899999999999988877543 477877777888899999999998 899999999999999999999999
Q ss_pred cCCccccc------------------------------cccccceeeeeeehhh
Q 005898 637 YGLSIVSE------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 637 fGla~~~~------------------------------d~~s~g~~l~~~~~~~ 660 (671)
+|+.+-.- |-|++||.|+|||.|-
T Consensus 395 ygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagr 448 (593)
T KOG0695|consen 395 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 448 (593)
T ss_pred cchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCC
Confidence 99985311 9999999999999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=165.09 Aligned_cols=171 Identities=18% Similarity=0.245 Sum_probs=142.8
Q ss_pred hcCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCC-CCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRH-PHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~~~~~ 559 (671)
..+|...++||+|+||.+|.|. ..+|+.||||.-.....+ .++..|..+.+.++| ..|..++.|..+..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~------- 84 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKD------- 84 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccc-------
Confidence 3578899999999999999998 568999999997654443 357788888888876 66777766665432
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec---CCCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN---EHRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~---~~~~~ki~D 636 (671)
.-.||||.. +.+|++...-... .++-.+.+.+|-|+..-++|+|.+ ++|||||||.|.|.. ....+.+.|
T Consensus 85 -ynvlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 85 -YNVLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred -cceeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 457999988 7799888765432 377788999999999999999998 689999999999985 335688999
Q ss_pred cCCccccccccccceeeeeeehhhhccccccc
Q 005898 637 YGLSIVSEDINSVGVRLLILMSFFFGSMTSCS 668 (671)
Q Consensus 637 fGla~~~~d~~s~g~~l~~~~~~~~~~~~~~~ 668 (671)
||+|+...|+-+--.|.|..-+...||.+|+|
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehh
Confidence 99999999999999999999999999999987
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.2e-21 Score=208.90 Aligned_cols=172 Identities=28% Similarity=0.451 Sum_probs=115.1
Q ss_pred CcCEEEcccccCCCCCcccccCCCCCCEEEeccCcc-----------------------ccccCCCCCCCCCCEEECCCC
Q 005898 191 SLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAI-----------------------SGSLPDLSSLGSLNVLNLSDN 247 (671)
Q Consensus 191 ~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l-----------------------~g~~p~~~~l~~L~~L~Ls~N 247 (671)
+|+++++++|+++ .+|+.++.+.+|+.++..+|++ +..+|....++.|++|+|..|
T Consensus 242 nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N 320 (1081)
T KOG0618|consen 242 NLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSN 320 (1081)
T ss_pred cceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhc
Confidence 4555555555555 3445555555555555555554 444444566889999999999
Q ss_pred CCCCCCCC---------------------CC-------CCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCc
Q 005898 248 KLDSNLPK---------------------LP-------RGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP 299 (671)
Q Consensus 248 ~l~~~~p~---------------------~~-------~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 299 (671)
++....+. ++ ..|+.|++.+|.++...-..+-..++|+.|+|++|+|...|.
T Consensus 321 ~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpa 400 (1081)
T KOG0618|consen 321 NLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPA 400 (1081)
T ss_pred cccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCH
Confidence 88643221 11 236678899999988877788888999999999999998888
Q ss_pred cccCCCCCcCeEecccCcCcccCCcccC----------------------CCCCccEEECcCCcCccc-CCCCCCCCCCC
Q 005898 300 PAIFSLPNISDLNLASNKFSGSLPKNLN----------------------CGGKLVFFDISNNKLTGG-LPSCLSNESDK 356 (671)
Q Consensus 300 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~----------------------~~~~L~~l~ls~N~l~g~-~p~~~~~~~~l 356 (671)
..+.++..|+.|+||+|+|+ .+|..+. .+++|+.+|+|.|+++-. +|... ..++|
T Consensus 401 s~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~L 478 (1081)
T KOG0618|consen 401 SKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNL 478 (1081)
T ss_pred HHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeechhhhhcCcceEEecccchhhhhhhhhhC-CCccc
Confidence 88899999999999999987 4555444 445566666666666422 22222 22556
Q ss_pred ceeccCCCc
Q 005898 357 RVVKFRGNC 365 (671)
Q Consensus 357 ~~l~l~~N~ 365 (671)
+.|++++|.
T Consensus 479 kyLdlSGN~ 487 (1081)
T KOG0618|consen 479 KYLDLSGNT 487 (1081)
T ss_pred ceeeccCCc
Confidence 666666664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=174.82 Aligned_cols=170 Identities=21% Similarity=0.302 Sum_probs=135.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCC--C----CcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRH--P----HLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~~~ 554 (671)
++.|.....+|+|.||.|-..... .+..||||+++...+. .+..+-|++++.++.+ | -+|++.+++.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr--- 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR--- 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc---
Confidence 567888899999999999998743 5789999999866543 3556779999999943 2 257777766543
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC------
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE------ 628 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~------ 628 (671)
....+|+|.| +-++++++.+.. ..+..-.+...++.|++++++|||+. .++|-||||+|||+-+
T Consensus 164 -----ghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 164 -----GHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred -----CceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 3678999988 458999998643 34577788999999999999999997 7999999999999832
Q ss_pred --------------CCcEEEcccCCccccc---------------------------cccccceeeeeeehhhhcccc
Q 005898 629 --------------HRIAKLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 629 --------------~~~~ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+..+||.|||-|.... |+||+|||++|+.+|..-..+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2457999999997633 999999999999998765443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-19 Score=182.36 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=172.5
Q ss_pred EEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccC-CcCCCCCCcccCCCCCcCEEEcccc
Q 005898 122 VLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDD-NFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 122 ~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
.++|..|+|+...|.+|..+++|+.||||+|+|+.+-|+.|.+|.+|.+|.+.+ |+|+...-+.|++|.+|+.|.+.-|
T Consensus 71 eirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan 150 (498)
T KOG4237|consen 71 EIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNAN 150 (498)
T ss_pred EEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChh
Confidence 456666777666666677777777777777777666667777777666665544 6666433356667777777777667
Q ss_pred cCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCC--CCCCC------------------C--
Q 005898 201 KLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDS--NLPKL------------------P-- 257 (671)
Q Consensus 201 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~--~~p~~------------------~-- 257 (671)
++.-.....|..+++|..|.+..|.+....- .+..+..++.+.+..|.+-. .+|.. +
T Consensus 151 ~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~r 230 (498)
T KOG4237|consen 151 HINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYR 230 (498)
T ss_pred hhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHH
Confidence 6665555666667777777776666653222 25556666666666555311 01100 0
Q ss_pred ------------------CCccEEEcCCCCCCCCch-hhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcC
Q 005898 258 ------------------RGLVMAFLSNNSFSGEIP-KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318 (671)
Q Consensus 258 ------------------~~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 318 (671)
.++..-..+.....+.-| ..|..+++|+.|+|++|+++++-+.+|.....++.|.|..|++
T Consensus 231 l~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l 310 (498)
T KOG4237|consen 231 LYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKL 310 (498)
T ss_pred HHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchH
Confidence 011111122222333334 4689999999999999999999999999999999999999999
Q ss_pred cccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCCc
Q 005898 319 SGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370 (671)
Q Consensus 319 ~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~~ 370 (671)
...-...|..+..|+.|+|.+|++|..-|-.+.....+..+++-.|.+..++
T Consensus 311 ~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 311 EFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred HHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence 8666667888999999999999999988988888889999999999887643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.8e-18 Score=176.87 Aligned_cols=170 Identities=25% Similarity=0.334 Sum_probs=138.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC------CCCcccccceeecCCCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR------HPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~~~ 556 (671)
.|....-.|+|-|++|.+|+.. .|.+||||++...... .+.=.+|+++|.++. --|.++|+-.|...
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk----- 506 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK----- 506 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-----
Confidence 4555556799999999999854 5889999999765432 234467899999884 24788888877654
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEEEc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLS 635 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~ki~ 635 (671)
+.++||+|-+.- +|.+.|...+...-|.......++.|+.-||..|-.. +|+|.||||.|||+++. ...|+|
T Consensus 507 ---nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 507 ---NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred ---ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 478999997754 8999998766555577888889999999999999875 89999999999999965 678999
Q ss_pred ccCCccccc----------------------------cccccceeeeeeehhhhccccc
Q 005898 636 DYGLSIVSE----------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 636 DfGla~~~~----------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
|||.|..+. |+||+||++||+.||.+-.||-
T Consensus 580 DfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 580 DFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 999986543 9999999999999998877763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=164.49 Aligned_cols=146 Identities=19% Similarity=0.333 Sum_probs=119.6
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEccCCch--------hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK--------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.||+|++|.||+|+. +|..|+||....... .....+.+|++++..++|++|+....++.+.+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-------- 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-------- 72 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--------
Confidence 5789999999999987 577899997643211 12346788999999999999988877765542
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++++|.+++... .+ .+..++.+++.+|+++|+. +++|||++|.||+++ ++.+++.|||.+
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 468999999999999988642 22 8889999999999999987 799999999999999 789999999999
Q ss_pred cccccccccceeee
Q 005898 641 IVSEDINSVGVRLL 654 (671)
Q Consensus 641 ~~~~d~~s~g~~l~ 654 (671)
+...+.+..+.-++
T Consensus 142 ~~~~~~~~~~~~~~ 155 (211)
T PRK14879 142 EFSKDLEDRAVDLH 155 (211)
T ss_pred cCCCcHHhhhccHH
Confidence 98877776665443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.2e-18 Score=188.78 Aligned_cols=151 Identities=18% Similarity=0.279 Sum_probs=117.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCC-c------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSS-K------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
...|...+.||+|+||+||+|++.....++.++.... . ....+.+.+|++++..++|++++..+.++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-- 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-- 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence 3445668899999999999998765443332222211 1 112456889999999999999998877776542
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++++|.+++. .+..++.++++++.|||+. +++|||+||+||++ +++.++|
T Consensus 410 ------~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 410 ------EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred ------CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEE
Confidence 4589999999999988775 3568899999999999987 79999999999999 5789999
Q ss_pred cccCCccccccccccceeeee
Q 005898 635 SDYGLSIVSEDINSVGVRLLI 655 (671)
Q Consensus 635 ~DfGla~~~~d~~s~g~~l~~ 655 (671)
.|||+++..++....+..++.
T Consensus 469 iDFGla~~~~~~~d~a~~l~~ 489 (535)
T PRK09605 469 IDFGLGKYSDLIEDKAVDLHV 489 (535)
T ss_pred EeCcccccCCchHhhhhhHHH
Confidence 999999988766555554443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-19 Score=162.83 Aligned_cols=162 Identities=33% Similarity=0.506 Sum_probs=142.1
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
.+.+++..+.|.|++|.++ .+|..+..|.+|+.|++++|++. .+|.+++.+++|+.|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4566777888899999995 56777999999999999999995 79999999999999999999988 789999999999
Q ss_pred CEEEcccccCC-CCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCC
Q 005898 193 TFLSMRNNKLA-GPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271 (671)
Q Consensus 193 ~~L~L~~N~l~-g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~ 271 (671)
+.|||.+|++. ..+|..|.-++.|+.|+|++|.|.-.+|+++.+++|+.|.+.+|.+-
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll--------------------- 163 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL--------------------- 163 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh---------------------
Confidence 99999999987 46889999999999999999999988888999999999988888653
Q ss_pred CCchhhhcCCcccceeecccccccCCCc
Q 005898 272 GEIPKQYGQLNQLQQLDMSFNALRGMPP 299 (671)
Q Consensus 272 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 299 (671)
.+|.+++.++.|++|.+.+|+++-.||
T Consensus 164 -~lpkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 164 -SLPKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred -hCcHHHHHHHHHHHHhcccceeeecCh
Confidence 578888888888888888888876665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-17 Score=170.91 Aligned_cols=146 Identities=23% Similarity=0.391 Sum_probs=123.0
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecC
Q 005898 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDG 551 (671)
Q Consensus 477 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 551 (671)
++....+.|...++||+|.|++||+|... ..+.||+|.+..... ......|+++|..+. |.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34445567888999999999999999843 467899999975543 245788999999995 99999999887654
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HR 630 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~ 630 (671)
+ .+.+|+||++.-+..++... ++......+......||+|+|+. +||||||||+|+|.+. .+
T Consensus 108 d--------~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~ 170 (418)
T KOG1167|consen 108 D--------QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQ 170 (418)
T ss_pred C--------eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccC
Confidence 3 78999999999998888864 67888888999999999999998 8999999999999985 46
Q ss_pred cEEEcccCCcc
Q 005898 631 IAKLSDYGLSI 641 (671)
Q Consensus 631 ~~ki~DfGla~ 641 (671)
.-.+.|||+|.
T Consensus 171 rg~LvDFgLA~ 181 (418)
T KOG1167|consen 171 RGVLVDFGLAQ 181 (418)
T ss_pred CceEEechhHH
Confidence 67899999996
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.8e-17 Score=163.56 Aligned_cols=142 Identities=13% Similarity=0.142 Sum_probs=108.9
Q ss_pred CCCcCceeccCCceEEEEEE--EcCCcEEEEEEccCCchh------------------------hHHHHHHHHHHHhcCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGR--LENGTSVAIRCLPSSKKY------------------------TVRNLKLRLDLLAKLR 537 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 537 (671)
.|+..+.||+|+||.||+|. ..+|+.||||.+...... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36677899999999999998 568999999998643210 1123568999999997
Q ss_pred CCCc--ccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCC-c
Q 005898 538 HPHL--VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPG-F 614 (671)
Q Consensus 538 H~ni--v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~-i 614 (671)
|..+ .+.+++ . ..++||||++++++..+.... ...+..+...++.+++.+++|||+. + |
T Consensus 109 ~~~i~~p~~~~~---~---------~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 109 EAGVPVPKPIAW---R---------RNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred hcCCCCCeeeEe---c---------CceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 6433 233321 1 248999999998887654322 1255556788999999999999987 7 9
Q ss_pred cccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 615 FNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 615 iHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
+||||||+||+++ ++++++.|||.+...+
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999998655
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=158.90 Aligned_cols=144 Identities=13% Similarity=0.154 Sum_probs=109.4
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch----------------------hhHHHHHHHHHHHh
Q 005898 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK----------------------YTVRNLKLRLDLLA 534 (671)
Q Consensus 477 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~----------------------~~~~~~~~E~~~l~ 534 (671)
++......+...+.||+|+||.||+|..++|+.||||++..... .....+.+|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33333334667789999999999999988899999998653220 01123677889999
Q ss_pred cCCCCCc--ccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCC
Q 005898 535 KLRHPHL--VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIP 612 (671)
Q Consensus 535 ~l~H~ni--v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~ 612 (671)
++.|+++ ++.++. ...++||||+++++|...... .....++.+++.++.++|+.
T Consensus 89 ~l~~~~i~v~~~~~~------------~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~--- 144 (198)
T cd05144 89 ALYEEGFPVPKPIDW------------NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH--- 144 (198)
T ss_pred HHHHcCCCCCceeec------------CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---
Confidence 9988753 333321 135899999999998765321 23457888999999999986
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
+|+||||||+||++++++.++|.|||++...+
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 89999999999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=4e-19 Score=187.14 Aligned_cols=255 Identities=24% Similarity=0.265 Sum_probs=164.9
Q ss_pred hhcccCCCCCCEEeccccccccc----CCccccCCCCCCEEEcccCcCCC------CCCccCCCCCccCEEEccCCcCCC
Q 005898 111 VTTLARLTSLRVLSLVSLGIWGS----LPDKIHRLYSLEYLDLSSNFLFG------SVPPKISTMVKLQTLILDDNFFNN 180 (671)
Q Consensus 111 ~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~L~~L~~L~Ls~N~l~~------~~p~~~~~l~~L~~L~L~~N~l~~ 180 (671)
...+..+.+|++|+++++.++.. ++..+...++|++|++++|.+.+ .++..+..+++|+.|++++|.+.+
T Consensus 16 ~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~ 95 (319)
T cd00116 16 TELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGP 95 (319)
T ss_pred HHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCCh
Confidence 34566677799999999887442 66667788889999998888752 234556778889999999888887
Q ss_pred CCCcccCCCCC---cCEEEcccccCCC----CCcccccCC-CCCCEEEeccCccccccC-----CCCCCCCCCEEECCCC
Q 005898 181 TIPNWFDSLPS---LTFLSMRNNKLAG----PFPSSIQRI-STLSDLDLSKNAISGSLP-----DLSSLGSLNVLNLSDN 247 (671)
Q Consensus 181 ~~p~~~~~l~~---L~~L~L~~N~l~g----~~p~~l~~l-~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~Ls~N 247 (671)
..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++... .+..+++|+.|++++|
T Consensus 96 ~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n 175 (319)
T cd00116 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANN 175 (319)
T ss_pred hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCC
Confidence 66666655555 8999998888873 233445566 888889999888874322 2556678888888888
Q ss_pred CCCCC----CCCC---CCCccEEEcCCCCCCCC----chhhhcCCcccceeecccccccCCCccccC-----CCCCcCeE
Q 005898 248 KLDSN----LPKL---PRGLVMAFLSNNSFSGE----IPKQYGQLNQLQQLDMSFNALRGMPPPAIF-----SLPNISDL 311 (671)
Q Consensus 248 ~l~~~----~p~~---~~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L 311 (671)
.+++. ++.. ...|+.+++++|.+++. ++..+..+++|++|++++|.+++.....+. ..+.|+.|
T Consensus 176 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L 255 (319)
T cd00116 176 GIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255 (319)
T ss_pred CCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEE
Confidence 88742 1111 13677777777776643 233455666777777777777653222221 13577777
Q ss_pred ecccCcCc----ccCCcccCCCCCccEEECcCCcCccc----CCCCCCCC-CCCceeccCCCc
Q 005898 312 NLASNKFS----GSLPKNLNCGGKLVFFDISNNKLTGG----LPSCLSNE-SDKRVVKFRGNC 365 (671)
Q Consensus 312 ~L~~N~l~----g~~p~~~~~~~~L~~l~ls~N~l~g~----~p~~~~~~-~~l~~l~l~~N~ 365 (671)
++++|.++ ..++..+....+|+.+|+++|.++.. +...+... +.++.+++.+|.
T Consensus 256 ~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred EccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 77777775 22333444456677777777777633 22222222 345555555553
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-17 Score=159.28 Aligned_cols=141 Identities=21% Similarity=0.325 Sum_probs=111.3
Q ss_pred eeccCCceEEEEEEEcCCcEEEEEEccCCc--------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 490 IMGEGSYGKLYKGRLENGTSVAIRCLPSSK--------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.||+|+||.||+|.+ +|..|+||...... ....+++.+|++++..++|+++.....++...+ .
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--------~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--------N 71 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--------C
Confidence 389999999999985 56789999864321 112356788999999999988766555554432 4
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++++|.+++.... . .++.++++++.++|.. +++|+|+||.||+++ ++.+++.|||+++
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CEEEEEEECCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 589999999999988875421 0 7899999999999986 899999999999999 7899999999998
Q ss_pred ccccccccceee
Q 005898 642 VSEDINSVGVRL 653 (671)
Q Consensus 642 ~~~d~~s~g~~l 653 (671)
.....+..+..+
T Consensus 138 ~~~~~~~~~~~~ 149 (199)
T TIGR03724 138 YSDEIEDKAVDL 149 (199)
T ss_pred CCCcHHhhhchH
Confidence 877655555433
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-18 Score=192.38 Aligned_cols=239 Identities=27% Similarity=0.366 Sum_probs=166.0
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
.+|++++++.|+++ .+|+.++.+.+|+.|+..+|+|+ .+|..+...++|+.|.+..|.+. .+|.....+++|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 35666666666664 34566666677777777666663 56666666666666666666666 45556666666666666
Q ss_pred ccccCCCCCccccc--------------------------CCCCCCEEEeccCcccc-ccCCCCCCCCCCEEECCCCCCC
Q 005898 198 RNNKLAGPFPSSIQ--------------------------RISTLSDLDLSKNAISG-SLPDLSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 198 ~~N~l~g~~p~~l~--------------------------~l~~L~~L~Ls~N~l~g-~~p~~~~l~~L~~L~Ls~N~l~ 250 (671)
..|+|. .+|+.+. .++.|+.|++.+|.++. .+|.+.+..+|+.|+|++|++.
T Consensus 318 ~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 318 QSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred hhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 666665 3333221 23456677778888765 3566788899999999999986
Q ss_pred CCCCCC---CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCccc-CCccc
Q 005898 251 SNLPKL---PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS-LPKNL 326 (671)
Q Consensus 251 ~~~p~~---~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~-~p~~~ 326 (671)
...... ...|+.|+||+|+++ .+|+.+.++..|++|...+|++...| .+..++.|+.+|++.|+|+-. +|...
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~ 473 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEAL 473 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech--hhhhcCcceEEecccchhhhhhhhhhC
Confidence 533322 245788999999998 78999999999999999999998877 789999999999999999843 44433
Q ss_pred CCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCC
Q 005898 327 NCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGN 364 (671)
Q Consensus 327 ~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N 364 (671)
..++|++|||++|.-.-.--..+..++.+...++.-|
T Consensus 474 -p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 474 -PSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred -CCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 3489999999999742111122333444444444444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.7e-16 Score=148.69 Aligned_cols=133 Identities=17% Similarity=0.179 Sum_probs=105.1
Q ss_pred CcCceeccCCceEEEEEEEcCCcEEEEEEccCCch---h-hHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccc
Q 005898 486 DMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK---Y-TVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 486 ~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~---~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.....+++|+||+||.+.- ++..++.+.+..... . ...-+.+|+++|++++ |+++++++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------------ 71 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------------ 71 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------------
Confidence 3467899999999997655 577788777765432 1 1235789999999995 58899998751
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCC-CCCceeecCCCcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-KTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-k~~NiLl~~~~~~ki~DfGl 639 (671)
..+++|||+++.+|...... ....+..+++++++|+|.. +|+|||| ||+||++++++.++|.|||+
T Consensus 72 ~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 72 GRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred CEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 35999999999998654321 1135678899999999997 8999999 79999999999999999999
Q ss_pred ccccc
Q 005898 640 SIVSE 644 (671)
Q Consensus 640 a~~~~ 644 (671)
|....
T Consensus 139 A~~~~ 143 (218)
T PRK12274 139 AVRGN 143 (218)
T ss_pred ceecC
Confidence 98654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.4e-18 Score=178.49 Aligned_cols=247 Identities=22% Similarity=0.237 Sum_probs=189.4
Q ss_pred EEeccccccc-ccCCccccCCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCCcCCC------CCCcccCCCC
Q 005898 122 VLSLVSLGIW-GSLPDKIHRLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDNFFNN------TIPNWFDSLP 190 (671)
Q Consensus 122 ~L~L~~n~l~-g~~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~ 190 (671)
.|+|..+.+. +..+..+..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677778886 55677788889999999999998543 56677888899999999998873 2345677899
Q ss_pred CcCEEEcccccCCCCCcccccCCCC---CCEEEeccCcccccc----C-CCCCC-CCCCEEECCCCCCCCCCCC----C-
Q 005898 191 SLTFLSMRNNKLAGPFPSSIQRIST---LSDLDLSKNAISGSL----P-DLSSL-GSLNVLNLSDNKLDSNLPK----L- 256 (671)
Q Consensus 191 ~L~~L~L~~N~l~g~~p~~l~~l~~---L~~L~Ls~N~l~g~~----p-~~~~l-~~L~~L~Ls~N~l~~~~p~----~- 256 (671)
+|+.|++++|.+.+..+..+..+.+ |+.|++++|.+++.. . .+..+ ++|+.|++++|.+++.... .
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998777777766666 999999999987421 1 24556 8999999999999853221 1
Q ss_pred --CCCccEEEcCCCCCCCC----chhhhcCCcccceeecccccccCCC----ccccCCCCCcCeEecccCcCcccCCccc
Q 005898 257 --PRGLVMAFLSNNSFSGE----IPKQYGQLNQLQQLDMSFNALRGMP----PPAIFSLPNISDLNLASNKFSGSLPKNL 326 (671)
Q Consensus 257 --~~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~g~~p~~~ 326 (671)
...++.+++++|.+++. ++..+..+++|+.|++++|.+++.. ...+..+++|+.|++++|.+++..+..+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 24799999999999853 3445666779999999999987553 3345678899999999999986333222
Q ss_pred C-----CCCCccEEECcCCcCc----ccCCCCCCCCCCCceeccCCCcCCC
Q 005898 327 N-----CGGKLVFFDISNNKLT----GGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 327 ~-----~~~~L~~l~ls~N~l~----g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
. ....|+.|++++|.++ ..+...+...+.++.+++++|.++.
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 1 2478999999999997 2334445556789999999998874
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=143.79 Aligned_cols=149 Identities=14% Similarity=0.179 Sum_probs=122.4
Q ss_pred cCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCC--CCcccccceeecCCCCCCcccceEEE
Q 005898 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRH--PHLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
+.+.||+|.++.||+++..+ ..++||....... ..++.+|+..+..++| .++++++++...+ +..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--------~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD--------GWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--------CccEE
Confidence 35679999999999999754 7899999865433 4678899999999987 4888887776543 25799
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
+|||++++.+..+ ++..+..++.+++++++++|....++++|+|+||+||++++.+.+++.|||.++..+
T Consensus 71 v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 71 LMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred EEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 9999998877543 566778889999999999998655579999999999999998999999999999888
Q ss_pred cccccceeeeee
Q 005898 645 DINSVGVRLLIL 656 (671)
Q Consensus 645 d~~s~g~~l~~~ 656 (671)
..+.++..++.+
T Consensus 141 ~~~d~~~~~~~~ 152 (155)
T cd05120 141 PAFDLAAALLFN 152 (155)
T ss_pred hHHHHHHHHHHh
Confidence 777777765443
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.6e-18 Score=153.64 Aligned_cols=160 Identities=29% Similarity=0.438 Sum_probs=89.1
Q ss_pred cCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCC
Q 005898 168 LQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDN 247 (671)
Q Consensus 168 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N 247 (671)
.+.|.|++|+++ .+|+.+..|.+|+.|++++|+++ .+|.+++++++|+.|+++.|++.-.+-.|++++.|++|||+.|
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltyn 112 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYN 112 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcccc
Confidence 333444444443 23334444444445555555544 4455555555555555555555433334555555555555555
Q ss_pred CCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccC
Q 005898 248 KLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327 (671)
Q Consensus 248 ~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 327 (671)
++.. ..+|..|-.++.|+-|+|+.|.|.-.|| .++.+++|+.|.+..|.+- .+|..++
T Consensus 113 nl~e--------------------~~lpgnff~m~tlralyl~dndfe~lp~-dvg~lt~lqil~lrdndll-~lpkeig 170 (264)
T KOG0617|consen 113 NLNE--------------------NSLPGNFFYMTTLRALYLGDNDFEILPP-DVGKLTNLQILSLRDNDLL-SLPKEIG 170 (264)
T ss_pred cccc--------------------ccCCcchhHHHHHHHHHhcCCCcccCCh-hhhhhcceeEEeeccCchh-hCcHHHH
Confidence 4432 1234445555666666666666664443 5666777777777777665 5677777
Q ss_pred CCCCccEEECcCCcCcccCCCCCCC
Q 005898 328 CGGKLVFFDISNNKLTGGLPSCLSN 352 (671)
Q Consensus 328 ~~~~L~~l~ls~N~l~g~~p~~~~~ 352 (671)
.++.|+.|.+.+|+++ .+|+.+++
T Consensus 171 ~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 171 DLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred HHHHHHHHhcccceee-ecChhhhh
Confidence 7777777777777776 56655554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.2e-16 Score=153.44 Aligned_cols=170 Identities=16% Similarity=0.257 Sum_probs=134.4
Q ss_pred cCCCcCceeccCCceEEEEEE-EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
-+|...++||+|.||+.+.|+ +-+++.||||.-....+ ..++..|-+..+.+ .-+.|...+-|-..+ -
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG--------~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEG--------K 97 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeecccc--------c
Confidence 358889999999999999998 66899999998654332 33455565555555 458888775443322 1
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-----CCcEEEc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-----HRIAKLS 635 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-----~~~~ki~ 635 (671)
.-.||+|.. +.+|++...=++ +.++..+...||.|+..-++|+|++ ..|.|||||+|.||.. ...+.+.
T Consensus 98 ~NiLVidLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 458999988 668877665332 3488999999999999999999997 7899999999999964 3458999
Q ss_pred ccCCccccccccccceeeeeeehhhhccccccc
Q 005898 636 DYGLSIVSEDINSVGVRLLILMSFFFGSMTSCS 668 (671)
Q Consensus 636 DfGla~~~~d~~s~g~~l~~~~~~~~~~~~~~~ 668 (671)
|||+|+.+.|-..--+|.|..-....||.+|-|
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeE
Confidence 999999999888888899988888888888865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.7e-16 Score=162.68 Aligned_cols=172 Identities=22% Similarity=0.321 Sum_probs=131.6
Q ss_pred CCCcCceeccCCceEEEEEEEcC--CcEEEEEEccCCchhhHHHHHHHHHHHhcCCC----CCcccccceee-cCCCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLEN--GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRH----PHLVCLLGHCI-DGGGRDD 556 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~~-~~~~~~~ 556 (671)
.|+..+.||+|+||.||++.... ...+|+|............+..|+.++..+.+ +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~----- 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE----- 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----
Confidence 78899999999999999998654 35788888765433222267888888888873 57777777663 22
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-----Cc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-----RI 631 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-----~~ 631 (671)
...++||+.. +.+|.+...... .+.++-.+.++|+.|+..+|+++|+. +++||||||.|+++... ..
T Consensus 94 ---~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 94 ---DFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred ---ceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccce
Confidence 3679999977 669988765433 45699999999999999999999987 89999999999999754 46
Q ss_pred EEEcccCCccccccccccce--eeeee-ehhhhccccccc
Q 005898 632 AKLSDYGLSIVSEDINSVGV--RLLIL-MSFFFGSMTSCS 668 (671)
Q Consensus 632 ~ki~DfGla~~~~d~~s~g~--~l~~~-~~~~~~~~~~~~ 668 (671)
+.+.|||+++.....-..|. +-..- -..++||.+|||
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S 205 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYAS 205 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCcccccc
Confidence 89999999985544333443 33333 356789999997
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=172.21 Aligned_cols=159 Identities=26% Similarity=0.417 Sum_probs=121.3
Q ss_pred CCCChHHHHHHHHHHhcCCCCCCCCCccCCCCCCCCCCCCCccceEeCCCCEeEEEecCCCCCCCCCCCCcccccccCCC
Q 005898 24 HQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSE 103 (671)
Q Consensus 24 ~~~~~~~~~~Ll~~k~~~~~~~~l~~W~~~~~~~C~~~~~~~~~v~C~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~l~~ 103 (671)
.++.+.|.+||+++|+.+.++.. .+|.. |+|......|.||.|.....+
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~-~~W~g---~~C~p~~~~w~Gv~C~~~~~~--------------------------- 415 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR-FGWNG---DPCVPQQHPWSGADCQFDSTK--------------------------- 415 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc-CCCCC---CCCCCcccccccceeeccCCC---------------------------
Confidence 34566899999999999876643 37953 567422224568999421100
Q ss_pred ccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCC
Q 005898 104 NFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIP 183 (671)
Q Consensus 104 n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 183 (671)
....++.|+|++|.+.|.+|..+++|++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|
T Consensus 416 ------------~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP 483 (623)
T PLN03150 416 ------------GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483 (623)
T ss_pred ------------CceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCc
Confidence 01125678888999999999999999999999999999999999989999999999999999999999
Q ss_pred cccCCCCCcCEEEcccccCCCCCcccccCC-CCCCEEEeccCc
Q 005898 184 NWFDSLPSLTFLSMRNNKLAGPFPSSIQRI-STLSDLDLSKNA 225 (671)
Q Consensus 184 ~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l-~~L~~L~Ls~N~ 225 (671)
..+++|++|++|+|++|+++|.+|..++.+ .++..+++++|.
T Consensus 484 ~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 484 ESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred hHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 999999999999999999999988887653 345556666554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=144.23 Aligned_cols=137 Identities=15% Similarity=0.228 Sum_probs=94.8
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchh--hHHHH----------------------HHHHHHHhcCCCCC--c
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY--TVRNL----------------------KLRLDLLAKLRHPH--L 541 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--i 541 (671)
.+.||+|+||.||+|+..+|+.||||++...... ....+ ..|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999998643211 11111 23444444444332 2
Q ss_pred ccccceeecCCCCCCcccceEEEEEecCCCCChhhh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCC
Q 005898 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH-ISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVK 620 (671)
Q Consensus 542 v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 620 (671)
.+.++. ...++||||+++|++... +.... .. .+...++.+++.++.++|.. .+|+|||||
T Consensus 82 ~~~~~~------------~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~ 142 (187)
T cd05119 82 PKPIDL------------NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLS 142 (187)
T ss_pred CceEec------------CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCC
Confidence 222211 135899999999654321 22111 11 45678899999999999982 279999999
Q ss_pred CCceeecCCCcEEEcccCCccccc
Q 005898 621 TNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 621 ~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
|+||+++ ++.+++.|||.+....
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhhEEEE-CCcEEEEECccccccc
Confidence 9999999 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.9e-17 Score=165.60 Aligned_cols=277 Identities=23% Similarity=0.245 Sum_probs=211.2
Q ss_pred CCCCCCCCCccceEeCCCCEeEEEecCCCCCCCCCCCCcccccccCCCccCCCcchhcccCCCCCCEEecccccccccCC
Q 005898 56 DFCYISSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLP 135 (671)
Q Consensus 56 ~~C~~~~~~~~~v~C~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p 135 (671)
.+|..+......|+|....++++ +.+.|..+..+ .|-.|.+....+.+|..+++||.|||++|+|+.+-|
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eV--P~~LP~~tvei--------rLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p 108 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEV--PANLPPETVEI--------RLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAP 108 (498)
T ss_pred CCcccCCCCCceEEccCCCcccC--cccCCCcceEE--------EeccCCcccCChhhccchhhhceecccccchhhcCh
Confidence 45665543444588876555543 33333322111 233444444445689999999999999999999999
Q ss_pred ccccCCCCCCEEEccc-CcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcc-cccCC
Q 005898 136 DKIHRLYSLEYLDLSS-NFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPS-SIQRI 213 (671)
Q Consensus 136 ~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~l~~l 213 (671)
+.|.+|.+|..|-+.+ |+|+...-..|++|..|+.|.+.-|++.-...+.|..|++|..|.+.+|.+. .++. .|..+
T Consensus 109 ~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l 187 (498)
T KOG4237|consen 109 DAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGL 187 (498)
T ss_pred HhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccch
Confidence 9999999988876655 9998655578999999999999999999888899999999999999999998 5555 88999
Q ss_pred CCCCEEEeccCcccc------------ccC-CCCCCCCCCEEEC-------------------------CCCCCCCCCCC
Q 005898 214 STLSDLDLSKNAISG------------SLP-DLSSLGSLNVLNL-------------------------SDNKLDSNLPK 255 (671)
Q Consensus 214 ~~L~~L~Ls~N~l~g------------~~p-~~~~l~~L~~L~L-------------------------s~N~l~~~~p~ 255 (671)
..++.+.+..|.+-- ..| .++...-.....+ +.....+..|.
T Consensus 188 ~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~ 267 (498)
T KOG4237|consen 188 AAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPA 267 (498)
T ss_pred hccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChH
Confidence 999999998887321 011 0111111111111 11112222332
Q ss_pred ----CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCC
Q 005898 256 ----LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGK 331 (671)
Q Consensus 256 ----~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~ 331 (671)
-.++|+.++|++|++++.-+.+|..+..+++|.|..|++...-...|.++..|+.|+|.+|+++..-|..|..+..
T Consensus 268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 1357899999999999999999999999999999999999888889999999999999999999999999999999
Q ss_pred ccEEECcCCcCc
Q 005898 332 LVFFDISNNKLT 343 (671)
Q Consensus 332 L~~l~ls~N~l~ 343 (671)
|..|+|-.|.+.
T Consensus 348 l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 348 LSTLNLLSNPFN 359 (498)
T ss_pred eeeeehccCccc
Confidence 999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.8e-15 Score=176.92 Aligned_cols=119 Identities=20% Similarity=0.277 Sum_probs=93.4
Q ss_pred CCC-CCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCc
Q 005898 536 LRH-PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGF 614 (671)
Q Consensus 536 l~H-~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 614 (671)
++| +||++++++|..+. .+....+..+.++||+ .++|++++... ...+++.+++.++.||++||+|||+. +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGN-LDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCcc-ccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 455 68888999874432 1112224578889988 55999999743 24599999999999999999999987 89
Q ss_pred cccCCCCCceeec-------------------CCCcEEEcccCCccc--------------------------------c
Q 005898 615 FNNRVKTNNILLN-------------------EHRIAKLSDYGLSIV--------------------------------S 643 (671)
Q Consensus 615 iHrDlk~~NiLl~-------------------~~~~~ki~DfGla~~--------------------------------~ 643 (671)
+||||||+|||++ .++.+|++|||+++. +
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999994 456788999998741 0
Q ss_pred c--------------cccccceeeeeeehhhh
Q 005898 644 E--------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 ~--------------d~~s~g~~l~~~~~~~~ 661 (671)
. |+||+||++|||+++..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~ 213 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVS 213 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCC
Confidence 0 99999999999998554
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.1e-14 Score=139.87 Aligned_cols=141 Identities=15% Similarity=0.196 Sum_probs=106.3
Q ss_pred Cceec-cCCceEEEEEEEcCCcEEEEEEccCCc-------------hhhHHHHHHHHHHHhcCCCCCc--ccccceeecC
Q 005898 488 SAIMG-EGSYGKLYKGRLENGTSVAIRCLPSSK-------------KYTVRNLKLRLDLLAKLRHPHL--VCLLGHCIDG 551 (671)
Q Consensus 488 ~~~iG-~G~~g~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 551 (671)
..+|| .|+.|+||+.+.. +..++||+..... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999998875 6789998875321 1123467889999999999886 5666665432
Q ss_pred CCCCCcccceEEEEEecCCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 552 GGRDDYAVNKVFLVYEFMSN-GNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
.+ .....++||||+++ .+|.+++... .++.. .+.++++++.++|+. +|+||||||.|||++.++
T Consensus 115 ~~----~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 HG----LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred cC----cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 21 01123699999997 6898887642 24332 356789999999997 899999999999999989
Q ss_pred cEEEcccCCccccc
Q 005898 631 IAKLSDYGLSIVSE 644 (671)
Q Consensus 631 ~~ki~DfGla~~~~ 644 (671)
.+++.|||.+....
T Consensus 180 ~v~LIDfg~~~~~~ 193 (239)
T PRK01723 180 KFWLIDFDRGELRT 193 (239)
T ss_pred CEEEEECCCcccCC
Confidence 99999999987653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.6e-14 Score=146.98 Aligned_cols=138 Identities=22% Similarity=0.338 Sum_probs=113.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-----C---CCcccccceeecCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-----H---PHLVCLLGHCIDGGG 553 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~~~~ 553 (671)
..|...++||=|.|++||.|... +.+-||+|+.+..... .+....||++|++++ | .+||+|+++|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG- 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG- 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence 56778899999999999999854 6789999998765433 455678999998874 2 37999999998765
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
++...+.||+|+. +-+|-.++.... .+-+......+|+.||..||.|||..| +|||-||||+|||+...
T Consensus 156 ---pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 156 ---PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred ---CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 3456899999999 558888887543 334888999999999999999999998 89999999999999643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-13 Score=141.46 Aligned_cols=146 Identities=29% Similarity=0.535 Sum_probs=122.1
Q ss_pred CCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchh---hHHHHHHHHHHHhcCCCC-CcccccceeecCCCCCCcccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY---TVRNLKLRLDLLAKLRHP-HLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~~~~~ 560 (671)
|.....+|.|+||.||++... ..+|+|.+...... ..+.+.+|+.+++.+.|+ +|+++.+++....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-------- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-------- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--------
Confidence 455678999999999999876 78999999754332 367899999999999988 7999999885432
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~DfGl 639 (671)
..++++||+.++++.+++........+.......+..+++.+++|+|.. +++|||+||+||+++... .+++.|||.
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 4799999999999996665432112488889999999999999999997 699999999999999988 799999999
Q ss_pred cccc
Q 005898 640 SIVS 643 (671)
Q Consensus 640 a~~~ 643 (671)
++..
T Consensus 149 ~~~~ 152 (384)
T COG0515 149 AKLL 152 (384)
T ss_pred ceec
Confidence 8744
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=156.75 Aligned_cols=110 Identities=28% Similarity=0.476 Sum_probs=101.1
Q ss_pred ccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcC
Q 005898 260 LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISN 339 (671)
Q Consensus 260 L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~ 339 (671)
+..|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|+.+..+.+|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 66789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCcccCCCCCCCC-CCCceeccCCCcCCCC
Q 005898 340 NKLTGGLPSCLSNE-SDKRVVKFRGNCLSSN 369 (671)
Q Consensus 340 N~l~g~~p~~~~~~-~~l~~l~l~~N~l~~~ 369 (671)
|+++|.+|..+... .++..+++.+|...+.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccC
Confidence 99999999988753 3566788888875543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.5e-13 Score=148.02 Aligned_cols=145 Identities=19% Similarity=0.265 Sum_probs=101.2
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhh----------------------------------------H
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYT----------------------------------------V 523 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~----------------------------------------~ 523 (671)
.|+ .+.||+|++|.||+|++.+|+.||||+....-... .
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 454 46899999999999999999999999975431100 0
Q ss_pred HHHHHHHHHHhcC----CCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHH
Q 005898 524 RNLKLRLDLLAKL----RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599 (671)
Q Consensus 524 ~~~~~E~~~l~~l----~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~i 599 (671)
-+|.+|++.+.++ +|.+-|..-.++.+.. +..+|||||+++++|.++......+ . .+.+++..+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-------~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~ 265 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRT-------SERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENL 265 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc-------CCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHH
Confidence 1245566555554 2333333323333221 2468999999999998876532111 2 345677666
Q ss_pred HH-HHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 600 AK-AVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 600 a~-gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
++ .+.++|.. +++|+|+||.||++++++.+++.|||++..++
T Consensus 266 ~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 65 46778876 89999999999999999999999999997765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2e-13 Score=156.54 Aligned_cols=148 Identities=25% Similarity=0.398 Sum_probs=109.9
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC---CCCcccccceeecCCCCC
Q 005898 479 KEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR---HPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 479 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~ 555 (671)
......|.+...||+|+||+||+|...+|+.||+|.-+....= +|.--.+++.+++ -+-|..+...+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~---- 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ---- 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC----
Confidence 3445668888999999999999999888999999997654320 1222223344444 12233333322222
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-------
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE------- 628 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~------- 628 (671)
+..+||+||.+.|+|-+++.. .+.++|.-.+-++.++++-++.||.. +|||+||||.|.+|..
T Consensus 767 ----~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 767 ----NASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred ----CcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence 245899999999999999873 45699999999999999999999997 8999999999999942
Q ss_pred CCcEEEcccCCcccc
Q 005898 629 HRIAKLSDYGLSIVS 643 (671)
Q Consensus 629 ~~~~ki~DfGla~~~ 643 (671)
.--.+|.|||.|..+
T Consensus 837 ~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDM 851 (974)
T ss_pred ccceEEEecccceee
Confidence 345899999998543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4e-14 Score=136.36 Aligned_cols=160 Identities=21% Similarity=0.403 Sum_probs=126.6
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEE
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLV 565 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv 565 (671)
..+|.+...|..|+|++.. ..+++|++... ...-.++|.+|.-.++-+.||||.+++|.|.++. ...++
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp--------nlv~i 265 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP--------NLVII 265 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC--------CceEe
Confidence 4567888899999999974 34555666533 2333578999999999999999999999998874 57899
Q ss_pred EecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc--c--cCCcc
Q 005898 566 YEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS--D--YGLSI 641 (671)
Q Consensus 566 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~--D--fGla~ 641 (671)
..|||.|+|+..||+.. ...++..+..++|.+||+|++|||+-- |-|..--|.+..+++|++.+++|+ | |.+-.
T Consensus 266 sq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred eeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 99999999999999764 456888999999999999999999853 334445789999999999998874 3 22211
Q ss_pred c---c---------------------ccccccceeeeeeeh
Q 005898 642 V---S---------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 642 ~---~---------------------~d~~s~g~~l~~~~~ 658 (671)
. + -|.||+.+.+||+.|
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t 384 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT 384 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence 1 1 199999999999876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5e-13 Score=150.24 Aligned_cols=159 Identities=19% Similarity=0.304 Sum_probs=122.0
Q ss_pred CcCceeccCCceEEEEEEE-cCCcEEEEEEcc----CCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 486 DMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLP----SSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 486 ~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~----~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
...+++|+|++|.|+...- ...+..+.|... ... ......+..|..+=..++|+|++..+..+.+..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~------ 394 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID------ 394 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc------
Confidence 4568899999998877763 334444444332 111 111122556777777899999998887776653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..+-+|||+++ ||...+... ..+...++..+..|+.+|+.|+|.. +|.|||+|++|++++.++.+||+|||
T Consensus 395 --~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 395 --GILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred --cchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 23444999999 999988753 2377788899999999999999997 89999999999999999999999999
Q ss_pred Cccccc-----------------------------------cccccceeeeeeehh
Q 005898 639 LSIVSE-----------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 639 la~~~~-----------------------------------d~~s~g~~l~~~~~~ 659 (671)
.+.... |+||+|++++.|.++
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~ 521 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG 521 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC
Confidence 885432 999999999999987
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.7e-14 Score=148.64 Aligned_cols=193 Identities=30% Similarity=0.379 Sum_probs=148.3
Q ss_pred CCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEE
Q 005898 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLS 196 (671)
Q Consensus 117 l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 196 (671)
++.-...||+.|.+ ..+|..+..+..|+.|.|++|.+. .+|..+.+|..|+.|+|+.|+++ .+|..++.|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~-~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRF-SELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhcccccc-ccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 44445667778877 478888888888888888888884 78888888888888888888887 6777777776 88888
Q ss_pred cccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCC-CCccEEEcCCCCCCCCch
Q 005898 197 MRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLP-RGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 197 L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~L~~l~l~~N~l~~~~p 275 (671)
+++|+++ .+|+.++.+..|..||.+.|.+...++.++.+.+|+.|.+..|++....+.+. -.|..||++.|+++ .+|
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLP 227 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecc
Confidence 8888887 78888888888888888888888777778888888888888888765555443 24677888888887 789
Q ss_pred hhhcCCcccceeecccccccCCCccccC---CCCCcCeEecccC
Q 005898 276 KQYGQLNQLQQLDMSFNALRGMPPPAIF---SLPNISDLNLASN 316 (671)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~N 316 (671)
-.|.+|+.|++|-|.+|.|...|. .+. ...-.++|+..-+
T Consensus 228 v~fr~m~~Lq~l~LenNPLqSPPA-qIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQSPPA-QICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred hhhhhhhhheeeeeccCCCCCChH-HHHhccceeeeeeecchhc
Confidence 999999999999999999986543 332 2223355665555
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.7e-12 Score=120.28 Aligned_cols=144 Identities=15% Similarity=0.106 Sum_probs=105.5
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCccc-ccceeecCCCCCCcccceEEEEE
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVC-LLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
.+.++.|.++.||+++.. +..|++|....... ....+.+|++.+..+.+.++++ ++++..+ ..++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----------~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPE----------TGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCC----------CCeEEE
Confidence 356899999999999865 77899999754432 1235678888888887666554 4433211 247999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCC--CCccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVI--PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~--~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
||+++.++... . . ....++.+++++++.||.... +.++|+|+++.||+++ ++.+++.|||.+...+
T Consensus 71 e~i~G~~l~~~-~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 71 EFIEGSELLTE-D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred EecCCCccccc-c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 99999887543 0 0 112456788999999998742 2469999999999999 5689999999999888
Q ss_pred cccccceeeee
Q 005898 645 DINSVGVRLLI 655 (671)
Q Consensus 645 d~~s~g~~l~~ 655 (671)
..|.++..+.+
T Consensus 139 ~~~Dla~~~~~ 149 (170)
T cd05151 139 PLFDLANFFSE 149 (170)
T ss_pred hHHHHHHHHHh
Confidence 77777766533
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.3e-13 Score=145.01 Aligned_cols=160 Identities=28% Similarity=0.360 Sum_probs=125.6
Q ss_pred eeccCCceEEEEEE----EcCCcEEEEEEccCCchh--hHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccceE
Q 005898 490 IMGEGSYGKLYKGR----LENGTSVAIRCLPSSKKY--TVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~----~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+|+||.|+..+ .+.|+.+|.|.+++.... .......|..++...+ ||.+|++...+..+ ...
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--------~kl 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--------GKL 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--------cch
Confidence 36999999999654 345788899888654321 1224566778888887 99999996655544 368
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
+++.+|..+|++...+.... ..+......+....|-+++++|.. .|+|||+|++||++|.+|.+|+.|||+++.
T Consensus 73 ~l~ld~~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 73 YLILDFLRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hHhhhhcccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 99999999999988876543 255555556666778899999987 899999999999999999999999999864
Q ss_pred c------------------------ccccccceeeeeeehhhhcc
Q 005898 643 S------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 643 ~------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
. .|-||+|+++++|+++....
T Consensus 147 ~v~~~~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf 191 (612)
T KOG0603|consen 147 AVKEKIACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPF 191 (612)
T ss_pred hHhhhhcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCC
Confidence 2 19999999999999986543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.2e-13 Score=145.70 Aligned_cols=176 Identities=31% Similarity=0.476 Sum_probs=125.8
Q ss_pred cCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCE
Q 005898 139 HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218 (671)
Q Consensus 139 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~ 218 (671)
..|.--...||+.|++. .+|..+..+..|..|.|..|.|. .+|..++++..|++|||+.|+++ .+|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 45666677899999996 79999999999999999999987 78999999999999999999998 7888888874 899
Q ss_pred EEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCC
Q 005898 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP 298 (671)
Q Consensus 219 L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 298 (671)
|-+++|+++..+++++.+..|..||.+.|.+.. +|..++.+.+|+.|++..|++...|
T Consensus 148 li~sNNkl~~lp~~ig~~~tl~~ld~s~nei~s----------------------lpsql~~l~slr~l~vrRn~l~~lp 205 (722)
T KOG0532|consen 148 LIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQS----------------------LPSQLGYLTSLRDLNVRRNHLEDLP 205 (722)
T ss_pred EEEecCccccCCcccccchhHHHhhhhhhhhhh----------------------chHHhhhHHHHHHHHHhhhhhhhCC
Confidence 999999999777778888889999998888764 3444444444444444444444444
Q ss_pred ccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCc
Q 005898 299 PPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 299 ~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~ 343 (671)
+. +..| .|..||++.|+++ .||-.|..+..|++|.|.+|.|+
T Consensus 206 ~E-l~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 206 EE-LCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HH-HhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 32 2222 2444455555444 44444444445555555554444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-12 Score=139.90 Aligned_cols=199 Identities=32% Similarity=0.488 Sum_probs=135.5
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCC-ccCEEEccCCcCCCCCCcccCCCCCcCEEEccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMV-KLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (671)
..|++..|.+...+ ..+..++.++.|++.+|.++ .+|+....+. +|+.|++++|.+. .+|..++.+++|+.|++++
T Consensus 96 ~~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 35777777764333 34566688899999999886 6777777775 8999999999887 5667788899999999999
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhc
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYG 279 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~ 279 (671)
|+++ .+|...+.+++|+.|++++|+++...+....+..|++|.+++|.+. .++..+.
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~----------------------~~~~~~~ 229 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII----------------------ELLSSLS 229 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce----------------------ecchhhh
Confidence 9988 6777776888899999999988855444455666888888887522 2344455
Q ss_pred CCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCC
Q 005898 280 QLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPS 348 (671)
Q Consensus 280 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~ 348 (671)
++.++..|.+++|++... +..+..+++++.|++++|.++ .++. +....+++.||+++|.++..+|.
T Consensus 230 ~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 230 NLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hcccccccccCCceeeec-cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 555555555555555543 234555555666666666665 2232 55556666666666666544443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.5e-12 Score=137.03 Aligned_cols=197 Identities=32% Similarity=0.491 Sum_probs=155.7
Q ss_pred CEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCC-CcCEEEcccccCCCCCcccccCCCCCCEEEecc
Q 005898 145 EYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLP-SLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSK 223 (671)
Q Consensus 145 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~ 223 (671)
..|+++.|.+.. .+..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++
T Consensus 96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 468888887742 3445666688889999999888 6777777774 8999999999887 6777788888888888888
Q ss_pred CccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccC
Q 005898 224 NAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIF 303 (671)
Q Consensus 224 N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 303 (671)
|+++...+..+.+++|+.|++++|+++ .+|........|++|++++|.+...+ ..+.
T Consensus 173 N~l~~l~~~~~~~~~L~~L~ls~N~i~----------------------~l~~~~~~~~~L~~l~~~~N~~~~~~-~~~~ 229 (394)
T COG4886 173 NDLSDLPKLLSNLSNLNNLDLSGNKIS----------------------DLPPEIELLSALEELDLSNNSIIELL-SSLS 229 (394)
T ss_pred chhhhhhhhhhhhhhhhheeccCCccc----------------------cCchhhhhhhhhhhhhhcCCcceecc-hhhh
Confidence 888865554457778888888777765 56666667778999999999644443 4678
Q ss_pred CCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCCc
Q 005898 304 SLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370 (671)
Q Consensus 304 ~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~~ 370 (671)
.+.++..+.+.+|++. .+|..+..+..++.|++++|.++ .++. ++...+++.+++++|.++...
T Consensus 230 ~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 230 NLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred hcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccc
Confidence 8999999999999987 34778888889999999999998 4554 888899999999999888543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.2e-11 Score=132.19 Aligned_cols=144 Identities=15% Similarity=0.191 Sum_probs=89.4
Q ss_pred cCCCcCceeccCCceEEEEEEEcC-CcEEEEEEccCCchh------------------------------h----HH---
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN-GTSVAIRCLPSSKKY------------------------------T----VR--- 524 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~------------------------------~----~~--- 524 (671)
..|+. +.||+|++|+||+|++++ |+.||||+....-.. - .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45766 789999999999999986 999999998643110 0 11
Q ss_pred ---HHHHHHHHHhcCC----CCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhh--hhcCCCCCCCCHHHHHHH
Q 005898 525 ---NLKLRLDLLAKLR----HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH--ISENTPGKVLNWSERLAV 595 (671)
Q Consensus 525 ---~~~~E~~~l~~l~----H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~--l~~~~~~~~l~~~~~~~i 595 (671)
+|.+|++.+.+++ +.+.|.+=.++++- ....+|||||++|+.+.+. +...+ .+ +..+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-------st~~VLvmE~i~G~~l~d~~~l~~~g----~d---~~~l 264 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-------CSETVMVMERMYGIPVSDVAALRAAG----TD---MKLL 264 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-------CCCceEEEeeecCccHHhHHHHHhcC----CC---HHHH
Confidence 2334444333332 32222222222221 1246899999999999764 22211 11 2222
Q ss_pred HHHHHH-HHHHhcCCCCCCccccCCCCCceeecCCC----cEEEcccCCccccc
Q 005898 596 LIGVAK-AVQFLHTGVIPGFFNNRVKTNNILLNEHR----IAKLSDYGLSIVSE 644 (671)
Q Consensus 596 ~~~ia~-gl~yLH~~~~~~iiHrDlk~~NiLl~~~~----~~ki~DfGla~~~~ 644 (671)
+...++ -+..++.. +++|+|+||.||+++.++ .+++.|||+...++
T Consensus 265 a~~~v~~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 265 AERGVEVFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHHHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 222221 11222333 799999999999999888 99999999997765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.1e-11 Score=123.43 Aligned_cols=172 Identities=18% Similarity=0.243 Sum_probs=110.8
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCC----------CCcccccceeec
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRH----------PHLVCLLGHCID 550 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~~ 550 (671)
+...+.||.|+++.||.++.. +|+.+|||...... ....+++++|.-....+.+ -.++-.++...-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445688999999999999965 69999999984322 3346778877755555433 122222222221
Q ss_pred CCCCC---------CcccceEEEEEecCCCCChhhhhh---cCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCcccc
Q 005898 551 GGGRD---------DYAVNKVFLVYEFMSNGNFRTHIS---ENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN 617 (671)
Q Consensus 551 ~~~~~---------~~~~~~~~Lv~Ey~~~GsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr 617 (671)
.+... .+..-..+++|+-+ .+||.+.+. ... ....+....|+.+-.|+.+.+++||+. +++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11000 11111346777777 458877653 221 122355667888889999999999997 89999
Q ss_pred CCCCCceeecCCCcEEEcccCCccccc-----------------------------------cccccceeeeeeehhh
Q 005898 618 RVKTNNILLNEHRIAKLSDYGLSIVSE-----------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 618 Dlk~~NiLl~~~~~~ki~DfGla~~~~-----------------------------------d~~s~g~~l~~~~~~~ 660 (671)
|||++|++++.+|.++++||+...... |.|++|+++|.+-|+-
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999997653211 9999999999987763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.1e-11 Score=129.93 Aligned_cols=114 Identities=25% Similarity=0.475 Sum_probs=100.3
Q ss_pred HhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCC
Q 005898 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIP 612 (671)
Q Consensus 533 l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~ 612 (671)
|+.++|.|+.+++|.|.++. ..+.|.+|++.|+|.+.+... ...++|..+..++.+|+.||+|+|...
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--------~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~-- 68 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--------EMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP-- 68 (484)
T ss_pred CcccchhhhhhheeeEecCC--------ceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--
Confidence 45789999999999999874 689999999999999999863 345999999999999999999999862
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCcccc---------------------------------------ccccccceee
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVS---------------------------------------EDINSVGVRL 653 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~---------------------------------------~d~~s~g~~l 653 (671)
-..|+.++++|+++|..+.+|++|||+.... .|++|+|+++
T Consensus 69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~ 148 (484)
T KOG1023|consen 69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM 148 (484)
T ss_pred ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence 2399999999999999999999999987554 1999999999
Q ss_pred eeeeh
Q 005898 654 LILMS 658 (671)
Q Consensus 654 ~~~~~ 658 (671)
||+++
T Consensus 149 ~ei~~ 153 (484)
T KOG1023|consen 149 YEILF 153 (484)
T ss_pred HHHHh
Confidence 99876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.2e-11 Score=114.40 Aligned_cols=78 Identities=27% Similarity=0.308 Sum_probs=67.7
Q ss_pred CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc--------
Q 005898 572 GNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS-------- 643 (671)
Q Consensus 572 GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~-------- 643 (671)
|+|.++++... ..++|.++..++.||++||+|||+.. ||+||++++++.+|+ ||+++..
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~ 67 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVD 67 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccccCCCc
Confidence 78999997532 35999999999999999999999862 999999999999999 9988642
Q ss_pred -----------------ccccccceeeeeeehhhhc
Q 005898 644 -----------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 -----------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|||+++...
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 103 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 2999999999999997653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.4e-10 Score=111.53 Aligned_cols=157 Identities=19% Similarity=0.286 Sum_probs=116.2
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCC--cccccceeecCCCCCCcccceEEE
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPH--LVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
.+.++.|.++.||+++..+|+.+++|....... ....++.+|++++..+++.+ +.+++.++.... .....++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-----~~~~~~~ 77 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-----VLGTPFY 77 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-----ccCCceE
Confidence 356899999999999887778999999764332 13457889999999997644 566666654321 0124589
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC----------------------------------
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV---------------------------------- 610 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~---------------------------------- 610 (671)
||||++++++...+.. ..++..++..++.++++.|.+||+..
T Consensus 78 v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 78 VMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 9999999888765431 13677788888888888888888521
Q ss_pred -------------------CCCccccCCCCCceeecC--CCcEEEcccCCccccccccccceee
Q 005898 611 -------------------IPGFFNNRVKTNNILLNE--HRIAKLSDYGLSIVSEDINSVGVRL 653 (671)
Q Consensus 611 -------------------~~~iiHrDlk~~NiLl~~--~~~~ki~DfGla~~~~d~~s~g~~l 653 (671)
...++|+|+++.||++++ +..+.|.||+.+...+-...+|..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~~~~Dla~~~ 217 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGDPLADLGWLL 217 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCChHHHHHHHH
Confidence 235799999999999998 6678999999998877555556544
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-10 Score=116.96 Aligned_cols=97 Identities=22% Similarity=0.368 Sum_probs=74.2
Q ss_pred CCCCCcccccceeecCC-----CCC--------------CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHH
Q 005898 536 LRHPHLVCLLGHCIDGG-----GRD--------------DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596 (671)
Q Consensus 536 l~H~niv~l~g~~~~~~-----~~~--------------~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~ 596 (671)
.+|||||++.++|.++- ... ......+|+||.-++. +|++++..+. .+...+.-+.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~l 347 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVIL 347 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHH
Confidence 47999999999887631 000 0112468999988876 8999987543 5666777788
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCceee--cCCC--cEEEcccCCc
Q 005898 597 IGVAKAVQFLHTGVIPGFFNNRVKTNNILL--NEHR--IAKLSDYGLS 640 (671)
Q Consensus 597 ~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl--~~~~--~~ki~DfGla 640 (671)
.|+.+|+.|||.+ +|.|||+|+.|||+ |+|. ...|+|||..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEccccee
Confidence 8999999999997 89999999999998 4444 4679999965
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-11 Score=137.63 Aligned_cols=167 Identities=19% Similarity=0.257 Sum_probs=128.9
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc-hhhHHHHHHHHHH--HhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK-KYTVRNLKLRLDL--LAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++...+.+|++.|=+|.||+.+.|. |+||++-+.. ....+.|.++++- ...++|||.+++.-+-... .
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~--------k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTD--------K 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhh--------H
Confidence 5666788999999999999998887 8899985543 3444555544332 5567999999986543322 2
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..|||=+|..+ +|++-+..+ ..|...+.+=||.|+..|+..+|.. +|.|+|||++|||++...=+.++||.--
T Consensus 95 AAylvRqyvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASF 167 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccccc
Confidence 35777788876 788777643 2367778888999999999999987 8999999999999999877889998765
Q ss_pred cccc------------------------------------------------cccccceeeeeeehhhhccccc
Q 005898 641 IVSE------------------------------------------------DINSVGVRLLILMSFFFGSMTS 666 (671)
Q Consensus 641 ~~~~------------------------------------------------d~~s~g~~l~~~~~~~~~~~~~ 666 (671)
|..- |+.|.||+.+|+++...+.|.+
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 4311 8899999999999987777665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.9e-11 Score=115.85 Aligned_cols=204 Identities=20% Similarity=0.218 Sum_probs=110.5
Q ss_pred hhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccC-CcCCCCCCcccCCC
Q 005898 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDD-NFFNNTIPNWFDSL 189 (671)
Q Consensus 111 ~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l 189 (671)
|-.+.-+.+|..+.++.+.-. .|-+....=+.|+++...+..++ ..| .+--...+..+.-+. ...+|..-..+..+
T Consensus 207 ~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTW 283 (490)
T KOG1259|consen 207 SFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVP-SLLPETILADPSGSEPSTSNGSALVSADTW 283 (490)
T ss_pred ccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-ccc-cccchhhhcCccCCCCCccCCceEEecchH
Confidence 334455566666666665321 12222223356777777655443 222 111122222221111 11233333445566
Q ss_pred CCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCC
Q 005898 190 PSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNS 269 (671)
Q Consensus 190 ~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~ 269 (671)
+.|+.|||++|.++ .+.++..-++.++.|++|+|.+. .+..+..|++|+.||||+|.++.
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~nLa~L~~L~~LDLS~N~Ls~------------------ 343 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQNLAELPQLQLLDLSGNLLAE------------------ 343 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehhhhhcccceEeecccchhHh------------------
Confidence 78888888888887 67777777888888888888876 34446667777777777776542
Q ss_pred CCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCC-cccCCCCCccEEECcCCcCc
Q 005898 270 FSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP-KNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 270 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~~~~L~~l~ls~N~l~ 343 (671)
+..+-..+-+.+.|.|+.|.+.... .+..+-+|..||+++|++...-. ..+++++.|+.+.|.+|.+.
T Consensus 344 ----~~Gwh~KLGNIKtL~La~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 344 ----CVGWHLKLGNIKTLKLAQNKIETLS--GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred ----hhhhHhhhcCEeeeehhhhhHhhhh--hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 2333344555666666666654332 34555566666666666542111 13344444444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.4e-10 Score=107.76 Aligned_cols=126 Identities=28% Similarity=0.335 Sum_probs=49.1
Q ss_pred cccCCCCCCEEecccccccccCCcccc-CCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCccc-CCCC
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIH-RLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWF-DSLP 190 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~-~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~ 190 (671)
.+.+..++++|+|++|.|... +.++ .+.+|+.|||++|.++. ++ .+..+++|+.|++++|+++. +++.+ ..++
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp 88 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLP 88 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-T
T ss_pred ccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCC
Confidence 345666789999999998643 3455 57899999999999974 43 57788999999999999985 44444 4689
Q ss_pred CcCEEEcccccCCCC-CcccccCCCCCCEEEeccCccccccCC-----CCCCCCCCEEEC
Q 005898 191 SLTFLSMRNNKLAGP-FPSSIQRISTLSDLDLSKNAISGSLPD-----LSSLGSLNVLNL 244 (671)
Q Consensus 191 ~L~~L~L~~N~l~g~-~p~~l~~l~~L~~L~Ls~N~l~g~~p~-----~~~l~~L~~L~L 244 (671)
+|+.|++++|++... .-..+..+++|+.|+|.+|.++.. +. +..+++|+.||-
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 999999999998742 124567889999999999988743 32 466788888764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.3e-09 Score=101.24 Aligned_cols=136 Identities=13% Similarity=0.152 Sum_probs=95.5
Q ss_pred ceeccCCceEEEEEEEcC-------CcEEEEEEccCCc----------------------hhhHHHH----HHHHHHHhc
Q 005898 489 AIMGEGSYGKLYKGRLEN-------GTSVAIRCLPSSK----------------------KYTVRNL----KLRLDLLAK 535 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~-------g~~vAvK~l~~~~----------------------~~~~~~~----~~E~~~l~~ 535 (671)
.+||.|.=+.||.|.-.+ +..+|||..+... ....+.+ ++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4799999863211 0012223 378888888
Q ss_pred CCC--CCcccccceeecCCCCCCcccceEEEEEecCCCCChhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-cCCCC
Q 005898 536 LRH--PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT-HISENTPGKVLNWSERLAVLIGVAKAVQFL-HTGVI 611 (671)
Q Consensus 536 l~H--~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~ 611 (671)
+.- -++..++++ . ..++||||+.++.+.. .+.+. .++..+...+..+++.++.++ |..
T Consensus 83 l~~~Gv~vP~pi~~--~----------~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~-- 144 (197)
T cd05146 83 MQKAGIPCPEVVVL--K----------KHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC-- 144 (197)
T ss_pred HHHcCCCCCeEEEe--c----------CCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence 864 445555543 1 3489999998754432 22221 244445667788999999999 554
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
+++|+||++.||++++ +.+.+.|||.|...+
T Consensus 145 -glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 -NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred -CeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 8999999999999974 689999999987665
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.94 E-value=9e-11 Score=120.81 Aligned_cols=115 Identities=23% Similarity=0.200 Sum_probs=63.4
Q ss_pred chhcccCCCCCCEEecccccccccCC--ccccCCCCCCEEEcccCcCCCCCC--ccCCCCCccCEEEccCCcCCCCCCcc
Q 005898 110 FVTTLARLTSLRVLSLVSLGIWGSLP--DKIHRLYSLEYLDLSSNFLFGSVP--PKISTMVKLQTLILDDNFFNNTIPNW 185 (671)
Q Consensus 110 ~~~~l~~l~~L~~L~L~~n~l~g~~p--~~~~~L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~ 185 (671)
+...=.++.+|+...|.+.... ..+ .....|++++.||||.|-++...| .....|++|+.|+|+.|++.-.....
T Consensus 113 i~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~ 191 (505)
T KOG3207|consen 113 IAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN 191 (505)
T ss_pred HHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc
Confidence 3344456777777777776552 222 245567777777777777654433 33456677777777777665322111
Q ss_pred -cCCCCCcCEEEcccccCCCC-CcccccCCCCCCEEEeccCc
Q 005898 186 -FDSLPSLTFLSMRNNKLAGP-FPSSIQRISTLSDLDLSKNA 225 (671)
Q Consensus 186 -~~~l~~L~~L~L~~N~l~g~-~p~~l~~l~~L~~L~Ls~N~ 225 (671)
-..++.|+.|.|+.|.|+.. +-..+..+++|+.|+|..|.
T Consensus 192 ~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~ 233 (505)
T KOG3207|consen 192 TTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANE 233 (505)
T ss_pred chhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccc
Confidence 12445566666666665521 11223345555666665553
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.9e-09 Score=96.93 Aligned_cols=144 Identities=21% Similarity=0.348 Sum_probs=103.7
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEE-ccCCc-------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRC-LPSSK-------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
..+++|+=..+|.+.+.+ ..+.+|. +++.- +-..+...+|+.++.+++--.|...+=+..+++
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-------- 72 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--------
Confidence 357899999999997753 3455554 33221 112345778999999987666655444555543
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
...++|||.++..|.+.+... +..++..|.+-+.-||.. +|+|+||.++||.+..+. +.+.|||++
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence 468999999998888888643 356667777777889997 899999999999998765 889999999
Q ss_pred cccccccccceeeee
Q 005898 641 IVSEDINSVGVRLLI 655 (671)
Q Consensus 641 ~~~~d~~s~g~~l~~ 655 (671)
...+++-..||=++.
T Consensus 139 ~~s~~~Ed~aVDl~V 153 (204)
T COG3642 139 EFSDEVEDKAVDLHV 153 (204)
T ss_pred cccccHHhhhchHHH
Confidence 887755555554443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-08 Score=92.57 Aligned_cols=164 Identities=21% Similarity=0.246 Sum_probs=112.9
Q ss_pred cCceeccCCceEEEEEEEcCCcEEEEEE-ccCCc-------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 487 MSAIMGEGSYGKLYKGRLENGTSVAIRC-LPSSK-------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~g~~vAvK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
....+-||+=+.|+++.++ |+...||. +.+.- .-..+..++|++.+++++--.|.-..=++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~------ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY------ 83 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC------
Confidence 4678899999999999886 66656654 33221 123566889999999987666655444554432
Q ss_pred cceEEEEEecCCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC---CcEEE
Q 005898 559 VNKVFLVYEFMSN-GNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH---RIAKL 634 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~---~~~ki 634 (671)
.-.++|||.++ -++.+++....... ..-......+..|.+.+.-||.+ .|+|+||..+||++..+ .++.+
T Consensus 84 --~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 84 --GGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred --CCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEE
Confidence 23699999976 36777776532211 11122267788888889999998 89999999999999654 45689
Q ss_pred cccCCccccccccccceeeeeeehhhhcc
Q 005898 635 SDYGLSIVSEDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 635 ~DfGla~~~~d~~s~g~~l~~~~~~~~~~ 663 (671)
.|||++....-.-.-||=+|.+-.-+..|
T Consensus 158 Idfgls~~s~~~EDKgVDLYVlErA~lsT 186 (229)
T KOG3087|consen 158 IDFGLSSVSRLPEDKGVDLYVLERAVLST 186 (229)
T ss_pred EeecchhcccCcccccceeeeehHhHhcc
Confidence 99999876553333588887765544333
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.5e-10 Score=124.62 Aligned_cols=130 Identities=33% Similarity=0.341 Sum_probs=73.7
Q ss_pred cCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
..+..++.+++..|.+.. +-..+..+++|+.|++..|+|.+ +...+..+++|++|+|++|.|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 345566666666666633 22335666677777777776643 33335566666666666666664322 345555666
Q ss_pred EEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCC
Q 005898 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 195 L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~ 250 (671)
|++++|.++. ...+..+++|+.+++++|.+...-+. ...+.+|+.+++.+|.+.
T Consensus 145 L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 145 LNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred heeccCcchh--ccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 6666666652 13344466666666666666533222 355556666666666543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.7e-09 Score=101.97 Aligned_cols=108 Identities=31% Similarity=0.428 Sum_probs=41.3
Q ss_pred ccCCCCCCEEEcccCcCCCCCCccCC-CCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccc-cCCCC
Q 005898 138 IHRLYSLEYLDLSSNFLFGSVPPKIS-TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSI-QRIST 215 (671)
Q Consensus 138 ~~~L~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l-~~l~~ 215 (671)
+.+..++++|+|++|.|+. + +.++ .+.+|+.|+|++|.++. ++ .+..+++|++|++++|+++. +++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 5566789999999999963 3 3565 68899999999999985 33 47789999999999999984 55545 46899
Q ss_pred CCEEEeccCccccc--cCCCCCCCCCCEEECCCCCCC
Q 005898 216 LSDLDLSKNAISGS--LPDLSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 216 L~~L~Ls~N~l~g~--~p~~~~l~~L~~L~Ls~N~l~ 250 (671)
|+.|++++|++... +-.+..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 99999999999743 334677899999999998775
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.3e-10 Score=115.84 Aligned_cols=191 Identities=26% Similarity=0.287 Sum_probs=129.4
Q ss_pred cccCCCCCCEEecccccccccCC--ccccCCCCCCEEEcccCcCCCCCCccC-CCCCccCEEEccCCcCCCC-CCcccCC
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLP--DKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNT-IPNWFDS 188 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p--~~~~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~-~p~~~~~ 188 (671)
....|++++.|||+.|-|+...| .....|++|+.|+||.|++.-...... ..++.|+.|.|+.+.++-. +-.-+..
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 56789999999999998864433 446789999999999999964333222 3678899999999988732 1223457
Q ss_pred CCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCcccccc--CCCCCCCCCCEEECCCCCCCCC-CCCCCCCccEEEc
Q 005898 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL--PDLSSLGSLNVLNLSDNKLDSN-LPKLPRGLVMAFL 265 (671)
Q Consensus 189 l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~--p~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~L~~l~l 265 (671)
+|+|+.|+|..|...+.--.....+..|+.|||++|++-... +..+.++.|+.|+++.+.+... +|+.
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~--------- 291 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDV--------- 291 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCc---------
Confidence 899999999999643333344556788999999999986544 4578889999998888876532 1111
Q ss_pred CCCCCCCCchhhhcCCcccceeecccccccCCCc-cccCCCCCcCeEecccCcCc
Q 005898 266 SNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP-PAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 266 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 319 (671)
..-+-...+++|++|+++.|++..... ..+..+++|+.|....|.|+
T Consensus 292 -------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 292 -------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred -------cchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 111112345567777777777754432 12334455555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4e-10 Score=110.59 Aligned_cols=133 Identities=25% Similarity=0.319 Sum_probs=93.5
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
.+..-..|+.|||++|.|+ .+.++..-++.++.|++|+|.+.. -..+..|.+|+.|||++|.++ .+-.|-.+|-++
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~--v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT--VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee--ehhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444556778888888773 556667777788888888887752 234777788888888888776 455566677778
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccc--cCCCCCCCCCCEEECCCCCCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGS--LPDLSSLGSLNVLNLSDNKLDS 251 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~--~p~~~~l~~L~~L~Ls~N~l~~ 251 (671)
++|.|+.|.+. --+.+.++-+|..||+++|++... +..+++|+.|+.+.|.+|.+.+
T Consensus 355 KtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 88888888775 235577777888888888877632 2346777777777777776654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=9.8e-10 Score=119.91 Aligned_cols=223 Identities=27% Similarity=0.294 Sum_probs=141.7
Q ss_pred hcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCC
Q 005898 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPS 191 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 191 (671)
..+..+++|..|++.+|.|.+... .+..+++|++|||++|.|+... .+..++.|+.|++++|.++.. ..+..+++
T Consensus 89 ~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~ 163 (414)
T KOG0531|consen 89 NHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKS 163 (414)
T ss_pred cccccccceeeeeccccchhhccc-chhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchh
Confidence 358889999999999999965433 3788999999999999997543 366777899999999999842 45667999
Q ss_pred cCEEEcccccCCCCCccc-ccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCC
Q 005898 192 LTFLSMRNNKLAGPFPSS-IQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSF 270 (671)
Q Consensus 192 L~~L~L~~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l 270 (671)
|+.+++++|+++..-+ . ...+.+++.+++..|.+. .+..+..+..+..+++.+|.++..-+..
T Consensus 164 L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i~~~~~l~-------------- 227 (414)
T KOG0531|consen 164 LKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKISKLEGLN-------------- 227 (414)
T ss_pred hhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh-cccchHHHHHHHHhhcccccceeccCcc--------------
Confidence 9999999999984433 2 578899999999999886 3444445555666677777765321110
Q ss_pred CCCchhhhcCCc--ccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCccc---
Q 005898 271 SGEIPKQYGQLN--QLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGG--- 345 (671)
Q Consensus 271 ~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~--- 345 (671)
.+. .|+.++++.|.+...+ ..+..+.++..|++.+|++...- .+.....+..+.+..|.+...
T Consensus 228 ---------~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 295 (414)
T KOG0531|consen 228 ---------ELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAI 295 (414)
T ss_pred ---------cchhHHHHHHhcccCcccccc-ccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhh
Confidence 011 2455555555554332 23344455555555555554321 122333444445555554311
Q ss_pred CCCC-CCCCCCCceeccCCCcCC
Q 005898 346 LPSC-LSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 346 ~p~~-~~~~~~l~~l~l~~N~l~ 367 (671)
.... ......+..+.+..|...
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~ 318 (414)
T KOG0531|consen 296 SQEYITSAAPTLVTLTLELNPIR 318 (414)
T ss_pred hccccccccccccccccccCccc
Confidence 1111 233444555556555544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.2e-09 Score=121.07 Aligned_cols=167 Identities=19% Similarity=0.310 Sum_probs=125.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc--CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE--NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~--~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 557 (671)
..|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+=..+. |+|++.+++...+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~----- 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR----- 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-----
Confidence 34556677999999999887643 34567777775443 122334445665555565 999999998876653
Q ss_pred ccceEEEEEecCCCCChhhhh-hcCCCCCCCCHHHHHHHHHHHHHHHHHhc-CCCCCCccccCCCCCceeecCCC-cEEE
Q 005898 558 AVNKVFLVYEFMSNGNFRTHI-SENTPGKVLNWSERLAVLIGVAKAVQFLH-TGVIPGFFNNRVKTNNILLNEHR-IAKL 634 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~iiHrDlk~~NiLl~~~~-~~ki 634 (671)
..+++.||..+|++...+ +... ...+-.....+..+...++.|+| .. ++.|||+||+|.+++..+ ..|+
T Consensus 95 ---~~~~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 95 ---SYLLSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred ---ccccccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence 679999999999998888 4322 12444556677888999999999 54 789999999999999999 9999
Q ss_pred cccCCccccc-----------------------------------cccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVSE-----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~~-----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+|..+. |+||.|+++..|+++...
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 9999985432 999999999998887554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.7e-09 Score=79.58 Aligned_cols=57 Identities=40% Similarity=0.577 Sum_probs=22.8
Q ss_pred CCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 144 LEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 144 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 344444444443333333344444444444444443333333444444444444444
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-09 Score=108.79 Aligned_cols=238 Identities=21% Similarity=0.258 Sum_probs=139.3
Q ss_pred hcccCCCCCCEEecccccccc----cCCccccCCCCCCEEEcccCcCCCCC----Cc-------cCCCCCccCEEEccCC
Q 005898 112 TTLARLTSLRVLSLVSLGIWG----SLPDKIHRLYSLEYLDLSSNFLFGSV----PP-------KISTMVKLQTLILDDN 176 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n~l~g----~~p~~~~~L~~L~~L~Ls~N~l~~~~----p~-------~~~~l~~L~~L~L~~N 176 (671)
+.+..+..++.|+|++|.|.. .+-..+.+.++|+.-++|. .++|.+ |+ .+-..++|++|+||+|
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDN 102 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDN 102 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccc
Confidence 445566777788888887742 2444566677777777763 344432 22 2344557777777777
Q ss_pred cCCCCCCcc----cCCCCCcCEEEcccccCCCCCcc-------------cccCCCCCCEEEeccCccccccC-----CCC
Q 005898 177 FFNNTIPNW----FDSLPSLTFLSMRNNKLAGPFPS-------------SIQRISTLSDLDLSKNAISGSLP-----DLS 234 (671)
Q Consensus 177 ~l~~~~p~~----~~~l~~L~~L~L~~N~l~g~~p~-------------~l~~l~~L~~L~Ls~N~l~g~~p-----~~~ 234 (671)
-|.-.-+.. +.++..|++|.|.+|.+.-.--. -...-+.|+++....|++..... .+.
T Consensus 103 A~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~ 182 (382)
T KOG1909|consen 103 AFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQ 182 (382)
T ss_pred ccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHH
Confidence 766443332 34566777777777765411000 11223455555555555532211 133
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCC----ccccCCCCCcCe
Q 005898 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP----PPAIFSLPNISD 310 (671)
Q Consensus 235 ~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~ 310 (671)
..+.|+.+.++.|.+... .. -.+-..+..+++|+.|||..|-|+..- ...+..+++|+.
T Consensus 183 ~~~~leevr~~qN~I~~e----------------G~-~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~E 245 (382)
T KOG1909|consen 183 SHPTLEEVRLSQNGIRPE----------------GV-TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRE 245 (382)
T ss_pred hccccceEEEecccccCc----------------hh-HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhee
Confidence 344555555555544210 00 013345677888888888888876432 234556788888
Q ss_pred EecccCcCcccCCccc-----CCCCCccEEECcCCcCcc----cCCCCCCCCCCCceeccCCCcCC
Q 005898 311 LNLASNKFSGSLPKNL-----NCGGKLVFFDISNNKLTG----GLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 311 L~L~~N~l~g~~p~~~-----~~~~~L~~l~ls~N~l~g----~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
|+++++.+...-...+ ...+.|+.+.+.+|.++- .+-.++...+.+..|++++|.+.
T Consensus 246 l~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 246 LNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 8888887763322111 224678899999998862 33456667888999999999885
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.2e-08 Score=79.04 Aligned_cols=61 Identities=33% Similarity=0.353 Sum_probs=56.6
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcC
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFF 178 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 178 (671)
++|++|++++|.+....++.|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999877778999999999999999999988888999999999999999975
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-08 Score=118.91 Aligned_cols=108 Identities=27% Similarity=0.351 Sum_probs=67.1
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
|..++.|++|||++|.=-+.+|..+++|-+|++|||+...+. .+|..+.+|.+|.+|++..+.....+|.....|++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 556777777777766555667777777777777777777765 5677777777777777776665555566566677777
Q ss_pred EEEccccc--CCCCCcccccCCCCCCEEEec
Q 005898 194 FLSMRNNK--LAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 194 ~L~L~~N~--l~g~~p~~l~~l~~L~~L~Ls 222 (671)
+|.+..-. .+...-.++.++.+|+.+...
T Consensus 646 ~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 646 VLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred EEEeeccccccchhhHHhhhcccchhhheee
Confidence 77664432 222222334455555555443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.6e-08 Score=106.77 Aligned_cols=143 Identities=21% Similarity=0.236 Sum_probs=110.1
Q ss_pred EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCC
Q 005898 504 LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP 583 (671)
Q Consensus 504 ~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~ 583 (671)
..++.+|.|...+.......+...+-++.|+.+|||||++++......+ ..|+|+|-+. -|..++.+.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--------~~ylvTErV~--Pl~~~lk~l-- 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--------TLYLVTERVR--PLETVLKEL-- 101 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC--------ceEEEeeccc--cHHHHHHHh--
Confidence 4578888888887654433445677788899999999999998776653 6899999764 466666642
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc--------------------
Q 005898 584 GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS-------------------- 643 (671)
Q Consensus 584 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~-------------------- 643 (671)
.-......+.||+.||.|||+.| .++|++|.-..|+++..|+-|+++|-+....
T Consensus 102 ----~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 ----GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred ----HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 23344555789999999999887 6899999999999999999999998655211
Q ss_pred --------ccccccceeeeeeehhhhccc
Q 005898 644 --------EDINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 644 --------~d~~s~g~~l~~~~~~~~~~~ 664 (671)
-|.|.+||..++++.+..++.
T Consensus 176 ~~~~s~~s~D~~~Lg~li~el~ng~~~~~ 204 (690)
T KOG1243|consen 176 EIDPSEWSIDSWGLGCLIEELFNGSLLTK 204 (690)
T ss_pred hcCccccchhhhhHHHHHHHHhCcccCcc
Confidence 188999999999888755443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.2e-09 Score=111.68 Aligned_cols=164 Identities=16% Similarity=0.216 Sum_probs=109.1
Q ss_pred ceeccCCceEEEEEEEcC----CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccc---ee-ecCCCCCCcccc
Q 005898 489 AIMGEGSYGKLYKGRLEN----GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG---HC-IDGGGRDDYAVN 560 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g---~~-~~~~~~~~~~~~ 560 (671)
+..++.++|.+..++... .+.++.|..+...........+++..+....|.+..-+.+ .- .....++-....
T Consensus 250 k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~ 329 (516)
T KOG1033|consen 250 KSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKV 329 (516)
T ss_pred ccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccccc
Confidence 445666666666554222 2344444444333222233444555555554444433322 00 000000000123
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..|+.|+++..++|++|+.++......+|...+.++.|++.|++| . ..+|||+||.||....+...||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876666678899999999999999999 2 5799999999999999999999999987
Q ss_pred cccc------------------------------------cccccceeeeeeeh
Q 005898 641 IVSE------------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 641 ~~~~------------------------------------d~~s~g~~l~~~~~ 658 (671)
.-.+ |++++|+++||++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 4322 99999999999776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.2e-07 Score=87.96 Aligned_cols=126 Identities=16% Similarity=0.256 Sum_probs=80.6
Q ss_pred EEEEEEEcCCcEEEEEEccCCc--------------h------------hhHHHHHHHHHHHhcCCCCC--cccccceee
Q 005898 498 KLYKGRLENGTSVAIRCLPSSK--------------K------------YTVRNLKLRLDLLAKLRHPH--LVCLLGHCI 549 (671)
Q Consensus 498 ~Vy~~~~~~g~~vAvK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~ 549 (671)
.||.|.-.+|..||||...... . ......++|.+.|.++...+ +.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999863210 0 01234678999999998764 45555332
Q ss_pred cCCCCCCcccceEEEEEecCC--CCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-cCCCCCCccccCCCCCceee
Q 005898 550 DGGGRDDYAVNKVFLVYEFMS--NGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL-HTGVIPGFFNNRVKTNNILL 626 (671)
Q Consensus 550 ~~~~~~~~~~~~~~Lv~Ey~~--~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDlk~~NiLl 626 (671)
...+||||++ +..+.. +.+.. ++......++.++.+.+..+ |.. +|+|+|+.+.||++
T Consensus 80 -----------~~~ivME~I~~~G~~~~~-l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv 140 (188)
T PF01163_consen 80 -----------RNVIVMEYIGEDGVPLPR-LKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILV 140 (188)
T ss_dssp -----------TTEEEEE--EETTEEGGC-HHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEE
T ss_pred -----------CCEEEEEecCCCccchhh-HHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEe
Confidence 2379999998 434433 33211 11234456667777766665 554 89999999999999
Q ss_pred cCCCcEEEcccCCccccc
Q 005898 627 NEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 627 ~~~~~~ki~DfGla~~~~ 644 (671)
+++ .+.|.|||.+....
T Consensus 141 ~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 141 DDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ETT-CEEE--GTTEEETT
T ss_pred ecc-eEEEEecCcceecC
Confidence 987 99999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.9e-09 Score=103.66 Aligned_cols=215 Identities=23% Similarity=0.268 Sum_probs=138.2
Q ss_pred hhcccCCCCCCEEecccc---cccccCCcc-------ccCCCCCCEEEcccCcCCCCCCc----cCCCCCccCEEEccCC
Q 005898 111 VTTLARLTSLRVLSLVSL---GIWGSLPDK-------IHRLYSLEYLDLSSNFLFGSVPP----KISTMVKLQTLILDDN 176 (671)
Q Consensus 111 ~~~l~~l~~L~~L~L~~n---~l~g~~p~~-------~~~L~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N 176 (671)
-..+.+.++|+..++++- .+...+|+. +-..++|++||||.|.|...-+. .+.++..|++|+|.+|
T Consensus 51 ~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~ 130 (382)
T KOG1909|consen 51 AKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNC 130 (382)
T ss_pred HHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcC
Confidence 345677778888888763 222334443 34566899999999988544333 3467888999999988
Q ss_pred cCCCCC-------------CcccCCCCCcCEEEcccccCCCC----CcccccCCCCCCEEEeccCcccc--c---cCCCC
Q 005898 177 FFNNTI-------------PNWFDSLPSLTFLSMRNNKLAGP----FPSSIQRISTLSDLDLSKNAISG--S---LPDLS 234 (671)
Q Consensus 177 ~l~~~~-------------p~~~~~l~~L~~L~L~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g--~---~p~~~ 234 (671)
.+.-.- -.-.++-++|+++...+|++... +-..|...+.|+.+.++.|.+.- . ...+.
T Consensus 131 Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~ 210 (382)
T KOG1909|consen 131 GLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALE 210 (382)
T ss_pred CCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHH
Confidence 765211 11234557899999999998632 22346777899999999998741 1 01267
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCcccc-----CCCCCcC
Q 005898 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI-----FSLPNIS 309 (671)
Q Consensus 235 ~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~ 309 (671)
.+++|++|||.+|-|+..-. -.+...+..+++|+.|+++.+.++..-...+ ...|+|+
T Consensus 211 ~~~~LevLdl~DNtft~egs-----------------~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~ 273 (382)
T KOG1909|consen 211 HCPHLEVLDLRDNTFTLEGS-----------------VALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLE 273 (382)
T ss_pred hCCcceeeecccchhhhHHH-----------------HHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCc
Confidence 88999999999998763210 0133445556667777777666654322211 2357778
Q ss_pred eEecccCcCccc----CCcccCCCCCccEEECcCCcC
Q 005898 310 DLNLASNKFSGS----LPKNLNCGGKLVFFDISNNKL 342 (671)
Q Consensus 310 ~L~L~~N~l~g~----~p~~~~~~~~L~~l~ls~N~l 342 (671)
.|.|.+|.++-. +-..+...+.|..|+|+.|.+
T Consensus 274 vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 274 VLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred eeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 888888877622 122334466788888888887
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=1e-06 Score=89.58 Aligned_cols=146 Identities=12% Similarity=0.075 Sum_probs=99.7
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEccCCchh-----------hHHHHHHHHHHHhcCCCCCcc--cccceeecCCCCC
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY-----------TVRNLKLRLDLLAKLRHPHLV--CLLGHCIDGGGRD 555 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv--~l~g~~~~~~~~~ 555 (671)
+++-+.....|++..+ +|+.+.||+....... ....+.+|...+.++...+|. +++++.....
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~--- 103 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS--- 103 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC---
Confidence 4444334445667666 5778999976433211 112477888888887554444 3455554321
Q ss_pred CcccceEEEEEecCCCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC------
Q 005898 556 DYAVNKVFLVYEFMSNG-NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE------ 628 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~G-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~------ 628 (671)
......-++|+|++++- +|.+++.... ....+...+..++.++++.+.-||.. +|+|+|++++|||++.
T Consensus 104 ~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 104 NPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred CCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCC
Confidence 01113568999999986 7988875422 12345667788999999999999997 8999999999999985
Q ss_pred -CCcEEEcccCCccc
Q 005898 629 -HRIAKLSDYGLSIV 642 (671)
Q Consensus 629 -~~~~ki~DfGla~~ 642 (671)
++.+.+.||+.+..
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 47899999998854
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.5e-08 Score=115.38 Aligned_cols=177 Identities=23% Similarity=0.277 Sum_probs=116.2
Q ss_pred CCCCCEEeccccc--ccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 117 LTSLRVLSLVSLG--IWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 117 l~~L~~L~L~~n~--l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
+++|+.|-+..|. +....++.|..++.|++||||+|.=-+.+|..+++|-+|++|+|++..+. .+|..+++|+.|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 4478888888886 43334445778999999999988766789999999999999999998888 78999999999999
Q ss_pred EEcccccCCCCCcccccCCCCCCEEEeccCcccccc---CCCCCCCCCCEEECCCCCCCCCCCC------CCCCccEEEc
Q 005898 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL---PDLSSLGSLNVLNLSDNKLDSNLPK------LPRGLVMAFL 265 (671)
Q Consensus 195 L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~---p~~~~l~~L~~L~Ls~N~l~~~~p~------~~~~L~~l~l 265 (671)
|++..+.-...+|.....|++|++|.+-........ -++.+|.+|+.+....... ..+-+ +....+.+.+
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV-LLLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh-HhHhhhhhhHHHHHHhHhhhh
Confidence 999888766666777777999999988765532211 1244555555555433222 00000 0011112222
Q ss_pred CCCCCCCCchhhhcCCcccceeecccccccC
Q 005898 266 SNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296 (671)
Q Consensus 266 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 296 (671)
.++... ..+..++.+.+|+.|.+.+.....
T Consensus 702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 702 EGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred cccccc-eeecccccccCcceEEEEcCCCch
Confidence 222221 344556667777777777766654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.5e-08 Score=109.96 Aligned_cols=110 Identities=26% Similarity=0.504 Sum_probs=74.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
..+|+..+.|-.|+||.||..+.+ +.+..|.| +.++... + +||..+-|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----------l-----Rnilt~a~-------------- 130 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----------L-----RNILTFAG-------------- 130 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----------h-----hccccccC--------------
Confidence 357888999999999999999865 46778873 3322211 1 12333321
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..+.| ||=.+.+...++ + |. +.+.+++|+|+- +|+|||+|+.|.+++.-|.+|++|||++
T Consensus 131 npfvv------gDc~tllk~~g~---l-Pv-------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 131 NPFVV------GDCATLLKNIGP---L-PV-------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred Cccee------chhhhhcccCCC---C-cc-------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence 12233 444444432211 1 11 126789999985 8999999999999999999999999999
Q ss_pred cc
Q 005898 641 IV 642 (671)
Q Consensus 641 ~~ 642 (671)
++
T Consensus 191 k~ 192 (1205)
T KOG0606|consen 191 KK 192 (1205)
T ss_pred hh
Confidence 75
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-07 Score=100.82 Aligned_cols=148 Identities=20% Similarity=0.216 Sum_probs=111.5
Q ss_pred HHhcCCCcCceeccCCceEEEEEEE--cCCcEEEEEEccCCchh--hHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRL--ENGTSVAIRCLPSSKKY--TVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~--~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
..+.+|.+...||.|.|+.|++... .++..+++|.+.+.... +...-..|+-+...+ .|.++++....+..-
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--- 338 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--- 338 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---
Confidence 3456788899999999999999864 46789999988654322 222223455555555 588888876554433
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAK 633 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~k 633 (671)
...|+--||+.+++.+....- ...++...++++..++++++.++|+. .++|+|+||+||++..+ +..+
T Consensus 339 -----r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 339 -----RQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred -----ccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence 256788999999988765522 23467778888999999999999975 79999999999999876 8889
Q ss_pred EcccCCcc
Q 005898 634 LSDYGLSI 641 (671)
Q Consensus 634 i~DfGla~ 641 (671)
++|||.++
T Consensus 408 ~~~~~~~t 415 (524)
T KOG0601|consen 408 LGDFGCWT 415 (524)
T ss_pred cccccccc
Confidence 99999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.5e-06 Score=92.34 Aligned_cols=156 Identities=16% Similarity=0.207 Sum_probs=114.3
Q ss_pred eEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCC-CCh
Q 005898 497 GKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSN-GNF 574 (671)
Q Consensus 497 g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~-GsL 574 (671)
.+.||+.. .||..|+.|++...+.+....--.-++.++++.|+|+|++.+++.... .....+.+||+|.|+ ++|
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t----F~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT----FGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc----cCcceEEEEEecCCCCchH
Confidence 46789974 489999999994333222112233467889999999999999887422 112468899999996 567
Q ss_pred hhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 575 RTHISENT------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 575 ~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
.++-.... .+..........++.|++-||.++|+. +..-+-|.+++|+++.+..++|+..|+.-+
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 65432111 123466677888999999999999997 677799999999999999999988887644
Q ss_pred cc-------------cccccceeeeeeehh
Q 005898 643 SE-------------DINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~~-------------d~~s~g~~l~~~~~~ 659 (671)
+. |.-.+|.++..+.|+
T Consensus 443 l~~d~~~~le~~Qq~D~~~lG~ll~aLAt~ 472 (655)
T KOG3741|consen 443 LQEDPTEPLESQQQNDLRDLGLLLLALATG 472 (655)
T ss_pred ecCCCCcchhHHhhhhHHHHHHHHHHHhhc
Confidence 32 777889888887776
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.1e-07 Score=89.39 Aligned_cols=101 Identities=19% Similarity=0.303 Sum_probs=80.1
Q ss_pred HHhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCC
Q 005898 532 LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGV 610 (671)
Q Consensus 532 ~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~ 610 (671)
-+-.+.|.|||++..|+.+.... ...+..++.|||+.|++..+|++-. ..+.+....-.+++-||..||.|||+ |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~---e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYE---EKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccc---cccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 35566799999998887664321 2346889999999999999998632 22345555667889999999999997 6
Q ss_pred CCCccccCCCCCceeecCCCcEEEcc
Q 005898 611 IPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 611 ~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
.|+|+|+++..+-|.+..++-+|++-
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred CCccccCCcchhheeecCCceEEecc
Confidence 78999999999999999998888853
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.2e-08 Score=105.14 Aligned_cols=194 Identities=28% Similarity=0.329 Sum_probs=132.0
Q ss_pred CCCCCEEecccccccccC-CccccCCCCCCEEEcccCcCCCCCCccCCCC-CccCEEEccCCcCC----------CCCCc
Q 005898 117 LTSLRVLSLVSLGIWGSL-PDKIHRLYSLEYLDLSSNFLFGSVPPKISTM-VKLQTLILDDNFFN----------NTIPN 184 (671)
Q Consensus 117 l~~L~~L~L~~n~l~g~~-p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~~p~ 184 (671)
++++++|.+-.--=.+.. |-.|..+.+|+.|.|.++.|+. . ..+..+ ..|++|.-+ |.+. |.+-.
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~n 159 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISN 159 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhcccccc
Confidence 455555555433222333 6678889999999999988852 1 111111 133444322 2221 11111
Q ss_pred ccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCC---CCCcc
Q 005898 185 WFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL---PRGLV 261 (671)
Q Consensus 185 ~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~ 261 (671)
.+ ....|.+.+.+.|.+. .+..++.-++.|+.|||++|+++..- .+..|++|+.|||+.|.++- +|.+ ...|+
T Consensus 160 s~-~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~L~ 235 (1096)
T KOG1859|consen 160 SP-VWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRH-VPQLSMVGCKLQ 235 (1096)
T ss_pred ch-hhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhcc-ccccchhhhhhe
Confidence 11 1246888888999987 67778888899999999999998543 67788999999999999864 3333 34588
Q ss_pred EEEcCCCCCCCCchhhhcCCcccceeecccccccCCCc-cccCCCCCcCeEecccCcCc
Q 005898 262 MAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP-PAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 262 ~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 319 (671)
.|.+++|.++. -..+.++++|+.||+++|-|.+.-. .-+..+..|+.|+|.+|.+.
T Consensus 236 ~L~lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 236 LLNLRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred eeeecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999998863 2457889999999999999887532 12456788999999999885
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.2e-06 Score=81.22 Aligned_cols=148 Identities=15% Similarity=0.193 Sum_probs=87.7
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCc--ccccceeecCCCCCCcccceEEEEE
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL--VCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
..||+|..+.||+. .|..+++|...... ...+..+|.+++..+..-.+ .+.++++.+++ ...+||
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--------~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--------RLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--------eeeeee
Confidence 67899999999984 24457788876433 23456889888888765444 45555554432 467899
Q ss_pred ecCCCCC-hhhh---------------------hhcCCCCCCCCHHHHHHHH-----------HHHH-HHHHHhcCC-CC
Q 005898 567 EFMSNGN-FRTH---------------------ISENTPGKVLNWSERLAVL-----------IGVA-KAVQFLHTG-VI 611 (671)
Q Consensus 567 Ey~~~Gs-L~~~---------------------l~~~~~~~~l~~~~~~~i~-----------~~ia-~gl~yLH~~-~~ 611 (671)
|+++|.+ +... +|.-.. .......+..-. ..+. ....+|... ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 9998863 1110 121100 011111111100 0111 112333221 12
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccccccccce
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGV 651 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~ 651 (671)
+..+|+|+.+.||++++++ +.|.||+.+...+-.+.++.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~Gdp~~Dla~ 191 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGYGNPLFDLGL 191 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCcCCHHHHHHH
Confidence 3578999999999999888 89999999988774444444
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-05 Score=79.51 Aligned_cols=135 Identities=16% Similarity=0.204 Sum_probs=91.6
Q ss_pred cCceeccCCceEEEEEEEcCCcEEEEEEccCCc----------h------------hhHHHHHHHHHHHhcCCCC--Ccc
Q 005898 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK----------K------------YTVRNLKLRLDLLAKLRHP--HLV 542 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~----------~------------~~~~~~~~E~~~l~~l~H~--niv 542 (671)
+.+.||-|.=+.||.|..+.|..+|||.=.... . .+.....+|.+.|.++.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 468899999999999999999999999742211 0 1134567888899888654 555
Q ss_pred cccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCC
Q 005898 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTN 622 (671)
Q Consensus 543 ~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~ 622 (671)
+.+++ +...+||||.++-.|...-- ..-+....+..+.+..+ .+| + . +|||+|+..-
T Consensus 175 ~P~~~------------nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~-~~~-~-~---GiVHGDlSef 231 (304)
T COG0478 175 KPIAW------------NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVR-KAY-R-R---GIVHGDLSEF 231 (304)
T ss_pred Ccccc------------ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHH-HHH-H-c---CccccCCchh
Confidence 55433 35689999999866543210 01122233333332221 222 3 2 7999999999
Q ss_pred ceeecCCCcEEEcccCCccccc
Q 005898 623 NILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 623 NiLl~~~~~~ki~DfGla~~~~ 644 (671)
||+++++|.+.+.||--+...+
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred eEEEecCCCEEEEeCcccccCC
Confidence 9999999999999998776543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.2e-06 Score=60.12 Aligned_cols=39 Identities=33% Similarity=0.605 Sum_probs=29.2
Q ss_pred hHHHHHHHHHHhcCC-CC-CCCCCccCCC-CCCCCCCCCCccceEeC
Q 005898 28 SSQTQVLLQLRKHLE-YP-KQLEIWINHG-ADFCYISSSTQVNITCQ 71 (671)
Q Consensus 28 ~~~~~~Ll~~k~~~~-~~-~~l~~W~~~~-~~~C~~~~~~~~~v~C~ 71 (671)
+.|++||++||+++. +| ..+.+|+.+. .+||+|. ||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~-----GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWS-----GVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCST-----TEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeec-----cEEeC
Confidence 579999999999998 45 5799998763 7999986 69994
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.2e-07 Score=90.50 Aligned_cols=186 Identities=26% Similarity=0.347 Sum_probs=99.8
Q ss_pred CCCCCCEEeccccccc--ccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCC-CCcccCCCCCc
Q 005898 116 RLTSLRVLSLVSLGIW--GSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNT-IPNWFDSLPSL 192 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~--g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L 192 (671)
.++.++.|||.+|.|+ ..|-..+.+|+.|++|+||.|.++..|-..-..+.+|+.|.|.+..+.-. ....+..+|.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 3567888899888885 34555567888899999999988654432224567888888887665432 22345677777
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC---CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD---LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNS 269 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~---~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~ 269 (671)
+.|.++.|++. .+++..|-.+..-|. +..++.+..+.++-|++...+|. +..+.+..|-
T Consensus 149 telHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpn----v~sv~v~e~P 210 (418)
T KOG2982|consen 149 TELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPN----VNSVFVCEGP 210 (418)
T ss_pred hhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhccc----chheeeecCc
Confidence 88888777443 222333333221111 22222233333333333333332 2222233332
Q ss_pred CCCC-chhhhcCCcccceeecccccccCCCc-cccCCCCCcCeEecccCcCc
Q 005898 270 FSGE-IPKQYGQLNQLQQLDMSFNALRGMPP-PAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 270 l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 319 (671)
+... -...+..++.+..|+|+.|++...-. ..+..++.|..|.+++|.+.
T Consensus 211 lK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 211 LKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred ccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 2111 11223344455566777776654321 24556666666777666654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.4e-08 Score=107.58 Aligned_cols=124 Identities=33% Similarity=0.374 Sum_probs=91.4
Q ss_pred CCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCc-ccCCCCCcCEEEc
Q 005898 119 SLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPN-WFDSLPSLTFLSM 197 (671)
Q Consensus 119 ~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L 197 (671)
.|...+.+.|.+. .+..++.-++.|+.|||++|+++. . +.+..|++|++|||++|.++ .+|. ....+. |+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v-~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-V-DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-h-HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4556677777773 455667778889999999998863 2 37888889999999999887 3443 223334 889999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccc--cCCCCCCCCCCEEECCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGS--LPDLSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~--~p~~~~l~~L~~L~Ls~N~l 249 (671)
++|.++.. ..+.+|.+|+.||+++|-+++. +..++.|..|..|+|.+|.+
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 99988732 4577888999999999988763 23467778888888888866
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.7e-05 Score=77.82 Aligned_cols=110 Identities=19% Similarity=0.249 Sum_probs=82.2
Q ss_pred HHHHHHHHHHhcCCCCCc--ccccceeecCCCCCCcccceEEEEEecCCCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHH
Q 005898 524 RNLKLRLDLLAKLRHPHL--VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG-NFRTHISENTPGKVLNWSERLAVLIGVA 600 (671)
Q Consensus 524 ~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~G-sL~~~l~~~~~~~~l~~~~~~~i~~~ia 600 (671)
....+|...+..++...| .+.+++.....+ .....++|+|++++- +|.+++..... .+-..+..++.+++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~----~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKG----GGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALA 128 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC----CceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHH
Confidence 456777777776654444 455566554321 113568999999984 79888875322 55667889999999
Q ss_pred HHHHHhcCCCCCCccccCCCCCceeecCCC---cEEEcccCCcccc
Q 005898 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHR---IAKLSDYGLSIVS 643 (671)
Q Consensus 601 ~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~---~~ki~DfGla~~~ 643 (671)
+.++-||.. +|+|+|+++.|||++.+. .+.+.||+-++..
T Consensus 129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999998 899999999999999876 8899999877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=8.5e-08 Score=84.16 Aligned_cols=104 Identities=29% Similarity=0.378 Sum_probs=55.9
Q ss_pred CCEEecccccccccCCccc---cCCCCCCEEEcccCcCCCCCCccCCC-CCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 120 LRVLSLVSLGIWGSLPDKI---HRLYSLEYLDLSSNFLFGSVPPKIST-MVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 120 L~~L~L~~n~l~g~~p~~~---~~L~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
+..++|+++.+ +.+++.. .....|...+|++|.+. .+|+.|.. .+-++.|+|++|.++ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~l-m~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQL-MYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchh-hHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 45566666666 3344433 33444555566666663 44544432 235555566666555 455555555566666
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccc
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAIS 227 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 227 (671)
+++.|.+. ..|..+..|.+|..||...|.+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 66555555 44555555555555555555443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.1e-05 Score=77.71 Aligned_cols=101 Identities=24% Similarity=0.306 Sum_probs=80.6
Q ss_pred HHHHHHhcCCC-CCcccccceeecCCCCCCcccceEEEEEecCCCCChhhh---hhcCCCCCCCCHHHHHHHHHHHHHHH
Q 005898 528 LRLDLLAKLRH-PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH---ISENTPGKVLNWSERLAVLIGVAKAV 603 (671)
Q Consensus 528 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~---l~~~~~~~~l~~~~~~~i~~~ia~gl 603 (671)
.|.-+|..+++ +++.+++|+|- .+.|.||.+.+++... +... ..-+|.+|.+||.++.+.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------------~~~v~E~~~~~~~~~~~~~l~~~---~~~~w~~R~~iA~~lL~~l 72 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------------RFYVVEYVGAGSLYGIYRPLSQF---LQSPWEQRAKIALQLLELL 72 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------------CEEEEEeecCccccccccccccc---cccCHHHHHHHHHHHHHHH
Confidence 46777888876 69999999994 2789999998766421 1111 1268999999999999999
Q ss_pred HHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 604 QFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 604 ~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+++++...-.+.-.|++++|+-+++++++|+.|..-+...
T Consensus 73 ~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 73 EELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 9999865445677999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.6e-05 Score=84.93 Aligned_cols=145 Identities=15% Similarity=0.234 Sum_probs=91.6
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhh----------------------------------------
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYT---------------------------------------- 522 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~---------------------------------------- 522 (671)
..|+ .+.|+.++-|.||+|++++|+.||||+....-...
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3454 37899999999999999999999999864321100
Q ss_pred HHHHHHHHHHHhcCC-----CCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHH
Q 005898 523 VRNLKLRLDLLAKLR-----HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597 (671)
Q Consensus 523 ~~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~ 597 (671)
.-++.+|..-+.+++ .+++.-. .+|++-. ....|+|||++|-.+.+...-... ..+ +..++.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP-~V~we~t-------~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~ 271 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVP-KVYWEYT-------TRRVLTMEWIDGIKISDIAALKSA--GID---RKELAE 271 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEec-eeehhcc-------CCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHH
Confidence 012344554444432 2333211 2333211 245899999999888776322111 133 444554
Q ss_pred HHHHH-HHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 598 GVAKA-VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 598 ~ia~g-l~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
..+++ +..+-.+ +++|.|..|.||+++.++..-.-|||+....+
T Consensus 272 ~~~~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 272 LLVRAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 44432 2222222 68999999999999999999999999987655
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.2e-05 Score=73.41 Aligned_cols=142 Identities=12% Similarity=0.048 Sum_probs=101.5
Q ss_pred eccCCceEEEEEEEcCCcEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCCC--cccccceeecCCCCCCcccceE
Q 005898 491 MGEGSYGKLYKGRLENGTSVAIRCLPSSK------KYTVRNLKLRLDLLAKLRHPH--LVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 491 iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~~~~~~~~ 562 (671)
-|+||-+-|++-.+. |+.+-+|+-...- ......|.+|...+.++...+ +.+++ ++.... ....-.-
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k---~~~~~rA 100 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK---IEGEWRA 100 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec---cCCceEE
Confidence 477888889997765 4468888865221 224567999999988885443 44444 332111 1112357
Q ss_pred EEEEecCCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc--EEEcccCC
Q 005898 563 FLVYEFMSN-GNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI--AKLSDYGL 639 (671)
Q Consensus 563 ~Lv~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~--~ki~DfGl 639 (671)
+||+|-+++ -+|.+++.+.. -...+...+..+..+||+.+.-||+. ++.|+|+-+.||+++.++. +++.||--
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 899998764 48988886532 12367778899999999999999997 8999999999999986656 89999965
Q ss_pred cc
Q 005898 640 SI 641 (671)
Q Consensus 640 a~ 641 (671)
++
T Consensus 177 ~r 178 (216)
T PRK09902 177 SR 178 (216)
T ss_pred cc
Confidence 53
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.8e-05 Score=84.44 Aligned_cols=138 Identities=18% Similarity=0.234 Sum_probs=87.5
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchh-------------------------------------hHHHHHHHH
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY-------------------------------------TVRNLKLRL 530 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-------------------------------------~~~~~~~E~ 530 (671)
.+.||.-+.|.||+|++++|+.||||+-+..-+. ..-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4678999999999999999999999986432110 011244554
Q ss_pred HHHhc----CCCCC------cccccceeecCCCCCCcccceEEEEEecCCCCChhhh--hhcCCCCCCCCHHHHHHHHHH
Q 005898 531 DLLAK----LRHPH------LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH--ISENTPGKVLNWSERLAVLIG 598 (671)
Q Consensus 531 ~~l~~----l~H~n------iv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~--l~~~~~~~~l~~~~~~~i~~~ 598 (671)
+-..+ ++|-+ |.+++..+. ....|+||||+|..+.+. +.+.+ ++-......+.+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----------t~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~i~~~l~~ 311 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----------TKRVLTMEYVDGIKINDLDAIDKRG----ISPHDILNKLVE 311 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----------cceEEEEEecCCccCCCHHHHHHcC----CCHHHHHHHHHH
Confidence 43332 34444 444443332 246899999999877554 43332 443333333322
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCceeecC----CCcEEEcccCCccccc
Q 005898 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNE----HRIAKLSDYGLSIVSE 644 (671)
Q Consensus 599 ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~----~~~~ki~DfGla~~~~ 644 (671)
+ |++.-...+++|.|=.|.||+++. ++++.+-|||+.+...
T Consensus 312 ~-----~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 312 A-----YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred H-----HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2 222211227899999999999983 6789999999987654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 671 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-24 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 7e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-54
Identities = 80/263 (30%), Positives = 116/263 (44%), Gaps = 11/263 (4%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L ++L+ L + + G I L+ L++SSN G +PP + LQ L L
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSL 276
Query: 174 DDNFFNNTIPNW-FDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
+N F IP++ + +LT L + N G P S L L LS N SG LP
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 233 --LSSLGSLNVLNLSDNKLDSNLP----KLPRGLVMAFLSNNSFSGEIPKQYGQ--LNQL 284
L + L VL+LS N+ LP L L+ LS+N+FSG I Q N L
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396
Query: 285 QQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344
Q+L + N G PP + + + L+L+ N SG++P +L KL + N L G
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456
Query: 345 GLPSCLSNESDKRVVKFRGNCLS 367
+P L + N L+
Sbjct: 457 EIPQELMYVKTLETLILDFNDLT 479
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-47
Identities = 78/338 (23%), Positives = 133/338 (39%), Gaps = 33/338 (9%)
Query: 29 SQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKI-------- 80
+ L+ + L L W + + C T +TC+D+ +T + +
Sbjct: 12 REIHQLISFKDVLPDKNLLPDW-SSNKNPC-----TFDGVTCRDDKVTSIDLSSKPLNVG 65
Query: 81 IGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDK--I 138
S++ + G S LS + I+ V+ SL L L + G + +
Sbjct: 66 FSAVSSSLLSLTGLESLF--LSNS-HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 139 HRLYSLEYLDLSSNFLFGSVP-PKISTMVKLQTLILDDNFFNNTIPNWFD---SLPSLTF 194
L++L++SSN L + L+ L L N + + L
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLP 254
L++ NK++G + R L LD+S N S +P L +L L++S NKL +
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFS 240
Query: 255 ----KLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIF-SLPNIS 309
L + +S+N F G IP L LQ L ++ N G P + + ++
Sbjct: 241 RAISTCTE-LKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 310 DLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLP 347
L+L+ N F G++P L +S+N +G LP
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-46
Identities = 55/245 (22%), Positives = 108/245 (44%), Gaps = 10/245 (4%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L L+ LR L L + G +P ++ + +LE L L N L G +P +S L + L
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
+N IP W L +L L + NN +G P+ + +L LDL+ N +G++P
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP-- 555
Query: 234 SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFL-----SNNSFSGEIPKQYGQLNQLQQLD 288
+++ + ++ N + + M + F G +Q +L+ +
Sbjct: 556 AAMFKQS-GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNL-NCGGKLVFFDISNNKLTGGLP 347
++ G P + ++ L+++ N SG +PK + + L ++ +N ++G +P
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY-LFILNLGHNDISGSIP 673
Query: 348 SCLSN 352
+ +
Sbjct: 674 DEVGD 678
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-45
Identities = 64/263 (24%), Positives = 111/263 (42%), Gaps = 28/263 (10%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
+L+ L L + G G +P + L L LS N+L G++P + ++ KL+ L L N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSS 235
IP + +L L + N L G PS + + L+ + LS N ++G +P +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 236 LGSLNVLNLSDNKLDSNLP----KLPRGLVMAFLSNNSFSGEIPKQYGQL---------- 281
L +L +L LS+N N+P L+ L+ N F+G IP +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRS-LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA 571
Query: 282 ----------NQLQQLDMSFNALR--GMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG 329
++ + N L G+ + L + N+ S + G +
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631
Query: 330 GKLVFFDISNNKLTGGLPSCLSN 352
G ++F D+S N L+G +P + +
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGS 654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-42
Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 10/242 (4%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLI 172
L+ T+L +SL + + G +P I RL +L L LS+N G++P ++ L L
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544
Query: 173 LDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAI--SGSL 230
L+ N FN TIP + N +AG I+ + + N + G
Sbjct: 545 LNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
Query: 231 P-DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF---LSNNSFSGEIPKQYGQLNQLQQ 286
L+ L + N N++ + +S N SG IPK+ G + L
Sbjct: 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFI 660
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGL 346
L++ N + G P + L ++ L+L+SNK G +P+ ++ L D+SNN L+G +
Sbjct: 661 LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPI 720
Query: 347 PS 348
P
Sbjct: 721 PE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-39
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 21/269 (7%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP 159
SLS N + RL +L +L L + G++P ++ SL +LDL++N G++P
Sbjct: 496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
Query: 160 PKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN--KLAGPFPSSIQRISTLS 217
+ Q+ + NF + + N + G + R+ST +
Sbjct: 556 AAMF----KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611
Query: 218 DLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLP----KLPRGLVMAFLSNNSFSG 272
+++ G + GS+ L++S N L +P + L + L +N SG
Sbjct: 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM-PYLFILNLGHNDISG 670
Query: 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKL 332
IP + G L L LD+S N L G P A+ +L +++++L++N SG +P+ G+
Sbjct: 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE----MGQF 726
Query: 333 VFFDIS----NNKLTGG-LPSCLSNESDK 356
F + N L G LP C + +D
Sbjct: 727 ETFPPAKFLNNPGLCGYPLPRCDPSNADG 755
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-26
Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 13/168 (7%)
Query: 191 SLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLD 250
S+ S N SS+ ++ L L LS + I+GS+ SL L+LS N L
Sbjct: 54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLS 113
Query: 251 SNLPKLP-----RGLVMAFLSNNSFSGEIPKQYG-QLNQLQQLDMSFNALRGMPPPAIF- 303
+ L GL +S+N+ G +LN L+ LD+S N++ G
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 304 --SLPNISDLNLASNKFSGSLP-KNLNCGGKLVFFDISNNKLTGGLPS 348
+ L ++ NK SG + L F D+S+N + G+P
Sbjct: 174 SDGCGELKHLAISGNKISGDVDVSRCV---NLEFLDVSSNNFSTGIPF 218
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-20
Identities = 41/170 (24%), Positives = 74/170 (43%)
Query: 79 KIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKI 138
I G + + N + + + L RL++ ++ S G
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 139 HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMR 198
S+ +LD+S N L G +P +I +M L L L N + +IP+ L L L +
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 199 NNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNK 248
+NKL G P ++ ++ L+++DLS N +SG +P++ + +N
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-52
Identities = 83/331 (25%), Positives = 141/331 (42%), Gaps = 32/331 (9%)
Query: 28 SSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSN 87
Q LLQ++K L P L W D C + + C D +
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSW-LPTTDCCNRTWL---GVLC------------DTDTQ 48
Query: 88 VGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSL-GIWGSLPDKIHRLYSLEY 146
+ + +L + + I S LA L L L + + + G +P I +L L Y
Sbjct: 49 TYRVNNLDLSGLNLPKPYPIPSS---LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 147 LDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPF 206
L ++ + G++P +S + L TL N + T+P SLP+L ++ N+++G
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 207 PSSIQRISTLS-DLDLSKNAISGSLPDLSSLGSLN--VLNLSDNKLDSNLPKL---PRGL 260
P S S L + +S+N ++G +P + +LN ++LS N L+ + L +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIP--PTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 261 VMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSG 320
L+ NS + ++ K G L LD+ N + G P + L + LN++ N G
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 321 SLPKNLNCGGKLVFFDISNNKLTGG--LPSC 349
+P+ N + +NNK G LP+C
Sbjct: 283 EIPQGGNL-QRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 132 GSLPDKIHRLYSLEYLDLSSNFLFGS--VPPKISTMVKLQTLIL-DDNFFNNTIPNWFDS 188
G L D + Y + LDLS L +P ++ + L L + N IP
Sbjct: 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDN 247
L L +L + + ++G P + +I TL LD S NA+SG+LP +SSL +L + N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 248 KLD-------SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPP 300
++ + KL + +S N +G+IP + LN L +D+S N L G
Sbjct: 160 RISGAIPDSYGSFSKLFTSM---TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215
Query: 301 AIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
S N ++LA N + L K L D+ NN++ G LP L+
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKN-LNGLDLRNNRIYGTLPQGLTQ 266
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 33/229 (14%)
Query: 147 LDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN--NTIPNWFDSLPSLTFLSMRN-NKLA 203
D + G + + ++ L L IP+ +LP L FL + N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 204 GPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVM 262
GP P +I +++ L L ++ +SG++PD LS + +L L+ S
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS----------------- 133
Query: 263 AFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN-ISDLNLASNKFSGS 321
N+ SG +P L L + N + G P + S + + ++ N+ +G
Sbjct: 134 ----YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 322 LPK---NLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367
+P NLN L F D+S N L G ++ + + + N L+
Sbjct: 190 IPPTFANLN----LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 40/154 (25%), Positives = 53/154 (34%), Gaps = 27/154 (17%)
Query: 206 FPSSIQRISTLSD----LDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGL 260
+ +TLS D G L D + +N L+LS L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL----------- 62
Query: 261 VMAFLSNNSFSGEIPKQYGQLNQLQQLDMS-FNALRGMPPPAIFSLPNISDLNLASNKFS 319
IP L L L + N L G PPAI L + L + S
Sbjct: 63 --------PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 320 GSLPKNL-NCGGKLVFFDISNNKLTGGLPSCLSN 352
G++P L LV D S N L+G LP +S+
Sbjct: 115 GAIPDFLSQIK-TLVTLDFSYNALSGTLPPSISS 147
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 61/188 (32%), Positives = 103/188 (54%), Gaps = 16/188 (8%)
Query: 456 VSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCL 515
+++A L +L+EATNNFD ++G G +GK+YKG L +G VA++
Sbjct: 12 INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR 71
Query: 516 PSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFR 575
+ + ++ L+ RHPHLV L+G C + L+Y++M NGN +
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM--------ILIYKYMENGNLK 123
Query: 576 THIS-ENTPGKVLNWSERLAVLIGVAKAVQFLHTG-VIPGFFNNR-VKTNNILLNEHRIA 632
H+ + P ++W +RL + IG A+ + +LHT +I +R VK+ NILL+E+ +
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAII-----HRDVKSINILLDENFVP 178
Query: 633 KLSDYGLS 640
K++D+G+S
Sbjct: 179 KITDFGIS 186
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 10/171 (5%)
Query: 471 RSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCL-PSSKKYTVRNLKLR 529
+ F+L EL+ A++NF I+G G +GK+YKGRL +GT VA++ L + +
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 530 LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGK-VLN 588
+++++ H +L+ L G C+ R LVY +M+NG+ + + E + L+
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTER--------LLVYPYMANGSVASCLRERPESQPPLD 129
Query: 589 WSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
W +R + +G A+ + +LH P + VK NILL+E A + D+GL
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 63/181 (34%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 471 RSFTLEELKEATNNFD------MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTV- 523
SF+ ELK TNNFD MGEG +G +YKG + N T+VA++ L + T
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 524 ---RNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISE 580
+ + ++AK +H +LV LLG DG LVY +M NG+ +S
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL--------CLVYVYMPNGSLLDRLSC 123
Query: 581 NTPGKVLNWSERLAVLIGVAKAVQFLHTG-VIPGFFNNR-VKTNNILLNEHRIAKLSDYG 638
L+W R + G A + FLH I +R +K+ NILL+E AK+SD+G
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHI-----HRDIKSANILLDEAFTAKISDFG 178
Query: 639 L 639
L
Sbjct: 179 L 179
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-36
Identities = 45/265 (16%), Positives = 97/265 (36%), Gaps = 22/265 (8%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
+ + + + K L L +++ + +P + + ++Q +
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 172 ILDDNFF--------NNTIPNWFDSLPSLTFLSMRNNKLA-GPFPSSIQRISTLSDLDLS 222
+ N + + + + N L P +S+Q++ L L+
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECL 338
Query: 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDS---NLPKLPRGLVMAFLSNNSFSGEIPKQY- 278
N + G LP S L LNL+ N++ N + ++N IP +
Sbjct: 339 YNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFD 397
Query: 279 -GQLNQLQQLDMSFNALRGMP-------PPAIFSLPNISDLNLASNKFSGSLPKNLNCGG 330
++ + +D S+N + + P F N+S +NL++N+ S + + G
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 331 KLVFFDISNNKLTGGLPSCLSNESD 355
L ++ N LT + L +E++
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENE 482
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-32
Identities = 40/270 (14%), Positives = 79/270 (29%), Gaps = 17/270 (6%)
Query: 98 NASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFG- 156
N + + +L + LSL G G +PD I +L LE L L S+
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 157 ---SVPPKISTMVKLQTLILDDNFFNNTIPNWFD--SLPSLTFLSMRNNKLAGPFPSSIQ 211
P IS + + + T ++ L + ++ S +
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 212 RISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271
+ + N I+ + L L + ++ +
Sbjct: 181 ITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENI--CEAWENENSEYAQQY 238
Query: 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF--------SGSLP 323
++ L L +++ P + +LP + +N+A N+
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 324 KNLNCGGKLVFFDISNNKLTGG-LPSCLSN 352
+ G K+ I N L + + L
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 52/285 (18%), Positives = 96/285 (33%), Gaps = 43/285 (15%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSV 158
N ++ + L L+L I +P +E L + N L +
Sbjct: 336 ECLYN-QLEGKLPAFGSEIKLASLNLAYNQI-TEIPANFCGFTEQVENLSFAHNKL-KYI 392
Query: 159 PPK--ISTMVKLQTLILDDNFFNNTIPNWFDSLP-------SLTFLSMRNNKLAGPFPSS 209
P ++ + + N + FD L +++ +++ NN+++
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452
Query: 210 IQRISTLSDLDLSKNAISG--------SLPDLSSLGSLNVLNLSDNKL--------DSNL 253
S LS ++L N ++ + + L ++L NKL + L
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTL 512
Query: 254 PKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQL------DMSFNALRGMPPPAIFSLPN 307
P L G+ LS NSFS P Q + L+ D N P I P+
Sbjct: 513 PYL-VGI---DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 308 ISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
++ L + SN + + + + DI +N S +
Sbjct: 568 LTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 43/268 (16%), Positives = 89/268 (33%), Gaps = 33/268 (12%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDK--IHRLYSLEYLDLSSNFL-------FGSVPPKIS 163
+ LS + +P+ + + +D S N + F + P
Sbjct: 372 FCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 164 TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-------PFPSSIQRISTL 216
+ + ++ L +N + F + L+ +++ N L + + L
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 217 SDLDLSKNAISGSLPDL--SSLGSLNVLNLSDNKLDS------NLPKLPRGLVMAF---L 265
+ +DL N ++ D ++L L ++LS N N L +G +
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTL-KGFGIRNQRDA 549
Query: 266 SNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKN 325
N E P+ L QL + N +R + PNIS L++ N
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEK---ITPNISVLDIKDNPNISIDLSY 606
Query: 326 LNCGGKLVFFDISNNKLTGGLPSCLSNE 353
+ + + + +K + C + +
Sbjct: 607 VCPYIEAGMYMLFYDKTQ-DIRGCDALD 633
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 32/230 (13%), Positives = 64/230 (27%), Gaps = 40/230 (17%)
Query: 103 ENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL-------F 155
+ + D T + ++ ++L + I + L ++L N L
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 156 GSVPPKISTMVKLQTLILDDNFFNNTIPNW-FDSLPSLTFLSMRNNKLAGPFPSSIQRIS 214
L ++ L N ++ +LP L + + N + FP+ S
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536
Query: 215 TLSDL------DLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSN 267
TL D N P+ ++ SL L + N + + +
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK----VNEKI------- 585
Query: 268 NSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNK 317
+ LD+ N + + L +K
Sbjct: 586 -------------TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 14/110 (12%), Positives = 32/110 (29%), Gaps = 6/110 (5%)
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP----PPAIFSLPNISDLNLASNKFSG 320
L SG +P GQL +L+ L + + + P I + + +
Sbjct: 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147
Query: 321 SLPKNLNCGG--KLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
+ L+ I+++ + + N ++
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 64/269 (23%), Positives = 99/269 (36%), Gaps = 20/269 (7%)
Query: 100 SLSENF----SIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLF 155
SLS +F ++ + + L +L+L I D L LE LDL N +
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 156 GSVPPK-ISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG--PFPSSIQR 212
+ + + + + L N + N F +PSL L +R L PS Q
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 213 ISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF------- 264
+ L+ LDLS N I+ D L L L +L+L N L G + F
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 265 ----LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSG 320
L +N F + + L +L+ +D+ N L +P + ++ LNL N +
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598
Query: 321 SLPKNLNCG-GKLVFFDISNNKLTGGLPS 348
K L D+ N S
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 50/274 (18%), Positives = 95/274 (34%), Gaps = 11/274 (4%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
R + L L + I P+ +L L+ L+L N L + L L
Sbjct: 43 ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTEL 102
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
L N N F +L L + +N L+ + ++ L +L LS N I
Sbjct: 103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162
Query: 232 D---LSSLGSLNVLNLSDNKLDSNLPKLPRGLVM---AFLSNNSFSGEIPKQYG---QLN 282
+ + + SL L LS N++ P + FL+N + ++
Sbjct: 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222
Query: 283 QLQQLDMSFNALRGMPPPAIFSL--PNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN 340
++ L +S + L L N++ L+L+ N + + +L +F + N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 341 KLTGGLPSCLSNESDKRVVKFRGNCLSSNVQNQH 374
+ L + R + + + ++
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-32
Identities = 60/295 (20%), Positives = 102/295 (34%), Gaps = 30/295 (10%)
Query: 100 SLSENF--SIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGS 157
SLS + + + + T+L +L L + D L LEY L N +
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287
Query: 158 VPPKISTMVKLQTLILDDNFFNNTI---------PNWFDSLPSLTFLSMRNNKLAGPFPS 208
+ + ++ L L +F +I F L L L+M +N + G +
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
Query: 209 SIQRISTLSDLDLSKNAISGSLPDLSSLG-----SLNVLNLSDNKLD-------SNLPKL 256
+ L L LS + S + L++LNL+ NK+ S L L
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 257 PRGLVMAFLSNNSFSGEIPKQY-GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLAS 315
L L N E+ Q L + ++ +S+N + + +P++ L L
Sbjct: 408 -EVL---DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463
Query: 316 NKFSG--SLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
S P L D+SNN + L ++ + N L+
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 49/231 (21%), Positives = 78/231 (33%), Gaps = 27/231 (11%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
S E D S L VP + T + L L N F LT L + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLV 261
+ P Q++ L L+L N +S + +L L+L N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK---------- 111
Query: 262 MAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321
+ NN F L LD+S N L L N+ +L L++NK
Sbjct: 112 ---IKNNPFVK--------QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 322 LPKNLNCGG--KLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370
+ L+ L ++S+N++ P C + L ++
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 39/185 (21%), Positives = 65/185 (35%), Gaps = 12/185 (6%)
Query: 100 SLSENF--SIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL--- 154
L ++DS + L +L +L L + I D + L LE LDL N L
Sbjct: 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519
Query: 155 -----FGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSS 209
G + + L L L+ N F+ F L L + + N L S
Sbjct: 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
Query: 210 IQRISTLSDLDLSKNAISGSLPDL--SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSN 267
+L L+L KN I+ + + +L L++ N D + + ++
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETH 639
Query: 268 NSFSG 272
+
Sbjct: 640 TNIPE 644
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-34
Identities = 58/371 (15%), Positives = 118/371 (31%), Gaps = 56/371 (15%)
Query: 6 GNLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQ 65
G L L+ + H+++ ++ L + L L+ IN + I ++
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 66 VN-----ITCQDNFITELKIIGDKPSNVGNF-----------------DGFASANASLSE 103
++ I N IT + + +A+
Sbjct: 423 ISLKDTQIGNLTNRITFI------SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476
Query: 104 NFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKIS 163
++ + + L L + L + LPD ++ L L+ L+++ N
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG--------- 527
Query: 164 TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLS 222
+ + D+ P + M N L P +S+Q++ L LD
Sbjct: 528 ------ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCV 581
Query: 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDS---NLPKLPRGLVMAFLSNNSFSGEIPKQY- 278
N + L + L L L N+++ + + S+N IP +
Sbjct: 582 HNKVR-HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639
Query: 279 -GQLNQLQQLDMSFNALRGMPP-----PAIFSLPNISDLNLASNKFSGSLPKNLNCGGKL 332
+ + +D S+N + + N S + L+ N+ + G +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 333 VFFDISNNKLT 343
+SNN +T
Sbjct: 700 STIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 40/282 (14%), Positives = 81/282 (28%), Gaps = 21/282 (7%)
Query: 82 GDKPSNVGNFDGFASANASLSENFSIDSFV----TTLARLTSLRVLSLVSLGIWGSLPDK 137
G + + + N +D + L + LSL G G +PD
Sbjct: 283 GKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 138 IHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWF-DSLPSLTFLS 196
I +L L+ L ++ S + + F D L
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402
Query: 197 MRNNKL-----AGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS 251
+ + + P + + + N I+ + L L ++ +++
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY 462
Query: 252 NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDL 311
+ + A + L L +++ P ++ LP + L
Sbjct: 463 DNIAV--DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520
Query: 312 NLASNKFSG---------SLPKNLNCGGKLVFFDISNNKLTG 344
N+A N+ L + + G K+ F + N L
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-29
Identities = 44/293 (15%), Positives = 92/293 (31%), Gaps = 34/293 (11%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWG------SLPDKIHRLYSLEYLDLSSNF 153
L ++ + + + +SL I + I RL L+ + +++
Sbjct: 402 DLLQDAI--NRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSP 459
Query: 154 LFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRI 213
V + D + +L LT + + N P + +
Sbjct: 460 FTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514
Query: 214 STLSDLDLSKNAISG---------SLPD-LSSLGSLNVLNLSDNKLDS-----NLPKLPR 258
L L+++ N L D + + + + N L+ +L K+ +
Sbjct: 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK 574
Query: 259 GLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318
L + +N + +G +L L + +N + +P + L + NK
Sbjct: 575 -LGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631
Query: 319 SGSLPKNLNCGG--KLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN 369
+P N + D S NK+ + + D + + LS N
Sbjct: 632 K-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 51/290 (17%), Positives = 99/290 (34%), Gaps = 42/290 (14%)
Query: 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPK--ISTM 165
+ L L L I +P+ +E L S N L +P ++
Sbjct: 586 RHLEAFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSV 643
Query: 166 VKLQTLILDDNFFNNTIPNWFDSLP-----SLTFLSMRNNKLAGPFPSSIQRISTLSDLD 220
+ ++ N + N S+ + + +++ N++ S +S +
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703
Query: 221 LSKNAISGSLPD---------LSSLGSLNVLNLSDNKL--------DSNLPKLPRGLVMA 263
LS N ++ S+P+ + L ++L NKL + LP L +
Sbjct: 704 LSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYL-SNM--- 758
Query: 264 FLSNNSFSGEIPKQYGQLNQLQQL------DMSFNALRGMPPPAIFSLPNISDLNLASNK 317
+S N FS P Q +QL+ D N + P I + P++ L + SN
Sbjct: 759 DVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 318 FSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367
+ + L +L DI++N + + + + +
Sbjct: 818 IR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 46/267 (17%), Positives = 88/267 (32%), Gaps = 40/267 (14%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDK--IHRLYSLEYLDLSSNFLFGSVPPKIST----- 164
A + L + +P+ +Y + +D S N + GS IS
Sbjct: 613 DFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDY 670
Query: 165 -MVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL-------AGPFPSSIQRISTL 216
+ T+ L N F + ++ + + NN + P + + L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 217 SDLDLSKNAISGSLPD---LSSLGSLNVLNLSDNKLDS------NLPKLPRGLVMA---F 264
+ +DL N ++ SL D ++L L+ +++S N S N +L + +
Sbjct: 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQL-KAFGIRHQRD 788
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS----G 320
N + P L QL + N +R + P + L++A N
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE---KLTPQLYILDIADNPNISIDVT 845
Query: 321 SLPKNLNCGGKLVFFDISNNKLTGGLP 347
S+ + G + + G
Sbjct: 846 SVCPYIEAG--MYVLLYDKTQDIRGCD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 33/269 (12%), Positives = 70/269 (26%), Gaps = 29/269 (10%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
A L + + + + + + + ++ L L
Sbjct: 272 KALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSL 330
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD- 232
+P+ L L LS + T + K+ I
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 233 -LSSLGSLNVLNLSDNKLDSNLPKLP-RGLVMAFLSNNSFSG------EIPKQYGQLNQL 284
L LN+ +L + ++ N P + L + I K +L +L
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 285 QQLDMSFNALRGMP-------------------PPAIFSLPNISDLNLASNKFSGSLPKN 325
Q + + + + +L +++D+ L + LP
Sbjct: 451 QIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
Query: 326 LNCGGKLVFFDISNNKLTGGLPSCLSNES 354
L +L +I+ N+
Sbjct: 511 LYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 18/169 (10%), Positives = 55/169 (32%), Gaps = 4/169 (2%)
Query: 205 PFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSL-NVLNLSDNKLDSNLP-KLPRGLVM 262
F +++ +++ + + + D +L ++ L+ + + S L
Sbjct: 243 SFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW 302
Query: 263 AFLSNNSFSGEIPK-QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321
F G+ P ++ L ++ +G P AI L + L+ ++ + S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 322 LPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDK-RVVKFRGNCLSSN 369
+ + +++ + + + + ++ N
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN 411
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 56/269 (20%), Positives = 97/269 (36%), Gaps = 18/269 (6%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLV--SLGIWGSLPDKIHRLYSLEYLDLSSNFLFGS 157
L+ + + L SL L L L G SL+YLDLS N +
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387
Query: 158 VPPKISTMVKLQTLILDDNFFNNTIPNW-FDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216
+ + +L+ L + F SL +L +L + + F +S+L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 217 SDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRG---LVMAFLSNNSFS 271
L ++ N+ + + L +L L+LS +L+ P L + +S+N+F
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLP-NISDLNLASNKFSGSLP-----KN 325
Y LN LQ LD S N + + P +++ LNL N F+ + +
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567
Query: 326 LNCGGKLVFFDISNNKLTGGLPSCLSNES 354
+ + ++ PS
Sbjct: 568 IK---DQRQLLVEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 53/276 (19%), Positives = 91/276 (32%), Gaps = 30/276 (10%)
Query: 104 NFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL--------- 154
++ +D + LT++ SLVS+ I + ++L+L +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 155 ----------FGSVPPKISTMVKLQTLILDDNFFN--NTIPNWFDSLPSLTFLSMRNNKL 202
G + L+ L L N + SL +L + N +
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRG- 259
S+ + L LD + + SL +L L++S + G
Sbjct: 386 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 260 --LVMAFLSNNSFSGEIPKQY-GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
L + ++ NSF +L L LD+S L + P A SL ++ LN++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 317 KFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
F C L D S N + L +
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 48/251 (19%), Positives = 84/251 (33%), Gaps = 18/251 (7%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
+ L+VL L I L L L L+ N + S + LQ L
Sbjct: 46 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAISGSL 230
+ + + L +L L++ +N + P ++ L LDLS N I
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165
Query: 231 P-DLSSLGSLNV----LNLSDNKLDSNLPKLPRG--LVMAFLSNNSFSGEIPKQ-YGQLN 282
DL L + + L+LS N ++ P + L L NN S + K L
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLA 225
Query: 283 QLQQLDMSFNALRG---MPPPAIFSLPNISDLNLASNKFS------GSLPKNLNCGGKLV 333
L+ + R + +L + +L + + + + NC +
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 334 FFDISNNKLTG 344
F + + +
Sbjct: 286 SFSLVSVTIER 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-29
Identities = 51/239 (21%), Positives = 81/239 (33%), Gaps = 14/239 (5%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF 177
S + L L + L+ LDLS + ++ L TLIL N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 178 FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSS 235
+ F L SL L LA I + TL +L+++ N I S+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 236 LGSLNVLNLSDNKLDS-------NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L +L L+LS NK+ S L ++P + LS N + P + ++ L +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 289 MSFNALRGMPPPAIF-SLPNISDLNLASNKFSGS---LPKNLNCGGKLVFFDISNNKLT 343
+ N L + L +F + + L I +L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 53/285 (18%), Positives = 94/285 (32%), Gaps = 20/285 (7%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDK-IHRLYSLEYLDLSSNFLFGS- 157
LS N ++ + L L+L + ++ I L LE L
Sbjct: 183 DLSLNP-MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 158 --VPPKISTMVKLQTLILDDN------FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSS 209
S + L L +++ ++ + I + F+ L +++ S+ + + S
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301
Query: 210 IQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLP-RGLVMAFLSNN 268
L+L L SL L + NK + ++ L LS N
Sbjct: 302 YN--FGWQHLELVNCKFGQFPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
Query: 269 --SFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNL 326
SF G + L+ LD+SFN + M L + L+ + ++
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 327 NCG-GKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370
L++ DIS+ + S V+K GN N
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 19/112 (16%), Positives = 31/112 (27%)
Query: 241 VLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPP 300
+ LP LS N + +LQ LD+S ++ +
Sbjct: 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 301 AIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
A SL ++S L L N + L L + +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 36/186 (19%), Positives = 80/186 (43%), Gaps = 17/186 (9%)
Query: 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDL 532
E L + + + G +G ++K +L VA++ P K + +N + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQN-EYEVYS 71
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
L ++H +++ +G G D ++L+ F G+ + N ++W+E
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDV----DLWLITAFHEKGSLSDFLKANV----VSWNEL 123
Query: 593 LAVLIGVAKAVQFLHTGVIPGFFNNR-------VKTNNILLNEHRIAKLSDYGLSIVSED 645
+ +A+ + +LH + ++ +K+ N+LL + A ++D+GL++ E
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 646 INSVGV 651
S G
Sbjct: 184 GKSAGD 189
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-31
Identities = 58/276 (21%), Positives = 108/276 (39%), Gaps = 13/276 (4%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP 159
L+ + + L L++L+ L L + SL +L + N +
Sbjct: 284 DLTAT-HLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 160 PK-ISTMVKLQTLILDDNFFNNT--IPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216
+ + L+ L L + + +L L L++ N+ + + L
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402
Query: 217 SDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRG---LVMAFLSNNSFS 271
LDL+ + +L L VLNLS + LD + +L G L L N F
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462
Query: 272 GEIPKQYG---QLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNC 328
++ L +L+ L +SF L + A SL ++ ++L+ N+ + S
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALS 521
Query: 329 GGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGN 364
K ++ ++++N ++ LPS L S +R + R N
Sbjct: 522 HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 53/250 (21%), Positives = 82/250 (32%), Gaps = 10/250 (4%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
TT +RL +L L L I+ D + L+ L L++N L +S L+ L
Sbjct: 51 TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
++ + +L L + +N ++ L LD NAI
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170
Query: 232 -DLSSLGSLNV--LNLSDNKLDSNLPKLPRGLVMA--FLSNNSFSGEIPKQYG--QLNQL 284
D+SSL LNL+ N + P V I K + L
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 285 QQLDMSFNALRGMPPPAIFSLPNIS--DLNLASNKFSGSLPKNLNCGGKLVFFDISNNKL 342
+ P L +S +NL + F +C L D++ L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 343 TGGLPSCLSN 352
+ LPS L
Sbjct: 291 S-ELPSGLVG 299
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 47/237 (19%), Positives = 83/237 (35%), Gaps = 20/237 (8%)
Query: 100 SLSEN-FSIDSFVTTLARLTSLRVLSLVS--LGIWGSLPDKIHRLYSLEYLDLSSNFLFG 156
S+ N ++ L L +LR L L + ++ L L+ L+LS N
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIP-NWFDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215
+L+ L L + F +L L L++ ++ L +
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 216 LSDLDLSKNAISGSLPD----LSSLGSLNVLNLSDNKLDS-------NLPKLPRGLVMAF 264
L L+L N L +LG L +L LS L S +L + +
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM-NHV---D 506
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321
LS+N + + L + L+++ N + + P + L +NL N +
Sbjct: 507 LSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 50/272 (18%), Positives = 98/272 (36%), Gaps = 20/272 (7%)
Query: 113 TLARLTSLRVLSL-VSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKIS--TMVKLQ 169
++ L LSL ++ + + L+ + + T+ L
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231
Query: 170 TLILDDNFFNNTIPNWFDSLP--SLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAIS 227
+D + P F+ L S+ ++++ + ++ S L +LDL+ +S
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
Query: 228 GSLPDLSSLGSLNVLNLSDNKLD-------SNLPKLPRGLVMAFLSNNSFSGEIPKQY-G 279
L L +L L LS NK + SN P L L + N+ E+
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL-THL---SIKGNTKRLELGTGCLE 347
Query: 280 QLNQLQQLDMSFNALRGMP--PPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDI 337
L L++LD+S + + + +L ++ LNL+ N+ + +L D+
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407
Query: 338 SNNKLTG-GLPSCLSNESDKRVVKFRGNCLSS 368
+ +L S N +V+ + L
Sbjct: 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 23/156 (14%), Positives = 50/156 (32%), Gaps = 22/156 (14%)
Query: 214 STLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG 272
++ L+ S N + S L +L L+L+ ++ + ++F
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-------------IHEDTFQS 79
Query: 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKL 332
++L L ++ N L M A+ + L S L+ L
Sbjct: 80 --------QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 333 VFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
+ +N ++ +V+ F+ N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 42/237 (17%), Positives = 90/237 (37%), Gaps = 10/237 (4%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
++ + + ++ + L ++ + ++ L L N + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSN 252
L++ +N L ++ +STL LDL+ N + +L S+ L+ ++N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNISRV 114
Query: 253 LPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFS-LPNISDL 311
+G +L+NN + G +++Q LD+ N + + + + + L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 312 NLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
NL N + + KL D+S+NKL + + + + R N L
Sbjct: 175 NLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 44/243 (18%), Positives = 74/243 (30%), Gaps = 19/243 (7%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
L L++LR L L + + ++ S+E L ++N + V S +
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVSC--SRGQGKKN 124
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAISGS 229
+ L +N + +L ++ N++ F TL L+L N I
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 230 LPDLSSLGSLNVLNLSDNKL---DSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ 286
+ L L+LS NKL + L NN I K L+
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAG-VTWISLRNNKLV-LIEKALRFSQNLEH 241
Query: 287 LDMSFNALRGMPPPAIFS-LPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGG 345
D+ N FS + + + K L +
Sbjct: 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCED 298
Query: 346 LPS 348
LP+
Sbjct: 299 LPA 301
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 31/228 (13%), Positives = 61/228 (26%), Gaps = 29/228 (12%)
Query: 112 TTLARLTSLRVLSL-------VSLGIWGSL--------------PDKIHRLYSLEYLDLS 150
L S+ L VS ++YLDL
Sbjct: 93 QELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 151 SNFLFG-SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSS 209
N + + ++ L+ L L NF + L L + +NKLA
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLAF-MGPE 209
Query: 210 IQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPK--LPRGLVMAFLS 266
Q + ++ + L N + + L +L +L N + + + ++
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268
Query: 267 NNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLA 314
+ + + +P P L + +
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 34/176 (19%), Positives = 70/176 (39%), Gaps = 15/176 (8%)
Query: 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDL 532
E +N + ++G G YG +YKG L + VA++ + + N + +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYR 60
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
+ + H ++ + + LV E+ NG+ ++S +T +W
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGR---MEYLLVMEYYPNGSLXKYLSLHT----SDWVSS 113
Query: 593 LAVLIGVAKAVQFLHTGVIPGFFNNR------VKTNNILLNEHRIAKLSDYGLSIV 642
+ V + + +LHT + G + + N+L+ +SD+GLS+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-28
Identities = 59/235 (25%), Positives = 87/235 (37%), Gaps = 11/235 (4%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL--FGSVPPKISTMVKLQTLILD 174
L L+ L+L S+ K L SL YLDLS N L G L+ L L
Sbjct: 327 LPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAISGSLPD- 232
N + F L L L +++ L S+ + L LD+S
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 233 LSSLGSLNVLNLSDNKLDSNLP----KLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L SLN L ++ N N L LS + L++LQ L+
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
MS N L + L ++S L+ + N+ S + L FF+++NN +
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 46/264 (17%), Positives = 81/264 (30%), Gaps = 14/264 (5%)
Query: 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKL 168
++ + + + LS++ + P L L+ L L+ N S+ K + L
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQL-KQFPTL--DLPFLKSLTLTMNKG--SISFKKVALPSL 352
Query: 169 QTLILDDNFFNNTIPN--WFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAI 226
L L N + + SL L + N ++ + L LD + +
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTL 411
Query: 227 SGSLP--DLSSLGSLNVLNLSDNKLDSNLPKLPRG---LVMAFLSNNSFSGEIPKQY-GQ 280
SL L L++S + + G L ++ NSF
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 281 LNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN 340
L LD+S L + +L + LN++ N + N L D S N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 341 KLTGGLPSCLSNESDKRVVKFRGN 364
++ N
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 45/275 (16%), Positives = 90/275 (32%), Gaps = 19/275 (6%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
+ + + L+ L L I H L+ L L L+ N + P S + L+ L
Sbjct: 50 YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAISG-- 228
+ + + L +L L++ +N + P+ ++ L +DLS N I
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169
Query: 229 --SLPDLSSLGSLNV-LNLSDNKLDSNLPKLPRGLVMAFL--SNNSFSGEIPK-QYGQLN 282
L L +N+ L++S N +D + +G+ + L N S I K L
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229
Query: 283 QLQQLDMSFNALRGM------PPPAIFSLPNIS--DLNLASNKFSGSLPKNLNCGGKLVF 334
L + + P + L +++ + L +C +
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289
Query: 335 FDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN 369
++ + + + + L
Sbjct: 290 MSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF 322
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 49/269 (18%), Positives = 87/269 (32%), Gaps = 19/269 (7%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF 177
+S + + L + L++LDLS + + L LIL N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 178 FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSS 235
+ P F L SL L KLA I ++ TL L+++ N I S+
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 236 LGSLNVLNLSDNKLDS-------NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L +L ++LS N + + L + P+ + +S N I Q Q +L +L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 289 MSFNALRGMPPPAIFS-LPNISDLNLASNKFSG-----SLPKNLN---CGGKLVFFDISN 339
+ N L + L +F ++ C + F ++
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 340 NKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
++ + G +
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKY 299
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 52/283 (18%), Positives = 88/283 (31%), Gaps = 19/283 (6%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDK-IHRLYSLEYLDLSSNFLFGSV- 158
+S N ID + L L+L ++ + L L L
Sbjct: 188 MSLNP-IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246
Query: 159 -----PPKISTMVKLQTLILDDNFFNNT--IPNWFDSLPSLTFLSMRNNKLAGPFPSSIQ 211
P + + + + N+ F L +++ +S+ + + +
Sbjct: 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK--YLEDVP 304
Query: 212 RISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLP-RGLVMAFLSNN-- 268
+ L + + + P L L L L L+ NK + K+ L LS N
Sbjct: 305 KHFKWQSLSIIRCQLK-QFPTLD-LPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNAL 362
Query: 269 SFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNC 328
SFSG N L+ LD+SFN M L + L+ + +
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAIIMSA-NFMGLEELQHLDFQHSTLKRVTEFSAFL 421
Query: 329 G-GKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370
KL++ DIS + +K GN N
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 33/142 (23%), Positives = 48/142 (33%), Gaps = 2/142 (1%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTL 171
L L L + L SL L ++ N + + + L L
Sbjct: 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
L FD+L L L+M +N L S ++ +LS LD S N I S
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
Query: 232 D-LSSLGSLNVLNLSDNKLDSN 252
SL NL++N +
Sbjct: 539 ILQHFPKSLAFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 4/151 (2%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVS-LGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV 158
+S + F LTSL L + +L + +L +LDLS L
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489
Query: 159 PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218
T+ +LQ L + N + ++ L SL+ L N++ +L+
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAF 549
Query: 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKL 249
+L+ N+++ + + L + L
Sbjct: 550 FNLTNNSVA-CICEHQKF--LQWVKEQKQFL 577
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 25/125 (20%), Positives = 39/125 (31%)
Query: 228 GSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQL 287
GSL + D KL +P LS N + ++LQ L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 288 DMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLP 347
D+S + + A L ++S+L L N P + + L KL
Sbjct: 62 DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLES 121
Query: 348 SCLSN 352
+
Sbjct: 122 FPIGQ 126
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-26
Identities = 42/237 (17%), Positives = 90/237 (37%), Gaps = 10/237 (4%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
++ + + ++ + L ++ + ++ L L N + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSN 252
L++ +N L ++ +STL LDL+ N + +L S+ L+ ++N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNISRV 114
Query: 253 LPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFS-LPNISDL 311
+G +L+NN + G +++Q LD+ N + + + + + L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 312 NLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
NL N + + KL D+S+NKL + + + + R N L
Sbjct: 175 NLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 3e-23
Identities = 42/237 (17%), Positives = 69/237 (29%), Gaps = 16/237 (6%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
L L++LR L L + + ++ S+E L ++N + V S +
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVSC--SRGQGKKN 124
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAISGS 229
+ L +N + +L ++ N++ F TL L+L N I
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 230 LPDLSSLGSLNVLNLSDNKL---DSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ 286
+ L L+LS NKL + L NN I K L+
Sbjct: 184 VKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAG-VTWISLRNNKLV-LIEKALRFSQNLEH 241
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
D+ N FS +A +N
Sbjct: 242 FDLRGNGFHCGTLRDFFSKNQ-RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 26/227 (11%), Positives = 62/227 (27%), Gaps = 13/227 (5%)
Query: 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKL 168
+F A +L L+L I+ + ++ L+ LDLSSN L + P+ + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGV 216
Query: 169 QTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA-GPFPSSIQRISTLSDLDLSKNAIS 227
+ L +N I +L +R N G + + +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 228 GSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSF-------SGEIPKQYGQ 280
+ + + + + L+ ++ + + +
Sbjct: 276 -TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334
Query: 281 LNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327
+ +++D R + L +
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 20/210 (9%), Positives = 54/210 (25%), Gaps = 13/210 (6%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
L+ L L S + + + + ++ L +N L + + L+ L N
Sbjct: 190 FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGN 247
Query: 177 FFN-NTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG-SLPDLS 234
F+ T+ ++F + ++ + + + + + P
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
Query: 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAF-------LSNNSFSGEIPKQYGQLNQLQQL 287
L +L + + + + I + + L
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITL 365
Query: 288 DMSFNALRGMPPPAIFSLPNISDLNLASNK 317
+ AL + + +
Sbjct: 366 EQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 13/185 (7%), Positives = 44/185 (23%), Gaps = 4/185 (2%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL----FGSVPPKISTMVKL 168
T + + RL +L+ + + + + +
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338
Query: 169 QTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG 228
+ + + I + L + L + + + L
Sbjct: 339 REIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE 398
Query: 229 SLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L +L + + + A + + + + + +L++L+
Sbjct: 399 LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLN 458
Query: 289 MSFNA 293
+
Sbjct: 459 GEADL 463
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/287 (18%), Positives = 101/287 (35%), Gaps = 25/287 (8%)
Query: 104 NFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYS--LEYLDLSSNFLFGSVPPK 161
+ + A + ++ + + + D + L+L S L P +
Sbjct: 42 DRNRWHSAWRQANSNNPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPL-PQFPDQ 99
Query: 162 ISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDL 221
+ LQ + +D +P+ L L++ N L P+SI ++ L +L +
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSI 157
Query: 222 SKNAISGSLPD----------LSSLGSLNVLNLSDNKLDSNLP----KLPRGLVMAFLSN 267
LP+ L +L L L + S LP L + L + N
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANL-QNLKSLKIRN 215
Query: 268 NSFSGEIPKQYGQLNQLQQLDMS-FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNL 326
+ S + L +L++LD+ ALR PP + L L +LP ++
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPP-IFGGRAPLKRLILKDCSNLLTLPLDI 273
Query: 327 NCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQNQ 373
+ +L D+ LPS ++ ++ + + Q++
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 44/222 (19%), Positives = 75/222 (33%), Gaps = 23/222 (10%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPP 160
+ + T+ + L L+L + +LP I L L L + + +P
Sbjct: 111 IDAA-GLMELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPE 168
Query: 161 KI---------STMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQ 211
+ +V LQ+L L+ ++P +L +L L +RN+ L+ +I
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226
Query: 212 RISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLP------RGLVMAF 264
+ L +LDL + P L L L D SNL LP L
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC---SNLLTLPLDIHRLTQLEKLD 283
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLP 306
L +P QL + + + + + P
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 42/254 (16%), Positives = 77/254 (30%), Gaps = 31/254 (12%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
+ L D + + D + ++
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-------NSNNPQIETR 63
Query: 177 FFNN--TIPNWFDSL--PSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
+ + P L +R+ L FP R+S L + + + LPD
Sbjct: 64 TGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPD 121
Query: 233 -LSSLGSLNVLNLSDNKLDSNLP----KLPRGLVMAFLSNNSFSGEIPK---------QY 278
+ L L L+ N L + LP L L + E+P+ ++
Sbjct: 122 TMQQFAGLETLTLARNPLRA-LPASIASL-NRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 279 GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDIS 338
L LQ L + + +R P +I +L N+ L + ++ S +L ++ KL D+
Sbjct: 180 QGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237
Query: 339 NNKLTGGLPSCLSN 352
P
Sbjct: 238 GCTALRNYPPIFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 16/103 (15%), Positives = 35/103 (33%), Gaps = 1/103 (0%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP 159
+ + + + + L L L L + P L+ L L ++P
Sbjct: 212 KIRNS-PLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270
Query: 160 PKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
I + +L+ L L + +P+ LP+ + + +
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 18/92 (19%), Positives = 34/92 (36%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPP 160
L ++ ++ L+ L L +LP IHRL LE LDL +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 161 KISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
I+ + +++ + + + P+
Sbjct: 296 LIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 17/155 (10%), Positives = 37/155 (23%), Gaps = 35/155 (22%)
Query: 226 ISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLV------------------------ 261
+ S L + + L L
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGS---TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNN 57
Query: 262 --MAFLSNNSFSGEIPKQYGQLNQ--LQQLDMSFNALRGMPPPAIFSLPNISDLNLASNK 317
+ + + Q L++ L P F L ++ + + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAG 115
Query: 318 FSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
LP + L ++ N L LP+ +++
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS 148
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 52/245 (21%), Positives = 90/245 (36%), Gaps = 12/245 (4%)
Query: 106 SIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTM 165
D +S+R L L ++ L L+ L+L+ N + +
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL 313
Query: 166 VKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNA 225
LQ L L N + F LP + ++ ++ N +A + + + L LDL NA
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373
Query: 226 ISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG-EIPKQYGQLNQL 284
++ + + S+ + LS NKL LPK+ + LS N +I ++ L
Sbjct: 374 LT----TIHFIPSIPDIFLSGNKL-VTLPKINLTANLIHLSENRLENLDILYFLLRVPHL 428
Query: 285 QQLDMSFNALRGMPPPAIFS-LPNISDLNLASNKFSGSLPKNLNCG-----GKLVFFDIS 338
Q L ++ N S P++ L L N + L L ++
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488
Query: 339 NNKLT 343
+N L
Sbjct: 489 HNYLN 493
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-21
Identities = 80/382 (20%), Positives = 131/382 (34%), Gaps = 68/382 (17%)
Query: 101 LSEN--FSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV 158
LS FS++S L L+VL+L I + + L +L+ L+LS N L
Sbjct: 273 LSHGFVFSLNSR--VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330
Query: 159 PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218
+ K+ + L N F L L L +R+N L ++I I ++ D
Sbjct: 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPD 385
Query: 219 LDLSKNAIS----------------------GSLPDLSSLGSLNVLNLSDNKLDS----N 252
+ LS N + L L + L +L L+ N+ S
Sbjct: 386 IFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQ 445
Query: 253 LPKLPRGLVMAFLSNNSFSGEI-----PKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN 307
P L FL N + L+ LQ L ++ N L +PP L
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505
Query: 308 ISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN--ESDKRVVKFRGNC 365
+ L+L SN+ + L N L DIS N+L P + D KF C
Sbjct: 506 LRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICEC 563
Query: 366 ------------------LSSNVQNQHPESYC------FEVRTERNQAGSKNVGKLVGII 401
+++ +P+S+ + K++ + I+
Sbjct: 564 ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIV 623
Query: 402 VGVLVIMVLLAFGFLVVCRRYC 423
V + + L+ + R +C
Sbjct: 624 CTVTLTLFLMTILTVTKFRGFC 645
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-21
Identities = 49/285 (17%), Positives = 93/285 (32%), Gaps = 29/285 (10%)
Query: 113 TLARLTSLRVLSLVSLGIWGSL--PDKIHRLYSLEYLDLSSNFLFG-SVPPKISTMVKLQ 169
L L L L G+ ++ L +L LDLS N + + P + L+
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 170 TLILDDNFFNNTIPNWFDSL--PSLTFLSMRNNKLAGPFPSSIQRIS------TLSDLDL 221
++ N + + L +L+F S+ N L + L LD+
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211
Query: 222 SKNAISGSLPD-------------LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF---- 264
S N + + L + + + GL +
Sbjct: 212 SGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHL 271
Query: 265 -LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP 323
LS+ + + L L+ L++++N + + A + L N+ LNL+ N
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331
Query: 324 KNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
N K+ + D+ N + + + R N L++
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 9e-21
Identities = 49/277 (17%), Positives = 101/277 (36%), Gaps = 38/277 (13%)
Query: 101 LSENF--SIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGS 157
LS N+ ++ + ++ L L++L L S ++ + L +L LDL S+ +
Sbjct: 31 LSFNYIRTVTA--SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI-YF 87
Query: 158 VPPKI-STMVKLQTLILDDNFFNNTI--PNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRI 213
+ P + L L L ++ + +F +L +LT L + N++ S ++
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 214 STLSDLDLSKNAIS----GSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF----- 264
++L +D S N I L L +L+ +L+ N L S + + F
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGK-TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206
Query: 265 ----LSNNSFSGEIPK------------QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNI 308
+S N ++ +I + + F+ ++ L
Sbjct: 207 EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 309 S--DLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
S L+L+ + L +++ NK+
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 34/226 (15%)
Query: 141 LYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTI-PNWFDSLPSLTFLSMR 198
L + E L LS N++ +V + +LQ L L + TI F +LP+L L +
Sbjct: 23 LNTTERLLLSFNYI-RTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 199 NNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD---LSSLGSLNVLNLSDNKLDSNLPK 255
++K+ P + Q + L +L L +S ++ +L +L L+LS N++ S
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS---- 137
Query: 256 LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSL--PNISDLNL 313
+ SF LN L+ +D S N + + + L +S +L
Sbjct: 138 --------LYLHPSFGK--------LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181
Query: 314 ASNKFSGSLPK------NLNCGGKLVFFDISNNKLTGGLPSCLSNE 353
A+N + N L D+S N T + SN
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNA 227
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 22/108 (20%), Positives = 36/108 (33%), Gaps = 4/108 (3%)
Query: 238 SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM 297
+ L +P++ LS N + L QLQ L++
Sbjct: 5 DGRIAFYRFCNLTQ-VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 298 PPPAIF-SLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNNKLT 343
F +LPN+ L+L S+K L + G L + L+
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLS 110
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 53/260 (20%), Positives = 111/260 (42%), Gaps = 17/260 (6%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
++ L+ L L L + + I + + L +L L L+ + + S ++ + K+ +
Sbjct: 81 ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNI--SDISPLANLTKMYS 136
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L L N N + + ++ L +L++ +K+ + I ++ L L L+ N I +
Sbjct: 137 LNLGANH-NLSDLSPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIE-DI 192
Query: 231 PDLSSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L+SL SL+ N++ + + + R L + NN + P L+QL L+
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITPVANMTR-LNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPS 348
+ N + + + L + LN+ SN+ S LN +L ++NN+L
Sbjct: 250 IGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 349 CLSNESDKRVVKFRGNCLSS 368
+ ++ + N ++
Sbjct: 306 VIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 53/237 (22%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
V T L S+ L + + S+ I L +LEYL+L+ N + + +S +VKL
Sbjct: 37 VVTQEELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNLNGNQI--TDISPLSNLVKLTN 92
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L + N T + +L +L L + + ++ S + ++ + L+L N L
Sbjct: 93 LYIGTN--KITDISALQNLTNLRELYLNEDNISDI--SPLANLTKMYSLNLGANHNLSDL 148
Query: 231 PDLSSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
LS++ LN L ++++K+ + + L L L+ N P L L
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTPIANLTD-LYSLSLNYNQIEDISP--LASLTSLHYFT 205
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP-KNLNCGGKLVFFDISNNKLTG 344
N + + P + ++ ++ L + +NK + P NL+ +L + +I N+++
Sbjct: 206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLS---QLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 23/236 (9%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
LA LT + L+L S + + L YL ++ + + I+ + L +L L
Sbjct: 128 LANLTKMYSLNL-GANHNLSDLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSL 184
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
+ N + P SL SL + + N++ + + ++ L+ L + N I+ L L
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNNKIT-DLSPL 239
Query: 234 SSLGSLNVLNLSDNKLD-----SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
++L L L + N++ +L KL + L + +N S L+QL L
Sbjct: 240 ANLSQLTWLEIGTNQISDINAVKDLTKL-KML---NVGSNQISD--ISVLNNLSQLNSLF 293
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP-KNLNCGGKLVFFDISNNKLT 343
++ N L I L N++ L L+ N + P +L+ K+ D +N +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLS---KMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 33/139 (23%), Positives = 67/139 (48%), Gaps = 7/139 (5%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
+T +A +T L L + + I P + L L +L++ +N + S + + KL+
Sbjct: 214 ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKM 269
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L + N ++ I ++L L L + NN+L I ++ L+ L LS+N I+ +
Sbjct: 270 LNVGSNQISD-ISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DI 326
Query: 231 PDLSSLGSLNVLNLSDNKL 249
L+SL ++ + ++ +
Sbjct: 327 RPLASLSKMDSADFANQVI 345
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 69/285 (24%), Positives = 114/285 (40%), Gaps = 54/285 (18%)
Query: 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILD 174
VL++ G+ +LPD + + L + N L S+P +L+TL +
Sbjct: 37 CLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNL-TSLPALPP---ELRTLEVS 89
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQR--------------ISTLSDLD 220
N ++P L L+ S L PS + + L +L
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELS 147
Query: 221 LSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQ 280
+S N ++ SLP L L L +N+L ++LP LP GL +S+N + +P +
Sbjct: 148 VSDNQLA-SLPAL--PSELCKLWAYNNQL-TSLPMLPSGLQELSVSDNQLA-SLPTLPSE 202
Query: 281 L-------NQ----------LQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP 323
L N+ L++L +S N L +P + +L ++ N+ + SLP
Sbjct: 203 LYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPV----LPSELKELMVSGNRLT-SLP 257
Query: 324 KNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
L+ + N+LT LP L + S + V GN LS
Sbjct: 258 MLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 21/207 (10%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
L+ LS+ + SLP L L +N L S+P S LQ L + DN
Sbjct: 140 PPGLQELSVSDNQL-ASLPALPS---ELCKLWAYNNQL-TSLPMLPS---GLQELSVSDN 191
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSL 236
++P L L NN+L P+ S L +L +S N ++ SLP
Sbjct: 192 QLA-SLP---TLPSELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPV--LP 240
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296
L L +S N+L S LP LP GL+ + N + +P+ L+ +++ N L
Sbjct: 241 SELKELMVSGNRLTS-LPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298
Query: 297 MPPPAIFSLPNISDLNLASNKFSGSLP 323
A+ + + + +F +
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 26/169 (15%), Positives = 55/169 (32%), Gaps = 9/169 (5%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
+ L+ L + + SLP L+ L +S N L S+P S L +L + N
Sbjct: 220 PSGLKELIVSGNRL-TSLPVLPS---ELKELMVSGNRL-TSLPMLPS---GLLSLSVYRN 271
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSL 236
+P L S T +++ N L+ +++ I++ +
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQ 285
L +D + + + + +L++ +
Sbjct: 331 TRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETE 379
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 8/92 (8%)
Query: 281 LNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN 340
N L++ + L + P + + +I+ L + N + SLP +L ++S N
Sbjct: 39 NNGNAVLNVGESGLTTL-PDCLPA--HITTLVIPDNNLT-SLPALP---PELRTLEVSGN 91
Query: 341 KLTGGLPSCLSNESDKRVVKFRGNCLSSNVQN 372
+LT LP + + L +
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG 122
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 29/232 (12%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
T L L VL L I + + L SL L+L N+L +P + KL+
Sbjct: 94 TFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRE 151
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSM-RNNKLAGPFPSSIQRISTLSDLDLSKNAISGS 229
L L +N + F+ +PSL L + KL + + + L L+L I
Sbjct: 152 LWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-D 210
Query: 230 LPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289
+P+L+ L L L +S N + SF G L+ L++L +
Sbjct: 211 MPNLTPLVGLEELEMSGNHFPE-------------IRPGSFHG--------LSSLKKLWV 249
Query: 290 SFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNN 340
+ + + A L ++ +LNLA N S SLP +L LV + +N
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 19/108 (17%), Positives = 38/108 (35%), Gaps = 2/108 (1%)
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296
+ + + L +P L N+ + L+ L+ L + N++R
Sbjct: 54 NQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ 113
Query: 297 MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNNKLT 343
+ A L +++ L L N + +P KL + NN +
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE 160
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-25
Identities = 57/320 (17%), Positives = 112/320 (35%), Gaps = 19/320 (5%)
Query: 17 SLFPLGTHQLQSSQTQVLLQLRKHLEYPKQLEI-------WINHGADFCYISSSTQVNIT 69
H + + + L ++ LE+ N + F I + Q N
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221
Query: 70 CQDNFITELKIIGDKPSNVGNFDGFASA------NASLSENFSIDSFVTTLARLTSLRVL 123
+ + ++ + + + N L F + L +L +
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281
Query: 124 SLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIP 183
+VS ++ + + + S + L +N +T+
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341
Query: 184 NWFDSLPSLTFLSMRNNKLA--GPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSL 239
L L L ++ N+L ++ +L LD+S+N++S S SL
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 240 NVLNLSDNKLDSNLP-KLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP 298
LN+S N L + LP + + L +N IPKQ +L LQ+L+++ N L+ +P
Sbjct: 402 LSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460
Query: 299 PPAIFSLPNISDLNLASNKF 318
L ++ + L +N +
Sbjct: 461 DGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 44/237 (18%), Positives = 72/237 (30%), Gaps = 14/237 (5%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
L++S N++ I ++ KL+ LI+ N + F L +L + +NKL
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPD---LSSLGSLNVLNLSDNKLDS----NLPK 255
S L LDLS NA +LP ++ L L LS L+ +
Sbjct: 82 VK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 256 LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLAS 315
L V+ L E P L + I + + NL
Sbjct: 138 LNISKVLLVLGETYGEKEDP---EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 316 NKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQN 372
+ L N + + N L + ++ + V
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 49/293 (16%), Positives = 102/293 (34%), Gaps = 23/293 (7%)
Query: 79 KIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKI 138
K +++ + E + SL ++ + L +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF--NTESLHIVFPTNKEFHFILDVSV 186
Query: 139 HRLYSLEYLDLSSN------FLFGSVPPKISTMVKLQTLILDDNFFN-NTIPNWFD--SL 189
+ +LE ++ F S+ K+ T KL L L++ N+
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246
Query: 190 PSLTFLSMRNNKLAGP-----FPSSIQRISTLSDLDLSKNAISGSLPDL-SSLGSLNVLN 243
++ + S+ N KL G F S + LS + + + ++N+ N
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 244 LSDNKLDSNLPKLPRGLVMA---FLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPP 300
+ + P + SNN + + + G L +L+ L + N L+ +
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366
Query: 301 A-IF-SLPNISDLNLASNKFSGSLPKNL-NCGGKLVFFDISNNKLTGGLPSCL 350
A + + ++ L+++ N S K + L+ ++S+N LT + CL
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 52/264 (19%), Positives = 87/264 (32%), Gaps = 12/264 (4%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
+ L+ LR+L + I LEYLDLS N L + V L+ L L
Sbjct: 41 ILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDL 97
Query: 174 DDNFFNN-TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
N F+ I F ++ L FL + L I ++ + L G D
Sbjct: 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS-KVLLVLGETYGEKED 156
Query: 233 LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFN 292
L N +L + + + ++N S + + + +
Sbjct: 157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS-----NIKCVLEDNKCSYFLS 211
Query: 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
L + S ++++ N F L L + +F ISN KL G L +
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFD 269
Query: 353 ESDKRVVKFRGNCLSSNVQNQHPE 376
S + + + S+V
Sbjct: 270 YSGTSLKALSIHQVVSDVFGFPQS 293
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 11/156 (7%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLVS--LGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV 158
S N D+ LT L L L L + + ++ SL+ LD+S N +
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 159 PPKI-STMVKLQTLILDDNFFNNTIPNWFDSLPS-LTFLSMRNNKLAGPFPSSIQRISTL 216
S L +L + N +TI F LP + L + +NK+ P + ++ L
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTI---FRCLPPRIKVLDLHSNKIKS-IPKQVVKLEAL 446
Query: 217 SDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
+L+++ N + S+PD L SL + L N D
Sbjct: 447 QELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 29/250 (11%), Positives = 84/250 (33%), Gaps = 23/250 (9%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPP---KISTMVKLQTLI 172
++ L+ L L + + S I L + L + P + L +
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172
Query: 173 LDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIS-----------TLSDLDL 221
+ F+ + ++ +L +++ + ++ TL++++
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
Query: 222 SKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLP--------RGLVMAFLSNNSFSGE 273
+ N+ + L ++ ++S+ KL L + L + + ++ F
Sbjct: 233 TWNSFI-RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291
Query: 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLV 333
Y + + + + + R + + L+ ++N + ++ +N +L
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351
Query: 334 FFDISNNKLT 343
+ N+L
Sbjct: 352 TLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 40/210 (19%), Positives = 59/210 (28%), Gaps = 56/210 (26%)
Query: 147 LDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPF 206
+D S N L VP +S K L + N+ + + SL L L
Sbjct: 5 VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRIL----------- 50
Query: 207 PSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF 264
+S N I L L L+LS NKL +
Sbjct: 51 -------------IISHNRIQ-YLDISVFKFNQELEYLDLSHNKL-VKIS---------- 85
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFS-LPNISDLNLASNKFSGSLP 323
L+ LD+SFNA +P F + + L L++ S
Sbjct: 86 -------------CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSV 132
Query: 324 KNLNCGGKL-VFFDISNNKLTGGLPSCLSN 352
+ V + P L +
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKEDPEGLQD 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 29/228 (12%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLV--SLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV 158
+ N ++F + L SL L L L G SL+YLDLS N + ++
Sbjct: 332 FTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 388
Query: 159 PPKISTMVKLQTLILDDNFFNNTIP-NWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLS 217
+ +L+ L + + F SL +L +L + + F +S+L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 218 DLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIP 275
L ++ N+ + + L +L L+LS +L+ LS +F+
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-------------LSPTAFNS--- 492
Query: 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP 323
L+ LQ L+M+ N L+ +P L ++ + L +N + S P
Sbjct: 493 -----LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 48/205 (23%), Positives = 79/205 (38%), Gaps = 16/205 (7%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
+PD + S + LDLS N L + +LQ L L + SL L
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
+ L + N + + +S+L L + ++ SL + + L +L LN++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
Query: 251 S-----NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQ----QLDMSFNALRGMPPPA 301
S L L LS+N L+Q+ LD+S N + + P A
Sbjct: 138 SFKLPEYFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 302 IFSLPNISDLNLASNKFSGSLPKNL 326
F + L L +N S ++ K
Sbjct: 197 -FKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 54/251 (21%), Positives = 89/251 (35%), Gaps = 20/251 (7%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
+ L+VL L I L L L L+ N + S+ S + LQ
Sbjct: 46 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQK 104
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA-GPFPSSIQRISTLSDLDLSKNAIS-- 227
L+ + + L +L L++ +N + P ++ L LDLS N I
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 228 --GSLPDLSSLGSLNV-LNLSDNKLDSNLPKLPRGLVMA--FLSNNSFSGEIPKQY-GQL 281
L L + LN+ L+LS N ++ P + + + L NN S + K L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGL 224
Query: 282 NQLQQLD------MSFNALRGMPPPAIFSLPN--ISDLNLASNKFSGSLPKNL-NCGGKL 332
L+ + L A+ L N I + LA + +L NC +
Sbjct: 225 AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284
Query: 333 VFFDISNNKLT 343
F + + +
Sbjct: 285 SSFSLVSVTIE 295
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 50/287 (17%), Positives = 93/287 (32%), Gaps = 46/287 (16%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDK-IHRLYSLEYLDLSSNFLFGS-- 157
LS N ++ + L L+L + ++ I L LE L
Sbjct: 184 LSLNP-MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 158 -VPPKISTMVKLQTLILDDN------FFNNTIPNWFDSLPSLTFLSMRNNKL----AGPF 206
S + L L +++ ++ + I + F+ L +++ S+ + + +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 207 PSSIQRI---------------STLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS 251
Q + +L L + N + L SL L+LS N L
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSF 361
Query: 252 ---------NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
L + L LS N + + L QL+ LD + L+ M ++
Sbjct: 362 KGCCSQSDFGTTSL-KYL---DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 303 F-SLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPS 348
F SL N+ L+++ + N L ++ N
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-19
Identities = 53/243 (21%), Positives = 86/243 (35%), Gaps = 30/243 (12%)
Query: 104 NFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKIS 163
++ +D + LT++ SLVS+ I + D + ++L+L + P +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD-FSYNFGWQHLELVNCKFGQ--FPTLK 323
Query: 164 TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA--GPFPSSIQRISTLSDLDL 221
+ L+ L N N LPSL FL + N L+ G S ++L LDL
Sbjct: 324 -LKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 222 SKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQL 281
S N + + L L L+ + L + F L
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQ------------MSEFSVFLS--------L 420
Query: 282 NQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKN-LNCGGKLVFFDISNN 340
L LD+S R L ++ L +A N F + + L F D+S
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 341 KLT 343
+L
Sbjct: 481 QLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 41/251 (16%), Positives = 82/251 (32%), Gaps = 27/251 (10%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL-FGSVPPKISTMVKLQTL 171
+ L+SL+ L V + I L +L+ L+++ N + +P S + L+ L
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 172 ILDDNFFNNTIPNWFDSLPSLTF----LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAIS 227
L N + L + L + N + P + + I L L L N S
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDS 213
Query: 228 GSLPD--LSSLGSLNVLNLSDNKLDS--NLPKLPRG----------LVMAFLSNNSFSGE 273
++ + L L V L + + NL K + + + +
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIF-SLPNISDLNLASNKFSGSLPKNLNCGGKL 332
I + L + + + + + ++ +N +F K+L
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR---- 329
Query: 333 VFFDISNNKLT 343
++NK
Sbjct: 330 --LTFTSNKGG 338
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 1/126 (0%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
+ L +L L + + + L SLE L ++ N + P I + + L
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L L P F+SL SL L+M +N+L R+++L + L N S
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534
Query: 231 PDLSSL 236
P + L
Sbjct: 535 PRIDYL 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 21/129 (16%), Positives = 36/129 (27%)
Query: 240 NVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP 299
+ LP LS N + +LQ LD+S ++ +
Sbjct: 10 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 300 PAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVV 359
A SL ++S L L N + L L + + + +
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 360 KFRGNCLSS 368
N + S
Sbjct: 130 NVAHNLIQS 138
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 25/233 (10%)
Query: 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILD 174
+ L L L + SLPD + + L+++ N L S+P + L+ L
Sbjct: 56 CLINQFSELQLNRLNL-SSLPDNLPP--QITVLEITQNAL-ISLPELPA---SLEYLDAC 108
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLS 234
DN + T+P + SL L + NN+L P + L ++ N ++ LP+
Sbjct: 109 DNRLS-TLP---ELPASLKHLDVDNNQLTM-LPELP---ALLEYINADNNQLT-MLPE-- 157
Query: 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ----LDMS 290
SL VL++ +N+L + LP+LP L +S N +P + + ++
Sbjct: 158 LPTSLEVLSVRNNQL-TFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCR 215
Query: 291 FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
N + + P I SL + L N S + ++L+ + +
Sbjct: 216 ENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 21/168 (12%)
Query: 188 SLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAI--SGSLPDLSSLGSLNVLNLS 245
SL +F N ++G + L + SL + + L L+
Sbjct: 12 SLSQNSF----YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLN 67
Query: 246 DNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFS 304
L S LP LP + + ++ N+ +P+ L+ LD N L +P
Sbjct: 68 RLNLSS-LPDNLPPQITVLEITQNALI-SLPE---LPASLEYLDACDNRLSTLPE----L 118
Query: 305 LPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
++ L++ +N+ + LP+ L + + NN+LT LP ++
Sbjct: 119 PASLKHLDVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPTS 161
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 39/235 (16%), Positives = 72/235 (30%), Gaps = 17/235 (7%)
Query: 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILD 174
TSL VLS+ + + LP+ SLE LD+S+N L S+P + +
Sbjct: 157 ELPTSLEVLSVRNNQL-TFLPELPE---SLEALDVSTNLL-ESLPAVPVRNHHSEETEIF 211
Query: 175 DNFFNN---TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
N IP SL + + +N L+ S+ + + D + S
Sbjct: 212 FRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS-MSD 270
Query: 232 DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF---LSNNSFSGEIPKQYGQLNQLQQLD 288
+ + + N + AF N+FS + +
Sbjct: 271 GQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTS 329
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+ L ++L S + ++ L + ++ L
Sbjct: 330 GFREQVAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 24/126 (19%), Positives = 48/126 (38%), Gaps = 11/126 (8%)
Query: 227 SGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ 286
+ LS N ++ + S K + + + N + + +NQ +
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEK-QALPGENRNEAVSLLKE--CLINQFSE 63
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGL 346
L ++ L + P + P I+ L + N SLP+ L + D +N+L+ L
Sbjct: 64 LQLNRLNLSSL-PDNLP--PQITVLEITQNALI-SLPELP---ASLEYLDACDNRLS-TL 115
Query: 347 PSCLSN 352
P ++
Sbjct: 116 PELPAS 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 48/258 (18%), Positives = 92/258 (35%), Gaps = 15/258 (5%)
Query: 90 NFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDL 149
+G N S S+ S V T+ ++R L + ++ L L ++ + +
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETV----TIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 150 SSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI---PNWFDSLPSLTFLSMRNNKLA--G 204
++ +F + L+ L L +N + PSL L + N L
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 205 PFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF 264
+ + L+ LD+S+N + LNLS + +P+ L +
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLD 437
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK 324
+SNN+ L +LQ+L +S N L+ +P P + + ++ N+
Sbjct: 438 VSNNNLD-SFSL---FLPRLQELYISRNKLKTLPD--ASLFPVLLVMKISRNQLKSVPDG 491
Query: 325 NLNCGGKLVFFDISNNKL 342
+ L + N
Sbjct: 492 IFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 48/249 (19%), Positives = 94/249 (37%), Gaps = 16/249 (6%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
+ D S S+P ++ +++L L N + +L L ++++++
Sbjct: 6 ASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDS-----NLPK 255
+ + +L LDLS N +S SL L SL LNL N + P
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
Query: 256 LPRGLVMAFLSNNSFSGEIPKQY-GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLA 314
L L + N EI + L L +L++ +LR ++ S+ +I L L
Sbjct: 122 LTN-LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLH 180
Query: 315 SNKFSGSLPKNLNCGGKLVFFDISNNKLTG---GLPSCLSNESDKRVVKFRGNCLSSNVQ 371
++ + L + + + ++ + L S + + FRG+ L+
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240
Query: 372 NQHPESYCF 380
N+ + +
Sbjct: 241 NELLKLLRY 249
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 54/261 (20%), Positives = 90/261 (34%), Gaps = 37/261 (14%)
Query: 105 FSIDSFVTTLARLT-SLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKIS 163
+D + + +L VL+ S L I L +E+ D + N L P +
Sbjct: 216 LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
Query: 164 TM--------VKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215
+ V ++ L + + + + L + +++ N+K+ S Q + +
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335
Query: 216 LSDLDLSKNAIS----GSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271
L LDLS+N + + + SL L LS N L S + K
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS-MQKTG----------EILL 384
Query: 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGK 331
L L LD+S N MP + + LNL+S + +
Sbjct: 385 T--------LKNLTSLDISRNTFHPMPD-SCQWPEKMRFLNLSSTGIR-VVKTCI--PQT 432
Query: 332 LVFFDISNNKLTGGLPSCLSN 352
L D+SNN L L
Sbjct: 433 LEVLDVSNNNLD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 37/249 (14%), Positives = 82/249 (32%), Gaps = 8/249 (3%)
Query: 100 SLSENFSIDSF-VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV 158
+ + A LTSL L + +L + + + + +L L + +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188
Query: 159 PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218
+ ++ L L D + + + + + S + L
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
Query: 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRG-LVMAFLSNNSFSGEIPKQ 277
L + + D +L L N S++ + S L K+ + + ++
Sbjct: 249 YILELSEV--EFDDC-TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 278 YGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVF--- 334
Y L +++++ + + + +P L ++ L+L+ N KN C G
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 335 FDISNNKLT 343
+S N L
Sbjct: 366 LVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 49/307 (15%), Positives = 96/307 (31%), Gaps = 53/307 (17%)
Query: 101 LSEN-FSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDK-IHRLYSLEYLDLSSNFLFGSV 158
L N + + LT+L+ L + ++ + + L SL L++ + L
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 159 PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218
+ ++ + L L + + + D L S+ +L +R+ LA S + S
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 219 L-----------DLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRG-------- 259
+ D S N + L + L + + + N L P
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284
Query: 260 ---LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
+ + ++ Y L +++++ + + + +P L ++ L+L+ N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344
Query: 317 KFSGSLPKNLNCGG-----------------------------KLVFFDISNNKLTGGLP 347
KN C G L DIS N
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPD 404
Query: 348 SCLSNES 354
SC E
Sbjct: 405 SCQWPEK 411
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 41/286 (14%), Positives = 90/286 (31%), Gaps = 33/286 (11%)
Query: 113 TLARLTSLRVLSLVSLGIWG-SLPDKIHRLYSLEYLDLSSNFLFGSVPPK-ISTMVKLQT 170
L+SL+ L+L+ + L +L+ L + + F + + + L
Sbjct: 93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAIS--- 227
L + N S+ + L++ ++ A +S++ L+L ++
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212
Query: 228 -GSLPDLSSLGSLNVLNLSDNKLDS----NLPKLPRGLV--------------MAFLSNN 268
LP + L + L L KL R ++ + + +
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272
Query: 269 SFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS---GSLPKN 325
+ +++L + L L + + + ++K S ++
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332
Query: 326 LNCGGKLVFFDISNNKLT---GGLPSCLSNESDKRVVKFRGNCLSS 368
L L F D+S N + +C + + N L S
Sbjct: 333 LK---SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 50/284 (17%), Positives = 94/284 (33%), Gaps = 41/284 (14%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPK-ISTMVKLQT 170
L +L+VL L S I D + L SLE+LDLS N L S+ + L+
Sbjct: 44 GDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKY 102
Query: 171 LILDDNFFNN-TIPNWFDSLPSLTFLSM-RNNKLAGPFPSSIQRISTLSDLDLSKNAISG 228
L L N + + + F +L +L L + + +++L++L++ ++
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR- 161
Query: 229 SLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ 286
+ L S+ ++ L L ++ AFL L+ ++
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSES-------------AFLLEIFADI--------LSSVRY 200
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFS-------GSLPKNLNCGGKLVFFDISN 339
L++ L + S + + + S L K L +L + +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 340 NKLTG------GLPSCLSNESDKRVVKFRGNCLSSNVQNQHPES 377
L G +S V R + +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 39/158 (24%), Positives = 60/158 (37%), Gaps = 23/158 (14%)
Query: 101 LSENF--SIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV 158
LS+N S+ L L +L L + +PD + +L+LSS + V
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGI-RVV 425
Query: 159 PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQRIS 214
I L+ L + NN + ++ LP L L + NKL
Sbjct: 426 KTCIPQ--TLEVLDVS----NNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPV----- 474
Query: 215 TLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
L + +S+N + S+PD L SL + L N D
Sbjct: 475 -LLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 19/109 (17%), Positives = 35/109 (32%)
Query: 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNAL 294
S + V + S L + LS N + LQ L + + +
Sbjct: 3 SCDASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 295 RGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+ A +SL ++ L+L+ N S L + ++ N
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 53/270 (19%), Positives = 91/270 (33%), Gaps = 52/270 (19%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLY-------------SLEYLDLSSNFLFGSVPP 160
+ S + P L+L++ L S+P
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL-SSLPE 88
Query: 161 KISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLD 220
L++L+ N +P SL SL + L+ P L L
Sbjct: 89 LPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLG 137
Query: 221 LSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQ 280
+S N + LP+L + L ++++ +N L LP LP L NN E+P +
Sbjct: 138 VSNNQLE-KLPELQNSSFLKIIDVDNNSL-KKLPDLPPSLEFIAAGNNQLE-ELP-ELQN 193
Query: 281 LNQLQQLDMSFNALRGMP------------------PPAIFSLPNISDLNLASNKFSGSL 322
L L + N+L+ +P P + +LP ++ + +N +L
Sbjct: 194 LPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TL 252
Query: 323 PKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
P L ++ +N LT LP +
Sbjct: 253 PDLP---PSLEALNVRDNYLT-DLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 46/221 (20%), Positives = 78/221 (35%), Gaps = 30/221 (13%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
+P + + S + + + PP ++ L D
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----------A 73
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDS 251
L + N L P L L S N+++ LP+ SL SL V N +
Sbjct: 74 HELELNNLGL-SSLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA--- 125
Query: 252 NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDL 311
L LP L +SNN ++P + + L+ +D+ N+L+ +P P++ +
Sbjct: 126 -LSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFI 178
Query: 312 NLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
+N+ LP+ N L NN L LP +
Sbjct: 179 AAGNNQLE-ELPELQNL-PFLTAIYADNNSLK-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-20
Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 29/236 (12%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
SL ++ + + LP+ + L L + +N L +P L++++ +N
Sbjct: 172 PPSLEFIAAGNNQL-EELPE-LQNLPFLTAIYADNNSL-KKLPDLPL---SLESIVAGNN 225
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSL 236
+LP LT + NN L P +L L++ N ++ LP+L
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLKT-LPDLP---PSLEALNVRDNYLT-DLPEL--P 276
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296
SL L++S+N S L +LP L S+N + L++L++S N L
Sbjct: 277 QSLTFLDVSENIF-SGLSELPPNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLIE 331
Query: 297 MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
+P P + L + N + +P+ L + N L P +
Sbjct: 332 LPA----LPPRLERLIASFNHLA-EVPELP---QNLKQLHVEYNPLR-EFPDIPES 378
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 49/283 (17%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L L L + + + LPD SLE + +N L P++ + L T+
Sbjct: 191 LQNLPFLTAIYADNNSL-KKLPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTIYA 244
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
D+N T+P+ PSL L++R+N L P Q ++ L + + +S P+L
Sbjct: 245 DNNLLK-TLPDL---PPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNL 299
Query: 234 SSL--------------GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYG 279
L SL LN+S+NKL LP LP L S N + E+P+
Sbjct: 300 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIASFNHLA-EVPEL-- 355
Query: 280 QLNQLQQLDMSFNALRGMPP---------------PAIFSLPNISDLNLASNKFSGSLPK 324
L+QL + +N LR P N+ L++ +N P
Sbjct: 356 -PQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413
Query: 325 NLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367
+ +++ ++ F +
Sbjct: 414 IP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 29/232 (12%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
+ L L +L L I ++ + L +L L+L N L ++P + KL+
Sbjct: 83 SFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKE 140
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSM-RNNKLAGPFPSSIQRISTLSDLDLSKNAISGS 229
L L +N + F+ +PSL L + +L+ + + +S L L+L+ +
Sbjct: 141 LWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199
Query: 230 LPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289
+P+L+ L L+ L+LS N L + + SF G L LQ+L M
Sbjct: 200 IPNLTPLIKLDELDLSGNHLSA-------------IRPGSFQG--------LMHLQKLWM 238
Query: 290 SFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNN 340
+ ++ + A +L ++ ++NLA N + LP +L L + +N
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 32/217 (14%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
+ L VP IST + L L +N N F L L L + N +
Sbjct: 44 QFSKVICVRKNL-REVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDS-------NL 253
+ ++ L+ L+L N ++ ++P+ L L L L +N ++S +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 254 PKLPRGLVMA------FLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN 307
P L R L + ++S +F G L+ L+ L+++ LR + P + L
Sbjct: 160 PSL-RRLDLGELKRLSYISEGAFEG--------LSNLRYLNLAMCNLREI--PNLTPLIK 208
Query: 308 ISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNNKLT 343
+ +L+L+ N S ++ G L + +++
Sbjct: 209 LDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 39/195 (20%), Positives = 79/195 (40%), Gaps = 21/195 (10%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
L +L L L + ++P+ L L+ L L +N + S+P + + L+
Sbjct: 107 AFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRR 164
Query: 171 LILDDNFFNNTIP-NWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGS 229
L L + + I F+ L +L +L++ L ++ + L +LDLS N +S +
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--EIPNLTPLIKLDELDLSGNHLS-A 221
Query: 230 LPD--LSSLGSLNVLNLSDNKLDS-------NLPKLPRGLVMAFLSNNSFSGEIPKQYGQ 280
+ L L L + +++ NL L L++N+ + +
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE----INLAHNNLTLLPHDLFTP 277
Query: 281 LNQLQQLDMSFNALR 295
L+ L+++ + N
Sbjct: 278 LHHLERIHLHHNPWN 292
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 36/156 (23%), Positives = 73/156 (46%), Gaps = 22/156 (14%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
G GS+G +++ +G+ VA++ L V + ++ +LRHP++V +G
Sbjct: 46 GAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG 609
+ +V E++S G+ + ++ + L+ RL++ VAK + +LH
Sbjct: 105 QP--------PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN- 155
Query: 610 VIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
N + K+ N+L+++ K+ D+GLS
Sbjct: 156 -----RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 46/231 (19%), Positives = 96/231 (41%), Gaps = 11/231 (4%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDN 176
+L L + I L +L L L +N + + P + +VKL+ L L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKN 110
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAI-SGSLPD--L 233
+P +L L + N++ S ++ + ++L N + S + +
Sbjct: 111 QLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 234 SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY-GQLNQLQQLDMSFN 292
+ L+ + ++D + + LP L L N + ++ LN L +L +SFN
Sbjct: 168 QGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFN 226
Query: 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
++ + ++ + P++ +L+L +NK +P L + + NN ++
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 31/210 (14%), Positives = 70/210 (33%), Gaps = 24/210 (11%)
Query: 113 TLARLTSLRVLSLVSLGI-WGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
L + V+ L + + + + + L Y+ ++ + ++P L
Sbjct: 140 VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTE 196
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L LD N L +L L + N ++ S+ L +L L+ N + +
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255
Query: 231 PD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289
P L+ + V+ L +N + + + F + + +
Sbjct: 256 PGGLADHKYIQVVYLHNNNISA----IGSN---DFCPPGYNTK--------KASYSGVSL 300
Query: 290 SFNALRGMP-PPAIFS-LPNISDLNLASNK 317
N ++ P+ F + + + L + K
Sbjct: 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 28/156 (17%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551
G+G YG++++G G +VA++ S + + + L LRH +++ + +
Sbjct: 17 GKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMTS 74
Query: 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVI 611
+++L+ + G+ ++ T L+ L +++ +A + LH +
Sbjct: 75 RHSS----TQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 612 PGFFNNRV-----KTNNILLNEHRIAKLSDYGLSIV 642
+ K+ NIL+ ++ ++D GL+++
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 56/235 (23%), Positives = 104/235 (44%), Gaps = 17/235 (7%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
+ L + L LGI D + L +L ++ S+N L + + + KL
Sbjct: 39 TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQL--TDITPLKNLTKLVD 94
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
+++++N + P +L +LT L++ NN++ ++ ++ L+ L+LS N IS +
Sbjct: 95 ILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTIS-DI 149
Query: 231 PDLSSLGSLNVLNLSDNKLD-SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289
LS L SL L+ + D L L L +S+N S +L L+ L
Sbjct: 150 SALSGLTSLQQLSFGNQVTDLKPLANLTT-LERLDISSNKVSD--ISVLAKLTNLESLIA 206
Query: 290 SFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344
+ N + + P + L N+ +L+L N+ L L D++NN+++
Sbjct: 207 TNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 21/234 (8%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L LT L + + + I P + L +L L L +N + + + + L L L
Sbjct: 86 LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLEL 141
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
N ++ L SL LS N + ++TL LD+S N +S + L
Sbjct: 142 SSNTISDISA--LSGLTSLQQLSFGNQVT---DLKPLANLTTLERLDISSNKVS-DISVL 195
Query: 234 SSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSF 291
+ L +L L ++N++ + L L L L+ N L L LD++
Sbjct: 196 AKLTNLESLIATNNQISDITPLGILTN-LDELSLNGNQLKD--IGTLASLTNLTDLDLAN 252
Query: 292 NALRGMPPPAIFSLPNISDLNLASNKFSGSLP-KNLNCGGKLVFFDISNNKLTG 344
N + + P + L +++L L +N+ S P L L +++ N+L
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLT---ALTNLELNENQLED 301
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 24/276 (8%)
Query: 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKL 168
S ++ LA+LT+L L + I P + L +L+ L L+ N L ++++ L
Sbjct: 190 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTLASLTNL 245
Query: 169 QTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG 228
L L +N +N P L LT L + N+++ S + ++ L++L+L++N +
Sbjct: 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLE- 300
Query: 229 SLPDLSSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ 286
+ +S+L +L L L N + S + L + L F NN S L +
Sbjct: 301 DISPISNLKNLTYLTLYFNNISDISPVSSLTK-LQRLFFYNNKVSD--VSSLANLTNINW 357
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGL 346
L N + + P + +L I+ L L ++ + L
Sbjct: 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--A 413
Query: 347 PSCLSNESDKRVVKFRGNCLSSNVQNQHPE-SYCFE 381
P+ +S+ + ++ N+ + E SY F
Sbjct: 414 PATISDGG-----SYTEPDITWNLPSYTNEVSYTFS 444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 11/214 (5%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L+ LT L L L + I S + L +L L+L+ N L IS + L L L
Sbjct: 261 LSGLTKLTELKLGANQI--SNISPLAGLTALTNLELNENQL--EDISPISNLKNLTYLTL 316
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
N ++ P SL L L NNK++ SS+ ++ ++ L N IS L L
Sbjct: 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQIS-DLTPL 371
Query: 234 SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI-PKQYGQLNQLQQLDMSFN 292
++L + L L+D + + + N I P + D+++N
Sbjct: 372 ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431
Query: 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNL 326
++ + + FSG++ + L
Sbjct: 432 LPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 38/205 (18%), Positives = 82/205 (40%), Gaps = 18/205 (8%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
L ++ + + + + + +L +T+ L +T L +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLD--SNLPKLPRGL 260
++ ++ L+ ++ S N ++ + L +L L + +++N++ + L L L
Sbjct: 59 KSI--DGVEYLNNLTQINFSNNQLT-DITPLKNLTKLVDILMNNNQIADITPLANLTN-L 114
Query: 261 VMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSG 320
L NN + P L L +L++S N + A+ L ++ L+ N+ +
Sbjct: 115 TGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTD 169
Query: 321 SLP-KNLNCGGKLVFFDISNNKLTG 344
P NL L DIS+NK++
Sbjct: 170 LKPLANLT---TLERLDISSNKVSD 191
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 29/156 (18%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551
G+G YG+++ G+ G VA++ ++++ + + + +RH +++ + I G
Sbjct: 46 GKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIAADIKG 103
Query: 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVI 611
G +++L+ ++ NG+ ++ T L+ L + + LHT +
Sbjct: 104 TGSW----TQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 612 PGFFNNRV-----KTNNILLNEHRIAKLSDYGLSIV 642
+ K+ NIL+ ++ ++D GL++
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 60/264 (22%), Positives = 95/264 (35%), Gaps = 41/264 (15%)
Query: 58 CYISSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANA-SLSENFSIDSFVTTLAR 116
CY + C + + P + A++ L N +
Sbjct: 8 CYNEPKVTTS--CPQQGLQAV------PVGI-----PAASQRIFLHGNRISHVPAASFRA 54
Query: 117 LTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILD 174
+L +L L S + + L LE LDLS N SV P + +L TL LD
Sbjct: 55 CRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-- 232
P F L +L +L +++N L + + + L+ L L N IS S+P+
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERA 172
Query: 233 LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFN 292
L SL+ L L N++ + ++F L +L L + N
Sbjct: 173 FRGLHSLDRLLLHQNRVAH-------------VHPHAFRD--------LGRLMTLYLFAN 211
Query: 293 ALRGMPPPAIFSLPNISDLNLASN 316
L +P A+ L + L L N
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 42/206 (20%), Positives = 71/206 (34%), Gaps = 29/206 (14%)
Query: 143 SLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM-RNN 200
+ + + L N + VP L L L N F L L L + N
Sbjct: 33 ASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 201 KLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPR 258
+L P++ + L L L + + L L +L L L DN L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA------- 143
Query: 259 GLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318
L +++F L L L + N + +P A L ++ L L N+
Sbjct: 144 ------LPDDTFRD--------LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 319 SGSLPKN-LNCGGKLVFFDISNNKLT 343
+ + + G+L+ + N L+
Sbjct: 190 A-HVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 21/106 (19%), Positives = 34/106 (32%), Gaps = 3/106 (2%)
Query: 240 NVLNLSDNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP 298
+ L + +P +P FL N S + L L + N L +
Sbjct: 14 VTTSCPQQGLQA-VPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 299 PPAIFSLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNNKLT 343
A L + L+L+ N S+ G G+L + L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 52/237 (21%), Positives = 91/237 (38%), Gaps = 30/237 (12%)
Query: 113 TLARLTSLRVLSLVS--LGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
+LT L LSL S L G SL+YLDLS N + ++ + +L+
Sbjct: 47 VFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEH 105
Query: 171 LILDDNFFNNTIP-NWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGS 229
L + + F SL +L +L + + F +S+L L ++ N+ +
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
Query: 230 LPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQL 287
+ L +L L+LS +L+ LS +F+ L+ LQ L
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLEQ-------------LSPTAFNS--------LSSLQVL 204
Query: 288 DMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNL--NCGGKLVFFDISNNKL 342
+MS N + L ++ L+ + N + K + L F +++ N
Sbjct: 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 57/232 (24%), Positives = 82/232 (35%), Gaps = 29/232 (12%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL-FGSVPPKI-STMVKLQTLILDD 175
+S L L S + +L L L LSSN L F + L+ L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 176 NFFNNTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAISGSLPD-- 232
N T+ + F L L L +++ L S + L LD+S +
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145
Query: 233 LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFN 292
+ L SL VL ++ N N + F+ L L LD+S
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFL------------PDIFTE--------LRNLTFLDLSQC 185
Query: 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKN-LNCGGKLVFFDISNNKLT 343
L + P A SL ++ LN++ N F SL C L D S N +
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 48/204 (23%), Positives = 72/204 (35%), Gaps = 26/204 (12%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
S + +S L SVP I + L L+ N + FD L LT LS+ +N L
Sbjct: 8 SGTEIRCNSKGL-TSVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 203 A--GPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGL 260
+ G S ++L LDLS N + + L L L+ + L
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE------ 118
Query: 261 VMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSG 320
+ F L L LD+S R L ++ L +A N F
Sbjct: 119 ------FSVFLS--------LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164
Query: 321 SLPKNLNCG-GKLVFFDISNNKLT 343
+ ++ L F D+S +L
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 4/118 (3%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
L+SL VL + + I L +L +LDLS L + P +++ LQ
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQV 203
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIST-LSDLDLSKNAIS 227
L + N F + + L SL L N + +Q + L+ L+L++N +
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 49/229 (21%), Positives = 81/229 (35%), Gaps = 26/229 (11%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDN 176
T R+L L I D+ LE L+L+ N + +V P + + L+TL L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LS 234
F L +LT L + NK+ Q + L L++ N + + S
Sbjct: 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
Query: 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNAL 294
L SL L L L S + + S L+ L L + +
Sbjct: 150 GLNSLEQLTLEKCNLTS-------------IPTEALSH--------LHGLIVLRLRHLNI 188
Query: 295 RGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+ + L + L ++ + ++ N G L I++ LT
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 52/238 (21%), Positives = 93/238 (39%), Gaps = 26/238 (10%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
++P+ I LDL N + + ++ L+ L L++N + P F++L +L
Sbjct: 25 AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
L +R+N+L +S L+ LD+S+N I L D L +L L + DN L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 251 SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISD 310
+S+ +FSG LN L+QL + L +P A+ L +
Sbjct: 142 Y-------------ISHRAFSG--------LNSLEQLTLEKCNLTSIPTEALSHLHGLIV 180
Query: 311 LNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
L L + + +L +IS+ + + + L++
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 26/210 (12%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTL 171
+ L SL L+L + + + L+ L L L + ++ + +L+ L
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI-NAIRDYSFKRLYRLKVL 205
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
+ + +T+ +LT LS+ + L +++ + L L+LS N IS ++
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIE 264
Query: 232 D--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289
L L L + L +L + +F G LN L+ L++
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAV-------------VEPYAFRG--------LNYLRVLNV 303
Query: 290 SFNALRGMPPPAIFSLPNISDLNLASNKFS 319
S N L + S+ N+ L L SN +
Sbjct: 304 SGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 22/108 (20%), Positives = 42/108 (38%), Gaps = 2/108 (1%)
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296
+ + + +P + L N ++ L++L+++ N +
Sbjct: 11 AQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 297 MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNNKLT 343
+ P A +L N+ L L SN+ +P + G L DIS NK+
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV 117
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-23
Identities = 34/179 (18%), Positives = 70/179 (39%), Gaps = 29/179 (16%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRL--------DLLA 534
+ + E G+L+KGR G + + K VR+ R L
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVV------KVLKVRDWSTRKSRDFNEECPRLR 62
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
HP+++ +LG C L+ +M G+ + E T V++ S+ +
Sbjct: 63 IFSHPNVLPVLGACQSPPA------PHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVK 115
Query: 595 VLIGVAKAVQFLHT--GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDINSVG 650
+ +A+ + FLHT +IP + + +++++E A++S + + +
Sbjct: 116 FALDMARGMAFLHTLEPLIP----RHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY 170
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 33/159 (20%), Positives = 69/159 (43%), Gaps = 14/159 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
++ ++G G++G + K + VAI+ + S + + L L+++ HP++V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIV 64
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L G C+ N V LV E+ G+ + P + ++ + ++
Sbjct: 65 KLYGACL----------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGLS 640
V +LH+ + +K N+LL + K+ D+G +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 54/235 (22%), Positives = 90/235 (38%), Gaps = 19/235 (8%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
+ L VL L + SLP I H L L +S+N L + LQ
Sbjct: 112 VFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQN 169
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L L N + +PSL ++ N L S++ + +LD S N+I+ +
Sbjct: 170 LQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VV 220
Query: 231 PDLSSLGSLNVLNLSDNKLDS--NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L +L L N L L P LV LS N + + ++ +L++L
Sbjct: 221 RG-PVNVELTILKLQHNNLTDTAWLLNYPG-LVEVDLSYNELEKIMYHPFVKMQRLERLY 278
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+S N L + +P + L+L+ N + +N +L + +N +
Sbjct: 279 ISNNRLVALNL-YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 41/242 (16%), Positives = 89/242 (36%), Gaps = 27/242 (11%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
+ L + + + L + + + ++ + +P + + +++
Sbjct: 15 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVEL 73
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L L+D F ++ L M N + P Q + L+ L L +N +S SL
Sbjct: 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 132
Query: 231 PD--LSSLGSLNVLNLSDNKLDS-------NLPKLPRGLVMAFLSNNSFSGEIPKQYGQL 281
P + L L++S+N L+ L + L LS+N + + +
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSL-QNL---QLSSNRLT-HVDL--SLI 185
Query: 282 NQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNK 341
L ++S+N L + + +L+ + N + + +N +L + +N
Sbjct: 186 PSLFHANVSYNLLSTLAI-----PIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNN 237
Query: 342 LT 343
LT
Sbjct: 238 LT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 41/219 (18%), Positives = 78/219 (35%), Gaps = 20/219 (9%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
+ + + + + T+ + + ++ DS +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
L++ + ++ + T+ L + NAI LP ++ L VL L N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL- 129
Query: 251 SNLP-----KLPRGLVMAFLSNNSFSGEIPKQYGQ-LNQLQQLDMSFNALRGMPPPAIFS 304
S+LP P+ L +SNN+ I Q LQ L +S N L +
Sbjct: 130 SSLPRGIFHNTPK-LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSL--- 184
Query: 305 LPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+P++ N++ N S +L + + D S+N +
Sbjct: 185 IPSLFHANVSYNLLS-TLAIPIA----VEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 30/199 (15%), Positives = 71/199 (35%), Gaps = 19/199 (9%)
Query: 155 FGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIS 214
+ + + + +D + +L + ++ +N+ + + +
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69
Query: 215 TLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDS-------NLPKLPRGLVMAFL 265
+ L+L+ I + + ++ L + N + N+P L L L
Sbjct: 70 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL-TVL---VL 124
Query: 266 SNNSFSGEIPKQ-YGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK 324
N S +P+ + +L L MS N L + + ++ +L L+SN+ +
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLS 183
Query: 325 NLNCGGKLVFFDISNNKLT 343
+ L ++S N L+
Sbjct: 184 LIP---SLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 36/160 (22%), Positives = 55/160 (34%), Gaps = 6/160 (3%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
+TLA ++ L I + + L L L N L + + L +
Sbjct: 199 STLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEV 253
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
L N + + F + L L + NN+L Q I TL LDLS N +
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVER 312
Query: 232 DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271
+ L L L N + + L LS+N +
Sbjct: 313 NQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD 352
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 34/178 (19%), Positives = 76/178 (42%), Gaps = 18/178 (10%)
Query: 492 GEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
G+G +G+ K E G + ++ L + T R + ++ L HP+++ +G
Sbjct: 19 GKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-G 609
++ + E++ G R I + WS+R++ +A + +LH+
Sbjct: 79 DK--------RLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 610 VIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLILMSFFFGSMTS 666
+I +R + ++N L+ E++ ++D+GL+ + D + L L +
Sbjct: 129 II-----HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 26/162 (16%), Positives = 71/162 (43%), Gaps = 15/162 (9%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551
G+G +G++++G+ G VA++ S ++ + + + LRH +++ +
Sbjct: 51 GKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNKD 108
Query: 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVI 611
G +++LV ++ +G+ +++ T + + + + A + LH ++
Sbjct: 109 NGTW----TQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 612 PGFFNNRV-----KTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ K+ NIL+ ++ ++D GL++ +
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 30/233 (12%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
L L L LV+ I + +K L L+ L +S N L +PP + + L L
Sbjct: 73 DFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNLPS--SLVEL 128
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA-GPFPSSIQRISTLSDLDLSKNAISGSL 230
+ DN F L ++ + M N L F L+ L +S+ ++ +
Sbjct: 129 RIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187
Query: 231 PDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMS 290
P +LN L+L NK+ + + ++L +L +
Sbjct: 188 PK-DLPETLNELHLDHNKIQA-------------IELEDLLR--------YSKLYRLGLG 225
Query: 291 FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
N +R + ++ LP + +L+L +NK S +P L L + N +T
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 25/127 (19%), Positives = 42/127 (33%), Gaps = 23/127 (18%)
Query: 113 TLARLTSLRVLSL-------VSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTM 165
L R + L L L + G LP +L L L +N L VP + +
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLP-------TLRELHLDNNKL-SRVPAGLPDL 263
Query: 166 VKLQTLILDDNFFNNTIPNWFDSL------PSLTFLSMRNNKLAGPF--PSSIQRISTLS 217
LQ + L N N F + +S+ NN + P++ + ++
Sbjct: 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323
Query: 218 DLDLSKN 224
+
Sbjct: 324 AIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 5/107 (4%)
Query: 238 SLNVLNLSDNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296
L V+ SD L + +PK + + L NN S + L L L + N +
Sbjct: 34 HLRVVQCSDLGLKA-VPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 297 MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+ A L + L ++ N +P NL LV I +N++
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR 136
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 11/98 (11%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL-------FGSVPPKISTM 165
+L+ L +LR L L + + +P + L L+ + L +N + F V +
Sbjct: 236 SLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVK-R 293
Query: 166 VKLQTLILDDNFFNNTI--PNWFDSLPSLTFLSMRNNK 201
+ L +N P F + + N K
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 7e-22
Identities = 54/235 (22%), Positives = 90/235 (38%), Gaps = 19/235 (8%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
+ L VL L + SLP I H L L +S+N L + LQ
Sbjct: 118 VFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQN 175
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L L N + +PSL ++ N L S++ + +LD S N+I+ +
Sbjct: 176 LQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VV 226
Query: 231 PDLSSLGSLNVLNLSDNKLDS--NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L +L L N L L P LV LS N + + ++ +L++L
Sbjct: 227 RG-PVNVELTILKLQHNNLTDTAWLLNYPG-LVEVDLSYNELEKIMYHPFVKMQRLERLY 284
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+S N L + +P + L+L+ N + +N +L + +N +
Sbjct: 285 ISNNRLVALNL-YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 5e-19
Identities = 41/242 (16%), Positives = 89/242 (36%), Gaps = 27/242 (11%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
+ L + + + L + + + ++ + +P + + +++
Sbjct: 21 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVEL 79
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L L+D F ++ L M N + P Q + L+ L L +N +S SL
Sbjct: 80 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 138
Query: 231 PD--LSSLGSLNVLNLSDNKLDS-------NLPKLPRGLVMAFLSNNSFSGEIPKQYGQL 281
P + L L++S+N L+ L + L LS+N + + +
Sbjct: 139 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSL-QNL---QLSSNRLT-HVDL--SLI 191
Query: 282 NQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNK 341
L ++S+N L + + +L+ + N + + +N +L + +N
Sbjct: 192 PSLFHANVSYNLLSTLAI-----PIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNN 243
Query: 342 LT 343
LT
Sbjct: 244 LT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 34/213 (15%), Positives = 68/213 (31%), Gaps = 27/213 (12%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
+ + + + + T+ + + ++ DS +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
L++ + ++ + T+ L + NAI LP ++ L VL L N L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
Query: 251 SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISD 310
S L F +L L MS N L + + ++ +
Sbjct: 137 S-------------LPRGIFHN--------TPKLTTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 311 LNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
L L+SN+ + + L ++S N L+
Sbjct: 176 LQLSSNRLTHVDLSLIP---SLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 4e-14
Identities = 36/160 (22%), Positives = 55/160 (34%), Gaps = 6/160 (3%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTL 171
+TLA ++ L I + + L L L N L + + L +
Sbjct: 205 STLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEV 259
Query: 172 ILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231
L N + + F + L L + NN+L Q I TL LDLS N +
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVER 318
Query: 232 DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271
+ L L L N + + L LS+N +
Sbjct: 319 NQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 8e-11
Identities = 34/167 (20%), Positives = 63/167 (37%), Gaps = 26/167 (15%)
Query: 180 NTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLG 237
I + + + F ++ + + + LP L S
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFR 75
Query: 238 SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM 297
+ +LNL+D +++ + +F+ + +Q+L M FNA+R +
Sbjct: 76 QVELLNLNDLQIEE-------------IDTYAFAY--------AHTIQKLYMGFNAIRYL 114
Query: 298 PPPAIFSLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNNKLT 343
PP ++P ++ L L N S SLP+ + KL +SNN L
Sbjct: 115 PPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 160
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 62/268 (23%), Positives = 96/268 (35%), Gaps = 39/268 (14%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYS---LEYLDLSSNFLFG 156
+ + T + + SL+ L++ + I + R+ L+ L L + + G
Sbjct: 50 KRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG 109
Query: 157 SVPPKIS--TMVKLQTLILDDNFFNNTIPNWFDSL-----PSLTFLSMRNNKLAGPFPSS 209
+ PP + T L L L + + T W L P L LS+
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWA-TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 210 IQRISTLSDLDLSKNAISGSLPDLSS-----LGSLNVLNLSDNKLDSNLPKLPRGLVMAF 264
++ LS LDLS N G +S+ +L VL L + +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM--------------- 213
Query: 265 LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLP-NISDLNLASNKFSGSLP 323
+ SG QLQ LD+S N+LR P ++ LNL+ +P
Sbjct: 214 ---ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP 269
Query: 324 KNLNCGGKLVFFDISNNKLTGGLPSCLS 351
K L KL D+S N+L PS
Sbjct: 270 KGL--PAKLSVLDLSYNRLD-RNPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 50/234 (21%), Positives = 76/234 (32%), Gaps = 36/234 (15%)
Query: 98 NASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPD-KIHRLYSLEYLDLSSNFLFG 156
N ++ T L L + ++ L + + L+ L ++
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNW----FDSLPSLTFLSMRNNKLA---GPFPSS 209
++ L TL L DN P+L L++RN + G +
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 210 IQRISTLSDLDLSKNAISGSLPDLSSLG--SLNVLNLSDNKLDSNLPKLPRGLVMAFLSN 267
L LDLS N++ + S LN LNLS L LP
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--------- 274
Query: 268 NSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321
+L LD+S+N L P P LP + +L+L N F S
Sbjct: 275 ---------------KLSVLDLSYNRLDRNPSPD--ELPQVGNLSLKGNPFLDS 311
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 37/176 (21%), Positives = 75/176 (42%), Gaps = 36/176 (20%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD-------LLA 534
N + +G+G +G ++KGR +++ + VAI+ L + + +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
L HP++V L G N +V EF+ G+ + + WS +L
Sbjct: 79 NLNHPNIVKLYGLMH----------NPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLR 126
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILL-----NEHRIAKLSDYGLS 640
+++ +A ++++ N + ++ NI L N AK++D+GLS
Sbjct: 127 LMLDIALGIEYMQN------QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-21
Identities = 55/247 (22%), Positives = 94/247 (38%), Gaps = 45/247 (18%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
L R +L+ L L S GI ++ + L SLE+LDLS N+L ++ + L
Sbjct: 71 DLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTF 128
Query: 171 LILDDN---------FFNNTI-----------------PNWFDSLPSLTFLSMRNNKLAG 204
L L N F++ F L L L + + L
Sbjct: 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188
Query: 205 PFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSN-LPKLPRGLV 261
P S++ I +S L L L + + S+ L L D LD+ +L G
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 262 MAF----------LSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDL 311
+ +++ S ++ K Q++ L +L+ S N L+ +P L ++ +
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKI 306
Query: 312 NLASNKF 318
L +N +
Sbjct: 307 WLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 45/214 (21%), Positives = 90/214 (42%), Gaps = 15/214 (7%)
Query: 148 DLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFP 207
SS L S+P ++ +++L L +N + +L L + +N +
Sbjct: 37 KGSSGSL-NSIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 208 SSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLP-----KLPRGL 260
S + +L LDLS N +S +L L SL LNL N + L +
Sbjct: 94 DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152
Query: 261 VMAFLSNNSFSGEIPKQ-YGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319
++ + ++F+ +I ++ + L L++L++ + L+ P ++ S+ N+S L L +
Sbjct: 153 ILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 320 GSLPKNL-NCGGKLVFFDISNNKLTGGLPSCLSN 352
L + + + ++ + L S LS
Sbjct: 212 -LLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 36/174 (20%), Positives = 65/174 (37%), Gaps = 37/174 (21%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQ 169
+ + LT L++L + ++ + + K L LE L++ ++ L S PK ++ +
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVS 201
Query: 170 TLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGP------------------------ 205
LIL + + D S+ L +R+ L
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 206 -------FPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
+ +IS L +L+ S+N + S+PD L SL + L N D
Sbjct: 262 TDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 46/201 (22%), Positives = 75/201 (37%), Gaps = 28/201 (13%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF 177
+L L ++ + L L+L L + T+ L TL L N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQ 88
Query: 178 FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSS 235
++P +LP+LT L + N+L +++ + L +L L N + +LP L+
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 236 LGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALR 295
L L+L++N L LP GL +G L L L + N+L
Sbjct: 147 TPKLEKLSLANNNLTE----LPAGL---------LNG--------LENLDTLLLQENSLY 185
Query: 296 GMPPPAIFSLPNISDLNLASN 316
+P F + L N
Sbjct: 186 TIPKGF-FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 33/227 (14%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDD 175
+ S ++ + +LP + + L LS N L + +L L LD
Sbjct: 9 VASHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLL-YTFSLATLMPYTRLTQLNLDR 64
Query: 176 NFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--L 233
T +LP L L + +N+L P Q + L+ LD+S N ++ SLP L
Sbjct: 65 A--ELTKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 234 SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNA 293
LG L L L N+L + LP GL + +L++L ++ N
Sbjct: 121 RGLGELQELYLKGNELKT----LPPGL---------LTP--------TPKLEKLSLANNN 159
Query: 294 LRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN 340
L +P + L N+ L L N ++PK L F + N
Sbjct: 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 46/202 (22%), Positives = 68/202 (33%), Gaps = 52/202 (25%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
S ++ L ++PP + L L +N LT L++ +L
Sbjct: 11 SHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVM 262
L +L L L+LS N+L S LP L + L
Sbjct: 68 T-------------------------KLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLP- 100
Query: 263 AFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSL 322
L LD+SFN L +P A+ L + +L L N+ +L
Sbjct: 101 --------------------ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TL 139
Query: 323 PKNL-NCGGKLVFFDISNNKLT 343
P L KL ++NN LT
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 27/108 (25%), Positives = 43/108 (39%), Gaps = 3/108 (2%)
Query: 236 LGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALR 295
+ S +N L + P LP+ + LS N +L QL++ L
Sbjct: 9 VASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 296 GMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+ +LP + L+L+ N+ SLP L D+S N+LT
Sbjct: 69 KL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 22/193 (11%)
Query: 139 HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197
L+ LDLS + ++ ++ L TLIL N + F L SL L
Sbjct: 49 FSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 198 RNNKL----AGPFPSSIQRISTLSDLDLSKNAISGSLPD---LSSLGSLNVLNLSDNKLD 250
L P + TL +L+++ N I S S+L +L L+LS NK+
Sbjct: 108 VETNLASLENFPI----GHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 251 S-------NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIF 303
S L ++P + LS N + I + +L++L + N L+ +P
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221
Query: 304 SLPNISDLNLASN 316
L ++ + L +N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 46/205 (22%), Positives = 79/205 (38%), Gaps = 30/205 (14%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQR 212
+P + + L L N + F S P L L + ++ G + Q
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY----QS 74
Query: 213 ISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDS-------NLPKLPRGLVMA 263
+S LS L L+ N I SL S L SL L + L S +L L + L
Sbjct: 75 LSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL-KEL--- 129
Query: 264 FLSNNSF-SGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN----ISDLNLASNKF 318
+++N S ++P+ + L L+ LD+S N ++ + + L L+L+ N
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 319 SGSLPKNLNCGGKLVFFDISNNKLT 343
+ + +L + N+L
Sbjct: 190 N-FIQPGAFKEIRLKELALDTNQLK 213
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 25/161 (15%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKLRHPHLVCLLGH 547
G G +GK+Y+ G VA++ T+ N++ L A L+HP+++ L G
Sbjct: 16 GIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
C+ + LV EF G +S GK + + + +A+ + +LH
Sbjct: 75 CLKE--------PNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLH 122
Query: 608 TGVIPGFFNNRVKTNNILLNE--------HRIAKLSDYGLS 640
I + +K++NIL+ + ++I K++D+GL+
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 52/248 (20%), Positives = 99/248 (39%), Gaps = 21/248 (8%)
Query: 99 ASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV 158
S+++ +I+ + L + ++ + + L + L + ++
Sbjct: 1 GSITQPTAINV-IFPDPALANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGV-TTI 56
Query: 159 PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218
+ + L L L DN + P +L +T L + N L I + ++
Sbjct: 57 EG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKT 111
Query: 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIPK 276
LDL+ I+ + L+ L +L VL L N++ S L L L + N S P
Sbjct: 112 LDLTSTQIT-DVTPLAGLSNLQVLYLDLNQITNISPLAGLTN-LQYLSIGNAQVSDLTP- 168
Query: 277 QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP-KNLNCGGKLVFF 335
L++L L N + + P + SLPN+ +++L +N+ S P N + L
Sbjct: 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS---NLFIV 222
Query: 336 DISNNKLT 343
++N +T
Sbjct: 223 TLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 42/218 (19%), Positives = 89/218 (40%), Gaps = 11/218 (5%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
V+ +A L S++ L L S I + + L +L+ L L N + + ++ + LQ
Sbjct: 100 VSAIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQI--TNISPLAGLTNLQY 155
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
L + + ++ P +L LT L +NK++ S + + L ++ L N IS +
Sbjct: 156 LSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS-DV 210
Query: 231 PDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI-PKQYGQLNQLQQLDM 289
L++ +L ++ L++ + + LV+ + I P ++
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNL 270
Query: 290 SFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327
++N L ++ + FSG++ + L
Sbjct: 271 TWN-LTSFINNVSYTFNQSVTFKNTTVPFSGTVTQPLT 307
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 34/153 (22%), Positives = 72/153 (47%), Gaps = 22/153 (14%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCL--PSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
G GS+G +YKG+ +G VA++ L + ++ K + +L K RH +++ +G+
Sbjct: 33 GSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT- 608
++ +V ++ + H+ + + + + A+ + +LH
Sbjct: 91 AP---------QLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 609 GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+I +R +K+NNI L+E K+ D+GL+
Sbjct: 140 SII-----HRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 28/151 (18%), Positives = 66/151 (43%), Gaps = 18/151 (11%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCL--PSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
G+G +G++Y GR +G VAIR + + ++ K + + RH ++V +G C+
Sbjct: 42 GKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG 609
+ ++ + + + VL+ ++ + + K + +LH
Sbjct: 100 SPP--------HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA- 148
Query: 610 VIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
G + +K+ N+ + ++ ++D+GL
Sbjct: 149 --KGILHKDLKSKNVFYDNGKV-VITDFGLF 176
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-18
Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 6/226 (2%)
Query: 98 NASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGS 157
N +++E + F + L SL + + + S + LS +
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344
Query: 158 VPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA--GPFPSSIQRIST 215
+ L N F +++ +L L L ++ N L + +S+
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS 404
Query: 216 LSDLDLSKNAISGSLPDL--SSLGSLNVLNLSDNKLDSNL-PKLPRGLVMAFLSNNSFSG 272
L LD+S N+++ D + S+ VLNLS N L ++ LP + + L NN
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM- 463
Query: 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318
IPK L LQ+L+++ N L+ +P L ++ + L N +
Sbjct: 464 SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 39/238 (16%), Positives = 77/238 (32%), Gaps = 21/238 (8%)
Query: 134 LPDKIHRLYSLEYLDLSSNFL----FGSVPPKISTMVKLQTLILDDNFFNNTIPNW---F 186
+ ++ L L+ ++ N + +++ L + L F
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 187 DSLPSLTFLSMRNNKLAGP-----FPSSIQRISTLSDLDLSKNAISGSLPDL-SSLGSLN 240
+ +L++ N + F S + +L + S L S +N
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 241 VLNLSDNKLDSNLPKLPRGLVMA---FLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM 297
+ LS + P + N F+ + + L +LQ L + N L+
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392
Query: 298 PPPAIFSLPNISDLNLASNKFSG--SLPKNLNCGG--KLVFFDISNNKLTGGLPSCLS 351
A N+S L + S + C ++ ++S+N LTG + CL
Sbjct: 393 FKVA-LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 43/248 (17%), Positives = 81/248 (32%), Gaps = 21/248 (8%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKIHRLY-SLEYLDLSSNFLFGSVPPKISTMVKLQTLILD 174
LT L L L + + L+ S LDL S + + + L L
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI-KGGETESLQIPNTTVLHLV 202
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAG-------PFPSSIQRISTLSDLDLSKNAIS 227
+ + S+ +L L + N KL F S + R TL ++ L +
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 228 --GSLPDLSSLGSLNV--LNLSDNKLDSNLPKLP--------RGLVMAFLSNNSFSGEIP 275
S+ V LN+ + + + + + L++ + N F
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFF 335
Y ++ +S + + S + + LN N F+ S+ + + +L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 336 DISNNKLT 343
+ N L
Sbjct: 383 ILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 54/298 (18%), Positives = 93/298 (31%), Gaps = 49/298 (16%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILD 174
L+ LRVL L I SL + LEYLD+S N L ++ M L+ L L
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLS 129
Query: 175 DNFFNN-TIPNWFDSLPSLTFLSMRNNKL-AGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
N F+ + F +L LTFL + K + LDL I G +
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETE 189
Query: 233 LSSLGSLNVLNLSDNKLD-----------------------------------SNLPKLP 257
+ + VL+L + S L + P
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249
Query: 258 RGLVMAFLSNNSFSGEIPK--QYGQLNQLQQLDMSFNALRGMPPPAIF-----SLPNISD 310
L + + K Q+ ++ L++ + F +L ++
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309
Query: 311 LNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368
++ + F S + ++ +S + C + S + F N +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD 367
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 37/214 (17%), Positives = 65/214 (30%), Gaps = 56/214 (26%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
+D S+ L VP + + + L L N + L L L + +N++
Sbjct: 32 LESMVDYSNRNLT-HVPKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
Query: 203 AGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGL 260
SL L L++S N+L + +
Sbjct: 89 R-------------------------SLDFHVFLFNQDLEYLDVSHNRLQN----ISCC- 118
Query: 261 VMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFS-LPNISDLNLASNKF- 318
+ L+ LD+SFN +P F L ++ L L++ KF
Sbjct: 119 -------------------PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 319 SGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
L + + D+ + + GG L
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 11/156 (7%)
Query: 101 LSENFSIDSFVTTLARLTSLRVLSL--VSLGIWGSLPDKIHRLYSLEYLDLSSNFL-FGS 157
++N DS + L L+ L L L + + + SLE LD+S N L +
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 158 VPPKISTMVKLQTLILDDNFFNNTIPNWFDSLP-SLTFLSMRNNKLAGPFPSSIQRISTL 216
+ + L L N ++ F LP + L + NN++ P + + L
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPKDVTHLQAL 475
Query: 217 SDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
+L+++ N + S+PD L SL + L DN D
Sbjct: 476 QELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 30/133 (22%), Positives = 59/133 (44%), Gaps = 7/133 (5%)
Query: 68 ITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVS 127
+ Q N + + N+ + + + SL+ ++ T A S+ VL+L S
Sbjct: 382 LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS----HAYDRTCAWAESILVLNLSS 437
Query: 128 LGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFD 187
+ GS+ + ++ LDL +N + S+P ++ + LQ L + N + FD
Sbjct: 438 NMLTGSVFRCLPP--KVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFD 494
Query: 188 SLPSLTFLSMRNN 200
L SL ++ + +N
Sbjct: 495 RLTSLQYIWLHDN 507
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 30/166 (18%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G+G +G + G G VA++C+ + T + ++ +LRH +LV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 77
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
LLG ++ G +++V E+M+ G+ ++ VL L + V +A
Sbjct: 78 QLLGVIVEEKG-------GLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEA 129
Query: 603 VQFLHTGVIPGFFNN--------RVKTNNILLNEHRIAKLSDYGLS 640
+++L NN R N+L++E +AK+SD+GL+
Sbjct: 130 MEYLEG-------NNFVHRDLAAR----NVLVSEDNVAKVSDFGLT 164
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 42/222 (18%), Positives = 77/222 (34%), Gaps = 16/222 (7%)
Query: 135 PDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193
RL L++L + + + L L LD N F F+ L +L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLE 106
Query: 194 FLSMRNNKLAGPF--PSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKL 249
L++ L G + + +++L L L N I P ++ +VL+L+ NK+
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166
Query: 250 DSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNIS 309
S + ++ F + +L+ + DM+ L F +I+
Sbjct: 167 KS----ICEEDLLNFQGKH-------FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
Query: 310 DLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLS 351
L+L+ N F S+ K + + S
Sbjct: 216 TLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 44/236 (18%), Positives = 90/236 (38%), Gaps = 39/236 (16%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYS---LEYLDLSSNFLFG 156
++E + + TS+ L L G S+ + + ++ L LS+++ G
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 157 SVPPKIS------------TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG 204
S + ++T L + + + F L L++ N++
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313
Query: 205 PFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVM 262
++ ++ L L+LS+N + S+ +L L VL+LS N + +
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA----------- 361
Query: 263 AFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318
L + SF G L L++L + N L+ +P L ++ + L +N +
Sbjct: 362 --LGDQSFLG--------LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 39/182 (21%), Positives = 63/182 (34%), Gaps = 26/182 (14%)
Query: 168 LQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSI-QRISTLSDLDLSKNAI 226
+ + L N F L L FL + ++ + +S+L L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 227 SGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQL 284
L + L +L VL L+ LD A LS N F L L
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDG-----------AVLSGNFFKP--------LTSL 131
Query: 285 QQLDMSFNALRGMPPPAIF-SLPNISDLNLASNKFSGSLPKNLN--CGGKLVFFDISNNK 341
+ L + N ++ + P + F ++ L+L NK ++L G +S+
Sbjct: 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSIT 191
Query: 342 LT 343
L
Sbjct: 192 LQ 193
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 49/256 (19%), Positives = 85/256 (33%), Gaps = 51/256 (19%)
Query: 116 RLTSLRVLSL-------VSLGIWGSLPDKIH---RLYSLEYLDLSSNFLFGSVPPKISTM 165
+ VL L + + K RL S+ D++ +L
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 166 VKLQTLILDDNFFNNTIPNWFDSLPSLT-----FLSMRNNKLAGPFPSSIQRI------- 213
+ TL L N F ++ F + T LS N + ++ +
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271
Query: 214 ---STLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNN 268
S + DLSK+ I +L S L L L+ N+++ + +N
Sbjct: 272 LEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINK-------------IDDN 317
Query: 269 SFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNC 328
+F G L L +L++S N L + +L + L+L+ N +L
Sbjct: 318 AFWG--------LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL 368
Query: 329 G-GKLVFFDISNNKLT 343
G L + N+L
Sbjct: 369 GLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 32/137 (23%), Positives = 51/137 (37%), Gaps = 7/137 (5%)
Query: 118 TSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDD 175
+ ++ L I +L + LE L L+ N + + + L L L
Sbjct: 275 SGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQ 332
Query: 176 NFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--L 233
NF + F++L L L + N + S + L +L L N + S+PD
Sbjct: 333 NFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIF 391
Query: 234 SSLGSLNVLNLSDNKLD 250
L SL + L N D
Sbjct: 392 DRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/134 (20%), Positives = 44/134 (32%), Gaps = 25/134 (18%)
Query: 214 STLSDLDLSKNAISGSLP--DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271
+ ++ +DLS N+I+ L S L L L + + NN+F
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIR------------NNTFR 76
Query: 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF-SGSLPKNL-NCG 329
G L+ L L + +N + A L N+ L L L N
Sbjct: 77 G--------LSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
Query: 330 GKLVFFDISNNKLT 343
L + +N +
Sbjct: 129 TSLEMLVLRDNNIK 142
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G+G +G + G G VA++C+ + T + ++ +LRH +LV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 249
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
LLG ++ G +++V E+M+ G+ ++ VL L + V +A
Sbjct: 250 QLLGVIVEEKG-------GLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEA 301
Query: 603 VQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
+++L NN V N+L++E +AK+SD+GL+
Sbjct: 302 MEYLEG-------NNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 38/161 (23%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 490 IMGEGSYGKLYKGRLE-----NGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHLVC 543
+GEG +GK+ R + G VA++ L P S + +LK +++L L H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
G C + GG + L+ EF+ +G+ + ++ +N +N ++L + + K +
Sbjct: 88 YKGICTEDGGNG------IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGM 139
Query: 604 QFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
+L + V N+L+ K+ D+GL+
Sbjct: 140 DYLGS-------RQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 34/168 (20%), Positives = 66/168 (39%), Gaps = 24/168 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHL 541
+ +G G +G ++ G N VAI+ + + +++ KL HP L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKL 65
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
V L G C++ + LV EFM +G ++ + L + + V +
Sbjct: 66 VQLYGVCLEQAP--------ICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCE 115
Query: 602 AVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
+ +L + N L+ E+++ K+SD+G++ D
Sbjct: 116 GMAYLEE-------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 34/168 (20%), Positives = 67/168 (39%), Gaps = 24/168 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHL 541
+ +G G +G + G+ + VA++ + + + + KL HP L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKL 65
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
V G C +++V E++SNG ++ + GK L S+ L + V +
Sbjct: 66 VKFYGVCSKE--------YPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCE 115
Query: 602 AVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
+ FL + + + N L++ K+SD+G++ D
Sbjct: 116 GMAFLES-------HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 37/195 (18%), Positives = 83/195 (42%), Gaps = 18/195 (9%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
++F+ A++G+G++G++ K R + AI+ + +++ + + + LLA L H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQY 63
Query: 541 LVCLLGHCIDGGGRDDYAVN-----KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
+V ++ +F+ E+ NG I + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 596 LIG-VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVR 652
L + +A+ ++H+ G+I +R +K NI ++E R K+ D+GL+ +
Sbjct: 121 LFRQILEALSYIHSQGII-----HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 653 LLILMSFFFGSMTSC 667
+ ++TS
Sbjct: 176 DSQNLPGSSDNLTSA 190
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 34/163 (20%), Positives = 75/163 (46%), Gaps = 24/163 (14%)
Query: 487 MSAIMGEGSYGKLYKGRLE-----NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+G+G++G + R + G VA++ L S + +R+ + +++L L+H ++
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
V G C G R+ + L+ E++ G+ R ++ ++ + ++ + L + K
Sbjct: 74 VKYKGVCYSAGRRN------LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICK 125
Query: 602 AVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
+++L T + T NIL+ K+ D+GL+
Sbjct: 126 GMEYLGT-------KRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-16
Identities = 32/166 (19%), Positives = 69/166 (41%), Gaps = 13/166 (7%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLI 172
T A++ SL ++L ++ + L I ++++ L +++ + IS + L+ L
Sbjct: 39 TEAQMNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLR 94
Query: 173 LDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
+ + L SLT L + ++ + I + ++ +DLS N +
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 233 LSSLGSLNVLNLSDNKLD-----SNLPKLPRGLVMAFLSNNSFSGE 273
L +L L LN+ + + + PKL L + + + G+
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRGIEDFPKL-NQL---YAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 30/185 (16%), Positives = 70/185 (37%), Gaps = 19/185 (10%)
Query: 168 LQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLS---DLDLSKN 224
+ + ++T + SLT++++ N + + + I DL ++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLTINNI 76
Query: 225 AISGSLPDLSSLGSLNVLNLSDNKLD----SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQ 280
+ + +S L +L L + + NL L L + +S+++ I +
Sbjct: 77 HAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS-LTLLDISHSAHDDSILTKINT 134
Query: 281 LNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP-KNLNCGGKLVFFDISN 339
L ++ +D+S+N P + +LP + LN+ + ++ KL +
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIEDFP---KLNQLYAFS 190
Query: 340 NKLTG 344
+ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 26/118 (22%), Positives = 50/118 (42%), Gaps = 3/118 (2%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
++ L++L L ++ + + L SL LD+S + S+ KI+T+ K+ +
Sbjct: 81 YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG 228
+ L N I +LP L L+++ + + I+ L+ L I G
Sbjct: 141 IDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 23/184 (12%), Positives = 66/184 (35%), Gaps = 30/184 (16%)
Query: 169 QTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG 228
+ L + N IP+ + + + + A + ++++L+ + L+ ++
Sbjct: 4 EQTGLKASQDNVNIPD--STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT- 57
Query: 229 SLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L + ++ L +++ +N + L+ L++L
Sbjct: 58 DLTGIEYAHNIKDLTINNIHA-TNYNPI----------------------SGLSNLERLR 94
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPS 348
+ + P + L +++ L+++ + S+ +N K+ D+S N +
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153
Query: 349 CLSN 352
L
Sbjct: 154 PLKT 157
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 34/158 (21%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 492 GEGSYGKLYKGRLE-----NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG 546
G+G++G + R + G VA++ L S + +R+ + +++L L+H ++V G
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL 606
C G R+ + L+ E++ G+ R ++ ++ + ++ + L + K +++L
Sbjct: 110 VCYSAGRRN------LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYL 161
Query: 607 HTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
T + T NIL+ K+ D+GL+
Sbjct: 162 GT-------KRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 36/166 (21%), Positives = 60/166 (36%), Gaps = 34/166 (20%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQR 212
+P + + + L+ N P F L + + NN++ F Q
Sbjct: 25 EIPTNLPETI--TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF----QG 78
Query: 213 ISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSF 270
+ +L+ L L N I+ LP L SL +L L+ NK++ L +F
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC----LRVD---------AF 124
Query: 271 SGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
L+ L L + N L+ + L I ++LA N
Sbjct: 125 QD--------LHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 27/122 (22%), Positives = 50/122 (40%), Gaps = 6/122 (4%)
Query: 133 SLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPNWFDSLP 190
+P L +DLS+N + + P + L +L+L N + F+ L
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLF 104
Query: 191 SLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNK 248
SL L + NK+ + Q + L+ L L N + ++ S L ++ ++L+ N
Sbjct: 105 SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNP 163
Query: 249 LD 250
Sbjct: 164 FI 165
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 34/159 (21%), Positives = 63/159 (39%), Gaps = 24/159 (15%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHCID 550
G G +G + G+ VAI+ + + + ++ L H LV L G C
Sbjct: 33 GTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV 610
+F++ E+M+NG ++ E + L + V +A+++L +
Sbjct: 91 Q--------RPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES-- 138
Query: 611 IPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
+ N L+N+ + K+SD+GLS D
Sbjct: 139 -----KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 59/207 (28%), Positives = 83/207 (40%), Gaps = 36/207 (17%)
Query: 118 TSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDD 175
+ L L S + SLP K HRL L L L+ N L ++P I + L+TL + D
Sbjct: 37 ADTKKLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTD 94
Query: 176 NFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQRISTLSDLDLSKNAISGSLP 231
N FD L +L L + N+L F ++ L+ L L N + SLP
Sbjct: 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVF----DSLTKLTYLSLGYNELQ-SLP 149
Query: 232 D--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289
L SL L L +N+L +P G F L +L+ L +
Sbjct: 150 KGVFDKLTSLKELRLYNNQLKR----VPEGA---------FDK--------LTELKTLKL 188
Query: 290 SFNALRGMPPPAIFSLPNISDLNLASN 316
N L+ +P A SL + L L N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 36/194 (18%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQR 212
++P I + L L N ++ F L L L + +NKL AG F +
Sbjct: 30 AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF----KE 83
Query: 213 ISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSF 270
+ L L ++ N + +LP L +L L L N+L S LP + F
Sbjct: 84 LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS----LPPRV---------F 129
Query: 271 SGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG- 329
L +L L + +N L+ +P L ++ +L L +N+ +P+
Sbjct: 130 DS--------LTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKL 180
Query: 330 GKLVFFDISNNKLT 343
+L + NN+L
Sbjct: 181 TELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLIL 173
+L +L L L + SLP ++ L L YL L N L S+P + + L+ L L
Sbjct: 107 QLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRL 164
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKN 224
+N FD L L L + NN+L + + L L L +N
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 2/108 (1%)
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296
+ N ++ S KL + +P L +N S K + +L +L+ L ++ N L+
Sbjct: 16 NNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT 75
Query: 297 MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG-GKLVFFDISNNKLT 343
+P L N+ L + NK +LP + L + N+L
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 41/184 (22%), Positives = 72/184 (39%), Gaps = 46/184 (25%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRLENG-----TSVAIRCLPSSKKYTVRNLKLR 529
L LKE F ++G G++G +YKG VAI+ L + L
Sbjct: 9 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 530 -LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----TPG 584
++A + +PH+ LLG C+ + V L+ + M G ++ E+
Sbjct: 67 EAYVMASVDNPHVCRLLGICLT---------STVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN--------RVKTNNILLNEHRIAKLSD 636
+LNW + +AK + +L R N+L+ + K++D
Sbjct: 118 YLLNWC------VQIAKGMNYLED-------RRLVHRDLAAR----NVLVKTPQHVKITD 160
Query: 637 YGLS 640
+GL+
Sbjct: 161 FGLA 164
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 39/219 (17%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 474 TLEELKEATNNFDMSAI-----MGEGSYGKLYKGRL----ENGTSVAIRCL-PSSKKYTV 523
++ ++ + +G G +G +Y G L A++ L + V
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 70
Query: 524 RNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP 583
++ HP+++ LLG C+ G +V +M +G+ R I T
Sbjct: 71 SQFLTEGIIMKDFSHPNVLSLLGICLRSEG-------SPLVVLPYMKHGDLRNFIRNETH 123
Query: 584 GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGL 639
+ + + VAK +++L + V N +L+E K++D+GL
Sbjct: 124 N--PTVKDLIGFGLQVAKGMKYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGL 174
Query: 640 S--IVSEDINSVGVRLLILM--------SFFFGSMTSCS 668
+ + ++ SV + + S T+ S
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 37/171 (21%), Positives = 78/171 (45%), Gaps = 26/171 (15%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRH 538
+F++ +G+G +G +Y R ++ +A++ L + K L+ +++ + LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
P+++ L G+ D +V+L+ E+ G + + K E+
Sbjct: 69 PNILRLYGYFHDA--------TRVYLILEYAPLGTVYRELQKL--SKF---DEQRTATYI 115
Query: 599 --VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSED 645
+A A+ + H+ VI +R +K N+LL K++D+G S+ +
Sbjct: 116 TELANALSYCHSKRVI-----HRDIKPENLLLGSAGELKIADFGWSVHAPS 161
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 32/167 (19%), Positives = 65/167 (38%), Gaps = 32/167 (19%)
Query: 487 MSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+ +G+G++G + R G VA++ L S R+ + + +L L +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----TPGKVLNWSERLAVLI 597
V G G + + LV E++ +G R + + ++L +S
Sbjct: 87 VKYRGVSYGPGRQS------LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS------S 134
Query: 598 GVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
+ K +++L + V NIL+ K++D+GL+
Sbjct: 135 QICKGMEYLGS-------RRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 31/156 (19%), Positives = 64/156 (41%), Gaps = 11/156 (7%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
GEG + + L +G A++ + ++ + D+ HP+++ L+ +C+
Sbjct: 38 GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR 97
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER--LAVLIGVAKAVQFLHT 608
G A ++ +L+ F G I +E L +L+G+ + ++ +H
Sbjct: 98 ERG----AKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIHA 152
Query: 609 GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644
G+ + +K NILL + L D G +
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 35/164 (21%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 487 MSAIMGEGSYGKLYKGRLEN-----GTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPH 540
+GEG +GK+ + G VA++ L + K +D+L L H H
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
++ G C D G + LV E++ G+ R ++ ++ + ++ L +
Sbjct: 95 IIKYKGCCEDAGAAS------LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQIC 144
Query: 601 KAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
+ + +LH + + N+LL+ R+ K+ D+GL+
Sbjct: 145 EGMAYLHA-------QHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 24/176 (13%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNW-FDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215
+VP + + L L N + W L +L L + +N L + +
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 216 LSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDS-------NLPKLPRGLVMAFLS 266
L LDLS N + +L + S L +L VL L +N + ++ +L + L +LS
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL-QKL---YLS 144
Query: 267 NNSFSGEIPKQ----YGQLNQLQQLDMSFNALRGMPPPAIFSLPNIS--DLNLASN 316
N S P + +L +L LD+S N L+ +P + LP L L +N
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 39/149 (26%), Positives = 63/149 (42%), Gaps = 14/149 (9%)
Query: 112 TTLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQ 169
T RLT+L L L + + + + +L YLDLSSN L ++ + S + L+
Sbjct: 58 WTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALE 115
Query: 170 TLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQRISTLSDLDLSKNA 225
L+L +N N F+ + L L + N++ ++ L LDLS N
Sbjct: 116 VLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELI-KDGNKLPKLMLLDLSSNK 174
Query: 226 IS----GSLPDLSSLGSLNVLNLSDNKLD 250
+ L L + N L L +N L+
Sbjct: 175 LKKLPLTDLQKLPAW-VKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 31/142 (21%), Positives = 51/142 (35%), Gaps = 33/142 (23%)
Query: 206 FPSSIQRISTLSDLDLSKNAISGSLP---DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVM 262
PS LDLS N +S L + L +L+ L LS N L+ +
Sbjct: 37 LPSYTAL------LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF----ISSE--- 82
Query: 263 AFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSL 322
+F + L+ LD+S N L + L + L L +N +
Sbjct: 83 ------AFVP--------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VV 127
Query: 323 PKNLNCG-GKLVFFDISNNKLT 343
+N +L +S N+++
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS 149
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 37/178 (20%), Positives = 71/178 (39%), Gaps = 41/178 (23%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLA------K 535
+ + +G G++G+++ GRL + T VA++ + L+ L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----PPDLKAKFLQEARILKQ 168
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
HP++V L+G C +++V E + G+F T + G L L +
Sbjct: 169 YSHPNIVRLIGVCTQK--------QPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQM 218
Query: 596 LIGVAKAVQFLHTGVIPGFFNN--------RVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ A +++L + R N L+ E + K+SD+G+S D
Sbjct: 219 VGDAAAGMEYLES-------KCCIHRDLAAR----NCLVTEKNVLKISDFGMSREEAD 265
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 5e-15
Identities = 39/207 (18%), Positives = 75/207 (36%), Gaps = 40/207 (19%)
Query: 140 RLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199
+L + + + + + +I +++ + + LP++T L +
Sbjct: 19 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNG 74
Query: 200 NKLAGPFPSSIQRISTLS---DLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL 256
NKL + I+ ++ L L L +N I L L L L L+L N + S++ L
Sbjct: 75 NKL-----TDIKPLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNGI-SDINGL 127
Query: 257 PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
L QL+ L + N + + + L + L+L N
Sbjct: 128 V----------------------HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN 163
Query: 317 KFSGSLPKNLNCGGKLVFFDISNNKLT 343
+ S + L KL +S N ++
Sbjct: 164 QIS-DIV-PLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 2e-14
Identities = 44/209 (21%), Positives = 78/209 (37%), Gaps = 15/209 (7%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
+ L ++ L L + + + L +L +L L N + + + + KL++L L
Sbjct: 61 IQYLPNVTKLFLNGNKL-TDIKP-LTNLKNLGWLFLDENKI-KDLSS-LKDLKKLKSLSL 116
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
+ N ++ I LP L L + NNK+ + + R++ L L L N IS + L
Sbjct: 117 EHNGISD-ING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIVPL 171
Query: 234 SSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIP---KQYGQLNQLQQLD 288
+ L L L LS N + L L L + L + + N ++ D
Sbjct: 172 AGLTKLQNLYLSKNHISDLRALAGLKN-LDVLELFSQECLNKPINHQSNLVVPNTVKNTD 230
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNK 317
S + + PN+
Sbjct: 231 GSLVTPEIISDDGDYEKPNVKWHLPEFTN 259
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 36/175 (20%), Positives = 73/175 (41%), Gaps = 31/175 (17%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSKKYTVRNLKLRLDLLA---- 534
N + I+GEG +G + +G L VA++ + K + + + L+
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM----KLDNSSQREIEEFLSEAAC 89
Query: 535 --KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN---TPGKVLNW 589
HP+++ LLG CI+ + + K ++ FM G+ T++ + T K +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQ---GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 590 SERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
L ++ +A +++L N + N +L + ++D+GLS
Sbjct: 147 QTLLKFMVDIALGMEYLSN-------RNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 36/163 (22%), Positives = 65/163 (39%), Gaps = 27/163 (16%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPN-WFDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215
+P I L L++N F F LP L ++ NNK+ + + S
Sbjct: 25 KIPEHIPQYT--AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 216 LSDLDLSKNAISGSLP--DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE 273
++++ L+ N + ++ L SL L L N++ + SF G
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC----VGND---------SFIG- 127
Query: 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
L+ ++ L + N + + P A +L ++S LNL +N
Sbjct: 128 -------LSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 5/115 (4%)
Query: 139 HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197
+L L ++ S+N + + + ++L N N F L SL L +
Sbjct: 54 KKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112
Query: 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
R+N++ S +S++ L L N I+ ++ +L SL+ LNL N +
Sbjct: 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 21/136 (15%), Positives = 48/136 (35%), Gaps = 31/136 (22%)
Query: 214 STLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271
++L L+ N + L L +N S+NK+ + +F
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-------------IEEGAFE 78
Query: 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK----NLN 327
G + + ++ ++ N L + L ++ L L SN+ + + L+
Sbjct: 79 G--------ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLS 129
Query: 328 CGGKLVFFDISNNKLT 343
+ + +N++T
Sbjct: 130 ---SVRLLSLYDNQIT 142
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 49/224 (21%), Positives = 84/224 (37%), Gaps = 18/224 (8%)
Query: 120 LRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179
+ + + +L +L LD ++ + + I + L LI N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNI- 76
Query: 180 NTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSL 239
T+ +LT+L+ +NKL + ++ L+ L+ N ++ D+S L
Sbjct: 77 TTLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL--DVSQNPLL 129
Query: 240 NVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP 299
LN + N L L N ++ QL LD SFN + +
Sbjct: 130 TYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELD- 186
Query: 300 PAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
+ ++ LN +N + L N N +L F D S+NKLT
Sbjct: 187 --VSQNKLLNRLNCDTNNIT-KLDLNQN--IQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 39/231 (16%), Positives = 83/231 (35%), Gaps = 22/231 (9%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLI 172
+++ L L+ + I L +++ L +LD SSN L + ++ + +L
Sbjct: 186 DVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKL-TEID--VTPLTQLTYFD 239
Query: 173 LDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
N + +L LT L L + + L L D
Sbjct: 240 CSVNPLT-ELDVS--TLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL-D 292
Query: 233 LSSLGSLNVLNLSDNKLDS-NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSF 291
++ L +L+ + +L + P+ LV +L+N + E+ +L+ L
Sbjct: 293 VTHNTQLYLLDCQAAGITELDLSQNPK-LVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 292 NALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKL 342
++ + +P +++ A + ++PK L +S + L
Sbjct: 349 AHIQDFSS--VGKIPALNNNFEAEGQTI-TMPKETLTNNSLT-IAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 30/179 (16%), Positives = 55/179 (30%), Gaps = 57/179 (31%)
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
FN+ P+ D+ S + S ++++TL+ LD ++I+ + +
Sbjct: 7 QTQSFNDWFPD--DNFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTGI 60
Query: 234 SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNA 293
L L L + N + + L LS N+ L L N
Sbjct: 61 EKLTGLTKLICTSNNI-TTLD----------LSQNT-------------NLTYLACDSN- 95
Query: 294 LRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
+++L++ KL + + NKLT S
Sbjct: 96 -------------KLTNLDVTPLT-------------KLTYLNCDTNKLTKLDVSQNPL 128
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 38/235 (16%), Positives = 77/235 (32%), Gaps = 54/235 (22%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILD 174
S + L L+ + ++P L ++ + +S + + + K+ + +
Sbjct: 30 PPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 175 DNFFNNTIP-NWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
+ I + LP L FL + N L PDL
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-------------------------MFPDL 123
Query: 234 SSLGSLN---VLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMS 290
+ + S + +L ++DN +++P N+F G N+ L +
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIP------------VNAFQ-------GLCNETLTLKLY 164
Query: 291 FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNL--NCGGKLVFFDISNNKLT 343
N + A F+ + + L NK+ + K+ D+S +T
Sbjct: 165 NNGFTSVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 31/176 (17%), Positives = 68/176 (38%), Gaps = 26/176 (14%)
Query: 101 LSENFSIDSF-VTTLARLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSV 158
+S + ++ + L+ + + + + + L L++L + + L
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMF 120
Query: 159 PP--KISTMVKLQTLILDDNFFNNTIP-NWFDSLPSLTF-LSMRNNKLAGPFPSSIQ--- 211
P K+ + L + DN + +IP N F L + T L + NN +S+Q
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-----TSVQGYA 175
Query: 212 -RISTLSDLDLSKNAISGSLPD--LSSLGS-LNVLNLSDNKLDS-------NLPKL 256
+ L + L+KN + + S ++L++S + + +L +L
Sbjct: 176 FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 17/108 (15%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 242 LNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQ-YGQLNQLQQLDMSFN-ALRGMPP 299
++ + +P LP L IP + L + ++ +S + L+ +
Sbjct: 16 FRVTCKDIQR-IPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLES 73
Query: 300 PAIFSLPNISDLNLASNKFSGSLP----KNLNCGGKLVFFDISNNKLT 343
+ ++L ++ + + + + + K L L F I N L
Sbjct: 74 HSFYNLSKVTHIEIRNTRNLTYIDPDALKELP---LLKFLGIFNTGLK 118
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 7e-15
Identities = 62/394 (15%), Positives = 123/394 (31%), Gaps = 73/394 (18%)
Query: 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVF- 334
+Q+ LN+ + + F L + F +L + +L
Sbjct: 199 RQFANLNREESILKFFEILSPV-------------YRFDKECFKCALGSSWIISVELAIG 245
Query: 335 --FDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQNQHPESYCFEVRTERNQAGSK 392
IS G P+ L++ + + +++ +++ AG+
Sbjct: 246 PEEGISYLTDKGANPTHLADFNQVQTIQYS-------NSEDKDRKGMLQLKI----AGAP 294
Query: 393 NVGKLVGIIVGVLVIMVLLAFGFLVVCRRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTN 452
+ + L I +A CR S K + +
Sbjct: 295 EP---LTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEK 351
Query: 453 ARYVSEAAKLGSEGLPAC---RSFTLEELKEATNNFDMSAIM-----GEGSYGKLYKGRL 504
S + A T I GEG +G +++G
Sbjct: 352 QGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIY 411
Query: 505 ENG----TSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559
+ +VAI+ + +VR L+ + + HPH+V L+G +
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--------- 462
Query: 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN-- 617
N V+++ E + G R+ + L+ + + ++ A+ +L +
Sbjct: 463 NPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLES-------KRFV 513
Query: 618 ------RVKTNNILLNEHRIAKLSDYGLSIVSED 645
R N+L++ + KL D+GLS ED
Sbjct: 514 HRDIAAR----NVLVSSNDCVKLGDFGLSRYMED 543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 27/171 (15%), Positives = 65/171 (38%), Gaps = 22/171 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENG----TSVAIRCLP--SSKKYTVRNLKLRLDLLAKL 536
F + ++G+G +G + + +L+ VA++ L + + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP---GKVLNWSERL 593
HPH+ L+G + + + ++ FM +G+ + + L +
Sbjct: 83 DHPHVAKLVGVSLRSRAKG--RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
++ +A +++L + N + N +L E ++D+GLS
Sbjct: 141 RFMVDIACGMEYLSS-------RNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 38/163 (23%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG 546
+ +G+G +G+++ G T VAI+ L L+ ++ KLRH LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 246
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL 606
+ +++V E+MS G+ + GK L + + + +A + ++
Sbjct: 247 VVSE---------EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV 296
Query: 607 HTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
N V + NIL+ E+ + K++D+GL+ + ED
Sbjct: 297 ER-------MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 37/172 (21%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRH 538
++FD+ +G+G +G +Y R +N +A++ L S K+ L+ +++ + LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
P+++ + + D +++L+ EF G + ++ G+ E+ +
Sbjct: 74 PNILRMYNYFHDR--------KRIYLMLEFAPRGELYKELQKH--GRF---DEQRSATFM 120
Query: 599 --VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDI 646
+A A+ + H VI +R +K N+L+ K++D+G S+ + +
Sbjct: 121 EELADALHYCHERKVI-----HRDIKPENLLMGYKGELKIADFGWSVHAPSL 167
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 35/181 (19%), Positives = 68/181 (37%), Gaps = 30/181 (16%)
Query: 474 TLEELKEATNNFDMSAI-----MGEGSYGKLYKGRL----ENGTSVAIRCL-PSSKKYTV 523
++ ++ + +G G +G +Y G L A++ L + V
Sbjct: 75 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 134
Query: 524 RNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP 583
++ HP+++ LLG C+ G +V +M +G+ R I T
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEG-------SPLVVLPYMKHGDLRNFIRNETH 187
Query: 584 GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGL 639
+ + + VAK ++FL + V N +L+E K++D+GL
Sbjct: 188 N--PTVKDLIGFGLQVAKGMKFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 640 S 640
+
Sbjct: 239 A 239
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 26/174 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLR 537
N + ++G G +G++ GRL + SVAI+ L + R+ ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
HP+++ L G V +V E+M NG+ + + ++ + + +L
Sbjct: 105 HPNIIRLEGVVTKS--------KPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLR 154
Query: 598 GVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSEDIN 647
G+A +++L V NIL+N + + K+SD+GL V ED
Sbjct: 155 GIASGMKYLSD-------MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 32/182 (17%), Positives = 67/182 (36%), Gaps = 45/182 (24%)
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSKKYTVRNLKLRLDL 532
+ E + + +G+GS+G + +G SVA++CL K + + D
Sbjct: 14 LIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEAMDDF 68
Query: 533 L------AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----T 582
+ L H +L+ L G + + +V E G+ + ++
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLT---------PPMKMVTELAPLGSLLDRLRKHQGHFL 119
Query: 583 PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYG 638
G + ++ + VA+ + +L + + N+LL + K+ D+G
Sbjct: 120 LGTLSRYA------VQVAEGMGYLES-------KRFIHRDLAARNLLLATRDLVKIGDFG 166
Query: 639 LS 640
L
Sbjct: 167 LM 168
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 34/165 (20%), Positives = 68/165 (41%), Gaps = 32/165 (19%)
Query: 490 IMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHC 548
+G G +G+++ G T VA++ L + L +L+ +L+H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT 608
++++ E+M NG+ + G L ++ L + +A+ + F+
Sbjct: 78 TQ---------EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 609 GVIPGFFNN--------RVKTNNILLNEHRIAKLSDYGLSIVSED 645
N NIL+++ K++D+GL+ + ED
Sbjct: 128 -------RNYIHRDLRAA----NILVSDTLSCKIADFGLARLIED 161
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 39/168 (23%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 487 MSAIMGEGSYGKLYKGRL----ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHL 541
+ I+G G G++ GRL + VAI+ L + R+ ++ + HP++
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
+ L G G +V E+M NG+ T + + + + +L GV
Sbjct: 113 IRLEGVVTRG--------RLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGA 162
Query: 602 AVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
+++L V N+L++ + + K+SD+GLS V ED
Sbjct: 163 GMRYLSD-------LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 37/169 (21%), Positives = 76/169 (44%), Gaps = 24/169 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENG-TSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPH 540
+ M +G G YG++Y+G + +VA++ L L+ ++ +++HP+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPN 70
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
LV LLG C +++ EFM+ GN ++ E + ++ L + ++
Sbjct: 71 LVQLLGVCTREP--------PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQIS 121
Query: 601 KAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
A+++L N + N L+ E+ + K++D+GLS +
Sbjct: 122 SAMEYLEK-------KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 32/160 (20%)
Query: 492 GEGSYGKLYKGRLENG---TSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGH 547
G G++G + +G VAI+ L + +R ++ +L +P++V L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL- 606
C + LV E G + + + S +L V+ +++L
Sbjct: 79 CQA---------EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE 127
Query: 607 -----HTGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
H R + N+LL AK+SD+GLS
Sbjct: 128 EKNFVH----------RDLAARNVLLVNRHYAKISDFGLS 157
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 35/176 (19%), Positives = 68/176 (38%), Gaps = 33/176 (18%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENG------TSVAIRCLPSSKKYTVRNLKLR-LDLLAK 535
MS +G+GS+G +Y+G + T VAI+ + + R L ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNF-------RTHISENTPGKVLN 588
H+V LLG G ++ E M+ G+ R ++ N +
Sbjct: 85 FNCHHVVRLLGVVSQGQ--------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 589 WSERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
S+ + + +A + +L+ N V N ++ E K+ D+G++
Sbjct: 137 LSKMIQMAGEIADGMAYLNA-------NKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 38/169 (22%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPH 540
+ + +S I+G+G+ +++GR + G AI+ + ++++R ++L KL H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V L + L+ EF G+ T + E + L SE L VL V
Sbjct: 69 IVKLF-AIEEETTTRHK-----VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 601 KAVQFLHTGVIPGFFNNRV-----KTNNILL----NEHRIAKLSDYGLS 640
+ L N + K NI+ + + KL+D+G +
Sbjct: 123 GGMNHLR--------ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 30/158 (18%), Positives = 65/158 (41%), Gaps = 22/158 (13%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551
G G +G+++ T VA++ + +V +++ L+H LV L
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 254
Query: 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVI 611
++++ EFM+ G+ + + G + + +A+ + F+
Sbjct: 255 --------EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ--- 302
Query: 612 PGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
N + + NIL++ + K++D+GL+ V ED
Sbjct: 303 ----RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 37/168 (22%), Positives = 75/168 (44%), Gaps = 22/168 (13%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLEN-GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+ M +G G YG++Y+G + +VA++ L V ++ +++HP+L
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNL 278
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
V LLG C +++ EFM+ GN ++ E + ++ L + ++
Sbjct: 279 VQLLGVCTREP--------PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISS 329
Query: 602 AVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
A+++L N + N L+ E+ + K++D+GLS +
Sbjct: 330 AMEYLEK-------KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 31/163 (19%), Positives = 66/163 (40%), Gaps = 25/163 (15%)
Query: 487 MSAIMGEGSYGKLYKGRL----ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHL 541
++G+G +G +Y G +N AI+ L ++ V L+ L HP++
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
+ L+G + G ++ +M +G+ I + + ++ + VA+
Sbjct: 85 LALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVAR 135
Query: 602 AVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
+++L V N +L+E K++D+GL+
Sbjct: 136 GMEYLAE-------QKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 38/163 (23%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG 546
+ +G+G +G+++ G T VAI+ L L+ ++ KLRH LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYA 329
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL 606
+ +++V E+MS G+ + GK L + + + +A + ++
Sbjct: 330 VVSE---------EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV 379
Query: 607 HTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
N V + NIL+ E+ + K++D+GL+ + ED
Sbjct: 380 ER-------MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 38/176 (21%), Positives = 73/176 (41%), Gaps = 27/176 (15%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGT-----SVAIRCL-PSSKKYTVRNLKLRLDLLAKL 536
+ ++G G +G++YKG L+ + VAI+ L + + ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
H +++ L G + ++ E+M NG + E + + + +L
Sbjct: 104 SHHNIIRLEGVISKY--------KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGML 153
Query: 597 IGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSEDINS 648
G+A +++L N V NIL+N + + K+SD+GLS V ED
Sbjct: 154 RGIAAGMKYLAN-------MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 41/184 (22%), Positives = 73/184 (39%), Gaps = 46/184 (25%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLKLR 529
L LKE F ++G G++G +YKG + VAI+ L + L
Sbjct: 9 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 530 -LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----TPG 584
++A + +PH+ LLG C+ + V L+ + M G ++ E+
Sbjct: 67 EAYVMASVDNPHVCRLLGICLT---------STVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN--------RVKTNNILLNEHRIAKLSD 636
+LNW + +AK + +L R N+L+ + K++D
Sbjct: 118 YLLNWC------VQIAKGMNYLED-------RRLVHRDLAAR----NVLVKTPQHVKITD 160
Query: 637 YGLS 640
+GL+
Sbjct: 161 FGLA 164
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 37/171 (21%)
Query: 492 GEGSYGKLYKGRLENG------TSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLL 545
GEG++GK++ N VA++ L + + ++ + +LL L+H H+V
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP------------GKVLNWSERL 593
G C +G + +V+E+M +G+ + + P L + L
Sbjct: 110 GVCTEGR--------PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
AV VA + +L + V T N L+ + + K+ D+G+S
Sbjct: 162 AVASQVAAGMVYLAG-------LHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 35/217 (16%), Positives = 70/217 (32%), Gaps = 33/217 (15%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDN 176
+ L V + LE +++S N + + + S + KL + ++
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 177 FFNNTI----PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
N + P F +LP+L +L + N + LD+ N ++
Sbjct: 90 ---NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 233 LSSLG---SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289
S +G +L L+ N + + N++F+G +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQE-------------IHNSAFNG--------TQLDELNLS 185
Query: 290 SFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNL 326
N L +P L+++ + SLP
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 33/164 (20%), Positives = 50/164 (30%), Gaps = 12/164 (7%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIH-RLYSLEYLDLSSNFLFGSVPPKIST--MVKLQ 169
L +L+ L + + GI LPD LD+ N ++ +
Sbjct: 99 AFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 157
Query: 170 TLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAIS-- 227
L L+ N + F+ NN L S LD+S+ I
Sbjct: 158 ILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217
Query: 228 --GSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNS 269
L +L L + + NL L L A L+ S
Sbjct: 218 PSYGLENLKKLRARSTYNLKKLPTLEKLVALME----ASLTYPS 257
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 29/169 (17%), Positives = 70/169 (41%), Gaps = 19/169 (11%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP-SSKKYTVRNLKLRLDLLAKLRHPH 540
+F+ +G G +G +++ + + + AI+ + +++ + + LAKL HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 541 LVCLLGHCIDGGGRDDYAVNK----VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
+V ++ + + +++ + N + ++ + S L +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 597 IGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ +A+AV+FLH + + K +NI + K+ D+GL
Sbjct: 125 LQIAEAVEFLH--------SKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 42/238 (17%), Positives = 82/238 (34%), Gaps = 23/238 (9%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
V L + +L + + L ++ + ++ + + L+
Sbjct: 12 VFPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKE 67
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIS--TLSDLDLSKNAISG 228
L L N ++ P L L LS+ N+L ++ I LS L L N +
Sbjct: 68 LHLSHNQISDLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELR- 119
Query: 229 SLPDLSSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQ 286
L L +L +L++ +NKL L L + L + L N + +L ++
Sbjct: 120 DTDSLIHLKNLEILSIRNNKLKSIVMLGFLSK-LEVLDLHGNEITNTGGLT--RLKKVNW 176
Query: 287 LDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSL-PKNLNCGGKLVFFDISNNKLT 343
+D++ P + P + N + + P ++ GG V +
Sbjct: 177 IDLTGQKCVNEP---VKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 8e-14
Identities = 38/169 (22%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPH 540
+ + +S I+G+G+ +++GR + G AI+ + ++++R ++L KL H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V L + L+ EF G+ T + E + L SE L VL V
Sbjct: 69 IVKLF-AIEEETTTRHK-----VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 601 KAVQFLHTGVIPGFFNNRV-----KTNNILL----NEHRIAKLSDYGLS 640
+ L N + K NI+ + + KL+D+G +
Sbjct: 123 GGMNHLR--------ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 28/171 (16%), Positives = 67/171 (39%), Gaps = 35/171 (20%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIR--CLPSSKKYTVRNLKLRLDLLAKLRHP 539
+ +GEGS+GK + E+G I+ + + + +LA ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG-----KVLNWSERLA 594
++V + +++V ++ G+ I+ ++L+W
Sbjct: 84 NIVQYRESFEEN--------GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW----- 130
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ + A++ +H + ++ K+ NI L + +L D+G++
Sbjct: 131 -FVQICLALKHVH--------DRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 38/169 (22%), Positives = 74/169 (43%), Gaps = 21/169 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+F ++G G +G+++K + +G + I+ + + + R +K LAKL H ++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA----LAKLDHVNI 66
Query: 542 VCLLGHCIDGGGRDDYAV--------NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
V G + + +F+ EF G I + G+ L+ L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLAL 125
Query: 594 AVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ + K V ++H+ +I NR +K +NI L + + K+ D+GL
Sbjct: 126 ELFEQITKGVDYIHSKKLI-----NRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 35/184 (19%), Positives = 69/184 (37%), Gaps = 50/184 (27%)
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLKLRLD 531
KE ++G G +G ++KG V I+ + ++ + D
Sbjct: 9 IFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64
Query: 532 ---LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----TPG 584
+ L H H+V LLG C + + LV +++ G+ H+ ++ P
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPG---------SSLQLVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN--------RVKTNNILLNEHRIAKLSD 636
+LNW + +AK + +L + R N+LL +++D
Sbjct: 116 LLLNWG------VQIAKGMYYLEE-------HGMVHRNLAAR----NVLLKSPSQVQVAD 158
Query: 637 YGLS 640
+G++
Sbjct: 159 FGVA 162
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 1e-13
Identities = 36/169 (21%), Positives = 70/169 (41%), Gaps = 14/169 (8%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVR-NLKLRLDLLAKL 536
+ ++M +G G +G + + + G VAI+ R L + ++ KL
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
HP++V DG + + L E+ G+ R ++++ L +L
Sbjct: 70 NHPNVVSAR-EVPDGL-QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 597 IGVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLS 640
++ A+++LH +I R +K NI+L + I K+ D G +
Sbjct: 128 SDISSALRYLHENRIIH-----RDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 36/172 (20%), Positives = 73/172 (42%), Gaps = 27/172 (15%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENG----TSVAIRCLPSSKKYTVRNLKLR-LDLLAKLR 537
++ +GEG +G +++G + +VAI+ + +VR L+ + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
HPH+V L+G + N V+++ E + G R+ + L+ + +
Sbjct: 75 HPHIVKLIGVITE---------NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAY 123
Query: 598 GVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLSIVSED 645
++ A+ +L + V N+L++ + KL D+GLS ED
Sbjct: 124 QLSTALAYLES-------KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 37/172 (21%), Positives = 70/172 (40%), Gaps = 38/172 (22%)
Query: 492 GEGSYGKLYKGRLENG------TSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLL 545
GEG++GK++ N VA++ L ++ + +LL L+H H+V
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSER 592
G C DG + +V+E+M +G+ + + P L S+
Sbjct: 84 GVCGDGD--------PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 593 LAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS 640
L + +A + +L + + V T N L+ + + K+ D+G+S
Sbjct: 136 LHIASQIASGMVYLAS-------QHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 37/186 (19%), Positives = 76/186 (40%), Gaps = 42/186 (22%)
Query: 474 TLEELKEATNNFDMSAIM------GEGSYGKLYKGRLENG---TSVAIRCL-PSSKKYTV 523
LEE++ D + G G++G + KG + +VA++ L + +
Sbjct: 2 ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 61
Query: 524 RNLKLR-LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT 582
++ L +++ +L +P++V ++G C LV E G ++ +N
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGICEA---------ESWMLVMEMAELGPLNKYLQQN- 111
Query: 583 PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNN--------RVKTNNILLNEHRIAKL 634
+ + + ++ V+ +++L +N R N+LL AK+
Sbjct: 112 --RHVKDKNIIELVHQVSMGMKYLEE-------SNFVHRDLAAR----NVLLVTQHYAKI 158
Query: 635 SDYGLS 640
SD+GLS
Sbjct: 159 SDFGLS 164
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 43/174 (24%)
Query: 492 GEGSYGKLYKGRLENG---TSVAIRCL-PSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLG 546
GEG++G++ K R++ AI+ + + K R+ L++L KL HP+++ LLG
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 93
Query: 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRT-------------HISENTPGKVLNWSERL 593
C G ++L E+ +GN N+ L+ + L
Sbjct: 94 ACEHRG--------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 594 AVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
VA+ + +L H R + NIL+ E+ +AK++D+GLS
Sbjct: 146 HFAADVARGMDYLSQKQFIH----------RDLAARNILVGENYVAKIADFGLS 189
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 38/180 (21%), Positives = 75/180 (41%), Gaps = 41/180 (22%)
Query: 492 GEGSYGKLYKGRLENG------TSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHLVCL 544
GE +GK+YKG L +VAI+ L ++ + L A+L+HP++VCL
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSE 591
LG + +++ + S+G+ + +P L +
Sbjct: 78 LGVVTKDQ--------PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 592 RLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKLSDYGLS--IVSED 645
+ ++ +A +++L + ++ V T N+L+ + K+SD GL + + D
Sbjct: 130 FVHLVAQIAAGMEYLSS-------HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 32/160 (20%)
Query: 492 GEGSYGKLYKGRLENG---TSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGH 547
G G++G + +G VAI+ L + +R ++ +L +P++V L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL- 606
C + LV E G + + + S +L V+ +++L
Sbjct: 405 CQA---------EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE 453
Query: 607 -----HTGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
H R + N+LL AK+SD+GLS
Sbjct: 454 EKNFVH----------RNLAARNVLLVNRHYAKISDFGLS 483
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 44/245 (17%), Positives = 91/245 (37%), Gaps = 45/245 (18%)
Query: 420 RRYCPRCTSEQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELK 479
+ + ++L + + + L+ R + A ++ ++ +LK
Sbjct: 8 HHHDYDIPTTENLYFQGAMGSELQSPEYK-LSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 480 E-ATNNFDMSAIMGEGSYGKLYKGRLENG------TSVAIRCLPSSKKYTVRNLKLRLDL 532
E N + +G G++G++Y+G++ VA++ LP + + LD
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-----CSEQDELDF 121
Query: 533 L------AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNF----RTHISENT 582
L +K H ++V +G + F++ E M+ G+ R +
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSL--------PRFILLELMAGGDLKSFLRETRPRPS 173
Query: 583 PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLN---EHRIAKLS 635
L + L V +A Q+L N+ + N LL R+AK+
Sbjct: 174 QPSSLAMLDLLHVARDIACGCQYLEE-------NHFIHRDIAARNCLLTCPGPGRVAKIG 226
Query: 636 DYGLS 640
D+G++
Sbjct: 227 DFGMA 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 35/194 (18%), Positives = 76/194 (39%), Gaps = 54/194 (27%)
Query: 467 LPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRN 525
P C + ++ A +G+G++G+++K R + G VA++
Sbjct: 10 CPFCDE---------VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK------------ 48
Query: 526 LKLRLD---------------LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMS 570
K+ ++ +L L+H ++V L+ C + ++LV++F
Sbjct: 49 -KVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE 107
Query: 571 NGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNIL 625
+ + +S SE V+ + + ++H N++ K N+L
Sbjct: 108 H-DLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH--------RNKILHRDMKAANVL 156
Query: 626 LNEHRIAKLSDYGL 639
+ + KL+D+GL
Sbjct: 157 ITRDGVLKLADFGL 170
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 16/228 (7%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
+ L ++ L L + + + L +L +L L N + + + KL++L L
Sbjct: 64 IQYLPNVTKLFLNGNKL-TDIKP-LANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSL 119
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
+ N ++ I LP L L + NNK+ + + R++ L L L N IS + L
Sbjct: 120 EHNGISD-ING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DIVPL 174
Query: 234 SSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNN---SFSGEIPKQYGQLNQLQQLD 288
+ L L L LS N + L L L + L + + N ++ D
Sbjct: 175 AGLTKLQNLYLSKNHISDLRALAGLKN-LDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 289 MSFNALRGMPPPAIFSLPNIS-DLNLASNKFSGSLPKNLNCGGKLVFF 335
S + + PN+ L +N+ S + + G F
Sbjct: 234 GSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 281
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 37/172 (21%), Positives = 67/172 (38%), Gaps = 35/172 (20%)
Query: 487 MSAIMGEGSYGKLYKGRLENG----TSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHL 541
++ I+GEG +G++Y+G N +VA++ + + ++ L HPH+
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
V L+G + +++ E G ++ N L + + + K
Sbjct: 76 VKLIGIIEE---------EPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICK 124
Query: 602 AVQFLHTGVIPGFFNN--------RVKTNNILLNEHRIAKLSDYGLSIVSED 645
A+ +L + N R NIL+ KL D+GLS ED
Sbjct: 125 AMAYLES-------INCVHRDIAVR----NILVASPECVKLGDFGLSRYIED 165
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 36/169 (21%), Positives = 65/169 (38%), Gaps = 28/169 (16%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVA---IRCLPSSKKYTVRNLKLRLDLLAKLRH 538
NF + +G G + ++Y+ L +G VA ++ + +DLL +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER--LAVL 596
P+++ I+ N++ +V E G+ I K L ER
Sbjct: 92 PNVIKYYASFIED--------NELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYF 142
Query: 597 IGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ + A++ +H + RV K N+ + + KL D GL
Sbjct: 143 VQLCSALEHMH--------SRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 44/186 (23%), Positives = 74/186 (39%), Gaps = 43/186 (23%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL--------ENGTSVAIRCLPSSKKYTVRNLKLRLDLLA 534
+ + +G+G++ K++KG + T V ++ L + + + +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
KL H HLV G C+ G ++ LV EF+ G+ T++ +N +N +L
Sbjct: 68 KLSHKHLVLNYGVCVCG--------DENILVQEFVKFGSLDTYLKKN--KNCINILWKLE 117
Query: 595 VLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLN--------EHRIAKLSDYGL 639
V +A A+ FL H V NILL KLSD G+
Sbjct: 118 VAKQLAAAMHFLEENTLIH----------GNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 640 SIVSED 645
SI
Sbjct: 168 SITVLP 173
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 47/170 (27%), Positives = 67/170 (39%), Gaps = 18/170 (10%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216
SVP I + L L F L LT+L++ N+L ++ L
Sbjct: 28 SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 217 SDLDLSKNAISGSLPDL--SSLGSLNVLNLSDNKLDSNLPKLPRG-------LVMAFLSN 267
L L+ N ++ SLP L L+ L L N+L S LP G L L+
Sbjct: 86 GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS----LPSGVFDRLTKLKELRLNT 140
Query: 268 NSFSGEIPK-QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
N IP + +L LQ L +S N L+ +P A L + + L N
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 42/161 (26%), Positives = 64/161 (39%), Gaps = 16/161 (9%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDN 176
L L S G+ L L +L+L N L ++ + + +L TL L +N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANN 93
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LS 234
+ FD L L L + N+L R++ L +L L+ N + S+P
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 235 SLGSLNVLNLSDNKLDSNLPKLPRG-------LVMAFLSNN 268
L +L L+LS N+L S +P G L L N
Sbjct: 153 KLTNLQTLSLSTNQLQS----VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 33/111 (29%), Positives = 49/111 (44%), Gaps = 4/111 (3%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLIL 173
LT L L L + + SLP + L L+ L L N L S+P + + KL+ L L
Sbjct: 81 DLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRL 138
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKN 224
+ N + FD L +L LS+ N+L + R+ L + L N
Sbjct: 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 37/181 (20%), Positives = 69/181 (38%), Gaps = 43/181 (23%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENG------TSVAIRCLPSSKKYTVRNLKLRLDLLA-- 534
N + +G G++G++Y+G++ VA++ LP + + LD L
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-----CSEQDELDFLMEA 84
Query: 535 ----KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNF----RTHISENTPGKV 586
K H ++V +G + F++ E M+ G+ R +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSL--------PRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 587 LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLN---EHRIAKLSDYGL 639
L + L V +A Q+L N+ + N LL R+AK+ D+G+
Sbjct: 137 LAMLDLLHVARDIACGCQYLEE-------NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 640 S 640
+
Sbjct: 190 A 190
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLL 533
L L++ F++ ++G G+YG++YKGR ++ G AI+ + + +K +++L
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINML 74
Query: 534 AKL-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
K H ++ G I ++++LV EF G+ + +NT G L
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGM--DDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131
Query: 593 LAVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ + + + LH VI +R +K N+LL E+ KL D+G+S
Sbjct: 132 AYICREILRGLSHLHQHKVI-----HRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 37/159 (23%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVC 543
+++ +G+G++GK+YK + E G A + + + + + + + +++LA HP++V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
LLG K++++ EF G I L + V + +A+
Sbjct: 81 LLGAYYHD--------GKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVVCRQMLEAL 130
Query: 604 QFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
FLH+ +I +R +K N+L+ +L+D+G+S
Sbjct: 131 NFLHSKRII-----HRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 48/166 (28%), Positives = 65/166 (39%), Gaps = 35/166 (21%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQR 212
SVP I T Q L L DN P FDSL +L L + +N+L G F
Sbjct: 33 SVPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF----DS 86
Query: 213 ISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSF 270
++ L+ LDL N ++ LP L L L + NKL LPRG
Sbjct: 87 LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE----LPRG----------- 130
Query: 271 SGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
+L L L + N L+ +P A L +++ L N
Sbjct: 131 -------IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 41/133 (30%), Positives = 59/133 (44%), Gaps = 6/133 (4%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDN 176
T+ ++L L I P L +L+ L L SN L G++P + ++ +L L L N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTN 98
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LS 234
FD L L L M NKL P I+R++ L+ L L +N + S+P
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFD 156
Query: 235 SLGSLNVLNLSDN 247
L SL L N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
G+G+YG +Y GR L N +AI+ +P + L + L L+H ++V LG +
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE 90
Query: 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA------VLIGVAKAVQ 604
+ + E + G+ + + G L +E+ +L G+
Sbjct: 91 N--------GFIKIFMEQVPGGSLSA-LLRSKWGP-LKDNEQTIGFYTKQILEGLK---- 136
Query: 605 FLHT-GVIPGFFNNR-VKTNNILLNEHR-IAKLSDYGLSIVSEDINS 648
+LH ++ +R +K +N+L+N + + K+SD+G S IN
Sbjct: 137 YLHDNQIV-----HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 37/168 (22%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHP 539
++++ +G GSYG+ K R +G + + L + + L ++LL +L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER--LAVLI 597
++V ID +++V E+ G+ + I++ T + E L V+
Sbjct: 66 NIVRYYDRIIDRTN------TTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMT 118
Query: 598 GVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ A++ H + V K N+ L+ + KL D+GL+
Sbjct: 119 QLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 47/276 (17%), Positives = 86/276 (31%), Gaps = 10/276 (3%)
Query: 43 YPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNVGNF-DGFASANASL 101
+ +W+ Q K + A+
Sbjct: 293 RNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLF 352
Query: 102 SENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPK 161
S++ + L S + L + L I + +L+ L L K
Sbjct: 353 RCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412
Query: 162 ISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDL 221
++ L + F + L + + L ++++ ++ LDL
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDL 470
Query: 222 SKNAISGSLPDLSSLGSLNVLNLSDNKLDS--NLPKLPRGLVMAFLSNNSFSG-EIPKQY 278
S N + P L++L L VL SDN L++ + LPR L L NN +
Sbjct: 471 SHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPR-LQELLLCNNRLQQSAAIQPL 529
Query: 279 GQLNQLQQLDMSFNALRGMPPP---AIFSLPNISDL 311
+L L++ N+L LP++S +
Sbjct: 530 VSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 2e-05
Identities = 26/161 (16%), Positives = 54/161 (33%), Gaps = 9/161 (5%)
Query: 186 FDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLS 245
+ L + K S ++ L +L+ ++ + + +L+ L
Sbjct: 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI--ILLMRALDPLLYE 401
Query: 246 DNKLD--SNLPKL-PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302
L S L + P + F E + ++ L ++ L + +
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--L 459
Query: 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343
L ++ L+L+ N+ +LP L L S+N L
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 28/188 (14%), Positives = 69/188 (36%), Gaps = 39/188 (20%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLD----------- 531
N++ + + +G + K+ ++ A++ S R+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 532 ------LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN---T 582
++ +++ + + G + ++V+++YE+M N +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY--------DEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 583 PGKVLNWSERLAVLI--GVAKAVQFLHT--GVIPGFFNNR-VKTNNILLNEHRIAKLSDY 637
++ I V + ++H + +R VK +NIL++++ KLSD+
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC-----HRDVKPSNILMDKNGRVKLSDF 196
Query: 638 GLSIVSED 645
G S D
Sbjct: 197 GESEYMVD 204
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 27/166 (16%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAI-RCLPSSKKYTVRNLKLR-LDLLAKLRHP 539
++ ++GEGSYG + K R + G VAI + L S V+ + +R + LL +LRH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
+LV LL C + +LV+EF+ + + G L++ L +
Sbjct: 85 NLVNLLEVCKKK--------KRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQI 133
Query: 600 AKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ F H ++ + K NIL+++ + KL D+G +
Sbjct: 134 INGIGFCH--------SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 44/192 (22%)
Query: 466 GLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAI------------ 512
G + T+ ++ A +G G+YG +YK R +G VA+
Sbjct: 1 GPLGSMA---------TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG 51
Query: 513 RCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG 572
LP S TVR + L L L HP++V L+ C + KV LV+E +
Sbjct: 52 GGLPIS---TVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDRE---IKVTLVFEHVDQ- 103
Query: 573 NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLN 627
+ RT++ + P L ++ + + FLH N + K NIL+
Sbjct: 104 DLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH--------ANCIVHRDLKPENILVT 154
Query: 628 EHRIAKLSDYGL 639
KL+D+GL
Sbjct: 155 SGGTVKLADFGL 166
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 28/158 (17%), Positives = 63/158 (39%), Gaps = 30/158 (18%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLP--SSKKYTVRNLKLRLDLLAKLRHP--HLVCLLGH 547
G G K+++ E AI+ + + T+ + + + L KL+ ++ L +
Sbjct: 37 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
I +++V E N + + + + K ++ ER + + +AV +H
Sbjct: 97 EITD--------QYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH 144
Query: 608 TGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ + K N L+ + + KL D+G++
Sbjct: 145 --------QHGIVHSDLKPANFLIVDGML-KLIDFGIA 173
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 40/196 (20%), Positives = 73/196 (37%), Gaps = 56/196 (28%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKLRLDLL--A 534
NN +G G++GK+ + + VA++ L S+ + + L+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-----AHADEKEALMSEL 100
Query: 535 KL-----RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT-----------HI 578
K+ +H ++V LLG C GG V ++ E+ G+
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGG--------PVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 579 SENTPGKVLNWSERLAVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEHRI 631
+ + + L VA+ + FL H R V N+LL +
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH----------RDVAARNVLLTNGHV 202
Query: 632 AKLSDYGLS--IVSED 645
AK+ D+GL+ I+++
Sbjct: 203 AKIGDFGLARDIMNDS 218
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 33/187 (17%), Positives = 80/187 (42%), Gaps = 50/187 (26%)
Query: 492 GEGSYGKLYKGRL--------ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKL-RHPHL 541
GEG +G++ + +VA++ L + + + +L ++++ + +H ++
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH-------------ISENTPGKVLN 588
+ LLG C G ++++ E+ S GN R + P + +
Sbjct: 150 INLLGACTQDG--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 589 WSERLAVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS- 640
+ + ++ +A+ +++L H R + N+L+ E+ + K++D+GL+
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIH----------RDLAARNVLVTENNVMKIADFGLAR 251
Query: 641 -IVSEDI 646
I + D
Sbjct: 252 DINNIDY 258
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 39/175 (22%), Positives = 84/175 (48%), Gaps = 26/175 (14%)
Query: 475 LEELKEATNNFDMSAI------MGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLK 527
LE+L+ + D +G+G+ G +Y + G VAIR + ++ +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 528 LRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
+ ++ + ++P++V L + G +++++V E+++ G+ ++E +
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTETC----M 113
Query: 588 NWSERLAVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ + AV +A++FLH+ VI +R +K++NILL KL+D+G
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVI-----HRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 28/158 (17%), Positives = 63/158 (39%), Gaps = 30/158 (18%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLP--SSKKYTVRNLKLRLDLLAKLRHP--HLVCLLGH 547
G G K+++ E AI+ + + T+ + + + L KL+ ++ L +
Sbjct: 18 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
I +++V E N + + + + K ++ ER + + +AV +H
Sbjct: 78 EITD--------QYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH 125
Query: 608 TGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ + K N L+ + + KL D+G++
Sbjct: 126 --------QHGIVHSDLKPANFLIVDGML-KLIDFGIA 154
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 34/152 (22%), Positives = 64/152 (42%), Gaps = 6/152 (3%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCI 549
EG + +Y+ + + +G A++ L S+++ R + + + KL HP++V
Sbjct: 37 AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96
Query: 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG 609
G D + L+ E G + + L+ L + +AVQ +H
Sbjct: 97 IGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 610 VIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
P +R +K N+LL+ KL D+G +
Sbjct: 156 KPP--IIHRDLKVENLLLSNQGTIKLCDFGSA 185
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 7e-12
Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 39/171 (22%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLK-------LR-LDLL 533
++ +GEGSYG ++K R + G VAI KK+ LR + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAI------KKFLESEDDPVIKKIALREIRML 56
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
+L+HP+LV LL + R ++ LV+E+ + + + +
Sbjct: 57 KQLKHPNLVNLL----EVFRRK----RRLHLVFEYCDH-TVLHELDRY--QRGVPEHLVK 105
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGL 639
++ +AV F H + K NIL+ +H + KL D+G
Sbjct: 106 SITWQTLQAVNFCH--------KHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 9e-12
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 52/179 (29%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD---------- 531
NF +GEG+YG +YK R G VA++ K+RLD
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALK-------------KIRLDTETEGVPSTA 49
Query: 532 -----LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV 586
LL +L HP++V LL NK++LV+EF+ + + + + +
Sbjct: 50 IREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQ-DLKKFM-DASALTG 99
Query: 587 LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ + L + + + F H ++RV K N+L+N KL+D+GL+
Sbjct: 100 IPLPLIKSYLFQLLQGLAFCH--------SHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 38/177 (21%), Positives = 81/177 (45%), Gaps = 27/177 (15%)
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--KYTVRNLKLR--LD 531
+ E +F + ++G+GS+ +Y+ + G VAI+ + K + +++ +
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVK 63
Query: 532 LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
+ +L+HP ++ L + D N V+LV E NG ++ K SE
Sbjct: 64 IHCQLKHPSILELYNYFEDS--------NYVYLVLEMCHNGEMNRYLKNR--VKPF--SE 111
Query: 592 RLA--VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSE 644
A + + + +LH+ G++ +R + +N+LL + K++D+GL+ +
Sbjct: 112 NEARHFMHQIITGMLYLHSHGIL-----HRDLTLSNLLLTRNMNIKIADFGLATQLK 163
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 41/193 (21%), Positives = 75/193 (38%), Gaps = 59/193 (30%)
Query: 492 GEGSYGKLYKGRLENG------TSVAIRCLPSSKKYTVRNLKLRLDLL------AKLRHP 539
GEG++G++++ R T VA++ L + ++ D A+ +P
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----ASADMQADFQREAALMAEFDNP 110
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT---------------------HI 578
++V LLG C G + L++E+M+ G+
Sbjct: 111 NIVKLLGVCAVGK--------PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 579 SENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIAKL 634
+ L+ +E+L + VA + +L V T N L+ E+ + K+
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE-------RKFVHRDLATRNCLVGENMVVKI 215
Query: 635 SDYGLS--IVSED 645
+D+GLS I S D
Sbjct: 216 ADFGLSRNIYSAD 228
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 29/158 (18%), Positives = 63/158 (39%), Gaps = 30/158 (18%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRC--LPSSKKYTVRNLKLRLDLLAKLRHP--HLVCLLGH 547
G G K+++ E AI+ L + T+ + + + L KL+ ++ L +
Sbjct: 65 GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH 607
I +++V E N + + + + K ++ ER + + +AV +H
Sbjct: 125 EITD--------QYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH 172
Query: 608 TGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ + K N L+ + + KL D+G++
Sbjct: 173 --------QHGIVHSDLKPANFLIVDGML-KLIDFGIA 201
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 43/200 (21%), Positives = 80/200 (40%), Gaps = 55/200 (27%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAK 535
N + +GEG +GK+ K T+VA++ L ++ +R+L ++L +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT------------------- 576
+ HPH++ L G C G + L+ E+ G+ R
Sbjct: 83 VNHPHVIKLYGACSQDG--------PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 577 --HISENTPGKVLNWSERLAVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLN 627
++ + L + ++ +++ +Q+L H R + NIL+
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH----------RDLAARNILVA 184
Query: 628 EHRIAKLSDYGLS--IVSED 645
E R K+SD+GLS + ED
Sbjct: 185 EGRKMKISDFGLSRDVYEED 204
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 33/187 (17%), Positives = 81/187 (43%), Gaps = 50/187 (26%)
Query: 492 GEGSYGKLYKGRL--------ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKL-RHPHL 541
GEG++G++ + +VA++ L + + + +L ++++ + +H ++
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH-------------ISENTPGKVLN 588
+ LLG C G ++++ E+ S GN R + P + +
Sbjct: 104 INLLGACTQDG--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 589 WSERLAVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS- 640
+ + ++ +A+ +++L H R + N+L+ E+ + K++D+GL+
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIH----------RDLAARNVLVTENNVMKIADFGLAR 205
Query: 641 -IVSEDI 646
I + D
Sbjct: 206 DINNIDY 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVC 543
D +GEGS G + R +G VA++ + K+ L + ++ +H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
+ + G +++++ EF+ G T I LN + V V +A+
Sbjct: 107 MYKSYLVG--------EELWVLMEFLQGGAL-TDIVSQVR---LNEEQIATVCEAVLQAL 154
Query: 604 QFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+LH GVI +R +K+++ILL KLSD+G
Sbjct: 155 AYLHAQGVI-----HRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 32/154 (20%), Positives = 59/154 (38%), Gaps = 19/154 (12%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLP--SSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHC 548
G + R G V +R + + V L+ L + HP++V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT 608
I N++++V FM+ G+ + +N +L GV KA+ ++H
Sbjct: 96 IAD--------NELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 609 -GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
G + +R VK ++IL++ LS +
Sbjct: 147 MGYV-----HRSVKASHILISVDGKVYLSGLRSN 175
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 33/173 (19%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR--LENGTSVA---IRC------LPSSKKYTVRNLKLRLD 531
++ A +GEG+YGK++K R G VA +R +P S T+R + + L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAV-LR 66
Query: 532 LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
L HP++V L C + K+ LV+E + + T++ + P +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRE---TKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTET 121
Query: 592 RLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGL 639
++ + + + FLH ++RV K NIL+ KL+D+GL
Sbjct: 122 IKDMMFQLLRGLDFLH--------SHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 51/182 (28%)
Query: 481 ATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD-------- 531
+++ F +G G+Y +YKG G VA++ +++LD
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK-------------EVKLDSEEGTPST 49
Query: 532 ------LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSN--GNFRTHISENTP 583
L+ +L+H ++V L NK+ LV+EFM N + +
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTE--------NKLTLVFEFMDNDLKKYMDSRTVGNT 101
Query: 584 GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYG 638
+ L + + + + F H N++ K N+L+N+ KL D+G
Sbjct: 102 PRGLELNLVKYFQWQLLQGLAFCHE--------NKILHRDLKPQNLLINKRGQLKLGDFG 153
Query: 639 LS 640
L+
Sbjct: 154 LA 155
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 41/199 (20%), Positives = 71/199 (35%), Gaps = 57/199 (28%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKLRLDLL--A 534
+ + +G G++G++ + +VA++ L K+ L+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGA--THSEHRALMSEL 81
Query: 535 KL-----RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT------------- 576
K+ H ++V LLG C GG + ++ EF GN T
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGG-------PLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 577 HISENTPGKVLNWSERLAVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEH 629
E+ L + VAK ++FL H R + NILL+E
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH----------RDLAARNILLSEK 184
Query: 630 RIAKLSDYGLS--IVSEDI 646
+ K+ D+GL+ I +
Sbjct: 185 NVVKICDFGLARDIYKDPD 203
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 39/192 (20%), Positives = 76/192 (39%), Gaps = 60/192 (31%)
Query: 492 GEGSYGKLYKGRL--------ENGTSVAIRCLPSSKKYTVRNLKLRLDLL--AKL----- 536
GEG++G++ T VA++ L K K DL+ ++
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDA--TEKDLSDLISEMEMMKMIG 132
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT-------------HISENTP 583
+H +++ LLG C G ++++ E+ S GN R + + P
Sbjct: 133 KHKNIINLLGACTQDG--------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 584 GKVLNWSERLAVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEHRIAKLSD 636
+ L+ + ++ VA+ +++L H R + N+L+ E + K++D
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIH----------RDLAARNVLVTEDNVMKIAD 234
Query: 637 YGLS--IVSEDI 646
+GL+ I D
Sbjct: 235 FGLARDIHHIDY 246
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 50/196 (25%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAK 535
N +G G++GK+ + + +VA++ L PS+ L L +L+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 536 L-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
L H ++V LLG C GG ++ E+ G+ + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGG--------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 595 V-----------LIG----VAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEHRIA 632
+ L+ VAK + FL H R + NILL RI
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH----------RDLAARNILLTHGRIT 184
Query: 633 KLSDYGLS--IVSEDI 646
K+ D+GL+ I ++
Sbjct: 185 KICDFGLARDIKNDSN 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 52/178 (29%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLD----------- 531
+ +GEG+YG +YK + G VA++ ++RLD
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALK-------------RIRLDAEDEGIPSTAI 67
Query: 532 ----LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
LL +L HP++V L+ + LV+EFM + + + + L
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSE--------RCLTLVFEFMEK-DLKKVL--DENKTGL 116
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
S+ L + + V H +R+ K N+L+N KL+D+GL+
Sbjct: 117 QDSQIKIYLYQLLRGVAHCH--------QHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 28/182 (15%)
Query: 471 RSFTLEELKEATNNFDMSAI------MGEGSYGKLYKGR-LENGTSVAIRCLP---SSKK 520
S ++ E D + +G GS+G +Y R + N VAI+ +
Sbjct: 36 GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 521 YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISE 580
+++ + L KLRHP+ + G + + +LV E+ + + E
Sbjct: 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--------HTAWLVMEYCLGSA--SDLLE 145
Query: 581 NTPGKVLNWSERLAVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYG 638
L E AV G + + +LH+ +I +R VK NILL+E + KL D+G
Sbjct: 146 VHKKP-LQEVEIAAVTHGALQGLAYLHSHNMI-----HRDVKAGNILLSEPGLVKLGDFG 199
Query: 639 LS 640
+
Sbjct: 200 SA 201
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 46/162 (28%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216
SVP I + L L+ N + FD L SLT L + NKL ++++L
Sbjct: 21 SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 217 SDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI 274
+ L+LS N + SLP+ L L L L+ N+L S LP G F
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS----LPDG---VF---------- 120
Query: 275 PKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
+L QL+ L + N L+ +P L ++ + L N
Sbjct: 121 ----DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 26/186 (13%), Positives = 57/186 (30%), Gaps = 32/186 (17%)
Query: 476 EELKEATNNFDMSAIMGEGSYGKLYKGR------LENGTSVAIRCLPSSKKYTVRNLKLR 529
E + + + ++GEG++ ++Y+ +N ++ + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 530 LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNW 589
++ L + + N LV E S G I+
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQ--------NGSVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 590 SERLAVLIG--VAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIA-----------KLS 635
+ L + + ++ +H +I G +K +N +L + L
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHG----DIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 636 DYGLSI 641
D G SI
Sbjct: 226 DLGQSI 231
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 28/203 (13%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDD 175
L S+ + + I S+ I L ++ YL L N L + + L LIL
Sbjct: 39 ELNSIDQIIANNSDI-KSVQG-IQYLPNVRYLALGGNKL--HDISALKELTNLTYLILTG 94
Query: 176 NFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--L 233
N + FD L +L L + N+L +++ L+ L+L+ N + SLP
Sbjct: 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVF 153
Query: 234 SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNA 293
L +L L+LS N+L S LP G+ + +L QL+ L + N
Sbjct: 154 DKLTNLTELDLSYNQLQS----LPEGV-----------------FDKLTQLKDLRLYQNQ 192
Query: 294 LRGMPPPAIFSLPNISDLNLASN 316
L+ +P L ++ + L N
Sbjct: 193 LKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 45/187 (24%), Positives = 81/187 (43%), Gaps = 29/187 (15%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
+ L S++ + +++ + I + ++ L L N + I L +L
Sbjct: 33 DAVTQNE-LNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-DISA-LKELTNL 87
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
T+L + N+L +++ L +L L +N + SLPD L +L LNL+ N+L
Sbjct: 88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 251 SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISD 310
S LP+G+ + +L L +LD+S+N L+ +P L + D
Sbjct: 147 S----LPKGV-----------------FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKD 185
Query: 311 LNLASNK 317
L L N+
Sbjct: 186 LRLYQNQ 192
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 44/191 (23%), Positives = 69/191 (36%), Gaps = 36/191 (18%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216
P + L + + + L S+ + N+ + IQ + +
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNV 65
Query: 217 SDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPK 276
L L N + + L L +L L L+ N+L S L N F
Sbjct: 66 RYLALGGNKLH-DISALKELTNLTYLILTGNQLQS-------------LPNGVFDK---- 107
Query: 277 QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK----NLNCGGKL 332
L L++L + N L+ +P L N++ LNLA N+ SLPK L L
Sbjct: 108 ----LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKL---TNL 159
Query: 333 VFFDISNNKLT 343
D+S N+L
Sbjct: 160 TELDLSYNQLQ 170
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 5e-11
Identities = 37/179 (20%), Positives = 71/179 (39%), Gaps = 53/179 (29%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD---------- 531
++ +GEG+YG ++K + E VA++ ++RLD
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK-------------RVRLDDDDEGVPSSA 48
Query: 532 -----LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV 586
LL +L+H ++V L K+ LV+EF + + + ++
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSD--------KKLTLVFEFCDQ-DLKKYF--DSCNGD 97
Query: 587 LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
L+ + L + K + F H + V K N+L+N + KL+++GL+
Sbjct: 98 LDPEIVKSFLFQLLKGLGFCH--------SRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 35/160 (21%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP-SSKKYTVRNLKLRLDLLAKLRHPHLV 542
F +G+GS+G+++KG VAI+ + + + +++ + +L++ P++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
G + K++++ E++ G+ + E P L+ ++ +L + K
Sbjct: 84 KYYGSYLKD--------TKLWIIMEYLGGGSA-LDLLEPGP---LDETQIATILREILKG 131
Query: 603 VQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ +LH+ I +R +K N+LL+EH KL+D+G++
Sbjct: 132 LDYLHSEKKI-----HRDIKAANVLLSEHGEVKLADFGVA 166
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 35/168 (20%), Positives = 61/168 (36%), Gaps = 32/168 (19%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHP 539
+ +G+G + K ++ + A + +P S K + + + + + L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VLI 597
H+V G D + VF+V E + + +E A L
Sbjct: 102 HVVGFHGFFED--------NDFVFVVLELCRRRSLLELHKRR--KAL---TEPEARYYLR 148
Query: 598 GVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ Q+LH NRV K N+ LNE K+ D+GL+
Sbjct: 149 QIVLGCQYLH--------RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 20/162 (12%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIR--CLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHC 548
G GS+ +YKG E VA K + K ++L L+HP++V
Sbjct: 35 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSW 94
Query: 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH- 607
+ LV E M++G +T++ KV+ + + K +QFLH
Sbjct: 95 ESTVKGKKC----IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 608 --TGVIPGFFNNR-VKTNNILLNEHR-IAKLSDYGLSIVSED 645
+I +R +K +NI + K+ D GL+ +
Sbjct: 148 RTPPII-----HRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 8e-11
Identities = 37/169 (21%), Positives = 61/169 (36%), Gaps = 34/169 (20%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--KYTVRNLKLR--LDLLAKLRH 538
+ +G+G + K ++ + A + +P S K R K+ + + L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAH 74
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VL 596
H+V G D + VF+V E + + +E A L
Sbjct: 75 QHVVGFHGFFED--------NDFVFVVLELCRRRSLLELHKRR--KAL---TEPEARYYL 121
Query: 597 IGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ Q+LH NRV K N+ LNE K+ D+GL+
Sbjct: 122 RQIVLGCQYLH--------RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 39/196 (19%), Positives = 70/196 (35%), Gaps = 65/196 (33%)
Query: 492 GEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKLRLDLL--AKL-----RH 538
G G++GK+ VA++ L + R L+ K+ H
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-----ADSSEREALMSELKMMTQLGSH 108
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT--------------------HI 578
++V LLG C G ++L++E+ G+ +
Sbjct: 109 ENIVNLLGACTLSG--------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 579 SENTPGKVLNWSERLAVLIGVAKAVQFL------HTGVIPGFFNNR-VKTNNILLNEHRI 631
E VL + + L VAK ++FL H R + N+L+ ++
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH----------RDLAARNVLVTHGKV 210
Query: 632 AKLSDYGLS--IVSED 645
K+ D+GL+ I+S+
Sbjct: 211 VKICDFGLARDIMSDS 226
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 22/201 (10%), Positives = 50/201 (24%), Gaps = 31/201 (15%)
Query: 467 LPACRSFTLE-ELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYT-- 522
P T++ L + + + G ++ R +E A++ + +
Sbjct: 45 WPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS 104
Query: 523 -VRNLKLRLDLLAKLRHPHLVCLLGHC------------------IDGGGRDDYAVNKVF 563
+ L A+L G+DDYAV
Sbjct: 105 ELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164
Query: 564 LVYEFM--SNGNFRTHISENTP-GKVLNWSERLAVLIGVAKAVQFLHT-GVIPGFFNNRV 619
L+ + + + + + L + G++ +
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV----HGHF 220
Query: 620 KTNNILLNEHRIAKLSDYGLS 640
+N+ + L D
Sbjct: 221 TPDNLFIMPDGRLMLGDVSAL 241
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 34/225 (15%), Positives = 73/225 (32%), Gaps = 32/225 (14%)
Query: 444 GFSSEVLTNARYVSEAAKLGSEGLPACRSFTLE-ELKEATNNFDMSAIMGEGSYGKLYKG 502
+ + + + + + + F +E EL E ++G+ +
Sbjct: 33 QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEA 92
Query: 503 R-LENGTSVAIRCLPSSKKYTVRNLK------LRLDLLAKLRHPH-------------LV 542
E G S + +++ +K LRL LL +++ LV
Sbjct: 93 TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152
Query: 543 CLLGHCID---GGGRDDYAVNKVFLVYEFMSNGN---FRTHISENTPGKVLNWSERLAVL 596
D V F +Y M + +S ++ K L RL +
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212
Query: 597 IGVAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ V + + LH G++ ++ +I+L++ L+ +
Sbjct: 213 LQVIRLLASLHHYGLVHT----YLRPVDIVLDQRGGVFLTGFEHL 253
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 33/178 (18%), Positives = 68/178 (38%), Gaps = 52/178 (29%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLD----------- 531
+ +GEG+YG +YK + G + A++ K+RL+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK-------------KIRLEKEDEGIPSTTI 48
Query: 532 ----LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
+L +L+H ++V L ++ LV+E + + + + + L
Sbjct: 49 REISILKELKHSNIVKLYDVIHTK--------KRLVLVFEHLDQ-DLKKLL--DVCEGGL 97
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
+ L+ + + + H + RV K N+L+N K++D+GL+
Sbjct: 98 ESVTAKSFLLQLLNGIAYCH--------DRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 475 LEELKEATNN------FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLK 527
L++L E + FD+ +GEGSYG +YK E G VAI+ +P ++ +
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEII 72
Query: 528 LRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
+ ++ + PH+V G +++V E+ G+ + I L
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKN--------TDLWIVMEYCGAGSV-SDIIRLRNKT-L 122
Query: 588 NWSERLAVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
E +L K +++LH I +R +K NILLN AKL+D+G++
Sbjct: 123 TEDEIATILQSTLKGLEYLHFMRKI-----HRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 35/178 (19%), Positives = 69/178 (38%), Gaps = 52/178 (29%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD---------- 531
+ +GEG+Y +YKG+ VA++ ++RL+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK-------------EIRLEHEEGAPCTAI 48
Query: 532 ----LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
LL L+H ++V L + LV+E++ + + ++ + G ++
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTE--------KSLTLVFEYLDK-DLKQYL--DDCGNII 97
Query: 588 NWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLS 640
N L + + + + H +V K N+L+NE KL+D+GL+
Sbjct: 98 NMHNVKLFLFQLLRGLAYCH--------RQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 36/207 (17%), Positives = 75/207 (36%), Gaps = 68/207 (32%)
Query: 459 AAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPS 517
+ P+ S + + +GEG+YG++YK +VAI+
Sbjct: 19 PGSMSVSAAPSATS---------IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---- 65
Query: 518 SKKYTVRNLKLRLD---------------LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562
++RL+ LL +L+H +++ L +++
Sbjct: 66 ---------RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--------HRL 108
Query: 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV--- 619
L++E+ N + + ++ +N ++ + L + V F H+ R
Sbjct: 109 HLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHS--------RRCLHR 156
Query: 620 --KTNNILLNEHRIA-----KLSDYGL 639
K N+LL+ + K+ D+GL
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 38/183 (20%), Positives = 70/183 (38%), Gaps = 39/183 (21%)
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLA 534
E +E + +G GS+G++++ + + G A+ KK + ++ L A
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV------KKVRLEVFRVEELVACA 105
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
L P +V L G +G V + E + G+ I + E A
Sbjct: 106 GLSSPRIVPLYGAVREG--------PWVNIFMELLEGGSLGQLIKQMGC-----LPEDRA 152
Query: 595 ------VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEH-RIAKLSDYGLSIVSED 645
L G+ +LHT ++ + VK +N+LL+ A L D+G ++ +
Sbjct: 153 LYYLGQALEGLE----YLHTRRIL-----HGDVKADNVLLSSDGSRAALCDFGHALCLQP 203
Query: 646 INS 648
Sbjct: 204 DGL 206
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 30/121 (24%), Positives = 47/121 (38%), Gaps = 17/121 (14%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216
+P I V L LD N F +P + LT + + NN+++ S ++ L
Sbjct: 24 VLPKGIPRDV--TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 217 SDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRG-------LVMAFLSN 267
L LS N + +P L SL +L+L N + +P G L +
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV----VPEGAFNDLSALSHLAIGA 135
Query: 268 N 268
N
Sbjct: 136 N 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 23/71 (32%), Positives = 35/71 (49%), Gaps = 2/71 (2%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPNWFDSLPS 191
+P ++ L +DLS+N + ++ + S M +L TLIL N P FD L S
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKS 103
Query: 192 LTFLSMRNNKL 202
L LS+ N +
Sbjct: 104 LRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 12/112 (10%)
Query: 145 EYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL-- 202
L L N VP ++S L + L +N + F ++ L L + N+L
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 203 --AGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
F + +L L L N IS +P+ + L +L+ L + N L
Sbjct: 93 IPPRTF----DGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 22/106 (20%)
Query: 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY 278
L L N + +LS+ L +++LS+N++ + LSN SFS
Sbjct: 36 LYLDGNQFTLVPKELSNYKHLTLIDLSNNRIST-------------LSNQSFS------- 75
Query: 279 GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK 324
+ QL L +S+N LR +PP L ++ L+L N S +P+
Sbjct: 76 -NMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 42/180 (23%), Positives = 74/180 (41%), Gaps = 42/180 (23%)
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD---- 531
++K ++ +GEG + +YK R VAI KK + + D
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAI------KKIKLGHRSEAKDGINR 57
Query: 532 -------LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG 584
LL +L HP+++ LL + + LV++FM + I
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHK--------SNISLVFDFMET-DLEVII--KDNS 106
Query: 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGL 639
VL S A ++ + +++LH + + K NN+LL+E+ + KL+D+GL
Sbjct: 107 LVLTPSHIKAYMLMTLQGLEYLH--------QHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 41/165 (24%), Positives = 65/165 (39%), Gaps = 22/165 (13%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPS---SKKYTVRNLKLRLDLLAKLRHP 539
+F + +G GSYG+++K R E+G A++ S K R L +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
V L +GG ++L E + + H G L ++ L
Sbjct: 118 CCVRLEQAWEEGG--------ILYLQTEL-CGPSLQQHCEAW--GASLPEAQVWGYLRDT 166
Query: 600 AKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIV 642
A+ LH+ G++ + VK NI L KL D+GL +
Sbjct: 167 LLALAHLHSQGLV-----HLDVKPANIFLGPRGRCKLGDFGLLVE 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 38/203 (18%), Positives = 73/203 (35%), Gaps = 49/203 (24%)
Query: 457 SEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL 515
+ EGL AC E + + + +G G++G ++ E V ++ +
Sbjct: 5 EPPKAVELEGLAACE-------GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFI 57
Query: 516 PSSK--------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV----NKVF 563
K + + L + +L+++ H +++ + +
Sbjct: 58 KKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV------------LDIFENQGFFQ 105
Query: 564 LVYEFMSNGN--FRTHISENTPGKVLNWSERLAVLI--GVAKAVQFLHT-GVIPGFFNNR 618
LV E +G F I + E LA I + AV +L +I +R
Sbjct: 106 LVMEKHGSGLDLF-AFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKDII-----HR 154
Query: 619 -VKTNNILLNEHRIAKLSDYGLS 640
+K NI++ E KL D+G +
Sbjct: 155 DIKDENIVIAEDFTIKLIDFGSA 177
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 1e-09
Identities = 37/175 (21%), Positives = 62/175 (35%), Gaps = 44/175 (25%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
GEG+YG++ +VA++ + + N+K + + L H ++V
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF----- 70
Query: 550 DGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV-----LIGVA 600
Y N +L E+ S G I + + E A L+
Sbjct: 71 -------YGHRREGNIQYLFLEYCSGGELFDRIEPD--IGM---PEPDAQRFFHQLMA-- 116
Query: 601 KAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLSIVSEDINSVG 650
V +LH + K N+LL+E K+SD+GL+ V N
Sbjct: 117 -GVVYLH--------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 35/169 (20%), Positives = 65/169 (38%), Gaps = 41/169 (24%)
Query: 492 GEGSYGKLYKGR---LENGTSVAIRCLPSSKKYTVRNL---KLR-LDLLAKLRHPHLVCL 544
G G+YG +YK + ++ A+ K+ + R + LL +L+HP+++ L
Sbjct: 30 GRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIALLRELKHPNVISL 83
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSN-----GNFRTHISENTPGKVLNWSERLAVLIGV 599
+ +A KV+L++++ + F N L ++L +
Sbjct: 84 QKVFL------SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 600 AKAVQFLHTGVIPGFFNNRV-----KTNNILL----NEHRIAKLSDYGL 639
+ +LH N V K NIL+ E K++D G
Sbjct: 138 LDGIHYLH--------ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 36/168 (21%), Positives = 76/168 (45%), Gaps = 24/168 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYT-VRNLKLRLDLLAKLRHPH 540
+++++ ++G G+ + VAI+ + K T + L + +++ HP+
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL------A 594
+V + ++++LV + +S G+ I ++ K + S L
Sbjct: 75 IVSYYTSFVVK--------DELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 595 VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+L V + +++LH G I +R VK NILL E +++D+G+S
Sbjct: 126 ILREVLEGLEYLHKNGQI-----HRDVKAGNILLGEDGSVQIADFGVS 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 36/162 (22%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNL-KLR--LDLLAKLRHPHLVCLLGH 547
G G++GK+ G G VA++ L K ++ + K++ + L RHPH++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL--- 76
Query: 548 CIDGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV-----LIG 598
Y V F+V E++S G +I ++ G+V E A ++
Sbjct: 77 ---------YQVISTPTDFFMVMEYVSGGELFDYICKH--GRV---EEMEARRLFQQILS 122
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
AV + H + +K N+LL+ H AK++D+GLS
Sbjct: 123 ---AVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 37/175 (21%), Positives = 62/175 (35%), Gaps = 44/175 (25%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
GEG+YG++ +VA++ + + N+K + + L H ++V
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF----- 70
Query: 550 DGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV-----LIGVA 600
Y N +L E+ S G I + + E A L+
Sbjct: 71 -------YGHRREGNIQYLFLEYCSGGELFDRIEPD--IGM---PEPDAQRFFHQLMA-- 116
Query: 601 KAVQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLSIVSEDINSVG 650
V +LH + K N+LL+E K+SD+GL+ V N
Sbjct: 117 -GVVYLH--------GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 39/168 (23%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR--LDLLAKLRHPHLVCLLGHC 548
G+G++ K+ R + G VAI+ + ++ KL + ++ L HP++V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL---- 79
Query: 549 IDGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG--VAKA 602
+ V ++L+ E+ S G ++ + G++ E+ A + A
Sbjct: 80 --------FEVIETEKTLYLIMEYASGGEVFDYLVAH--GRM---KEKEARSKFRQIVSA 126
Query: 603 VQFLHTGVIPGFFNNRV-----KTNNILLNEHRIAKLSDYGLSIVSED 645
VQ+ H R+ K N+LL+ K++D+G S
Sbjct: 127 VQYCH--------QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 38/216 (17%), Positives = 72/216 (33%), Gaps = 33/216 (15%)
Query: 454 RYVSEAAKLGSEGL-PACRSFTLE-ELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSV 510
S A L S L + F +E EL E ++G+ + E G S
Sbjct: 47 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106
Query: 511 AIRCLPSSKKYTVRNLK------LRLDLLAKLRHPHLVCLLGHCID-------------- 550
+ +++ +K LRL LL +++ + I
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 551 --GGGRDDYAVNKVFLVYEFMSNGN---FRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
D V F +Y M + +S ++ K L RL + + V + +
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226
Query: 606 LHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
LH G++ ++ +I+L++ L+ +
Sbjct: 227 LHHYGLVHT----YLRPVDIVLDQRGGVFLTGFEHL 258
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 38/177 (21%), Positives = 71/177 (40%), Gaps = 46/177 (25%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRL----DLLAKLRH 538
+ M ++GEGSYGK+ + E A++ L K + N + + LL +LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 539 PHLVCLLGHCIDGGGRDDYAV------NKVFLVYEFMSNGNFR--THISENTPGKVLNWS 590
+++ L V K+++V E+ G + E +
Sbjct: 66 KNVIQL------------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRF---P 107
Query: 591 ERLAV-----LIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
A LI +++LH+ G++ ++ +K N+LL K+S G++
Sbjct: 108 VCQAHGYFCQLID---GLEYLHSQGIV-----HKDIKPGNLLLTTGGTLKISALGVA 156
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 32/179 (17%), Positives = 69/179 (38%), Gaps = 20/179 (11%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIR--CLPSSKKYTVRNLKLRLDLLAKL-R 537
T F +G G +G ++K +G AI+ P + +N + A L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVL 596
H H+V + + + + E+ + G+ ISEN +E +L
Sbjct: 70 HSHVVRYFSAWAED--------DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 597 IGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRL 653
+ V + ++++H+ ++ + +K +NI ++ I + N V ++
Sbjct: 122 LQVGRGLRYIHSMSLV-----HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 36/162 (22%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNL-KLR--LDLLAKLRHPHLVCLLGH 547
G G++GK+ G+ G VA++ L K ++ + K+R + L RHPH++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL--- 81
Query: 548 CIDGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV-----LIG 598
Y V + +F+V E++S G +I +N G++ E+ + ++
Sbjct: 82 ---------YQVISTPSDIFMVMEYVSGGELFDYICKN--GRL---DEKESRRLFQQILS 127
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
V + H + +K N+LL+ H AK++D+GLS
Sbjct: 128 ---GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 21/95 (22%), Positives = 32/95 (33%), Gaps = 1/95 (1%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNW-FDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215
+ L L +++ + L L L++ + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 216 LSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLD 250
LS L+LS NA+ SL L LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 16/93 (17%), Positives = 35/93 (37%), Gaps = 2/93 (2%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPK-ISTMVKLQTLILDDNFFNNTIPNWFDSLPS 191
+ +L L + + + + + + +L+ L + + P+ F P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 192 LTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKN 224
L+ L++ N L + +L +L LS N
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 29/123 (23%), Positives = 43/123 (34%), Gaps = 22/123 (17%)
Query: 221 LSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQ 280
A+ SL L +L L + + + +L L G
Sbjct: 16 TRDGALD-SLHHLPGAENLTELYIENQQ---HLQHLELR---------DLRG-------- 54
Query: 281 LNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN 340
L +L+ L + + LR + P A P +S LNL+ N SL G L +S N
Sbjct: 55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
Query: 341 KLT 343
L
Sbjct: 114 PLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 23/80 (28%), Positives = 33/80 (41%), Gaps = 2/80 (2%)
Query: 101 LSENFSIDSFVT-TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP 159
+ + L L LR L++V G+ PD H L L+LS N L S+
Sbjct: 38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL-ESLS 96
Query: 160 PKISTMVKLQTLILDDNFFN 179
K + LQ L+L N +
Sbjct: 97 WKTVQGLSLQELVLSGNPLH 116
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 28/185 (15%)
Query: 471 RSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR 529
F + + + +G G+YG++ R AI+ + + T N KL
Sbjct: 25 GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL 84
Query: 530 --LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
+ +L L HP+++ L D +LV E G I
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFEDK--------RNYYLVMECYKGGELFDEIIHRM----- 131
Query: 588 NWSERLA--VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLS 640
++E A ++ V V +LH ++ +R +K N+LL + + K+ D+GLS
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHKHNIV-----HRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 641 IVSED 645
V E+
Sbjct: 187 AVFEN 191
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 32/124 (25%), Positives = 52/124 (41%), Gaps = 17/124 (13%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPN-WFDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215
+P I L+L+DN + F LP L L ++ N+L G P++ + S
Sbjct: 22 EIPRDIPLHT--TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 216 LSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRG-------LVMAFLS 266
+ +L L +N I + + L L LNL DN++ + G L L+
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC----VMPGSFEHLNSLTSLNLA 134
Query: 267 NNSF 270
+N F
Sbjct: 135 SNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 29/114 (25%), Positives = 41/114 (35%), Gaps = 14/114 (12%)
Query: 145 EYLDLSSNFLFGSVPPK--ISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL 202
L L+ N L G + + L L L N PN F+ + L + NK+
Sbjct: 32 TELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 203 ----AGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLD 250
F + L L+L N IS + L SL LNL+ N +
Sbjct: 91 KEISNKMF----LGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 139 HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPN-WFDSLPSLTFLS 196
RL L L+L N L + P +Q L L +N I N F L L L+
Sbjct: 51 GRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKTLN 108
Query: 197 MRNNKLAGPFPSSIQRISTLSDLDLSKN 224
+ +N+++ P S + +++L+ L+L+ N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 37/172 (21%), Positives = 78/172 (45%), Gaps = 26/172 (15%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
F ++G G++ +++ + G A++C+ S + +L+ + +L K++H +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI--G 598
+V L +LV + +S G I E ++E+ A L+
Sbjct: 68 IVTLEDIYEST--------THYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQ 114
Query: 599 VAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIVSED 645
V AV++LH G++ +R +K N+L E+ ++D+GLS + ++
Sbjct: 115 VLSAVKYLHENGIV-----HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 34/171 (19%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
+++D+ +G G++G +++ G + A + + + + ++ + ++ LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN-FRTHISENTPGKVLNWSERLAVLIG- 598
LV L D N++ ++YEFMS G F E+ SE AV
Sbjct: 216 LVNLHDAFEDD--------NEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMR 262
Query: 599 -VAKAVQFLHTGVIPGFFNNRV-----KTNNILL---NEHRIAKLSDYGLS 640
V K + +H N K NI+ + + KL D+GL+
Sbjct: 263 QVCKGLCHMH--------ENNYVHLDLKPENIMFTTKRSNEL-KLIDFGLT 304
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 2e-08
Identities = 30/216 (13%), Positives = 64/216 (29%), Gaps = 50/216 (23%)
Query: 467 LPACRS---FTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLP------- 516
+ C T +GEG +G++++ + T VAI+ +
Sbjct: 2 MGECSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLV 59
Query: 517 -SSKKYTVRNLKLRLDLLAKL---------RHPHLVCLLGHCI----------------- 549
S + T + + + +L R + L
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 550 -----DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQ 604
D + +++F+V EF G E K+ + + ++L + ++
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGG----IDLEQMRTKLSSLATAKSILHQLTASLA 175
Query: 605 FLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
F + + N+LL + + KL
Sbjct: 176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNG 209
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 30/134 (22%), Positives = 47/134 (35%), Gaps = 25/134 (18%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
R L L I + + L + +D S N + + +L+TL++
Sbjct: 15 YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLV 71
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL 233
++N +LP LT L + NN + L DLD L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNS-----------LVELGDLD-----------PL 109
Query: 234 SSLGSLNVLNLSDN 247
+SL SL L + N
Sbjct: 110 ASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 28/156 (17%), Positives = 55/156 (35%), Gaps = 25/156 (16%)
Query: 147 LDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPF 206
+ L++ + + + + V+ + L L I N +L + +N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---- 54
Query: 207 PSSIQRIST---LSDLDLSKNAISGSLPDL-SSLGSLNVLNLSDNKLDS-----NLPKLP 257
+ L L ++ N I L +L L L L++N L L L
Sbjct: 55 -RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK 113
Query: 258 RGLVMAFLSNNSFSGEIPKQY-----GQLNQLQQLD 288
L + N + + K Y ++ Q++ LD
Sbjct: 114 S-LTYLCILRNPVTNK--KHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 22/105 (20%), Positives = 41/105 (39%), Gaps = 9/105 (8%)
Query: 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS--NLPKLPRGLVMAFLSNNSFSGEIPK 276
+ L+ I ++ L+L K+ NL S+N EI K
Sbjct: 2 VKLTAELIE-QAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDN----EIRK 56
Query: 277 QYG--QLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319
G L +L+ L ++ N + + +LP++++L L +N
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 33/165 (20%), Positives = 74/165 (44%), Gaps = 38/165 (23%)
Query: 490 IMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549
++G GS+G +++ +L VAI+ + K++ R L+ ++ ++HP++V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNVVDLK-AFF 101
Query: 550 --DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA------- 600
+G +D+ + LV E++ T + +L + +
Sbjct: 102 YSNGDKKDE---VFLNLVLEYV----------PETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 601 ---KAVQFLHT-GVIPGFFNNR-VKTNNILLNEHR-IAKLSDYGL 639
+++ ++H+ G+ +R +K N+LL+ + KL D+G
Sbjct: 149 QLLRSLAYIHSIGIC-----HRDIKPQNLLLDPPSGVLKLIDFGS 188
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 88/636 (13%), Positives = 169/636 (26%), Gaps = 216/636 (33%)
Query: 52 NHGADFCYISSSTQVNITCQD-------NFITEL--KIIGDKPSNVGNFDGFASANASLS 102
+H DF + + +D F+ K + D P ++ +
Sbjct: 4 HHHMDF----ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI-----LSKEE---- 50
Query: 103 ENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKI 162
ID + + ++ L S +++ + + E L ++ FL
Sbjct: 51 ----IDHIIMSKDAVSGTLRL----FWTLLSKQEEMVQKFVEEVLRINYKFL-------- 94
Query: 163 STMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG--PF-PSSIQRISTLSDL 219
M ++T P S+ + ++ R+ F ++ R+ L
Sbjct: 95 --MSPIKTEQRQ--------P----SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL 140
Query: 220 DLSKNAISGSLPDLSS---------LGS----LNVLNLSDNKLDSNLPKLPRGLVMAFLS 266
+ A L +L LGS + + K+ +
Sbjct: 141 ---RQA----LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD------------ 181
Query: 267 NNSF---SGEIPKQYGQLNQLQ----QLDMSFNALRGMPPPAIFSLPNISD-LN--LASN 316
F L LQ Q+D ++ + + +I L L S
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 317 KFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVK-FRGNC--L----SSN 369
+ L LV L N + + F +C L
Sbjct: 242 PYENCL---------LV----------------LLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 370 VQNQHPESYCFEVRTERNQAG-----SKNV-GKLVGIIVGVLVIMVLLAFGFLVVCRRYC 423
V + + + + + K++ K + L
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL------------------ 318
Query: 424 PRCTSEQHLLH-----KSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEEL 478
PR + +S++D AT N ++V + L +L L
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLAT------WDNWKHV------NCDKLTTIIESSLNVL 366
Query: 479 K--EATNNFDMSAIMGEGS------YGKLYKGRLENGT-SVAIRCLPSS------KKYTV 523
+ E FD ++ + ++ +++ V + S K+ T+
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 524 RNLKLRLDLLAKLR-----HPHLV----CLLGHCIDGGGR---DDY-------------- 557
+ L+L KL H +V D D Y
Sbjct: 427 SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH 486
Query: 558 -----AVNKVFLVYEFMSNGNFRTHISENTPGKVLN 588
VFL + F+ + N G +LN
Sbjct: 487 PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 7e-06
Identities = 84/569 (14%), Positives = 151/569 (26%), Gaps = 190/569 (33%)
Query: 32 QVLLQLRKHLEYPKQL--EIWIN-HGADFCYISSSTQVNITCQDNFITELKIIGDKPSNV 88
Q L+LR+ L +L + G + C K+ +
Sbjct: 135 QPYLKLRQAL---LELRPAKNVLIDGVLGS--GKTWVALDVCLSY-----KVQCKMDFKI 184
Query: 89 GNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRL-YSLEYL 147
F +L S ++ + L +L + W S D + + +
Sbjct: 185 -----FW---LNLKNCNSPETVLEMLQKLLYQIDPN------WTSRSDHSSNIKLRIHSI 230
Query: 148 DLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFP 207
L S P + L L+L + N N F+ L L+ R ++
Sbjct: 231 QAELRRLLKSKPYENC----L--LVLLN-VQNAKAWNAFN-LSCKILLTTRFKQVT---- 278
Query: 208 SSIQRISTLSDLDLSKNAISGSLPDLSSLGSL-NVLNLSDNKLDSNLPK-----LPRGLV 261
+S + +S + S +L L L+ LP+ PR L
Sbjct: 279 ---DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD----LPREVLTTNPRRLS 331
Query: 262 M--AFLSNNSFSGEIPKQYGQLN--QLQQ-LDMSFNALRGMPPP---------AIFSLPN 307
+ + + + +N +L ++ S N L P ++F
Sbjct: 332 IIAESIRDGL---ATWDNWKHVNCDKLTTIIESSLNVL---EPAEYRKMFDRLSVF---- 381
Query: 308 ISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVV-----KFR 362
P + + I L S + + K V K
Sbjct: 382 ---------------PPSAH---------IPTILL-----SLIWFDVIKSDVMVVVNKLH 412
Query: 363 GNCLSSNVQNQHPESYC------FEVRTERNQAGSKNVGKLVGIIVGVLVIMVLLAFGFL 416
L V+ Q ES E++ + + + +V +
Sbjct: 413 KYSL---VEKQPKESTISIPSIYLELKVKLENEYALH-RSIVD------------HYNIP 456
Query: 417 VVCRRYCPRCTSE--------QHL---LHKSVQDNSATGFSSEVLTNARYVSEAAKLGSE 465
+ + H+ L T F V + R++ K+ +
Sbjct: 457 ---KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLF-RMVFLDFRFLE--QKIRHD 510
Query: 466 GLPACRSF----TLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY 521
S TL++L K YK + + KY
Sbjct: 511 STAWNASGSILNTLQQL-------------------KFYKPYI----------CDNDPKY 541
Query: 522 TVRNLKLRLDLLAK-----LRHPHLVCLL 545
R + LD L K + + LL
Sbjct: 542 E-RLVNAILDFLPKIEENLICSKYT-DLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 48/251 (19%), Positives = 67/251 (26%), Gaps = 82/251 (32%)
Query: 435 KSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTL-------------EELKEA 481
K VQD +L+ + R F EE+
Sbjct: 36 KDVQD-----MPKSILSKEE-IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI 89
Query: 482 TNNFDMSAIMGE--------GSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDL- 532
F MS I E Y + + RL N V KY V L+ L L
Sbjct: 90 NYKFLMSPIKTEQRQPSMMTRMYIE-QRDRLYNDNQVF-------AKYNVSRLQPYLKLR 141
Query: 533 --LAKLRHPHLVCLLGHCIDGG-GR--------DDYAV-----NKVF------------- 563
L +LR V + G G G+ Y V K+F
Sbjct: 142 QALLELRPAKNVLIDG---VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV 198
Query: 564 ------LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFL-------HTGV 610
L+Y+ N R+ S N ++ + L L+ L +
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258
Query: 611 IPGFFNNRVKT 621
FN K
Sbjct: 259 WNA-FNLSCKI 268
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 36/175 (20%), Positives = 78/175 (44%), Gaps = 35/175 (20%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR 537
+ ++ + ++G GS+G +Y+ +L ++G VAI+ + K++ R L+ ++ KL
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLD 105
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
H ++V L + G V + LV +++ T +V R +
Sbjct: 106 HCNIVRLR-YFFYSSGEKKDEV-YLNLVLDYV----------PETVYRVARHYSRAKQTL 153
Query: 598 G----------VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHR-IAKLSDYGL 639
+ +++ ++H+ G+ +R +K N+LL+ + KL D+G
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGIC-----HRDIKPQNLLLDPDTAVLKLCDFGS 203
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 39/182 (21%), Positives = 70/182 (38%), Gaps = 30/182 (16%)
Query: 470 CRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS---KKYTVRN 525
+ LE N F ++G+G +G++ ++ G A + L K+
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 526 LKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENT 582
+L K+ +V L YA + + LV M+ G+ + HI
Sbjct: 231 ALNEKQILEKVNSRFVVSLA-----------YAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 583 PGKVLNWSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYG 638
+ E AV + ++ LH ++ R +K NILL++H ++SD G
Sbjct: 280 QAG---FPEARAVFYAAEICCGLEDLHRERIV-----YRDLKPENILLDDHGHIRISDLG 331
Query: 639 LS 640
L+
Sbjct: 332 LA 333
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 40/184 (21%), Positives = 73/184 (39%), Gaps = 32/184 (17%)
Query: 470 CRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKY-----TV 523
+ LE + F ++G G +G+++ ++ G A + L +KK
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL--NKKRLKKRKGY 229
Query: 524 RNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISE 580
+ + +LAK+ +V L YA + LV M+ G+ R HI
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLA-----------YAFETKTDLCLVMTIMNGGDIRYHIY- 277
Query: 581 NTPGKVLNWSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSD 636
N + E A+ + ++ LH +I R +K N+LL++ ++SD
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII-----YRDLKPENVLLDDDGNVRISD 332
Query: 637 YGLS 640
GL+
Sbjct: 333 LGLA 336
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 3/92 (3%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR 537
++ + F + + G+G++G + G+ G SVAI+ + ++ R L++ + LA L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLH 77
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFM 569
HP++V L G D + +V E++
Sbjct: 78 HPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYV 108
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 37/172 (21%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRN-----LKLRLDLLAKL 536
N F+ ++G+G++GK+ + G A++ L K+ V +L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KKEVIVAKDEVAHTLTENRVLQNS 205
Query: 537 RHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
RHP L L Y+ +++ V E+ + G H+S + +SE
Sbjct: 206 RHPFLTALK-----------YSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDR 249
Query: 594 AVLIG--VAKAVQFLHT--GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
A G + A+ +LH+ V+ R +K N++L++ K++D+GL
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVV-----YRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 38/171 (22%), Positives = 80/171 (46%), Gaps = 36/171 (21%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKY-----TVRNLKLRLDLLAKL 536
++F++ +G+GS+GK+ + + A++ + +K+ VRN+ L ++ L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM--NKQKCVERNEVRNVFKELQIMQGL 72
Query: 537 RHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
HP LV L Y+ +F+V + + G+ R H+ + +++ E
Sbjct: 73 EHPFLVNL-----------WYSFQDEEDMFMVVDLLLGGDLRYHLQ-----QNVHFKEET 116
Query: 594 AVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
L + A+ +L +I +R +K +NILL+EH ++D+ ++
Sbjct: 117 VKLFICELVMALDYLQNQRII-----HRDMKPDNILLDEHGHVHITDFNIA 162
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 34/174 (19%), Positives = 57/174 (32%), Gaps = 52/174 (29%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYT------VRNLKLRLDLLAKLRHPHLVCL 544
G G++G R VA++ + + N + LRHP++V
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRS-------LRHPNIVRF 81
Query: 545 LGHCIDGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV----- 595
V + ++ E+ S G I G+ SE A
Sbjct: 82 ------------KEVILTPTHLAIIMEYASGGELYERICNA--GRF---SEDEARFFFQQ 124
Query: 596 LIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIA--KLSDYGLSIVSED 645
L+ V + H+ + +R +K N LL+ K+ D+G S S
Sbjct: 125 LLS---GVSYCHSMQIC-----HRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 36/185 (19%), Positives = 74/185 (40%), Gaps = 29/185 (15%)
Query: 472 SFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK---KYTVRNLK 527
F ++ + ++G+GS+G++ + G A++ + + K +L
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 528 LRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVL 587
+ LL +L HP+++ L D +LV E + G I
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDK--------GYFYLVGEVYTGGELFDEIISRK----- 121
Query: 588 NWSERLA--VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLS 640
+SE A ++ V + ++H ++ +R +K N+LL ++ ++ D+GLS
Sbjct: 122 RFSEVDAARIIRQVLSGITYMHKNKIV-----HRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 641 IVSED 645
E
Sbjct: 177 THFEA 181
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 41/162 (25%), Positives = 59/162 (36%), Gaps = 50/162 (30%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216
SVP I + L L+ N + FD L LT LS+ N++
Sbjct: 21 SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ------------- 65
Query: 217 SDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI 274
SLPD L L +L L +NKL S LP G F
Sbjct: 66 ------------SLPDGVFDKLTKLTILYLHENKLQS----LPNG---VF---------- 96
Query: 275 PKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316
+L QL++L + N L+ +P L ++ + L +N
Sbjct: 97 ----DKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 5/95 (5%)
Query: 133 SLPDKI-HRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFNNTIPN-WFDSL 189
SLP + +L L L LS N + S+P + + KL L L +N ++PN FD L
Sbjct: 42 SLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKL-QSLPNGVFDKL 99
Query: 190 PSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKN 224
L L++ N+L R+++L + L N
Sbjct: 100 TQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 34/174 (19%), Positives = 73/174 (41%), Gaps = 28/174 (16%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR--LDLLAKLRH 538
+++ ++G+GS+G++ K + A++ + + + ++LL KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VL 596
P+++ L D + ++V E + G I + +SE A ++
Sbjct: 81 PNIMKLFEILEDS--------SSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARII 127
Query: 597 IGVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIVSED 645
V + ++H ++ +R +K NILL + K+ D+GLS +
Sbjct: 128 KQVFSGITYMHKHNIV-----HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 41/183 (22%), Positives = 77/183 (42%), Gaps = 35/183 (19%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--------KYTVRNLKLR 529
K + + MS +G G+ G++ + VAIR + K N++
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 530 LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNW 589
+++L KL HP ++ + ++ + ++V E M G + N ++
Sbjct: 191 IEILKKLNHPCIIKI---------KNFFDAEDYYIVLELMEGGELFDKVVGN--KRL--- 236
Query: 590 SERLAVLI--GVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIV 642
E L + AVQ+LH G+I +R +K N+LL E + K++D+G S +
Sbjct: 237 KEATCKLYFYQMLLAVQYLHENGII-----HRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 643 SED 645
+
Sbjct: 292 LGE 294
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 26/168 (15%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LD-LLAKLRHP 539
+ +G G+YG + K +G +A++ + S+ + L LD ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFM--SNGNFRTHISENTPGKVLNWSERL--AV 595
++V G G ++ E M S F ++ + E + +
Sbjct: 82 YIVQFYGALFREG--------DCWICMELMSTSFDKFYKYVYSVLDDVI---PEEILGKI 130
Query: 596 LIGVAKAVQFLHT--GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ KA+ L +I +R +K +NILL+ KL D+G+S
Sbjct: 131 TLATVKALNHLKENLKII-----HRDIKPSNILLDRSGNIKLCDFGIS 173
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 40/183 (21%), Positives = 75/183 (40%), Gaps = 35/183 (19%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--------KYTVRNLKLR 529
K + + MS +G G+ G++ + VAI+ + K N++
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 530 LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNW 589
+++L KL HP ++ + ++ + ++V E M G + N
Sbjct: 66 IEILKKLNHPCIIKI---------KNFFDAEDYYIVLELMEGGELFDKVVGNK-----RL 111
Query: 590 SERLAVLI--GVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIV 642
E L + AVQ+LH G+I +R +K N+LL E + K++D+G S +
Sbjct: 112 KEATCKLYFYQMLLAVQYLHENGII-----HRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 643 SED 645
+
Sbjct: 167 LGE 169
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 26/173 (15%), Positives = 61/173 (35%), Gaps = 27/173 (15%)
Query: 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLV 542
+F ++G G+ G + + + VA++ + + LL + HP+++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
D ++ E + + ++ + E + +L
Sbjct: 82 RYFCTEKDR--------QFQYIAIELCA-ATLQEYVEQ--KDFAHLGLEPITLLQQTTSG 130
Query: 603 VQFLHT-GVIPGFFNNR-VKTNNILL-----NEHRIAKLSDYGLSIVSEDINS 648
+ LH+ ++ +R +K +NIL+ + A +SD+GL
Sbjct: 131 LAHLHSLNIV-----HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 40/158 (25%), Positives = 63/158 (39%), Gaps = 29/158 (18%)
Query: 492 GEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPHLVCLLGHCI 549
G G+ G ++K +G +A + + K +RN +R L +L + P++V G
Sbjct: 42 GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101
Query: 550 DGGGRDDYAVNKVFLVYEFMSNG------NFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
G ++ + E M G I E GKV I V K +
Sbjct: 102 SDG--------EISICMEHMDGGSLDQVLKKAGRIPEQILGKVS---------IAVIKGL 144
Query: 604 QFLHTGVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+L +R VK +NIL+N KL D+G+S
Sbjct: 145 TYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 31/179 (17%), Positives = 68/179 (37%), Gaps = 33/179 (18%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR--- 537
N++ I+G G + + A++ + + + +++ A L+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 538 -------HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWS 590
HP+++ L FLV++ M G +++E S
Sbjct: 76 ILRKVSGHPNIIQLKDTYETN--------TFFFLVFDLMKKGELFDYLTEKV-----TLS 122
Query: 591 ERLA--VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSED 645
E+ ++ + + + LH ++ +R +K NILL++ KL+D+G S +
Sbjct: 123 EKETRKIMRALLEVICALHKLNIV-----HRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 39/174 (22%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLR--------LDLL 533
N+F + I+G G +G++Y R + G A++CL KK L L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL--DKKRIKMKQGETLALNERIMLSLV 246
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWS 590
+ P +VC+ YA +K+ + + M+ G+ H+S + +S
Sbjct: 247 STGDCPFIVCM-----------SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFS 290
Query: 591 ERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
E + ++ +H V+ R +K NILL+EH ++SD GL+
Sbjct: 291 EADMRFYAAEIILGLEHMHNRFVV-----YRDLKPANILLDEHGHVRISDLGLA 339
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 39/176 (22%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRN------LKLRLDLLAKL 536
+ + ++G+G +G ++ G L + VAI+ +P ++ L + LL K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 537 R----HPHLVCLLGHCIDGGGRDDYAV-NKVFLVYEFMSNGN--FRTHISENTPGKVLNW 589
HP ++ LL D + LV E F +I+E G +
Sbjct: 92 GAGGGHPGVIRLL---------DWFETQEGFMLVLERPLPAQDLF-DYITEK--GPL--- 136
Query: 590 SERLAVLI--GVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHR-IAKLSDYGLS 640
E + V A+Q H+ GV+ +R +K NIL++ R AKL D+G
Sbjct: 137 GEGPSRCFFGQVVAAIQHCHSRGVV-----HRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 34/174 (19%), Positives = 73/174 (41%), Gaps = 28/174 (16%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR--LDLLAKLRH 538
+++ ++G+GS+G++ K + A++ + + + ++LL KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VL 596
P+++ L D + ++V E + G I + +SE A ++
Sbjct: 81 PNIMKLFEILEDS--------SSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARII 127
Query: 597 IGVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIVSED 645
V + ++H ++ +R +K NILL + K+ D+GLS +
Sbjct: 128 KQVFSGITYMHKHNIV-----HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 29/173 (16%), Positives = 70/173 (40%), Gaps = 23/173 (13%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHP 539
+ F +G G++G ++ +G I+ + + + + ++ +++L L HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI-- 597
+++ + D + +++V E G I + SE +
Sbjct: 81 NIIKIFEVFEDY--------HNMYIVMETCEGGELLERIVSAQA-RGKALSEGYVAELMK 131
Query: 598 GVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIVSED 645
+ A+ + H+ V+ ++ +K NIL + H K+ D+GL+ + +
Sbjct: 132 QMMNALAYFHSQHVV-----HKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 41/178 (23%), Positives = 75/178 (42%), Gaps = 30/178 (16%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLR-----LDLLAKL 536
+F I+GEGS+ + R AI+ L K++ ++ K+ D++++L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRL 87
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
HP V L D K++ + NG +I K+ ++ E
Sbjct: 88 DHPFFVKLYFTFQDD--------EKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRF 134
Query: 597 IG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSEDINSVG 650
+ A+++LH G+I +R +K NILLNE +++D+G + V +
Sbjct: 135 YTAEIVSALEYLHGKGII-----HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 187
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 36/171 (21%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRN-----LKLRLDLLAKL 536
N+FD ++G+G++GK+ R G A++ L K+ + +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQNT 62
Query: 537 RHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
RHP L L YA +++ V E+ + G H+S + ++E
Sbjct: 63 RHPFLTALK-----------YAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEER 106
Query: 594 AVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
A G + A+++LH+ V+ R +K N++L++ K++D+GL
Sbjct: 107 ARFYGAEIVSALEYLHSRDVV-----YRDIKLENLMLDKDGHIKITDFGLC 152
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 26/108 (24%), Positives = 47/108 (43%), Gaps = 14/108 (12%)
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
A L HP +V + D G + A ++V E++ R + P + +
Sbjct: 67 AALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAI 119
Query: 594 AVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGL 639
V+ +A+ F H G+I +R VK NI+++ K+ D+G+
Sbjct: 120 EVIADACQALNFSHQNGII-----HRDVKPANIMISATNAVKVMDFGI 162
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 37/172 (21%), Positives = 75/172 (43%), Gaps = 28/172 (16%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
++ F++ + +G G+ +Y+ + A++ L K + ++ + +L +L HP+
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPN 109
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI--G 598
++ L ++ LV E ++ G I E +SER A
Sbjct: 110 IIKLKEIFETP--------TEISLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQ 156
Query: 599 VAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIVSED 645
+ +AV +LH G++ +R +K N+L K++D+GLS + E
Sbjct: 157 ILEAVAYLHENGIV-----HRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 37/169 (21%), Positives = 68/169 (40%), Gaps = 51/169 (30%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSK----------KYTVRNLKLRLDLLAKLRHPH 540
GEGS+GK+ + VA++ + + + LKL LRHPH
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL-------LRHPH 70
Query: 541 LVCLLGHCIDGGGRDDYAV----NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV- 595
++ L Y V + +V E+ + G +I E ++ +E
Sbjct: 71 IIKL------------YDVITTPTDIVMVIEY-AGGELFDYIVEK--KRM---TEDEGRR 112
Query: 596 ----LIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+I A+++ H + +K N+LL+++ K++D+GLS
Sbjct: 113 FFQQIIC---AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 9e-07
Identities = 33/172 (19%), Positives = 62/172 (36%), Gaps = 26/172 (15%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
+ + +G GS+G++ A + +P V K ++++ L HP+
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VLIG 598
++ L D ++LV E + G + + E A ++
Sbjct: 68 IIRLYETFEDN--------TDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKD 114
Query: 599 VAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIVSED 645
V AV + H V +R +K N L + KL D+GL+ +
Sbjct: 115 VLSAVAYCHKLNVA-----HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 39/199 (19%), Positives = 84/199 (42%), Gaps = 28/199 (14%)
Query: 457 SEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL 515
A+ G + + F + + ++N+D+ +G+G++ + + G A + +
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 516 PSSKKYTVRNLKLR--LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN 573
+ K KL + KL+HP++V L + + +LV++ ++ G
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTGGE 114
Query: 574 FRTHISENTPGKVLNWSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILL--- 626
I +SE A + +++ + H+ G++ +R +K N+LL
Sbjct: 115 LFEDIVARE-----FYSEADASHCIQQILESIAYCHSNGIV-----HRNLKPENLLLASK 164
Query: 627 NEHRIAKLSDYGLSIVSED 645
+ KL+D+GL+I D
Sbjct: 165 AKGAAVKLADFGLAIEVND 183
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 29/173 (16%), Positives = 65/173 (37%), Gaps = 31/173 (17%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR 537
KE + ++ +G G +G +++ + + + + +K + +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIAR 59
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
H +++ L ++ +++EF+S + I+ +ER V
Sbjct: 60 HRNILHLHESFESM--------EELVMIFEFISGLDIFERINT----SAFELNEREIVSY 107
Query: 598 G--VAKAVQFLHTGVIPGFFNNRV----KTNNILL---NEHRIAKLSDYGLSI 641
V +A+QFLH +N + NI+ I K+ ++G +
Sbjct: 108 VHQVCEALQFLH-------SHNIGHFDIRPENIIYQTRRSSTI-KIIEFGQAR 152
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 37/181 (20%), Positives = 75/181 (41%), Gaps = 32/181 (17%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRL------- 530
KE +D ++G G + + G A++ + + + +
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 531 -DLLAKLR-HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN 588
+L ++ HPH++ L+ + +FLV++ M G +++E
Sbjct: 150 THILRQVAGHPHIITLIDSYESS--------SFMFLVFDLMRKGELFDYLTEKV-----A 196
Query: 589 WSERLA--VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSE 644
SE+ ++ + +AV FLH ++ +R +K NILL+++ +LSD+G S E
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANNIV-----HRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 645 D 645
Sbjct: 252 P 252
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 41/189 (21%), Positives = 72/189 (38%), Gaps = 56/189 (29%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD------------------- 531
G+GSYG + + T A++ L K R
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 532 -------LLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN-FRTHISENTP 583
+L KL HP++V L + DD + +++V+E ++ G + P
Sbjct: 82 QVYQEIAILKKLDHPNVVKL--VEV----LDDPNEDHLYMVFELVNQGPVM--EVPTLKP 133
Query: 584 GKVLNWSERLAV-----LIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSD 636
SE A LI K +++LH +I +R +K +N+L+ E K++D
Sbjct: 134 -----LSEDQARFYFQDLI---KGIEYLHYQKII-----HRDIKPSNLLVGEDGHIKIAD 180
Query: 637 YGLSIVSED 645
+G+S +
Sbjct: 181 FGVSNEFKG 189
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 35/164 (21%), Positives = 71/164 (43%), Gaps = 19/164 (11%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LD-LLAKLRHP 539
++ + +G G+YG + K R + +G +A++ + ++ + L LD + + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
V G G V++ E M + + G+ + + + +
Sbjct: 67 FTVTFYGALFREG--------DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 600 AKAVQFLHT--GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
KA++ LH+ VI +R VK +N+L+N K+ D+G+S
Sbjct: 119 VKALEHLHSKLSVI-----HRDVKPSNVLINALGQVKMCDFGIS 157
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 34/170 (20%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKL-RHP 539
N+ + MG G+ G+++K R + G +A++ + S L LD++ K P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG------NFRTHISENTPGKVLNWSERL 593
++V G I VF+ E M + I E GK+
Sbjct: 85 YIVQCFGTFITNT--------DVFIAMELMGTCAEKLKKRMQGPIPERILGKMT------ 130
Query: 594 AVLIGVAKAVQFLHT--GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ + KA+ +L GVI +R VK +NILL+E KL D+G+S
Sbjct: 131 ---VAIVKALYYLKEKHGVI-----HRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 36/174 (20%), Positives = 77/174 (44%), Gaps = 28/174 (16%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR--LDLLAKLRH 538
++N+D+ +G+G++ + + G A + + + K KL + KL+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA--VL 596
P++V L + + +LV++ ++ G I +SE A +
Sbjct: 65 PNIVRLHDSIQEE--------SFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCI 111
Query: 597 IGVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSIVSED 645
+ +++ + H+ G++ +R +K N+LL + KL+D+GL+I D
Sbjct: 112 QQILESIAYCHSNGIV-----HRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 28/133 (21%), Positives = 49/133 (36%), Gaps = 25/133 (18%)
Query: 116 RLTSLRVLSLVSLGI-WGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILD 174
+ ++ L L + G L LE+L + L + + + KL+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELS 72
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLS 234
DN + + + P+LT L++ NK I LS ++ L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNK-----------IKDLSTIE-----------PLK 110
Query: 235 SLGSLNVLNLSDN 247
L +L L+L +
Sbjct: 111 KLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 30/129 (23%), Positives = 47/129 (36%), Gaps = 28/129 (21%)
Query: 218 DLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS--NLPKLPRGLVMAFLSNNSFSGEIP 275
LD S++ L L+ + L S NLPKL +
Sbjct: 23 VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNK----------------- 65
Query: 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSG-SLPKNLNCGGKLVF 334
L++L++S N + G PN++ LNL+ NK S + L L
Sbjct: 66 --------LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117
Query: 335 FDISNNKLT 343
D+ N ++T
Sbjct: 118 LDLFNCEVT 126
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 36/173 (20%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYT------VRNLKL-RLDLLA 534
+F+ ++G+GS+GK+ A++ L KK V + + L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRVLAL 397
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
+ P L L +++++ V E+++ G+ HI +V + E
Sbjct: 398 PGKPPFLTQLH-----------SCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKE 441
Query: 592 RLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
AV +A + FL + G+I R +K +N++L+ K++D+G+
Sbjct: 442 PHAVFYAAEIAIGLFFLQSKGII-----YRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 43/182 (23%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRN------LKLRLDLLAKL 536
+ + ++G G +G +Y G + + VAI+ + + + + + LL K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 537 RH--PHLVCLLGHCIDGGGRDDYAV----NKVFLVYEFMSNGN--FRTHISENTPGKVLN 588
++ L + L+ E F I+E G +
Sbjct: 104 SSGFSGVIRL------------LDWFERPDSFVLILERPEPVQDLF-DFITER--GAL-- 146
Query: 589 WSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRI-AKLSDYGLSIVS 643
E LA V +AV+ H GV+ +R +K NIL++ +R KL D+G +
Sbjct: 147 -QEELARSFFWQVLEAVRHCHNCGVL-----HRDIKDENILIDLNRGELKLIDFGSGALL 200
Query: 644 ED 645
+D
Sbjct: 201 KD 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 37/195 (18%), Positives = 69/195 (35%), Gaps = 39/195 (20%)
Query: 472 SFTLEELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK----------- 519
+ ++ + ++ +G G+YG++ + + AI+ + S+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 520 --KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH 577
+ + + LL L HP+++ L D +LV EF G
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK--------KYFYLVTEFYEGGELFEQ 136
Query: 578 ISENTPGKVLNWSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHR 630
I + E A I + + +LH ++ +R +K NILL N
Sbjct: 137 IINRH-----KFDECDAANIMKQILSGICYLHKHNIV-----HRDIKPENILLENKNSLL 186
Query: 631 IAKLSDYGLSIVSED 645
K+ D+GLS
Sbjct: 187 NIKIVDFGLSSFFSK 201
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 30/170 (17%), Positives = 66/170 (38%), Gaps = 32/170 (18%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
+ +D+ +G G++G +++ G + + + +K + ++ +L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN-FRTHISENTPGKVLNWSERLAVLI-- 597
L+ L D ++ L+ EF+S G F +E+ SE +
Sbjct: 110 LINLHDAFEDK--------YEMVLILEFLSGGELFDRIAAEDY-----KMSEAEVINYMR 156
Query: 598 GVAKAVQFLHTGVIPGFFNNRV----KTNNILL---NEHRIAKLSDYGLS 640
+ ++ +H ++ V K NI+ + K+ D+GL+
Sbjct: 157 QACEGLKHMH-------EHSIVHLDIKPENIMCETKKASSV-KIIDFGLA 198
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 33/195 (16%), Positives = 62/195 (31%), Gaps = 44/195 (22%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHL 541
N I+G GS G + G VA++ + + LL + HP++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNV 71
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN----TPGKVLNWSERLAVLI 597
+ +++ E N N + + K+ +++L
Sbjct: 72 IRYYCSETTD--------RFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 598 GVAKAVQFLHTGVIPGFFNNRV-----KTNNILL-------------NEHRIAKLSDYGL 639
+A V LH + ++ K NIL+ E+ +SD+GL
Sbjct: 123 QIASGVAHLH--------SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 640 S-IVSEDINSVGVRL 653
+ +S L
Sbjct: 175 CKKLDSGQSSFRTNL 189
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 40/175 (22%)
Query: 483 NNFDMSAIMGEGSYGK--LYKGRLENGTSV--AIRCLPSSKKYTVRNLKLRL------DL 532
F++ ++G+G YGK + T A++ L K VRN K ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKAERNI 74
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNW 589
L +++HP +V L YA K++L+ E++S G + + +
Sbjct: 75 LEEVKHPFIVDL--I---------YAFQTGGKLYLILEYLSGGELFMQLE-----REGIF 118
Query: 590 SERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
E A ++ A+ LH G+I R +K NI+LN KL+D+GL
Sbjct: 119 MEDTACFYLAEISMALGHLHQKGII-----YRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 35/216 (16%), Positives = 73/216 (33%), Gaps = 58/216 (26%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLRHPH 540
+F+ MG G +G +++ + + + AI+ + + R +R + LAKL HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 541 LV-------------------------------------------------CLLGHCIDG 551
+V G
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-GV 610
+ +++ + N + ++ + L + I +A+AV+FLH+ G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 611 IPGFFNNR-VKTNNILLNEHRIAKLSDYGLSIVSED 645
+ +R +K +NI + K+ D+GL +
Sbjct: 186 M-----HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 41/196 (20%), Positives = 79/196 (40%), Gaps = 32/196 (16%)
Query: 463 GSEGLPACRSFTLEELKEATN---NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRC---- 514
GS G+ L+ + +++ ++G+G + + + E G A++
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 515 -LPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN 573
SS + +LK + L+HPH+V LL +++V+EFM +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--------GMLYMVFEFMDGAD 112
Query: 574 -FRTHISENTPGKVLNWSERLAVLI--GVAKAVQFLHT-GVIPGFFNNR-VKTNNILL-- 626
+ G V SE +A + +A+++ H +I +R VK + +LL
Sbjct: 113 LCFEIVKRADAGFVY--SEAVASHYMRQILEALRYCHDNNII-----HRDVKPHCVLLAS 165
Query: 627 -NEHRIAKLSDYGLSI 641
KL +G++I
Sbjct: 166 KENSAPVKLGGFGVAI 181
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 40/187 (21%), Positives = 75/187 (40%), Gaps = 34/187 (18%)
Query: 476 EELKEATNNF----DMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRL 530
++L + F ++ +G GSY + A++ + SK+ +++
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI-- 68
Query: 531 DLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWS 590
LL +HP+++ L DG V++V E M G I +S
Sbjct: 69 -LLRYGQHPNIITLKDVYDDG--------KYVYVVTELMKGGELLDKILRQK-----FFS 114
Query: 591 ERLAVLI--GVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHR----IAKLSDYGLSIV 642
ER A + + K V++LH GV+ +R +K +NIL + ++ D+G +
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVV-----HRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 643 SEDINSV 649
N +
Sbjct: 170 LRAENGL 176
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 33/168 (19%), Positives = 67/168 (39%), Gaps = 32/168 (19%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ I+G G +G+++K G +A + + + +K + ++ +L H +L+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN-FRTHISENTPGKVLNWSERLAVLI--GV 599
L N + LV E++ G F I E+ N +E +L +
Sbjct: 150 QLYDAFESK--------NDIVLVMEYVDGGELFDRIIDESY-----NLTELDTILFMKQI 196
Query: 600 AKAVQFLHTGVIPGFFNNRV----KTNNILL---NEHRIAKLSDYGLS 640
+ ++ +H + K NIL + +I K+ D+GL+
Sbjct: 197 CEGIRHMHQ-------MYILHLDLKPENILCVNRDAKQI-KIIDFGLA 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 21/108 (19%), Positives = 48/108 (44%), Gaps = 18/108 (16%)
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
++L H ++V ++ D DD +LV E++ +I + P L+ +
Sbjct: 66 SQLSHQNIVSMI----DVDEEDDCY----YLVMEYIEGPTLSEYIESHGP---LSVDTAI 114
Query: 594 AVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGL 639
+ ++ H ++ +R +K NIL++ ++ K+ D+G+
Sbjct: 115 NFTNQILDGIKHAHDMRIV-----HRDIKPQNILIDSNKTLKIFDFGI 157
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 35/170 (20%), Positives = 69/170 (40%), Gaps = 28/170 (16%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR--LDLLAKLRH 538
T + + +G+G++ + + + G A + + K + KL + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI- 597
P++V L + +L+++ ++ G I +SE A
Sbjct: 70 PNIVRLHDSISEE--------GHHYLIFDLVTGGELFEDIVARE-----YYSEADASHCI 116
Query: 598 -GVAKAVQFLHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLSI 641
+ +AV H GV+ +R +K N+LL + KL+D+GL+I
Sbjct: 117 QQILEAVLHCHQMGVV-----HRNLKPENLLLASKLKGAAVKLADFGLAI 161
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 28/133 (21%), Positives = 49/133 (36%), Gaps = 25/133 (18%)
Query: 116 RLTSLRVLSLVSLGI-WGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILD 174
++R L L + G + +LE+L L + L + + KL+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELS 79
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLS 234
+N + + LP+LT L++ NK + +S L+ L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNK-----------LKDISTLE-----------PLK 117
Query: 235 SLGSLNVLNLSDN 247
L L L+L +
Sbjct: 118 KLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 33/130 (25%), Positives = 52/130 (40%), Gaps = 30/130 (23%)
Query: 218 DLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS--NLPKLPRGLVMAFLSNNSFSGEIP 275
LD K+ + +L L+L + L S NLPKLP+
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPK----------------- 72
Query: 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS--GSLPKNLNCGGKLV 333
L++L++S N + G LPN++ LNL+ NK +L + L L
Sbjct: 73 --------LKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLK 123
Query: 334 FFDISNNKLT 343
D+ N ++T
Sbjct: 124 SLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 25/101 (24%), Positives = 39/101 (38%), Gaps = 7/101 (6%)
Query: 106 SIDSFVTTLARLTSLRVLSL--VSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKIS 163
+ A +L LSL V L +LP +L L+ L+LS N +FG +
Sbjct: 37 NDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAE 92
Query: 164 TMVKLQTLILDDNFFNN-TIPNWFDSLPSLTFLSMRNNKLA 203
+ L L L N + + L L L + N ++
Sbjct: 93 KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 32/146 (21%), Positives = 56/146 (38%), Gaps = 33/146 (22%)
Query: 107 IDSFVTTLARLTSLRVLSLVSLGIWGSLPDKI---HRLYSLEYLDLSSNFLFGSVPPKIS 163
I+ TL+ L + + L+L + I +KI + +L L L N + + +
Sbjct: 37 IEKMDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLI-KKIENLDA 90
Query: 164 TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSK 223
L+ L + N ++ + L +L L M NNK I+ ++D
Sbjct: 91 VADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNK-----------ITNWGEID--- 134
Query: 224 NAISGSLPDLSSLGSLNVLNLSDNKL 249
L++L L L L+ N L
Sbjct: 135 --------KLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 6/102 (5%)
Query: 218 DLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIP 275
+L I LS+L + L LS N ++ S+L + L + L N +I
Sbjct: 29 ELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSGMEN-LRILSLGRNLIK-KIE 86
Query: 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNK 317
+ L++L +S+N + + I L N+ L +++NK
Sbjct: 87 NLDAVADTLEELWISYNQIASLSG--IEKLVNLRVLYMSNNK 126
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 39/186 (20%), Positives = 78/186 (41%), Gaps = 34/186 (18%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGH 547
++G G GK+ + A++ L K + ++L + + PH+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79
Query: 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI--GVAKAVQF 605
+ + +V E + G + I + ++ER A I + +A+Q+
Sbjct: 80 YENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQY 132
Query: 606 LHT-GVIPGFFNNR-VKTNNILL---NEHRIAKLSDYGLS-IVSE-------DINSVGVR 652
LH+ + +R VK N+L + I KL+D+G + + D+ S+GV
Sbjct: 133 LHSINIA-----HRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVI 187
Query: 653 LLILMS 658
+ IL+
Sbjct: 188 MYILLC 193
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 18/108 (16%)
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
+L+ PH+V + D G D ++ ++ + + P L +
Sbjct: 89 GRLQEPHVVPIH----DFGEIDGQL----YVDMRLINGVDLAAMLRRQGP---LAPPRAV 137
Query: 594 AVLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGL 639
A++ + A+ H G +R VK NIL++ A L D+G+
Sbjct: 138 AIVRQIGSALDAAHAAGAT-----HRDVKPENILVSADDFAYLVDFGI 180
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 37/176 (21%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDL------LA 534
++++M +G G + + K R G A + + + + R R ++ L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
++RHP+++ L + V L+ E +S G ++E + +E A
Sbjct: 64 EIRHPNIITLHDIFENK--------TDVVLILELVSGGELFDFLAEKE-----SLTEDEA 110
Query: 595 VLIG--VAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIA----KLSDYGLS 640
+ V +LH K NI+L + + KL D+G++
Sbjct: 111 TQFLKQILDGVHYLH-------SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 37/182 (20%), Positives = 64/182 (35%), Gaps = 39/182 (21%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDL------LA 534
+ +D+ +G G + + K R G A + + + R R ++ L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN-FRTHISENTPGKVLNWSERL 593
++ HP+++ L + V L+ E +S G F + + SE
Sbjct: 71 QVLHPNIITLHDVYENR--------TDVVLILELVSGGELFDFLAQKE------SLSEEE 116
Query: 594 AVLIG--VAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIA----KLSDYGLSIVS 643
A + V +LH K NI+L + I KL D+GL+
Sbjct: 117 ATSFIKQILDGVNYLH-------TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 644 ED 645
ED
Sbjct: 170 ED 171
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 8e-06
Identities = 34/178 (19%), Positives = 61/178 (34%), Gaps = 39/178 (21%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDL------LA 534
+ +D+ +G G + + K R G A + + + R R ++ L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGN-FRTHISENTPGKVLNWSERL 593
++ H +++ L + V L+ E +S G F + + SE
Sbjct: 71 QVLHHNVITLHDVYENR--------TDVVLILELVSGGELFDFLAQKE------SLSEEE 116
Query: 594 AVLIG--VAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIA----KLSDYGLSI 641
A + V +LH K NI+L + I KL D+GL+
Sbjct: 117 ATSFIKQILDGVNYLH-------TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 24/117 (20%), Positives = 48/117 (41%), Gaps = 15/117 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYT-VRNLKLRLDLLAK 535
+ + +G G++G++ + +VA++ L ++ R L L +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 536 L-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
+ H ++V LLG C GG + ++ EF GN T++ V ++
Sbjct: 82 IGHHLNVVNLLGACTKPGG-------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 40/223 (17%), Positives = 71/223 (31%), Gaps = 60/223 (26%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYT-----VRNLKLRLDL 532
E + + +G+GSYG + + AI+ + +K V +K + L
Sbjct: 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG-------------------- 572
+ KL HP++ L D + LV E G
Sbjct: 82 MKKLHHPNIARLYEVYEDE--------QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 573 ---------------NFRTHISENTPGKVLNWSERLA--VLIGVAKAVQFLHT-GVIPGF 614
I E+L ++ + A+ +LH G+
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC--- 190
Query: 615 FNNR-VKTNNILLNEHRIA--KLSDYGLSIVSEDINSVGVRLL 654
+R +K N L + ++ KL D+GLS +N+ +
Sbjct: 191 --HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGM 231
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 41/229 (17%), Positives = 85/229 (37%), Gaps = 48/229 (20%)
Query: 143 SLEYLDLSSNFL-FGSVPPKISTMVKLQTLILDDNFFNNT----IPNWFDSLPSLTFLSM 197
++ LD+ L + + + Q + LDD I + P+L L++
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 198 RNNKLAGPFPSSIQRIS--------TLSDLDLSKNAIS----GSLPD-LSSLGSLNVLNL 244
R+N+L + + + L L ++ G L L +L +L L+L
Sbjct: 64 RSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 245 SDNKL-DSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIF 303
SDN L D+ L + L L +L++L + + +L +
Sbjct: 121 SDNLLGDAGL----QLLCEGLLDPQC-------------RLEKLQLEYCSLSAASCEPLA 163
Query: 304 SL----PNISDLNLASNKFSGSLPKNL-----NCGGKLVFFDISNNKLT 343
S+ P+ +L +++N + + + L + +L + + +T
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 40/323 (12%), Positives = 90/323 (27%), Gaps = 82/323 (25%)
Query: 101 LSENFSIDSFVTTLARL-----TSLRVLSLVSLGI----WGSLPDKIHRLYSLEYLDLSS 151
L N D V + + ++ LSL + + G L + L +L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 152 NFLFGSVPPKISTMV-----KLQTLILDDNFFNNT----IPNWFDSLPSLTFLSMRNNKL 202
N L + + + +L+ L L+ + + + + P L++ NN +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 203 ---------------------------------AGPFPSSIQRISTLSDLDLSKNAISG- 228
+ ++L +L L N +
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 229 -----SLPDLSSLGSLNVLNLSDNKLD-------SNLPKLPRGLVMAFLSNNSFSGEIPK 276
L L L + + + + + L L+ N E +
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302
Query: 277 QYGQL-----NQLQQLDMSFNAL--RGMPP--PAIFSLPNISDLNLASNKFS-------G 320
+ QL+ L + + + + +L +++N+
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362
Query: 321 SLPKNLNCGGKLVFFDISNNKLT 343
L +++ ++
Sbjct: 363 QGLGQPGS--VLRVLWLADCDVS 383
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 34/172 (19%), Positives = 73/172 (42%), Gaps = 37/172 (21%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRN------LKLRLDLLAK 535
+F+ ++G+GS+GK+ A++ L K +++ + + L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLALP 77
Query: 536 LRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
+ P L L +++++ V E+++ G+ HI +V + E
Sbjct: 78 GKPPFLTQLH-----------SCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEP 121
Query: 593 LAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
AV +A + FL + G+I R +K +N++L+ K++D+G+
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGII-----YRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 38/173 (21%)
Query: 483 NNFDMSAIMGEGSYGKLY----KGRLENGTSVAIRCLPSSKKYTVRNLKLRL----DLLA 534
+ F++ ++G+GS+GK++ + A++ L K ++R D+L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL--KKATLKVRDRVRTKMERDILV 81
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
++ HP +V L H YA K++L+ +F+ G+ T +S K + ++E
Sbjct: 82 EVNHPFIVKL--H---------YAFQTEGKLYLILDFLRGGDLFTRLS-----KEVMFTE 125
Query: 592 RLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+A A+ LH+ G+I R +K NILL+E KL+D+GLS
Sbjct: 126 EDVKFYLAELALALDHLHSLGII-----YRDLKPENILLDEEGHIKLTDFGLS 173
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 36/170 (21%), Positives = 75/170 (44%), Gaps = 34/170 (20%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKL-------RLDLLA 534
+ FD +G GS+G++ + E+G A++ L K V LK + +L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL---DKQKVVKLKQIEHTLNEK-RILQ 96
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
+ P LV L D + +++V E+++ G +H+ ++ +SE A
Sbjct: 97 AVNFPFLVKLEFSFKDN--------SNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHA 143
Query: 595 VLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ ++LH+ +I R +K N+L+++ +++D+G +
Sbjct: 144 RFYAAQIVLTFEYLHSLDLI-----YRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 34/158 (21%), Positives = 65/158 (41%), Gaps = 29/158 (18%)
Query: 492 GEGSYGKLYKG---RLENGTSVAIRCLPSSKKYTVRNLKLRLD----LLAKLRHPHLVCL 544
G G +Y + NG V ++ L S + LA++ HP +V +
Sbjct: 89 AHGGLGWIYLALDRNV-NGRPVVLKGLVHSGD---AEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 545 LGHCIDGGGRDDYAVNKV-FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
+ D + V ++V E++ + + + L +E +A L+ + A+
Sbjct: 145 ----FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPAL 195
Query: 604 QFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGL 639
+LH+ G++ +K NI+L E ++ KL D G
Sbjct: 196 SYLHSIGLV-----YNDLKPENIMLTEEQL-KLIDLGA 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 46/226 (20%), Positives = 84/226 (37%), Gaps = 44/226 (19%)
Query: 429 EQHLLHKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMS 488
H H + + + + + A E A S L+ +FD+
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ-------DFDLL 57
Query: 489 AIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKL------RLDLLAKLRHPHL 541
++G GSY K+ RL + A+R + K+ + + + HP L
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVV--KKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 542 VCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
V L +++F V E+++ G+ H+ + E A
Sbjct: 116 VGLH-----------SCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEHARFYS 159
Query: 599 --VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
++ A+ +LH G+I R +K +N+LL+ KL+DYG+
Sbjct: 160 AEISLALNYLHERGII-----YRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 37/172 (21%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRN------LKLRLDLLAK 535
+NF+ ++G+GS+GK+ R+ E G A++ L K +++ + + L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTEKRILSLA 80
Query: 536 LRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
HP L L +++F V EF++ G+ HI K + E
Sbjct: 81 RNHPFLTQLF-----------CCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEA 124
Query: 593 LAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
A + A+ FLH G+I R +K +N+LL+ KL+D+G+
Sbjct: 125 RARFYAAEIISALMFLHDKGII-----YRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 39/173 (22%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKL-------RLDLLA 534
+F + ++G+GS+GK++ + AI+ L KK V + L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSL 73
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSE 591
HP L + +F V E+++ G+ HI +
Sbjct: 74 AWEHPFLTHMF-----------CTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDL 117
Query: 592 RLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
A + +QFLH+ G++ R +K +NILL++ K++D+G+
Sbjct: 118 SRATFYAAEIILGLQFLHSKGIV-----YRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 15/108 (13%), Positives = 40/108 (37%), Gaps = 5/108 (4%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
+ + + +G GS+G + + +E+G A++ + +Y R L ++ L H +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDHVN 61
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN 588
++ L+ + G + + N + ++
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 34/97 (35%), Positives = 46/97 (47%), Gaps = 13/97 (13%)
Query: 157 SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQR 212
SVP I T Q L L DN P FD L LT L + NN+L AG F +
Sbjct: 23 SVPTGIPT--TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVF----DK 76
Query: 213 ISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDN 247
++ L+ L L+ N + S+P +L SL + L +N
Sbjct: 77 LTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 21/143 (14%), Positives = 54/143 (37%), Gaps = 14/143 (9%)
Query: 434 HKSVQDNSATGFSSEVLTNARYVSEAAKLGSEGLPACRSFTLEELKEATNNFDMSAIMGE 493
H++ + ++ ++ + K P + + +++ ++G
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 494 GSYGKLYKGR-LENGTSVAIRCL------PSSKKYTVRNLKLRLDLLAKLRHPHLVCLLG 546
GSYG + + VAI+ + K +R + +L +L H H+V +L
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILNRLNHDHVVKVL- 118
Query: 547 HCIDGGGRDDYAVNKVFLVYEFM 569
+ + + +++++V E
Sbjct: 119 DIVIPKDVEKF--DELYVVLEIA 139
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 40/172 (23%), Positives = 76/172 (44%), Gaps = 37/172 (21%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRN------LKLRLDLLAK 535
++F ++G+GS+GK+ R A++ L KK ++ + R LL
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL--QKKAILKKKEEKHIMSERNVLLKN 95
Query: 536 LRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
++HP LV L H ++ +K++ V ++++ G H+ + + E
Sbjct: 96 VKHPFLVGL--H---------FSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEP 139
Query: 593 LAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
A +A A+ +LH+ ++ R +K NILL+ L+D+GL
Sbjct: 140 RARFYAAEIASALGYLHSLNIV-----YRDLKPENILLDSQGHIVLTDFGLC 186
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 41/176 (23%)
Query: 483 NNFDMSAIMGEGSYGKLY----KGRLENGTSVAIRCLPSSKKYTVRNLKL-------RLD 531
NF++ ++G G+YGK++ + G A++ L K V+ K R
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQV 111
Query: 532 LLAKLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLN 588
L + P LV L H YA K+ L+ ++++ G TH+S +
Sbjct: 112 LEHIRQSPFLVTL--H---------YAFQTETKLHLILDYINGGELFTHLS-----QRER 155
Query: 589 WSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
++E + + A++ LH G+I R +K NILL+ + L+D+GLS
Sbjct: 156 FTEHEVQIYVGEIVLALEHLHKLGII-----YRDIKLENILLDSNGHVVLTDFGLS 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 31/180 (17%), Positives = 74/180 (41%), Gaps = 37/180 (20%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRL--- 530
+++++ +F++ ++G G++G++ +L A++ L K+ +
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL---NKWEMLKRAETACFR 122
Query: 531 ---DLLAKLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPG 584
D+L + L YA N ++LV ++ G+ T +S
Sbjct: 123 EERDVLVNGDSKWITTLH-----------YAFQDDNNLYLVMDYYVGGDLLTLLS-KFED 170
Query: 585 KVLNWSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
++ E +A + A+ +H + +R +K +NIL++ + +L+D+G
Sbjct: 171 RL---PEEMARFYLAEMVIAIDSVHQLHYV-----HRDIKPDNILMDMNGHIRLADFGSC 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 34/180 (18%), Positives = 81/180 (45%), Gaps = 37/180 (20%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKL----- 528
L+E++ ++F++ ++G G++ ++ ++ + G A++ + +K ++ ++
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM--NKWDMLKRGEVSCFRE 110
Query: 529 -RLDLLAKLRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPG 584
R D+L + L +A N ++LV E+ G+ T +S+ G
Sbjct: 111 ER-DVLVNGDRRWITQLH-----------FAFQDENYLYLVMEYYVGGDLLTLLSK--FG 156
Query: 585 KVLNWSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ + +A + A+ +H G + +R +K +NILL+ +L+D+G
Sbjct: 157 ERI--PAEMARFYLAEIVMAIDSVHRLGYV-----HRDIKPDNILLDRCGHIRLADFGSC 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 32/177 (18%), Positives = 64/177 (36%), Gaps = 37/177 (20%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDL------LA 534
+ +D +G G + + K R G A + + + + R R D+ L
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
+++HP+++ L + V L+ E ++ G ++E + +E A
Sbjct: 70 EIQHPNVITLHEVYENK--------TDVILILELVAGGELFDFLAEKE-----SLTEEEA 116
Query: 595 VLIG--VAKAVQFLHTGVIPGFFNNRV----KTNNILLNEHRIA----KLSDYGLSI 641
+ V +LH K NI+L + + K+ D+GL+
Sbjct: 117 TEFLKQILNGVYYLH-------SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 37/172 (21%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKL------RLDLLAK 535
+FD+ ++G GSY K+ RL + A++ + K+ + + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV--KKELVNDDEDIDWVQTEKHVFEQA 66
Query: 536 LRHPHLVCLLGHCIDGGGRDDYA---VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
HP LV L +++F V E+++ G+ H+ + E
Sbjct: 67 SNHPFLVGLH-----------SCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEE 110
Query: 593 LAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
A ++ A+ +LH G+I R +K +N+LL+ KL+DYG+
Sbjct: 111 HARFYSAEISLALNYLHERGII-----YRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 38/169 (22%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRL------DLLAK 535
+F + +G GS+G+++ R NG A++ L KK V LK +L+
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL---KKEIVVRLKQVEHTNDERLMLSI 62
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
+ HP ++ + G D ++F++ +++ G + + K + +A
Sbjct: 63 VTHPFIIRMWGTFQDA--------QQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAK 109
Query: 596 LIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
V A+++LH+ +I R +K NILL+++ K++D+G +
Sbjct: 110 FYAAEVCLALEYLHSKDII-----YRDLKPENILLDKNGHIKITDFGFA 153
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 29/152 (19%), Positives = 55/152 (36%), Gaps = 18/152 (11%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKI--HRLYSLEYLDL---SSNFLFGSVPPKIS----- 163
+L+ L ++S G+ S+ + I L +LE L L ++ F
Sbjct: 189 KKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248
Query: 164 -TMVKLQTLILDDNFFNNTIPNWF---DSLPSLTFLSMRNNKL----AGPFPSSIQRIST 215
L+ L + D N + F D LP L + + L A + +I
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 216 LSDLDLSKNAISGSLPDLSSLGSLNVLNLSDN 247
L +++ N +S + +++SD+
Sbjct: 309 LKFINMKYNYLSDEMKKELQKSLPMKIDVSDS 340
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 39/246 (15%), Positives = 69/246 (28%), Gaps = 66/246 (26%)
Query: 143 SLEYLDLSSNFL-------FGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195
S++ + LS N + I++ L+ D F ++L L
Sbjct: 33 SVKEIVLSGNTIGTEAARWLSEN---IASKKDLEIAEFSDIFTGRVKDEIPEALRLLL-- 87
Query: 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGS-----LPDLSSLGSLNVLNLSDNKL- 249
++ + L + LS NA + + LS L L L +N L
Sbjct: 88 ------------QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135
Query: 250 ---------------DSNLPKLPRGLVMAFLSNNSFSGE----IPKQYGQLNQLQQLDMS 290
+ K L N K + L + M
Sbjct: 136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMV 195
Query: 291 FNALR--GMPP---PAIFSLPNISDLNLASNKF--------SGSLPKNLNCGGKLVFFDI 337
N +R G+ + + L+L N F + +L N L +
Sbjct: 196 QNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN----LRELGL 251
Query: 338 SNNKLT 343
++ L+
Sbjct: 252 NDCLLS 257
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 38/187 (20%), Positives = 81/187 (43%), Gaps = 38/187 (20%)
Query: 480 EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL-----PSSKKYTVRNLKLRLDLL 533
+ + + +GEG+YG + N VAI+ + + + T+R +K+ L
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI----L 79
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
+ RH +++ + I + V++V + M E K+L ++ L
Sbjct: 80 LRFRHENIIGIN-DIIRAPTIEQM--KDVYIVQDLM----------ETDLYKLLK-TQHL 125
Query: 594 A------VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS-IVSE 644
+ L + + ++++H+ V+ +R +K +N+LLN K+ D+GL+ +
Sbjct: 126 SNDHICYFLYQILRGLKYIHSANVL-----HRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 645 DINSVGV 651
D + G
Sbjct: 181 DHDHTGF 187
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 34/174 (19%)
Query: 480 EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL------PSSKKYTVRNLKLRLDL 532
E + +G G+YG + +G VAI+ L K R L L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL---- 76
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMS---NGNFRTHISENTPGKVLNW 589
L ++H +++ LL ++ +LV FM SE
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNF--YDFYLVMPFMQTDLQKIMGLKFSE--------- 125
Query: 590 SERLAVLI-GVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
E++ L+ + K ++++H+ GV+ +R +K N+ +NE K+ D+GL+
Sbjct: 126 -EKIQYLVYQMLKGLKYIHSAGVV-----HRDLKPGNLAVNEDCELKILDFGLA 173
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 34/174 (19%), Positives = 69/174 (39%), Gaps = 34/174 (19%)
Query: 480 EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL------PSSKKYTVRNLKLRLDL 532
+ +G G+ G + +VAI+ L + K R L L
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVL---- 77
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN---W 589
+ + H +++ LL + + V++V E M + +V+
Sbjct: 78 MKCVNHKNIIGLLN--VFTPQKSLEEFQDVYIVMELM----------DANLCQVIQMELD 125
Query: 590 SERLAVLI-GVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
ER++ L+ + ++ LH+ G+I +R +K +NI++ K+ D+GL+
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGII-----HRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 33/172 (19%), Positives = 67/172 (38%), Gaps = 30/172 (17%)
Query: 480 EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL------PSSKKYTVRNLKLRLDL 532
+ +G G+ G + +VAI+ L + K R L L
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL---- 114
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN---W 589
+ + H +++ LL +++ V+LV E M + +V+
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEF--QDVYLVMELM----------DANLCQVIQMELD 162
Query: 590 SERLAVLI-GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
ER++ L+ + ++ LH+ G + +K +NI++ K+ D+GL+
Sbjct: 163 HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 35/176 (19%), Positives = 75/176 (42%), Gaps = 37/176 (21%)
Query: 480 EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL------PSSKKYTVRNLKLRLDL 532
E + + +G G+YG + + G VA++ L K T R L+L
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL---- 81
Query: 533 LAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
L ++H +++ LL +++ N V+LV M ++ ++
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEF--NDVYLVTHLM----------GADLNNIVK-CQK 128
Query: 593 LA------VLIGVAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
L ++ + + ++++H+ +I +R +K +N+ +NE K+ D+GL+
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADII-----HRDLKPSNLAVNEDCELKILDFGLA 179
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 38/176 (21%), Positives = 75/176 (42%), Gaps = 31/176 (17%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRL--- 530
+ +L+ ++++ ++G G++G++ R A++ L SK ++
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWE 118
Query: 531 --DLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLN 588
D++A P +V L D +++V E+M G+ +S V
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDD--------RYLYMVMEYMPGGDLVNLMSN---YDV-- 165
Query: 589 WSERLAVLIG--VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
E+ A V A+ +H+ G I +R VK +N+LL++ KL+D+G
Sbjct: 166 -PEKWARFYTAEVVLALDAIHSMGFI-----HRDVKPDNMLLDKSGHLKLADFGTC 215
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.98 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.96 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.95 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.94 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.94 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.94 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.94 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.94 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.93 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.93 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.93 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.93 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.93 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.93 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.93 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.92 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.92 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.91 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.91 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.91 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.91 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.7 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.92 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.77 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.64 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.35 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.34 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.22 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.17 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.08 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.07 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.68 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.66 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.66 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.41 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.12 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.94 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.65 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.56 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.38 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.21 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.06 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.0 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.88 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.86 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.4 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.84 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.14 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 80.5 |
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.13 Aligned_cols=295 Identities=26% Similarity=0.427 Sum_probs=250.4
Q ss_pred CCChHHHHHHHHHHhcCCCCCCCCCccCCCCCCCC--CCCCCccceEeCC----CCEeEEEecCCCCCCCCCCCCccccc
Q 005898 25 QLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCY--ISSSTQVNITCQD----NFITELKIIGDKPSNVGNFDGFASAN 98 (671)
Q Consensus 25 ~~~~~~~~~Ll~~k~~~~~~~~l~~W~~~~~~~C~--~~~~~~~~v~C~~----~~v~~l~l~~~~~~~~~~~~~~~~~~ 98 (671)
.|.++|++||++||+++.+|..+++|..+ .|||. |. ||+|+. ++|+.+++.+..+.+.
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~-~~~C~~~w~-----gv~C~~~~~~~~l~~L~L~~~~l~~~---------- 65 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWL-----GVLCDTDTQTYRVNNLDLSGLNLPKP---------- 65 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTT-SCTTTTCST-----TEEECCSSSCCCEEEEEEECCCCSSC----------
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCC-CCCCcCCCc-----ceEeCCCCCCceEEEEECCCCCccCC----------
Confidence 47889999999999999888778899765 78998 75 699964 6788888876543210
Q ss_pred ccCCCccCCCcchhcccCCCCCCEEeccc-ccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCc
Q 005898 99 ASLSENFSIDSFVTTLARLTSLRVLSLVS-LGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF 177 (671)
Q Consensus 99 ~~l~~n~~~~~~~~~l~~l~~L~~L~L~~-n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 177 (671)
..+|..++++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.
T Consensus 66 ---------~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 136 (313)
T 1ogq_A 66 ---------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136 (313)
T ss_dssp ---------EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred ---------cccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence 04567788889999999984 88888889889999999999999999988888888899999999999999
Q ss_pred CCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCC-CCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCC
Q 005898 178 FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIS-TLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPK 255 (671)
Q Consensus 178 l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~-~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~ 255 (671)
+++.+|..++++++|++|++++|++++.+|..+..++ +|+.|++++|.+++.+|. +..++ |+.|++++|+++
T Consensus 137 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~----- 210 (313)
T 1ogq_A 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE----- 210 (313)
T ss_dssp EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE-----
T ss_pred cCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc-----
Confidence 9888888888899999999999999888888888887 889999999988877775 55554 777777666554
Q ss_pred CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEE
Q 005898 256 LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFF 335 (671)
Q Consensus 256 ~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l 335 (671)
+.+|..|..+++|+.|++++|++++.+|. +..+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 211 ----------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 273 (313)
T 1ogq_A 211 ----------------GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273 (313)
T ss_dssp ----------------ECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEE
T ss_pred ----------------CcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEE
Confidence 46778888999999999999999988876 7889999999999999999999999999999999
Q ss_pred ECcCCcCcccCCCCCCCCCCCceeccCCCc-CCC
Q 005898 336 DISNNKLTGGLPSCLSNESDKRVVKFRGNC-LSS 368 (671)
Q Consensus 336 ~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~-l~~ 368 (671)
++++|+++|.+|.. ..+++++.+++.+|. +.|
T Consensus 274 ~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 274 NVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp ECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred ECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 99999999999987 778889999999996 544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=394.78 Aligned_cols=339 Identities=27% Similarity=0.356 Sum_probs=191.1
Q ss_pred hcccCCCChHHHHHHHHHHhcCCCCCCCCCccCCCCCCCCCCCCCccceEeCCCCEeEEEecCCCCCCC--------CCC
Q 005898 20 PLGTHQLQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNV--------GNF 91 (671)
Q Consensus 20 ~~~~~~~~~~~~~~Ll~~k~~~~~~~~l~~W~~~~~~~C~~~~~~~~~v~C~~~~v~~l~l~~~~~~~~--------~~~ 91 (671)
..+++++.++|++||++||+++.||..+++|..+ .|||.|. ||+|+.++|+++++.+..+.+. ..+
T Consensus 3 ~~~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~-~~~C~w~-----gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L 76 (768)
T 3rgz_A 3 QASPSQSLYREIHQLISFKDVLPDKNLLPDWSSN-KNPCTFD-----GVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSL 76 (768)
T ss_dssp -----CCHHHHHHHHHHHHTTCSCTTSSTTCCTT-SCGGGST-----TEEEETTEEEEEECTTSCCCEEHHHHHHHTTTC
T ss_pred cCccccCCHHHHHHHHHHHhhCCCcccccCCCCC-CCCcCCc-----ceEECCCcEEEEECCCCCcCCccCccChhHhcc
Confidence 3445556678999999999999888788999854 7999986 6999988999999988755431 111
Q ss_pred CCcccccccCCCccCCCcchhcccCCCCCCEEecccccccccCCc--cccCCCCCCEEEcccCcCCCCCCccC-CCCCcc
Q 005898 92 DGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPD--KIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKL 168 (671)
Q Consensus 92 ~~~~~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~--~~~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~~L 168 (671)
..+.. .+++.+ ....+|..++++++|++|+|++|.+.|.+|. .++++++|++|||++|.+++.+|..+ .++++|
T Consensus 77 ~~L~~--l~~~~~-~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L 153 (768)
T 3rgz_A 77 TGLES--LFLSNS-HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL 153 (768)
T ss_dssp TTCCE--EECTTS-CEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTC
T ss_pred Ccccc--cCCcCC-CcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCC
Confidence 10000 001111 0112234555566666666666666555555 55555556666665555555555443 445555
Q ss_pred CEEEccCCcCCCCCCcc---c----------------------CCCCCcCEEEcccccCCCCCcccccCCCCCCEEEecc
Q 005898 169 QTLILDDNFFNNTIPNW---F----------------------DSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSK 223 (671)
Q Consensus 169 ~~L~L~~N~l~~~~p~~---~----------------------~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~ 223 (671)
++|+|++|.+++..|.. + .++++|++|++++|++++.+|. ++++++|++|++++
T Consensus 154 ~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~ 232 (768)
T 3rgz_A 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG 232 (768)
T ss_dssp SEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCS
T ss_pred CEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcC
Confidence 55555555544444333 2 3444444455555555444444 55555555555555
Q ss_pred CccccccCC-CCCCCCCCEEECCCCCCCCCCCCC-CCCccEEEcCCCCCCCCchhhhcCC-cccceeecccccccCCCcc
Q 005898 224 NAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKL-PRGLVMAFLSNNSFSGEIPKQYGQL-NQLQQLDMSFNALRGMPPP 300 (671)
Q Consensus 224 N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~-~~~L~~l~l~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~ 300 (671)
|.+++.+|. +..+++|++|++++|++++.+|.. ..+|+.+++++|.+++.+|..+... ++|++|++++|++++.+|.
T Consensus 233 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~ 312 (768)
T 3rgz_A 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312 (768)
T ss_dssp SCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCG
T ss_pred CcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccch
Confidence 555544442 445555555555555555444433 2345555555555555555555443 5666666666666666665
Q ss_pred ccCCCCCcCeEecccCcCcccCCcc-cCCCCCccEEECcCCcCcccCCCCCCCCC-CCceeccCCCcCCC
Q 005898 301 AIFSLPNISDLNLASNKFSGSLPKN-LNCGGKLVFFDISNNKLTGGLPSCLSNES-DKRVVKFRGNCLSS 368 (671)
Q Consensus 301 ~~~~l~~L~~L~L~~N~l~g~~p~~-~~~~~~L~~l~ls~N~l~g~~p~~~~~~~-~l~~l~l~~N~l~~ 368 (671)
.+..+++|+.|+|++|+++|.+|.. +..+++|+.|++++|+++|.+|..+..++ +++.+++++|.+++
T Consensus 313 ~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~ 382 (768)
T 3rgz_A 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382 (768)
T ss_dssp GGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEE
T ss_pred HHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCC
Confidence 5666666666666666666555544 55555666666666666655665555544 55555555555543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.55 Aligned_cols=166 Identities=25% Similarity=0.519 Sum_probs=146.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 46778899999999999999863 47889999998776667789999999999999999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENT----------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL 626 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl 626 (671)
..+||||||++|+|.++|+... ....++|.+++.|+.|||+||+|||+. +||||||||+|||+
T Consensus 89 ----~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl 161 (299)
T 4asz_A 89 ----PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLV 161 (299)
T ss_dssp ----SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred ----EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEE
Confidence 6899999999999999997532 235699999999999999999999987 79999999999999
Q ss_pred cCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehh
Q 005898 627 NEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 627 ~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~ 659 (671)
++++++||+|||+|+... |+||+||++|||+|.
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~ 226 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 226 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999996421 999999999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=336.91 Aligned_cols=166 Identities=25% Similarity=0.488 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR---- 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 45777889999999999999864 47899999998776667789999999999999999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTP------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..+||||||++|+|.++++.... ..+++|.++++|+.|||+||+|||+. +||||||||+||
T Consensus 117 ----~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NI 189 (329)
T 4aoj_A 117 ----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNC 189 (329)
T ss_dssp ----SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred ----EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhE
Confidence 68999999999999999975422 24699999999999999999999986 799999999999
Q ss_pred eecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehh
Q 005898 625 LLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~ 659 (671)
|+|+++++||+|||+|+... |+||+||++|||+|.
T Consensus 190 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~ 256 (329)
T 4aoj_A 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY 256 (329)
T ss_dssp EEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcC
Confidence 99999999999999997532 999999999999984
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=332.49 Aligned_cols=165 Identities=26% Similarity=0.444 Sum_probs=142.9
Q ss_pred CCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.++..+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~---- 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ---- 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC----
Confidence 3556788999999999999862 46799999997543 334678999999999999999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNN 623 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~N 623 (671)
..+||||||++|+|.++|+...+ ...++|.++++|+.|||+||+|||+. +||||||||+|
T Consensus 103 ----~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N 175 (308)
T 4gt4_A 103 ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175 (308)
T ss_dssp ----SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ----EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence 57999999999999999975321 23599999999999999999999997 79999999999
Q ss_pred eeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehh
Q 005898 624 ILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 624 iLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~ 659 (671)
||+|+++++||+|||+|+... |+||+||++|||+|.
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~ 243 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhC
Confidence 999999999999999997532 999999999999984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.70 Aligned_cols=165 Identities=23% Similarity=0.430 Sum_probs=143.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++++..+.||+|+||+||+|++.+ .||||+++.. .....++|.+|+++|++++|||||+++|+|.++
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-------- 104 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-------- 104 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--------
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC--------
Confidence 3567788999999999999998753 5999998643 344567899999999999999999999998643
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..+||||||++|+|.++|+... ..++|.+++.|+.|||+||+|||+. +||||||||+|||+|+++++||+|||+
T Consensus 105 -~~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 105 -NLAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp -SCEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred -eEEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence 4799999999999999997643 3499999999999999999999986 899999999999999999999999999
Q ss_pred ccccc-----------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+... |+||+||++|||+||...
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P 236 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence 96421 999999999999997543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=356.85 Aligned_cols=311 Identities=19% Similarity=0.303 Sum_probs=193.6
Q ss_pred hHHHHHHHHHHhcCCCCC---------CCCCccCCCCCCCCCCCCCccceEeC-CCCEeEEEecCCCCCCCCCCCCcccc
Q 005898 28 SSQTQVLLQLRKHLEYPK---------QLEIWINHGADFCYISSSTQVNITCQ-DNFITELKIIGDKPSNVGNFDGFASA 97 (671)
Q Consensus 28 ~~~~~~Ll~~k~~~~~~~---------~l~~W~~~~~~~C~~~~~~~~~v~C~-~~~v~~l~l~~~~~~~~~~~~~~~~~ 97 (671)
..|++||.++++++..+. ...+|+.+ .++|.|. .+.||+|+ .++|++|++.+..+.
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~--~~~GV~C~~~~~V~~L~L~~~~l~----------- 94 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWG--AQPGVSLNSNGRVTGLSLEGFGAS----------- 94 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTT--CCTTEEECTTCCEEEEECTTSCCE-----------
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCccccc--CCCCeEEcCCCCEEEEEecCcccC-----------
Confidence 479999999999986542 23479865 7999982 23479995 468999999776543
Q ss_pred cccCCCccCCCcchhcccCCCCCCEEecccc-------------------------------------------------
Q 005898 98 NASLSENFSIDSFVTTLARLTSLRVLSLVSL------------------------------------------------- 128 (671)
Q Consensus 98 ~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n------------------------------------------------- 128 (671)
+.+|+++++|++|++|+|++|
T Consensus 95 ----------g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~ 164 (636)
T 4eco_A 95 ----------GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164 (636)
T ss_dssp ----------EEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred ----------CcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHH
Confidence 234455666666666666555
Q ss_pred -----------------------------cccccCCccccCCCCCCEEEcccCcCCCC-----------------CCccC
Q 005898 129 -----------------------------GIWGSLPDKIHRLYSLEYLDLSSNFLFGS-----------------VPPKI 162 (671)
Q Consensus 129 -----------------------------~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~-----------------~p~~~ 162 (671)
+++| +|+.|+++++|++|+|++|+++|. +|+.+
T Consensus 165 l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l 243 (636)
T 4eco_A 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDL 243 (636)
T ss_dssp HHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred HhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhh
Confidence 2334 566666666666666666666654 66666
Q ss_pred C--CCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccccc-CCC-CCcccccCC------CCCCEEEeccCccccccCC
Q 005898 163 S--TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNK-LAG-PFPSSIQRI------STLSDLDLSKNAISGSLPD 232 (671)
Q Consensus 163 ~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~g-~~p~~l~~l------~~L~~L~Ls~N~l~g~~p~ 232 (671)
+ ++++|++|+|++|.+.+.+|..++++++|++|++++|+ ++| .+|..++++ ++|+.|++++|+++ .+|.
T Consensus 244 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp CGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred hhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 6 66666666666666666666666666666666666665 665 566666554 66666666666666 3443
Q ss_pred ---CCCCCCCCEEECCCCCCCCCCCCC--CCCccEEEcCCCCCCCCchhhhcCCcc-cceeecccccccCCCccccCCCC
Q 005898 233 ---LSSLGSLNVLNLSDNKLDSNLPKL--PRGLVMAFLSNNSFSGEIPKQYGQLNQ-LQQLDMSFNALRGMPPPAIFSLP 306 (671)
Q Consensus 233 ---~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~l~l~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~ 306 (671)
++.+++|+.|++++|+++|.+|.+ ..+|+.+++++|+++ .+|..++.+++ |+.|++++|.++ .+|..+..++
T Consensus 323 ~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~ 400 (636)
T 4eco_A 323 ETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400 (636)
T ss_dssp HHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTC
T ss_pred hhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcc
Confidence 566666666666666666666622 134566666666665 55666666666 666666666666 3334444433
Q ss_pred --CcCeEecccCcCcccCCcccC-------CCCCccEEECcCCcCcccCCCCC-CCCCCCceeccCCCcCC
Q 005898 307 --NISDLNLASNKFSGSLPKNLN-------CGGKLVFFDISNNKLTGGLPSCL-SNESDKRVVKFRGNCLS 367 (671)
Q Consensus 307 --~L~~L~L~~N~l~g~~p~~~~-------~~~~L~~l~ls~N~l~g~~p~~~-~~~~~l~~l~l~~N~l~ 367 (671)
+|+.|++++|++++.+|..+. .+.+|+.|++++|+++ .+|..+ ..+++++.+++++|.++
T Consensus 401 l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS
T ss_pred cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC
Confidence 566666666666666666555 5556666666666666 344432 33555666666666655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=359.56 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=126.4
Q ss_pred chhcccCCCCCCEEecccccccc-----------------cCCcccc--CCCCCCEEEcccCcCCCCCCccCCCCCccCE
Q 005898 110 FVTTLARLTSLRVLSLVSLGIWG-----------------SLPDKIH--RLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170 (671)
Q Consensus 110 ~~~~l~~l~~L~~L~L~~n~l~g-----------------~~p~~~~--~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 170 (671)
+|..+++|++|++|+|++|.++| .+|+.++ ++++|++|+|++|++.+.+|..|+++++|++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 44555555555555555555555 2555544 5555555555555555555555555555555
Q ss_pred EEccCCc-CCC-CCCcccCCCC-------CcCEEEcccccCCCCCcc--cccCCCCCCEEEeccCccccccCCCCCCCCC
Q 005898 171 LILDDNF-FNN-TIPNWFDSLP-------SLTFLSMRNNKLAGPFPS--SIQRISTLSDLDLSKNAISGSLPDLSSLGSL 239 (671)
Q Consensus 171 L~L~~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~g~~p~--~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L 239 (671)
|+|++|+ ++| .+|..+++++ +|++|+|++|+++ .+|. .++++++|+.|+|++|.++ .+|.+..+++|
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L 597 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKL 597 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcc
Confidence 5555554 554 4554443333 5555555555555 4555 5555555555555555555 44455555555
Q ss_pred CEEECCCCCCCCCCCCCC---CC-ccEEEcCCCCCCCCchhhhcCCcc--cceeecccccccCCCcccc---C--CCCCc
Q 005898 240 NVLNLSDNKLDSNLPKLP---RG-LVMAFLSNNSFSGEIPKQYGQLNQ--LQQLDMSFNALRGMPPPAI---F--SLPNI 308 (671)
Q Consensus 240 ~~L~Ls~N~l~~~~p~~~---~~-L~~l~l~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~~~---~--~l~~L 308 (671)
+.|+|++|+++ .+|... .. |+.|++++|.++ .+|..+..++. |+.|+|++|++++.+|... . .+++|
T Consensus 598 ~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L 675 (876)
T 4ecn_A 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675 (876)
T ss_dssp SEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCE
T ss_pred eEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCc
Confidence 55555555555 333221 23 555555555555 44554444432 5555555555555443211 1 22355
Q ss_pred CeEecccCcCcccCCccc-CCCCCccEEECcCCcCcccCCCCCCCCC--------CCceeccCCCcCC
Q 005898 309 SDLNLASNKFSGSLPKNL-NCGGKLVFFDISNNKLTGGLPSCLSNES--------DKRVVKFRGNCLS 367 (671)
Q Consensus 309 ~~L~L~~N~l~g~~p~~~-~~~~~L~~l~ls~N~l~g~~p~~~~~~~--------~l~~l~l~~N~l~ 367 (671)
+.|+|++|+++ .+|..+ ..+++|+.|+|++|+++ .+|..+.... +|+.|++++|.++
T Consensus 676 ~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~ 741 (876)
T 4ecn_A 676 STVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT 741 (876)
T ss_dssp EEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC
T ss_pred CEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc
Confidence 55555555555 334332 24455555555555555 4444332211 4555555555554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.37 Aligned_cols=169 Identities=21% Similarity=0.396 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~------- 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG------- 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-------
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-------
Confidence 57899999999999999999964 7999999999654 2344678999999999999999999999998754
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..|+|||||++|+|.+++.... ...+++.+...++.||+.||+|||+. +||||||||+|||+++++.+||+|||+
T Consensus 97 -~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 97 -SLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp -EEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred -EEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 7899999999999999997543 23578999999999999999999997 899999999999999999999999999
Q ss_pred ccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+... |+||+||++|||++|....
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF 225 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 97654 9999999999999986543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=327.74 Aligned_cols=166 Identities=23% Similarity=0.366 Sum_probs=148.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+ .
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--------~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--------E 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--------E
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--------E
Confidence 56888999999999999999965 79999999997554444567899999999999999999999998764 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.|||||||++|+|.+++... .+++.+...++.||+.||+|||+. +||||||||+|||+++++.+||+|||+|+
T Consensus 146 ~~ivmEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 89999999999999999753 389999999999999999999997 89999999999999999999999999997
Q ss_pred ccc------------------------------cccccceeeeeeehhhhcc
Q 005898 642 VSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 642 ~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
.+. |+||+||++|||++|....
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 270 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 542 9999999999999986543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.83 Aligned_cols=168 Identities=17% Similarity=0.370 Sum_probs=141.0
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++.+.++||+|+||+||+|++ +|+.||||++..... ....++.|+..+.+++|||||+++|+|.+.+. .....+
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~----~~~~~~ 77 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNG----TWTQLW 77 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS----SSEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC----CceEEE
Confidence 466788999999999999998 589999999965432 22234456666788999999999999986531 123689
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC-----CCCccccCCCCCceeecCCCcEEEcccC
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV-----IPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
||||||++|+|.++++.. .++|.++.+++.|+|+||+|||+++ .++||||||||+|||+|+++++||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999999864 3899999999999999999999863 4689999999999999999999999999
Q ss_pred Ccccc----------------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS----------------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~----------------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+|+.. .|+||+||++|||+|+..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~ 216 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCC
Confidence 98532 199999999999998743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.25 Aligned_cols=167 Identities=23% Similarity=0.366 Sum_probs=149.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE------ 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC------
Confidence 46999999999999999999964 79999999996432 233577999999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+++|+|.+++.... .+++.+...++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 106 --~~yivmEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 106 --KLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp --EEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred --EEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 7899999999999999998643 389999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc--------------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE--------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~--------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+... |+||+||++|+|++|....
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 234 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 997532 9999999999999986654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=314.19 Aligned_cols=170 Identities=24% Similarity=0.359 Sum_probs=144.8
Q ss_pred CcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 486 DMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 486 ~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+..++||+|+||+||+|+.. ++..||||++... .....+.|.+|+++|++++|||||+++++|.+... .....
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~----~~~~~ 104 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK----GKKCI 104 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET----TEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC----CCcEE
Confidence 55678999999999999965 6899999999643 23446789999999999999999999999865311 11368
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEcccCCcc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLSDYGLSI 641 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~DfGla~ 641 (671)
|||||||++|+|.+++.... .+++.....++.||+.||+|||++. ++||||||||+|||+++ ++.+||+|||+|+
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999999998643 4899999999999999999999863 35999999999999984 7999999999997
Q ss_pred ccc---------------------------cccccceeeeeeehhhhcc
Q 005898 642 VSE---------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 642 ~~~---------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
..+ |+||+||++|||+||....
T Consensus 181 ~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf 229 (290)
T 3fpq_A 181 LKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 533 9999999999999986543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=329.13 Aligned_cols=166 Identities=23% Similarity=0.369 Sum_probs=149.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||+++++|.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-------- 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-------- 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--------
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--------
Confidence 356889999999999999999965 79999999997655445567899999999999999999999998764
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
.+|||||||++|+|.+++... .+++.+...++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccc
Confidence 789999999999999999753 389999999999999999999997 8999999999999999999999999999
Q ss_pred cccc------------------------------cccccceeeeeeehhhhc
Q 005898 641 IVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+.+. |+||+||++|||++|...
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~P 346 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 7542 999999999999998654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=349.62 Aligned_cols=264 Identities=31% Similarity=0.450 Sum_probs=166.1
Q ss_pred cchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCC
Q 005898 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDS 188 (671)
Q Consensus 109 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 188 (671)
.+|..+.++++|++|+|++|.+.+.+|..++++++|++|+|++|.+++.+|..+..+++|++|+|++|++++.+|.++++
T Consensus 409 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 488 (768)
T 3rgz_A 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488 (768)
T ss_dssp ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGG
T ss_pred ccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhc
Confidence 34444445555555555555555555555555555555555555555455555555555555555555555555555555
Q ss_pred CCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCC---C-----
Q 005898 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPR---G----- 259 (671)
Q Consensus 189 l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~---~----- 259 (671)
+++|++|++++|++++.+|..++.+++|+.|+|++|+++|.+|. +..+++|+.|++++|+++|.+|.... .
T Consensus 489 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~ 568 (768)
T 3rgz_A 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 568 (768)
T ss_dssp CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCS
T ss_pred CCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhh
Confidence 55555555555555555555555555555555555555544442 44455555555555555544442100 0
Q ss_pred -----------------------------------------ccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCC
Q 005898 260 -----------------------------------------LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMP 298 (671)
Q Consensus 260 -----------------------------------------L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 298 (671)
+..++++.|.++|.+|..++.+++|+.|||++|+++|.+
T Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~i 648 (768)
T 3rgz_A 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648 (768)
T ss_dssp TTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCC
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccC
Confidence 001122224444444555556778899999999999999
Q ss_pred ccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCCcCC
Q 005898 299 PPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQN 372 (671)
Q Consensus 299 ~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~~~~ 372 (671)
|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..++.|+.+++++|.++|.+|.
T Consensus 649 p~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~ 722 (768)
T 3rgz_A 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCS
T ss_pred CHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876553
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=322.24 Aligned_cols=176 Identities=24% Similarity=0.413 Sum_probs=150.6
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCC-CCccccc
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRH-PHLVCLL 545 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~ 545 (671)
..++++...++|+..+.||+|+||+||+|++. +++.||||++.... ....++|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 44556666788999999999999999999854 23689999997654 3346789999999999976 8999999
Q ss_pred ceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCC
Q 005898 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIP 612 (671)
Q Consensus 546 g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~ 612 (671)
|+|.+.+ +..++|||||++|+|.++|+... ....++|.+++.++.|||+||+|||+.
T Consensus 135 g~~~~~~-------~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--- 204 (353)
T 4ase_A 135 GACTKPG-------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--- 204 (353)
T ss_dssp EEECCTT-------SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEEecC-------CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---
Confidence 9997643 25799999999999999997532 134589999999999999999999997
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehh
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~ 659 (671)
+||||||||+|||+++++++||+|||+|+... |+||+||++|||+|.
T Consensus 205 ~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~ 283 (353)
T 4ase_A 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283 (353)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence 79999999999999999999999999997532 999999999999984
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.44 Aligned_cols=163 Identities=23% Similarity=0.292 Sum_probs=143.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.+.|+..++||+|+||+||+|+.. +|+.||||+++.... ..+|+.+|++++|||||++++++.+.+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~-------- 123 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP-------- 123 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT--------
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC--------
Confidence 346778889999999999999965 799999999975432 246999999999999999999998764
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~DfGl 639 (671)
..|||||||++|+|.++++..+ .+++.+...++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 7899999999999999998653 499999999999999999999997 899999999999999987 699999999
Q ss_pred ccccc-----------------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE-----------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~-----------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+... |+||+||++|||++|....
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf 256 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 96421 9999999999999986543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=305.15 Aligned_cols=166 Identities=24% Similarity=0.409 Sum_probs=141.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~------ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD------ 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS------
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC------
Confidence 5799999999999999999995 479999999996542 233567999999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+ +|+|.+++.... .+++.+...++.||+.||+|||++ +|+||||||+|||+++++++||+|||
T Consensus 87 --~~~ivmEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 87 --EIIMVIEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp --EEEEEEECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred --EEEEEEeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence 789999999 689999997654 499999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+... |+||+||++|+|++|....
T Consensus 158 la~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF 212 (275)
T 3hyh_A 158 LSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212 (275)
T ss_dssp CC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC
Confidence 997532 9999999999999986543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.81 Aligned_cols=173 Identities=21% Similarity=0.411 Sum_probs=142.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC----
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD---- 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~---- 556 (671)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999965 79999999996443 3345779999999999999999999999876431100
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
......|+|||||++|+|.+++.........++.....++.||++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 01124799999999999999998755444567888899999999999999997 899999999999999999999999
Q ss_pred cCCcccc-----------------------c-------------------cccccceeeeeeeh
Q 005898 637 YGLSIVS-----------------------E-------------------DINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~-----------------------~-------------------d~~s~g~~l~~~~~ 658 (671)
||+|+.. . |+||+||++|||++
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 9998642 0 99999999999996
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=314.96 Aligned_cols=167 Identities=27% Similarity=0.433 Sum_probs=140.9
Q ss_pred cCCCcCceeccCCceEEEEEEE----cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..+.||+|+||+||+|+. .+++.||||+++... ......+.+|+++|++++|||||++++++.+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG---- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT----
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----
Confidence 4688999999999999999985 247899999996542 223346889999999999999999999998764
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..|+|||||++|+|.+++.... .+++.+...++.||+.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 100 ----~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 100 ----KLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp ----EEEEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred ----EEEEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 7899999999999999998654 389999999999999999999997 899999999999999999999999
Q ss_pred cCCccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 637 YGLSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
||+|+... |+||+||++|||++|....
T Consensus 170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF 226 (304)
T 3ubd_A 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226 (304)
T ss_dssp SEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCC
Confidence 99997532 9999999999999986543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=305.31 Aligned_cols=268 Identities=22% Similarity=0.261 Sum_probs=179.0
Q ss_pred CCCccCCCcchhcccCCCCCCEEecccccccccC-CccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSL-PDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 101 l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~-p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
++.|...+..|..++++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|.++++|++|+|++|.++
T Consensus 37 Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 116 (455)
T 3v47_A 37 LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116 (455)
T ss_dssp CCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCB
T ss_pred ecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCC
Confidence 3444333334555666666666666666665444 344666666666666666666655666666666666666666666
Q ss_pred CCCCcc--cCCCCCcCEEEcccccCCCCCccc-ccCCCCCCEEEeccCccccccCC-C----------------------
Q 005898 180 NTIPNW--FDSLPSLTFLSMRNNKLAGPFPSS-IQRISTLSDLDLSKNAISGSLPD-L---------------------- 233 (671)
Q Consensus 180 ~~~p~~--~~~l~~L~~L~L~~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~g~~p~-~---------------------- 233 (671)
+.+|.. +.++++|++|++++|++++..|.. +.++++|++|++++|.+++..|. +
T Consensus 117 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~ 196 (455)
T 3v47_A 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196 (455)
T ss_dssp THHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCS
T ss_pred ccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccc
Confidence 544433 666666666666666666555554 56666666666666666554442 1
Q ss_pred ------------CCCCCCCEEECCCCCCCCCCCC------------------------------------------CCCC
Q 005898 234 ------------SSLGSLNVLNLSDNKLDSNLPK------------------------------------------LPRG 259 (671)
Q Consensus 234 ------------~~l~~L~~L~Ls~N~l~~~~p~------------------------------------------~~~~ 259 (671)
..+++|+.|++++|++++..|. ...+
T Consensus 197 ~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (455)
T 3v47_A 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG 276 (455)
T ss_dssp TTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSC
T ss_pred hhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccC
Confidence 1335677777777766432110 0135
Q ss_pred ccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcC
Q 005898 260 LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISN 339 (671)
Q Consensus 260 L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~ 339 (671)
++.+++++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 277 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 356 (455)
T 3v47_A 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356 (455)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCS
T ss_pred ceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCC
Confidence 77778888888777777888888888888888888888777777888888888888888777777777788888888888
Q ss_pred CcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 340 NKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 340 N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
|++++..|..+..+++|+.+++++|.+++
T Consensus 357 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 357 NHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred CcccccChhhccccccccEEECCCCcccc
Confidence 88887777777778888888888887775
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=304.57 Aligned_cols=172 Identities=19% Similarity=0.326 Sum_probs=146.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.....- ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~--~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY--GEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT--TTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc--ccC
Confidence 46889999999999999999964 79999999996543 33456788999999999999999999988653210 012
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..+|||||||+ |+|.+++.... .+++.+...++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 46899999996 78999997643 499999999999999999999997 899999999999999999999999999
Q ss_pred ccccc-----------------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE-----------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~-----------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+.+. |+||+||++|||++|....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 96421 9999999999999987544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.77 Aligned_cols=277 Identities=19% Similarity=0.222 Sum_probs=182.5
Q ss_pred CChHHHHHHHHHHhcC-CCC-CCCCCcc---CCCCCCCCCCCCCccceEeCCCCEeEEEecCCCCCCCCCCCCccccccc
Q 005898 26 LQSSQTQVLLQLRKHL-EYP-KQLEIWI---NHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANAS 100 (671)
Q Consensus 26 ~~~~~~~~Ll~~k~~~-~~~-~~l~~W~---~~~~~~C~~~~~~~~~v~C~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~ 100 (671)
+..+|++||++||+.+ .++ ..+.+|. ....++|.|. |+.|..-.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~-----g~~~~~~~-------------------------- 72 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT-----GRALKATA-------------------------- 72 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSH-----HHHHHHHH--------------------------
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccC-----CcchhhhH--------------------------
Confidence 4468999999999987 355 3456784 3346789885 58884100
Q ss_pred CCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCC
Q 005898 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNN 180 (671)
Q Consensus 101 l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 180 (671)
. . -.-...+.++.|+|++|.+. .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++
T Consensus 73 --~-----~--l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~- 140 (328)
T 4fcg_A 73 --D-----L--LEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR- 140 (328)
T ss_dssp --H-----H--HHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-
T ss_pred --H-----H--HhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-
Confidence 0 0 00112345667777777775 66666777777777777777776 66777777777777777777776
Q ss_pred CCCcccCCCCCcCEEEcccccCCCCCcccccC---------CCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCC
Q 005898 181 TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQR---------ISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS 251 (671)
Q Consensus 181 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~---------l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~ 251 (671)
.+|..++++++|++|++++|++.+.+|..+.. +++|+.|+|++|.++..++.+..+++|++|+|++|++++
T Consensus 141 ~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC
T ss_pred cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc
Confidence 66777777777777777777777777766554 777777777777776333346666666666666665542
Q ss_pred CCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCC
Q 005898 252 NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGK 331 (671)
Q Consensus 252 ~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~ 331 (671)
+|..++.+++|+.|++++|++.+.+|..+..+++|+.|+|++|++.+.+|..+..+++
T Consensus 221 ----------------------l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~ 278 (328)
T 4fcg_A 221 ----------------------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278 (328)
T ss_dssp ----------------------CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTT
T ss_pred ----------------------CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCC
Confidence 3445666666666666666666666666666677777777776666666766666667
Q ss_pred ccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 332 LVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 332 L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
|+.|++++|++.+.+|..++++++++.+.+..|.+.
T Consensus 279 L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 777777777776677776666666666666655443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=311.24 Aligned_cols=169 Identities=24% Similarity=0.400 Sum_probs=146.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.++|+..++||+|+||+||+|+.. +|+.||||++.+.. .....+.++++++++.++|||||++++++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~-- 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--
Confidence 357999999999999999999965 79999999996432 111233445577888999999999999998764
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
.+|+|||||++|+|..++.... .+++.....++.||+.||+|||+. +||||||||+|||+|++|.+||
T Consensus 266 ------~lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 266 ------KLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp ------EEEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ------EEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 7999999999999999998653 389999999999999999999997 8999999999999999999999
Q ss_pred cccCCccccc-----------------------------cccccceeeeeeehhhhccc
Q 005898 635 SDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 635 ~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
+|||+|+... |+||+||++|||++|.....
T Consensus 334 ~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 334 SDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp CCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999997543 99999999999999876653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=296.26 Aligned_cols=258 Identities=19% Similarity=0.206 Sum_probs=139.4
Q ss_pred hhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCC
Q 005898 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLP 190 (671)
Q Consensus 111 ~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 190 (671)
+..|.++++|++|+|++|.+.+..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.+++
T Consensus 49 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 128 (477)
T 2id5_A 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128 (477)
T ss_dssp TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred HhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccc
Confidence 44555555555555555555555555555555555555555555543334455555555555555555555555555555
Q ss_pred CcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCC------------------
Q 005898 191 SLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDS------------------ 251 (671)
Q Consensus 191 ~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~------------------ 251 (671)
+|++|++++|++++..|..|..+++|+.|+|++|.+++..+. +..+++|+.|++++|.+++
T Consensus 129 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 208 (477)
T 2id5_A 129 NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208 (477)
T ss_dssp TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEE
T ss_pred cCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCC
Confidence 555555555555554455555555555555555555543332 4444555555555554443
Q ss_pred ------CCCCC---CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccC
Q 005898 252 ------NLPKL---PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSL 322 (671)
Q Consensus 252 ------~~p~~---~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~ 322 (671)
.+|.. ..+|+.+++++|.+++..+..+..+++|+.|+|++|.+++.++..+..+++|+.|+|++|++++..
T Consensus 209 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 288 (477)
T 2id5_A 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVE 288 (477)
T ss_dssp CCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEEC
T ss_pred CCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceEC
Confidence 33321 124555555555555433345555555666666666555555555555555666666666555555
Q ss_pred CcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 323 PKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 323 p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
|..+..+++|+.|++++|++++..+..+..+++++.+++++|.+.+
T Consensus 289 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp TTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred HHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 5555555556666666665554444444555555555555555543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=291.39 Aligned_cols=143 Identities=19% Similarity=0.348 Sum_probs=125.8
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
...+.|+..+.||+|+||+||+|+.+ +++.||||++..... ..++.+|+++|..+ +|||||++++++.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~-- 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKND-- 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT--
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECC--
Confidence 34577999999999999999999742 467899999865432 35688999999998 6999999999998753
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAK 633 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~k 633 (671)
..|+||||+++|+|.+++. .+++.+...++.|++.||+|||+. +|+||||||+|||++.+ +.+|
T Consensus 94 ------~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 94 ------HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp ------EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred ------EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence 7899999999999999984 288999999999999999999997 89999999999999977 7999
Q ss_pred EcccCCcc
Q 005898 634 LSDYGLSI 641 (671)
Q Consensus 634 i~DfGla~ 641 (671)
|+|||+|+
T Consensus 159 l~DFGla~ 166 (361)
T 4f9c_A 159 LVDFGLAQ 166 (361)
T ss_dssp ECCCTTCE
T ss_pred ECcCCCCc
Confidence 99999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=306.93 Aligned_cols=169 Identities=24% Similarity=0.423 Sum_probs=150.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-------- 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-------- 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS--------
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--------
Confidence 367999999999999999999965 79999999998766666778999999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC--CcEEEcccC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH--RIAKLSDYG 638 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~--~~~ki~DfG 638 (671)
..|+|||||++|+|.+++.... ..+++.+...++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEEEEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 7899999999999999986532 3489999999999999999999997 89999999999999854 899999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+.++ |+||+||++|||++|....
T Consensus 303 ~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf 356 (573)
T 3uto_A 303 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356 (573)
T ss_dssp SCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 997542 9999999999999987643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=289.27 Aligned_cols=252 Identities=19% Similarity=0.205 Sum_probs=229.3
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCC-CccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEE
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV-PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLS 196 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 196 (671)
++|++|+|++|.+.+..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 67999999999999999999999999999999999998666 56799999999999999999999999999999999999
Q ss_pred cccccCCCCCccc--ccCCCCCCEEEeccCccccccCC--CCCCCCCCEEECCCCCCCCCCCCCC---------------
Q 005898 197 MRNNKLAGPFPSS--IQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKLP--------------- 257 (671)
Q Consensus 197 L~~N~l~g~~p~~--l~~l~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~L~Ls~N~l~~~~p~~~--------------- 257 (671)
+++|++++.+|.. +..+++|++|+|++|.+++..|. +..+++|++|++++|++++..|...
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999999877766 99999999999999999998776 7899999999999999988766421
Q ss_pred ----------------------CCccEEEcCCCCCCCCchhhhcCC----------------------------------
Q 005898 258 ----------------------RGLVMAFLSNNSFSGEIPKQYGQL---------------------------------- 281 (671)
Q Consensus 258 ----------------------~~L~~l~l~~N~l~~~~p~~~~~l---------------------------------- 281 (671)
.+|+.+++++|.+++.+|..+...
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 358889999999988777665432
Q ss_pred -----cccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCC
Q 005898 282 -----NQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDK 356 (671)
Q Consensus 282 -----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l 356 (671)
++|+.|++++|.+++.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|..+..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 589999999999999999999999999999999999999999999999999999999999998889999999999
Q ss_pred ceeccCCCcCCCC
Q 005898 357 RVVKFRGNCLSSN 369 (671)
Q Consensus 357 ~~l~l~~N~l~~~ 369 (671)
+.+++++|.+++.
T Consensus 350 ~~L~Ls~N~l~~~ 362 (455)
T 3v47_A 350 EVLDLSYNHIRAL 362 (455)
T ss_dssp CEEECCSSCCCEE
T ss_pred CEEECCCCccccc
Confidence 9999999998754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=282.80 Aligned_cols=232 Identities=28% Similarity=0.454 Sum_probs=212.9
Q ss_pred CCCCEEecccccccc--cCCccccCCCCCCEEEccc-CcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 118 TSLRVLSLVSLGIWG--SLPDKIHRLYSLEYLDLSS-NFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g--~~p~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
.+++.|+|++|.+.| .+|..|+++++|++|+|++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 468999999999999 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCC-CCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCC
Q 005898 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLG-SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG 272 (671)
Q Consensus 195 L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~-~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~ 272 (671)
|++++|++++.+|..+..+++|++|++++|.+++.+|. +..++ +|+.|++++|+++ +
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~---------------------~ 188 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT---------------------G 188 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE---------------------E
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeee---------------------c
Confidence 99999999999999999999999999999999988774 77776 7888888777654 4
Q ss_pred CchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCC
Q 005898 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352 (671)
Q Consensus 273 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~ 352 (671)
.+|..+..++ |+.|++++|.+++.+|..+..+++|+.|+|++|++++.+|. +..+++|+.|++++|+++|.+|..+..
T Consensus 189 ~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 266 (313)
T 1ogq_A 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQ 266 (313)
T ss_dssp ECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGG
T ss_pred cCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhc
Confidence 6677888887 99999999999999999999999999999999999988777 788899999999999999999999999
Q ss_pred CCCCceeccCCCcCCCCcCC
Q 005898 353 ESDKRVVKFRGNCLSSNVQN 372 (671)
Q Consensus 353 ~~~l~~l~l~~N~l~~~~~~ 372 (671)
+++++.+++++|.+++..+.
T Consensus 267 l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 267 LKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp CTTCCEEECCSSEEEEECCC
T ss_pred CcCCCEEECcCCcccccCCC
Confidence 99999999999999876543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=296.93 Aligned_cols=256 Identities=20% Similarity=0.199 Sum_probs=212.7
Q ss_pred Ccchh-cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCccc
Q 005898 108 DSFVT-TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWF 186 (671)
Q Consensus 108 ~~~~~-~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 186 (671)
..+|+ .+.++++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|
T Consensus 64 ~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~ 143 (597)
T 3oja_B 64 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 143 (597)
T ss_dssp SEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHh
Confidence 34444 46889999999999999988888899999999999999999988888888999999999999999996666667
Q ss_pred CCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCC-------------------CCCEEECCCC
Q 005898 187 DSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLG-------------------SLNVLNLSDN 247 (671)
Q Consensus 187 ~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~-------------------~L~~L~Ls~N 247 (671)
+++++|++|+|++|.+++..|..|..+++|+.|+|++|.+++.. +..++ +|+.|++++|
T Consensus 144 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n 221 (597)
T 3oja_B 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 221 (597)
T ss_dssp TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSS
T ss_pred ccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCccccccCCchhheeeccCC
Confidence 89999999999999999888888999999999999999988653 22333 4555555555
Q ss_pred CCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccC
Q 005898 248 KLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327 (671)
Q Consensus 248 ~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 327 (671)
.++...+..+.+|+.|++++|.+++ +..++.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|.+++ +|..+.
T Consensus 222 ~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~ 298 (597)
T 3oja_B 222 SINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ 298 (597)
T ss_dssp CCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSS
T ss_pred cccccccccCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccc
Confidence 5554444455678899999999986 4678899999999999999999988899999999999999999986 577777
Q ss_pred CCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCC
Q 005898 328 CGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN 369 (671)
Q Consensus 328 ~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~ 369 (671)
.+++|+.|+|++|.++ .+|..+..+++|+.|++++|.+++.
T Consensus 299 ~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~ 339 (597)
T 3oja_B 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 339 (597)
T ss_dssp CCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred cCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc
Confidence 7889999999999998 6777777888899999999988753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=303.70 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=221.3
Q ss_pred chhccc--CCCCCCEEecccccccccCCccccCCCCCCEEEcccCc-CCC-CCCccCCCC------CccCEEEccCCcCC
Q 005898 110 FVTTLA--RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNF-LFG-SVPPKISTM------VKLQTLILDDNFFN 179 (671)
Q Consensus 110 ~~~~l~--~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~ 179 (671)
+|..++ ++++|++|+|++|.+.|.+|+.|+++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|.++
T Consensus 239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 889988 99999999999999999999999999999999999998 988 899888876 99999999999999
Q ss_pred CCCCc--ccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCC-CCEEECCCCCCCCCCCCC
Q 005898 180 NTIPN--WFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGS-LNVLNLSDNKLDSNLPKL 256 (671)
Q Consensus 180 ~~~p~--~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~-L~~L~Ls~N~l~~~~p~~ 256 (671)
.+|. .++++++|++|++++|+++|.+| .++.+++|+.|++++|.++..++.+..+++ |+.|++++|+++ .+|..
T Consensus 319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~ 395 (636)
T 4eco_A 319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNI 395 (636)
T ss_dssp -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSC
T ss_pred -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchh
Confidence 8898 89999999999999999999999 899999999999999999944445888888 999999999998 66654
Q ss_pred C-----CCccEEEcCCCCCCCCchhhhc-------CCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCc
Q 005898 257 P-----RGLVMAFLSNNSFSGEIPKQYG-------QLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPK 324 (671)
Q Consensus 257 ~-----~~L~~l~l~~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~ 324 (671)
. .+|+.+++++|.+++.+|..+. .+++|+.|++++|+++..++..+..+++|+.|+|++|+++ .+|.
T Consensus 396 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~ 474 (636)
T 4eco_A 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPK 474 (636)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCS
T ss_pred hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCH
Confidence 2 2688999999999999998888 7789999999999999777766777899999999999998 6666
Q ss_pred ccCCCC--------CccEEECcCCcCcccCCCCCC--CCCCCceeccCCCcCCC
Q 005898 325 NLNCGG--------KLVFFDISNNKLTGGLPSCLS--NESDKRVVKFRGNCLSS 368 (671)
Q Consensus 325 ~~~~~~--------~L~~l~ls~N~l~g~~p~~~~--~~~~l~~l~l~~N~l~~ 368 (671)
...... +|+.|++++|+++ .+|..+. .+++++.+++++|.+++
T Consensus 475 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ 527 (636)
T 4eco_A 475 NSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK 527 (636)
T ss_dssp SSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred HHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC
Confidence 543322 8889999999998 7888776 88889999999998885
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-30 Score=290.51 Aligned_cols=295 Identities=19% Similarity=0.211 Sum_probs=198.9
Q ss_pred CEeEEEecCCCCCCCC--CCCCcc-cccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcc
Q 005898 74 FITELKIIGDKPSNVG--NFDGFA-SANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLS 150 (671)
Q Consensus 74 ~v~~l~l~~~~~~~~~--~~~~~~-~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls 150 (671)
.++.+++.++...+.. .+.+.. ....+++.|...+..|..|.++++|++|+|++|.+.+..|+.|+++++|++|+|+
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECT
T ss_pred CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEcc
Confidence 4666777665543221 122111 1223455555444556678888888888888888888888888888888888888
Q ss_pred cCcCCCCCCccCCCCCccCEEEccCCcCCC-CCCcccCCCCCcCEEEcccccCCCCCcccccCCC---------------
Q 005898 151 SNFLFGSVPPKISTMVKLQTLILDDNFFNN-TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIS--------------- 214 (671)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~--------------- 214 (671)
+|.+++..|..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..++.++
T Consensus 113 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~ 192 (606)
T 3vq2_A 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192 (606)
T ss_dssp TSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCC
T ss_pred CCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCC
Confidence 888887777788888888888888888876 5788888888888888888887765444332211
Q ss_pred --------------------------------------------------------------------------------
Q 005898 215 -------------------------------------------------------------------------------- 214 (671)
Q Consensus 215 -------------------------------------------------------------------------------- 214 (671)
T Consensus 193 l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~ 272 (606)
T 3vq2_A 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272 (606)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCT
T ss_pred cceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccc
Confidence
Q ss_pred -----------------------------------CCCEEEeccCccccccCC---------------------CCCCCC
Q 005898 215 -----------------------------------TLSDLDLSKNAISGSLPD---------------------LSSLGS 238 (671)
Q Consensus 215 -----------------------------------~L~~L~Ls~N~l~g~~p~---------------------~~~l~~ 238 (671)
+|+.|++++|.+ +.+|. +..+++
T Consensus 273 ~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~ 351 (606)
T 3vq2_A 273 DFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKVALPS 351 (606)
T ss_dssp TCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCCCCTT
T ss_pred cccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhccCCC
Confidence 122222222222 11110 122344
Q ss_pred CCEEECCCCCCCCC-------------------------CC-CC--CCCccEEEcCCCCCCCCch-hhhcCCcccceeec
Q 005898 239 LNVLNLSDNKLDSN-------------------------LP-KL--PRGLVMAFLSNNSFSGEIP-KQYGQLNQLQQLDM 289 (671)
Q Consensus 239 L~~L~Ls~N~l~~~-------------------------~p-~~--~~~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L~L 289 (671)
|++|++++|++++. +| .+ ..+|+.+++++|.+++..| ..+..+++|+.|++
T Consensus 352 L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 431 (606)
T 3vq2_A 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431 (606)
T ss_dssp CCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEEC
T ss_pred CCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEEC
Confidence 44455554444322 11 11 2456777777777777766 57778888888888
Q ss_pred ccccccCCCccccCCCCCcCeEecccCcCcc-cCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 290 SFNALRGMPPPAIFSLPNISDLNLASNKFSG-SLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 290 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g-~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
++|.+++.+|..+..+++|+.|++++|++++ .+|..+..+++|+.|++++|++++..|..+..+++++.+++++|.+++
T Consensus 432 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 511 (606)
T 3vq2_A 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511 (606)
T ss_dssp TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred cCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCC
Confidence 8888888877778888888888888888877 367777778888888888888887777777778888888888887775
Q ss_pred C
Q 005898 369 N 369 (671)
Q Consensus 369 ~ 369 (671)
.
T Consensus 512 ~ 512 (606)
T 3vq2_A 512 L 512 (606)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-30 Score=291.47 Aligned_cols=255 Identities=20% Similarity=0.192 Sum_probs=146.1
Q ss_pred hcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCc-ccCCCC
Q 005898 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPN-WFDSLP 190 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~ 190 (671)
..+.++++|++|+|++|.+. .+|+.+.++++|++|++++|.+.+..|..+.++++|++|++++|.+.+.+|. .+..++
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 34555666666666666554 4555566666666666666666555555556666666666666665555543 255566
Q ss_pred CcCEEEcccccCCCCC--cccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCC----CCCccEE
Q 005898 191 SLTFLSMRNNKLAGPF--PSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKL----PRGLVMA 263 (671)
Q Consensus 191 ~L~~L~L~~N~l~g~~--p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~----~~~L~~l 263 (671)
+|++|++++|++++.. |..+..+++|+.|++++|.+++..|. +..+++|+.|++++|++++..|.. ..+|+.+
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 6666666666655443 44555566666666666665555443 455566666666666555543321 2455566
Q ss_pred EcCCCCCCCCchhhhcCCcccceeecccccccCC---CccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCC
Q 005898 264 FLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM---PPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN 340 (671)
Q Consensus 264 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N 340 (671)
++++|.+++..|..++.+++|++|++++|++++. .+..+..+++|+.|++++|++++..|..+..+++|+.|++++|
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 6666666555555556666666666666665542 1234555566666666666666555555555666666666666
Q ss_pred cCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 341 KLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 341 ~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
++++..|..+..++.+ .+++++|.+++
T Consensus 511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~ 537 (606)
T 3t6q_A 511 RLTSSSIEALSHLKGI-YLNLASNHISI 537 (606)
T ss_dssp CCCGGGGGGGTTCCSC-EEECCSSCCCC
T ss_pred ccCcCChhHhCccccc-EEECcCCcccc
Confidence 6665555555555555 56666665553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=290.27 Aligned_cols=128 Identities=23% Similarity=0.177 Sum_probs=83.7
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|......+.+|.++++|++|+|++|.|.+..|+.|.+|++|++|+|++|+|++..|..|.++++|++|+|++|+++
T Consensus 58 dLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~ 137 (635)
T 4g8a_A 58 DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 137 (635)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCC
T ss_pred EeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCC
Confidence 35555443333446677777777777777776666666777777777777777776555556677777777777777776
Q ss_pred CCCCcccCCCCCcCEEEcccccCCC-CCcccccCCCCCCEEEeccCccc
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAIS 227 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~g-~~p~~l~~l~~L~~L~Ls~N~l~ 227 (671)
+..+..|+++++|++|++++|++++ .+|..++.+++|++|++++|+++
T Consensus 138 ~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 186 (635)
T 4g8a_A 138 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 186 (635)
T ss_dssp CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence 6555566777777777777777654 35666666677777766666553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=276.32 Aligned_cols=255 Identities=20% Similarity=0.208 Sum_probs=202.9
Q ss_pred Ccchhc-ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCccc
Q 005898 108 DSFVTT-LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWF 186 (671)
Q Consensus 108 ~~~~~~-l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 186 (671)
..+|.. +.++++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.++...+..|
T Consensus 58 ~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~ 137 (390)
T 3o6n_A 58 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 137 (390)
T ss_dssp SEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred hhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHh
Confidence 445544 6889999999999999988888889999999999999999988778888999999999999999985444557
Q ss_pred CCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCC-------------------CCEEECCCC
Q 005898 187 DSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGS-------------------LNVLNLSDN 247 (671)
Q Consensus 187 ~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~-------------------L~~L~Ls~N 247 (671)
.++++|++|++++|++++..|..+..+++|+.|++++|.+++.. +..+++ |+.|++++|
T Consensus 138 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n 215 (390)
T 3o6n_A 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 215 (390)
T ss_dssp TTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCCSEEECCSSCSEEECCSS
T ss_pred cCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccccccCCCCcceEEECCCC
Confidence 88999999999999998877888999999999999999887642 333444 555555555
Q ss_pred CCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccC
Q 005898 248 KLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327 (671)
Q Consensus 248 ~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 327 (671)
.++........+|+.+++++|.+++. ..++.+++|+.|++++|.+++.+|..+..+++|+.|+|++|++++ +|..+.
T Consensus 216 ~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~ 292 (390)
T 3o6n_A 216 SINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ 292 (390)
T ss_dssp CCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSS
T ss_pred eeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccC
Confidence 55444334456788888888888763 567888888888888888888888888888888888888888875 566667
Q ss_pred CCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 328 CGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 328 ~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
.+++|+.|++++|+++ .+|..+..+++++.+++++|.++.
T Consensus 293 ~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~ 332 (390)
T 3o6n_A 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT 332 (390)
T ss_dssp CCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC
T ss_pred CCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce
Confidence 7788888888888887 566667777888888888888764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=276.23 Aligned_cols=185 Identities=32% Similarity=0.580 Sum_probs=161.7
Q ss_pred ccccCHHHHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCccccccee
Q 005898 470 CRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHC 548 (671)
Q Consensus 470 ~~~~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~ 548 (671)
...++++++....++|+..+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999975432 2234689999999999999999999999
Q ss_pred ecCCCCCCcccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 549 ~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
.+.+ ..++||||+++|+|.+++.... ....++|..+..++.+++.||+|||+.+.++|+||||||+||+++
T Consensus 97 ~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 97 MTPT--------ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168 (326)
T ss_dssp CCSS--------CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred ecCC--------ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence 8653 5689999999999999998643 334599999999999999999999998777899999999999999
Q ss_pred CCCcEEEcccCCccccc-------------------------------cccccceeeeeeehhhhc
Q 005898 628 EHRIAKLSDYGLSIVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 628 ~~~~~ki~DfGla~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++.+||+|||+++... |+||+||++|+|+++...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 234 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCS
T ss_pred CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCc
Confidence 99999999999986421 999999999999997654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-29 Score=287.30 Aligned_cols=268 Identities=21% Similarity=0.185 Sum_probs=210.3
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|...+..|..|.++++|++|+|++|.+.+..|+.|+++++|++|+|++|++++..|..|+++++|++|+|++|.++
T Consensus 39 ~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 118 (606)
T 3t6q_A 39 EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118 (606)
T ss_dssp ECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCS
T ss_pred EccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcc
Confidence 45555555555678888888889998888888888888888888889999888888888888888888888888888888
Q ss_pred CCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCC--EEECCCCCCCCCCCCC
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLN--VLNLSDNKLDSNLPKL 256 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~--~L~Ls~N~l~~~~p~~ 256 (671)
+..|..++++++|++|++++|++++..++.+..+++|+.|++++|.+++..|. +..+++|+ .|++++|.+++..|..
T Consensus 119 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~ 198 (606)
T 3t6q_A 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGA 198 (606)
T ss_dssp CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTT
T ss_pred cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhH
Confidence 76677788888888888888888864434444588888888888888877654 67777777 7888888887765543
Q ss_pred CC------------------------------------------------------CccEEEcCCCCCCCCchhhhcCCc
Q 005898 257 PR------------------------------------------------------GLVMAFLSNNSFSGEIPKQYGQLN 282 (671)
Q Consensus 257 ~~------------------------------------------------------~L~~l~l~~N~l~~~~p~~~~~l~ 282 (671)
.. .++.+++++|.+++..+..|+.++
T Consensus 199 ~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~ 278 (606)
T 3t6q_A 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278 (606)
T ss_dssp TTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCT
T ss_pred hhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhcccc
Confidence 21 456777888888877777788888
Q ss_pred ccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCC-CCCCCCCceecc
Q 005898 283 QLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSC-LSNESDKRVVKF 361 (671)
Q Consensus 283 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~-~~~~~~l~~l~l 361 (671)
+|++|++++|+++.. |..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+++.+|.. +..+++++.+++
T Consensus 279 ~L~~L~l~~n~l~~l-p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l 357 (606)
T 3t6q_A 279 GLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357 (606)
T ss_dssp TCSEEECTTSCCSCC-CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEEC
T ss_pred CCCEEeccCCccCCC-ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEEC
Confidence 888888888888844 446778888888888888888777777888888888888888887777654 677788888888
Q ss_pred CCCcCCC
Q 005898 362 RGNCLSS 368 (671)
Q Consensus 362 ~~N~l~~ 368 (671)
++|.+++
T Consensus 358 ~~n~l~~ 364 (606)
T 3t6q_A 358 SHDDIET 364 (606)
T ss_dssp CSSCCCE
T ss_pred CCCcccc
Confidence 8887764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-29 Score=296.01 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=124.1
Q ss_pred chhccc--CCCCCCEEecccccccccCCccccCCCCCCEEEcccCc-CCC-CCCccCCCCC-------ccCEEEccCCcC
Q 005898 110 FVTTLA--RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNF-LFG-SVPPKISTMV-------KLQTLILDDNFF 178 (671)
Q Consensus 110 ~~~~l~--~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l 178 (671)
+|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..+++++ +|++|+|++|.+
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L 560 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence 555555 66666666666666666666666666666666666665 555 4554433333 555555555555
Q ss_pred CCCCCc--ccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCC-CCEEECCCCCCC-----
Q 005898 179 NNTIPN--WFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGS-LNVLNLSDNKLD----- 250 (671)
Q Consensus 179 ~~~~p~--~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~-L~~L~Ls~N~l~----- 250 (671)
+ .+|. .++++++|+.|+|++|+++ .+| .++.+++|+.|+|++|.++..++.+..+++ |+.|+|++|+++
T Consensus 561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~ 637 (876)
T 4ecn_A 561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNI 637 (876)
T ss_dssp C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCCSCCSC
T ss_pred C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCCcCchh
Confidence 5 4555 5555555555555555555 455 555555555555555555522223444544 555555555544
Q ss_pred --------------------CCCCCCC--------CCccEEEcCCCCCCCCchhh-hcCCcccceeecccccccCCCccc
Q 005898 251 --------------------SNLPKLP--------RGLVMAFLSNNSFSGEIPKQ-YGQLNQLQQLDMSFNALRGMPPPA 301 (671)
Q Consensus 251 --------------------~~~p~~~--------~~L~~l~l~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~ 301 (671)
+.+|.++ .+|+.|++++|.++ .+|.. +..+++|+.|+|++|+++..++..
T Consensus 638 ~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~ 716 (876)
T 4ecn_A 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENS 716 (876)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred hhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence 4333322 13444445555444 23322 234455555555555555333322
Q ss_pred cCC-------CCCcCeEecccCcCcccCCcccC--CCCCccEEECcCCcCcccCCCCCCCCCCCceeccCC
Q 005898 302 IFS-------LPNISDLNLASNKFSGSLPKNLN--CGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRG 363 (671)
Q Consensus 302 ~~~-------l~~L~~L~L~~N~l~g~~p~~~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~ 363 (671)
+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|++++
T Consensus 717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCC
T ss_pred hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCC
Confidence 221 124555555555554 4444443 44555555555555554 444444555555555544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-29 Score=278.57 Aligned_cols=131 Identities=21% Similarity=0.262 Sum_probs=84.2
Q ss_pred CCCCCCCEEECCCCCCCCCCCCC---CCCccEEEcCCCCCCC--CchhhhcCCcccceeecccccccC-CCccccCCCCC
Q 005898 234 SSLGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLSNNSFSG--EIPKQYGQLNQLQQLDMSFNALRG-MPPPAIFSLPN 307 (671)
Q Consensus 234 ~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~ 307 (671)
..+++|++|++++|++++.+|.. ...|+.+++++|++++ .+|..++.+++|++|++++|.+++ .++..+..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 45566666666666666655532 2456666677776665 455666666677777777777666 33334566666
Q ss_pred cCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 308 ISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 308 L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
|+.|++++|++++.+|..+. .+|+.||+++|+++ .+|..+..+++++.+++++|.++
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 457 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence 77777777776666665543 56677777777776 66666666677777777777666
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=296.76 Aligned_cols=296 Identities=20% Similarity=0.217 Sum_probs=236.0
Q ss_pred CCEeEEEecCCCCCCCC--CCCCcc-cccccCCCccCCCcc-hhcccCCCCCCEEecccccccccCCccccCCCCCCEEE
Q 005898 73 NFITELKIIGDKPSNVG--NFDGFA-SANASLSENFSIDSF-VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLD 148 (671)
Q Consensus 73 ~~v~~l~l~~~~~~~~~--~~~~~~-~~~~~l~~n~~~~~~-~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~ 148 (671)
..++.|++.++...+.. .+..+. ....+++.|.....+ |..|.++++|++|+|++|.+.+..|+.|+++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 45777887766543221 122111 122345555444555 67788899999999999988888888899999999999
Q ss_pred cccCcCCCCCCcc--CCCCCccCEEEccCCcCCCCCC-cccCCCCCcCEEEcccccCCCCCcccccCC--CCCCEEEecc
Q 005898 149 LSSNFLFGSVPPK--ISTMVKLQTLILDDNFFNNTIP-NWFDSLPSLTFLSMRNNKLAGPFPSSIQRI--STLSDLDLSK 223 (671)
Q Consensus 149 Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l--~~L~~L~Ls~ 223 (671)
|++|.+++.+|.. |.++++|++|+|++|.+++..| ..|+++++|++|+|++|.+++..|..+..+ ++|+.|+++.
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~ 183 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence 9999888766665 8888999999999998887655 578889999999999998888888888777 7888888888
Q ss_pred CccccccCC-CCCCCC------CCEEECCCCCCCCCCCCC----------------------------------------
Q 005898 224 NAISGSLPD-LSSLGS------LNVLNLSDNKLDSNLPKL---------------------------------------- 256 (671)
Q Consensus 224 N~l~g~~p~-~~~l~~------L~~L~Ls~N~l~~~~p~~---------------------------------------- 256 (671)
|.+.+..|. +..+++ |+.|++++|.+++.+|..
T Consensus 184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l 263 (844)
T 3j0a_A 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263 (844)
T ss_dssp SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence 888876653 444443 899999999876654421
Q ss_pred -CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEE
Q 005898 257 -PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFF 335 (671)
Q Consensus 257 -~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l 335 (671)
..+++.+++++|.+++..|..|..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 343 (844)
T 3j0a_A 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343 (844)
T ss_dssp TTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEE
T ss_pred ccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEE
Confidence 1468889999999998888889999999999999999999999889999999999999999998888899999999999
Q ss_pred ECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 336 DISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 336 ~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
++++|.+++..+..+..+++|+.|++++|.+++
T Consensus 344 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 376 (844)
T 3j0a_A 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT 376 (844)
T ss_dssp ECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred ECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence 999999988777788888899999999888764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-31 Score=274.83 Aligned_cols=178 Identities=35% Similarity=0.692 Sum_probs=156.3
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
.+.++...+++|+..+.||+|+||.||+|+..+|+.||||++........+++.+|++++++++||||++++++|.+.+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN- 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT-
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-
Confidence 3344556788999999999999999999998889999999987665556788999999999999999999999987653
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcE
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ 632 (671)
..++||||+++|+|.+++.... ....++|.++..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 109 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 109 -------EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178 (321)
T ss_dssp -------CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCE
T ss_pred -------eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCE
Confidence 5799999999999999997543 234699999999999999999999997 89999999999999999999
Q ss_pred EEcccCCcccc--------------------------------ccccccceeeeeeehhhhc
Q 005898 633 KLSDYGLSIVS--------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 633 ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+|||+++.. .|+||+||++|+|+++...
T Consensus 179 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCc
Confidence 99999998531 1999999999999998643
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=260.05 Aligned_cols=246 Identities=19% Similarity=0.259 Sum_probs=219.8
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
+.|++|+|++|.+.+..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 57899999999999888888999999999999999999888999999999999999999998 5676654 79999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCcccc--ccC-CCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCc
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISG--SLP-DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI 274 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g--~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~ 274 (671)
++|++++..+..+..+++|+.|++++|.++. ..+ .+..+++|++|++++|+++......+.+|+.+++++|.+++..
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~ 208 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD 208 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEEC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccC
Confidence 9999998888889999999999999999963 444 3788999999999999998765556789999999999999988
Q ss_pred hhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCC--
Q 005898 275 PKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN-- 352 (671)
Q Consensus 275 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~-- 352 (671)
|..+..+++|+.|++++|.+++.++..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..+..
T Consensus 209 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~ 287 (330)
T 1xku_A 209 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287 (330)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS
T ss_pred HHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc
Confidence 999999999999999999999999988999999999999999999 88989999999999999999999766665543
Q ss_pred ----CCCCceeccCCCcCC
Q 005898 353 ----ESDKRVVKFRGNCLS 367 (671)
Q Consensus 353 ----~~~l~~l~l~~N~l~ 367 (671)
...+..+++++|.+.
T Consensus 288 ~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 288 YNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp CCTTSCCCSEEECCSSSSC
T ss_pred cccccccccceEeecCccc
Confidence 356778899998875
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=297.52 Aligned_cols=271 Identities=21% Similarity=0.217 Sum_probs=240.8
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccC-CccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSL-PDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFF 178 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~-p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 178 (671)
+++.|......+..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.+
T Consensus 30 dLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l 109 (844)
T 3j0a_A 30 LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL 109 (844)
T ss_dssp EEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCC
T ss_pred ECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCC
Confidence 56667666666789999999999999999777777 78899999999999999999999999999999999999999999
Q ss_pred CCCCCcc--cCCCCCcCEEEcccccCCCCCc-ccccCCCCCCEEEeccCccccccCC-CCCC--CCCCEEECCCCCCCCC
Q 005898 179 NNTIPNW--FDSLPSLTFLSMRNNKLAGPFP-SSIQRISTLSDLDLSKNAISGSLPD-LSSL--GSLNVLNLSDNKLDSN 252 (671)
Q Consensus 179 ~~~~p~~--~~~l~~L~~L~L~~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l--~~L~~L~Ls~N~l~~~ 252 (671)
++.+|.. |+++++|++|+|++|.+++..| ..|+++++|+.|+|++|.+++..|. +..+ ++|+.|++++|.+.+.
T Consensus 110 ~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~ 189 (844)
T 3j0a_A 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSR 189 (844)
T ss_dssp SSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCC
T ss_pred CcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccc
Confidence 9877765 9999999999999999998765 5799999999999999999987764 5555 8999999999999987
Q ss_pred CCCCC---------CCccEEEcCCCCCCCCchhhhcC--------------------------------------Ccccc
Q 005898 253 LPKLP---------RGLVMAFLSNNSFSGEIPKQYGQ--------------------------------------LNQLQ 285 (671)
Q Consensus 253 ~p~~~---------~~L~~l~l~~N~l~~~~p~~~~~--------------------------------------l~~L~ 285 (671)
.|... ..|+.+++++|.+++.+|..+.. .++|+
T Consensus 190 ~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~ 269 (844)
T 3j0a_A 190 VSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVR 269 (844)
T ss_dssp CCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCC
T ss_pred cccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCcc
Confidence 76432 13899999999988877765543 26899
Q ss_pred eeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCc
Q 005898 286 QLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNC 365 (671)
Q Consensus 286 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~ 365 (671)
.|++++|.+.+.++..+..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|..+..+++++.+++++|.
T Consensus 270 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 349 (844)
T 3j0a_A 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349 (844)
T ss_dssp EEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCC
T ss_pred EEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999889999999999999999998
Q ss_pred CCCCc
Q 005898 366 LSSNV 370 (671)
Q Consensus 366 l~~~~ 370 (671)
+.+..
T Consensus 350 i~~~~ 354 (844)
T 3j0a_A 350 IAIIQ 354 (844)
T ss_dssp CCCCC
T ss_pred CCccC
Confidence 87543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=277.96 Aligned_cols=263 Identities=25% Similarity=0.277 Sum_probs=178.5
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|...+..+..+.++++|++|+|++|.+.+..|+.|+++++|++|||++|+++ .+|.. .+++|++|+|++|+++
T Consensus 58 ~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~ 134 (562)
T 3a79_B 58 SLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD 134 (562)
T ss_dssp ECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCS
T ss_pred ECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCcc
Confidence 45556555555567888888888888888888877888888888888888888886 56655 7888888888888887
Q ss_pred C-CCCcccCCCCCcCEEEcccccCCC-------------------------CCcccccCCC-------------------
Q 005898 180 N-TIPNWFDSLPSLTFLSMRNNKLAG-------------------------PFPSSIQRIS------------------- 214 (671)
Q Consensus 180 ~-~~p~~~~~l~~L~~L~L~~N~l~g-------------------------~~p~~l~~l~------------------- 214 (671)
+ .+|..|+++++|++|++++|++++ ..|..+..++
T Consensus 135 ~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~ 214 (562)
T 3a79_B 135 VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214 (562)
T ss_dssp BCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCE
T ss_pred ccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhh
Confidence 6 356778888888888887777653 2233332222
Q ss_pred --------------------------------------------------------------CCCEEEeccCccccccCC
Q 005898 215 --------------------------------------------------------------TLSDLDLSKNAISGSLPD 232 (671)
Q Consensus 215 --------------------------------------------------------------~L~~L~Ls~N~l~g~~p~ 232 (671)
+|++|++++|.++|.+|.
T Consensus 215 ~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~ 294 (562)
T 3a79_B 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294 (562)
T ss_dssp EEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCC
T ss_pred hcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccc
Confidence 455555555555555443
Q ss_pred -C-----------------------------------------------------CCCCCCCEEECCCCCCCCCCCCC--
Q 005898 233 -L-----------------------------------------------------SSLGSLNVLNLSDNKLDSNLPKL-- 256 (671)
Q Consensus 233 -~-----------------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~-- 256 (671)
+ ..+++|++|++++|++++.+|..
T Consensus 295 ~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 374 (562)
T 3a79_B 295 EEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374 (562)
T ss_dssp CCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCC
T ss_pred hhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhc
Confidence 1 45566777777777776655543
Q ss_pred -CCCccEEEcCCCCCCC--CchhhhcCCcccceeecccccccC-CCccccCCCCCcCeEecccCcCcccCCcccCCCCCc
Q 005898 257 -PRGLVMAFLSNNSFSG--EIPKQYGQLNQLQQLDMSFNALRG-MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKL 332 (671)
Q Consensus 257 -~~~L~~l~l~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L 332 (671)
..+|+.+++++|++++ .+|..++.+++|+.|++++|++++ .++..+..+++|+.|++++|++++.+|..+. .+|
T Consensus 375 ~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L 452 (562)
T 3a79_B 375 TLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV 452 (562)
T ss_dssp SCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC
T ss_pred ccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC
Confidence 2456677777777765 334556677777777777777776 4444466667777777777777766665543 567
Q ss_pred cEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 333 VFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 333 ~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
+.|++++|+++ .+|..+..+++++.+++++|.++.
T Consensus 453 ~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC
T ss_pred CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC
Confidence 77777777777 566666677777777777777763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=269.53 Aligned_cols=176 Identities=25% Similarity=0.352 Sum_probs=154.2
Q ss_pred ccCHHHHHHHhcC----------CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCC
Q 005898 472 SFTLEELKEATNN----------FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540 (671)
Q Consensus 472 ~~~~~~~~~~~~~----------f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n 540 (671)
.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4677888777764 666778999999999999976 79999999997665555678999999999999999
Q ss_pred cccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCC
Q 005898 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVK 620 (671)
Q Consensus 541 iv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 620 (671)
|++++++|...+ ..++||||+++|+|.+++... .++|..+..++.|+++||+|||+. +|+|||||
T Consensus 104 iv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlk 168 (321)
T 2c30_A 104 VVEMYKSYLVGE--------ELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168 (321)
T ss_dssp BCCEEEEEEETT--------EEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred cceEEEEEEECC--------EEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCC
Confidence 999999998753 689999999999999998643 489999999999999999999997 89999999
Q ss_pred CCceeecCCCcEEEcccCCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 621 TNNILLNEHRIAKLSDYGLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 621 ~~NiLl~~~~~~ki~DfGla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+||+++.++.+||+|||+++.. .|+||+|+++|+|+++...
T Consensus 169 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred HHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999987532 1999999999999997543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=287.88 Aligned_cols=267 Identities=21% Similarity=0.196 Sum_probs=158.9
Q ss_pred CCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCC
Q 005898 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNN 180 (671)
Q Consensus 101 l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 180 (671)
++.|...+..+..+.++++|++|+|++|.+.+..|..|+++++|++|+|++|++++..+..|.++++|++|+|++|.+++
T Consensus 32 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~ 111 (680)
T 1ziw_A 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111 (680)
T ss_dssp CCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred CCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc
Confidence 44443333334456667777777777777766666667777777777777776664444456677777777777777666
Q ss_pred CCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC---CCCCCCCCEEECCCCCCCCCCCCCC
Q 005898 181 TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD---LSSLGSLNVLNLSDNKLDSNLPKLP 257 (671)
Q Consensus 181 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~---~~~l~~L~~L~Ls~N~l~~~~p~~~ 257 (671)
..|..|+++++|++|++++|.+++..|..++++++|++|++++|.+++..+. ...+++|+.|++++|++++..|...
T Consensus 112 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~ 191 (680)
T 1ziw_A 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191 (680)
T ss_dssp CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGG
T ss_pred cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhh
Confidence 5556666777777777777777666666666677777777777766655543 2344566666666666655444310
Q ss_pred ------------------------------CCccEEEcCCCCCCCCchhhhcCCcc--cceeecccccccCCCccccCCC
Q 005898 258 ------------------------------RGLVMAFLSNNSFSGEIPKQYGQLNQ--LQQLDMSFNALRGMPPPAIFSL 305 (671)
Q Consensus 258 ------------------------------~~L~~l~l~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~~~~~l 305 (671)
..++.+++++|.+++..|..|..++. |+.|++++|++++.+|..+..+
T Consensus 192 ~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l 271 (680)
T 1ziw_A 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL 271 (680)
T ss_dssp GGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTC
T ss_pred hhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCc
Confidence 23455555555555555555555433 5555555555555555555555
Q ss_pred CCcCeEecccCcCcccCCcccC---------------------------------CCCCccEEECcCCcCcccCCCCCCC
Q 005898 306 PNISDLNLASNKFSGSLPKNLN---------------------------------CGGKLVFFDISNNKLTGGLPSCLSN 352 (671)
Q Consensus 306 ~~L~~L~L~~N~l~g~~p~~~~---------------------------------~~~~L~~l~ls~N~l~g~~p~~~~~ 352 (671)
++|+.|++++|++++..|..+. .+++|+.|++++|.+++..|..+..
T Consensus 272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 351 (680)
T 1ziw_A 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351 (680)
T ss_dssp TTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTT
T ss_pred ccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhcc
Confidence 5555555555555555554444 4455555555555555555555555
Q ss_pred CCCCceeccCCCcCC
Q 005898 353 ESDKRVVKFRGNCLS 367 (671)
Q Consensus 353 ~~~l~~l~l~~N~l~ 367 (671)
+++++.+++++|.++
T Consensus 352 l~~L~~L~Ls~n~~~ 366 (680)
T 1ziw_A 352 LINLKYLSLSNSFTS 366 (680)
T ss_dssp CTTCCEEECTTCBSC
T ss_pred ccCCcEEECCCCchh
Confidence 555555555555443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=270.47 Aligned_cols=167 Identities=23% Similarity=0.370 Sum_probs=147.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|+.++||||+++++++.+.+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 87 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK------ 87 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS------
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC------
Confidence 45788999999999999999996 58999999999653 2344677899999999999999999999997653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.+...++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 88 --~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 88 --TLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred --EEEEEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence 7899999999999999997643 389999999999999999999997 89999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|++|...
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 213 (328)
T 3fe3_A 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213 (328)
T ss_dssp CCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred CceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 98532 1999999999999997554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=259.38 Aligned_cols=245 Identities=21% Similarity=0.233 Sum_probs=217.7
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|++|+|++|.+.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 58999999999999888889999999999999999999888999999999999999999998 6776655 89999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCcccc--ccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCc
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISG--SLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI 274 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g--~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~ 274 (671)
++|++++..+..+..+++|+.|++++|.++. ..|. +..+ +|+.|++++|++++.....+.+|+.+++++|.+++..
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~ 209 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIE 209 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCccccCCCCEEECCCCcCCccC
Confidence 9999997666779999999999999999963 4443 6666 9999999999998865566788999999999999988
Q ss_pred hhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCC-
Q 005898 275 PKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNE- 353 (671)
Q Consensus 275 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~- 353 (671)
|..+..+++|+.|++++|++++.++..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..+...
T Consensus 210 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 288 (332)
T 2ft3_A 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG 288 (332)
T ss_dssp TTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSS
T ss_pred HHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccc
Confidence 899999999999999999999999989999999999999999999 789889999999999999999997766665443
Q ss_pred -----CCCceeccCCCcCC
Q 005898 354 -----SDKRVVKFRGNCLS 367 (671)
Q Consensus 354 -----~~l~~l~l~~N~l~ 367 (671)
..++.+++++|.+.
T Consensus 289 ~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 289 FGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp CCSSSCCBSEEECCSSSSC
T ss_pred cccccccccceEeecCccc
Confidence 45778899998776
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=275.16 Aligned_cols=251 Identities=24% Similarity=0.229 Sum_probs=212.7
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.++...+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 47899999999999999999999999999999999999988999999999999999999999776678999999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCC---CCCCccEEEcCCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPK---LPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~L~~l~l~~N~l~~~ 273 (671)
++|++++..|..+..+++|+.|++++|.+++..| .+..+++|+.|++++|++++..+. -..+|+.+++++|.+++.
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 9999999889999999999999999999998777 489999999999999999875442 234566666666666655
Q ss_pred chhhhcCCc------------------------ccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCC
Q 005898 274 IPKQYGQLN------------------------QLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG 329 (671)
Q Consensus 274 ~p~~~~~l~------------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~ 329 (671)
.+..|..++ +|+.|++++|++++.++..+..+++|+.|+|++|++++..+..+..+
T Consensus 192 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 271 (477)
T 2id5_A 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271 (477)
T ss_dssp CTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTC
T ss_pred ChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhcccc
Confidence 554555444 55566666677777766677888888888888888887777778888
Q ss_pred CCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 330 GKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 330 ~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
.+|+.|+|++|++++..|..+..+++|+.+++++|.+++
T Consensus 272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 310 (477)
T 2id5_A 272 LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310 (477)
T ss_dssp TTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC
T ss_pred ccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce
Confidence 888888888888888888888888888888888888774
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-29 Score=281.87 Aligned_cols=295 Identities=19% Similarity=0.177 Sum_probs=236.2
Q ss_pred CEeEEEecCCCCCCC--CCCCCc-ccccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcc
Q 005898 74 FITELKIIGDKPSNV--GNFDGF-ASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLS 150 (671)
Q Consensus 74 ~v~~l~l~~~~~~~~--~~~~~~-~~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls 150 (671)
.++.+++.++...+. ..+.+. .....+++.|...+..|..++++++|++|+|++|.+.+..|..++++++|++|+|+
T Consensus 57 ~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 136 (606)
T 3vq2_A 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA 136 (606)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECC
T ss_pred cCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCC
Confidence 467777776654332 112221 11234566676666668899999999999999999998888899999999999999
Q ss_pred cCcCCC-CCCccCCCCCccCEEEccCCcCCCCCCcccC------------------------------------------
Q 005898 151 SNFLFG-SVPPKISTMVKLQTLILDDNFFNNTIPNWFD------------------------------------------ 187 (671)
Q Consensus 151 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~------------------------------------------ 187 (671)
+|.+++ .+|..|+++++|++|+|++|.+++..|..++
T Consensus 137 ~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~ 216 (606)
T 3vq2_A 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFN 216 (606)
T ss_dssp SSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCS
T ss_pred CCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCcc
Confidence 999986 6799999999999999999988765443221
Q ss_pred --------------------------------------------------------------------------------
Q 005898 188 -------------------------------------------------------------------------------- 187 (671)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (671)
T Consensus 217 ~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~ 296 (606)
T 3vq2_A 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296 (606)
T ss_dssp CHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCC
T ss_pred chhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCcc
Confidence
Q ss_pred ---------------------------------------------------CCCCcCEEEcccccCCCC--CcccccCCC
Q 005898 188 ---------------------------------------------------SLPSLTFLSMRNNKLAGP--FPSSIQRIS 214 (671)
Q Consensus 188 ---------------------------------------------------~l~~L~~L~L~~N~l~g~--~p~~l~~l~ 214 (671)
.+++|++|++++|++++. +|..+..++
T Consensus 297 ~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~ 376 (606)
T 3vq2_A 297 IKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376 (606)
T ss_dssp CCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCS
T ss_pred chhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCC
Confidence 122333344444444332 245555666
Q ss_pred CCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCC-CC---CCCccEEEcCCCCCCCCchhhhcCCcccceeecc
Q 005898 215 TLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLP-KL---PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMS 290 (671)
Q Consensus 215 ~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p-~~---~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls 290 (671)
+|+.|++++|.+++..+.+..+++|+.|++++|++++..| .. ..+|+.+++++|.+++..|..++.+++|+.|+++
T Consensus 377 ~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 456 (606)
T 3vq2_A 377 SLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456 (606)
T ss_dssp CCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECT
T ss_pred cccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECC
Confidence 6666666666666655567889999999999999988776 22 4689999999999999999999999999999999
Q ss_pred cccccC-CCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 291 FNALRG-MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 291 ~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
+|.+++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|..+..+++++.+++++|.++.
T Consensus 457 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 535 (606)
T 3vq2_A 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535 (606)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC
T ss_pred CCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc
Confidence 999998 478889999999999999999999999999999999999999999999999999999999999999999884
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=265.48 Aligned_cols=170 Identities=19% Similarity=0.385 Sum_probs=151.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|...+.||+|+||+||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.+.+ .
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--------~ 81 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK--------R 81 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--------E
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC--------e
Confidence 46778899999999999999975 68999999987766667788999999999999999999999998753 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ..++|.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccce
Confidence 899999999999999998642 3499999999999999999999997 79999999999999999999999999985
Q ss_pred cc--------------------------------------------ccccccceeeeeeehhhhcccc
Q 005898 642 VS--------------------------------------------EDINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 642 ~~--------------------------------------------~d~~s~g~~l~~~~~~~~~~~~ 665 (671)
.. .|+||+|+++|+|+++....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 31 2999999999999987655443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=264.48 Aligned_cols=166 Identities=22% Similarity=0.380 Sum_probs=147.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.+.|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-------- 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-------- 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--------
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--------
Confidence 45788999999999999999985 579999999987555445677899999999999999999999998754
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++... .+++.++..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 689999999999999999764 389999999999999999999997 8999999999999999999999999987
Q ss_pred cccc------------------------------cccccceeeeeeehhhhc
Q 005898 641 IVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+... |+||+||++|+|+++...
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 215 (297)
T 3fxz_A 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (297)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 5321 999999999999997543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=281.73 Aligned_cols=175 Identities=18% Similarity=0.270 Sum_probs=150.7
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeec
Q 005898 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550 (671)
Q Consensus 475 ~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 550 (671)
+.++....++|+..++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++..++|||||+++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4555566788999999999999999999976 588999999964321 123348899999999999999999999987
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
.+ ..|+|||||++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+|||++.++
T Consensus 146 ~~--------~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 146 DN--------NLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG 212 (437)
T ss_dssp SS--------EEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred CC--------EEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence 53 7899999999999999998632 3489999999999999999999987 899999999999999999
Q ss_pred cEEEcccCCcccc------------------------------------ccccccceeeeeeehhhhc
Q 005898 631 IAKLSDYGLSIVS------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 631 ~~ki~DfGla~~~------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.+||+|||+|+.. .|+||+||++|||++|...
T Consensus 213 ~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P 280 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280 (437)
T ss_dssp CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence 9999999998431 1999999999999997654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=262.57 Aligned_cols=180 Identities=38% Similarity=0.592 Sum_probs=157.6
Q ss_pred cccCHHHHHHHhcCCCcC------ceeccCCceEEEEEEEcCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcCCCCC
Q 005898 471 RSFTLEELKEATNNFDMS------AIMGEGSYGKLYKGRLENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKLRHPH 540 (671)
Q Consensus 471 ~~~~~~~~~~~~~~f~~~------~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~n 540 (671)
..++++++..++++|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999887 8999999999999986 57899999986432 234578999999999999999
Q ss_pred cccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCC
Q 005898 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVK 620 (671)
Q Consensus 541 iv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk 620 (671)
|+++++++.+.+ ..++||||+++|+|.+++........++|..+..++.++++||+|||+. +|+|||||
T Consensus 92 i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlk 160 (307)
T 2nru_A 92 LVELLGFSSDGD--------DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIK 160 (307)
T ss_dssp BCCEEEEECSSS--------SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred eEEEEEEEecCC--------ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCC
Confidence 999999997653 5799999999999999987544345699999999999999999999987 89999999
Q ss_pred CCceeecCCCcEEEcccCCcccc-------------------------------ccccccceeeeeeehhhhc
Q 005898 621 TNNILLNEHRIAKLSDYGLSIVS-------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 621 ~~NiLl~~~~~~ki~DfGla~~~-------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+||++++++.+||+|||+++.. .|+||+|+++|+|+++...
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCC
Confidence 99999999999999999987532 1999999999999997543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-30 Score=270.78 Aligned_cols=168 Identities=24% Similarity=0.407 Sum_probs=146.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 555 (671)
..++|+..++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++..+ +|||||++++++.+.+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~--- 97 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD--- 97 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC---
Confidence 3468999999999999999999965 68999999997532 23456788999999988 6999999999998753
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..|+||||+++|+|..++.... .+++.++..++.+++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 98 -----~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 98 -----RLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp -----EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred -----EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence 7899999999999999997643 389999999999999999999997 89999999999999999999999
Q ss_pred ccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 636 DYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 636 DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|||+++... |+||+||++|||++|...
T Consensus 167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 223 (353)
T 3txo_A 167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223 (353)
T ss_dssp CCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCC
Confidence 999987421 999999999999997554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=257.51 Aligned_cols=259 Identities=22% Similarity=0.229 Sum_probs=221.6
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|......+..+.++++|++|+|++|.+.+..|..|+++++|++|+|++|+++ .+|..+. ++|++|++++|.++
T Consensus 60 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~ 136 (332)
T 2ft3_A 60 DLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR 136 (332)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCC
T ss_pred ECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccC
Confidence 45555544444668999999999999999999999999999999999999999997 6777665 89999999999999
Q ss_pred CCCCcccCCCCCcCEEEcccccCC--CCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCC-
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLA--GPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL- 256 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~--g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~- 256 (671)
+..+..|.++++|++|++++|.++ +..|..+..+ +|+.|++++|.+++.+..+. ++|+.|++++|++++..+..
T Consensus 137 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l 213 (332)
T 2ft3_A 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDL 213 (332)
T ss_dssp CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSS
T ss_pred ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHh
Confidence 877778999999999999999996 4778888888 99999999999997554443 79999999999999877653
Q ss_pred --CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCC-----
Q 005898 257 --PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCG----- 329 (671)
Q Consensus 257 --~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~----- 329 (671)
..+|+.+++++|.+++..|..+..+++|+.|++++|+++.. |..+..+++|+.|++++|++++..+..+...
T Consensus 214 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 292 (332)
T 2ft3_A 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVK 292 (332)
T ss_dssp TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBC-CTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSS
T ss_pred cCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeec-ChhhhcCccCCEEECCCCCCCccChhHccccccccc
Confidence 35799999999999998888999999999999999999954 5568999999999999999998777766543
Q ss_pred -CCccEEECcCCcCc--ccCCCCCCCCCCCceeccCCCc
Q 005898 330 -GKLVFFDISNNKLT--GGLPSCLSNESDKRVVKFRGNC 365 (671)
Q Consensus 330 -~~L~~l~ls~N~l~--g~~p~~~~~~~~l~~l~l~~N~ 365 (671)
..|+.+++++|.++ +..|..+..++.++.+++++|.
T Consensus 293 ~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 57899999999987 6677778888999999998874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=268.46 Aligned_cols=166 Identities=23% Similarity=0.362 Sum_probs=146.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 78 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD------ 78 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS------
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC------
Confidence 56888999999999999999965 79999999996432 234567899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|..++.... .+++.....++.+|+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 79 --~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 79 --RLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred --EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeecc
Confidence 7899999999999999997643 389999999999999999999997 89999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|||++|...
T Consensus 151 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 204 (337)
T 1o6l_A 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred chhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCC
Confidence 98641 1999999999999997643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=271.49 Aligned_cols=166 Identities=20% Similarity=0.505 Sum_probs=144.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc--------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE--------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
.++|+..+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+++|+++ +|||||+++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 457888999999999999999852 35579999997543 34567899999999999 899999999999765
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
+ ..++||||+++|+|.+++....+ ...++|.++..++.||++||+|||+. +|+|||
T Consensus 160 ~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 228 (370)
T 2psq_A 160 G--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 228 (370)
T ss_dssp S--------SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred C--------CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 3 57999999999999999976431 24589999999999999999999997 899999
Q ss_pred CCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeeh
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
|||+||++++++.+||+|||+++... |+||+||++|||++
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 300 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHT
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 99999999999999999999986321 99999999999998
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=254.92 Aligned_cols=260 Identities=22% Similarity=0.192 Sum_probs=221.0
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|...+..+..+.++++|++|+|++|.+.+..|..|+++++|++|+|++|+++ .+|..+. ++|++|++++|.++
T Consensus 58 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~ 134 (330)
T 1xku_A 58 DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT 134 (330)
T ss_dssp ECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCC
T ss_pred ECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCccc
Confidence 45555544444558999999999999999999988999999999999999999997 5776665 79999999999999
Q ss_pred CCCCcccCCCCCcCEEEcccccCC--CCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCC-
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLA--GPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL- 256 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~--g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~- 256 (671)
+..+..|.++++|++|++++|.++ +..|..+..+++|+.|++++|.++.....+. ++|++|++++|++++..|..
T Consensus 135 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~ 212 (330)
T 1xku_A 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASL 212 (330)
T ss_dssp BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGG
T ss_pred ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHh
Confidence 888888999999999999999996 4778899999999999999999986544443 89999999999998876643
Q ss_pred --CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCC------
Q 005898 257 --PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNC------ 328 (671)
Q Consensus 257 --~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~------ 328 (671)
..+|+.+++++|.+++..+..+..+++|+.|++++|+++.. |..+..+++|+.|++++|++++..+..+..
T Consensus 213 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~ 291 (330)
T 1xku_A 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 291 (330)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTT
T ss_pred cCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccC-ChhhccCCCcCEEECCCCcCCccChhhcCCcccccc
Confidence 36799999999999988888999999999999999999954 557899999999999999999877666643
Q ss_pred CCCccEEECcCCcCcc--cCCCCCCCCCCCceeccCCCc
Q 005898 329 GGKLVFFDISNNKLTG--GLPSCLSNESDKRVVKFRGNC 365 (671)
Q Consensus 329 ~~~L~~l~ls~N~l~g--~~p~~~~~~~~l~~l~l~~N~ 365 (671)
...++.+++++|.+.. ..|..+..+..++.+++++|+
T Consensus 292 ~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 292 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 3678999999999863 456677778889999998874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=278.74 Aligned_cols=172 Identities=22% Similarity=0.298 Sum_probs=148.6
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 476 EELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 476 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
+++....++|+..++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++|||||+++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 444556678999999999999999999975 689999999864221 1234588999999999999999999999875
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
+ ..|+||||+++|+|.++++.. .+++..+..++.+|+.||+|||+. +|+||||||+|||++.++.
T Consensus 142 ~--------~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 142 R--------YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp S--------EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred C--------EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 3 789999999999999999753 388999999999999999999997 8999999999999999999
Q ss_pred EEEcccCCcccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++.. .|+||+||++|||++|...
T Consensus 207 ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 272 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272 (410)
T ss_dssp EEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred EEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence 999999998431 2999999999999997654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=275.16 Aligned_cols=136 Identities=23% Similarity=0.214 Sum_probs=92.1
Q ss_pred CCCCCCCEEECCCCCCCCCCCCC--CCCccEEEcCCCCCCCCch-hhhcCCcccceeecccccccCCCccccCCCCCcCe
Q 005898 234 SSLGSLNVLNLSDNKLDSNLPKL--PRGLVMAFLSNNSFSGEIP-KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISD 310 (671)
Q Consensus 234 ~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 310 (671)
..+++|++|++++|.+++..+.+ ..+|+.+++++|.+++..| ..+..+++|++|++++|.+++.+|..+..+++|+.
T Consensus 370 ~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 449 (570)
T 2z63_A 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449 (570)
T ss_dssp HTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred cccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcE
Confidence 34567777777777766543322 3466777777777766554 45666777777777777777777666777777777
Q ss_pred EecccCcCc-ccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCC
Q 005898 311 LNLASNKFS-GSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN 369 (671)
Q Consensus 311 L~L~~N~l~-g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~ 369 (671)
|++++|.++ +.+|..+..+++|+.|++++|++++..|..+..+++++.+++++|.+++.
T Consensus 450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 509 (570)
T 2z63_A 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSV 509 (570)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCC
Confidence 777777776 56676677777777777777777766676777777777777777766653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=265.40 Aligned_cols=171 Identities=25% Similarity=0.465 Sum_probs=144.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..++|+..+.||+|+||+||+|+. +|+.||||++.... ....+++.+|++++++++||||+++++++.+.+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP------ 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT------
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC------
Confidence 456788899999999999999987 58899999986543 334578999999999999999999999997653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++........+++..+..++.|+++||+|||+.. ++|+||||||+||++++++.+||+|||
T Consensus 108 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 108 --NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp --CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred --ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCC
Confidence 57999999999999999986443334899999999999999999999872 239999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+++.. .|+||+||++|+|+++..
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 237 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCC
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 98531 199999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=271.11 Aligned_cols=163 Identities=28% Similarity=0.529 Sum_probs=139.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|+.. ++..||||+++.. .....++|.+|++++++++|||||+++++|.+.+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK----- 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----
Confidence 46888999999999999999864 5778999999754 3445678999999999999999999999997653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.++++... ..++|.++..++.||++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 120 ---~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 120 ---PVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp ---SCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ---ceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence 5799999999999999997542 3599999999999999999999987 7999999999999999999999999
Q ss_pred CCccccc---------------------------------cccccceeeeeeeh
Q 005898 638 GLSIVSE---------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 638 Gla~~~~---------------------------------d~~s~g~~l~~~~~ 658 (671)
|+++... |+||+|+++|||++
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt 245 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHh
Confidence 9985421 99999999999988
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=276.49 Aligned_cols=293 Identities=24% Similarity=0.180 Sum_probs=201.8
Q ss_pred CEeEEEecCCCCCCC--CCCCCcc-cccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcc
Q 005898 74 FITELKIIGDKPSNV--GNFDGFA-SANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLS 150 (671)
Q Consensus 74 ~v~~l~l~~~~~~~~--~~~~~~~-~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls 150 (671)
.++.+++.++...+. ..+.... ....+++.|...+..|..++++++|++|+|++|.+.+..|..|+++++|++|+|+
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 106 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106 (549)
T ss_dssp TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence 466777766554322 1122111 1123455555545555678888888888888888877777778888888888888
Q ss_pred cCcCCC-CCCccCCCCCccCEEEccCCcCCCCCC-cccCCCCCcCEEEcccccCCCCCcccccC----------------
Q 005898 151 SNFLFG-SVPPKISTMVKLQTLILDDNFFNNTIP-NWFDSLPSLTFLSMRNNKLAGPFPSSIQR---------------- 212 (671)
Q Consensus 151 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~l~~---------------- 212 (671)
+|.+++ ..|..++++++|++|++++|.+.+.+| ..|.++++|++|++++|++++.+|..+..
T Consensus 107 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~ 186 (549)
T 2z81_A 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186 (549)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT
T ss_pred CCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccc
Confidence 888875 356677888888888888887544554 56777777777777777777666655433
Q ss_pred --------CCCCCEEEeccCcccccc------------------------------------------------------
Q 005898 213 --------ISTLSDLDLSKNAISGSL------------------------------------------------------ 230 (671)
Q Consensus 213 --------l~~L~~L~Ls~N~l~g~~------------------------------------------------------ 230 (671)
+++|++|++++|.+++..
T Consensus 187 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~ 266 (549)
T 2z81_A 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266 (549)
T ss_dssp HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECC
T ss_pred cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccccc
Confidence 456666666666665520
Q ss_pred -----------------------------------------------------------CC-C-CCCCCCCEEECCCCCC
Q 005898 231 -----------------------------------------------------------PD-L-SSLGSLNVLNLSDNKL 249 (671)
Q Consensus 231 -----------------------------------------------------------p~-~-~~l~~L~~L~Ls~N~l 249 (671)
|. + ..+++|++|++++|++
T Consensus 267 ~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l 346 (549)
T 2z81_A 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346 (549)
T ss_dssp SCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCC
T ss_pred ccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCcc
Confidence 00 0 2367888999999988
Q ss_pred CCCCC------CCCCCccEEEcCCCCCCCCch--hhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCccc
Q 005898 250 DSNLP------KLPRGLVMAFLSNNSFSGEIP--KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321 (671)
Q Consensus 250 ~~~~p------~~~~~L~~l~l~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ 321 (671)
++.+| ....+|+.+++++|++++..+ ..++.+++|++|++++|++++. |..+..+++|+.|++++|++++
T Consensus 347 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~~~~L~~L~Ls~N~l~~- 424 (549)
T 2z81_A 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPM-PDSCQWPEKMRFLNLSSTGIRV- 424 (549)
T ss_dssp CHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCC-CSCCCCCTTCCEEECTTSCCSC-
T ss_pred ccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccC-ChhhcccccccEEECCCCCccc-
Confidence 87543 123578888899888876433 4578888888888888888854 4466777777777777777653
Q ss_pred CCcc------------------cCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCCc
Q 005898 322 LPKN------------------LNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNV 370 (671)
Q Consensus 322 ~p~~------------------~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~~ 370 (671)
+|.. ...+++|+.|++++|+++ .+|. ...+++++.+++++|.+++..
T Consensus 425 l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~ 489 (549)
T 2z81_A 425 VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVP 489 (549)
T ss_dssp CCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCC
T ss_pred ccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcC
Confidence 2221 125778999999999998 6776 456888999999999988643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=264.61 Aligned_cols=166 Identities=20% Similarity=0.372 Sum_probs=146.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~------ 79 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ------ 79 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS------
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC------
Confidence 56888999999999999999975 79999999996432 223567889999999999999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++..+..++.+|+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 80 --~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 80 --QIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp --EEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred --EEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecC
Confidence 7899999999999999998643 489999999999999999999987 89999999999999999999999999
Q ss_pred Cccccc---------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|++|...
T Consensus 152 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 202 (318)
T 1fot_A 152 FAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202 (318)
T ss_dssp SCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence 986421 999999999999997543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=264.64 Aligned_cols=177 Identities=21% Similarity=0.396 Sum_probs=147.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC----
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD---- 555 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~---- 555 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999976 79999999997433 334678999999999999999999999987643210
Q ss_pred ---------------------------------------------CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHH
Q 005898 556 ---------------------------------------------DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWS 590 (671)
Q Consensus 556 ---------------------------------------------~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~ 590 (671)
.......++||||+++|+|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 00012379999999999999999876555567888
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc---------------------------
Q 005898 591 ERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------- 643 (671)
Q Consensus 591 ~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------- 643 (671)
.+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999987 8999999999999999999999999997531
Q ss_pred ---------------ccccccceeeeeeehhhh
Q 005898 644 ---------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 644 ---------------~d~~s~g~~l~~~~~~~~ 661 (671)
.|+||+||++|+|+++..
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~ 274 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCC
Confidence 199999999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=263.00 Aligned_cols=167 Identities=24% Similarity=0.485 Sum_probs=146.2
Q ss_pred cCCCcCceeccCCceEEEEEEE-----cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|++ .+++.||||++........+++.+|++++++++||||++++++|...+.
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 85 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---- 85 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH----
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC----
Confidence 5678889999999999999984 2688999999987766667889999999999999999999999865321
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 86 --~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 86 --RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp --TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred --CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccC
Confidence 24799999999999999997643 2489999999999999999999987 8999999999999999999999999
Q ss_pred CCccccc---------------------------------cccccceeeeeeehhh
Q 005898 638 GLSIVSE---------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 638 Gla~~~~---------------------------------d~~s~g~~l~~~~~~~ 660 (671)
|+++... |+||+|+++|+|+++.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence 9986421 9999999999999963
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=278.61 Aligned_cols=262 Identities=23% Similarity=0.259 Sum_probs=181.1
Q ss_pred ccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcC
Q 005898 99 ASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFF 178 (671)
Q Consensus 99 ~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 178 (671)
.+++.|...+..|..+.++++|++|+|++|.+.+..|+.|+++++|++|||++|+++ .+|.. .+++|++|+|++|.+
T Consensus 26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l 102 (520)
T 2z7x_B 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAF 102 (520)
T ss_dssp EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCC
T ss_pred EECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCcc
Confidence 356666666666678999999999999999999988999999999999999999997 57766 899999999999999
Q ss_pred CC-CCCcccCCCCCcCEEEcccccCCCCCcccccCCCCC--CEEEeccCcc--ccccCC-CCCCC---------------
Q 005898 179 NN-TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL--SDLDLSKNAI--SGSLPD-LSSLG--------------- 237 (671)
Q Consensus 179 ~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L--~~L~Ls~N~l--~g~~p~-~~~l~--------------- 237 (671)
++ .+|..|+++++|++|++++|++++ ..+..+++| +.|++++|.+ ++..|. +..+.
T Consensus 103 ~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~ 179 (520)
T 2z7x_B 103 DALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179 (520)
T ss_dssp SSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCC
T ss_pred ccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchh
Confidence 87 578999999999999999999986 457778888 9999999988 555442 33321
Q ss_pred --------------------------------------------------------------------CCCEEECCCCCC
Q 005898 238 --------------------------------------------------------------------SLNVLNLSDNKL 249 (671)
Q Consensus 238 --------------------------------------------------------------------~L~~L~Ls~N~l 249 (671)
+|++|++++|++
T Consensus 180 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l 259 (520)
T 2z7x_B 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259 (520)
T ss_dssp CCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEE
T ss_pred hhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccc
Confidence 455566666666
Q ss_pred CCCCCCCC--------CCccEEEcCCCCCCCCch-hh-------------------------hcCCcccceeeccccccc
Q 005898 250 DSNLPKLP--------RGLVMAFLSNNSFSGEIP-KQ-------------------------YGQLNQLQQLDMSFNALR 295 (671)
Q Consensus 250 ~~~~p~~~--------~~L~~l~l~~N~l~~~~p-~~-------------------------~~~l~~L~~L~Ls~N~l~ 295 (671)
+|.+|... ..|+.+++++|.+ .+| .. +..+++|++|++++|+++
T Consensus 260 ~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~ 337 (520)
T 2z7x_B 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337 (520)
T ss_dssp ESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCC
T ss_pred cCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccC
Confidence 55555322 1222333333333 122 11 145556666666666666
Q ss_pred CCCccccCCCCCcCeEecccCcCcc--cCCcccCCCCCccEEECcCCcCcccCCCC-CCCCCCCceeccCCCcCCC
Q 005898 296 GMPPPAIFSLPNISDLNLASNKFSG--SLPKNLNCGGKLVFFDISNNKLTGGLPSC-LSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 296 ~~~~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~~~~L~~l~ls~N~l~g~~p~~-~~~~~~l~~l~l~~N~l~~ 368 (671)
+.+|..+..+++|+.|+|++|++++ .+|..+..+++|+.|++++|.+++.+|.. +..+++++.+++++|.+++
T Consensus 338 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 338 DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp TTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred hhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 6555566666666666666666665 44555666666666666666666544443 4455566666666666554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=263.99 Aligned_cols=163 Identities=26% Similarity=0.504 Sum_probs=143.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
+.|+..+.||+|+||.||+|+.. .+..||||+++.. .....+++.+|++++++++||||++++++|.+.+
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 123 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR----- 123 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG-----
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence 46778899999999999999974 3456999999764 3445678999999999999999999999997643
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ..+++.++..++.+++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 124 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 124 ---LAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp ---CCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ---ccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCC
Confidence 5799999999999999997542 3499999999999999999999997 8999999999999999999999999
Q ss_pred CCccccc---------------------------------cccccceeeeeeeh
Q 005898 638 GLSIVSE---------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 638 Gla~~~~---------------------------------d~~s~g~~l~~~~~ 658 (671)
|+++... |+||+||++|+|++
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 249 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 9986421 99999999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=277.08 Aligned_cols=176 Identities=19% Similarity=0.281 Sum_probs=151.1
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceee
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 549 (671)
.+++.....++|+..++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++.+++|||||++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555556788999999999999999999975 79999999996432 122345889999999999999999999998
Q ss_pred cCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 550 ~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
+.+ ..|+||||+++|+|.+++.... ..+++..+..++.+|+.||+|||+. +|+||||||+|||+|++
T Consensus 132 ~~~--------~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 132 DEN--------YLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC 198 (412)
T ss_dssp CSS--------EEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred eCC--------EEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC
Confidence 753 7899999999999999997642 2489999999999999999999987 89999999999999999
Q ss_pred CcEEEcccCCcccc--------------------------------------ccccccceeeeeeehhhhc
Q 005898 630 RIAKLSDYGLSIVS--------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 630 ~~~ki~DfGla~~~--------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++||+|||+++.. .|+||+||++|||++|...
T Consensus 199 g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 269 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269 (412)
T ss_dssp SCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC
Confidence 99999999998421 1999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=259.13 Aligned_cols=166 Identities=17% Similarity=0.302 Sum_probs=146.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 84 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD------ 84 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS------
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC------
Confidence 56888999999999999999964 7899999998543 2344578999999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 85 --~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 85 --CYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred --eEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence 6899999999999999997643 489999999999999999999987 79999999999999999999999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+|+++|+|+++...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 211 (294)
T 4eqm_A 157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211 (294)
T ss_dssp SSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred CccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 98532 1999999999999997554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=258.78 Aligned_cols=226 Identities=20% Similarity=0.253 Sum_probs=197.0
Q ss_pred CCCEeEEEecCCCCCCCCCCCCcccccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEccc
Q 005898 72 DNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSS 151 (671)
Q Consensus 72 ~~~v~~l~l~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~ 151 (671)
..+|+.+++.+..+. .+|..++++++|++|+|++|.+. .+|..++++++|++|+|++
T Consensus 80 ~~~l~~L~L~~n~l~----------------------~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~ 136 (328)
T 4fcg_A 80 QPGRVALELRSVPLP----------------------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136 (328)
T ss_dssp STTCCEEEEESSCCS----------------------SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEES
T ss_pred ccceeEEEccCCCch----------------------hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCC
Confidence 356788888665322 45667888999999999999998 8999999999999999999
Q ss_pred CcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCC---------CCCcCEEEcccccCCCCCcccccCCCCCCEEEec
Q 005898 152 NFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDS---------LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 222 (671)
|+++ .+|..+.++++|++|+|++|.+.+.+|..++. +++|++|++++|+++ .+|..++++++|+.|+|+
T Consensus 137 n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~ 214 (328)
T 4fcg_A 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214 (328)
T ss_dssp CCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEE
T ss_pred Cccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEcc
Confidence 9998 88999999999999999999999999988765 999999999999999 899999999999999999
Q ss_pred cCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCcccc
Q 005898 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302 (671)
Q Consensus 223 ~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 302 (671)
+|.+++.++.+..+++|++|++++|++.+ .+|..++.+++|+.|++++|++.+.+|..+
T Consensus 215 ~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~---------------------~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~ 273 (328)
T 4fcg_A 215 NSPLSALGPAIHHLPKLEELDLRGCTALR---------------------NYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273 (328)
T ss_dssp SSCCCCCCGGGGGCTTCCEEECTTCTTCC---------------------BCCCCTTCCCCCCEEECTTCTTCCBCCTTG
T ss_pred CCCCCcCchhhccCCCCCEEECcCCcchh---------------------hhHHHhcCCCCCCEEECCCCCchhhcchhh
Confidence 99999877788999999999998877654 456667778888888888888888888888
Q ss_pred CCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCc
Q 005898 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 303 ~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~ 343 (671)
..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 274 ~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp GGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 88888888888888888888888888888888888877654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=266.59 Aligned_cols=168 Identities=23% Similarity=0.364 Sum_probs=146.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch------hhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.+.|+..+.||+|+||+||+|+.. +|+.||||.+..... ...+++.+|+.+|.+++|||||++++++.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-- 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-- 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence 457888999999999999999965 699999999965432 13578999999999999999999999998653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC----
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR---- 630 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~---- 630 (671)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++
T Consensus 89 ------~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 89 ------DVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp ------EEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred ------EEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 7899999999999999997543 489999999999999999999997 899999999999998776
Q ss_pred cEEEcccCCccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 631 IAKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 631 ~~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
.+||+|||+++... |+||+||++|+|++|....
T Consensus 157 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp CEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 79999999986421 9999999999999976543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=271.94 Aligned_cols=168 Identities=23% Similarity=0.374 Sum_probs=145.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~ 556 (671)
.++|+..++||+|+||+||+|+.. +++.||||+++... ....+.+.+|..++.++ +|||||++++++.+.+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~---- 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES---- 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----
Confidence 457889999999999999999975 68899999997542 22334578899998877 8999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|..++.... .+++..+..++.+|+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 127 ----~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 127 ----RLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred ----EEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 7899999999999999997643 389999999999999999999997 799999999999999999999999
Q ss_pred cCCcccc------------------------------ccccccceeeeeeehhhhcc
Q 005898 637 YGLSIVS------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||+++.. .|+||+||++|||++|....
T Consensus 197 FGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf 253 (396)
T 4dc2_A 197 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253 (396)
T ss_dssp CTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9998641 19999999999999976544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=266.75 Aligned_cols=169 Identities=23% Similarity=0.374 Sum_probs=146.1
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
...++|+..++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|.+++..+ +||||+++++++.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~-- 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-- 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS--
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC--
Confidence 34578999999999999999999975 68999999996532 22356678899998876 9999999999998753
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 92 ------~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 92 ------NLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp ------EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred ------EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEE
Confidence 7899999999999999997643 389999999999999999999997 8999999999999999999999
Q ss_pred cccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++... |+||+||++|+|++|...
T Consensus 160 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 217 (345)
T 1xjd_A 160 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217 (345)
T ss_dssp CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCC
Confidence 9999986421 999999999999997543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=287.09 Aligned_cols=223 Identities=22% Similarity=0.312 Sum_probs=151.6
Q ss_pred chhcccCC----CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcc
Q 005898 110 FVTTLARL----TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNW 185 (671)
Q Consensus 110 ~~~~l~~l----~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 185 (671)
+|..+..+ ++|+.|+|++|.+.+..|..|+++++|++|+|++|.+++..| +..+++|++|+|++|.+++..
T Consensus 22 l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~--- 96 (487)
T 3oja_A 22 LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL--- 96 (487)
T ss_dssp HHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE---
T ss_pred hHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC---
Confidence 44444444 378888888888888888888888888888888888876555 888888888888888887532
Q ss_pred cCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCCCCCCccEEE
Q 005898 186 FDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAF 264 (671)
Q Consensus 186 ~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~ 264 (671)
..++|++|++++|.+++..+. .+++|+.|+|++|.+++.+| .++.+++|+.|+|++|.+++
T Consensus 97 --~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------------- 158 (487)
T 3oja_A 97 --VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT------------- 158 (487)
T ss_dssp --ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE-------------
T ss_pred --CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC-------------
Confidence 237888888888888865543 35678888888888887766 36677777777777776654
Q ss_pred cCCCCCCCCchhhhc-CCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCc
Q 005898 265 LSNNSFSGEIPKQYG-QLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 265 l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~ 343 (671)
.+|..+. .+++|+.|+|++|.+++.++ ...+++|+.|+|++|.+++..| .+..+++|+.|++++|.++
T Consensus 159 --------~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 159 --------VNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp --------EEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC
T ss_pred --------cChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCc
Confidence 4444443 45666666666666665532 2345666666666666665333 3555566666666666666
Q ss_pred ccCCCCCCCCCCCceeccCCCcCC
Q 005898 344 GGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 344 g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
+ +|..+..+++++.+++++|.+.
T Consensus 228 ~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 228 L-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp E-ECTTCCCCTTCCEEECTTCCBC
T ss_pred c-cchhhccCCCCCEEEcCCCCCc
Confidence 3 5555555666666666666554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=265.54 Aligned_cols=166 Identities=23% Similarity=0.388 Sum_probs=145.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.++ +|||||++++++.+.+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~----- 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----- 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC-----
Confidence 46888999999999999999975 6899999999653 233456788999999988 8999999999998653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 84 ---~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 84 ---RLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred ---EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence 7899999999999999997643 389999999999999999999997 8999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+||++|||++|...
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 209 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred cccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 998641 1999999999999997653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=263.63 Aligned_cols=171 Identities=22% Similarity=0.431 Sum_probs=145.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++|+..++||+|+||+||+|+.. ++.||||++..... ....+.+|+.++++++|||||++++++.+... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS----VDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS----SSEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCC----CCce
Confidence 467888999999999999999875 78999999965433 34556779999999999999999999987531 1235
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC-------CCCccccCCCCCceeecCCCcEEE
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV-------IPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-------~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
.++||||+++|+|.+++... .++|..+..++.|+++||+|||+.+ .++|+||||||+||++++++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 79999999999999999763 3899999999999999999999861 247999999999999999999999
Q ss_pred cccCCccccc-------------------------------------cccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVSE-------------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~~-------------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++... |+||+||++|+|+++...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~p 237 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTT
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCC
Confidence 9999984310 999999999999998543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=271.60 Aligned_cols=166 Identities=23% Similarity=0.449 Sum_probs=145.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..++|+..+.||+|+||.||+|+.. +++.||||.++... ....++|.+|+++|++++|||||+++++|.+.+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ------ 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS------
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC------
Confidence 3457888899999999999999986 78999999997543 333567899999999999999999999997653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.++++... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 186 --~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 186 --PIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred --CcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence 5799999999999999997532 2489999999999999999999997 79999999999999999999999999
Q ss_pred Ccccc--------------------------------ccccccceeeeeeehh
Q 005898 639 LSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 639 la~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
+++.. .|+||+||++|||+++
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~ 311 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL 311 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 98531 1999999999999984
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-29 Score=260.33 Aligned_cols=167 Identities=18% Similarity=0.269 Sum_probs=146.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+++++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-------- 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-------- 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--------
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC--------
Confidence 357888999999999999999965 68999999987543 34567899999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC--CCcEEEcccC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE--HRIAKLSDYG 638 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~--~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 7899999999999999997542 3489999999999999999999997 8999999999999987 7899999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|+++...
T Consensus 150 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 202 (321)
T 1tki_A 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202 (321)
T ss_dssp TCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred CCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 986531 999999999999997654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=269.15 Aligned_cols=167 Identities=24% Similarity=0.400 Sum_probs=146.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||+++++|.+.+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------ 88 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE------ 88 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS------
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC------
Confidence 56888999999999999999965 68999999986432 233567899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|..++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 89 --~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 89 --DMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp --EEEEEECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred --EEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccc
Confidence 7899999999999999998643 489999999999999999999997 89999999999999999999999999
Q ss_pred Ccccc--------------------------------ccccccceeeeeeehhhhcc
Q 005898 639 LSIVS--------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~--------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
+++.. .|+||+||++|+|++|....
T Consensus 161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 98642 19999999999999976543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-27 Score=276.27 Aligned_cols=297 Identities=20% Similarity=0.159 Sum_probs=222.1
Q ss_pred CEeEEEecCCCCCCCCC--CCCc-ccccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcc
Q 005898 74 FITELKIIGDKPSNVGN--FDGF-ASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLS 150 (671)
Q Consensus 74 ~v~~l~l~~~~~~~~~~--~~~~-~~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls 150 (671)
.++.+++.++...+... +... .....+++.|...+..|..++++++|++|+|++|.+.+..+..|+++++|++|+|+
T Consensus 26 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 105 (680)
T 1ziw_A 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105 (680)
T ss_dssp TCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECC
Confidence 46777777665443221 1111 11223556666556667788999999999999999986666679999999999999
Q ss_pred cCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCccccc--CCCCCCEEEeccCcccc
Q 005898 151 SNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQ--RISTLSDLDLSKNAISG 228 (671)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~--~l~~L~~L~Ls~N~l~g 228 (671)
+|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|++++..|..+. .+++|+.|++++|.+++
T Consensus 106 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~ 185 (680)
T 1ziw_A 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185 (680)
T ss_dssp SSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCC
T ss_pred CCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccc
Confidence 9999877778899999999999999999988888899999999999999999887777654 45889999999998887
Q ss_pred ccCC-CCC---------------------------CCCCCEEECCCCCCCCCCCCCC-----CCccEEEcCCCCCCCCch
Q 005898 229 SLPD-LSS---------------------------LGSLNVLNLSDNKLDSNLPKLP-----RGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 229 ~~p~-~~~---------------------------l~~L~~L~Ls~N~l~~~~p~~~-----~~L~~l~l~~N~l~~~~p 275 (671)
..|. +.. .++|+.|++++|.+++..|... .+|+.+++++|.+++..|
T Consensus 186 ~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~ 265 (680)
T 1ziw_A 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265 (680)
T ss_dssp BCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECT
T ss_pred cChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCc
Confidence 6653 221 1566777777777776665543 237777777777777667
Q ss_pred hhhcCCcccceeecccccccCCCcc---------------------------------ccCCCCCcCeEecccCcCcccC
Q 005898 276 KQYGQLNQLQQLDMSFNALRGMPPP---------------------------------AIFSLPNISDLNLASNKFSGSL 322 (671)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~---------------------------------~~~~l~~L~~L~L~~N~l~g~~ 322 (671)
..|+.+++|++|++++|++++.+|. .+..+++|+.|++++|++++..
T Consensus 266 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~ 345 (680)
T 1ziw_A 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCC
T ss_pred ccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCC
Confidence 7777777777777777777666553 3455677888888889999888
Q ss_pred CcccCCCCCccEEECcCCcCcccCCC--CCC--CCCCCceeccCCCcCCCCc
Q 005898 323 PKNLNCGGKLVFFDISNNKLTGGLPS--CLS--NESDKRVVKFRGNCLSSNV 370 (671)
Q Consensus 323 p~~~~~~~~L~~l~ls~N~l~g~~p~--~~~--~~~~l~~l~l~~N~l~~~~ 370 (671)
|..+..+++|+.|++++|.+++.... .+. ..+.++.+++++|.+++..
T Consensus 346 ~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~ 397 (680)
T 1ziw_A 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397 (680)
T ss_dssp TTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC
T ss_pred hhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC
Confidence 88899999999999999987543221 222 1257899999999988643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=263.06 Aligned_cols=225 Identities=25% Similarity=0.253 Sum_probs=182.1
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|++|+|++|++.+..|+.|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 57899999999999999999999999999999999999888899999999999999999999877788999999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC--CCCCCCCCEEECCCCCCCCCCCCC--CCCccEEEcCCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKL--PRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~l~l~~N~l~~~ 273 (671)
++|+++...+..|.++++|+.|++++|+..+.++. +..+++|++|+|++|++++. |.+ ..+|+.|++++|.+++.
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCccc
Confidence 99999976677899999999999999655455553 78999999999999998753 433 24566677777777666
Q ss_pred chhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCc
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~ 343 (671)
.|..|..+++|+.|++++|++++.++..+..+++|+.|+|++|++++..+..+..+.+|+.|+|++|.+.
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 6666777777777777777777766666666777777777777776655556666666777777777665
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=265.33 Aligned_cols=166 Identities=18% Similarity=0.334 Sum_probs=146.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------ 114 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS------ 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC------
Confidence 57888999999999999999975 79999999986432 233567899999999999999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 115 --~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 115 --NLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred --EEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence 7899999999999999998643 389999999999999999999987 89999999999999999999999999
Q ss_pred Cccccc---------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|++|...
T Consensus 187 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 237 (350)
T 1rdq_E 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp TCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCC
Confidence 986431 999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-29 Score=262.38 Aligned_cols=166 Identities=24% Similarity=0.393 Sum_probs=144.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++|||||++++++.+.+
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-------- 78 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-------- 78 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS--------
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--------
Confidence 57888999999999999999975 789999999865432 23467899999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecc
Confidence 689999999999999998754 3489999999999999999999987 8999999999999999999999999998
Q ss_pred ccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 641 IVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. .|+||+||++|+|+++...
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 207 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 532 1999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-29 Score=260.65 Aligned_cols=171 Identities=25% Similarity=0.346 Sum_probs=148.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+... .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~ 82 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT------R 82 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT------C
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC------c
Confidence 46888899999999999999975 58999999997543 2345778899999999999999999999876532 2
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee----cCCCcEEEcc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL----NEHRIAKLSD 636 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl----~~~~~~ki~D 636 (671)
..++||||+++|+|.+++........+++.++..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5799999999999999998654444599999999999999999999997 89999999999999 7888999999
Q ss_pred cCCcccc-------------------------------------ccccccceeeeeeehhhhc
Q 005898 637 YGLSIVS-------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+++.. .|+||+||++|+|+++...
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~p 222 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9998541 2999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=267.28 Aligned_cols=169 Identities=17% Similarity=0.260 Sum_probs=144.1
Q ss_pred HhcCCCcCceeccCCceEEEEEE------EcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC---CCCcccccceeecC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGR------LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR---HPHLVCLLGHCIDG 551 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~ 551 (671)
..+.|...+.||+|+||+||+|+ ..+++.||||++.... ..++.+|++++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678889999999999999994 4568999999997553 356778888888887 99999999999875
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISEN--TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE- 628 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~- 628 (671)
+ ..++|||||++|+|.+++... .....++|..+..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 140 ~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 140 N--------GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNG 208 (365)
T ss_dssp S--------CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGG
T ss_pred C--------CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccc
Confidence 4 679999999999999999742 1245699999999999999999999997 7999999999999998
Q ss_pred ----------CCcEEEcccCCccccc--------------------------------cccccceeeeeeehhhhcc
Q 005898 629 ----------HRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 629 ----------~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
++.+||+|||+|+... |+||+||++|||++|.+..
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 8999999999995321 9999999999999987543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-29 Score=262.34 Aligned_cols=166 Identities=25% Similarity=0.449 Sum_probs=138.6
Q ss_pred hcCCCcCceeccCCceEEEEEEE----cCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG- 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence 35688899999999999999986 478999999997542 223456889999999999999999999998653
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEE
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAK 633 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~k 633 (671)
..++||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 95 -------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 95 -------KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp -------CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred -------EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence 6899999999999999997643 388999999999999999999997 899999999999999999999
Q ss_pred EcccCCcccc------------------------------ccccccceeeeeeehhhh
Q 005898 634 LSDYGLSIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 634 i~DfGla~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+|||+++.. .|+||+||++|+|+++..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 219 (327)
T 3a62_A 162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219 (327)
T ss_dssp ECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence 9999998531 199999999999999754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=270.15 Aligned_cols=296 Identities=21% Similarity=0.207 Sum_probs=204.6
Q ss_pred CEeEEEecCCCCCCCC--CCCCcc-cccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcc
Q 005898 74 FITELKIIGDKPSNVG--NFDGFA-SANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLS 150 (671)
Q Consensus 74 ~v~~l~l~~~~~~~~~--~~~~~~-~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls 150 (671)
.++.+++.++...+.. .+.+.. ....+++.|...+..+..|.++++|++|+|++|.+.+..|..|+++++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 4666777665543221 122211 1223455554444445678888888888888888888777888888888888888
Q ss_pred cCcCCCCCCccCCCCCccCEEEccCCcCCC-CCCcccCCCCCcCEEEcccccCCCCCcccccCCCCC----CEEEeccCc
Q 005898 151 SNFLFGSVPPKISTMVKLQTLILDDNFFNN-TIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL----SDLDLSKNA 225 (671)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L----~~L~Ls~N~ 225 (671)
+|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..++.+++| +.|++++|.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 888876555578888888888888888876 468888888888888888888776555444444333 334443333
Q ss_pred --------------------------------------------------------------------------------
Q 005898 226 -------------------------------------------------------------------------------- 225 (671)
Q Consensus 226 -------------------------------------------------------------------------------- 225 (671)
T Consensus 189 l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~ 268 (570)
T 2z63_A 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268 (570)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETT
T ss_pred ceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcch
Confidence
Q ss_pred -------------------------cccccCCCCC------------------------------------------CCC
Q 005898 226 -------------------------ISGSLPDLSS------------------------------------------LGS 238 (671)
Q Consensus 226 -------------------------l~g~~p~~~~------------------------------------------l~~ 238 (671)
+++..+.+.. +++
T Consensus 269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 348 (570)
T 2z63_A 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348 (570)
T ss_dssp EEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTT
T ss_pred hhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCC
Confidence 3321111111 222
Q ss_pred CCEEECCCCCCCCCC--CC---CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCc-cccCCCCCcCeEe
Q 005898 239 LNVLNLSDNKLDSNL--PK---LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP-PAIFSLPNISDLN 312 (671)
Q Consensus 239 L~~L~Ls~N~l~~~~--p~---~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~ 312 (671)
|+.|++++|++++.. |. -..+|+.+++++|.+++..+ .+..+++|+.|++++|.+++.++ ..+..+++|+.|+
T Consensus 349 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 427 (570)
T 2z63_A 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427 (570)
T ss_dssp CCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEE
T ss_pred CCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEe
Confidence 223333333222211 00 01345555555555554333 37788899999999999998876 5688999999999
Q ss_pred cccCcCcccCCcccCCCCCccEEECcCCcCc-ccCCCCCCCCCCCceeccCCCcCCCCc
Q 005898 313 LASNKFSGSLPKNLNCGGKLVFFDISNNKLT-GGLPSCLSNESDKRVVKFRGNCLSSNV 370 (671)
Q Consensus 313 L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~-g~~p~~~~~~~~l~~l~l~~N~l~~~~ 370 (671)
+++|.+++.+|..+..+++|+.|++++|.++ +.+|..+..+++++.+++++|.+++..
T Consensus 428 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~ 486 (570)
T 2z63_A 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486 (570)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred CcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCC
Confidence 9999999999999999999999999999998 689999999999999999999988643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=265.07 Aligned_cols=168 Identities=19% Similarity=0.343 Sum_probs=148.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.+.|+..+.||+|+||.||+|+.. +|+.||+|.+..........+.+|+++|++++|||||++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-------- 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-------- 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--------
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC--------
Confidence 467899999999999999999965 78999999998765555678999999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC--CCcEEEcccC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE--HRIAKLSDYG 638 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~--~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 7899999999999999987532 3489999999999999999999987 8999999999999974 5789999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|++|...
T Consensus 197 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 249 (387)
T 1kob_A 197 LATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249 (387)
T ss_dssp TCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred cceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCC
Confidence 986432 999999999999997653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=267.89 Aligned_cols=176 Identities=24% Similarity=0.434 Sum_probs=150.0
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccc
Q 005898 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCL 544 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 544 (671)
+...++....++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++.++ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455566678899999999999999999974 246799999997643 33457799999999999 79999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCC-----------------------------------------
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP----------------------------------------- 583 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~----------------------------------------- 583 (671)
+++|.+.+ ...++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~-------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 92 LGACTKPG-------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp EEEECSTT-------SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred eeeeecCC-------CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 99998754 247999999999999999975431
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 584 ----------------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 584 ----------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 241 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 241 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEecccee
Confidence 12289999999999999999999997 79999999999999999999999999986
Q ss_pred ccc--------------------------------cccccceeeeeeeh
Q 005898 642 VSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 642 ~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
... |+||+||++|+|++
T Consensus 242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 290 (359)
T 3vhe_A 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290 (359)
T ss_dssp CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHh
Confidence 421 99999999999998
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=259.02 Aligned_cols=250 Identities=19% Similarity=0.214 Sum_probs=214.0
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|++|+|++|.+.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|+++++|++|++
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 48999999999998877778999999999999999999888889999999999999999999765566999999999999
Q ss_pred ccccCCCCCcc--cccCCCCCCEEEeccCc-cccccC-CCCCCCCCCEEECCCCCCCCCCCCCC---CCccEEEcCCCCC
Q 005898 198 RNNKLAGPFPS--SIQRISTLSDLDLSKNA-ISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKLP---RGLVMAFLSNNSF 270 (671)
Q Consensus 198 ~~N~l~g~~p~--~l~~l~~L~~L~Ls~N~-l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~L~~l~l~~N~l 270 (671)
++|++++ +|. .+..+++|+.|++++|. +++..+ .+..+++|+.|++++|++++..|... .+|+.+++++|.+
T Consensus 132 ~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 132 LGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp TTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred CCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 9999985 554 78999999999999994 666555 48899999999999999998777643 5688999999999
Q ss_pred CCCchhhhcCCcccceeecccccccCCCccccC---CCCCcCeEecccCcCcc----cCCcccCCCCCccEEECcCCcCc
Q 005898 271 SGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIF---SLPNISDLNLASNKFSG----SLPKNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 271 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~g----~~p~~~~~~~~L~~l~ls~N~l~ 343 (671)
+...+..+..+++|+.|++++|.+++.++..+. ..+.++.++|++|.+++ .+|..+..+++|+.||+++|+++
T Consensus 211 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~ 290 (353)
T 2z80_A 211 ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK 290 (353)
T ss_dssp TTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC
T ss_pred ccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC
Confidence 744444456789999999999999998766543 45778899999999887 47888889999999999999999
Q ss_pred ccCCCC-CCCCCCCceeccCCCcCCCC
Q 005898 344 GGLPSC-LSNESDKRVVKFRGNCLSSN 369 (671)
Q Consensus 344 g~~p~~-~~~~~~l~~l~l~~N~l~~~ 369 (671)
.+|.. +..+++++.+++++|.+.+.
T Consensus 291 -~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 291 -SVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp -CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred -ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 67766 48899999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-29 Score=252.85 Aligned_cols=163 Identities=23% Similarity=0.439 Sum_probs=145.0
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||.||+|+..+++.||||++..... ..+++.+|++++++++||||+++++++.+.+ ..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~ 80 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--------PI 80 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--------SE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--------ce
Confidence 46788899999999999999988889999999975432 3467999999999999999999999997653 58
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccc
Confidence 99999999999999997543 3589999999999999999999987 799999999999999999999999999863
Q ss_pred cc-------------------------------cccccceeeeeeehh
Q 005898 643 SE-------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~~-------------------------------d~~s~g~~l~~~~~~ 659 (671)
.. |+||+|+++|+|+++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~ 203 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 203 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcC
Confidence 21 999999999999983
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-29 Score=260.53 Aligned_cols=166 Identities=22% Similarity=0.375 Sum_probs=145.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch------hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
+.|+..+.||+|+||.||+|+.. +|+.||||.+..... ...+++.+|++++++++||||+++++++.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--- 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence 45888999999999999999975 689999999865322 13678999999999999999999999998653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC----c
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR----I 631 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~----~ 631 (671)
..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++ .
T Consensus 88 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 88 -----DVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp -----EEEEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCC
T ss_pred -----EEEEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCC
Confidence 689999999999999999754 3489999999999999999999987 899999999999999877 8
Q ss_pred EEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++..+ |+||+||++|+|+++...
T Consensus 157 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp EEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred EEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 9999999986431 999999999999997654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=263.48 Aligned_cols=167 Identities=22% Similarity=0.426 Sum_probs=145.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------ 101 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES------ 101 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS------
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC------
Confidence 467899999999999999999965 68999999996542 334567899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC---CcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH---RIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~---~~~ki~ 635 (671)
..++||||+++|+|.+++.... .+++.++..++.||++||+|||+. +|+||||||+||+++.+ +.+||+
T Consensus 102 --~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 102 --FHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp --EEEEEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred --EEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEe
Confidence 6899999999999999987543 489999999999999999999997 89999999999999865 459999
Q ss_pred ccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 636 DYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 636 DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|||+++... |+||+||++|+|++|...
T Consensus 174 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 229 (362)
T 2bdw_A 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229 (362)
T ss_dssp CCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999985421 999999999999998654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=273.30 Aligned_cols=259 Identities=21% Similarity=0.171 Sum_probs=218.5
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|...+..+..++++++|++|+|++|.+.+..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|.++
T Consensus 81 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 160 (597)
T 3oja_B 81 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 160 (597)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCC
Confidence 45555555555568999999999999999999998999999999999999999998666666799999999999999999
Q ss_pred CCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCcccc-------------------ccCCCCCCCCCC
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG-------------------SLPDLSSLGSLN 240 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g-------------------~~p~~~~l~~L~ 240 (671)
+..|..|+++++|++|++++|.+++.. ++.+++|+.|++++|.+++ ..+. ..++|+
T Consensus 161 ~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~--~~~~L~ 235 (597)
T 3oja_B 161 RIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGP--VNVELT 235 (597)
T ss_dssp BCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECS--CCSCCC
T ss_pred CCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccc--cCCCCC
Confidence 999999999999999999999998653 3445555555555555543 2222 236899
Q ss_pred EEECCCCCCCCCCCCC--CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcC
Q 005898 241 VLNLSDNKLDSNLPKL--PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318 (671)
Q Consensus 241 ~L~Ls~N~l~~~~p~~--~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 318 (671)
.|+|++|.+++. +.+ ..+|+.|++++|.+++.+|..|+.+++|+.|+|++|.+++. |..+..+++|+.|+|++|.+
T Consensus 236 ~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l 313 (597)
T 3oja_B 236 ILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHL 313 (597)
T ss_dssp EEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCC
T ss_pred EEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCC
Confidence 999999999874 322 46899999999999999999999999999999999999996 44667899999999999999
Q ss_pred cccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCC
Q 005898 319 SGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN 369 (671)
Q Consensus 319 ~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~ 369 (671)
+ .+|..+..+++|+.|++++|.+++. | +..++.++.+++++|.+++.
T Consensus 314 ~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 314 L-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp C-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred C-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 9 6788888899999999999999865 3 56678899999999988753
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=272.77 Aligned_cols=247 Identities=18% Similarity=0.126 Sum_probs=183.2
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|++|+|++|.+.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.++ .+|.. .+++|++|++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 78999999999999988899999999999999999999988999999999999999999999 67776 8999999999
Q ss_pred ccccCCC-CCcccccCCCCCCEEEeccCccccccCCCCCCCCC--CEEECCCCCC--CCCCCCCC---------------
Q 005898 198 RNNKLAG-PFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSL--NVLNLSDNKL--DSNLPKLP--------------- 257 (671)
Q Consensus 198 ~~N~l~g-~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L--~~L~Ls~N~l--~~~~p~~~--------------- 257 (671)
++|++++ .+|..++++++|++|++++|.+++. .+..+++| +.|++++|++ ++..|...
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n 206 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCc
Confidence 9999997 5678999999999999999999762 34444555 8888888877 44433210
Q ss_pred ---------------------------------------------------------------------CCccEEEcCCC
Q 005898 258 ---------------------------------------------------------------------RGLVMAFLSNN 268 (671)
Q Consensus 258 ---------------------------------------------------------------------~~L~~l~l~~N 268 (671)
.+|+.+++++|
T Consensus 207 ~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n 286 (562)
T 3a79_B 207 SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286 (562)
T ss_dssp SCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEE
T ss_pred cchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEecc
Confidence 14555666666
Q ss_pred CCCCCchhhh-----------------------------------------------------cCCcccceeeccccccc
Q 005898 269 SFSGEIPKQY-----------------------------------------------------GQLNQLQQLDMSFNALR 295 (671)
Q Consensus 269 ~l~~~~p~~~-----------------------------------------------------~~l~~L~~L~Ls~N~l~ 295 (671)
.++|.+|..+ +.+++|++|++++|+++
T Consensus 287 ~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~ 366 (562)
T 3a79_B 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366 (562)
T ss_dssp EECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCC
T ss_pred EeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccc
Confidence 6666665544 45556666666666666
Q ss_pred CCCccccCCCCCcCeEecccCcCcc--cCCcccCCCCCccEEECcCCcCcccCCCC-CCCCCCCceeccCCCcCCCC
Q 005898 296 GMPPPAIFSLPNISDLNLASNKFSG--SLPKNLNCGGKLVFFDISNNKLTGGLPSC-LSNESDKRVVKFRGNCLSSN 369 (671)
Q Consensus 296 ~~~~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~~~~L~~l~ls~N~l~g~~p~~-~~~~~~l~~l~l~~N~l~~~ 369 (671)
+.+|..+..+++|+.|+|++|++++ .+|..+..+++|+.|++++|++++.+|.. +..+++++.+++++|.+++.
T Consensus 367 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp TTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred cchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence 6666666666666666666666664 33445566666666666666666544442 45556666666666666543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=259.10 Aligned_cols=167 Identities=25% Similarity=0.373 Sum_probs=143.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||+||+|+..+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 92 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER------- 92 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-------
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-------
Confidence 356888999999999999999988899999999864432 23467889999999999999999999997653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 93 -~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 93 -CLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp -CEEEEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred -EEEEEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcC
Confidence 68999999985 8888876543 3489999999999999999999987 899999999999999999999999999
Q ss_pred ccccc-------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+||++|+|+++...
T Consensus 166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 219 (311)
T 3niz_A 166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219 (311)
T ss_dssp CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCC
Confidence 85421 999999999999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-29 Score=275.28 Aligned_cols=167 Identities=19% Similarity=0.453 Sum_probs=146.7
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 479 KEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 479 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
....++|+..+.||+|+||.||+|+..++..||||+++... ...++|.+|+++|++++|||||++++++.+.
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKE------- 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSS-------
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC-------
Confidence 34456788899999999999999999888999999997643 3467899999999999999999999998632
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++|||||++|+|.++++... ...+++.++..++.||++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 256 --~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 256 --PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp --SCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred --ccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence 5799999999999999997431 12478999999999999999999997 79999999999999999999999999
Q ss_pred Cccccc-------------------------------cccccceeeeeeehh
Q 005898 639 LSIVSE-------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 639 la~~~~-------------------------------d~~s~g~~l~~~~~~ 659 (671)
+++... |+||+||++|||+++
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~ 381 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence 997531 999999999999993
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=261.34 Aligned_cols=225 Identities=26% Similarity=0.234 Sum_probs=175.5
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++++.|+|++|++.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++...+..|..+++|++|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 57899999999999988899999999999999999999888889999999999999999999777778999999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC--CCCCCCCCEEECCCCCCCCCCCCC--CCCccEEEcCCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD--LSSLGSLNVLNLSDNKLDSNLPKL--PRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~l~l~~N~l~~~ 273 (671)
++|+++...+..|.++++|+.|+|++|+..+.++. +..+++|++|+|++|+++. +|.+ ..+|+.|+|++|.+++.
T Consensus 144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEE
T ss_pred CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCcc
Confidence 99999977777899999999999999655555553 7889999999999998874 3433 23566666666666655
Q ss_pred chhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCc
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~ 343 (671)
.|..|..+++|+.|+|++|++++.++..+..+++|+.|+|++|++++..+..+..+.+|+.|+|++|.+.
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 5666666666666666666666666666666666666666666666555555555666666666666654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=271.93 Aligned_cols=164 Identities=26% Similarity=0.530 Sum_probs=144.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++|+..+.||+|+||.||+|+.. |+.||||+++... ..++|.+|+++|++++|||||+++++|.+.+ ..
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------~~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-------GG 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-------SC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-------Cc
Confidence 456888899999999999999875 7899999997653 4568999999999999999999999987653 25
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|||||++|+|.++++... ...+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 899999999999999998643 23479999999999999999999997 89999999999999999999999999986
Q ss_pred ccc---------------------------cccccceeeeeeehh
Q 005898 642 VSE---------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 642 ~~~---------------------------d~~s~g~~l~~~~~~ 659 (671)
... |+||+||++|||+++
T Consensus 338 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 382 (450)
T 1k9a_A 338 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 382 (450)
T ss_dssp ECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 422 999999999999983
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-29 Score=264.52 Aligned_cols=168 Identities=20% Similarity=0.319 Sum_probs=146.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 555 (671)
..++|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|..++..+ +||||+++++++.+.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--- 94 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--- 94 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS---
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC---
Confidence 3467999999999999999999976 58899999996532 23356788999999988 7999999999987653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..|+||||+++|+|.+++.... .+++..+..++.+|+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 95 -----~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 95 -----RLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp -----EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred -----EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence 7899999999999999998643 389999999999999999999997 89999999999999999999999
Q ss_pred ccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 636 DYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 636 DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|||+++... |+||+||++|||++|...
T Consensus 164 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 220 (353)
T 2i0e_A 164 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220 (353)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred eCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCC
Confidence 999986421 999999999999997543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=265.72 Aligned_cols=163 Identities=21% Similarity=0.352 Sum_probs=138.8
Q ss_pred cCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEE
Q 005898 487 MSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLV 565 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv 565 (671)
..++||+|+||.||+|+.. +|+.||||++........+++.+|+++|++++|||||+++++|.+.+ ..++|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--------~~~lv 164 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN--------DIVLV 164 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--------EEEEE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--------EEEEE
Confidence 3568999999999999964 79999999998766566788999999999999999999999998753 68999
Q ss_pred EecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee--cCCCcEEEcccCCcccc
Q 005898 566 YEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL--NEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 566 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl--~~~~~~ki~DfGla~~~ 643 (671)
|||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++ ++++.+||+|||+++..
T Consensus 165 ~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999887532 3489999999999999999999997 79999999999999 56789999999998642
Q ss_pred c-----------------------------cccccceeeeeeehhhhc
Q 005898 644 E-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 ~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
. |+||+||++|+|+++...
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 287 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 1 999999999999997653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=252.42 Aligned_cols=231 Identities=25% Similarity=0.239 Sum_probs=176.8
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCC--CCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFG--SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
++|++|+|++|.+....+..|.++++|++|+|++|.++. ..|..+..+++|++|+|++|.++ .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 578899999999875444557899999999999998863 33666777888999999998887 467778888899999
Q ss_pred EcccccCCCCCc-ccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCC
Q 005898 196 SMRNNKLAGPFP-SSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 196 ~L~~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~ 273 (671)
++++|++++..+ ..+..+++|++|++++|.+++..+. +..+++|++|++++|.+++. .
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--------------------~ 166 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN--------------------F 166 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG--------------------E
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc--------------------c
Confidence 999888886554 5788888888888888888877765 67788888888888776531 2
Q ss_pred chhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCC
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNE 353 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~ 353 (671)
+|..+..+++|++|++++|++++.+|..+..+++|+.|+|++|++++..+..+..+++|+.||+++|++++..|..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 45556667777777777777777777777777777777777777776666667777777777777777777777777666
Q ss_pred -CCCceeccCCCcCCCC
Q 005898 354 -SDKRVVKFRGNCLSSN 369 (671)
Q Consensus 354 -~~l~~l~l~~N~l~~~ 369 (671)
++++.+++++|.+++.
T Consensus 247 ~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 247 PSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CTTCCEEECTTCCEECS
T ss_pred hccCCEEEccCCCeecc
Confidence 3677777777777653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-29 Score=263.18 Aligned_cols=245 Identities=23% Similarity=0.245 Sum_probs=161.8
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcC-CCCCCccCC-------CCCccCEEEccCCcCCCCCCcc
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFL-FGSVPPKIS-------TMVKLQTLILDDNFFNNTIPNW 185 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~ 185 (671)
++..++|+.|++++|.+ .+|..+... |+.|+|++|.+ .+.+|..+. ++++|++|+|++|.+++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34445556666666665 555544433 55666666665 334454444 5566666666666666555555
Q ss_pred c--CCCCCcCEEEcccccCCCCCcccccCC-----CCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCC----
Q 005898 186 F--DSLPSLTFLSMRNNKLAGPFPSSIQRI-----STLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNL---- 253 (671)
Q Consensus 186 ~--~~l~~L~~L~L~~N~l~g~~p~~l~~l-----~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~---- 253 (671)
+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..| .+..+++|++|++++|++.+.+
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 4 5566666666666666554 5555554 566666666666655553 3555666666666666654431
Q ss_pred ---CCCCCCccEEEcCCCCCCC--Cch-hhhcCCcccceeecccccccCCCc-cccCCCCCcCeEecccCcCcccCCccc
Q 005898 254 ---PKLPRGLVMAFLSNNSFSG--EIP-KQYGQLNQLQQLDMSFNALRGMPP-PAIFSLPNISDLNLASNKFSGSLPKNL 326 (671)
Q Consensus 254 ---p~~~~~L~~l~l~~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~g~~p~~~ 326 (671)
+.-..+|+.+++++|++++ .++ ..+..+++|+.|++++|++++.+| +.+..+++|+.|+|++|+++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 1223456666666666662 223 345678999999999999999875 45667899999999999998 788877
Q ss_pred CCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 327 NCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 327 ~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
. .+|+.||+++|++++. |. +..+++++.+++++|.+++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 6 7899999999999976 66 8888999999999998875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-29 Score=256.81 Aligned_cols=168 Identities=23% Similarity=0.362 Sum_probs=140.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--------------------------hhHHHHHHHHHHHh
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--------------------------YTVRNLKLRLDLLA 534 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--------------------------~~~~~~~~E~~~l~ 534 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888999999999999999964 689999999865421 11356889999999
Q ss_pred cCCCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCc
Q 005898 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGF 614 (671)
Q Consensus 535 ~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 614 (671)
+++||||+++++++.+..+ ...++||||+++|+|.+++.. ..+++.++..++.|+++||+|||+. +|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNE------DHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp TCCCTTBCCEEEEEECSSS------SEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hCCCCCCCeEEEEEEcCCC------CEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999986421 368999999999999886543 3489999999999999999999997 89
Q ss_pred cccCCCCCceeecCCCcEEEcccCCcccc---------------------------------ccccccceeeeeeehhhh
Q 005898 615 FNNRVKTNNILLNEHRIAKLSDYGLSIVS---------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 615 iHrDlk~~NiLl~~~~~~ki~DfGla~~~---------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+||||||+||+++.++.+||+|||+++.. .|+||+||++|+|+++..
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999999999999999988531 199999999999999764
Q ss_pred c
Q 005898 662 G 662 (671)
Q Consensus 662 ~ 662 (671)
.
T Consensus 239 p 239 (298)
T 2zv2_A 239 P 239 (298)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=274.92 Aligned_cols=267 Identities=22% Similarity=0.222 Sum_probs=206.6
Q ss_pred ccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcC
Q 005898 99 ASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFF 178 (671)
Q Consensus 99 ~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 178 (671)
.+++.|...+..|..+.++++|++|+|++|.+.+..|+.|+++++|++|||++|++++..|..|+++++|++|+|++|.+
T Consensus 31 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 110 (549)
T 2z81_A 31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110 (549)
T ss_dssp EECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCC
T ss_pred EECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcc
Confidence 35666665555577899999999999999999999999999999999999999999987777899999999999999999
Q ss_pred CC-CCCcccCCCCCcCEEEcccccCCCCCc-ccccCCCCCCEEEeccCccccccCC-CC---------------------
Q 005898 179 NN-TIPNWFDSLPSLTFLSMRNNKLAGPFP-SSIQRISTLSDLDLSKNAISGSLPD-LS--------------------- 234 (671)
Q Consensus 179 ~~-~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~-~~--------------------- 234 (671)
++ .+|..++++++|++|++++|++.+.+| ..+..+++|++|++++|.+++.+|. +.
T Consensus 111 ~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~ 190 (549)
T 2z81_A 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190 (549)
T ss_dssp SSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHH
T ss_pred cccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchh
Confidence 87 467889999999999999999666666 5899999999999999999987664 33
Q ss_pred ---CCCCCCEEECCCCCCCCCC----C--CCC------------------------------------------------
Q 005898 235 ---SLGSLNVLNLSDNKLDSNL----P--KLP------------------------------------------------ 257 (671)
Q Consensus 235 ---~l~~L~~L~Ls~N~l~~~~----p--~~~------------------------------------------------ 257 (671)
.+++|++|++++|++++.. + ...
T Consensus 191 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~ 270 (549)
T 2z81_A 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270 (549)
T ss_dssp HHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCC
T ss_pred hHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccccccccc
Confidence 3567888888888877631 0 001
Q ss_pred ---------------------------------------CCccEEEcCCCCCCCCchhhh-cCCcccceeecccccccCC
Q 005898 258 ---------------------------------------RGLVMAFLSNNSFSGEIPKQY-GQLNQLQQLDMSFNALRGM 297 (671)
Q Consensus 258 ---------------------------------------~~L~~l~l~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~ 297 (671)
..++.+++++|.++ .+|..+ ..+++|+.|++++|++++.
T Consensus 271 ~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~ 349 (549)
T 2z81_A 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEE 349 (549)
T ss_dssp CCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHH
T ss_pred ccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccc
Confidence 12444555555554 355544 4677788888888887776
Q ss_pred Ccc---ccCCCCCcCeEecccCcCcccCC--cccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 298 PPP---AIFSLPNISDLNLASNKFSGSLP--KNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 298 ~~~---~~~~l~~L~~L~L~~N~l~g~~p--~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
.|+ .+..+++|+.|+|++|++++..+ ..+..+++|+.||+++|+++ .+|..+..+++++.+++++|.++
T Consensus 350 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~ 423 (549)
T 2z81_A 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423 (549)
T ss_dssp HHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS
T ss_pred cccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc
Confidence 532 35677778888888887775432 34667777888888888877 57777777777888888887766
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-29 Score=276.50 Aligned_cols=165 Identities=25% Similarity=0.495 Sum_probs=146.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
..+|+..+.||+|+||.||+|+.. ++..||||.++.... ..++|.+|+++|++++|||||+++++|.+.+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------- 289 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-------- 289 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--------
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCC--------
Confidence 456888899999999999999976 488999999976433 4678999999999999999999999997653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++|||||++|+|.++++... ...+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred cEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 5799999999999999998643 24589999999999999999999997 8999999999999999999999999998
Q ss_pred cccc-------------------------------cccccceeeeeeehh
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~ 659 (671)
+... |+||+||++|||+++
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 6421 999999999999983
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=254.92 Aligned_cols=167 Identities=29% Similarity=0.400 Sum_probs=145.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CC-------cEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NG-------TSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g-------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
++|+..+.||+|+||.||+|+.. ++ ..||+|.+........+.+.+|++++++++||||+++++++.+.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-- 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT--
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC--
Confidence 46788899999999999999854 34 479999997666666788999999999999999999999998753
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc---
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI--- 631 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~--- 631 (671)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 154 (289)
T 4fvq_A 86 ------ENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKT 154 (289)
T ss_dssp ------CCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGG
T ss_pred ------CCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccc
Confidence 5699999999999999998642 3489999999999999999999997 7999999999999998887
Q ss_pred -----EEEcccCCccccc---------------------------cccccceeeeeeehhhhc
Q 005898 632 -----AKLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 -----~ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++... |+||+|+++|+|+++...
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 155 GNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp TBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999985421 999999999999996443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-29 Score=263.91 Aligned_cols=169 Identities=23% Similarity=0.433 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|++++++++|||||++++++.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 99 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG---- 99 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----
Confidence 46888999999999999999865 79999999985322 123578999999999999999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc---E
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI---A 632 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~---~ 632 (671)
..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +
T Consensus 100 ----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 100 ----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp ----EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred ----EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence 7899999999999988876432 234589999999999999999999997 8999999999999986554 9
Q ss_pred EEcccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 633 KLSDYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 633 ki~DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+|||+++... |+||+||++|+|+++...
T Consensus 173 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp EECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 999999985421 999999999999997544
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=249.26 Aligned_cols=226 Identities=20% Similarity=0.208 Sum_probs=189.7
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCC--CCCcccCCCCCcCEEEcc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNN--TIPNWFDSLPSLTFLSMR 198 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~ 198 (671)
+.++.++++++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++. ..|..+..+++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 45777777774 4565443 689999999999975444557899999999999999873 336677788999999999
Q ss_pred cccCCCCCcccccCCCCCCEEEeccCccccccC--CCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchh
Q 005898 199 NNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP--DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPK 276 (671)
Q Consensus 199 ~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~ 276 (671)
+|.++ .+|..+..+++|+.|++++|.+++..+ .+..+++|++|++++|.+++ ..|.
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~---------------------~~~~ 144 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV---------------------AFNG 144 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE---------------------CSTT
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc---------------------cchh
Confidence 99988 578888899999999999999987665 47788888888888776643 4566
Q ss_pred hhcCCcccceeecccccccC-CCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCC
Q 005898 277 QYGQLNQLQQLDMSFNALRG-MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESD 355 (671)
Q Consensus 277 ~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 355 (671)
.+..+++|++|++++|.+++ ..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..+..+..+++
T Consensus 145 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 224 (306)
T 2z66_A 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224 (306)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTT
T ss_pred hcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCccc
Confidence 78889999999999999998 67778999999999999999999998999999999999999999999877778888999
Q ss_pred CceeccCCCcCCCCcC
Q 005898 356 KRVVKFRGNCLSSNVQ 371 (671)
Q Consensus 356 l~~l~l~~N~l~~~~~ 371 (671)
++.+++++|.+++..+
T Consensus 225 L~~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 225 LQVLDYSLNHIMTSKK 240 (306)
T ss_dssp CCEEECTTSCCCBCSS
T ss_pred CCEeECCCCCCcccCH
Confidence 9999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=271.08 Aligned_cols=150 Identities=21% Similarity=0.410 Sum_probs=120.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++|||||++++++...+.. ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~ 129 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE---KF 129 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT---TC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc---cC
Confidence 57899999999999999999865 7899999998653 234467899999999999999999999998654311 12
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...|+||||+. |+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 46899999985 69999987543 499999999999999999999997 899999999999999999999999999
Q ss_pred ccc
Q 005898 640 SIV 642 (671)
Q Consensus 640 a~~ 642 (671)
|+.
T Consensus 203 a~~ 205 (458)
T 3rp9_A 203 ART 205 (458)
T ss_dssp CBC
T ss_pred chh
Confidence 853
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=260.60 Aligned_cols=168 Identities=27% Similarity=0.487 Sum_probs=146.2
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGG 552 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 552 (671)
...++|+..+.||+|+||.||+|+.. +++.||||+++... ....+++.+|++++++++||||++++++|.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578899999999999999999864 34789999997543 334678999999999999999999999997653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCC
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTP---------------------GKVLNWSERLAVLIGVAKAVQFLHTGVI 611 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~ 611 (671)
..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||+.
T Consensus 124 --------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-- 193 (343)
T 1luf_A 124 --------PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 193 (343)
T ss_dssp --------SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred --------ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence 57999999999999999976321 14699999999999999999999997
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
+|+||||||+||++++++.+||+|||+++.. .|+||+|+++|+|++
T Consensus 194 -~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 271 (343)
T 1luf_A 194 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271 (343)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence 8999999999999999999999999988531 199999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=253.39 Aligned_cols=167 Identities=22% Similarity=0.312 Sum_probs=143.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK------- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-------
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-------
Confidence 46888899999999999999975 68999999996433 333577889999999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++ ++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 75 -~~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 75 -KLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp -EEEEEEECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred -EEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 78999999986 6666555432 3499999999999999999999997 899999999999999999999999999
Q ss_pred ccccc-------------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
++... |+||+||++|+|+++...+
T Consensus 148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred ceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 85321 9999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=255.41 Aligned_cols=163 Identities=24% Similarity=0.428 Sum_probs=142.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++|+..+.||+|+||.||+|+..++..||||++..... ..+++.+|++++.+++||||+++++++.+.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~ 93 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--------P 93 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--------S
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC--------C
Confidence 457888899999999999999998888999999976533 3467999999999999999999999997653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred eEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccc
Confidence 899999999999999997632 2489999999999999999999997 89999999999999999999999999986
Q ss_pred ccc-------------------------------cccccceeeeeeeh
Q 005898 642 VSE-------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 642 ~~~-------------------------------d~~s~g~~l~~~~~ 658 (671)
... |+||+|+++|+|++
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t 216 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 321 99999999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=267.66 Aligned_cols=168 Identities=22% Similarity=0.369 Sum_probs=145.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..++|+..+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG----- 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-----
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-----
Confidence 3467889999999999999999864 79999999997543 334567899999999999999999999998653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec---CCCcEEE
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN---EHRIAKL 634 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~---~~~~~ki 634 (671)
..++||||+++|+|.+++.... .+++.+...++.|++.||+|||+. +|+||||||+||+++ +++.+||
T Consensus 84 ---~~~lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 84 ---HHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp ---EEEEEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ---EEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEE
Confidence 7899999999999999988653 389999999999999999999997 899999999999998 4688999
Q ss_pred cccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++... |+||+||++|+|++|...
T Consensus 155 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~P 212 (444)
T 3soa_A 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212 (444)
T ss_dssp CCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 9999985321 999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-29 Score=273.95 Aligned_cols=167 Identities=22% Similarity=0.344 Sum_probs=137.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..++||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||++++++|.+.+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----- 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence 457889999999999999999964 7999999998643 2233466889999999999999999999998754
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC-CCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++|||||++|+|..++.... .+++..+..++.|+++||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 222 ---~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 ---RLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp ---EEEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred ---EEEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 6899999999999999997643 48999999999999999999997 5 799999999999999999999999
Q ss_pred cCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+||++|+|++|...
T Consensus 293 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 348 (446)
T 4ejn_A 293 FGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348 (446)
T ss_dssp CCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCC
Confidence 99986421 999999999999996543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=256.42 Aligned_cols=169 Identities=24% Similarity=0.350 Sum_probs=132.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------- 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN------- 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-------
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-------
Confidence 357888999999999999999864 68999999996543 223467889999999999999999999997653
Q ss_pred ceEEEEEecCCCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENT---PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||++ |+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 77 -~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 77 -KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp -EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred -eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECc
Confidence 7899999998 59999886431 224589999999999999999999987 899999999999999999999999
Q ss_pred cCCccccc-------------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+||++|+|++|...
T Consensus 152 fg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 208 (317)
T 2pmi_A 152 FGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPL 208 (317)
T ss_dssp CSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99985321 999999999999998643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-29 Score=260.59 Aligned_cols=165 Identities=22% Similarity=0.376 Sum_probs=144.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 82 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT------ 82 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC------
Confidence 5788899999999999999996 578999999986432 112357899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+ +|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 --~~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 83 --DIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp --EEEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred --EEEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence 689999999 789999887643 389999999999999999999997 79999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|++|...
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~P 207 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCC
Confidence 985321 999999999999997654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=275.12 Aligned_cols=169 Identities=20% Similarity=0.272 Sum_probs=147.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----- 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-----
Confidence 456888999999999999999975 79999999996432 223567889999999999999999999988653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 258 ---~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ---ALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp ---EEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ---EEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 7899999999999999987543 23489999999999999999999997 8999999999999999999999999
Q ss_pred CCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 638 GLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+++... |+||+||++|||++|...
T Consensus 331 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~P 384 (576)
T 2acx_A 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384 (576)
T ss_dssp TTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCS
T ss_pred ccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 9996431 999999999999997654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=261.13 Aligned_cols=166 Identities=23% Similarity=0.401 Sum_probs=136.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..+.|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||++++++|.+.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT------- 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS-------
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-------
Confidence 3567889999999999999999976 68899999997543 3467889999999999999999999998653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~D 636 (671)
..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 122 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 122 -EISLVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp -EEEEEECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred -eEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence 6899999999999999987543 489999999999999999999997 7999999999999975 89999999
Q ss_pred cCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+||++|+|+++...
T Consensus 195 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 249 (349)
T 2w4o_A 195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249 (349)
T ss_dssp CC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 99986421 999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=254.43 Aligned_cols=166 Identities=20% Similarity=0.334 Sum_probs=144.1
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-------- 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--------
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--------
Confidence 46788899999999999999988899999999865432 22467889999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 74 RLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp CEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred eEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccc
Confidence 68999999985 9998887542 3489999999999999999999997 8999999999999999999999999987
Q ss_pred cccc-------------------------------cccccceeeeeeehhhhc
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+... |+||+||++|+|+++...
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (288)
T 1ob3_A 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (288)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 4310 999999999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=261.68 Aligned_cols=166 Identities=20% Similarity=0.317 Sum_probs=144.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++|||||++++++.+.+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-------- 89 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 89 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS--------
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC--------
Confidence 357888999999999999999975 799999999975433 2367889999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc--EEEcccC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI--AKLSDYG 638 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~--~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 6899999999999999987643 389999999999999999999987 7999999999999987765 9999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|++|...
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P 217 (361)
T 3uc3_A 164 YSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217 (361)
T ss_dssp CC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence 98621 2999999999999997654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-29 Score=264.93 Aligned_cols=166 Identities=23% Similarity=0.436 Sum_probs=142.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.++|+..+.||+|+||+||+|++. +++.||||++... ......++.+|+.++++++|||||++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 356888899999999999999843 4678999999754 3445567999999999999999999999997653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENT----PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
..++||||+++|+|.+++.... ....+++.++..++.||++||+|||+. +|+||||||+|||++.++
T Consensus 148 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 148 ------PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp ------SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred ------CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence 5699999999999999997632 224589999999999999999999997 899999999999999554
Q ss_pred ---cEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 631 ---IAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 631 ---~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
.+||+|||+++.. .|+||+||++|||++
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 5999999998521 199999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-29 Score=264.66 Aligned_cols=167 Identities=22% Similarity=0.357 Sum_probs=136.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHH-HhcCCCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDL-LAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|..+ ++.++|||||++++++.+.+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~---- 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD---- 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----
Confidence 357889999999999999999975 68899999996543 2234556777776 57789999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..|+||||+++|+|.+++.... .+++.....++.+|+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 113 ----~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 113 ----KLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 7899999999999999997643 388999999999999999999987 799999999999999999999999
Q ss_pred cCCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 637 YGLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+++.. .|+||+||++|||++|...
T Consensus 183 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 238 (373)
T 2r5t_A 183 FGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238 (373)
T ss_dssp CCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9998641 1999999999999987543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.66 Aligned_cols=166 Identities=19% Similarity=0.411 Sum_probs=138.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhc--CCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAK--LRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||.||+|+. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++.+... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~----~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH----SS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET----TE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC----CC
Confidence 35788899999999999999987 6899999998643 23455666666655 899999999998765321 12
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC-----CCCccccCCCCCceeecCCCcEEE
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV-----IPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
...++||||+++|+|.++++.. .+++..+.+++.|++.||+|||... ..+|+||||||+||+++.++.+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred ceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3689999999999999999643 4999999999999999999999311 238999999999999999999999
Q ss_pred cccCCccc----------------------------------------cccccccceeeeeeehh
Q 005898 635 SDYGLSIV----------------------------------------SEDINSVGVRLLILMSF 659 (671)
Q Consensus 635 ~DfGla~~----------------------------------------~~d~~s~g~~l~~~~~~ 659 (671)
+|||+++. ..|+||+||++|+|+++
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 99998732 12999999999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=258.98 Aligned_cols=171 Identities=19% Similarity=0.310 Sum_probs=145.3
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~---- 86 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP---- 86 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET----
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC----
Confidence 35688899999999999999996 578999999997542 2335678999999999999999999999876421
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
.....++||||+++|+|.++++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 1124599999999999999997643 489999999999999999999997 7999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+|+++|+|+++...
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 218 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 998532 1999999999999997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=250.31 Aligned_cols=163 Identities=22% Similarity=0.408 Sum_probs=144.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++|+..+.||+|+||.||+|+..++..||||++..... ..+++.+|++++.+++||||+++++++.+.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY--------P 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--------S
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--------c
Confidence 356888899999999999999998888999999975432 3467999999999999999999999997643 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred eEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccce
Confidence 899999999999999997642 2489999999999999999999997 89999999999999999999999999985
Q ss_pred cc-------------------------------ccccccceeeeeeeh
Q 005898 642 VS-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 642 ~~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
.. .|+||+|+++|+|++
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 200 (268)
T 3sxs_A 153 YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200 (268)
T ss_dssp ECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHT
T ss_pred ecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHc
Confidence 32 199999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=256.53 Aligned_cols=166 Identities=25% Similarity=0.318 Sum_probs=140.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..++||+|+||+||+|+.. +|+.||||++.... .....++.+|+..+.++ +|||||+++++|.+.+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~------ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG------ 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT------
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC------
Confidence 46889999999999999999976 79999999986432 23344555666665555 8999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+ +|+|.+++.... ..++|..+..++.|++.||+|||+. +|+||||||+||+++.++++||+|||
T Consensus 131 --~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 131 --ILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp --EEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred --EEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 789999999 679999887643 3499999999999999999999987 79999999999999999999999999
Q ss_pred Cccccc----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|||+++...
T Consensus 203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 203 LLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp TCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred eeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 985431 999999999999998543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=269.77 Aligned_cols=166 Identities=28% Similarity=0.455 Sum_probs=146.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~------ 89 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS------ 89 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC------
Confidence 56888999999999999999975 799999999964321 23567899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 90 --~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 90 --DIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp --EEEEEEECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred --EEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence 6899999999999999997543 489999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|++|...
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P 215 (476)
T 2y94_A 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215 (476)
T ss_dssp SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence 986421 999999999999997543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=255.52 Aligned_cols=167 Identities=22% Similarity=0.395 Sum_probs=141.6
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||.||+|+.. ++.||||++.... ..+.|.+|++++++++||||+++++++.+ ..
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----------~~ 74 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN----------PV 74 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT----------TT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC----------Cc
Confidence 45778899999999999999875 7889999996432 45789999999999999999999998863 35
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc-EEEcccCCcc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI-AKLSDYGLSI 641 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~-~ki~DfGla~ 641 (671)
++||||+++|+|.+++........+++..+..++.|+++||+|||+....+|+||||||+||++++++. +||+|||+++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999986544345789999999999999999999954337999999999999998876 7999999985
Q ss_pred cc---------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS---------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~---------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+|+++|+|+++...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 202 (307)
T 2eva_A 155 DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCT
T ss_pred ccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 32 1999999999999997543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-29 Score=271.64 Aligned_cols=165 Identities=24% Similarity=0.470 Sum_probs=144.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
..++|+..+.||+|+||.||+|+..++..||||+++... ...++|.+|+++|++++|||||++++++.+.
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------- 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE--------- 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---------
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCC---------
Confidence 456688889999999999999999888889999997643 2357899999999999999999999998652
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++|||||++|+|.+++.... ...+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred ceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 4799999999999999997421 23489999999999999999999997 7999999999999999999999999998
Q ss_pred cccc-------------------------------cccccceeeeeeehh
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~ 659 (671)
+... |+||+|+++|||+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 377 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence 6421 999999999999994
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=256.54 Aligned_cols=174 Identities=18% Similarity=0.385 Sum_probs=136.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcC-Cc---EEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLEN-GT---SVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~-g~---~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
..++|+..+.||+|+||.||+|+... +. .||||++... .....+++.+|++++++++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45678899999999999999998653 32 7999999754 234567899999999999999999999999865311
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENT---PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
......++||||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 101 --~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 101 --GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred --cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 01123489999999999999986432 123589999999999999999999997 7999999999999999999
Q ss_pred EEEcccCCccccc--------------------------------cccccceeeeeeehh
Q 005898 632 AKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 632 ~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~ 659 (671)
+||+|||+++... |+||+||++|+|+++
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 9999999985421 999999999999994
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=254.65 Aligned_cols=166 Identities=27% Similarity=0.505 Sum_probs=144.3
Q ss_pred hcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG-- 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--
Confidence 45788889999999999999985 245789999997543 345678999999999999999999999987653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCC
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTP---------------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPG 613 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 613 (671)
..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||+. +
T Consensus 100 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ 170 (314)
T 2ivs_A 100 ------PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K 170 (314)
T ss_dssp ------SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ------ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 57999999999999999976432 23489999999999999999999997 7
Q ss_pred ccccCCCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeeh
Q 005898 614 FFNNRVKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 614 iiHrDlk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~ 658 (671)
|+||||||+||++++++.+||+|||+++.. .|+||+|+++|+|++
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999998532 199999999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=261.70 Aligned_cols=166 Identities=23% Similarity=0.487 Sum_probs=144.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc--------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE--------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
.++|...+.||+|+||.||+|+.. ++..||||++.... ....+++.+|+++++++ +|||||+++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999852 23579999997543 34467899999999999 899999999999765
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
+ ..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||+. +|+|||
T Consensus 148 ~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 216 (382)
T 3tt0_A 148 G--------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 216 (382)
T ss_dssp S--------SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred C--------ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 3 57999999999999999976432 24599999999999999999999997 899999
Q ss_pred CCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeeh
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
|||+||++++++.+||+|||+++... |+||+||++|+|++
T Consensus 217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp CCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 99999999999999999999986321 99999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=250.31 Aligned_cols=164 Identities=12% Similarity=0.117 Sum_probs=143.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+.|+..+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|++.+.+++||||+++++++.+.+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~------ 104 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA------ 104 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT------
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC------
Confidence 56888999999999999999975 58999999997543 234578999999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+++|+|.+++... ....+..+++.|++.||+|||+. +|+||||||+||++++++.+||+++|
T Consensus 105 --~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 105 --GGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp --EEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred --cEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence 689999999999999998532 35567889999999999999997 89999999999999999999999998
Q ss_pred Cccccc---cccccceeeeeeehhhhc
Q 005898 639 LSIVSE---DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~---d~~s~g~~l~~~~~~~~~ 662 (671)
.....+ |+||+||++|+|++|...
T Consensus 175 ~~~~~~~~~Di~slG~il~elltg~~P 201 (286)
T 3uqc_A 175 TMPDANPQDDIRGIGASLYALLVNRWP 201 (286)
T ss_dssp CCTTCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred ccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 765543 999999999999997654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=255.47 Aligned_cols=245 Identities=19% Similarity=0.185 Sum_probs=216.6
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
+.++.+++++. .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34556666664 4666554 68999999999999988999999999999999999999988899999999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCC----CCCCccEEEcCCCCCCCCch
Q 005898 201 KLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPK----LPRGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 201 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~L~~l~l~~N~l~~~~p 275 (671)
++++..+..|..+++|++|+|++|.++...+ .+..+++|+.|++++|+..+.++. -..+|+.|++++|++++ +|
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc
Confidence 9997777779999999999999999997666 388999999999999655554443 24689999999999986 44
Q ss_pred hhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCC
Q 005898 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESD 355 (671)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 355 (671)
.+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 5889999999999999999999999999999999999999999999999999999999999999999877788888999
Q ss_pred CceeccCCCcCCCCc
Q 005898 356 KRVVKFRGNCLSSNV 370 (671)
Q Consensus 356 l~~l~l~~N~l~~~~ 370 (671)
++.+++++|.+.+++
T Consensus 292 L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 292 LVELHLHHNPWNCDC 306 (452)
T ss_dssp CCEEECCSSCEECST
T ss_pred CCEEEccCCCcCCCC
Confidence 999999999887654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=261.96 Aligned_cols=168 Identities=25% Similarity=0.434 Sum_probs=138.8
Q ss_pred CCCcCceeccCCceEEEEEEEc--CC--cEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE--NG--TSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~--~g--~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.|+..++||+|+||.||+|+.. ++ ..||||.+.... ....++|.+|+.++++++|||||+++++|.+.+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------ 163 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE------ 163 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS------
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC------
Confidence 3566789999999999999863 22 468999986533 345678999999999999999999999986543
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
...++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 164 -~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 164 -GSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred -CCeEEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence 25689999999999999997543 3488999999999999999999997 89999999999999999999999999
Q ss_pred Ccccc----------------------------------ccccccceeeeeeehhhhcc
Q 005898 639 LSIVS----------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~----------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
+++.. .|+||+||++|+|+++...+
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 98632 19999999999999954433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=258.51 Aligned_cols=162 Identities=25% Similarity=0.449 Sum_probs=136.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcE----EEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTS----VAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~----vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..+.||+|+||.||+|+.. +++. ||+|.+.... ....+++.+|++++++++|||||+++++|.+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 46888899999999999999854 4543 5888886432 34467899999999999999999999999864
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++|+||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 90 ----~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D 160 (327)
T 3poz_A 90 ----TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp ----SEEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred ----CeEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEcc
Confidence 4689999999999999998643 3489999999999999999999997 899999999999999999999999
Q ss_pred cCCccccc--------------------------------cccccceeeeeeeh
Q 005898 637 YGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
||+++... |+||+||++|+|++
T Consensus 161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 214 (327)
T 3poz_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence 99985321 99999999999999
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=249.22 Aligned_cols=167 Identities=22% Similarity=0.354 Sum_probs=147.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.+.|+..+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------- 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-------- 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--------
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--------
Confidence 346888999999999999999975 57899999997655555678999999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee---cCCCcEEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL---NEHRIAKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl---~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... .+++.++..++.+++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 6899999999999999887643 389999999999999999999987 79999999999999 78899999999
Q ss_pred CCcccc----------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|+|+++...
T Consensus 154 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (277)
T 3f3z_A 154 GLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPP 206 (277)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCC
Confidence 998542 2999999999999997543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=271.58 Aligned_cols=170 Identities=19% Similarity=0.306 Sum_probs=147.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------ 258 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT------ 258 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS------
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC------
Confidence 56888899999999999999975 79999999996432 223567899999999999999999999987653
Q ss_pred cceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|..++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 259 --~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 259 --DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp --EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred --EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence 7899999999999999987643 234599999999999999999999997 8999999999999999999999999
Q ss_pred CCccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 638 GLSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+++... |+||+||++|||++|....
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF 389 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCC
Confidence 9985421 9999999999999976543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=267.22 Aligned_cols=171 Identities=21% Similarity=0.275 Sum_probs=142.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+.+|+.++|||||++++++...... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~--~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL--EE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST--TT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc--cc
Confidence 467888999999999999999864 6899999999754 234467789999999999999999999999764311 11
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....|+|||||++ ++.+.+.. .+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 2468999999986 46666643 288999999999999999999997 79999999999999999999999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+... |+||+||++|+|++|....
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF 263 (464)
T 3ttj_A 210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263 (464)
T ss_dssp CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCC
Confidence 986422 9999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=258.12 Aligned_cols=166 Identities=28% Similarity=0.394 Sum_probs=143.8
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+.|+..+.||+|+||.||+|+. .+|+.||||++.... ....+++.+|++++++++|||||+++++|.+.+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH------ 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT------
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC------
Confidence 4588889999999999999996 579999999996432 233567899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||++ |++.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 128 --~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 128 --TAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp --EEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred --eEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 7899999997 68888775432 3489999999999999999999997 79999999999999999999999999
Q ss_pred Ccccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|+++...
T Consensus 200 ~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 252 (348)
T 1u5q_A 200 SASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252 (348)
T ss_dssp TCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 98532 1999999999999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=263.91 Aligned_cols=172 Identities=24% Similarity=0.338 Sum_probs=148.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+. .
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------~ 82 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT------R 82 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT------C
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC------C
Confidence 46788899999999999999975 58999999997543 2345678899999999999999999999886532 2
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee----cCCCcEEEcc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL----NEHRIAKLSD 636 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl----~~~~~~ki~D 636 (671)
..++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEec
Confidence 5799999999999999998654444599999999999999999999997 89999999999999 7788899999
Q ss_pred cCCcccc-------------------------------------ccccccceeeeeeehhhhcc
Q 005898 637 YGLSIVS-------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||+++.. .|+||+||++|+|++|....
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf 223 (396)
T 4eut_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223 (396)
T ss_dssp GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSE
T ss_pred CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9998542 19999999999999976543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=255.83 Aligned_cols=168 Identities=23% Similarity=0.381 Sum_probs=147.8
Q ss_pred cCCCcCceeccCCceEEEEEEE-----cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---- 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---- 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS----
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC----
Confidence 5688899999999999999984 3688999999987766667789999999999999999999999875431
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++.... ..+++.++..++.+++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 99 --~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 99 --QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp --CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred --ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence 36899999999999999997532 2489999999999999999999987 8999999999999999999999999
Q ss_pred CCccccc---------------------------------cccccceeeeeeehhhh
Q 005898 638 GLSIVSE---------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~~---------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|+++... |+||+|+++|+|+++..
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 9986321 99999999999999744
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=252.79 Aligned_cols=247 Identities=19% Similarity=0.192 Sum_probs=201.9
Q ss_pred CCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
.+.+|++|++++|.+....+..+.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 46789999999999876555568999999999999999998888899999999999999999999888999999999999
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCC---------------
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRG--------------- 259 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------------- 259 (671)
++++|+++...+..+.++++|++|++++|.+++..|. +..+++|++|++++|++++........
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~ 202 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 202 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEE
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccC
Confidence 9999999954444579999999999999999988775 889999999999999998653332333
Q ss_pred ----ccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEE
Q 005898 260 ----LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFF 335 (671)
Q Consensus 260 ----L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l 335 (671)
++.+++++|.++.. |.. ..++|+.|++++|.+++. +.+..+++|+.|+|++|.+++..|..+..+++|+.|
T Consensus 203 ~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 277 (390)
T 3o6n_A 203 IPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 277 (390)
T ss_dssp CCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred CCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEE
Confidence 45555555555432 222 245788888888888775 367788888888888888888888888888888888
Q ss_pred ECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 336 DISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 336 ~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
++++|++++ +|.....+++++.+++++|.++.
T Consensus 278 ~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~ 309 (390)
T 3o6n_A 278 YISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH 309 (390)
T ss_dssp ECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC
T ss_pred ECCCCcCcc-cCcccCCCCCCCEEECCCCccee
Confidence 888888875 56666777888888888887763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=249.80 Aligned_cols=163 Identities=20% Similarity=0.401 Sum_probs=136.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.++|+..+.||+|+||.||+|+.. .+..||||.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 88 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN----- 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC-----
Confidence 356888999999999999999864 24579999987543 34467799999999999999999999998542
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 89 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 89 ----PVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred ----ccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence 4689999999999999997643 3489999999999999999999997 899999999999999999999999
Q ss_pred cCCcccc-------------------------------ccccccceeeeeeeh
Q 005898 637 YGLSIVS-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+++.. .|+||+|+++|+|++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~ 212 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred cccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHh
Confidence 9988532 199999999999997
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=252.23 Aligned_cols=168 Identities=26% Similarity=0.508 Sum_probs=142.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-----cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG--- 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---
Confidence 3477889999999999999984 368899999997443 3345789999999999999999999999986532
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 98 ---~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 98 ---NGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ---ceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence 25799999999999999996532 3489999999999999999999997 899999999999999999999999
Q ss_pred cCCccccc---------------------------------cccccceeeeeeehhhh
Q 005898 637 YGLSIVSE---------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 637 fGla~~~~---------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
||+++... |+||+|+++|+|+++..
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence 99985321 99999999999999644
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=275.83 Aligned_cols=165 Identities=24% Similarity=0.470 Sum_probs=145.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
..++|+..+.||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++|||||+++++|.+.
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------- 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE--------- 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---------
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeec---------
Confidence 345688889999999999999999888889999997643 2357899999999999999999999998652
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++|||||++|+|.++++... ...+++.++..++.||++||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred cceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 4799999999999999997431 23489999999999999999999997 7999999999999999999999999999
Q ss_pred cccc-------------------------------cccccceeeeeeehh
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~ 659 (671)
+... |+||+||++|||+++
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 6431 999999999999994
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=260.71 Aligned_cols=170 Identities=22% Similarity=0.314 Sum_probs=147.4
Q ss_pred hcCCCcCceeccC--CceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEG--SYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G--~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.++|+..+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 99 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN---- 99 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC----
Confidence 3568889999999 99999999975 79999999996543 334567889999999999999999999998753
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++|||||++|+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 100 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 100 ----ELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred ----EEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 7899999999999999997642 23489999999999999999999997 899999999999999999999999
Q ss_pred cCCcccc---------------------------------------ccccccceeeeeeehhhhcc
Q 005898 637 YGLSIVS---------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~---------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||.+... .|+||+||++|+|+++....
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 9875310 19999999999999976543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=247.51 Aligned_cols=167 Identities=26% Similarity=0.471 Sum_probs=138.7
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch----hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK----YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. |+.||||++..... ...+.+.+|+++++.++||||++++++|.+.+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 79 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP------ 79 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-------
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC------
Confidence 56888899999999999999975 88999999865422 23567899999999999999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC--------CC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE--------HR 630 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~--------~~ 630 (671)
..++||||+++|+|.+++... .+++..+..++.|+++||+|||+....+|+||||||+||++++ ++
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 80 --NLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp ---CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred --ceEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence 579999999999999998642 4899999999999999999999985545999999999999986 67
Q ss_pred cEEEcccCCccccc----------------------------cccccceeeeeeehhhhc
Q 005898 631 IAKLSDYGLSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 631 ~~ki~DfGla~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
.+||+|||+++... |+||+|+++|+|+++...
T Consensus 154 ~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 213 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213 (271)
T ss_dssp CEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred ceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 89999999986321 999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=263.69 Aligned_cols=168 Identities=26% Similarity=0.383 Sum_probs=142.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--------hhHHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
..++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++|++++|||||++++++...
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4578999999999999999999865 689999999864321 1223588999999999999999999998643
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC--
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-- 629 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-- 629 (671)
..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 213 ---------~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 213 ---------DYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp ---------EEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSS
T ss_pred ---------ceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCC
Confidence 5799999999999999887543 489999999999999999999987 79999999999999754
Q ss_pred -CcEEEcccCCccccc--------------------------------cccccceeeeeeehhhhcc
Q 005898 630 -RIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 630 -~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+.+||+|||+++... |+||+||++|+|+++....
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf 344 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344 (419)
T ss_dssp SCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 459999999986421 9999999999999976543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=252.14 Aligned_cols=167 Identities=23% Similarity=0.346 Sum_probs=143.6
Q ss_pred cCCCc-CceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDM-SAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~-~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.|+. .++||+|+||.||+|+. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~------- 84 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED------- 84 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-------
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-------
Confidence 34655 47899999999999985 47999999999766555567899999999885 7999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc---EEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI---AKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~---~ki~D 636 (671)
..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 85 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 85 -RFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred -EEEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence 7899999999999999997643 489999999999999999999997 8999999999999998766 99999
Q ss_pred cCCcccc------------------------------------------ccccccceeeeeeehhhhcc
Q 005898 637 YGLSIVS------------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~------------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||+++.. .|+||+||++|+|+++....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 226 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence 9987421 19999999999999976543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=247.71 Aligned_cols=167 Identities=24% Similarity=0.441 Sum_probs=141.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh---h----HHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY---T----VRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~---~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
++|+..+.||+|+||.||+|+.. +++.||||++...... . .+++.+|++++++++||||+++++++.+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--- 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---
Confidence 56888899999999999999974 7899999998643221 1 16789999999999999999999998653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc---
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI--- 631 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~--- 631 (671)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.. ++|+||||||+||+++.++.
T Consensus 96 -------~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 96 -------PRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp -------TEEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCS
T ss_pred -------CeEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCc
Confidence 279999999999999887543 35999999999999999999999872 23999999999999988776
Q ss_pred --EEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 632 --AKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 --~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++... |+||+||++|+|+++...
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 227 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227 (287)
T ss_dssp CCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999885321 999999999999997544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=252.30 Aligned_cols=158 Identities=23% Similarity=0.345 Sum_probs=137.9
Q ss_pred CceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccceEEEE
Q 005898 488 SAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVNKVFLV 565 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~~Lv 565 (671)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|++++..++ |||||++++++.+.. ..++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~--------~~~lv 84 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL--------HTFLV 84 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--------EEEEE
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC--------EEEEE
Confidence 478999999999999975 6899999999643 3467789999999997 999999999998653 68999
Q ss_pred EecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC---cEEEcccCCccc
Q 005898 566 YEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR---IAKLSDYGLSIV 642 (671)
Q Consensus 566 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~---~~ki~DfGla~~ 642 (671)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 85 MELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp ECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999998643 499999999999999999999987 899999999999998665 899999999964
Q ss_pred cc------------------------------cccccceeeeeeehhhhc
Q 005898 643 SE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 643 ~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
.. |+||+||++|+|+++...
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 208 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 21 999999999999997554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-28 Score=248.41 Aligned_cols=169 Identities=24% Similarity=0.407 Sum_probs=143.7
Q ss_pred cCCCcCceeccCCceEEEEEEEcC----CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN----GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..|+..+.||+|+||.||+|+..+ +..||||.+.... ....+++.+|++++++++||||++++++|.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----- 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-----
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC-----
Confidence 457778999999999999998642 2368999987543 344678999999999999999999999987543
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 100 --~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 100 --GSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp --SCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred --CceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence 25789999999999999997532 3489999999999999999999997 8999999999999999999999999
Q ss_pred CCcccc----------------------------------ccccccceeeeeeehhhhcc
Q 005898 638 GLSIVS----------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~----------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|+++.. .|+||+|+++|+|+++...+
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 232 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 998532 19999999999999965444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=245.51 Aligned_cols=171 Identities=22% Similarity=0.363 Sum_probs=145.8
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+.+ ++.||||++.... ....+++.+|++++++++||||++++++|.+.++ .
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~ 82 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA------P 82 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS------S
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC------C
Confidence 46788899999999999999985 8899999997543 3446789999999999999999999999987531 2
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+.. ++|+||||||+||++++++.++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccce
Confidence 5799999999999999998643 235899999999999999999999862 24999999999999999999999988876
Q ss_pred cc----------------------------cccccccceeeeeeehhhhc
Q 005898 641 IV----------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~----------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
.. ..|+||+|+++|+|+++...
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 161 FSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp CTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred eeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 32 13999999999999996543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-26 Score=251.01 Aligned_cols=172 Identities=25% Similarity=0.192 Sum_probs=87.6
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
++++++|++|+|++|.+.+. | ++++++|++|+|++|++++ +| ++.+++|++|++++|.+++. | ++.+++|+
T Consensus 81 ~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~ 151 (457)
T 3bz5_A 81 LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLT 151 (457)
T ss_dssp CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCC
T ss_pred cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCC
Confidence 55555555555555555442 2 5555555555555555554 23 55555555555555555542 2 45555555
Q ss_pred EEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCC
Q 005898 194 FLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 194 ~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~ 273 (671)
+|++++|+..+.+ .+..+++|+.|++++|++++. | +..+++|+.|++++|++++..-.-..+|+.+++++|++++
T Consensus 152 ~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~-l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~- 226 (457)
T 3bz5_A 152 ELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D-VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTE- 226 (457)
T ss_dssp EEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C-CTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSC-
T ss_pred EEECCCCCccccc--ccccCCcCCEEECCCCcccee-c-cccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccc-
Confidence 5555555444443 244555555555555555542 2 4455555555555555544311112345555555555554
Q ss_pred chhhhcCCcccceeecccccccCCCccc
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPA 301 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 301 (671)
+| ++.+++|+.|++++|++++.++..
T Consensus 227 ip--~~~l~~L~~L~l~~N~l~~~~~~~ 252 (457)
T 3bz5_A 227 ID--VTPLTQLTYFDCSVNPLTELDVST 252 (457)
T ss_dssp CC--CTTCTTCSEEECCSSCCSCCCCTT
T ss_pred cC--ccccCCCCEEEeeCCcCCCcCHHH
Confidence 33 445555555555555555544433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=256.87 Aligned_cols=167 Identities=24% Similarity=0.482 Sum_probs=141.9
Q ss_pred HhcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
..++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456788899999999999999985 245689999997543 23456799999999999 8999999999998653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHhcCCCCC
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTPG--------------------KVLNWSERLAVLIGVAKAVQFLHTGVIP 612 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~ 612 (671)
..++||||+++|+|.+++...... ..++|.++..++.|+++||+|||+.
T Consensus 123 --------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 191 (344)
T 1rjb_A 123 --------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--- 191 (344)
T ss_dssp --------SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred --------ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 579999999999999999764321 3489999999999999999999997
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeeh
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
+|+||||||+||+++.++.+||+|||+++... |+||+|+++|+|++
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 269 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence 89999999999999999999999999985321 99999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=252.35 Aligned_cols=167 Identities=28% Similarity=0.471 Sum_probs=144.8
Q ss_pred hcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCch-hhHHHHHHHHHHHhcC-CCCCcccccceeecCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKK-YTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 553 (671)
.++|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++.++ +||||++++++|.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC-
Confidence 45688889999999999999985 3567999999975433 3457899999999999 9999999999997653
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTP---------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||+. +|+|||
T Consensus 101 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d 170 (313)
T 1t46_A 101 -------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (313)
T ss_dssp -------SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred -------CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence 57999999999999999976432 22589999999999999999999997 899999
Q ss_pred CCCCceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||+||++++++.+||+|||+++.. .|+||+|+++|+|+++
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999998532 1999999999999983
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-28 Score=259.32 Aligned_cols=169 Identities=25% Similarity=0.407 Sum_probs=138.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~ 556 (671)
..++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++.+++ |||||++++++...+.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--- 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND--- 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---
Confidence 4578999999999999999999864 7999999998643 3345667889999999997 9999999999976432
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...|+|||||+ |+|..++... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 84 ---~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D 152 (388)
T 3oz6_A 84 ---RDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVAD 152 (388)
T ss_dssp ---SCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred ---CEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecC
Confidence 25899999998 6999988753 489999999999999999999997 899999999999999999999999
Q ss_pred cCCcccc----------------------------------------------------ccccccceeeeeeehhhhcc
Q 005898 637 YGLSIVS----------------------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~----------------------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||+|+.. .|+||+||++|||++|....
T Consensus 153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 9998531 19999999999999976443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=274.80 Aligned_cols=155 Identities=25% Similarity=0.433 Sum_probs=138.0
Q ss_pred eeccCCceEEEEEEEc---CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEE
Q 005898 490 IMGEGSYGKLYKGRLE---NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLV 565 (671)
Q Consensus 490 ~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv 565 (671)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++++|.+. ..++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---------~~~lv 413 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---------ALMLV 413 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---------SEEEE
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---------CeEEE
Confidence 7999999999999864 46689999997643 33567899999999999999999999999752 47999
Q ss_pred EecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccccc-
Q 005898 566 YEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE- 644 (671)
Q Consensus 566 ~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~- 644 (671)
||||++|+|.+++... ...+++.++..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999999754 24599999999999999999999997 79999999999999999999999999986421
Q ss_pred --------------------------------cccccceeeeeeeh
Q 005898 645 --------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 645 --------------------------------d~~s~g~~l~~~~~ 658 (671)
|+||+||++|||++
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 534 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 99999999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-28 Score=250.40 Aligned_cols=166 Identities=25% Similarity=0.364 Sum_probs=145.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR------- 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-------
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-------
Confidence 56888999999999999999975 69999999986543 233567889999999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++++|..++.... .+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 -~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 76 -RLHLVFEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp -EEEEEEECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred -eEEEEEEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 6899999999999998887543 389999999999999999999987 899999999999999999999999999
Q ss_pred ccccc-------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+|+++|+|+++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 202 (311)
T 4agu_A 149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202 (311)
T ss_dssp CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 85321 999999999999997543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-28 Score=253.92 Aligned_cols=166 Identities=20% Similarity=0.513 Sum_probs=142.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE--------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL--------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~--------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
.++|+..+.||+|+||.||+|+. .++..||||++.... ....+++.+|+++++++ +||||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46788899999999999999986 346789999997543 34567899999999999 899999999999765
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
+ ..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||+. +|+|||
T Consensus 114 ~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 182 (334)
T 2pvf_A 114 G--------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 182 (334)
T ss_dssp S--------CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred C--------ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence 3 67999999999999999976432 23489999999999999999999997 899999
Q ss_pred CCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeeh
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
|||+||++++++.+||+|||+++... |+||+|+++|+|++
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence 99999999999999999999985321 99999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=257.53 Aligned_cols=172 Identities=22% Similarity=0.325 Sum_probs=140.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.+.|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++......+ .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~--~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD--D 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT--T
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc--c
Confidence 356888999999999999999964 7999999999543 2334577899999999999999999999987653111 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++||||+ +++|.+++... .+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 23569999999 78999998753 389999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc----------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+++..+ |+||+||++|+|++|....
T Consensus 174 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 226 (367)
T 1cm8_A 174 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226 (367)
T ss_dssp TCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 986421 9999999999999976543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=246.92 Aligned_cols=168 Identities=22% Similarity=0.333 Sum_probs=144.4
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
.+....+||+|+||.||+|+. .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+ ..
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~ 94 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG--------FI 94 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT--------EE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC--------cE
Confidence 355566899999999999996 478899999997765555678999999999999999999999998653 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCcEEEcccCCcc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRIAKLSDYGLSI 641 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~~ki~DfGla~ 641 (671)
++||||+++|+|.+++........+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 99999999999999998754444578999999999999999999997 8999999999999997 8999999999885
Q ss_pred cc--------------------------------ccccccceeeeeeehhhhc
Q 005898 642 VS--------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~--------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
.. .|+||+|+++|+|+++...
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (295)
T 2clq_A 172 RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224 (295)
T ss_dssp ESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred ccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 31 1999999999999997543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=245.39 Aligned_cols=163 Identities=23% Similarity=0.431 Sum_probs=145.0
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||.||+|+..+++.||||++..... ..+++.+|++++++++||||+++++++.+.+ ..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~ 78 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--------PI 78 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS--------SC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--------Ce
Confidence 46778899999999999999988888999999976433 3468999999999999999999999997653 57
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999999997642 3489999999999999999999997 799999999999999999999999999864
Q ss_pred c-------------------------------ccccccceeeeeeehh
Q 005898 643 S-------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 643 ~-------------------------------~d~~s~g~~l~~~~~~ 659 (671)
. .|+||+|+++|+|+++
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhcc
Confidence 2 1999999999999984
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=242.23 Aligned_cols=233 Identities=23% Similarity=0.227 Sum_probs=184.8
Q ss_pred CCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCc-CCCCCCcccCCCCCcCEE
Q 005898 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF-FNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 117 l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L 195 (671)
.++|++|+|++|.+.+..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..+..+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 3589999999999988888889999999999999999998889999999999999999997 776668899999999999
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCC---CCCccEEEcCCCCCC
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLSNNSFS 271 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~~N~l~ 271 (671)
++++|++++..|..+..+++|++|++++|.+++..+. +..+++|++|++++|++++..+.. ..+|+.+++++|.++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 9999999988888899999999999999999987765 788999999999999887655432 346777777777777
Q ss_pred CCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCC
Q 005898 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCL 350 (671)
Q Consensus 272 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~ 350 (671)
+..|..|..+++|+.|++++|++++.++..+..+++|+.|+|++|.++...+.. .....++.++.+.|.+.+..|..+
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence 766777777777777777777777777666777777777777777776543321 001123444455666666666554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=248.03 Aligned_cols=167 Identities=21% Similarity=0.396 Sum_probs=145.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT----- 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC-----
Confidence 467888999999999999999865 67899999986432 122567899999999999999999999998653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ---~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 83 ---RVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp ---EEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred ---EEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence 6899999999999999987643 389999999999999999999987 8999999999999999999999999
Q ss_pred CCcccc----------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|+|+++...
T Consensus 154 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 206 (279)
T 3fdn_A 154 GWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206 (279)
T ss_dssp CEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCC
Confidence 987432 2999999999999987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=252.97 Aligned_cols=167 Identities=24% Similarity=0.487 Sum_probs=145.9
Q ss_pred cCCCcCceeccCCceEEEEEEE-----cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|++ .+|+.||||++........+.+.+|++++++++||||+++++++...+.
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 116 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---- 116 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC----
Confidence 4678889999999999999984 3688999999987666667889999999999999999999999876431
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
...++||||+++|+|.+++.... ..+++.++..++.++++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 117 --~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 117 --RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred --CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecC
Confidence 25799999999999999998643 3489999999999999999999987 8999999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehhh
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
|+++.. .|+||+|+++|+|+++.
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~ 245 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTT
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcC
Confidence 998542 19999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=250.36 Aligned_cols=165 Identities=25% Similarity=0.472 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-----CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-----NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+.|+..+.||+|+||.||++++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 107 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA--- 107 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT---
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC---
Confidence 34588899999999999998652 68899999997643 3446779999999999999999999999987532
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...++||||+++|+|.+++... .+++.++..++.+++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 108 ---~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~D 177 (318)
T 3lxp_A 108 ---ASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGD 177 (318)
T ss_dssp ---TEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ---ceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECC
Confidence 3689999999999999999754 289999999999999999999997 799999999999999999999999
Q ss_pred cCCccccc---------------------------------cccccceeeeeeehhh
Q 005898 637 YGLSIVSE---------------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 637 fGla~~~~---------------------------------d~~s~g~~l~~~~~~~ 660 (671)
||+++... |+||+|+++|+|+++.
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~ 234 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99985421 9999999999999974
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=256.54 Aligned_cols=173 Identities=21% Similarity=0.359 Sum_probs=147.3
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceee
Q 005898 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549 (671)
Q Consensus 477 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 549 (671)
++....++|+..+.||+|+||.||+|+.. +++.||||.+.... ....+++.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678999999999999999999753 36789999997543 334567999999999999999999999997
Q ss_pred cCCCCCCcccceEEEEEecCCCCChhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCC
Q 005898 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTN 622 (671)
Q Consensus 550 ~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~ 622 (671)
+.+ ..++||||+++|+|.+++.... ....+++..+.+++.|+++||+|||+. +|+||||||+
T Consensus 99 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~ 167 (322)
T 1p4o_A 99 QGQ--------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAAR 167 (322)
T ss_dssp SSS--------SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGG
T ss_pred cCC--------ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccc
Confidence 653 5799999999999999987421 123578999999999999999999997 7999999999
Q ss_pred ceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehhh
Q 005898 623 NILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSFF 660 (671)
Q Consensus 623 NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~ 660 (671)
||++++++.+||+|||+++.. .|+||+|+++|+|+++.
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 999999999999999998532 19999999999999843
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-28 Score=248.73 Aligned_cols=169 Identities=21% Similarity=0.385 Sum_probs=144.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|...+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-------- 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-------- 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--------
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC--------
Confidence 45788899999999999999965 68999999986543 234678999999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee---cCCCcEEEcc
Q 005898 561 KVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL---NEHRIAKLSD 636 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl---~~~~~~ki~D 636 (671)
..++||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 689999999999999988642 1234599999999999999999999987 79999999999999 4568899999
Q ss_pred cCCccccc----------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+|+++|+|+++...
T Consensus 171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~p 224 (285)
T 3is5_A 171 FGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLP 224 (285)
T ss_dssp CCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCC
Confidence 99996421 999999999999997543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-28 Score=252.41 Aligned_cols=166 Identities=23% Similarity=0.359 Sum_probs=145.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch------hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
+.|+..+.||+|+||.||+|+.. +|+.||||.+..... ...+++.+|++++++++||||+++++++.+.+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 88 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT--- 88 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC---
Confidence 46888999999999999999975 689999999865321 13678999999999999999999999998653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC----c
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR----I 631 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~----~ 631 (671)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++ .
T Consensus 89 -----~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 89 -----DVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp -----EEEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCC
T ss_pred -----EEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCC
Confidence 6899999999999999997543 489999999999999999999997 899999999999999887 7
Q ss_pred EEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++... |+||+|+++|+|+++...
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp EEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred EEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence 9999999985421 999999999999997654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-28 Score=257.14 Aligned_cols=168 Identities=20% Similarity=0.322 Sum_probs=145.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch--------hhHHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK--------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
..++|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346788999999999999999985 4789999999865421 1234678899999999999999999999865
Q ss_pred CCCCCcccceEEEEEecCCCC-ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNG-NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~G-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
+ ..++||||+..| +|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 102 ~--------~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 102 G--------FFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp S--------EEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred C--------EEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence 3 789999999887 9999997643 499999999999999999999997 899999999999999999
Q ss_pred cEEEcccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 631 IAKLSDYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 631 ~~ki~DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
.+||+|||+++... |+||+||++|+|+++...
T Consensus 168 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 229 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229 (335)
T ss_dssp CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCc
Confidence 99999999986321 999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-28 Score=277.39 Aligned_cols=169 Identities=20% Similarity=0.311 Sum_probs=146.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 555 (671)
..++|+..++||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~--- 415 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--- 415 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS---
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC---
Confidence 3567999999999999999999965 68899999997432 22356788899999988 7999999999887653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..|+||||+++|+|..+++... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 416 -----~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 416 -----RLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp -----EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred -----EEEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 7899999999999999998643 389999999999999999999997 89999999999999999999999
Q ss_pred ccCCccccc------------------------------cccccceeeeeeehhhhcc
Q 005898 636 DYGLSIVSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 636 DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|||+|+... |+||+||++|||++|....
T Consensus 485 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf 542 (674)
T 3pfq_A 485 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542 (674)
T ss_dssp CCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCC
Confidence 999987421 9999999999999976543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=252.66 Aligned_cols=167 Identities=22% Similarity=0.307 Sum_probs=146.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|...+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----- 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----
Confidence 456888999999999999999975 6889999998643 2345677899999999999999999999998653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++++|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 115 ---~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 ---FVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp ---EEEEEECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred ---eEEEEEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 6899999999999999887543 489999999999999999999997 8999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+|+++|+|+++...
T Consensus 186 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 240 (335)
T 2owb_A 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240 (335)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred cCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCC
Confidence 998542 1999999999999997543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=247.03 Aligned_cols=166 Identities=22% Similarity=0.310 Sum_probs=145.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 88 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND------ 88 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS------
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC------
Confidence 56788899999999999999975 6889999998643 2344677899999999999999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 89 --~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 89 --FVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred --EEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEecc
Confidence 6899999999999999887543 489999999999999999999997 89999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+|+++|+|+++...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 214 (294)
T 2rku_A 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214 (294)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 98542 1999999999999997543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=245.49 Aligned_cols=169 Identities=20% Similarity=0.300 Sum_probs=144.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~----- 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD----- 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT-----
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----
Confidence 456888999999999999999975 7999999998753 233456788999999999 9999999999998753
Q ss_pred ccceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC--------
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-------- 628 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-------- 628 (671)
..++||||+++|+|.+++.... ....+++.++..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 85 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 85 ---HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred ---eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence 7899999999999999997531 123589999999999999999999997 8999999999999984
Q ss_pred -----------CCcEEEcccCCcccc---------------------------ccccccceeeeeeehhhh
Q 005898 629 -----------HRIAKLSDYGLSIVS---------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 629 -----------~~~~ki~DfGla~~~---------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
...+||+|||+++.. .|+||+||++|+|+++..
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred cccccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 447999999987532 299999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-28 Score=256.86 Aligned_cols=176 Identities=22% Similarity=0.311 Sum_probs=149.4
Q ss_pred cCHHHHHHHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-----CCCcccccc
Q 005898 473 FTLEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-----HPHLVCLLG 546 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g 546 (671)
+++++.....++|+..++||+|+||.||+|+. .+++.||||++.... ...+.+..|++++.+++ |||||++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33344444567899999999999999999997 478999999997543 34567888999999987 999999999
Q ss_pred eeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee
Q 005898 547 HCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL 626 (671)
Q Consensus 547 ~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl 626 (671)
++...+ ..++||||+ +|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++
T Consensus 104 ~~~~~~--------~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 170 (360)
T 3llt_A 104 KFMYYD--------HMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILL 170 (360)
T ss_dssp EEEETT--------EEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred eeeECC--------eeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEE
Confidence 998753 789999999 899999997643 23489999999999999999999987 89999999999999
Q ss_pred cC-------------------------CCcEEEcccCCccccc---------------------------cccccceeee
Q 005898 627 NE-------------------------HRIAKLSDYGLSIVSE---------------------------DINSVGVRLL 654 (671)
Q Consensus 627 ~~-------------------------~~~~ki~DfGla~~~~---------------------------d~~s~g~~l~ 654 (671)
++ ++.+||+|||+++... |+||+||++|
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 75 7899999999996422 9999999999
Q ss_pred eeehhhhc
Q 005898 655 ILMSFFFG 662 (671)
Q Consensus 655 ~~~~~~~~ 662 (671)
+|+++...
T Consensus 251 ell~g~~p 258 (360)
T 3llt_A 251 ELYTGSLL 258 (360)
T ss_dssp HHHHSSCS
T ss_pred HHHHCCCC
Confidence 99998543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-28 Score=246.21 Aligned_cols=164 Identities=21% Similarity=0.458 Sum_probs=143.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.+.|+..+.||+|+||.||+|+..++..||||.+..... ..+.+.+|++++++++||||+++++++.+. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---------~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---------P 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---------S
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcCC---------C
Confidence 356888899999999999999988888999999975432 357899999999999999999999988642 4
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 799999999999999987431 12489999999999999999999987 89999999999999999999999999985
Q ss_pred ccc-------------------------------cccccceeeeeeehh
Q 005898 642 VSE-------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 642 ~~~-------------------------------d~~s~g~~l~~~~~~ 659 (671)
... |+||+|+++|+|+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 206 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence 421 999999999999983
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=255.85 Aligned_cols=162 Identities=23% Similarity=0.433 Sum_probs=139.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcE----EEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTS----VAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~----vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..+.||+|+||.||+|+.. +++. ||+|.+.... ....+.+.+|+.++++++||||++++++|.+.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS----- 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS-----
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence 46788899999999999999864 5554 7888875432 22345678899999999999999999998643
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 88 ----~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 158 (325)
T 3kex_A 88 ----SLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD 158 (325)
T ss_dssp ----SEEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred ----ccEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence 5799999999999999997542 3488999999999999999999997 799999999999999999999999
Q ss_pred cCCccccc--------------------------------cccccceeeeeeeh
Q 005898 637 YGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
||+++... |+||+||++|+|++
T Consensus 159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 212 (325)
T 3kex_A 159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212 (325)
T ss_dssp CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHh
Confidence 99996431 99999999999999
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-28 Score=260.05 Aligned_cols=167 Identities=26% Similarity=0.393 Sum_probs=144.5
Q ss_pred hcCCCcCceeccCCceEEEEEEE----cCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788999999999999999986 378999999986432 12345678899999999 6999999999987653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcE
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ 632 (671)
..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 133 --------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 133 --------KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp --------EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred --------eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence 6899999999999999997643 389999999999999999999987 79999999999999999999
Q ss_pred EEcccCCcccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 633 KLSDYGLSIVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 633 ki~DfGla~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+|||+++.. .|+||+||++|+|+++...
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999988531 1999999999999997543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=245.79 Aligned_cols=167 Identities=21% Similarity=0.349 Sum_probs=142.5
Q ss_pred CCcCceeccCCceEEEEEEEc-CC---cEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NG---TSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
|+..++||+|+||.||+|+.. ++ ..||||.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 95 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE------- 95 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-------
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-------
Confidence 555689999999999999853 33 379999997543 345678999999999999999999999997653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||+.+|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 23489999999999999997632 3589999999999999999999997 799999999999999999999999999
Q ss_pred cccc----------------------------------ccccccceeeeeeehhhhcc
Q 005898 640 SIVS----------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~----------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
++.. .|+||+|+++|+|+++...+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 8521 19999999999999965544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=245.60 Aligned_cols=168 Identities=22% Similarity=0.410 Sum_probs=146.4
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN----- 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS-----
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC-----
Confidence 35688899999999999999996 4799999999864321 22467899999999999999999999998653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+||
T Consensus 85 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 85 ---YVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp ---EEEEEEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred ---eEEEEEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence 6899999999999999997542 3589999999999999999999997 8999999999999999999999999
Q ss_pred CCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++... .|+||+|+++|+|+++...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (278)
T 3cok_A 157 GLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211 (278)
T ss_dssp TTCEECC----------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred cceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 998542 2999999999999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=261.20 Aligned_cols=150 Identities=20% Similarity=0.375 Sum_probs=129.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++|||||++++++...+. ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL---LK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT---TT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC---Cc
Confidence 357889999999999999999965 6899999999753 23446789999999999999999999999876431 11
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....|+||||+. |+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 246899999997 5999999754 3499999999999999999999997 89999999999999999999999999
Q ss_pred Ccc
Q 005898 639 LSI 641 (671)
Q Consensus 639 la~ 641 (671)
+|+
T Consensus 175 la~ 177 (432)
T 3n9x_A 175 LAR 177 (432)
T ss_dssp TCE
T ss_pred Ccc
Confidence 985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.2e-28 Score=274.89 Aligned_cols=155 Identities=24% Similarity=0.404 Sum_probs=137.0
Q ss_pred ceeccCCceEEEEEEEc---CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE---NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
+.||+|+||.||+|.+. +++.||||+++... ....+++.+|+++|++++|||||+++++|.+. ..+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---------~~~ 445 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---------SWM 445 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---------SEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---------CEE
Confidence 47999999999999753 46789999997543 23467899999999999999999999999643 478
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+|||||++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 446 lv~E~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EEEEccCCCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 9999999999999997643 489999999999999999999997 7999999999999999999999999998532
Q ss_pred c---------------------------------cccccceeeeeeeh
Q 005898 644 E---------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 644 ~---------------------------------d~~s~g~~l~~~~~ 658 (671)
. |+||+||++|||++
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 1 99999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=249.48 Aligned_cols=174 Identities=21% Similarity=0.345 Sum_probs=147.1
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++....+ ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG----AKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET----TEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC----CCc
Confidence 35788899999999999999996 5799999999876666667889999999999999999999999874221 123
Q ss_pred eEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++... .....+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 689999999999999998752 1234599999999999999999999997 899999999999999999999999997
Q ss_pred ccc------------------------------------------cccccccceeeeeeehhhhc
Q 005898 640 SIV------------------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~------------------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
++. ..|+||+|+++|+|+++...
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 532 12999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-28 Score=256.79 Aligned_cols=174 Identities=24% Similarity=0.331 Sum_probs=144.1
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCCCcccccceeecC
Q 005898 478 LKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-----KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551 (671)
Q Consensus 478 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 551 (671)
+....++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++|||||+++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445677999999999999999999964 6889999998543 223457899999999999999999999999865
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCC-------------------------------------CCCCCCHHHHHH
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENT-------------------------------------PGKVLNWSERLA 594 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------------------------------~~~~l~~~~~~~ 594 (671)
+ ..++||||+++|+|.+++.... ....+++.....
T Consensus 101 ~--------~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 101 Q--------YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp S--------EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred C--------eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 3 7899999999999999885210 011235667788
Q ss_pred HHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC--cEEEcccCCcccc-----------------------------
Q 005898 595 VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR--IAKLSDYGLSIVS----------------------------- 643 (671)
Q Consensus 595 i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~--~~ki~DfGla~~~----------------------------- 643 (671)
++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++..
T Consensus 173 i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 173 IMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 999999999999997 799999999999998766 8999999998531
Q ss_pred -------ccccccceeeeeeehhhhc
Q 005898 644 -------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 644 -------~d~~s~g~~l~~~~~~~~~ 662 (671)
.|+||+||++|+|+++...
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~p 275 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVP 275 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 1999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=254.25 Aligned_cols=179 Identities=20% Similarity=0.335 Sum_probs=150.0
Q ss_pred HHHHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc-----------hhhHHHHHHHHHHHhcCCCCCccc
Q 005898 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK-----------KYTVRNLKLRLDLLAKLRHPHLVC 543 (671)
Q Consensus 475 ~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~-----------~~~~~~~~~E~~~l~~l~H~niv~ 543 (671)
.+++....+.|+..+.||+|+||.||+|+..+|+.||||++.... ....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 467778889999999999999999999998889999999985321 112478999999999999999999
Q ss_pred ccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCc
Q 005898 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNN 623 (671)
Q Consensus 544 l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~N 623 (671)
+++++...+.. .....++||||++ |+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 94 ~~~~~~~~~~~---~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 94 LRDIFVHFEEP---AMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CSEEEEECCTT---TCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred eeeeEEeccCC---CcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 99998764321 1246899999998 68888887542 3589999999999999999999997 79999999999
Q ss_pred eeecCCCcEEEcccCCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 624 ILLNEHRIAKLSDYGLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 624 iLl~~~~~~ki~DfGla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|++++++.+||+|||+++.. .|+||+||++|+|+++...
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 233 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233 (362)
T ss_dssp EEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence 99999999999999998531 1999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-28 Score=254.08 Aligned_cols=165 Identities=17% Similarity=0.278 Sum_probs=143.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+. .+|+.||||++..... .+++.+|+++++++ +||||+++++++.+.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-------- 78 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-------- 78 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--------
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--------
Confidence 5688899999999999999996 5799999999865432 24688999999999 9999999999988753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc-----EEEc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI-----AKLS 635 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~-----~ki~ 635 (671)
..++||||+ +|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred ccEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 689999999 99999999864 23599999999999999999999997 8999999999999998887 9999
Q ss_pred ccCCcccc-------------------------------------ccccccceeeeeeehhhhcc
Q 005898 636 DYGLSIVS-------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 636 DfGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|||+++.. .|+||+||++|+|++|....
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence 99998632 19999999999999975543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=247.81 Aligned_cols=174 Identities=21% Similarity=0.428 Sum_probs=140.4
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCC
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 553 (671)
...++|...+.||+|+||.||+|+.. ++..||||++... .....+++.+|++++++++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34567888999999999999999854 3458999999654 23445779999999999999999999999987532
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcC---CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISEN---TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
. .....++||||+++|+|.+++... .....+++.++..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 111 ~---~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 111 Q---GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred c---CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 1 112469999999999999998542 2235699999999999999999999987 799999999999999999
Q ss_pred cEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 631 IAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 631 ~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
.+||+|||+++.. .|+||+|+++|+|+++
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 245 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhc
Confidence 9999999998532 1999999999999993
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-28 Score=255.86 Aligned_cols=168 Identities=23% Similarity=0.317 Sum_probs=147.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 104 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-------- 104 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--------
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--------
Confidence 56888999999999999999975 7899999999754 3344678999999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||+++|+|.+++.... .+++..+..++.+++.||+|||+.+ +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 6899999999999999997643 3899999999999999999999732 6899999999999999999999999998
Q ss_pred ccc----------------------------ccccccceeeeeeehhhhcc
Q 005898 641 IVS----------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 641 ~~~----------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
+.. .|+||+||++|+|+++....
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 230 (360)
T 3eqc_A 180 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230 (360)
T ss_dssp HHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred cccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 531 19999999999999986543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=248.34 Aligned_cols=166 Identities=25% Similarity=0.439 Sum_probs=143.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+.|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.+.+ .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~ 80 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--------H 80 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS--------E
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC--------E
Confidence 46888999999999999999975 79999999998655445567899999999999999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee---cCCCcEEEcccC
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL---NEHRIAKLSDYG 638 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl---~~~~~~ki~DfG 638 (671)
.++||||+++|+|.+++.... .+++.+...++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 899999999999999987543 389999999999999999999997 79999999999999 788999999999
Q ss_pred Ccccc----------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+|+++|+|+++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 206 (304)
T 2jam_A 155 LSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206 (304)
T ss_dssp TTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 88632 1999999999999997543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-26 Score=239.66 Aligned_cols=241 Identities=23% Similarity=0.305 Sum_probs=171.5
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
+.++++|++|+|++|.+.. +| .+.++++|++|++++|.+++ +|. +..+++|++|++++|.....++. +..+++|+
T Consensus 84 ~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~ 158 (347)
T 4fmz_A 84 LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSP-LSNMTGLN 158 (347)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCC
T ss_pred hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccC-chh-hccCCceeEEECCCCCCcccccc-hhhCCCCc
Confidence 7778888888888887755 33 57788888888888888764 333 77788888888888765544443 77788888
Q ss_pred EEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCC-CCCCCccEEEcCCCCCCC
Q 005898 194 FLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLP-KLPRGLVMAFLSNNSFSG 272 (671)
Q Consensus 194 ~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~L~~l~l~~N~l~~ 272 (671)
+|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ ....+|+.+++++|.+++
T Consensus 159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~~ 235 (347)
T 4fmz_A 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITD 235 (347)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC
T ss_pred EEEecCCCcCCchh--hccCCCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCccCC
Confidence 88888887774333 7777888888888887775433 6677777777777777765443 123567777777777775
Q ss_pred CchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCC
Q 005898 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352 (671)
Q Consensus 273 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~ 352 (671)
..+ +..+++|+.|++++|.+++. +.+..+++|+.|++++|++++. ..+..+++|+.|++++|.+++..|..+..
T Consensus 236 ~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 309 (347)
T 4fmz_A 236 LSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309 (347)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHT
T ss_pred Ccc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhc
Confidence 443 77777777777777777765 3567777777777777777753 34666777777777777777777766777
Q ss_pred CCCCceeccCCCcCCC
Q 005898 353 ESDKRVVKFRGNCLSS 368 (671)
Q Consensus 353 ~~~l~~l~l~~N~l~~ 368 (671)
+++++.+++++|.+++
T Consensus 310 l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 310 LTNLTTLFLSQNHITD 325 (347)
T ss_dssp CTTCSEEECCSSSCCC
T ss_pred cccCCEEEccCCcccc
Confidence 7777777777777764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-26 Score=240.39 Aligned_cols=279 Identities=20% Similarity=0.282 Sum_probs=228.2
Q ss_pred CCEeEEEecCCCCCCCCCCCCcc-cccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEccc
Q 005898 73 NFITELKIIGDKPSNVGNFDGFA-SANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSS 151 (671)
Q Consensus 73 ~~v~~l~l~~~~~~~~~~~~~~~-~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~ 151 (671)
..++.+++.+........+.... ....+++.|.. ..+ +.+.++++|++|+|++|.+.+. |. +..+++|++|++++
T Consensus 66 ~~L~~L~l~~n~i~~~~~~~~l~~L~~L~L~~n~i-~~~-~~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~ 141 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKI-TDI-SALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLNLGA 141 (347)
T ss_dssp TTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCC-CCC-GGGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEECTT
T ss_pred CCccEEEccCCccccchhhhcCCcCCEEEccCCcc-cCc-hHHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEECCC
Confidence 35777888776554432222211 11234444433 233 4699999999999999999764 43 99999999999999
Q ss_pred CcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC
Q 005898 152 NFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231 (671)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p 231 (671)
|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|.+++ ++. +..+++|+.|++++|.+++..+
T Consensus 142 n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~ 216 (347)
T 4fmz_A 142 NHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP 216 (347)
T ss_dssp CTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG
T ss_pred CCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch
Confidence 97665554 49999999999999999986544 8899999999999999985 444 8899999999999999997655
Q ss_pred CCCCCCCCCEEECCCCCCCCCCC-CCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCe
Q 005898 232 DLSSLGSLNVLNLSDNKLDSNLP-KLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISD 310 (671)
Q Consensus 232 ~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 310 (671)
+..+++|+.|++++|++++..+ ....+|+.+++++|.+++. +.+..+++|+.|++++|++++. +.+..+++|+.
T Consensus 217 -~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~ 291 (347)
T 4fmz_A 217 -VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNS 291 (347)
T ss_dssp -GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred -hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCE
Confidence 8889999999999999987654 2246899999999999864 4689999999999999999987 35889999999
Q ss_pred EecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 311 LNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 311 L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
|++++|++++..|..+..+++|+.|++++|++++..| +..+++++.+++++|.++
T Consensus 292 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9999999999999999999999999999999998777 778899999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=251.33 Aligned_cols=175 Identities=25% Similarity=0.427 Sum_probs=148.2
Q ss_pred CHHHHHHHhcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCccccc
Q 005898 474 TLEELKEATNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLL 545 (671)
Q Consensus 474 ~~~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~ 545 (671)
...++....++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444567899999999999999999984 356899999997643 33456799999999999 799999999
Q ss_pred ceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCC
Q 005898 546 GHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIP 612 (671)
Q Consensus 546 g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~ 612 (671)
++|.+.+ ...++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+.
T Consensus 98 ~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--- 167 (316)
T 2xir_A 98 GACTKPG-------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--- 167 (316)
T ss_dssp EEECCTT-------SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEecCC-------CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---
Confidence 9987643 247999999999999999976432 12388999999999999999999997
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeeh
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
+|+||||||+||++++++.+||+|||+++... |+||+|+++|+|++
T Consensus 168 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 89999999999999999999999999985321 99999999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=244.30 Aligned_cols=171 Identities=23% Similarity=0.359 Sum_probs=144.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.|+..+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++..... ...
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~ 102 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK----GKK 102 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS----SCE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC----CCc
Confidence 3667788999999999999864 6889999998643 23456789999999999999999999998875321 123
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-CCCcEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-EHRIAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... .+++..+..++.+++.||+|||+.. ++|+||||||+||+++ +++.+||+|||+
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred eEEEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 6899999999999999997643 3899999999999999999999872 2499999999999998 789999999999
Q ss_pred ccccc---------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+.... |+||+|+++|+|+++...
T Consensus 179 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p 228 (290)
T 1t4h_A 179 ATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp GGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred cccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCC
Confidence 85321 999999999999997543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=247.66 Aligned_cols=174 Identities=26% Similarity=0.373 Sum_probs=140.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc-----hhhHHHHHHHHHHHhcC---CCCCcccccceeecC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK-----KYTVRNLKLRLDLLAKL---RHPHLVCLLGHCIDG 551 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~ 551 (671)
..++|+..+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+++++++ +||||++++++|.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999995 478999999986322 11124566777776665 499999999999875
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
... .....++||||+. |+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 87 ~~~---~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 87 RTD---REIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CSS---SEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred CCC---CceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 421 1125799999997 59999997643 23489999999999999999999997 7999999999999999999
Q ss_pred EEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++... |+||+||++|+|+++...
T Consensus 159 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 218 (308)
T 3g33_A 159 VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 218 (308)
T ss_dssp EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCS
T ss_pred EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCC
Confidence 9999999986422 999999999999987643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=261.36 Aligned_cols=134 Identities=28% Similarity=0.276 Sum_probs=121.5
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
+++++|||++|.|++..|..|.++++|++|||++|+|++..|..|.+|++|++|+|++|++++..|.+|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 36899999999999888889999999999999999999888889999999999999999999877788999999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccc-cCC-CCCCCCCCEEECCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGS-LPD-LSSLGSLNVLNLSDNKLDS 251 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-~p~-~~~l~~L~~L~Ls~N~l~~ 251 (671)
++|++++..|..|+++++|++|+|++|.+++. +|. +..+++|++|++++|++++
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 187 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 187 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccc
Confidence 99999987777899999999999999999764 444 6788999999999887643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=250.31 Aligned_cols=171 Identities=20% Similarity=0.396 Sum_probs=138.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHH--HhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDL--LAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||.||+|+. +++.||||++.... .+++..|.++ +..++||||+++++++...... ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~---~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD---GR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT---SC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccC---CC
Confidence 35788899999999999999976 58999999986443 2334444444 5568999999999866432111 12
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC------CCCccccCCCCCceeecCCCcEE
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV------IPGFFNNRVKTNNILLNEHRIAK 633 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------~~~iiHrDlk~~NiLl~~~~~~k 633 (671)
...++||||+++|+|.+++.... .+|..+..++.|+++||+|||+.+ .++|+||||||+||++++++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 35789999999999999997543 589999999999999999999863 23799999999999999999999
Q ss_pred EcccCCcccc---------------------------------------------ccccccceeeeeeehhhhcc
Q 005898 634 LSDYGLSIVS---------------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 634 i~DfGla~~~---------------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|+|||+++.. .|+||+||++|||+++...+
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999998531 29999999999999985544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=246.61 Aligned_cols=165 Identities=25% Similarity=0.486 Sum_probs=146.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..++|+..+.||+|+||.||+|+.. ++..||||.+.... ...+++.+|++++++++||||+++++++.+.+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP------- 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-------
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-------
Confidence 4567888899999999999999976 58899999997543 34578999999999999999999999987653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 -~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 83 -PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp -SEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred -CEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence 6899999999999999997643 34589999999999999999999987 799999999999999999999999999
Q ss_pred ccccc-------------------------------cccccceeeeeeeh
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~ 658 (671)
++... |+||+|+++|+|++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 85421 99999999999998
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-26 Score=250.96 Aligned_cols=219 Identities=22% Similarity=0.262 Sum_probs=197.5
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|......+..|.++++|++|+|++|.+.+..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|.++
T Consensus 70 ~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~ 149 (440)
T 3zyj_A 70 NLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE 149 (440)
T ss_dssp ECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC
T ss_pred EccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCccc
Confidence 45666555555678999999999999999999988899999999999999999999777778999999999999999999
Q ss_pred CCCCcccCCCCCcCEEEcccccCCCCCcc-cccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCC--
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLAGPFPS-SIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL-- 256 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~-- 256 (671)
...+..|.++++|++|++++|+..+.+|. .|..+++|+.|+|++|.++ .+|.+..+++|+.|+|++|++++..|..
T Consensus 150 ~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 228 (440)
T 3zyj_A 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQ 228 (440)
T ss_dssp EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTT
T ss_pred ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhc
Confidence 87778999999999999999655445554 7899999999999999998 5678999999999999999999877754
Q ss_pred -CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCc
Q 005898 257 -PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 257 -~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
..+|+.|++++|++++..|..|..+++|+.|+|++|++++.++..+..+++|+.|+|++|.+.
T Consensus 229 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred cCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 367999999999999999999999999999999999999999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=258.24 Aligned_cols=167 Identities=20% Similarity=0.369 Sum_probs=137.6
Q ss_pred cCCCcC-ceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHH-hcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMS-AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLL-AKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~-~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|... ++||+|+||+||+|+.. +|+.||||++... ..+.+|++++ +..+||||+++++++..... ..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~----~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA----GR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET----TE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeeccc----CC
Confidence 345554 68999999999999965 7899999999643 3467788876 45589999999998864110 11
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~D 636 (671)
...++||||+++|+|.+++.... ...+++.++..++.||++||+|||+. +|+||||||+|||++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 36899999999999999998643 24599999999999999999999987 8999999999999997 78999999
Q ss_pred cCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+||++|+|++|...
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 262 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 99986421 999999999999997653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=250.16 Aligned_cols=163 Identities=23% Similarity=0.442 Sum_probs=139.3
Q ss_pred cCCCcCceeccCCceEEEEEEEcC-----CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLEN-----GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+.|+..+.||+|+||.||+|+... +..||||++.... ....+++.+|++++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 119 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 119 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC----
Confidence 356667899999999999998642 2369999997543 344567999999999999999999999997643
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 120 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 120 ----PMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp ----SEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred ----CcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence 6899999999999999997642 3489999999999999999999997 799999999999999999999999
Q ss_pred cCCcccc---------------------------------ccccccceeeeeeeh
Q 005898 637 YGLSIVS---------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~---------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+++.. .|+||+|+++|+|++
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 245 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHc
Confidence 9998532 199999999999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=244.01 Aligned_cols=165 Identities=24% Similarity=0.406 Sum_probs=144.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch------hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
++|+..+.||+|+||.||+|+.. +|+.||||.+..... ...+++.+|++++++++||||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC---
Confidence 45788899999999999999976 689999999864321 13678999999999999999999999998653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC----c
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR----I 631 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~----~ 631 (671)
..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++++ .
T Consensus 82 -----~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 82 -----DVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp -----EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred -----eEEEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence 6899999999999999997543 489999999999999999999987 899999999999998877 8
Q ss_pred EEEcccCCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 632 AKLSDYGLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 632 ~ki~DfGla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+||+|||++... .|+||+|+++|+|+++..
T Consensus 151 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 209 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209 (283)
T ss_dssp EEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCC
Confidence 999999998642 199999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=243.22 Aligned_cols=167 Identities=22% Similarity=0.418 Sum_probs=144.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES------ 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS------
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC------
Confidence 467888999999999999999965 68999999986432 334577889999999999999999999997653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc---EEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI---AKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~---~ki~ 635 (671)
..++||||+++|+|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 79 --~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 79 --FHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred --EEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 6799999999999998887643 489999999999999999999997 8999999999999986655 9999
Q ss_pred ccCCcccc-----------------------------ccccccceeeeeeehhhhc
Q 005898 636 DYGLSIVS-----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 636 DfGla~~~-----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|||++... .|+||+|+++|+|+++...
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (284)
T 3kk8_A 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206 (284)
T ss_dssp CCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 99998432 2999999999999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=253.55 Aligned_cols=163 Identities=25% Similarity=0.450 Sum_probs=139.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||+||+|+.. +|+.||||++..... +..+|++++.++ +|||||++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~------- 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK------- 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS-------
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC-------
Confidence 456888999999999999999975 689999999975432 245678888877 7999999999998653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC----CcEEEc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH----RIAKLS 635 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~----~~~ki~ 635 (671)
..++||||+++|+|.+++.... .+++.....++.+|+.||+|||+. +|+||||||+||++.++ +.+||+
T Consensus 90 -~~~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 90 -YVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp -EEEEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred -EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 7899999999999999987543 489999999999999999999997 89999999999998543 359999
Q ss_pred ccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 636 DYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 636 DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|||+++... |+||+||++|+|++|...
T Consensus 163 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 219 (342)
T 2qr7_A 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219 (342)
T ss_dssp CCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCC
Confidence 999986421 999999999999998654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-25 Score=247.46 Aligned_cols=238 Identities=21% Similarity=0.181 Sum_probs=198.5
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
.++.+++|++|+|++|.+.+. | ++++++|++|+|++|++++. | ++++++|++|++++|.+++ +| ++.+++|
T Consensus 59 ~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L 129 (457)
T 3bz5_A 59 GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLL 129 (457)
T ss_dssp TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTC
T ss_pred hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcC
Confidence 578899999999999999874 4 89999999999999999874 4 8899999999999999987 45 8899999
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG 272 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~ 272 (671)
++|++++|++++ +| ++.+++|+.|++++|...+.+ .+..+++|+.|++++|++++....-...|+.+++++|++++
T Consensus 130 ~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~l~l~~l~~L~~L~l~~N~l~~ 205 (457)
T 3bz5_A 130 TYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTNNITK 205 (457)
T ss_dssp CEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEECCSSCCCCCCCTTCTTCCEEECCSSCCSC
T ss_pred CEEECCCCccce-ec--cccCCcCCEEECCCCCccccc-ccccCCcCCEEECCCCccceeccccCCCCCEEECcCCcCCe
Confidence 999999999997 43 888999999999999776666 57889999999999999988432335679999999999987
Q ss_pred CchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCC-------CccEEECcCCcCccc
Q 005898 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGG-------KLVFFDISNNKLTGG 345 (671)
Q Consensus 273 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~-------~L~~l~ls~N~l~g~ 345 (671)
. .++.+++|+.|++++|++++.+ +..+++|+.|++++|++++..+..+..+. +|+.+++++|.+.|.
T Consensus 206 ~---~l~~l~~L~~L~Ls~N~l~~ip---~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~ 279 (457)
T 3bz5_A 206 L---DLNQNIQLTFLDCSSNKLTEID---VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIY 279 (457)
T ss_dssp C---CCTTCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCE
T ss_pred e---ccccCCCCCEEECcCCcccccC---ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCc
Confidence 5 3888999999999999999953 78899999999999999987665555544 566777788877777
Q ss_pred CCCCCCCCCCCceeccCCCcCCCCcC
Q 005898 346 LPSCLSNESDKRVVKFRGNCLSSNVQ 371 (671)
Q Consensus 346 ~p~~~~~~~~l~~l~l~~N~l~~~~~ 371 (671)
+| .+.+++++.+++++|.+.+..+
T Consensus 280 ~~--~~~l~~L~~L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 280 FQ--AEGCRKIKELDVTHNTQLYLLD 303 (457)
T ss_dssp EE--CTTCTTCCCCCCTTCTTCCEEE
T ss_pred cc--ccccccCCEEECCCCcccceec
Confidence 77 3567788888888887665544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=247.48 Aligned_cols=166 Identities=17% Similarity=0.290 Sum_probs=144.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~----- 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG----- 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC-----
Confidence 467999999999999999999975 78999999997542 223477899999999999999999999998753
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... .+++.++..++.++++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 108 ---~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Df 178 (309)
T 2h34_A 108 ---QLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDF 178 (309)
T ss_dssp ---EEEEEEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSC
T ss_pred ---eEEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecC
Confidence 7899999999999999998643 489999999999999999999997 7999999999999999999999999
Q ss_pred CCcccc-------------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+|+++|+|+++..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (309)
T 2h34_A 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233 (309)
T ss_dssp CC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSC
T ss_pred ccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCC
Confidence 987431 299999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-28 Score=252.56 Aligned_cols=167 Identities=20% Similarity=0.335 Sum_probs=139.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
..++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH----- 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-----
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-----
Confidence 4567999999999999999999854 789999999965432 23456889999999999999999999998753
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee-----cCCCcE
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL-----NEHRIA 632 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl-----~~~~~~ 632 (671)
..++||||++ |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+
T Consensus 107 ---~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 107 ---RLHLIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp ---EEEEEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEE
T ss_pred ---EEEEEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceE
Confidence 7899999998 59999997653 389999999999999999999997 79999999999999 455669
Q ss_pred EEcccCCccccc-------------------------------cccccceeeeeeehhhhc
Q 005898 633 KLSDYGLSIVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 633 ki~DfGla~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+|||+++... |+||+||++|+|+++...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 237 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL 237 (329)
T ss_dssp EECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999884311 999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=244.45 Aligned_cols=163 Identities=22% Similarity=0.389 Sum_probs=141.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEcC----CcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLEN----GTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.++|+..+.||+|+||.||+|+... +..||||.+... .....+.+.+|++++++++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE----- 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----
Confidence 4578889999999999999998642 346999999764 334567899999999999999999999998653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 86 ----~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 156 (281)
T 3cc6_A 86 ----PTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGD 156 (281)
T ss_dssp ----SCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECC
T ss_pred ----CCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCc
Confidence 3589999999999999997542 3489999999999999999999987 799999999999999999999999
Q ss_pred cCCcccc-------------------------------ccccccceeeeeeeh
Q 005898 637 YGLSIVS-------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~-------------------------------~d~~s~g~~l~~~~~ 658 (671)
||+++.. .|+||+|+++|+|++
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt 209 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence 9988532 199999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=250.43 Aligned_cols=179 Identities=21% Similarity=0.343 Sum_probs=148.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..+|+..++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.+++ ||||+++++++...........
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346888999999999999999964 78999999987666666778999999999996 9999999999864321111123
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||+. |+|.+++........+++.++..++.|++.||+|||+.. ++|+||||||+||++++++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 46899999996 799998875333345999999999999999999999862 2399999999999999999999999999
Q ss_pred cccc---------------------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS---------------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~---------------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++.. .|+||+||++|+|+++...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 8531 1999999999999987543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=252.35 Aligned_cols=228 Identities=23% Similarity=0.322 Sum_probs=195.2
Q ss_pred cchhcccCCCCCCEEecccccc-cccCCcccc-------CCCCCCEEEcccCcCCCCCCccC--CCCCccCEEEccCCcC
Q 005898 109 SFVTTLARLTSLRVLSLVSLGI-WGSLPDKIH-------RLYSLEYLDLSSNFLFGSVPPKI--STMVKLQTLILDDNFF 178 (671)
Q Consensus 109 ~~~~~l~~l~~L~~L~L~~n~l-~g~~p~~~~-------~L~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l 178 (671)
.+|..+... |+.|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+ ..+++|++|+|++|.+
T Consensus 56 ~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 133 (312)
T 1wwl_A 56 ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133 (312)
T ss_dssp CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBC
T ss_pred ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCC
Confidence 455555544 89999999999 567888776 89999999999999999999887 8999999999999999
Q ss_pred CCCCCcccCCC-----CCcCEEEcccccCCCCCcccccCCCCCCEEEeccCcccccc---CCC--CCCCCCCEEECCCCC
Q 005898 179 NNTIPNWFDSL-----PSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL---PDL--SSLGSLNVLNLSDNK 248 (671)
Q Consensus 179 ~~~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~---p~~--~~l~~L~~L~Ls~N~ 248 (671)
++. |..++.+ ++|++|++++|++++..|..++.+++|++|++++|++.+.+ +.+ ..+++|++|++++|+
T Consensus 134 ~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~ 212 (312)
T 1wwl_A 134 ATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212 (312)
T ss_dssp SSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSC
T ss_pred cch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCc
Confidence 987 8888777 99999999999999888899999999999999999988753 334 889999999999999
Q ss_pred CCCC--CC-C---CCCCccEEEcCCCCCCCCch-hhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCccc
Q 005898 249 LDSN--LP-K---LPRGLVMAFLSNNSFSGEIP-KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321 (671)
Q Consensus 249 l~~~--~p-~---~~~~L~~l~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ 321 (671)
+++. ++ . ...+|+.+++++|++++.+| ..+..+++|++|+|++|+++.. |..+. ++|+.|+|++|++++.
T Consensus 213 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~i-p~~~~--~~L~~L~Ls~N~l~~~ 289 (312)
T 1wwl_A 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGLP--AKLSVLDLSYNRLDRN 289 (312)
T ss_dssp CCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSC-CSSCC--SEEEEEECCSSCCCSC
T ss_pred CcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChh-hhhcc--CCceEEECCCCCCCCC
Confidence 9842 22 1 23689999999999998875 5567789999999999999954 44555 8999999999999976
Q ss_pred CCcccCCCCCccEEECcCCcCcc
Q 005898 322 LPKNLNCGGKLVFFDISNNKLTG 344 (671)
Q Consensus 322 ~p~~~~~~~~L~~l~ls~N~l~g 344 (671)
|. +..+++|+.|++++|.+++
T Consensus 290 -p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 290 -PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -CC-TTTSCEEEEEECTTCTTTC
T ss_pred -hh-HhhCCCCCEEeccCCCCCC
Confidence 66 8899999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=249.62 Aligned_cols=168 Identities=20% Similarity=0.417 Sum_probs=140.6
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcC--CCCCcccccceeecCCCCCCc
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL--RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~~~~~~~ 557 (671)
...++|+..+.||+|+||.||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++.+..+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~---- 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG---- 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG----
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC----
Confidence 34567999999999999999999875 8999999986432 23445555665554 99999999999887532
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC-----CCCccccCCCCCceeecCCCcE
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV-----IPGFFNNRVKTNNILLNEHRIA 632 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlk~~NiLl~~~~~~ 632 (671)
.....++||||+++|+|.+++... .+++.++..++.+++.||+|||+.. .++|+||||||+||+++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 123689999999999999999754 3899999999999999999999862 3479999999999999999999
Q ss_pred EEcccCCcccc----------------------------------------ccccccceeeeeeehh
Q 005898 633 KLSDYGLSIVS----------------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 633 ki~DfGla~~~----------------------------------------~d~~s~g~~l~~~~~~ 659 (671)
||+|||+++.. .|+||+||++|||+++
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999998421 3999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=244.94 Aligned_cols=166 Identities=20% Similarity=0.410 Sum_probs=144.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 87 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK------ 87 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS------
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC------
Confidence 56888999999999999999975 68899999986432 122467899999999999999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 88 --~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 88 --RIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp --EEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred --EEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence 6899999999999999997643 389999999999999999999987 89999999999999999999999999
Q ss_pred Ccccc----------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++... .|+||+|+++|+|+++...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (284)
T 2vgo_A 160 WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211 (284)
T ss_dssp TCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred ccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCC
Confidence 87432 1999999999999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=265.17 Aligned_cols=166 Identities=25% Similarity=0.403 Sum_probs=140.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.|+..+.||+|+||+||+|+.. ++..||||++.... ....+.+.+|+++++.++|||||+++++|.+..
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------- 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR------- 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-------
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-------
Confidence 45888999999999999999975 78999999997543 223567899999999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~D 636 (671)
..++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 110 -~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 110 -NYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred -EEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEE
Confidence 6899999999999999887543 389999999999999999999997 8999999999999976 45699999
Q ss_pred cCCccccc----------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+||++|+|+++...
T Consensus 183 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~p 236 (494)
T 3lij_A 183 FGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP 236 (494)
T ss_dssp CTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCC
Confidence 99985422 999999999999997654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=235.58 Aligned_cols=224 Identities=20% Similarity=0.237 Sum_probs=184.5
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
+.++.+++++. .+|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 46777777774 456544 468999999999999877788999999999999999999888999999999999999999
Q ss_pred c-CCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhh
Q 005898 201 K-LAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY 278 (671)
Q Consensus 201 ~-l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~ 278 (671)
. ++...|..+..+++|++|++++|.+++..|. +..+++|++|++++|++++ ..+..|
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---------------------~~~~~~ 149 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA---------------------LPDDTF 149 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------------------CCTTTT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc---------------------cCHhHh
Confidence 7 7766688899999999999999999987665 7889999999988887754 334456
Q ss_pred cCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCce
Q 005898 279 GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRV 358 (671)
Q Consensus 279 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~ 358 (671)
+.+++|+.|++++|++++.++..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..+..+..+++++.
T Consensus 150 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 229 (285)
T 1ozn_A 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (285)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred ccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCE
Confidence 77778888888888888777777778888888888888888777888888888888888888888765566777788888
Q ss_pred eccCCCcCCC
Q 005898 359 VKFRGNCLSS 368 (671)
Q Consensus 359 l~l~~N~l~~ 368 (671)
+++++|.+.+
T Consensus 230 L~l~~N~~~c 239 (285)
T 1ozn_A 230 LRLNDNPWVC 239 (285)
T ss_dssp EECCSSCEEC
T ss_pred EeccCCCccC
Confidence 8888887764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=245.70 Aligned_cols=173 Identities=24% Similarity=0.387 Sum_probs=145.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+.. .
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~ 79 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT------N 79 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG------G
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC------C
Confidence 56888999999999999999975 78999999996532 344677999999999999999999999886432 1
Q ss_pred ceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCC--CCCccccCCCCCceeecCCCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGV--IPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.. ..+|+||||||+||++++++.+||+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 36899999999999999987532 2345899999999999999999999862 11299999999999999999999999
Q ss_pred cCCcccc------------------------------ccccccceeeeeeehhhh
Q 005898 637 YGLSIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 637 fGla~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
||+++.. .|+||+|+++|+|+++..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 214 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 9987532 199999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=243.03 Aligned_cols=167 Identities=24% Similarity=0.388 Sum_probs=146.2
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 78 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN------- 78 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-------
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-------
Confidence 356888999999999999999975 78999999986433 234578999999999999999999999998653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 79 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 79 -IQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp -EEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -EEEEEEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence 689999999999999998753 3489999999999999999999987 899999999999999999999999998
Q ss_pred cccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+... .|+||+|+++|+|+++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 207 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 8521 1999999999999997543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=264.62 Aligned_cols=168 Identities=24% Similarity=0.403 Sum_probs=146.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.+.|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG----- 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence 346888999999999999999975 79999999986432 334678999999999999999999999998753
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee---cCCCcEEE
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL---NEHRIAKL 634 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl---~~~~~~ki 634 (671)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 100 ---~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 ---YFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp ---EEEEEECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred ---EEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 7899999999999999987543 489999999999999999999997 79999999999999 46789999
Q ss_pred cccCCccccc----------------------------cccccceeeeeeehhhhcc
Q 005898 635 SDYGLSIVSE----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 635 ~DfGla~~~~----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|||+++... |+||+||++|+|++|....
T Consensus 171 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 171 IDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp CCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCC
Confidence 9999885421 9999999999999976543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=249.98 Aligned_cols=166 Identities=25% Similarity=0.398 Sum_probs=143.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||++++++|.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK------ 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT------
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC------
Confidence 356888999999999999999975 68999999986443 333566889999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++++|..++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 98 --~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 98 --RWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp --EEEEEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred --EEEEEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 6899999999999988766433 389999999999999999999997 89999999999999999999999999
Q ss_pred Ccccc-------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS-------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~-------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+++.. .|+||+||++|+|+++..
T Consensus 170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (331)
T 4aaa_A 170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223 (331)
T ss_dssp TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCC
Confidence 98531 199999999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=263.53 Aligned_cols=167 Identities=23% Similarity=0.374 Sum_probs=142.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch-------------hhHHHHHHHHHHHhcCCCCCcccccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK-------------YTVRNLKLRLDLLAKLRHPHLVCLLGH 547 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 547 (671)
.+.|...+.||+|+||+||+|+.. +++.||||++..... ...+++.+|++++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999965 688999999865321 235678999999999999999999999
Q ss_pred eecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 548 ~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
|.+.. ..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 115 ~~~~~--------~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 115 FEDKK--------YFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLE 180 (504)
T ss_dssp EECSS--------EEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred EEcCC--------EEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEe
Confidence 98653 7899999999999999887643 389999999999999999999997 899999999999998
Q ss_pred CCC---cEEEcccCCccccc----------------------------cccccceeeeeeehhhhc
Q 005898 628 EHR---IAKLSDYGLSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 628 ~~~---~~ki~DfGla~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
.++ .+||+|||+++... |+||+||++|+|++|...
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~p 246 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP 246 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCC
Confidence 765 69999999986422 999999999999997554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=252.20 Aligned_cols=171 Identities=23% Similarity=0.404 Sum_probs=147.3
Q ss_pred HHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--------hhHHHHHHHHHHHhcC-CCCCcccccce
Q 005898 478 LKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--------YTVRNLKLRLDLLAKL-RHPHLVCLLGH 547 (671)
Q Consensus 478 ~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~ 547 (671)
.....++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445567999999999999999999975 799999999864321 1245688999999999 79999999999
Q ss_pred eecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 548 ~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
+...+ ..++||||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++
T Consensus 169 ~~~~~--------~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 169 YESSS--------FMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD 234 (365)
T ss_dssp EEBSS--------EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred EeeCC--------EEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 87653 7899999999999999997543 489999999999999999999997 899999999999999
Q ss_pred CCCcEEEcccCCcccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 628 EHRIAKLSDYGLSIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 628 ~~~~~ki~DfGla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.+||+|||++... .|+||+||++|+|+++...
T Consensus 235 ~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 9999999999987531 2999999999999997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-28 Score=253.08 Aligned_cols=166 Identities=20% Similarity=0.353 Sum_probs=140.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh-hHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++.+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------- 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-------- 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS--------
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC--------
Confidence 46788899999999999999975 7899999998654322 1224567999999999999999999998653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 74 SLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp CEEEEEECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEEEEecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 6899999997 59999887643 3589999999999999999999987 8999999999999999999999999987
Q ss_pred cccc-------------------------------cccccceeeeeeehhhhc
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+... |+||+||++|+|+++...
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 148 RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp ECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 5311 999999999999997643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-25 Score=246.03 Aligned_cols=221 Identities=30% Similarity=0.432 Sum_probs=110.7
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
+++++++|++|++++|.+.+ +|+.+ .+|++|++++|++++ +| .++++++|++|++++|.+++ +|... ++|
T Consensus 148 ~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L 217 (454)
T 1jl5_A 148 ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSL 217 (454)
T ss_dssp CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTC
T ss_pred ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Ccc
Confidence 35555555555555555543 33322 245555555555543 33 35555555555555555553 33221 345
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG 272 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~ 272 (671)
++|++++|+++ .+|. ++.+++|+.|++++|++++ +|. .+++|+.|++++|++++ +|..+.+|+.+++++|.+++
T Consensus 218 ~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~--~~~~L~~L~l~~N~l~~-l~~~~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 218 ESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSG 291 (454)
T ss_dssp CEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCS--CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSE
T ss_pred cEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-ccc--cccccCEEECCCCcccc-cCcccCcCCEEECcCCccCc
Confidence 55555555554 4442 5555555555555555554 222 12455555555555544 34444455555555555554
Q ss_pred --CchhhhcCCcccceeecccccccCCCccccCCC-CCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCC
Q 005898 273 --EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSL-PNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSC 349 (671)
Q Consensus 273 --~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~ 349 (671)
.+| ++|+.|++++|++++.+ .+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|.
T Consensus 292 l~~~~------~~L~~L~l~~N~l~~i~-----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~- 354 (454)
T 1jl5_A 292 LSELP------PNLYYLNASSNEIRSLC-----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE- 354 (454)
T ss_dssp ESCCC------TTCCEEECCSSCCSEEC-----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC-
T ss_pred ccCcC------CcCCEEECcCCcCCccc-----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc-
Confidence 222 23344444444433321 12 356666666666664 4443 355666666666666 3554
Q ss_pred CCCCCCCceeccCCCcCCC
Q 005898 350 LSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 350 ~~~~~~l~~l~l~~N~l~~ 368 (671)
.+++++.+++++|.+++
T Consensus 355 --~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 355 --LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp --CCTTCCEEECCSSCCSS
T ss_pred --hhhhccEEECCCCCCCc
Confidence 24556666666666665
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=249.64 Aligned_cols=162 Identities=25% Similarity=0.449 Sum_probs=138.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcE----EEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTS----VAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~----vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
++|+..++||+|+||.||+|+.. +++. ||+|.+... .....+++.+|+.++++++||||++++++|.+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence 56888999999999999999864 5554 577777543 233467899999999999999999999999864
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ----~~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~D 160 (327)
T 3lzb_A 90 ----TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp ----SEEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred ----CceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEcc
Confidence 4789999999999999997643 3489999999999999999999997 899999999999999999999999
Q ss_pred cCCccccc--------------------------------cccccceeeeeeeh
Q 005898 637 YGLSIVSE--------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 637 fGla~~~~--------------------------------d~~s~g~~l~~~~~ 658 (671)
||+++... |+||+||++|+|++
T Consensus 161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 214 (327)
T 3lzb_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp TTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence 99986421 99999999999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=242.97 Aligned_cols=161 Identities=25% Similarity=0.428 Sum_probs=140.1
Q ss_pred CCCcCc-eeccCCceEEEEEEEc---CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSA-IMGEGSYGKLYKGRLE---NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~-~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+|...+ .||+|+||.||+|+.. ++..||||++.... ....+++.+|++++++++||||+++++++...
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------- 82 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------- 82 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-------
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC-------
Confidence 344444 8999999999999853 57889999997643 34567899999999999999999999998532
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 83 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 83 --ALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp --SEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred --CcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccc
Confidence 579999999999999999743 23589999999999999999999997 89999999999999999999999999
Q ss_pred Ccccc---------------------------------ccccccceeeeeeeh
Q 005898 639 LSIVS---------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 639 la~~~---------------------------------~d~~s~g~~l~~~~~ 658 (671)
+++.. .|+||+|+++|+|++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 208 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHc
Confidence 98532 199999999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=255.67 Aligned_cols=172 Identities=15% Similarity=0.288 Sum_probs=140.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEcC------CcEEEEEEccCCchhh-----------HHHHHHHHHHHhcCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLEN------GTSVAIRCLPSSKKYT-----------VRNLKLRLDLLAKLRHPHLVCL 544 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~------g~~vAvK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l 544 (671)
.++|+..+.||+|+||.||+|+... ++.||||++....... ...+.+|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999998754 4789999987554211 1234456677888999999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
++++.+... .....++||||+ +|+|.+++.... ..++|.++..++.|++.||+|||+. +|+||||||+||
T Consensus 114 ~~~~~~~~~----~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni 183 (364)
T 3op5_A 114 WGSGLHDKN----GKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL 183 (364)
T ss_dssp EEEEEEEET----TEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred EeeeeeccC----CcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence 999876421 113579999999 999999997642 3599999999999999999999997 899999999999
Q ss_pred eec--CCCcEEEcccCCcccc-------------------------------------ccccccceeeeeeehhhhcc
Q 005898 625 LLN--EHRIAKLSDYGLSIVS-------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 625 Ll~--~~~~~ki~DfGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|++ .++.+||+|||+++.. .|+||+||++|+|+++....
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 999 8899999999999431 09999999999999975443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=247.82 Aligned_cols=169 Identities=24% Similarity=0.442 Sum_probs=145.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..+.|+..+.||+|+||.||+|+.. +++.||+|.+........+++.+|++++++++||||+++++++.+.+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 89 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG------- 89 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--------
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-------
Confidence 3467888999999999999999976 68999999997665556778999999999999999999999998653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... ..+++.++..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 90 -~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 90 -KLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred -eEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCC
Confidence 6899999999999999887532 3489999999999999999999997 799999999999999999999999998
Q ss_pred ccc-----------------------------------cccccccceeeeeeehhhhc
Q 005898 640 SIV-----------------------------------SEDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~-----------------------------------~~d~~s~g~~l~~~~~~~~~ 662 (671)
+.. ..|+||+|+++|+|+++...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 521 12999999999999987544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=253.50 Aligned_cols=167 Identities=27% Similarity=0.439 Sum_probs=137.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchh-----hHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKY-----TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
..+.|+..+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-- 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC--
Confidence 3467899999999999999999965 6899999999643221 1246889999999999999999999997653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
..++||||+++ +|..++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||
T Consensus 86 ------~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 86 ------NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp ------CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ------ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEE
Confidence 67999999986 8888886532 3588899999999999999999997 7999999999999999999999
Q ss_pred cccCCccccc-------------------------------cccccceeeeeeehhhh
Q 005898 635 SDYGLSIVSE-------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 635 ~DfGla~~~~-------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
+|||+++... |+||+||++|+|+++..
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 154 ADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999985421 99999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=254.11 Aligned_cols=171 Identities=20% Similarity=0.324 Sum_probs=132.2
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~--~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL--EE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG--GG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc--cc
Confidence 35788899999999999999985 47899999999653 234467788999999999999999999998764211 11
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 23579999999 6899988864 2489999999999999999999987 89999999999999999999999999
Q ss_pred Cccccc----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|++|...
T Consensus 178 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 229 (367)
T 2fst_X 178 LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 229 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 985421 999999999999997643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=252.23 Aligned_cols=168 Identities=26% Similarity=0.471 Sum_probs=144.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CC-----cEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NG-----TSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
..++|+..+.||+|+||.||+|+.. ++ +.||||.+.... ....+.+.+|+++++++ +||||++++++|.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4567888999999999999999864 23 479999997543 33467799999999999 8999999999997653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCC
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENT-----------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKT 621 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~ 621 (671)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||
T Consensus 124 --------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 124 --------PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp --------SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred --------ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 5799999999999999986421 123589999999999999999999997 899999999
Q ss_pred CceeecCCCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 622 NNILLNEHRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 622 ~NiLl~~~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
+||++++++.+||+|||+++.. .|+||+||++|+|+++
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcC
Confidence 9999999999999999998632 1999999999999983
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=245.39 Aligned_cols=170 Identities=19% Similarity=0.365 Sum_probs=141.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC---chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS---KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++... .....+++.+|++++++++||||+++++++.+.+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----- 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN----- 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----
Confidence 35688899999999999999996 47999999998642 2345678999999999999999999999998753
Q ss_pred ccceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++... .....+++..+..++.++++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 106 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 106 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp ---EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred ---cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEe
Confidence 689999999999999998642 1234589999999999999999999997 899999999999999999999999
Q ss_pred cCCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 637 YGLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+++.. .|+||+|+++|+|+++...
T Consensus 180 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 235 (310)
T 2wqm_A 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235 (310)
T ss_dssp C------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9987532 1999999999999997654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-28 Score=260.23 Aligned_cols=177 Identities=16% Similarity=0.184 Sum_probs=139.7
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC---chhhHHHHHHHH---HHHhcCCCCCccccc-------ce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS---KKYTVRNLKLRL---DLLAKLRHPHLVCLL-------GH 547 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~ 547 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999995 57999999999632 334467899999 566677899999998 44
Q ss_pred eecCCC---------CCCcccceEEEEEecCCCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCc
Q 005898 548 CIDGGG---------RDDYAVNKVFLVYEFMSNGNFRTHISENTP----GKVLNWSERLAVLIGVAKAVQFLHTGVIPGF 614 (671)
Q Consensus 548 ~~~~~~---------~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 614 (671)
+.+.+. .+.......++||||+ +|+|.+++..... ...++|..+..++.||++||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 443310 0000001378999999 6899999975311 12355788999999999999999997 89
Q ss_pred cccCCCCCceeecCCCcEEEcccCCccc----------------------------------c---ccccccceeeeeee
Q 005898 615 FNNRVKTNNILLNEHRIAKLSDYGLSIV----------------------------------S---EDINSVGVRLLILM 657 (671)
Q Consensus 615 iHrDlk~~NiLl~~~~~~ki~DfGla~~----------------------------------~---~d~~s~g~~l~~~~ 657 (671)
+||||||+|||+++++.+||+|||+|+. . .|+||+||++|+|+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999852 1 19999999999999
Q ss_pred hhhhc
Q 005898 658 SFFFG 662 (671)
Q Consensus 658 ~~~~~ 662 (671)
++...
T Consensus 308 tg~~P 312 (377)
T 3byv_A 308 CADLP 312 (377)
T ss_dssp HSSCC
T ss_pred HCCCC
Confidence 97543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=244.70 Aligned_cols=167 Identities=20% Similarity=0.367 Sum_probs=140.6
Q ss_pred cCCCcC-ceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHH-hcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMS-AIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLL-AKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~-~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|... ++||+|+||.||+|+. .+++.||||++... ..+.+|++++ +..+||||+++++++..... ..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~----~~ 87 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA----GR 87 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET----TE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcC----CC
Confidence 455555 7899999999999996 47899999999643 3567788887 66699999999998875110 11
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~D 636 (671)
...++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 36899999999999999998643 24599999999999999999999997 8999999999999998 78999999
Q ss_pred cCCccccc--------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE--------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~--------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+||++|+|+++...
T Consensus 164 fg~a~~~~~~~~~~~~DiwslG~il~el~tg~~p 197 (299)
T 3m2w_A 164 FGFAKETTGEKYDKSCDMWSLGVIMYILLCGYPP 197 (299)
T ss_dssp CTTCEECTTCGGGGHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccCCchhhHHHHHHHHHHHHHCCCC
Confidence 99997643 999999999999997544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=241.88 Aligned_cols=165 Identities=28% Similarity=0.431 Sum_probs=145.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 84 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT------ 84 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS------
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC------
Confidence 56888899999999999999975 79999999986432 123567899999999999999999999988653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 85 --~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 85 --DFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred --eEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecc
Confidence 6899999999999999997643 389999999999999999999997 79999999999999999999999999
Q ss_pred Ccccc------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
++... .|+||+|+++|+|+++..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 209 (276)
T 2h6d_A 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209 (276)
T ss_dssp GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCC
Confidence 87532 199999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=244.62 Aligned_cols=165 Identities=22% Similarity=0.446 Sum_probs=138.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||.||+|+.. ..||||+++... ....+.+.+|++++++++||||+++++++...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-------- 92 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-------- 92 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--------
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC--------
Confidence 456888999999999999999864 359999986543 34567899999999999999999999976542
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 93 -~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 93 -QLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp -SCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred -ccEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcccee
Confidence 4799999999999999996542 3589999999999999999999997 799999999999999999999999998
Q ss_pred cccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++.. .|+||+|+++|+|+++...
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 7421 2999999999999996543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=255.64 Aligned_cols=175 Identities=18% Similarity=0.295 Sum_probs=139.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC--
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD-- 556 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~-- 556 (671)
...++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+|+++|+.++|||||++++++...+....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 5799999999865432 23479999999999999999999866431100
Q ss_pred ----------------------------cccceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhc
Q 005898 557 ----------------------------YAVNKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLH 607 (671)
Q Consensus 557 ----------------------------~~~~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH 607 (671)
......++||||++ |+|.+.+... .....+++..+..++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 11234789999998 5887777541 12345999999999999999999999
Q ss_pred CCCCCCccccCCCCCceeec-CCCcEEEcccCCccccc------------------------------cccccceeeeee
Q 005898 608 TGVIPGFFNNRVKTNNILLN-EHRIAKLSDYGLSIVSE------------------------------DINSVGVRLLIL 656 (671)
Q Consensus 608 ~~~~~~iiHrDlk~~NiLl~-~~~~~ki~DfGla~~~~------------------------------d~~s~g~~l~~~ 656 (671)
+. +|+||||||+||+++ +++.+||+|||+|+... |+||+||++|+|
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 87 899999999999998 68999999999996421 999999999999
Q ss_pred ehhhhc
Q 005898 657 MSFFFG 662 (671)
Q Consensus 657 ~~~~~~ 662 (671)
+++...
T Consensus 236 l~g~~p 241 (383)
T 3eb0_A 236 ILGKPL 241 (383)
T ss_dssp HHSSCS
T ss_pred HhCCCC
Confidence 997643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=248.83 Aligned_cols=165 Identities=30% Similarity=0.569 Sum_probs=141.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcE--EEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTS--VAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~--vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..+.||+|+||.||+|+.. ++.. ||||.+.... ....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-----
Confidence 56888899999999999999864 5664 4999987532 33456789999999999 8999999999998753
Q ss_pred ccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..++||||+++|+|.+++.... ....+++.++..++.|+++||+|||+. +|+||||||+||
T Consensus 100 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI 173 (327)
T 1fvr_A 100 ---YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 173 (327)
T ss_dssp ---EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred ---ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceE
Confidence 7899999999999999997542 224689999999999999999999987 899999999999
Q ss_pred eecCCCcEEEcccCCccccc-----------------------------cccccceeeeeeeh
Q 005898 625 LLNEHRIAKLSDYGLSIVSE-----------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~ 658 (671)
+++.++.+||+|||+++... |+||+||++|+|++
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 236 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHc
Confidence 99999999999999985211 99999999999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=250.53 Aligned_cols=165 Identities=19% Similarity=0.278 Sum_probs=143.4
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCC--CCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRH--PHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~~ 558 (671)
+.|+..+.||+|+||.||+|+..+++.||||++... .....+.+.+|++++.+++| |||+++++++.+..
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~------ 82 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ------ 82 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS------
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC------
Confidence 458888999999999999999888999999998643 33445789999999999987 99999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||| +.+|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 83 --~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG 152 (343)
T 3dbq_A 83 --YIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG 152 (343)
T ss_dssp --EEEEEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred --EEEEEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecc
Confidence 7899999 56889999998653 489999999999999999999997 799999999999997 5789999999
Q ss_pred Ccccc-------------------------------------------ccccccceeeeeeehhhhcc
Q 005898 639 LSIVS-------------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~-------------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
+++.. .|+||+||++|+|+++....
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf 220 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcc
Confidence 98531 29999999999999976543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=263.77 Aligned_cols=167 Identities=23% Similarity=0.396 Sum_probs=144.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
+.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------- 94 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS------- 94 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-------
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-------
Confidence 46888999999999999999975 78999999985422 224577899999999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec---CCCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN---EHRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~---~~~~~ki~D 636 (671)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|
T Consensus 95 -~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 95 -SFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred -EEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEE
Confidence 7899999999999999887643 389999999999999999999997 799999999999995 457899999
Q ss_pred cCCccccc----------------------------cccccceeeeeeehhhhcc
Q 005898 637 YGLSIVSE----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~~----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
||+++... |+||+||++|+|+++....
T Consensus 168 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99986421 9999999999999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=246.68 Aligned_cols=162 Identities=22% Similarity=0.389 Sum_probs=142.2
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+... .
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~------~ 106 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVS------R 106 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT------C
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC------C
Confidence 5688899999999999999986 478999999997543 467899999999997 9999999999986432 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~DfGl 639 (671)
..++||||+++|+|.+++.. +++.++..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 67999999999999998853 78999999999999999999987 899999999999999776 899999999
Q ss_pred ccccc------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+||++|+|+++...
T Consensus 178 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 230 (330)
T 3nsz_A 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230 (330)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCC
Confidence 96321 999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=245.53 Aligned_cols=172 Identities=16% Similarity=0.293 Sum_probs=140.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC------
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD------ 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~------ 555 (671)
++|+..+.||+|+||.||+|+.. +|+.||||++........+++.+|++++++++||||+++++++......-
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56888899999999999999976 58999999998766666788999999999999999999999886432100
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-CCCcEEE
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-EHRIAKL 634 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-~~~~~ki 634 (671)
.......++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 011247899999998 699999864 2488999999999999999999997 899999999999997 5679999
Q ss_pred cccCCccccc----------------------------------cccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVSE----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~~----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++..+ |+||+||++|+|+++...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9999986321 999999999999997543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=243.53 Aligned_cols=166 Identities=22% Similarity=0.386 Sum_probs=146.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT------- 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-------
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-------
Confidence 356888899999999999999864 78999999996543 334678999999999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.. ..+++.++..++.++++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 94 -~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 94 -KLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp -EEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred -eEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence 68999999999999999864 2489999999999999999999997 899999999999999999999999999
Q ss_pred ccccc------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+.... |+||+|+++|+|+++...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCC
Confidence 84321 999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=247.24 Aligned_cols=166 Identities=26% Similarity=0.390 Sum_probs=140.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--------hhHHHHHHHHHHHhcCCCCCcccccceeecCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--------YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGG 552 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 552 (671)
.++|+..+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 356888999999999999999965 689999999864321 1234588999999999999999999998653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc-
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI- 631 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~- 631 (671)
..++||||+++|+|.+++... ..+++.....++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 88 --------~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 88 --------DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp --------SEEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred --------ceEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence 479999999999999988753 3489999999999999999999987 8999999999999987654
Q ss_pred --EEEcccCCcccc--------------------------------ccccccceeeeeeehhhhc
Q 005898 632 --AKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 --~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++.. .|+||+||++|+|+++...
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218 (322)
T ss_dssp CCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred CeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998542 1999999999999997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=244.65 Aligned_cols=163 Identities=26% Similarity=0.519 Sum_probs=138.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++|+..+.||+|+||.||+|+.. |+.||||++.... ..+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-------~~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-------GG 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC---------C
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-------Cc
Confidence 356888999999999999999874 8899999997543 3567999999999999999999999876543 25
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ...+++..+..++.++++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccc
Confidence 799999999999999987532 12378999999999999999999997 79999999999999999999999999885
Q ss_pred cc---------------------------ccccccceeeeeeeh
Q 005898 642 VS---------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 642 ~~---------------------------~d~~s~g~~l~~~~~ 658 (671)
.. .|+||+|+++|+|++
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 209 (278)
T 1byg_A 166 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHh
Confidence 32 199999999999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=244.26 Aligned_cols=172 Identities=22% Similarity=0.394 Sum_probs=143.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC------
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR------ 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~------ 554 (671)
..+|+..+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++...+-.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888999999999999999976 79999999997543 3567899999999999999999987541100
Q ss_pred --CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcE
Q 005898 555 --DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIA 632 (671)
Q Consensus 555 --~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ 632 (671)
........++||||+++|+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 0001235799999999999999997532 23589999999999999999999987 89999999999999999999
Q ss_pred EEcccCCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 633 KLSDYGLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 633 ki~DfGla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
||+|||+++.. .|+||+|+++|+|+++..
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~ 219 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCS
T ss_pred EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCC
Confidence 99999987542 199999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=250.16 Aligned_cols=170 Identities=21% Similarity=0.264 Sum_probs=141.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+.. ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL--EE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST--TT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccc--cc
Confidence 357888999999999999999864 6899999999653 234456789999999999999999999998765311 11
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++||||+++ +|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 2368999999975 78888753 288999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++... |+||+||++|+|++|...
T Consensus 173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 225 (371)
T 2xrw_A 173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 225 (371)
T ss_dssp C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 985421 999999999999998543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=242.35 Aligned_cols=166 Identities=22% Similarity=0.327 Sum_probs=145.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---------hhhHHHHHHHHHHHhcCC-CCCcccccceeec
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---------KYTVRNLKLRLDLLAKLR-HPHLVCLLGHCID 550 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 550 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++.+++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 68999999986432 122456889999999996 9999999999976
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR 630 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~ 630 (671)
.. ..++||||+++|+|.+++.... .+++.++..++.+++.||+|||+. +|+||||||+||++++++
T Consensus 96 ~~--------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 96 NT--------FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 161 (298)
T ss_dssp SS--------EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred CC--------eEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCC
Confidence 53 7899999999999999997643 489999999999999999999987 899999999999999999
Q ss_pred cEEEcccCCcccc-----------------------------------ccccccceeeeeeehhhh
Q 005898 631 IAKLSDYGLSIVS-----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 631 ~~ki~DfGla~~~-----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
.+||+|||++... .|+||+|+++|+|+++..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 227 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227 (298)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence 9999999988531 299999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=252.98 Aligned_cols=164 Identities=20% Similarity=0.283 Sum_probs=142.4
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCC--CCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLR--HPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~~~ 558 (671)
+.|+..+.||+|+||.||+|+..+++.||||++... .....+++.+|+++|.+++ |||||++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~------ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ------ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS------
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC------
Confidence 458889999999999999999878999999998643 3445678999999999997 599999999988653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||| +.+|+|.+++.... .+++.++..++.||++||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 130 --~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 130 --YIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp --EEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred --EEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecC
Confidence 6899999 56889999998653 489999999999999999999997 799999999999996 5899999999
Q ss_pred Ccccc-------------------------------------------ccccccceeeeeeehhhhc
Q 005898 639 LSIVS-------------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~-------------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+++.. .|+||+||++|+|+++...
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~P 266 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCc
Confidence 98531 2999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=258.49 Aligned_cols=170 Identities=21% Similarity=0.303 Sum_probs=137.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|||||+++++|...... .....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~--~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEK--KDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETT--TTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCC--Cccee
Confidence 35788899999999999999975 699999999865432 235799999999999999999988653211 01124
Q ss_pred EEEEEecCCCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC-CcEEEcccCC
Q 005898 562 VFLVYEFMSNGNFRTHISE-NTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGL 639 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~-~~~ki~DfGl 639 (671)
.++||||+++ ++.+.+.. ......+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 6799999986 66665542 11234599999999999999999999987 89999999999999965 6789999999
Q ss_pred ccccc------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+||++|||++|...
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p 256 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 96421 999999999999998644
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-25 Score=246.56 Aligned_cols=238 Identities=25% Similarity=0.347 Sum_probs=119.0
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCC----------
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIP---------- 183 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p---------- 183 (671)
+.++++|++|++++|.+.+..| ++++++|++|+|++|.+++. |+ +.++++|++|++++|.+++ +|
T Consensus 86 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~ 160 (466)
T 1o6v_A 86 LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-ISALSGLTSLQQ 160 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CGGGTTCTTCSE
T ss_pred hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-ChhhccCCcccE
Confidence 4445555555555554443332 44555555555555544432 21 4444455555554444443 11
Q ss_pred ----------cccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCC
Q 005898 184 ----------NWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNL 253 (671)
Q Consensus 184 ----------~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~ 253 (671)
..+.++++|++|++++|.+++. ..+..+++|+.|++++|.+++..| ++.+++|+.|++++|++++.
T Consensus 161 L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~- 236 (466)
T 1o6v_A 161 LSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI- 236 (466)
T ss_dssp EEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-
T ss_pred eecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc-
Confidence 1144555555555555555432 235555555555555555554433 44455555555555555432
Q ss_pred CCC--CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCC
Q 005898 254 PKL--PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGK 331 (671)
Q Consensus 254 p~~--~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~ 331 (671)
+.+ ..+|+.+++++|.+++..| +..+++|+.|++++|.+++.++ +..+++|+.|++++|++++..| +..+++
T Consensus 237 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~ 310 (466)
T 1o6v_A 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKN 310 (466)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTT
T ss_pred hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCC
Confidence 211 2345555555555554433 5555555555555555555443 4555555555555555554333 444555
Q ss_pred ccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 332 LVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 332 L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
|+.|++++|++++..| +..+++++.+++++|.+++
T Consensus 311 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 311 LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 5555555555554444 3445555555555555543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=250.15 Aligned_cols=174 Identities=19% Similarity=0.345 Sum_probs=142.7
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++.+....-....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999997 479999999985433 2234578899999999999999999999987431100012
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||+++ +|...+.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 7877776542 3489999999999999999999997 899999999999999999999999998
Q ss_pred cccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++.. .|+||+||++|+|+++...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 228 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 7431 0999999999999997543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=250.33 Aligned_cols=168 Identities=19% Similarity=0.326 Sum_probs=145.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchh-----------------hHHHHHHHHHHHhcCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKY-----------------TVRNLKLRLDLLAKLRHPHLVCL 544 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l 544 (671)
.++|+..+.||+|+||.||+|+. +|+.||||++...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999998 8999999998643211 11789999999999999999999
Q ss_pred cceeecCCCCCCcccceEEEEEecCCCCChhhh------hhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC-CCCCCcccc
Q 005898 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTH------ISENTPGKVLNWSERLAVLIGVAKAVQFLHT-GVIPGFFNN 617 (671)
Q Consensus 545 ~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHr 617 (671)
++++.+.+ ..++||||+++|+|.++ +... ....+++..+..++.|++.||+|||+ . +|+||
T Consensus 109 ~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~ 176 (348)
T 2pml_X 109 EGIITNYD--------EVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHR 176 (348)
T ss_dssp SEEEESSS--------EEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECC
T ss_pred EEEEeeCC--------eEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeec
Confidence 99998753 78999999999999998 5432 13569999999999999999999998 5 89999
Q ss_pred CCCCCceeecCCCcEEEcccCCcccc------------------------------ccccccceeeeeeehhhhc
Q 005898 618 RVKTNNILLNEHRIAKLSDYGLSIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 618 Dlk~~NiLl~~~~~~ki~DfGla~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||||+||+++.++.+||+|||++... .|+||+|+++|+|+++...
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998541 2999999999999997543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=248.86 Aligned_cols=170 Identities=21% Similarity=0.323 Sum_probs=145.1
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE---QM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT---TC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc---cc
Confidence 357888999999999999999865 78899999997543 33457789999999999999999999998764311 12
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||++ |+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 36899999997 5999988753 389999999999999999999997 899999999999999999999999998
Q ss_pred ccccc----------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+||++|+|+++...
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 231 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCC
Confidence 85311 999999999999997643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=242.07 Aligned_cols=163 Identities=23% Similarity=0.373 Sum_probs=139.7
Q ss_pred cCCCcCc-eeccCCceEEEEEEEc---CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSA-IMGEGSYGKLYKGRLE---NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~-~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+.|+..+ .||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++...
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 90 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE----- 90 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-----
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCC-----
Confidence 4566666 8999999999999642 46889999997543 23357899999999999999999999998432
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 91 ----~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 91 ----SWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp ----SEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ----CcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEcc
Confidence 5799999999999999998643 389999999999999999999997 899999999999999999999999
Q ss_pred cCCcccc---------------------------------ccccccceeeeeeeh-hh
Q 005898 637 YGLSIVS---------------------------------EDINSVGVRLLILMS-FF 660 (671)
Q Consensus 637 fGla~~~---------------------------------~d~~s~g~~l~~~~~-~~ 660 (671)
||+++.. .|+||+|+++|+|++ +.
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 218 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 218 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCC
Confidence 9998532 199999999999998 43
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=246.42 Aligned_cols=171 Identities=22% Similarity=0.373 Sum_probs=131.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..++|+..+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++...+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD------ 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS------
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC------
Confidence 356788999999999999999985 478999999986543 334567889999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEE
Q 005898 559 VNKVFLVYEFMSNGNFRTHISEN-----TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAK 633 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~k 633 (671)
..++||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+|
T Consensus 87 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 87 --ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred --CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence 689999999999999988641 1234589999999999999999999997 799999999999999999999
Q ss_pred EcccCCcccc------------------------------------ccccccceeeeeeehhhhc
Q 005898 634 LSDYGLSIVS------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 634 i~DfGla~~~------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+|||+++.. .|+||+|+++|+|+++...
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 226 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999976321 1999999999999997543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-25 Score=246.37 Aligned_cols=279 Identities=24% Similarity=0.306 Sum_probs=200.6
Q ss_pred CEeEEEecCCCCCCCCCCCCcc-cccccCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccC
Q 005898 74 FITELKIIGDKPSNVGNFDGFA-SANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSN 152 (671)
Q Consensus 74 ~v~~l~l~~~~~~~~~~~~~~~-~~~~~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N 152 (671)
.++.+++.+....+...+.... .....++.|... .+++ ++++++|++|+|++|.+.+..| +.++++|++|++++|
T Consensus 69 ~L~~L~Ls~n~l~~~~~~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n 144 (466)
T 1o6v_A 69 NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSN 144 (466)
T ss_dssp TCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEE
T ss_pred CCCEEECCCCccCCchhhhccccCCEEECCCCccc-cChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCC
Confidence 4677777766544322222111 111233334332 3333 7788888888888887765433 777788888888777
Q ss_pred cCCCCCC-------------------ccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCC
Q 005898 153 FLFGSVP-------------------PKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRI 213 (671)
Q Consensus 153 ~l~~~~p-------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l 213 (671)
.+++..+ ..+.++++|++|++++|.+++. ..+..+++|++|++++|++++..| ++.+
T Consensus 145 ~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 220 (466)
T 1o6v_A 145 TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGIL 220 (466)
T ss_dssp EECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGC
T ss_pred ccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--cccc
Confidence 7654210 1266778888899999988753 347888999999999999887655 7778
Q ss_pred CCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCC-CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccc
Q 005898 214 STLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFN 292 (671)
Q Consensus 214 ~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 292 (671)
++|+.|++++|.+++ ++.+..+++|+.|++++|.+++..|- -..+|+.+++++|.+++..| +..+++|+.|++++|
T Consensus 221 ~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n 297 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN 297 (466)
T ss_dssp TTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSS
T ss_pred CCCCEEECCCCCccc-chhhhcCCCCCEEECCCCccccchhhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCC
Confidence 889999999888875 46677888888888888888776541 23578888888888886544 778888888888888
Q ss_pred cccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCC
Q 005898 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN 369 (671)
Q Consensus 293 ~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~ 369 (671)
++++.++ +..+++|+.|+|++|++++..| +..+++|+.|++++|++++. ..+..+++++.+++++|.+++.
T Consensus 298 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~ 368 (466)
T 1o6v_A 298 QLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDL 368 (466)
T ss_dssp CCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBC
T ss_pred cccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCcc
Confidence 8888765 6778888888888888887666 56778888888888888764 3567778888888888887754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=247.47 Aligned_cols=167 Identities=25% Similarity=0.462 Sum_probs=139.9
Q ss_pred hcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.++|+..+.||+|+||.||+|+. .+++.||||.+... .....+++.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--
Confidence 35688899999999999999984 25779999999754 3445678999999999999999999999998653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC--
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTP----GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-- 628 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-- 628 (671)
..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 107 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 107 ------PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp ------SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred ------CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCC
Confidence 56999999999999999986432 24589999999999999999999997 8999999999999984
Q ss_pred -CCcEEEcccCCcccc--------------------------------ccccccceeeeeeehh
Q 005898 629 -HRIAKLSDYGLSIVS--------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 629 -~~~~ki~DfGla~~~--------------------------------~d~~s~g~~l~~~~~~ 659 (671)
+..+||+|||+++.. .|+||+|+++|+|+++
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 456999999987521 1999999999999983
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=256.22 Aligned_cols=172 Identities=20% Similarity=0.329 Sum_probs=138.2
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
..|+..++||+|+||+||+|+...+..||||++...... ..+|+++|+.++|||||+++++|...+.. ......
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~--~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDK--KDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSS--SSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCC--CCceEE
Confidence 457888999999999999999877677999988654322 24699999999999999999998764321 112347
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-CCCcEEEcccCCcc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-EHRIAKLSDYGLSI 641 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-~~~~~ki~DfGla~ 641 (671)
++||||++++.+....+.......+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+||+|||+|+
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 89999998754443332222234589999999999999999999997 899999999999999 79999999999996
Q ss_pred ccc------------------------------cccccceeeeeeehhhhcc
Q 005898 642 VSE------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 642 ~~~------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
... |+||+||++|+|++|....
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 421 9999999999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=240.71 Aligned_cols=170 Identities=24% Similarity=0.377 Sum_probs=143.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc----hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--- 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK--- 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---
Confidence 467999999999999999999964 78999999986532 2235779999999999999999999999864321
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...++||||+++| +.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ---~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d 152 (305)
T 2wtk_C 81 ---QKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA 152 (305)
T ss_dssp ----CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ---CeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence 3689999999986 777776532 34589999999999999999999997 899999999999999999999999
Q ss_pred cCCcccc----------------------------------ccccccceeeeeeehhhhc
Q 005898 637 YGLSIVS----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||++... .|+||+|+++|+|+++...
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence 9998532 1999999999999997543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=243.46 Aligned_cols=169 Identities=18% Similarity=0.403 Sum_probs=142.9
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhc--CCCCCcccccceeecCCCCCC
Q 005898 479 KEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAK--LRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 479 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~~~~~ 556 (671)
....++|+..+.||+|+||.||+|+. +|+.||||++... ..+++.+|++++.. ++||||+++++++....+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~--- 110 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG--- 110 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS---
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC---
Confidence 34456799999999999999999987 4899999998643 34567888888877 799999999999887542
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC-----CCCccccCCCCCceeecCCCc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV-----IPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlk~~NiLl~~~~~ 631 (671)
.....++||||+++|+|.+++... .+++.++..++.+++.||+|||... ..+|+||||||+||++++++.
T Consensus 111 -~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 111 -TWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp -SCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred -ccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 123689999999999999999753 3899999999999999999999310 138999999999999999999
Q ss_pred EEEcccCCccc----------------------------------------cccccccceeeeeeehh
Q 005898 632 AKLSDYGLSIV----------------------------------------SEDINSVGVRLLILMSF 659 (671)
Q Consensus 632 ~ki~DfGla~~----------------------------------------~~d~~s~g~~l~~~~~~ 659 (671)
+||+|||+++. ..|+||+||++|+|+++
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99999998732 13999999999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=240.33 Aligned_cols=165 Identities=16% Similarity=0.250 Sum_probs=142.4
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ..+++.+|++++.++ +|+|++++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-------- 79 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-------- 79 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--------
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--------
Confidence 5688899999999999999995 579999999986443 234688899999999 7999999999987653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc-----EEEc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI-----AKLS 635 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~-----~ki~ 635 (671)
..++||||+ +|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++. +||+
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred eeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 689999999 999999998643 3489999999999999999999987 8999999999999987776 9999
Q ss_pred ccCCcccc-------------------------------------ccccccceeeeeeehhhhcc
Q 005898 636 DYGLSIVS-------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 636 DfGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|||+++.. .|+||+|+++|+|+++....
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 218 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCc
Confidence 99998531 19999999999999876543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-27 Score=240.93 Aligned_cols=172 Identities=21% Similarity=0.374 Sum_probs=144.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC-----
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD----- 555 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----- 555 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++.+....-
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 456888999999999999999964 7999999999643 334578999999999999999999999887532100
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
.......++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 001246899999999999999998643 3478899999999999999999997 79999999999999999999999
Q ss_pred ccCCcccc---------------------------------------------ccccccceeeeeeehh
Q 005898 636 DYGLSIVS---------------------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 636 DfGla~~~---------------------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||+++.. .|+||+||++|+|++.
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p 227 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence 99987521 1999999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=245.64 Aligned_cols=170 Identities=16% Similarity=0.293 Sum_probs=144.1
Q ss_pred HhcCCCcC-ceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCC
Q 005898 481 ATNNFDMS-AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 481 ~~~~f~~~-~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 555 (671)
..+.|... +.||+|+||.||+|+.. +|+.||||++..... ...+++.+|+.++.+++ ||||+++++++.+.+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~--- 102 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS--- 102 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS---
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC---
Confidence 33445555 88999999999999965 699999999975432 23578999999999995 699999999998653
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcE
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIA 632 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ 632 (671)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+
T Consensus 103 -----~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 103 -----EIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp -----EEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred -----eEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 6899999999999999986432 34589999999999999999999997 8999999999999997 7899
Q ss_pred EEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 633 KLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 633 ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+|||+++... |+||+|+++|+|+++...
T Consensus 174 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232 (327)
T ss_dssp EECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999985421 999999999999997553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-27 Score=253.37 Aligned_cols=167 Identities=20% Similarity=0.367 Sum_probs=131.1
Q ss_pred CCc-CceeccCCceEEEEEEEc---CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 485 FDM-SAIMGEGSYGKLYKGRLE---NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 485 f~~-~~~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
|+. .++||+|+||.||+|+.. +++.||||++..... .+.+.+|+++|++++|||||++++++.+..+ .
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------~ 93 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHAD------R 93 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT------T
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC------C
Confidence 443 568999999999999965 578999999975432 2468899999999999999999999965331 3
Q ss_pred eEEEEEecCCCCChhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee----cCCC
Q 005898 561 KVFLVYEFMSNGNFRTHISEN------TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL----NEHR 630 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl----~~~~ 630 (671)
..++||||+++ +|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 78999999974 888777531 1123489999999999999999999997 79999999999999 7789
Q ss_pred cEEEcccCCccccc----------------------------------cccccceeeeeeehhhhcc
Q 005898 631 IAKLSDYGLSIVSE----------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 631 ~~ki~DfGla~~~~----------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
.+||+|||+|+... |+||+||++|+|+++....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999985311 9999999999999976443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=242.60 Aligned_cols=167 Identities=27% Similarity=0.430 Sum_probs=140.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..+.|+..+.||+|+||.||+|+.. +|+.||||.+.... ..+++.+|++++.+++||||+++++++.+.+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT------- 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-------
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-------
Confidence 4567889999999999999999975 68999999997543 2467899999999999999999999998653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++||||+++|+|.+++.... ..+++.++..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 98 -~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 98 -DLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp -EEEEEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred -EEEEEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 6899999999999999987422 3489999999999999999999987 899999999999999999999999999
Q ss_pred cccc------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+... .|+||+|+++|+|+++...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (314)
T 3com_A 172 AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224 (314)
T ss_dssp CEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred chhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 8432 1999999999999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-27 Score=240.26 Aligned_cols=171 Identities=22% Similarity=0.333 Sum_probs=135.8
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.++...++.++||||+++++++.+.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~------ 79 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG------ 79 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC------
Confidence 35688899999999999999996 479999999997542 222334555566688899999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISEN-TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||++ |+|.+++... .....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+||
T Consensus 80 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 80 --DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp --SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred --CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence 6899999997 5888877541 1234599999999999999999999985 26899999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehhhhcc
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
|+++.. .|+||+||++|+|+++....
T Consensus 155 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 155 GISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred CCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 987431 19999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=247.50 Aligned_cols=170 Identities=21% Similarity=0.329 Sum_probs=142.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.+.|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++...+... .
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~--~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR--N 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST--T
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc--c
Confidence 356888899999999999999865 7999999999753 2334578899999999999999999999998654210 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++||||+. |+|.+++.. .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 123499999998 688887742 389999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++..+ |+||+||++|+|++|...
T Consensus 190 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 241 (371)
T 4exu_A 190 LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL 241 (371)
T ss_dssp CC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 985321 999999999999997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-27 Score=252.46 Aligned_cols=174 Identities=13% Similarity=0.131 Sum_probs=128.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHH---HHHHhcCCCCCccccc-------ce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLR---LDLLAKLRHPHLVCLL-------GH 547 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~-------g~ 547 (671)
...|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+| ++.|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345888899999999999999965 78999999997643 2345667788 455666 799988754 33
Q ss_pred eecCCCC---------CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHhcCCCCC
Q 005898 548 CIDGGGR---------DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER------LAVLIGVAKAVQFLHTGVIP 612 (671)
Q Consensus 548 ~~~~~~~---------~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gl~yLH~~~~~ 612 (671)
+...+.. +.+.....++|||||+ |+|.+++.... ..+.+..+ ..++.|+++||+|||+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 3332210 0011135899999999 89999997632 12456666 88889999999999987
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|+||||||+|||+++++.+||+|||+|+..+ |+||+||++|+|++|...
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 79999999999999999999999999985422 999999999999997654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=248.97 Aligned_cols=170 Identities=16% Similarity=0.226 Sum_probs=136.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCCchh-----------hHHHHHHHHHHHhcCCCCCcccccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSSKKY-----------TVRNLKLRLDLLAKLRHPHLVCLLGH 547 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g~ 547 (671)
++|+..+.||+|+||.||+|+.. ++..||||+....... ..+.+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999974 5788999998754321 12346788899999999999999999
Q ss_pred eecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 548 CIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 548 ~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
+.+... .....++||||+ +|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 117 ~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 117 GLTEFK----GRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEESS----SCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccC----CCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 876311 113789999999 999999997643 599999999999999999999987 899999999999999
Q ss_pred CCC--cEEEcccCCcccc-------------------------------------ccccccceeeeeeehhhhcc
Q 005898 628 EHR--IAKLSDYGLSIVS-------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 628 ~~~--~~ki~DfGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
.++ .+||+|||+++.. .|+||+||++|+|+++....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 887 9999999999532 19999999999999976443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=265.17 Aligned_cols=164 Identities=21% Similarity=0.404 Sum_probs=142.7
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc----CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
..+.|+..+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+.+|++++|||||++++++.+.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN---- 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 3466888899999999999999864 24679999987543 34457899999999999999999999998542
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 464 -----~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 464 -----PVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred -----ceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence 4799999999999999998643 3489999999999999999999997 89999999999999999999999
Q ss_pred ccCCccccc-------------------------------cccccceeeeeeeh
Q 005898 636 DYGLSIVSE-------------------------------DINSVGVRLLILMS 658 (671)
Q Consensus 636 DfGla~~~~-------------------------------d~~s~g~~l~~~~~ 658 (671)
|||+++... |+||+||++|||++
T Consensus 534 DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 587 (656)
T 2j0j_A 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587 (656)
T ss_dssp CCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 999986421 99999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=246.77 Aligned_cols=181 Identities=23% Similarity=0.269 Sum_probs=134.2
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 476 EELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 476 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
++.....++|+..+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|++.++.++||||+++++++...+..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445567789999999999999999999975 689999999865432 234567788888999999999999998764321
Q ss_pred CCcccceEEEEEecCCCCChhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhc--CCCCCCccccCCCCCceeecC-CC
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISE-NTPGKVLNWSERLAVLIGVAKAVQFLH--TGVIPGFFNNRVKTNNILLNE-HR 630 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH--~~~~~~iiHrDlk~~NiLl~~-~~ 630 (671)
+ ......++||||+++ +|...+.. ......+++..+..++.+++.||+||| +. +|+||||||+||+++. ++
T Consensus 95 ~-~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 95 D-RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp C-TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred c-ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 1 112247899999986 55444432 122345899999999999999999999 54 8999999999999996 89
Q ss_pred cEEEcccCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 631 IAKLSDYGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 631 ~~ki~DfGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
.+||+|||+++... |+||+||++|+|+++...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p 231 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231 (360)
T ss_dssp EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999986421 999999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=251.91 Aligned_cols=166 Identities=20% Similarity=0.303 Sum_probs=141.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC------CCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL------RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 554 (671)
...|+..++||+|+||.||+|+.. +++.||||++.... ...+++.+|++++..+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-- 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN-- 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC--
Confidence 346888999999999999999865 68999999997643 3346677888887776 6779999999998653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc--E
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI--A 632 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~--~ 632 (671)
..++||||+. |+|.+++.... ...+++..+..++.||++||+|||+. +|+||||||+|||++.++. +
T Consensus 173 ------~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 173 ------HICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp ------EEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred ------eEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 7899999996 69999887643 23489999999999999999999987 8999999999999999887 9
Q ss_pred EEcccCCccccc---------------------------cccccceeeeeeehhhh
Q 005898 633 KLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 633 ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~ 661 (671)
||+|||+|+... |+||+||++|+|++|..
T Consensus 242 kL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 242 KVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp EECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 999999985321 99999999999999854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=244.42 Aligned_cols=170 Identities=21% Similarity=0.336 Sum_probs=144.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... .....++.+|++++++++||||+++++++....- ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF---ENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS---TTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc---Ccc
Confidence 467888999999999999999975 78999999996543 3345678899999999999999999998865321 112
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||++ |+|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 46899999997 6999988753 489999999999999999999987 899999999999999999999999998
Q ss_pred cccc-----------------------------------------ccccccceeeeeeehhhhc
Q 005898 640 SIVS-----------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~-----------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
++.. .|+||+||++|+|+++...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 222 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence 8521 1999999999999987643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=246.21 Aligned_cols=235 Identities=22% Similarity=0.277 Sum_probs=192.0
Q ss_pred CcchhcccCCCCCCEEecccccccccCCccccCCCCC-------------CEEEcccCcCCCCCCccCCCCCccCEEEcc
Q 005898 108 DSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSL-------------EYLDLSSNFLFGSVPPKISTMVKLQTLILD 174 (671)
Q Consensus 108 ~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L-------------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 174 (671)
+.+|.+++++++|++|++++|.+.|.+|..++++.+| ++|++++|.+++ +|.. .++|++|+++
T Consensus 24 ~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~ 99 (454)
T 1jl5_A 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVAS 99 (454)
T ss_dssp ----------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECC
T ss_pred hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEcc
Confidence 6788999999999999999999999999999999875 999999999976 5542 3789999999
Q ss_pred CCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCC
Q 005898 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLP 254 (671)
Q Consensus 175 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p 254 (671)
+|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +|+++.+++|++|++++|++++ +|
T Consensus 100 ~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp 169 (454)
T 1jl5_A 100 CNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LP 169 (454)
T ss_dssp SSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CC
T ss_pred CCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cC
Confidence 999997 7754 4789999999999985 4432 2689999999999997 6789999999999999999987 77
Q ss_pred CCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccE
Q 005898 255 KLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVF 334 (671)
Q Consensus 255 ~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~ 334 (671)
..+.+|+.+++++|++++ +| .++.+++|+.|++++|++++.+. . .++|+.|++++|+++ .+|. +..+++|+.
T Consensus 170 ~~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-~---~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~ 241 (454)
T 1jl5_A 170 DLPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-L---PLSLESIVAGNNILE-ELPE-LQNLPFLTT 241 (454)
T ss_dssp CCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-C---CTTCCEEECCSSCCS-SCCC-CTTCTTCCE
T ss_pred CCcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-C---cCcccEEECcCCcCC-cccc-cCCCCCCCE
Confidence 777899999999999987 66 68999999999999999998543 2 258999999999998 6774 888899999
Q ss_pred EECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 335 FDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 335 l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
|++++|++++ +|.. .++++.+++++|.+++
T Consensus 242 L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~ 271 (454)
T 1jl5_A 242 IYADNNLLKT-LPDL---PPSLEALNVRDNYLTD 271 (454)
T ss_dssp EECCSSCCSS-CCSC---CTTCCEEECCSSCCSC
T ss_pred EECCCCcCCc-cccc---ccccCEEECCCCcccc
Confidence 9999999985 5543 3578888888888775
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-27 Score=246.55 Aligned_cols=179 Identities=23% Similarity=0.411 Sum_probs=149.2
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCC
Q 005898 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 477 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 554 (671)
++....+.|+..+.||+|+||.||+|+.. +|+.||||++..... ..+++.+|++++.++ +||||+++++++......
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33445678999999999999999999974 789999999865432 346789999999998 799999999999764210
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
......++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 97 --~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 97 --GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred --cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 01246899999999999999997642 23588999999999999999999997 7999999999999999999999
Q ss_pred cccCCcccc-----------------------------------ccccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVS-----------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~-----------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
+|||++... .|+||+||++|+|+++...
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 999987531 2999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=244.64 Aligned_cols=169 Identities=21% Similarity=0.327 Sum_probs=142.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++...+.. ...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~ 101 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL--RNF 101 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG--GGC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc--ccc
Confidence 56788899999999999999965 7999999999653 233457789999999999999999999998765311 011
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...++||||++ |+|.+++.. .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 24599999997 688887743 389999999999999999999997 899999999999999999999999999
Q ss_pred ccccc----------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++..+ |+||+||++|+|++|...
T Consensus 173 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 223 (353)
T 3coi_A 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL 223 (353)
T ss_dssp TTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 85421 999999999999997543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-27 Score=249.53 Aligned_cols=163 Identities=18% Similarity=0.318 Sum_probs=137.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc---------CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCccc----------
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE---------NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVC---------- 543 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~---------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 543 (671)
++|+..+.||+|+||.||+|+.. +++.||||.+... +.+.+|++++++++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57888999999999999999865 3789999998754 35789999999999999998
Q ss_pred -----ccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 544 -----LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 544 -----l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
+++++...+ ...++||||+ +|+|.+++.... ...+++.++..++.|++.||+|||+. +|+|||
T Consensus 117 ~~i~~~~~~~~~~~-------~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D 184 (352)
T 2jii_A 117 LAIPTCMGFGVHQD-------KYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGN 184 (352)
T ss_dssp CSCCCCCEEEEETT-------TEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred cCccchhhccccCC-------cEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence 455555422 3789999999 999999998641 23599999999999999999999997 899999
Q ss_pred CCCCceeecCCC--cEEEcccCCcccc-------------------------------------ccccccceeeeeeehh
Q 005898 619 VKTNNILLNEHR--IAKLSDYGLSIVS-------------------------------------EDINSVGVRLLILMSF 659 (671)
Q Consensus 619 lk~~NiLl~~~~--~~ki~DfGla~~~-------------------------------------~d~~s~g~~l~~~~~~ 659 (671)
|||+||++++++ .+||+|||+++.. .|+||+||++|+|+++
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999998 9999999998421 1999999999999997
Q ss_pred hhc
Q 005898 660 FFG 662 (671)
Q Consensus 660 ~~~ 662 (671)
...
T Consensus 265 ~~p 267 (352)
T 2jii_A 265 FLP 267 (352)
T ss_dssp CCT
T ss_pred CCC
Confidence 543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=239.70 Aligned_cols=162 Identities=21% Similarity=0.413 Sum_probs=134.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc--CCc--EEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE--NGT--SVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~--~g~--~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
++|+..+.||+|+||.||+|+.. +++ .||||++.... ....+++.+|++++++++||||+++++++.+.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 93 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence 56888999999999999999853 333 68999986532 33467899999999999999999999998764
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..++||||+++|+|.+++.... ..+++.++..++.++++||+|||+. +|+||||||+||++++++.+||+
T Consensus 94 -----~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~ 163 (291)
T 1u46_A 94 -----PMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 163 (291)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred -----CceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEc
Confidence 3689999999999999987532 2489999999999999999999997 89999999999999999999999
Q ss_pred ccCCcccc---------------------------------ccccccceeeeeeeh
Q 005898 636 DYGLSIVS---------------------------------EDINSVGVRLLILMS 658 (671)
Q Consensus 636 DfGla~~~---------------------------------~d~~s~g~~l~~~~~ 658 (671)
|||+++.. .|+||+|+++|+|++
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 219 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 99987542 199999999999998
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=243.64 Aligned_cols=247 Identities=19% Similarity=0.182 Sum_probs=205.4
Q ss_pred cCCCccCCCcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
+++.|...+..+..+.++++|++|+|++|.+.+..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|.++
T Consensus 58 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 137 (353)
T 2z80_A 58 DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK 137 (353)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS
T ss_pred ECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc
Confidence 45555433333447999999999999999999988999999999999999999998655555999999999999999999
Q ss_pred CCCC-cccCCCCCcCEEEccccc-CCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCC-
Q 005898 180 NTIP-NWFDSLPSLTFLSMRNNK-LAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPK- 255 (671)
Q Consensus 180 ~~~p-~~~~~l~~L~~L~L~~N~-l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~- 255 (671)
...+ ..+.++++|++|++++|+ +++..|..+..+++|+.|++++|.+++..|. +..+++|++|++++|+++...+.
T Consensus 138 ~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 217 (353)
T 2z80_A 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF 217 (353)
T ss_dssp SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHH
T ss_pred ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhh
Confidence 5433 489999999999999994 7766678899999999999999999998664 88999999999999998543222
Q ss_pred --CCCCccEEEcCCCCCCCCchhhhc---CCcccceeecccccccC----CCccccCCCCCcCeEecccCcCcccCCcc-
Q 005898 256 --LPRGLVMAFLSNNSFSGEIPKQYG---QLNQLQQLDMSFNALRG----MPPPAIFSLPNISDLNLASNKFSGSLPKN- 325 (671)
Q Consensus 256 --~~~~L~~l~l~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~g~~p~~- 325 (671)
...+|+.+++++|.+++..+..+. ....++.+++++|.+++ .+|..+..+++|+.|+|++|+++ .+|..
T Consensus 218 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~ 296 (353)
T 2z80_A 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGI 296 (353)
T ss_dssp HHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTT
T ss_pred hhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHH
Confidence 256899999999999986655443 45678888888888876 35667889999999999999999 56665
Q ss_pred cCCCCCccEEECcCCcCcccCC
Q 005898 326 LNCGGKLVFFDISNNKLTGGLP 347 (671)
Q Consensus 326 ~~~~~~L~~l~ls~N~l~g~~p 347 (671)
+..+++|+.|++++|.+++..|
T Consensus 297 ~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 297 FDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp TTTCTTCCEEECCSSCBCCCHH
T ss_pred HhcCCCCCEEEeeCCCccCcCC
Confidence 5889999999999999998665
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=266.75 Aligned_cols=168 Identities=23% Similarity=0.335 Sum_probs=141.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc--CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE--NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~--~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||+++++|.+.+.. ..
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~---~~ 156 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH---GD 156 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT---SC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC---CC
Confidence 67889999999999999999975 68999999986543 34456789999999999999999999999875411 01
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...|+||||+++|+|.+++.. .++|.++..++.||++||+|||+. +|+||||||+||+++++ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 126999999999999887753 489999999999999999999997 79999999999999986 999999999
Q ss_pred ccccc-------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+||++|+|+++...
T Consensus 228 a~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~ 275 (681)
T 2pzi_A 228 VSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT 275 (681)
T ss_dssp CEETTCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCE
T ss_pred chhcccCCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCC
Confidence 86432 999999999999987544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=235.21 Aligned_cols=167 Identities=23% Similarity=0.392 Sum_probs=144.5
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 94 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS------ 94 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS------
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC------
Confidence 356889999999999999999975 78999999986432 234678999999999999999999999998653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC---CcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH---RIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~---~~~ki~ 635 (671)
..++||||+++|+|.+++.... .+++.++..++.++++||+|||+. +|+||||||+||+++.+ +.+||+
T Consensus 95 --~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 95 --SFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp --EEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred --eEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEe
Confidence 6899999999999999887543 389999999999999999999997 89999999999999754 579999
Q ss_pred ccCCcccc----------------------------ccccccceeeeeeehhhhc
Q 005898 636 DYGLSIVS----------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 636 DfGla~~~----------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|||+++.. .|+||+|+++|+|+++...
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (287)
T 2wei_A 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221 (287)
T ss_dssp STTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCC
Confidence 99988532 1999999999999997543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-27 Score=249.13 Aligned_cols=237 Identities=23% Similarity=0.234 Sum_probs=176.4
Q ss_pred hcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCC
Q 005898 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPS 191 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 191 (671)
..+..+++|++|+|++|.+.+..|..|.++++|++|+|++|.+++..| +..+++|++|+|++|.+++. | ..++
T Consensus 28 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~ 100 (317)
T 3o53_A 28 SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPS 100 (317)
T ss_dssp HHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTT
T ss_pred HHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCC
Confidence 344566788999999998888877888899999999999998876554 88888899999998888743 2 3478
Q ss_pred cCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCCC----CCCccEEEcC
Q 005898 192 LTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKL----PRGLVMAFLS 266 (671)
Q Consensus 192 L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~L~~l~l~ 266 (671)
|++|++++|++++..+.. +++|+.|++++|.+++..+ .+..+++|++|++++|++++..+.. ...|+.++++
T Consensus 101 L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~ 177 (317)
T 3o53_A 101 IETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (317)
T ss_dssp CCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred cCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECC
Confidence 888888888888654433 5778888888888887766 4677888888888888887654431 3567777777
Q ss_pred CCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCc-cc
Q 005898 267 NNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLT-GG 345 (671)
Q Consensus 267 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~-g~ 345 (671)
+|.+++. |. ...+++|+.|++++|++++.++. +..+++|+.|+|++|+++ .+|..+..+++|+.|++++|.++ +.
T Consensus 178 ~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 178 YNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp TSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred CCcCccc-cc-ccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcC
Confidence 7777654 32 23477777777777777776654 677777777777777777 46666777777777777777777 66
Q ss_pred CCCCCCCCCCCceeccC
Q 005898 346 LPSCLSNESDKRVVKFR 362 (671)
Q Consensus 346 ~p~~~~~~~~l~~l~l~ 362 (671)
+|.++..++.++.+++.
T Consensus 254 ~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 254 LRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp HHHHHHTCHHHHHHHHH
T ss_pred HHHHHhccccceEEECC
Confidence 66666666666666665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-25 Score=226.56 Aligned_cols=206 Identities=25% Similarity=0.226 Sum_probs=143.5
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|++|+|++|.+.+..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 36888888888888777778888888888888888887767777888888888888888888777777888888888888
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccc-cC-CCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCch
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGS-LP-DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~-~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p 275 (671)
++|++++..+..+..+++|+.|++++|.+++. +| .+..+++|+.|++++|++++ ..+
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~---------------------~~~ 166 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS---------------------IYC 166 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE---------------------ECG
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc---------------------CCH
Confidence 88888766666677777777777777777652 23 36666677777666665543 223
Q ss_pred hhhcCCcccc----eeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCccc
Q 005898 276 KQYGQLNQLQ----QLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGG 345 (671)
Q Consensus 276 ~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~ 345 (671)
..+..+++|+ .|++++|.+++.++..+. ..+|+.|+|++|++++..+..+..+++|+.|++++|.+++.
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred HHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 3444444444 566666666666554333 33566666666666655444556666666666666666543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=237.05 Aligned_cols=168 Identities=18% Similarity=0.329 Sum_probs=139.8
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..++|+..+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++..++|++++..+++|...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~------- 77 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG------- 77 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET-------
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCC-------
Confidence 446799999999999999999996 5789999998754332 235888999999999999998888776533
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee---cCCCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL---NEHRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl---~~~~~~ki~D 636 (671)
+..++||||+ +|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 3679999999 999999987532 2499999999999999999999997 89999999999999 7889999999
Q ss_pred cCCcccc-------------------------------------ccccccceeeeeeehhhhcc
Q 005898 637 YGLSIVS-------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||+++.. .|+||+||++|+|+++....
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence 9998531 19999999999999986543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.5e-27 Score=243.07 Aligned_cols=168 Identities=23% Similarity=0.370 Sum_probs=137.3
Q ss_pred HHhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch------hhHHHHHHHHHHHhcC----CCCCccccccee
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK------YTVRNLKLRLDLLAKL----RHPHLVCLLGHC 548 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g~~ 548 (671)
...++|+..+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3456799999999999999999986 4789999999965432 1233466788888888 899999999998
Q ss_pred ecCCCCCCcccceEEEEEec-CCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 549 IDGGGRDDYAVNKVFLVYEF-MSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 549 ~~~~~~~~~~~~~~~Lv~Ey-~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
.+.+ ..++|||| +++|+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++
T Consensus 108 ~~~~--------~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 108 ETQE--------GFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILID 173 (312)
T ss_dssp -------------CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEE
T ss_pred ecCC--------eEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEe
Confidence 7653 57999999 78999999998643 389999999999999999999987 899999999999999
Q ss_pred -CCCcEEEcccCCcccc-----------------------------ccccccceeeeeeehhhh
Q 005898 628 -EHRIAKLSDYGLSIVS-----------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 628 -~~~~~ki~DfGla~~~-----------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+++.+||+|||+++.. .|+||+|+++|+|+++..
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 8899999999997542 299999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=240.05 Aligned_cols=173 Identities=24% Similarity=0.368 Sum_probs=140.5
Q ss_pred HhcCCCcCceeccCCceEEEEEEE--cCCcEEEEEEccCCch--hhHHHHHHHHHHHhcC---CCCCcccccceeecCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL--ENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKL---RHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~--~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~ 553 (671)
+.++|+..+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+++++.+ +||||++++++|.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 4688999999864321 1123456677666555 89999999999873210
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEE
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAK 633 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~k 633 (671)
. .....++||||++ |+|.+++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 ~---~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 89 D---RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp S---SEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred C---CCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 0 1236899999998 69999987643 23489999999999999999999997 899999999999999999999
Q ss_pred EcccCCccccc-----------------------------cccccceeeeeeehhhh
Q 005898 634 LSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 634 i~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|+|||+++... |+||+||++|+|+++..
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 99999985421 99999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=235.47 Aligned_cols=166 Identities=19% Similarity=0.339 Sum_probs=142.0
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... .+++.+|+++++.++|++++..++++...+ .
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-------~ 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG-------D 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEET-------T
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCC-------C
Confidence 46788899999999999999996 5799999999865433 246889999999999999888887775533 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee---cCCCcEEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL---NEHRIAKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl---~~~~~~ki~Df 637 (671)
..++||||+ +|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++ ++++.+||+||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred ceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 679999999 899999997532 3499999999999999999999997 89999999999999 58899999999
Q ss_pred CCcccc-------------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS-------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~-------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+||++|+|+++...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 214 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 998531 1999999999999997554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=246.37 Aligned_cols=173 Identities=18% Similarity=0.223 Sum_probs=141.6
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC--------CCCcccccceeecCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR--------HPHLVCLLGHCIDGG 552 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~~~~ 552 (671)
.++|+..+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367889999999999999999864 6899999999754 334567889999999886 788999999887321
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC--
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-- 630 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-- 630 (671)
. .....++||||+ +|++.+++.... ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++
T Consensus 115 ~----~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 V----NGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp T----TEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred C----CCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 0 113689999999 567766665432 235899999999999999999999853 699999999999999775
Q ss_pred -----------------------------------------------cEEEcccCCccccc-------------------
Q 005898 631 -----------------------------------------------IAKLSDYGLSIVSE------------------- 644 (671)
Q Consensus 631 -----------------------------------------------~~ki~DfGla~~~~------------------- 644 (671)
.+||+|||+++...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhc
Confidence 79999999985321
Q ss_pred --------cccccceeeeeeehhhhcc
Q 005898 645 --------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 645 --------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+||+||++|+|+++....
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf 293 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLF 293 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCC
Confidence 9999999999999986543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=222.77 Aligned_cols=215 Identities=20% Similarity=0.242 Sum_probs=185.6
Q ss_pred cCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccC
Q 005898 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQR 212 (671)
Q Consensus 133 ~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~ 212 (671)
.+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|++++|++++..|..+..
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 4565443 57999999999998877778999999999999999999877888999999999999999999888888999
Q ss_pred CCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeeccc
Q 005898 213 ISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSF 291 (671)
Q Consensus 213 l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 291 (671)
+++|++|++++|.+++..+ .+..+++|++|++++|++++ ..+|..++.+++|+.|++++
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--------------------~~l~~~~~~l~~L~~L~Ls~ 158 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS--------------------FKLPEYFSNLTNLEHLDLSS 158 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC--------------------CCCCGGGGGCTTCCEEECCS
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCccce--------------------ecCchhhccCCCCCEEECCC
Confidence 9999999999999988766 47888999999888887653 13688899999999999999
Q ss_pred ccccCCCccccCCCCCcC----eEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 292 NALRGMPPPAIFSLPNIS----DLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 292 N~l~~~~~~~~~~l~~L~----~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
|++++.++..+..+++|+ .|++++|++++..+..+. ..+|+.|++++|++++..+..+..+++++.+++++|.+.
T Consensus 159 N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp SCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred CCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 999999988888777777 899999999976665554 458999999999999776667788999999999999998
Q ss_pred CCc
Q 005898 368 SNV 370 (671)
Q Consensus 368 ~~~ 370 (671)
+.+
T Consensus 238 c~c 240 (276)
T 2z62_A 238 CSC 240 (276)
T ss_dssp CCT
T ss_pred ccC
Confidence 643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-26 Score=238.63 Aligned_cols=167 Identities=21% Similarity=0.326 Sum_probs=142.6
Q ss_pred cCCCcCceeccCCceEEEEEEE--cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCC------cccccceeecCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL--ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH------LVCLLGHCIDGGGR 554 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 554 (671)
++|+..+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+++++.++|++ ++++++++.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~-- 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG-- 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT--
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC--
Confidence 5788899999999999999986 368899999997543 34567889999998887765 899999987653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC------
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE------ 628 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~------ 628 (671)
..++||||+ +|+|.+++.... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 91 ------~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 91 ------HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp ------EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEE
T ss_pred ------cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccc
Confidence 789999999 889999987643 23589999999999999999999997 8999999999999987
Q ss_pred -------------CCcEEEcccCCccccc---------------------------cccccceeeeeeehhhhcc
Q 005898 629 -------------HRIAKLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 629 -------------~~~~ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
++.+||+|||+++... |+||+||++|+|+++....
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 6789999999986422 9999999999999985543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=226.15 Aligned_cols=210 Identities=23% Similarity=0.309 Sum_probs=162.7
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
.+..+++|+.|++++|.+.. ++ .+..+++|++|+|++|.+++ + +.+..+++|++|+|++|.+++..|..|+++++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~~-~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp CHHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccccceeeeeeCCCCccc-cc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 34567778888888877743 33 47778888888888888765 2 467778888888888888887666777788888
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFS 271 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~ 271 (671)
++|++++|++++..|..+..+++|++|++++|.+++..+. +..+++|+.|++++|+++
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--------------------- 170 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ--------------------- 170 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC---------------------
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC---------------------
Confidence 8888888888766666677788888888888887766654 567777777777776654
Q ss_pred CCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCC
Q 005898 272 GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLS 351 (671)
Q Consensus 272 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~ 351 (671)
+..|..++.+++|+.|++++|++++.++..+..+++|+.|+|++|.+.+..| .|+.++++.|+++|.+|.+++
T Consensus 171 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-------~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 171 SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-------TTHHHHHHHHHTGGGBBCTTS
T ss_pred ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-------HHHHHHHHHHhCCCcccCccc
Confidence 3445567888899999999999999998888899999999999998886544 688889999999999999887
Q ss_pred CCC
Q 005898 352 NES 354 (671)
Q Consensus 352 ~~~ 354 (671)
.+.
T Consensus 244 ~~~ 246 (272)
T 3rfs_A 244 SVA 246 (272)
T ss_dssp CBC
T ss_pred ccC
Confidence 654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-26 Score=236.98 Aligned_cols=236 Identities=19% Similarity=0.220 Sum_probs=204.8
Q ss_pred CCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcc
Q 005898 119 SLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMR 198 (671)
Q Consensus 119 ~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 198 (671)
.++.++++.+.+...++..+..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..| +..+++|++|+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45667788888866666677788899999999999998888899999999999999999987655 9999999999999
Q ss_pred cccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCC---CCCccEEEcCCCCCCCCch
Q 005898 199 NNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 199 ~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~~N~l~~~~p 275 (671)
+|++++. | ..++|+.|++++|.+++..+. .+++|+.|++++|++++..|.. ..+|+.+++++|.+++..|
T Consensus 89 ~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 89 NNYVQEL-L----VGPSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SSEEEEE-E----ECTTCCEEECCSSCCSEEEEC--CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred CCccccc-c----CCCCcCEEECCCCccCCcCcc--ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 9999843 2 348999999999999987654 4788999999999999876643 3679999999999998888
Q ss_pred hhh-cCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCC
Q 005898 276 KQY-GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNES 354 (671)
Q Consensus 276 ~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 354 (671)
..+ ..+++|++|++++|.+++.++ ...+++|+.|+|++|++++. |..+..+++|+.|++++|+++ .+|..+..++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred HHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCC
Confidence 777 478999999999999998843 34589999999999999965 555888999999999999999 5788899999
Q ss_pred CCceeccCCCcCC
Q 005898 355 DKRVVKFRGNCLS 367 (671)
Q Consensus 355 ~l~~l~l~~N~l~ 367 (671)
+++.+++++|.+.
T Consensus 238 ~L~~L~l~~N~~~ 250 (317)
T 3o53_A 238 NLEHFDLRGNGFH 250 (317)
T ss_dssp TCCEEECTTCCCB
T ss_pred CCCEEEccCCCcc
Confidence 9999999999886
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-25 Score=248.00 Aligned_cols=284 Identities=27% Similarity=0.315 Sum_probs=207.1
Q ss_pred CCccCCCCCCCCCCCC---CccceEeCCCCEeEEEecCCCCCCCCCCCCcccccccCCCccCCCcchhcccCCCCCCEEe
Q 005898 48 EIWINHGADFCYISSS---TQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLS 124 (671)
Q Consensus 48 ~~W~~~~~~~C~~~~~---~~~~v~C~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~~l~~l~~L~~L~ 124 (671)
+.|... .++|.|.+. .+....|....++.+++.+..+......-........++.|. +..+|. .+++|++|+
T Consensus 13 ~~W~~~-~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~~lp~~l~~~L~~L~L~~N~-l~~lp~---~l~~L~~L~ 87 (622)
T 3g06_A 13 SAWRRA-APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNN-LTSLPA---LPPELRTLE 87 (622)
T ss_dssp HHHHHT-CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCSCCCSCCCTTCSEEEECSCC-CSCCCC---CCTTCCEEE
T ss_pred HHHHhc-CCcchhccccccCcccccccCCCCcEEEecCCCcCccChhhCCCCcEEEecCCC-CCCCCC---cCCCCCEEE
Confidence 457654 577877421 001133444457778877665442211000111122344443 234554 567888888
Q ss_pred cccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCC
Q 005898 125 LVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG 204 (671)
Q Consensus 125 L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 204 (671)
|++|.++ .+|. .+++|++|+|++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|++++|++++
T Consensus 88 Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 88 VSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS 155 (622)
T ss_dssp ECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred cCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC
Confidence 8888886 4565 67888888888888875 454 56788888888888875 5653 4788888888888874
Q ss_pred CCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCccc
Q 005898 205 PFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQL 284 (671)
Q Consensus 205 ~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L 284 (671)
+|.. +++|+.|++++|.+++ +| ..+++|+.|++++|++++ +|..+.+|..+++++|.++ .+|. .+++|
T Consensus 156 -l~~~---~~~L~~L~L~~N~l~~-l~--~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~-~l~~---~~~~L 223 (622)
T 3g06_A 156 -LPAL---PSELCKLWAYNNQLTS-LP--MLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLT-SLPA---LPSGL 223 (622)
T ss_dssp -CCCC---CTTCCEEECCSSCCSC-CC--CCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS-SCCC---CCTTC
T ss_pred -cCCc---cCCCCEEECCCCCCCC-Cc--ccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCccc-ccCC---CCCCC
Confidence 5543 4678888888888886 44 457899999999999986 6667788999999999998 4554 34789
Q ss_pred ceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCC
Q 005898 285 QQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGN 364 (671)
Q Consensus 285 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N 364 (671)
+.|++++|++++.+ ..+++|+.|+|++|+++ .+|. .+++|+.|+|++|+++ .+|..+..+++++.+++++|
T Consensus 224 ~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N 294 (622)
T 3g06_A 224 KELIVSGNRLTSLP----VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294 (622)
T ss_dssp CEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSC
T ss_pred CEEEccCCccCcCC----CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCC
Confidence 99999999999865 45689999999999998 5666 5678999999999999 88999999999999999999
Q ss_pred cCCCC
Q 005898 365 CLSSN 369 (671)
Q Consensus 365 ~l~~~ 369 (671)
.+++.
T Consensus 295 ~l~~~ 299 (622)
T 3g06_A 295 PLSER 299 (622)
T ss_dssp CCCHH
T ss_pred CCCCc
Confidence 98864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=235.98 Aligned_cols=169 Identities=23% Similarity=0.348 Sum_probs=139.5
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHH-HHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLD-LLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+++.+|+. +++.++||||+++++++.+.+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~------- 94 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG------- 94 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-------
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-------
Confidence 57888899999999999999975 78999999997543 333455666666 778889999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 560 NKVFLVYEFMSNGNFRTHISE--NTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++ +|.+++.. ......+++..+..++.++++||+|||+. ++|+||||||+||+++.++.+||+||
T Consensus 95 -~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 95 -DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp -EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred -ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccC
Confidence 68999999985 88777653 11234589999999999999999999985 26899999999999999999999999
Q ss_pred CCcccc---------------------------------ccccccceeeeeeehhhhc
Q 005898 638 GLSIVS---------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~---------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
|+++.. .|+||+|+++|+|+++...
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 998531 1999999999999997543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=248.68 Aligned_cols=193 Identities=24% Similarity=0.251 Sum_probs=135.8
Q ss_pred CCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEec
Q 005898 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 143 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 222 (671)
+|++|+|++|.+++..|..|..+++|++|+|++|.+++..| ++.+++|++|+|++|.+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l-------------------- 92 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-------------------- 92 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEE--------------------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcC--------------------
Confidence 55555555555555444555555555555555555544333 44455555555555544
Q ss_pred cCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCcccc
Q 005898 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302 (671)
Q Consensus 223 ~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 302 (671)
++..+. ++|+.|++++|.+++..+....+|+.|++++|.+++..|..++.+++|+.|+|++|.+++.+|..+
T Consensus 93 ----~~l~~~----~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 164 (487)
T 3oja_A 93 ----QELLVG----PSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164 (487)
T ss_dssp ----EEEEEC----TTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGG
T ss_pred ----CCCCCC----CCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHH
Confidence 433221 455555555555555444444556666677777777788889999999999999999999988888
Q ss_pred C-CCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 303 F-SLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 303 ~-~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
. .+++|+.|+|++|.+++..+ ...+++|+.|+|++|.+++..| .+..+++++.+++++|.+++
T Consensus 165 ~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 165 AASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp GGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE
T ss_pred hhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc
Confidence 6 79999999999999997733 3358999999999999997544 58889999999999999985
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-24 Score=219.76 Aligned_cols=181 Identities=26% Similarity=0.310 Sum_probs=97.2
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|+.|+|++|.+.+..+..|.++++|++|+|++|+++...+..|.++++|++|+|++|.+++..+..|.++++|++|++
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 35666666666665555556666666666666666665444444556666666666666666544455566666666666
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchh
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPK 276 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~ 276 (671)
++|++++..|..|..+++|+.|+|++|.+++..+. +..+++|+.|++++|++++ ..+.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------------------~~~~ 175 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR---------------------VPEG 175 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC---------------------CCTT
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE---------------------eChh
Confidence 66666555455555555555555555555544333 3444555554444443332 2222
Q ss_pred hhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCc
Q 005898 277 QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 277 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
.|..+++|+.|++++|++++.++..+..+++|+.|+|++|.+.
T Consensus 176 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred HhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 3444445555555555555444444444444444444444443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-26 Score=248.74 Aligned_cols=167 Identities=20% Similarity=0.303 Sum_probs=138.3
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..++||+|+||.||+|+. .+++.||||++..... .+++.+|++++..++|++.+..+.++.... +
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~-------~ 76 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEG-------D 76 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEET-------T
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC-------C
Confidence 35788999999999999999996 5799999998865433 235788999999998865555544443322 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee---cCCCcEEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL---NEHRIAKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl---~~~~~~ki~Df 637 (671)
..++||||+ +|+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+||
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence 679999999 999999997532 3499999999999999999999997 89999999999999 68899999999
Q ss_pred CCccccc-------------------------------------cccccceeeeeeehhhhcc
Q 005898 638 GLSIVSE-------------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~~-------------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+++... |+||+||++|||+++....
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf 213 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9985311 9999999999999975543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=258.46 Aligned_cols=176 Identities=19% Similarity=0.252 Sum_probs=146.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++...... ...+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~--~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL--APND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC--CTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc--cCCC
Confidence 57999999999999999999864 6899999998754 344567899999999999999999999987652110 0124
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc---EEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI---AKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~---~ki~Df 637 (671)
..++||||+++|+|.+++........+++..+..++.+++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 6799999999999999998755445689999999999999999999997 8999999999999997654 999999
Q ss_pred CCccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 638 GLSIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 638 Gla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+++... |+||+||++|+|++|....
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 9986521 9999999999999985543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=241.45 Aligned_cols=154 Identities=19% Similarity=0.300 Sum_probs=120.1
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc--------hhhHHHHHHHHHHHhcCC---------CCCccccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--------KYTVRNLKLRLDLLAKLR---------HPHLVCLL 545 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~ 545 (671)
++|+..+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577889999999999999987 68999999996432 223477899999998886 55555555
Q ss_pred c-----------------eeecCCCC-----CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 005898 546 G-----------------HCIDGGGR-----DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603 (671)
Q Consensus 546 g-----------------~~~~~~~~-----~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl 603 (671)
+ ++.+..+. +.......++||||+++|++.+.+.+ ..+++.+...++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 4 44321000 00012478999999999977666643 3489999999999999999
Q ss_pred HHhc-CCCCCCccccCCCCCceeecCCC--------------------cEEEcccCCccccc
Q 005898 604 QFLH-TGVIPGFFNNRVKTNNILLNEHR--------------------IAKLSDYGLSIVSE 644 (671)
Q Consensus 604 ~yLH-~~~~~~iiHrDlk~~NiLl~~~~--------------------~~ki~DfGla~~~~ 644 (671)
+||| +. +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 233 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER 233 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC
Confidence 9999 66 799999999999999887 99999999997643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=240.23 Aligned_cols=170 Identities=22% Similarity=0.293 Sum_probs=141.4
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCC-----cccccceeecCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPH-----LVCLLGHCIDGGG 553 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~n-----iv~l~g~~~~~~~ 553 (671)
..++|+..+.||+|+||+||+|+.. +++.||||++.... ...+++.+|++++..++ |++ |+++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~- 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN- 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT-
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC-
Confidence 3568999999999999999999865 68899999997543 33567888988888885 554 899999887653
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec--CCCc
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN--EHRI 631 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~--~~~~ 631 (671)
..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||.+. .+|+||||||+|||++ +++.
T Consensus 130 -------~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 130 -------HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp -------EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCC
T ss_pred -------ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCc
Confidence 7899999996 59999987643 234899999999999999999999632 3799999999999994 5788
Q ss_pred EEEcccCCccccc---------------------------cccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++... |+||+||++|+|++|...
T Consensus 200 ~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp EEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999985422 999999999999997643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=234.34 Aligned_cols=166 Identities=19% Similarity=0.281 Sum_probs=143.6
Q ss_pred HhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCC--CCCcccccceeecCCCCCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLR--HPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~ 556 (671)
..+.|+..+.||+|+||.||+|+..+++.||||++... .....+.+.+|++++.+++ ||||+++++++.+.+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~---- 101 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---- 101 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS----
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC----
Confidence 34678889999999999999999888999999998643 3345678999999999997 599999999998653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||| +.+|+|.+++.... .+++.++..++.|+++||+|||+. +|+||||||+||++++ +.+||+|
T Consensus 102 ----~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 102 ----YIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ----EEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred ----EEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 6899999 56889999998643 489999999999999999999997 8999999999999975 8999999
Q ss_pred cCCcccc-------------------------------------------ccccccceeeeeeehhhhc
Q 005898 637 YGLSIVS-------------------------------------------EDINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~-------------------------------------------~d~~s~g~~l~~~~~~~~~ 662 (671)
||+++.. .|+||+|+++|+|+++...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCc
Confidence 9998531 2999999999999987653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-26 Score=239.36 Aligned_cols=168 Identities=20% Similarity=0.316 Sum_probs=143.0
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch------hhHHHHHHHHHHHhcCC--CCCcccccceeecC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK------YTVRNLKLRLDLLAKLR--HPHLVCLLGHCIDG 551 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~ 551 (671)
..++|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++ ||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 356788999999999999999985 4789999999864321 12245778999999996 59999999999865
Q ss_pred CCCCCcccceEEEEEecCCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-CC
Q 005898 552 GGRDDYAVNKVFLVYEFMSN-GNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-EH 629 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-~~ 629 (671)
+ ..++||||+.+ |+|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++ ++
T Consensus 121 ~--------~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 121 D--------SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp S--------EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred C--------cEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 3 68999999986 89999997643 489999999999999999999987 899999999999999 78
Q ss_pred CcEEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 630 RIAKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 630 ~~~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+.+||+|||+++... |+||+|+++|+|+++...
T Consensus 187 ~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 248 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248 (320)
T ss_dssp TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence 999999999885321 999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=236.00 Aligned_cols=169 Identities=25% Similarity=0.406 Sum_probs=135.9
Q ss_pred hcCCCcC-ceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMS-AIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~-~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|... ++||+|+||.||+|+.. +|+.||||++..... .. .+....+..++||||+++++++..... ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~----~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-AR---QEVDHHWQASGGPHIVCILDVYENMHH----GK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HH---HHHHHHHHHTTSTTBCCEEEEEEEEET----TE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HH---HHHHHHHHhcCCCChHHHHHHHhhccC----CC
Confidence 4567774 56999999999999976 799999999975422 11 222334567799999999999875221 11
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~D 636 (671)
...++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred ceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 35899999999999999998643 24599999999999999999999997 8999999999999976 45699999
Q ss_pred cCCccccc----------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+++... |+||+||++|+|+++...
T Consensus 175 fg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (336)
T 3fhr_A 175 FGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228 (336)
T ss_dssp CTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred cccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99985421 999999999999997654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=239.36 Aligned_cols=166 Identities=19% Similarity=0.427 Sum_probs=139.9
Q ss_pred HHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 480 EATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 480 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
...++|+..+.||+|+||.||+|+... .||||++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 102 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP----- 102 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-----
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence 345678899999999999999998753 49999986432 223456888999999999999999999998753
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++ ++.+||+||
T Consensus 103 ---~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 103 ---HLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp ---CEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred ---ceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence 6899999999999999997643 3589999999999999999999997 899999999999998 679999999
Q ss_pred CCcccc--------------------------------------------ccccccceeeeeeehhhh
Q 005898 638 GLSIVS--------------------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~--------------------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
|+++.. .|+||+|+++|+|+++..
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 975321 299999999999999754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-23 Score=213.43 Aligned_cols=201 Identities=24% Similarity=0.310 Sum_probs=148.3
Q ss_pred CCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccc
Q 005898 120 LRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199 (671)
Q Consensus 120 L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (671)
++.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.++...+..|.++++|++|++++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 457888888886 4666554 6789999999999876667888899999999999988866556678888888888888
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhh
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY 278 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~ 278 (671)
|++++..+..+..+++|+.|++++|.+++..+. +..+++|++|+|++|++++ ..+..|
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~---------------------~~~~~~ 153 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS---------------------LPKGVF 153 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------------------CCTTTT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCc---------------------cCHhHc
Confidence 888866666677888888888888888776654 5677777777776665542 223345
Q ss_pred cCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcc
Q 005898 279 GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344 (671)
Q Consensus 279 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g 344 (671)
..+++|+.|++++|++++.++..+..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.+
T Consensus 154 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 667777777777777777777667777777777777777775555556666667777777666653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=234.31 Aligned_cols=166 Identities=19% Similarity=0.332 Sum_probs=139.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CC-cEEEEEEccCCchhhHHHHHHHHHHHhcCCCCC------cccccceeecCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NG-TSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH------LVCLLGHCIDGGGR 554 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 554 (671)
++|+..+.||+|+||+||+|+.. ++ +.||||++.... ...+.+.+|++++++++|++ ++.+++++...+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~-- 95 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG-- 95 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT--
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC--
Confidence 57888999999999999999864 44 789999997543 34567889999999998776 888888887653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceee--------
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL-------- 626 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl-------- 626 (671)
..++||||+ +|++.+++.... ...+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 96 ------~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 96 ------HMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp ------EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred ------eEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence 789999999 667777776543 23589999999999999999999987 89999999999999
Q ss_pred -----------cCCCcEEEcccCCccccc---------------------------cccccceeeeeeehhhhc
Q 005898 627 -----------NEHRIAKLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 627 -----------~~~~~~ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+.++.+||+|||+++... |+||+||++|+|+++...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 678899999999986421 999999999999997554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=244.66 Aligned_cols=164 Identities=18% Similarity=0.231 Sum_probs=132.5
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
..|+..++||+|+||+||.....+|+.||||++..... +.+.+|+++++++ +|||||++++++.+.. .
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--------~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ--------F 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT--------E
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC--------E
Confidence 45788899999999997655556789999999865332 2356899999999 7999999999987653 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-----CCCcEEEcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-----EHRIAKLSD 636 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-----~~~~~ki~D 636 (671)
.++||||++ |+|.+++..... ...+.++..++.||++||+|||+. +|+||||||+||+++ ....+||+|
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred EEEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 899999996 699999976432 244456678999999999999997 799999999999994 334688999
Q ss_pred cCCcccc------------------------------------ccccccceeeeeeehhhhcc
Q 005898 637 YGLSIVS------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
||+++.. .|+||+||++|+|+++...+
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~p 229 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBT
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9987431 19999999999999943333
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-25 Score=244.38 Aligned_cols=164 Identities=20% Similarity=0.240 Sum_probs=130.1
Q ss_pred CCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcccceEE
Q 005898 485 FDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
|...++||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +|||||++++++.+.+ ..+
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--------~~~ 85 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDR--------FLY 85 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS--------EEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCC--------eEE
Confidence 44568899999999987766679999999986432 35678899999876 8999999999887653 789
Q ss_pred EEEecCCCCChhhhhhcCCCC-C---CCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC----------
Q 005898 564 LVYEFMSNGNFRTHISENTPG-K---VLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH---------- 629 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~-~---~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~---------- 629 (671)
+||||+. |+|.+++...... . ...+..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccC
Confidence 9999995 6999999764321 1 123345678999999999999987 89999999999999754
Q ss_pred ---CcEEEcccCCcccc-----------------------------------------ccccccceeeeeeehhhhcc
Q 005898 630 ---RIAKLSDYGLSIVS-----------------------------------------EDINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 630 ---~~~ki~DfGla~~~-----------------------------------------~d~~s~g~~l~~~~~~~~~~ 663 (671)
+.+||+|||+++.. .|+||+||++|||+++...|
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 58999999988531 29999999999999843333
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=237.91 Aligned_cols=171 Identities=19% Similarity=0.280 Sum_probs=142.2
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-----------CCCcccccceeec
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-----------HPHLVCLLGHCID 550 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 550 (671)
++|+..+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688899999999999999996 478999999997543 34567889999998886 8999999999875
Q ss_pred CCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec---
Q 005898 551 GGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN--- 627 (671)
Q Consensus 551 ~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~--- 627 (671)
.+. .....++||||+ +|+|.+++.... ...+++..+..++.||+.||+|||+.+ +|+||||||+||+++
T Consensus 98 ~~~----~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 98 KGP----NGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EET----TEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred cCC----CCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 421 113689999999 889999987643 234899999999999999999999853 699999999999994
Q ss_pred ---CCCcEEEcccCCccccc---------------------------cccccceeeeeeehhhhc
Q 005898 628 ---EHRIAKLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 628 ---~~~~~ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
..+.+||+|||+++..+ |+||+||++|+|+++...
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 234 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred CCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 44589999999986422 999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-25 Score=229.76 Aligned_cols=167 Identities=26% Similarity=0.333 Sum_probs=129.4
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.++..+++.++||||+++++++.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~------ 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT------ 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS------
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC------
Confidence 356888899999999999999975 799999999975432 22334555566788899999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+ ++.+..+.... ...+++..+..++.++++||+|||+.+ +|+||||||+||+++.++.+||+|||
T Consensus 98 --~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 98 --DVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp --EEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred --cEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECC
Confidence 689999999 44555544432 234899999999999999999999731 68999999999999999999999999
Q ss_pred Ccccc----------------------------------ccccccceeeeeeehhhh
Q 005898 639 LSIVS----------------------------------EDINSVGVRLLILMSFFF 661 (671)
Q Consensus 639 la~~~----------------------------------~d~~s~g~~l~~~~~~~~ 661 (671)
+++.. .|+||+|+++|+|+++..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 88431 299999999999999753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-23 Score=216.26 Aligned_cols=201 Identities=24% Similarity=0.307 Sum_probs=107.9
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
+.++++|+.+++++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+ . +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCC
Confidence 455666666666666664 3444332 456666666666665555566666666666666666654322 1 5556666
Q ss_pred EEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCC
Q 005898 194 FLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG 272 (671)
Q Consensus 194 ~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~ 272 (671)
+|++++|+++ .+|..+..+++|+.|++++|++++..|. +..+++|++|+|++|++++
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~--------------------- 138 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT--------------------- 138 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC---------------------
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc---------------------
Confidence 6666666665 4555555555555555555555544432 4455555555555444432
Q ss_pred CchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcC
Q 005898 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKL 342 (671)
Q Consensus 273 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l 342 (671)
..+..|..+++|+.|+|++|++++.++..+..+++|+.|+|++|+++ .+|..+....+|+.++|++|.+
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 22233444555555555555555555544455555555555555554 3444444444444444444444
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=244.25 Aligned_cols=153 Identities=15% Similarity=0.187 Sum_probs=113.8
Q ss_pred eccCCceEEEEEE-EcCCcEEEEEEccCCc----------hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCcc
Q 005898 491 MGEGSYGKLYKGR-LENGTSVAIRCLPSSK----------KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 491 iG~G~~g~Vy~~~-~~~g~~vAvK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.+.|+.|.+++++ ...|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++.+..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~------ 315 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ------ 315 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS------
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC------
Confidence 5677777777765 4468999999996431 22356799999999999 6999999999998764
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..||||||++||+|.+.+...++ ++.. +|+.||+.||+|+|++ +||||||||+|||+++++.+||+|||
T Consensus 316 --~~yLVMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG 384 (569)
T 4azs_A 316 --SGWLVMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG 384 (569)
T ss_dssp --EEEEEEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred --EEEEEEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence 78999999999999999986543 5543 5899999999999998 89999999999999999999999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhh
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFF 660 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~ 660 (671)
+|+... |+|+.|+++|++.++.
T Consensus 385 lAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 385 SIVTTPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TEESCC---CCSHHHHHHHHHHHHHHC-----------------CCCCTTH
T ss_pred cCeeCCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhcccc
Confidence 997542 7888888888877654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-23 Score=214.43 Aligned_cols=205 Identities=22% Similarity=0.239 Sum_probs=175.0
Q ss_pred cccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCC
Q 005898 137 KIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216 (671)
Q Consensus 137 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L 216 (671)
.++++++|+++++++|.++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|++++. |.. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcC
Confidence 4778899999999999997 5676664 6889999999999888888899999999999999998853 333 778889
Q ss_pred CEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccC
Q 005898 217 SDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296 (671)
Q Consensus 217 ~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 296 (671)
+.|++++|.++..+..+..+++|++|++++|+++ +..|..|..+++|++|+|++|++++
T Consensus 80 ~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~---------------------~l~~~~~~~l~~L~~L~L~~N~l~~ 138 (290)
T 1p9a_G 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT---------------------SLPLGALRGLGELQELYLKGNELKT 138 (290)
T ss_dssp CEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCC---------------------CCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred CEEECCCCcCCcCchhhccCCCCCEEECCCCcCc---------------------ccCHHHHcCCCCCCEEECCCCCCCc
Confidence 9999999988855445777888888888777665 3445678889999999999999999
Q ss_pred CCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 297 MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 297 ~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
.++..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+.....++.+++++|.+.+
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 99988999999999999999999766667788999999999999999 788888888899999999998874
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=219.59 Aligned_cols=227 Identities=22% Similarity=0.261 Sum_probs=176.7
Q ss_pred CCCCEEeccccccccc-CCc--cccCCCCCCEEEcccCcCCCCCCccC--CCCCccCEEEccCCcCCCCCC----cccCC
Q 005898 118 TSLRVLSLVSLGIWGS-LPD--KIHRLYSLEYLDLSSNFLFGSVPPKI--STMVKLQTLILDDNFFNNTIP----NWFDS 188 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~-~p~--~~~~L~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 188 (671)
..++.|.+.++.+... +.. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 3577888887766432 111 12345679999999999999999888 899999999999999998766 34567
Q ss_pred CCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccc---cCC--CCCCCCCCEEECCCCCCCCCCCCCCCCccEE
Q 005898 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGS---LPD--LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMA 263 (671)
Q Consensus 189 l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~---~p~--~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l 263 (671)
+++|++|+|++|++++..|..+..+++|++|+|++|++.+. .+. +..+++|++|+|++|+++..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l----------- 212 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETP----------- 212 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCH-----------
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCch-----------
Confidence 99999999999999988888999999999999999998763 222 36788888888888776420
Q ss_pred EcCCCCCCCCchh-hhcCCcccceeecccccccCCCccccCCC---CCcCeEecccCcCcccCCcccCCCCCccEEECcC
Q 005898 264 FLSNNSFSGEIPK-QYGQLNQLQQLDMSFNALRGMPPPAIFSL---PNISDLNLASNKFSGSLPKNLNCGGKLVFFDISN 339 (671)
Q Consensus 264 ~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~ 339 (671)
+..+. .++.+++|++|||++|++++..|+.+..+ ++|+.|+|++|+++ .+|..+. ++|+.|||++
T Consensus 213 --------~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~ 281 (310)
T 4glp_A 213 --------TGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSS 281 (310)
T ss_dssp --------HHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCS
T ss_pred --------HHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCC
Confidence 01122 35778899999999999998877677666 68999999999998 6777664 7899999999
Q ss_pred CcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 340 NKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 340 N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
|++++. |. +..+++++.+++++|+++.
T Consensus 282 N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 282 NRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 999863 33 4567888999999998873
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=214.17 Aligned_cols=221 Identities=22% Similarity=0.272 Sum_probs=185.4
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
.++..+++..+.+... ..+..+++|+.|++++|.++. + +.+..+++|++|+|++|.+++ + ..+..+++|++|++
T Consensus 19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 3444556666666444 346788999999999999863 3 358889999999999999986 3 47889999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchh
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPK 276 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~ 276 (671)
++|++++..|..+..+++|++|++++|.+++.++. +..+++|++|++++|++++ ..|.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---------------------~~~~ 151 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS---------------------LPKG 151 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------------------CCTT
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc---------------------cCHH
Confidence 99999987777789999999999999999987775 6888899998888877653 4455
Q ss_pred hhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCC
Q 005898 277 QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDK 356 (671)
Q Consensus 277 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l 356 (671)
.++.+++|+.|++++|++++.++..+..+++|+.|++++|++++..|..+..+++|+.|++++|.++|..| .+
T Consensus 152 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-------~l 224 (272)
T 3rfs_A 152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GI 224 (272)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-------TT
T ss_pred HhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-------HH
Confidence 67889999999999999999999889999999999999999999888889999999999999999987644 57
Q ss_pred ceeccCCCcCCCCcCC
Q 005898 357 RVVKFRGNCLSSNVQN 372 (671)
Q Consensus 357 ~~l~l~~N~l~~~~~~ 372 (671)
+.+++..|.++|.++.
T Consensus 225 ~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 225 RYLSEWINKHSGVVRN 240 (272)
T ss_dssp HHHHHHHHHTGGGBBC
T ss_pred HHHHHHHHhCCCcccC
Confidence 8888889998876553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=205.64 Aligned_cols=195 Identities=17% Similarity=0.205 Sum_probs=144.1
Q ss_pred CCCEEecccccccccCCccccCCCCCCEEEcccCc-CCCCCCccCCCCCccCEEEccC-CcCCCCCCcccCCCCCcCEEE
Q 005898 119 SLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNF-LFGSVPPKISTMVKLQTLILDD-NFFNNTIPNWFDSLPSLTFLS 196 (671)
Q Consensus 119 ~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 196 (671)
+|++|+|++|++.+..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |.+++..|..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 78899999999988777789999999999999997 7766666888899999999998 888877777888899999999
Q ss_pred cccccCCCCCcccccCCCCCC---EEEeccC-ccccccCC-CCCCCCCC-EEECCCCCCCCCCCCCCCCccEEEcCCCCC
Q 005898 197 MRNNKLAGPFPSSIQRISTLS---DLDLSKN-AISGSLPD-LSSLGSLN-VLNLSDNKLDSNLPKLPRGLVMAFLSNNSF 270 (671)
Q Consensus 197 L~~N~l~g~~p~~l~~l~~L~---~L~Ls~N-~l~g~~p~-~~~l~~L~-~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l 270 (671)
+++|++++ +|. +..+++|+ .|++++| .+++..+. +..+++|+ .|++++|+++.
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~------------------- 170 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS------------------- 170 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCE-------------------
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcc-------------------
Confidence 99998886 676 77888887 8888888 88776654 67788888 88887776652
Q ss_pred CCCchhhhcCCcccceeeccccc-ccCCCccccCCC-CCcCeEecccCcCcccCCcccCCCCCccEEECcCC
Q 005898 271 SGEIPKQYGQLNQLQQLDMSFNA-LRGMPPPAIFSL-PNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN 340 (671)
Q Consensus 271 ~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N 340 (671)
+|......++|+.|++++|+ +++.++..+..+ ++|+.|++++|++++ +|.. .+.+|+.|+++++
T Consensus 171 ---i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 171 ---VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp ---ECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred ---cCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 22221122566666776663 666666666666 666667776666663 3332 3455666666554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=218.44 Aligned_cols=202 Identities=18% Similarity=0.213 Sum_probs=157.8
Q ss_pred CCCCCCEEecccccccccCCccc--cCCCCCCEEEcccCcCCCCCC----ccCCCCCccCEEEccCCcCCCCCCcccCCC
Q 005898 116 RLTSLRVLSLVSLGIWGSLPDKI--HRLYSLEYLDLSSNFLFGSVP----PKISTMVKLQTLILDDNFFNNTIPNWFDSL 189 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~g~~p~~~--~~L~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 189 (671)
.+++|++|+|++|.+.+..|..+ .++++|++|+|++|.+++..| ..+..+++|++|+|++|.+++..|..|+++
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 45679999999999999999998 999999999999999988666 456789999999999999999888999999
Q ss_pred CCcCEEEcccccCCCC--Cc--ccccCCCCCCEEEeccCccccccCC----CCCCCCCCEEECCCCCCCCCCCCCCCCcc
Q 005898 190 PSLTFLSMRNNKLAGP--FP--SSIQRISTLSDLDLSKNAISGSLPD----LSSLGSLNVLNLSDNKLDSNLPKLPRGLV 261 (671)
Q Consensus 190 ~~L~~L~L~~N~l~g~--~p--~~l~~l~~L~~L~Ls~N~l~g~~p~----~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~ 261 (671)
++|++|+|++|++.+. ++ ..+..+++|++|+|++|+++...+. +..+++|++|+|++|++++..|
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p------- 241 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVN------- 241 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCC-------
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccch-------
Confidence 9999999999998753 32 2347899999999999999743321 4678899999999988876544
Q ss_pred EEEcCCCCCCCCchhhhcCC---cccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECc
Q 005898 262 MAFLSNNSFSGEIPKQYGQL---NQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDIS 338 (671)
Q Consensus 262 ~l~l~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls 338 (671)
..+..+ ++|++|+|++|+++..+ ..+. ++|+.|+|++|++++. |. +..+++|+.|+++
T Consensus 242 --------------~~~~~~~~~~~L~~L~Ls~N~l~~lp-~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~ 302 (310)
T 4glp_A 242 --------------PSAPRCMWSSALNSLNLSFAGLEQVP-KGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLD 302 (310)
T ss_dssp --------------SCCSSCCCCTTCCCEECCSSCCCSCC-SCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECS
T ss_pred --------------hhHHhccCcCcCCEEECCCCCCCchh-hhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECc
Confidence 233333 46777777777777443 3332 6777777777777753 32 4556777777777
Q ss_pred CCcCc
Q 005898 339 NNKLT 343 (671)
Q Consensus 339 ~N~l~ 343 (671)
+|.++
T Consensus 303 ~N~l~ 307 (310)
T 4glp_A 303 GNPFL 307 (310)
T ss_dssp STTTS
T ss_pred CCCCC
Confidence 77775
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.5e-24 Score=229.89 Aligned_cols=178 Identities=17% Similarity=0.195 Sum_probs=132.2
Q ss_pred HhcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch---hhHHHHHHHHHHHhcCCC-CCcccccce--------
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK---YTVRNLKLRLDLLAKLRH-PHLVCLLGH-------- 547 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l~g~-------- 547 (671)
.+..|...++||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.+++.++| +|......+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345577789999999999999995 4799999999874332 235779999999999987 433222211
Q ss_pred -eecCCCC---------CCcccceEEEEEecCCCCChhhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCC
Q 005898 548 -CIDGGGR---------DDYAVNKVFLVYEFMSNGNFRTHISE----NTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPG 613 (671)
Q Consensus 548 -~~~~~~~---------~~~~~~~~~Lv~Ey~~~GsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 613 (671)
+...+.. ........+++|+++ +|+|.+++.. ......++|..++.++.|+++||+|||+. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1110000 000122456777765 6799988742 12234588999999999999999999987 8
Q ss_pred ccccCCCCCceeecCCCcEEEcccCCccc------------------------------------cccccccceeeeeee
Q 005898 614 FFNNRVKTNNILLNEHRIAKLSDYGLSIV------------------------------------SEDINSVGVRLLILM 657 (671)
Q Consensus 614 iiHrDlk~~NiLl~~~~~~ki~DfGla~~------------------------------------~~d~~s~g~~l~~~~ 657 (671)
|+||||||+|||++.++.+||+|||+++. ..|+||+||++|+|+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999741 239999999999999
Q ss_pred hhhhc
Q 005898 658 SFFFG 662 (671)
Q Consensus 658 ~~~~~ 662 (671)
++...
T Consensus 312 tg~~P 316 (413)
T 3dzo_A 312 CADLP 316 (413)
T ss_dssp HSSCC
T ss_pred HCCCC
Confidence 97553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=202.32 Aligned_cols=203 Identities=18% Similarity=0.239 Sum_probs=169.3
Q ss_pred cCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCc-CCCCCCcccCCCCCcCEEEccc-ccCCCCCcccc
Q 005898 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF-FNNTIPNWFDSLPSLTFLSMRN-NKLAGPFPSSI 210 (671)
Q Consensus 133 ~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~l 210 (671)
.+|. +. .+|++|+|++|++++..+..|.++++|++|++++|. ++...+..|.++++|++|++++ |++++..|..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4565 33 389999999999998777799999999999999997 8876677899999999999998 99997777789
Q ss_pred cCCCCCCEEEeccCccccccCCCCCCCCCC---EEECCCC-CCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccc-
Q 005898 211 QRISTLSDLDLSKNAISGSLPDLSSLGSLN---VLNLSDN-KLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQ- 285 (671)
Q Consensus 211 ~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~- 285 (671)
..+++|+.|++++|.+++ +|.+..+++|+ +|++++| ++ ++..+..|..+++|+
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l---------------------~~i~~~~~~~l~~L~~ 159 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYM---------------------TSIPVNAFQGLCNETL 159 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTC---------------------CEECTTTTTTTBSSEE
T ss_pred CCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcch---------------------hhcCcccccchhccee
Confidence 999999999999999997 66677777777 7776666 44 334455688899999
Q ss_pred eeecccccccCCCccccCCCCCcCeEecccCc-CcccCCcccCCC-CCccEEECcCCcCcccCCCCCCCCCCCceeccCC
Q 005898 286 QLDMSFNALRGMPPPAIFSLPNISDLNLASNK-FSGSLPKNLNCG-GKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRG 363 (671)
Q Consensus 286 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~~-~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~ 363 (671)
.|++++|+++..++..+.. ++|+.|+|++|+ +++..+..+..+ .+|+.||+++|++++ +|.. .+++++.|++++
T Consensus 160 ~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~ 235 (239)
T 2xwt_C 160 TLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARN 235 (239)
T ss_dssp EEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTT
T ss_pred EEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccC
Confidence 9999999999777655555 899999999995 997777788888 999999999999995 5544 466788888776
Q ss_pred C
Q 005898 364 N 364 (671)
Q Consensus 364 N 364 (671)
+
T Consensus 236 ~ 236 (239)
T 2xwt_C 236 T 236 (239)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-24 Score=234.43 Aligned_cols=244 Identities=20% Similarity=0.261 Sum_probs=170.8
Q ss_pred cchhcccCCCCCCEEeccccccccc----CCccccCCCCCCEEEcccC---cCCCCCCccC-------CCCCccCEEEcc
Q 005898 109 SFVTTLARLTSLRVLSLVSLGIWGS----LPDKIHRLYSLEYLDLSSN---FLFGSVPPKI-------STMVKLQTLILD 174 (671)
Q Consensus 109 ~~~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~L~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~L~ 174 (671)
.++..+..+++|++|+|++|.+.+. ++..+.++++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 3456677788888888888888765 3344668888888888885 4445556554 677888888888
Q ss_pred CCcCCC----CCCcccCCCCCcCEEEcccccCCCCCcccc----cCC---------CCCCEEEeccCccc-cccC----C
Q 005898 175 DNFFNN----TIPNWFDSLPSLTFLSMRNNKLAGPFPSSI----QRI---------STLSDLDLSKNAIS-GSLP----D 232 (671)
Q Consensus 175 ~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l----~~l---------~~L~~L~Ls~N~l~-g~~p----~ 232 (671)
+|.++. .+|..+.++++|++|+|++|.+++..+..+ ..+ ++|+.|+|++|.++ +.+| .
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 888876 466677778888888888887764333333 333 77777777777776 3344 2
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeeccccccc----CCCccccCCCCCc
Q 005898 233 LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALR----GMPPPAIFSLPNI 308 (671)
Q Consensus 233 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L 308 (671)
+..+++|+.|++++|+++.. .+...+|..+..+++|+.|+|++|.++ +.+|..+..+++|
T Consensus 183 l~~~~~L~~L~L~~n~l~~~----------------g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L 246 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPE----------------GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHH----------------HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred HHhCCCcCEEECcCCCCCHh----------------HHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCc
Confidence 44566777777777665410 000023446777888888888888886 5566677788888
Q ss_pred CeEecccCcCccc----CCccc--CCCCCccEEECcCCcCcc----cCCCCC-CCCCCCceeccCCCcCCC
Q 005898 309 SDLNLASNKFSGS----LPKNL--NCGGKLVFFDISNNKLTG----GLPSCL-SNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 309 ~~L~L~~N~l~g~----~p~~~--~~~~~L~~l~ls~N~l~g----~~p~~~-~~~~~l~~l~l~~N~l~~ 368 (671)
+.|+|++|.+++. +|..+ ..+++|+.|+|++|.+++ .+|..+ .++++++.+++++|.+++
T Consensus 247 ~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 8888888888765 55655 337788888888888887 477766 556788888888888874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=209.98 Aligned_cols=195 Identities=24% Similarity=0.407 Sum_probs=145.2
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
+.++++|+.|++++|.+.. +| .+..+++|++|+|++|.+++ +|+ +..+++|++|+|++|.+++ +| .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 4567788888888888754 45 57888888888888888875 444 8888888888888888875 33 678888888
Q ss_pred EEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCC
Q 005898 194 FLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 194 ~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~ 273 (671)
+|++++|++++ +|. +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++
T Consensus 111 ~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~---------------------- 165 (308)
T 1h6u_A 111 TLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD---------------------- 165 (308)
T ss_dssp EEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC----------------------
T ss_pred EEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC----------------------
Confidence 88888888875 443 7888888888888888876544 7777888888887776653
Q ss_pred chhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcc
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g 344 (671)
++. +..+++|+.|++++|++++.++ +..+++|+.|+|++|++++..| +..+++|+.|++++|.+++
T Consensus 166 ~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 166 LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 222 6667777777777777776654 6677777777777777775543 6667777777777777764
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.8e-22 Score=198.64 Aligned_cols=177 Identities=27% Similarity=0.309 Sum_probs=108.2
Q ss_pred CCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccc
Q 005898 120 LRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199 (671)
Q Consensus 120 L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (671)
.+.++++++.+. .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 455666666664 4554443 4677777777777666666677777777777777777766666667777777777777
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhh
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY 278 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~ 278 (671)
|++++..|..+..+++|++|+|++|.+++..+. +..+++|+.|+|++|++++ ..|..|
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---------------------~~~~~~ 151 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS---------------------IPAGAF 151 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------------------CCTTTT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc---------------------cCHHHc
Confidence 777655555566666666666666666654443 3555555555555554432 223345
Q ss_pred cCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcc
Q 005898 279 GQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSG 320 (671)
Q Consensus 279 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g 320 (671)
+.+++|+.|+|++|++++.++..+..+++|+.|+|++|++++
T Consensus 152 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 555556666666666665555555555555555555555554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-21 Score=197.49 Aligned_cols=179 Identities=23% Similarity=0.314 Sum_probs=147.9
Q ss_pred CCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEec
Q 005898 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 143 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 222 (671)
+.+++++++|.++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+++|+.|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 5778999999986 5776665 688999999999998888889999999999999999998777888889999999999
Q ss_pred cCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccc
Q 005898 223 KNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPA 301 (671)
Q Consensus 223 ~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 301 (671)
+|.+++..+. +..+++|++|+|++|++++ ..+..|..+++|+.|+|++|++++.++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 150 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKS---------------------LPSGVFDRLTKLKELRLNTNQLQSIPAGA 150 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------------------CCTTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCC---------------------cChhHhccCCcccEEECcCCcCCccCHHH
Confidence 9998876664 5778888888887776653 33445677888889999999988888878
Q ss_pred cCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCccc
Q 005898 302 IFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGG 345 (671)
Q Consensus 302 ~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~ 345 (671)
+..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++.
T Consensus 151 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 88888888888888888877777788888888888888888765
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-21 Score=217.56 Aligned_cols=222 Identities=26% Similarity=0.307 Sum_probs=186.5
Q ss_pred CcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccC
Q 005898 108 DSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFD 187 (671)
Q Consensus 108 ~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 187 (671)
..+|..+. ++|++|+|++|.+. .+|. .+++|++|+|++|+++ .+|. .+++|++|+|++|.+++ +|.
T Consensus 53 ~~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~--- 118 (622)
T 3g06_A 53 TTLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA--- 118 (622)
T ss_dssp SCCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---
T ss_pred CccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---
Confidence 36666665 79999999999997 5666 6789999999999997 4666 77999999999999986 555
Q ss_pred CCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCC
Q 005898 188 SLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSN 267 (671)
Q Consensus 188 ~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~ 267 (671)
.+++|+.|++++|++++ +|.. +++|++|+|++|.+++.. . .+++|+.|++++|++++ +|..+.+|+.|++++
T Consensus 119 ~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~-~--~~~~L~~L~L~~N~l~~-l~~~~~~L~~L~Ls~ 190 (622)
T 3g06_A 119 LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLP-A--LPSELCKLWAYNNQLTS-LPMLPSGLQELSVSD 190 (622)
T ss_dssp CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCC-C--CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCS
T ss_pred CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcC-C--ccCCCCEEECCCCCCCC-CcccCCCCcEEECCC
Confidence 67899999999999985 6764 489999999999998643 3 35789999999999987 567778999999999
Q ss_pred CCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCC
Q 005898 268 NSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLP 347 (671)
Q Consensus 268 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p 347 (671)
|.+++ +|.. +++|+.|++++|.++..+. .+++|+.|+|++|++++ +| ..+++|+.|++++|+++ .+|
T Consensus 191 N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp 257 (622)
T 3g06_A 191 NQLAS-LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLP 257 (622)
T ss_dssp SCCSC-CCCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCC
T ss_pred CCCCC-CCCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCC
Confidence 99985 5543 4789999999999997664 35899999999999996 66 45588999999999999 577
Q ss_pred CCCCCCCCCceeccCCCcCC
Q 005898 348 SCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 348 ~~~~~~~~l~~l~l~~N~l~ 367 (671)
. .+++++.|++++|.++
T Consensus 258 ~---~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 258 M---LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp C---CCTTCCEEECCSSCCC
T ss_pred c---ccccCcEEeCCCCCCC
Confidence 6 4678999999999988
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-23 Score=222.17 Aligned_cols=245 Identities=18% Similarity=0.201 Sum_probs=189.8
Q ss_pred CCCccCCCcchhcccCCCCCCEEecccccccccCC----ccccCCC-CCCEEEcccCcCCCCCCccCCCC-----CccCE
Q 005898 101 LSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLP----DKIHRLY-SLEYLDLSSNFLFGSVPPKISTM-----VKLQT 170 (671)
Q Consensus 101 l~~n~~~~~~~~~l~~l~~L~~L~L~~n~l~g~~p----~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~ 170 (671)
++.|...+.+|..+...++|++|+|++|.+.+..+ +.+.+++ +|++|+|++|.+++..+..+..+ ++|++
T Consensus 5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~ 84 (362)
T 3goz_A 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS 84 (362)
T ss_dssp CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence 33344445666667777779999999999987766 7788888 89999999999988777777665 89999
Q ss_pred EEccCCcCCCCCCcccC----CC-CCcCEEEcccccCCCCCcccccC-----CCCCCEEEeccCccccccC-----CCCC
Q 005898 171 LILDDNFFNNTIPNWFD----SL-PSLTFLSMRNNKLAGPFPSSIQR-----ISTLSDLDLSKNAISGSLP-----DLSS 235 (671)
Q Consensus 171 L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~g~~p~~l~~-----l~~L~~L~Ls~N~l~g~~p-----~~~~ 235 (671)
|+|++|.+++..+..+. .+ ++|++|+|++|++++..+..+.. .++|++|+|++|.++...+ .+..
T Consensus 85 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~ 164 (362)
T 3goz_A 85 LNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAA 164 (362)
T ss_dssp EECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHT
T ss_pred EECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhc
Confidence 99999999887776444 44 89999999999998776665543 3699999999999985332 1344
Q ss_pred CC-CCCEEECCCCCCCCCCCC--------CCCCccEEEcCCCCCCCC----chhhhcC-CcccceeecccccccCCCcc-
Q 005898 236 LG-SLNVLNLSDNKLDSNLPK--------LPRGLVMAFLSNNSFSGE----IPKQYGQ-LNQLQQLDMSFNALRGMPPP- 300 (671)
Q Consensus 236 l~-~L~~L~Ls~N~l~~~~p~--------~~~~L~~l~l~~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~~~- 300 (671)
++ +|++|+|++|++++..+. .+.+|+.+++++|.+++. ++..+.. .++|+.|+|++|.+++..+.
T Consensus 165 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~ 244 (362)
T 3goz_A 165 IPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLEN 244 (362)
T ss_dssp SCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHH
T ss_pred CCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHH
Confidence 54 899999999999775542 235899999999998863 5556665 45899999999999887663
Q ss_pred ---ccCCCCCcCeEecccCcCccc-------CCcccCCCCCccEEECcCCcCccc
Q 005898 301 ---AIFSLPNISDLNLASNKFSGS-------LPKNLNCGGKLVFFDISNNKLTGG 345 (671)
Q Consensus 301 ---~~~~l~~L~~L~L~~N~l~g~-------~p~~~~~~~~L~~l~ls~N~l~g~ 345 (671)
.+..+++|+.|+|++|.+.+. ++..+..+.+|+.||+++|++.+.
T Consensus 245 l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 245 LKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 346778999999999985433 344667788899999999998765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-24 Score=232.03 Aligned_cols=217 Identities=18% Similarity=0.244 Sum_probs=177.2
Q ss_pred ccCCccccCCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCC---cCCCCCCccc-------CCCCCcCEEEc
Q 005898 132 GSLPDKIHRLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDN---FFNNTIPNWF-------DSLPSLTFLSM 197 (671)
Q Consensus 132 g~~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L 197 (671)
..++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|
T Consensus 22 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~L 101 (386)
T 2ca6_A 22 KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRL 101 (386)
T ss_dssp HTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEEC
T ss_pred HHHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEEC
Confidence 35777888999999999999999865 3455889999999999996 4556667655 78999999999
Q ss_pred ccccCCC----CCcccccCCCCCCEEEeccCccccccCC-----CCCC---------CCCCEEECCCCCCCCCCCCCCCC
Q 005898 198 RNNKLAG----PFPSSIQRISTLSDLDLSKNAISGSLPD-----LSSL---------GSLNVLNLSDNKLDSNLPKLPRG 259 (671)
Q Consensus 198 ~~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-----~~~l---------~~L~~L~Ls~N~l~~~~p~~~~~ 259 (671)
++|.+++ .+|..+..+++|+.|+|++|.++...+. +..+ ++|++|+|++|+++.
T Consensus 102 s~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~-------- 173 (386)
T 2ca6_A 102 SDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN-------- 173 (386)
T ss_dssp CSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG--------
T ss_pred CCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc--------
Confidence 9999987 4788889999999999999999754332 2333 788888888777641
Q ss_pred ccEEEcCCCCCCCCch---hhhcCCcccceeeccccccc--C---CCccccCCCCCcCeEecccCcCc----ccCCcccC
Q 005898 260 LVMAFLSNNSFSGEIP---KQYGQLNQLQQLDMSFNALR--G---MPPPAIFSLPNISDLNLASNKFS----GSLPKNLN 327 (671)
Q Consensus 260 L~~l~l~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~~~~~~~l~~L~~L~L~~N~l~----g~~p~~~~ 327 (671)
+.+| ..+..+++|+.|++++|+++ | ..+..+..+++|+.|+|++|.++ +.+|..+.
T Consensus 174 ------------~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~ 241 (386)
T 2ca6_A 174 ------------GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241 (386)
T ss_dssp ------------GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred ------------HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc
Confidence 2344 57778899999999999998 3 44447888999999999999997 77888899
Q ss_pred CCCCccEEECcCCcCccc----CCCCC--CCCCCCceeccCCCcCCC
Q 005898 328 CGGKLVFFDISNNKLTGG----LPSCL--SNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 328 ~~~~L~~l~ls~N~l~g~----~p~~~--~~~~~l~~l~l~~N~l~~ 368 (671)
.+++|+.|+|++|.+++. +|..+ +.+++++.|++++|.++.
T Consensus 242 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp GCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred cCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 999999999999999876 56665 347899999999999875
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-23 Score=224.03 Aligned_cols=247 Identities=19% Similarity=0.157 Sum_probs=201.9
Q ss_pred EEecccccccccCCccccCCCCCCEEEcccCcCCCCCC----ccCCCCC-ccCEEEccCCcCCCCCCcccCCC-----CC
Q 005898 122 VLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP----PKISTMV-KLQTLILDDNFFNNTIPNWFDSL-----PS 191 (671)
Q Consensus 122 ~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 191 (671)
.++|+.|+++|.+|+.+...++|++|||++|.+++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46889999999999988888889999999999987766 7788888 99999999999998888777765 99
Q ss_pred cCEEEcccccCCCCCcccccC----C-CCCCEEEeccCccccccCC-----CCC-CCCCCEEECCCCCCCCCCC------
Q 005898 192 LTFLSMRNNKLAGPFPSSIQR----I-STLSDLDLSKNAISGSLPD-----LSS-LGSLNVLNLSDNKLDSNLP------ 254 (671)
Q Consensus 192 L~~L~L~~N~l~g~~p~~l~~----l-~~L~~L~Ls~N~l~g~~p~-----~~~-l~~L~~L~Ls~N~l~~~~p------ 254 (671)
|++|+|++|++++..+..+.. + ++|+.|+|++|.+++..+. +.. .++|++|+|++|+++...+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999887775544 4 8999999999999876553 344 3699999999999985332
Q ss_pred --CCCCCccEEEcCCCCCCCCchhhhc----CC-cccceeecccccccCCC----ccccCC-CCCcCeEecccCcCcccC
Q 005898 255 --KLPRGLVMAFLSNNSFSGEIPKQYG----QL-NQLQQLDMSFNALRGMP----PPAIFS-LPNISDLNLASNKFSGSL 322 (671)
Q Consensus 255 --~~~~~L~~l~l~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~----~~~~~~-l~~L~~L~L~~N~l~g~~ 322 (671)
..+.+|+.|++++|.+++..+..+. .+ ++|+.|||++|.+++.. +..+.. .++|+.|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 2335899999999999988776554 44 69999999999999843 334444 459999999999998754
Q ss_pred C----cccCCCCCccEEECcCCcCccc-------CCCCCCCCCCCceeccCCCcCCC
Q 005898 323 P----KNLNCGGKLVFFDISNNKLTGG-------LPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 323 p----~~~~~~~~L~~l~ls~N~l~g~-------~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
+ ..+..+.+|+.|++++|.+++. ++..+..++.++.+++++|.+..
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 4 3456778999999999995432 34566778889999999998764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=218.62 Aligned_cols=185 Identities=27% Similarity=0.396 Sum_probs=131.0
Q ss_pred CCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcc
Q 005898 119 SLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMR 198 (671)
Q Consensus 119 ~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 198 (671)
+|+.|+|++|++.+ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|.|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78899999998876 777663 78999999999887 577 457888899999998887 777 665 88889998
Q ss_pred cccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhh
Q 005898 199 NNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY 278 (671)
Q Consensus 199 ~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~ 278 (671)
+|++++ +|. .+++|+.|+|++|.+++ +|. .+++|+.|+|++|++++ +|.+..+|+.|+|++|.|+ .+|. +
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L~~-lp~l~~~L~~L~Ls~N~L~-~lp~-~ 198 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLTF-LPELPESLEALDVSTNLLE-SLPA-V 198 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS-SCCC-C
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCCCC-cchhhCCCCEEECcCCCCC-chhh-H
Confidence 888886 666 67888888888888887 454 57788888888888876 4444456666666666666 4454 4
Q ss_pred cCCccc-------ceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccC
Q 005898 279 GQLNQL-------QQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327 (671)
Q Consensus 279 ~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 327 (671)
.. +| +.|+|++|+|+.+| ..+..+++|+.|+|++|++++.+|..+.
T Consensus 199 ~~--~L~~~~~~L~~L~Ls~N~l~~lp-~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 251 (571)
T 3cvr_A 199 PV--RNHHSEETEIFFRCRENRITHIP-ENILSLDPTCTIILEDNPLSSRIRESLS 251 (571)
T ss_dssp C----------CCEEEECCSSCCCCCC-GGGGGSCTTEEEECCSSSCCHHHHHHHH
T ss_pred HH--hhhcccccceEEecCCCcceecC-HHHhcCCCCCEEEeeCCcCCCcCHHHHH
Confidence 33 45 66666666666433 3444466666666666666665555443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-22 Score=227.33 Aligned_cols=157 Identities=13% Similarity=0.170 Sum_probs=118.1
Q ss_pred CcCceeccCCceEEEEEEEcCCcEEEEEEccCCc--------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 486 DMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 486 ~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
...++||+|+||.||+|+. .++.+|+|+..... ....+.+.+|++++++++||||+++..++.+.+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD----- 412 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT-----
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC-----
Confidence 3467899999999999954 47889998864321 112456899999999999999997766666543
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..++||||+++|+|.+++.. +..++.|+++||+|||+. +|+||||||+|||+++ ++||+||
T Consensus 413 ---~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 413 ---NKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp ---TTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCC
T ss_pred ---ccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEEC
Confidence 45999999999999999874 568999999999999987 7999999999999998 9999999
Q ss_pred CCccccccccccceeeeeeehhhhcccccc
Q 005898 638 GLSIVSEDINSVGVRLLILMSFFFGSMTSC 667 (671)
Q Consensus 638 Gla~~~~d~~s~g~~l~~~~~~~~~~~~~~ 667 (671)
|+++...+.-..+..++.+...+.||+.|.
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~ 503 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEK 503 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGG
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcC
Confidence 999988764444444444455566666664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-21 Score=216.58 Aligned_cols=186 Identities=24% Similarity=0.406 Sum_probs=143.8
Q ss_pred CCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEec
Q 005898 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 143 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 222 (671)
+|+.|+|++|++++ +|..+. ++|++|+|++|.|+ .+| ..+++|++|++++|+|++ +|. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888876 776653 77888888888888 567 457888888888888886 777 655 88888888
Q ss_pred cCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCcccc
Q 005898 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302 (671)
Q Consensus 223 ~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 302 (671)
+|.+++ +|. .+++|+.|+|++|++++ +|..+.+|+.|++++|.+++ +|. |. ++|+.|+|++|+|+.+++ +
T Consensus 129 ~N~l~~-lp~--~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~--~ 198 (571)
T 3cvr_A 129 NNQLTM-LPE--LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA--V 198 (571)
T ss_dssp SSCCSC-CCC--CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC--C
T ss_pred CCcCCC-CCC--cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh--H
Confidence 888887 555 67888888888888877 56566788888888888886 666 55 788888888888885554 4
Q ss_pred CCCCCc-------CeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCC
Q 005898 303 FSLPNI-------SDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352 (671)
Q Consensus 303 ~~l~~L-------~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~ 352 (671)
.. +| +.|+|++|+++ .+|..+..+++|+.|+|++|.+++.+|..+..
T Consensus 199 ~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 199 PV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp C----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred HH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 43 66 88888888888 57777777888888888888888877766544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-23 Score=220.96 Aligned_cols=202 Identities=22% Similarity=0.255 Sum_probs=138.4
Q ss_pred hcccCC--CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCC-CCccCCCCCccCEEEccCCcCCCCCCcccCC
Q 005898 112 TTLARL--TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGS-VPPKISTMVKLQTLILDDNFFNNTIPNWFDS 188 (671)
Q Consensus 112 ~~l~~l--~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 188 (671)
..+..+ ++++.|++++|.+.+..|. +.++++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.
T Consensus 62 ~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~ 140 (336)
T 2ast_B 62 DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK 140 (336)
T ss_dssp HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT
T ss_pred HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc
Confidence 345555 7889999999998877665 56789999999999988765 7788888999999999999888888888888
Q ss_pred CCCcCEEEcccc-cCCC-CCcccccCCCCCCEEEeccC-ccccc-cCC-CCCCC-CCCEEECCCC--CCC-CCCCCC---
Q 005898 189 LPSLTFLSMRNN-KLAG-PFPSSIQRISTLSDLDLSKN-AISGS-LPD-LSSLG-SLNVLNLSDN--KLD-SNLPKL--- 256 (671)
Q Consensus 189 l~~L~~L~L~~N-~l~g-~~p~~l~~l~~L~~L~Ls~N-~l~g~-~p~-~~~l~-~L~~L~Ls~N--~l~-~~~p~~--- 256 (671)
+++|++|++++| .+++ .+|..+..+++|+.|++++| .+++. ++. +..++ +|++|++++| .++ +.+|..
T Consensus 141 ~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~ 220 (336)
T 2ast_B 141 NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 220 (336)
T ss_dssp CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhh
Confidence 999999999998 6765 36777888899999999999 88763 333 66778 8888888888 343 212211
Q ss_pred CCCccEEEcCCCC-CCCCchhhhcCCcccceeecccccccCCCcc---ccCCCCCcCeEecccC
Q 005898 257 PRGLVMAFLSNNS-FSGEIPKQYGQLNQLQQLDMSFNALRGMPPP---AIFSLPNISDLNLASN 316 (671)
Q Consensus 257 ~~~L~~l~l~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N 316 (671)
..+|+.+++++|. +++..+..+..+++|+.|++++|. +..+. .+..+++|+.|++++|
T Consensus 221 ~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 221 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence 2344445555544 444444444455555555555543 11111 2344455555555544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=202.52 Aligned_cols=207 Identities=22% Similarity=0.319 Sum_probs=173.7
Q ss_pred ecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCC
Q 005898 124 SLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA 203 (671)
Q Consensus 124 ~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 203 (671)
.+..+.+...+ .+.++++|++|++++|.++. +| .+..+++|++|+|++|.+++. |. +..+++|++|++++|+++
T Consensus 25 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~ 98 (308)
T 1h6u_A 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLK 98 (308)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCC
Confidence 34444444432 35678899999999999974 55 688999999999999999864 44 999999999999999998
Q ss_pred CCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcc
Q 005898 204 GPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQ 283 (671)
Q Consensus 204 g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~ 283 (671)
+ +| .+..+++|+.|++++|.+++. +.+..+++|+.|++++|++++ +|. ++.+++
T Consensus 99 ~-~~-~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~----------------------~~~-l~~l~~ 152 (308)
T 1h6u_A 99 N-VS-AIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITN----------------------ISP-LAGLTN 152 (308)
T ss_dssp C-CG-GGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCC----------------------CGG-GGGCTT
T ss_pred C-ch-hhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCc----------------------Ccc-ccCCCC
Confidence 5 44 689999999999999999874 558889999999998887653 222 788999
Q ss_pred cceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCC
Q 005898 284 LQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRG 363 (671)
Q Consensus 284 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~ 363 (671)
|+.|++++|++++.++ +..+++|+.|++++|++++..| +..+++|+.|++++|++++..| +..+++++.+++++
T Consensus 153 L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~ 226 (308)
T 1h6u_A 153 LQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (308)
T ss_dssp CCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred ccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccC
Confidence 9999999999998766 8999999999999999996544 7889999999999999997654 78899999999999
Q ss_pred CcCCC
Q 005898 364 NCLSS 368 (671)
Q Consensus 364 N~l~~ 368 (671)
|.+++
T Consensus 227 N~i~~ 231 (308)
T 1h6u_A 227 QTITN 231 (308)
T ss_dssp EEEEC
T ss_pred Ceeec
Confidence 98874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-24 Score=236.69 Aligned_cols=259 Identities=17% Similarity=0.180 Sum_probs=145.4
Q ss_pred cchhcccCCCCCCEEecccccccccCCcccc-----CCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCCcCC
Q 005898 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIH-----RLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 109 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~-----~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
.++..+.++++|++|+|++|.+.+..+..+. .+++|++|+|++|++++. ++..+..+++|++|+|++|.++
T Consensus 104 ~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 183 (461)
T 1z7x_W 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183 (461)
T ss_dssp HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence 3455666666666666666666543333222 244566666666666542 2444555666666666666655
Q ss_pred CCCCcccC-----CCCCcCEEEcccccCCCC----CcccccCCCCCCEEEeccCcccccc-----CC-CCCCCCCCEEEC
Q 005898 180 NTIPNWFD-----SLPSLTFLSMRNNKLAGP----FPSSIQRISTLSDLDLSKNAISGSL-----PD-LSSLGSLNVLNL 244 (671)
Q Consensus 180 ~~~p~~~~-----~l~~L~~L~L~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~~-----p~-~~~l~~L~~L~L 244 (671)
...+..+. .+++|++|++++|.+++. +|..+..+++|+.|++++|.++... +. +..+++|++|++
T Consensus 184 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L 263 (461)
T 1z7x_W 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263 (461)
T ss_dssp HHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEEC
Confidence 43333332 245666666666666643 4555566666666666666665421 11 234566666666
Q ss_pred CCCCCCCC----CCCC---CCCccEEEcCCCCCCCCchhhhcC-----CcccceeecccccccCC----CccccCCCCCc
Q 005898 245 SDNKLDSN----LPKL---PRGLVMAFLSNNSFSGEIPKQYGQ-----LNQLQQLDMSFNALRGM----PPPAIFSLPNI 308 (671)
Q Consensus 245 s~N~l~~~----~p~~---~~~L~~l~l~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L 308 (671)
++|+++.. ++.. ..+|+.+++++|.+++..+..+.. .++|+.|++++|.+++. .+..+..+++|
T Consensus 264 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 343 (461)
T 1z7x_W 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343 (461)
T ss_dssp TTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred cCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence 66666542 2221 245666666666665443333332 24666666666666654 23444555666
Q ss_pred CeEecccCcCcccCCcccCC-----CCCccEEECcCCcCcc----cCCCCCCCCCCCceeccCCCcCC
Q 005898 309 SDLNLASNKFSGSLPKNLNC-----GGKLVFFDISNNKLTG----GLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 309 ~~L~L~~N~l~g~~p~~~~~-----~~~L~~l~ls~N~l~g----~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
+.|+|++|.+++..+..+.. .++|+.|++++|.+++ .+|..+..+++++.+++++|.++
T Consensus 344 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 66777666666543333221 4566667777666664 55655555666666666666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=190.72 Aligned_cols=163 Identities=22% Similarity=0.203 Sum_probs=136.3
Q ss_pred CCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEE
Q 005898 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLS 196 (671)
Q Consensus 117 l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 196 (671)
.++|++|+|++|.+.+..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 35799999999999887777899999999999999999876667789999999999999999977777789999999999
Q ss_pred cccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCch
Q 005898 197 MRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 197 L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p 275 (671)
+++|++++..+..+..+++|+.|++++|.+++.++. +..+++|+.|++++|.+.+..
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~---------------------- 164 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC---------------------- 164 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT----------------------
T ss_pred cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC----------------------
Confidence 999999977777789999999999999999987765 788999999999998765432
Q ss_pred hhhcCCcccceeecccccccCCCccccCCCCC
Q 005898 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN 307 (671)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 307 (671)
++|+.|+++.|+++|.+|..++.++.
T Consensus 165 ------~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 165 ------PGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ------TTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ------CCHHHHHHHHHhCCceeeccCccccC
Confidence 35666666666666666666655543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.4e-21 Score=198.74 Aligned_cols=142 Identities=13% Similarity=0.152 Sum_probs=114.9
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch------------------hhHHHHHHHHHHHhcCCC
Q 005898 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK------------------YTVRNLKLRLDLLAKLRH 538 (671)
Q Consensus 477 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~l~~l~H 538 (671)
.+......|+..+.||+|+||.||+|+..+|+.||||.+..... .....+.+|+++|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444455667799999999999999997799999999964321 13567899999999999
Q ss_pred CCcccccceeecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 539 ~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
| +++.+++... ..++||||+++|+|.+ +.. .....++.|+++||+|||+. +|+|||
T Consensus 163 -~-~~v~~~~~~~---------~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrD 218 (282)
T 1zar_A 163 -G-LAVPKVYAWE---------GNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGD 218 (282)
T ss_dssp -T-SSSCCEEEEE---------TTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred -C-CCcCeEEecc---------ceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence 5 7777765432 4599999999999988 432 12347999999999999987 899999
Q ss_pred CCCCceeecCCCcEEEcccCCccccc
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
|||+||+++ ++.+||+|||+|+...
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEETT
T ss_pred CCHHHEEEE-CCcEEEEECCCCeECC
Confidence 999999999 9999999999998765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-22 Score=214.38 Aligned_cols=245 Identities=18% Similarity=0.181 Sum_probs=199.8
Q ss_pred CCCEEecccccccccCCccccCC--CCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCC-CCcccCCCCCcCEE
Q 005898 119 SLRVLSLVSLGIWGSLPDKIHRL--YSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNT-IPNWFDSLPSLTFL 195 (671)
Q Consensus 119 ~L~~L~L~~n~l~g~~p~~~~~L--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 195 (671)
.++.|++++|.+. |..+..+ ++++.|++++|.+.+..|. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3788999998876 5667777 8999999999999876665 66899999999999999876 88889999999999
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccC-ccccc-cCC-CCCCCCCCEEECCCC-CCCCC-CCCC---CC-CccEEEcC
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKN-AISGS-LPD-LSSLGSLNVLNLSDN-KLDSN-LPKL---PR-GLVMAFLS 266 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N-~l~g~-~p~-~~~l~~L~~L~Ls~N-~l~~~-~p~~---~~-~L~~l~l~ 266 (671)
++++|++++..|..++.+++|+.|++++| .+++. ++. +..+++|++|++++| .+++. ++.. .. +|+.++++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999999889999999999999999999 68752 444 678899999999999 88753 3321 34 89999999
Q ss_pred CC--CCC-CCchhhhcCCcccceeeccccc-ccCCCccccCCCCCcCeEecccCc-CcccCCcccCCCCCccEEECcCCc
Q 005898 267 NN--SFS-GEIPKQYGQLNQLQQLDMSFNA-LRGMPPPAIFSLPNISDLNLASNK-FSGSLPKNLNCGGKLVFFDISNNK 341 (671)
Q Consensus 267 ~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~~~~L~~l~ls~N~ 341 (671)
+| .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. ++......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 99 566 5678888999999999999999 787777789999999999999995 33222225778899999999998
Q ss_pred CcccCCCCCCCC-CCCceeccCCCcCCCCcC
Q 005898 342 LTGGLPSCLSNE-SDKRVVKFRGNCLSSNVQ 371 (671)
Q Consensus 342 l~g~~p~~~~~~-~~l~~l~l~~N~l~~~~~ 371 (671)
++. ..+..+ ..+..+++++|.+++..+
T Consensus 283 i~~---~~~~~l~~~l~~L~l~~n~l~~~~~ 310 (336)
T 2ast_B 283 VPD---GTLQLLKEALPHLQINCSHFTTIAR 310 (336)
T ss_dssp SCT---TCHHHHHHHSTTSEESCCCSCCTTC
T ss_pred cCH---HHHHHHHhhCcceEEecccCccccC
Confidence 332 122222 236677789999887543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-20 Score=183.19 Aligned_cols=125 Identities=26% Similarity=0.338 Sum_probs=70.6
Q ss_pred EEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccccc
Q 005898 122 VLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNK 201 (671)
Q Consensus 122 ~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 201 (671)
.++.+++++. .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|+
T Consensus 11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 87 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87 (208)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence 4455555553 234332 3466677777776665555556666666666666666665544555666666666666666
Q ss_pred CCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCC
Q 005898 202 LAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 202 l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l 249 (671)
+++..+..+..+++|++|++++|.+++..+. +..+++|+.|++++|++
T Consensus 88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 136 (208)
T 2o6s_A 88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136 (208)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCcc
Confidence 6644444455566666666666655544443 34455555555444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=199.90 Aligned_cols=221 Identities=18% Similarity=0.122 Sum_probs=156.5
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCC-ccCCCCCccCE-EEccCCcCCCCCCcccCCCCCcCEE
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP-PKISTMVKLQT-LILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
+++++|+|++|.|+...+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.++.|+++...|..|..+++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 578999999999987666789999999999999999877666 46789998876 5677899998888999999999999
Q ss_pred EcccccCCCCCcccccCCCCCCEEEecc-CccccccCC-CCCCC-CCCEEECCCCCCCCCCCCCC--CCccEEEcCC-CC
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSK-NAISGSLPD-LSSLG-SLNVLNLSDNKLDSNLPKLP--RGLVMAFLSN-NS 269 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~-N~l~g~~p~-~~~l~-~L~~L~Ls~N~l~~~~p~~~--~~L~~l~l~~-N~ 269 (671)
++++|++++..+..+....++..|+++. |.+....+. +..+. .++.|+|++|+++...+... ..+..+++++ |.
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~ 189 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN 189 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCc
Confidence 9999999977666777788889999976 456544432 55553 68888898888875444432 2456666654 44
Q ss_pred CCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcC
Q 005898 270 FSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKL 342 (671)
Q Consensus 270 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l 342 (671)
++...++.|..+++|+.|||++|+|+..++..+.++ +.|.+.++.--..+| .+..+++|+.++++++.-
T Consensus 190 l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L---~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL---KKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp CCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTC---CEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred ccCCCHHHhccCcccchhhcCCCCcCccChhhhccc---hHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence 443333456777777777777777776666544433 333333333223455 355666666676665543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=8.6e-24 Score=232.54 Aligned_cols=258 Identities=20% Similarity=0.191 Sum_probs=132.1
Q ss_pred chhcccCCCCCCEEecccccccccCCccc-cCCC----CCCEEEcccCcCCC----CCCccCCCCCccCEEEccCCcCCC
Q 005898 110 FVTTLARLTSLRVLSLVSLGIWGSLPDKI-HRLY----SLEYLDLSSNFLFG----SVPPKISTMVKLQTLILDDNFFNN 180 (671)
Q Consensus 110 ~~~~l~~l~~L~~L~L~~n~l~g~~p~~~-~~L~----~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 180 (671)
++..+..+++|++|+|++|.+....+..+ ..+. +|++|+|++|+++. .+|..+..+++|++|+|++|.++.
T Consensus 48 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 127 (461)
T 1z7x_W 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 127 (461)
T ss_dssp HHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred HHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCch
Confidence 44555666666666666666654333222 2333 46666666666652 345666666666666666666554
Q ss_pred CCCccc-----CCCCCcCEEEcccccCCCC----CcccccCCCCCCEEEeccCccccccCC-C-----CCCCCCCEEECC
Q 005898 181 TIPNWF-----DSLPSLTFLSMRNNKLAGP----FPSSIQRISTLSDLDLSKNAISGSLPD-L-----SSLGSLNVLNLS 245 (671)
Q Consensus 181 ~~p~~~-----~~l~~L~~L~L~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~-----~~l~~L~~L~Ls 245 (671)
..+..+ ...++|++|++++|++++. ++..+..+++|+.|++++|.++...+. + ...++|+.|+++
T Consensus 128 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 207 (461)
T 1z7x_W 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLE 207 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEcc
Confidence 322222 2244566666666666542 244445556666666666665543221 1 124456666666
Q ss_pred CCCCCCC----CCCC---CCCccEEEcCCCCCCCCc-----hhhhcCCcccceeecccccccCC----CccccCCCCCcC
Q 005898 246 DNKLDSN----LPKL---PRGLVMAFLSNNSFSGEI-----PKQYGQLNQLQQLDMSFNALRGM----PPPAIFSLPNIS 309 (671)
Q Consensus 246 ~N~l~~~----~p~~---~~~L~~l~l~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~ 309 (671)
+|.+++. ++.. ..+|+.+++++|.++... +..+..+++|++|++++|.++.. ++..+..+++|+
T Consensus 208 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~ 287 (461)
T 1z7x_W 208 SCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK 287 (461)
T ss_dssp TSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCC
T ss_pred CCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcc
Confidence 6655542 1211 245556666666554321 11222455566666666655543 233444455566
Q ss_pred eEecccCcCcccCCcccC-----CCCCccEEECcCCcCccc----CCCCCCCCCCCceeccCCCcCC
Q 005898 310 DLNLASNKFSGSLPKNLN-----CGGKLVFFDISNNKLTGG----LPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 310 ~L~L~~N~l~g~~p~~~~-----~~~~L~~l~ls~N~l~g~----~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
.|+|++|.+++..+..+. ..++|+.|++++|.+++. +|..+..+++++.+++++|.++
T Consensus 288 ~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 354 (461)
T 1z7x_W 288 ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354 (461)
T ss_dssp EEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred eEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence 666666655433222221 123555666666655543 3334444455555565555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=7.8e-20 Score=193.75 Aligned_cols=236 Identities=17% Similarity=0.127 Sum_probs=178.6
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCC-cccCCCCCcCE-EEcc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIP-NWFDSLPSLTF-LSMR 198 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~ 198 (671)
++++-++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|+. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 46777888885 577666 3689999999999986556789999999999999999987776 46889999876 6667
Q ss_pred cccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCC-CCCCCCCCC----CCCCccEEEcCCCCCCC
Q 005898 199 NNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSD-NKLDSNLPK----LPRGLVMAFLSNNSFSG 272 (671)
Q Consensus 199 ~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~-N~l~~~~p~----~~~~L~~l~l~~N~l~~ 272 (671)
.|+++...|..|..+++|++|++++|.+++..+. +....++..|++.+ |++....+. ....++.+++++|+++.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999987788999999999999999999876553 45566788888866 455443332 23467789999999984
Q ss_pred CchhhhcCCcccceeecc-cccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCC
Q 005898 273 EIPKQYGQLNQLQQLDMS-FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLS 351 (671)
Q Consensus 273 ~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~ 351 (671)
+|.......+|+.|+++ +|.++.+++..|..+++|+.|+|++|+++...+..+ .+|+.|.+.++.--..+|. +.
T Consensus 169 -i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP~-l~ 243 (350)
T 4ay9_X 169 -IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLPT-LE 243 (350)
T ss_dssp -ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCCC-TT
T ss_pred -CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCCC-ch
Confidence 55555566789999987 477887777788899999999999999985444444 4555555554433336663 66
Q ss_pred CCCCCceeccCCC
Q 005898 352 NESDKRVVKFRGN 364 (671)
Q Consensus 352 ~~~~l~~l~l~~N 364 (671)
++++|+.+++.++
T Consensus 244 ~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 244 KLVALMEASLTYP 256 (350)
T ss_dssp TCCSCCEEECSCH
T ss_pred hCcChhhCcCCCC
Confidence 7777877776543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.7e-21 Score=221.93 Aligned_cols=232 Identities=14% Similarity=0.139 Sum_probs=112.8
Q ss_pred ChHHHHHHHHHHhcCCCC--CCCCCccCCCCCCCCCCCCCccceEeCCCCEeEEEecCCCCCCCCCCCCcccccccCCCc
Q 005898 27 QSSQTQVLLQLRKHLEYP--KQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSEN 104 (671)
Q Consensus 27 ~~~~~~~Ll~~k~~~~~~--~~l~~W~~~~~~~C~~~~~~~~~v~C~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~l~~n 104 (671)
...++++|+++..+...+ ..-..|.......+.|. ++++...+++.+++.+.....
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~~~l~L~~n~~~~----------------- 187 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTAT-----NSAVSTPLTPKIELFANGKDE----------------- 187 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCC-----CceecCCccceEEeeCCCCCc-----------------
Confidence 456788999998765322 12334643323445553 456655667777665443221
Q ss_pred cCCCcchhcccCCCC-----CCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCC
Q 005898 105 FSIDSFVTTLARLTS-----LRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFN 179 (671)
Q Consensus 105 ~~~~~~~~~l~~l~~-----L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 179 (671)
.+..+..... +..++++.|.+. ..|+.+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+
T Consensus 188 -----~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~ 260 (727)
T 4b8c_D 188 -----ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT 260 (727)
T ss_dssp ----------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS
T ss_pred -----chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc
Confidence 1111111111 222233334433 45677888888888888888886 67777778888888888888888
Q ss_pred CCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q 005898 180 NTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRG 259 (671)
Q Consensus 180 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 259 (671)
.+|..|++|++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+..++.++.+++|+.|+|++|.|++
T Consensus 261 -~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~-------- 330 (727)
T 4b8c_D 261 -ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEK-------- 330 (727)
T ss_dssp -CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCS--------
T ss_pred -ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCC--------
Confidence 77888888888888888888887 67888888888888888888887444457777777777777666543
Q ss_pred ccEEEcCCCCCCCCchhhhcCCcc-cceeecccccccCCCccccCCCCCcCeEecccC
Q 005898 260 LVMAFLSNNSFSGEIPKQYGQLNQ-LQQLDMSFNALRGMPPPAIFSLPNISDLNLASN 316 (671)
Q Consensus 260 L~~l~l~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 316 (671)
.+|..+..+.. +..|+|++|.+++.+|.. |..|++++|
T Consensus 331 -------------~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 331 -------------QFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp -------------HHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred -------------CChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 45555544321 223667777777666643 344455555
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-19 Score=177.17 Aligned_cols=134 Identities=28% Similarity=0.280 Sum_probs=123.2
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|++|+|++|.+.+..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 78999999999999999999999999999999999997666677899999999999999999887788999999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSN 252 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~ 252 (671)
++|+++ .+|..+..+++|+.|+|++|++++..+. +..+++|+.|++++|.+...
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 999999 7899999999999999999999977764 78899999999999987653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.9e-20 Score=209.23 Aligned_cols=174 Identities=26% Similarity=0.353 Sum_probs=108.3
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
+..|++|+.|+|++|.+.. +| .+..|++|+.|+|++|++++..| +..+++|+.|+|++|.+++ +| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 4455666666666666643 33 36666666666666666654333 6666666666666666654 22 466666666
Q ss_pred EEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCC
Q 005898 194 FLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 194 ~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~ 273 (671)
.|+|++|++++ + +.+..+++|+.|+|++|.+++. +.+..+++|+.|+|++|+++ +.
T Consensus 113 ~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~---------------------~~ 168 (605)
T 1m9s_A 113 SLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQIS---------------------DI 168 (605)
T ss_dssp EEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCC---------------------CC
T ss_pred EEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCC---------------------Cc
Confidence 66666666654 2 3456666666666666666654 45555666666655555443 33
Q ss_pred chhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCccc
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ 321 (671)
.| +..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++++.
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 33 66777788888888888775 2477778888888888877754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=204.72 Aligned_cols=127 Identities=30% Similarity=0.411 Sum_probs=57.5
Q ss_pred ccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 114 l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
+..|++|+.|+|++|.+.+..| +.++++|+.|+|++|.+++ +| .+..+++|+.|+|++|.+++ + +.+..|++|+
T Consensus 61 l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~ 134 (605)
T 1m9s_A 61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE 134 (605)
T ss_dssp GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCS
T ss_pred HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccC
Confidence 4444444444444444443322 4444444444444444432 22 34444444444444444443 1 2344444444
Q ss_pred EEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCC
Q 005898 194 FLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 194 ~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l 249 (671)
.|+|++|++++. ..+..+++|+.|+|++|.+++.+| +..+++|+.|+|++|++
T Consensus 135 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 135 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp EEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred EEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCC
Confidence 444444444432 334444444444444444444433 44444444444444433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=185.38 Aligned_cols=123 Identities=27% Similarity=0.333 Sum_probs=55.6
Q ss_pred CCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
.+++|+.|++++|.+... | .+..+++|++|+|++|++++..| +.++++|++|+|++|.+++ +| .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 444555555555554322 2 24455555555555555543222 4455555555555555443 12 24444555555
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCC
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDN 247 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N 247 (671)
++++|++++. +.+..+++|+.|++++|.+++. +.+..+++|+.|++++|
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N 166 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDN 166 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSS
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCC
Confidence 5555544431 2344444444444444444432 33344444444444433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=185.54 Aligned_cols=188 Identities=23% Similarity=0.331 Sum_probs=148.8
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
..+.+..+.+.+.. .+..+++|++|++++|.+.. +| .+..+++|++|+|++|.+++..| +.++++|++|++++|
T Consensus 27 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 27 IKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 33445555554433 25678899999999999864 44 48889999999999999987544 899999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcC
Q 005898 201 KLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQ 280 (671)
Q Consensus 201 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~ 280 (671)
++++ + +.+..+++|+.|++++|.+++. +.+..+++|+.|++++|++++ + ..++.
T Consensus 101 ~l~~-~-~~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~----------------------~-~~l~~ 154 (291)
T 1h6t_A 101 KVKD-L-SSLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD----------------------I-TVLSR 154 (291)
T ss_dssp CCCC-G-GGGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC----------------------C-GGGGG
T ss_pred cCCC-C-hhhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc----------------------c-hhhcc
Confidence 9985 3 3488999999999999999864 678888899999888887653 2 35677
Q ss_pred CcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcc
Q 005898 281 LNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344 (671)
Q Consensus 281 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g 344 (671)
+++|+.|++++|++++.++ +..+++|+.|++++|.+++ +| .+..+++|+.|++++|.++.
T Consensus 155 l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 155 LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred CCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 8888888888888888765 7788888888888888875 34 37778888888888888874
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=188.43 Aligned_cols=175 Identities=25% Similarity=0.292 Sum_probs=108.5
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCC-CCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKIS-TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (671)
+.++++++++. .+|..+. ..++.|+|++|+|++..+..+. ++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 35566666664 3454443 3466777777777665555565 677777777777777666666677777777777777
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhh
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY 278 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~ 278 (671)
|++++..+..|..+++|+.|+|++|.+++..|. +..+++|+.|+|++|++++.. +..|
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~---------------------~~~~ 156 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP---------------------VELI 156 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC---------------------GGGT
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC---------------------HHHh
Confidence 777655555666777777777777777665543 566667777666666654311 1112
Q ss_pred ---cCCcccceeecccccccCCCccccCCCCC--cCeEecccCcCc
Q 005898 279 ---GQLNQLQQLDMSFNALRGMPPPAIFSLPN--ISDLNLASNKFS 319 (671)
Q Consensus 279 ---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~ 319 (671)
..+++|+.|+|++|+|++.++..+..+++ ++.|+|++|.+.
T Consensus 157 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp C----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 44566666677777666666666666655 366666666665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.8e-19 Score=181.07 Aligned_cols=139 Identities=13% Similarity=0.140 Sum_probs=105.9
Q ss_pred CCcCceeccCCceEEEEEEE-cCCcE--EEEEEccCCch------------------------hhHHHHHHHHHHHhcCC
Q 005898 485 FDMSAIMGEGSYGKLYKGRL-ENGTS--VAIRCLPSSKK------------------------YTVRNLKLRLDLLAKLR 537 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~-~~g~~--vAvK~l~~~~~------------------------~~~~~~~~E~~~l~~l~ 537 (671)
|+..+.||+|+||.||+|+. .+|+. ||||+++.... .....+.+|++.|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999997 68999 99998643211 11236889999999999
Q ss_pred CCCcccccceeecCCCCCCcccceEEEEEecCCC-C----ChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhc-CCCC
Q 005898 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSN-G----NFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH-TGVI 611 (671)
Q Consensus 538 H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~-G----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~ 611 (671)
|+++.....+... ..+|||||+.+ | +|.++... .++.....++.+++.|+.||| +.
T Consensus 129 ~~~i~~p~~~~~~----------~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~-- 190 (258)
T 1zth_A 129 EAGVSVPQPYTYM----------KNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA-- 190 (258)
T ss_dssp HTTCCCCCEEEEE----------TTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS--
T ss_pred hCCCCCCeEEEcC----------CCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC--
Confidence 8875332222221 35899999942 4 56555432 224456789999999999999 76
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
+|+||||||+|||+++ .++|+|||+|+..+
T Consensus 191 -givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 191 -ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp -CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred -CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 8999999999999998 99999999998765
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.6e-18 Score=169.68 Aligned_cols=151 Identities=28% Similarity=0.353 Sum_probs=84.9
Q ss_pred EEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCc
Q 005898 146 YLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNA 225 (671)
Q Consensus 146 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 225 (671)
.++.+++.++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+++...+..|..+++|+.|+|++|+
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 3444444442 3343332 445555555555555555555555555555555555543333344555555555555555
Q ss_pred cccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCC
Q 005898 226 ISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFS 304 (671)
Q Consensus 226 l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 304 (671)
+++..+. +..+++|++|+|++|+++ .+|..+..+++|+.|+|++|++++.++..+..
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~----------------------~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 157 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT----------------------ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC----------------------SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred CCccChhHhCcchhhCeEeccCCccc----------------------ccCcccccCCCCCEEECCCCcCCccCHHHHhC
Confidence 5544443 455566666665555443 34555566667777777777777766666666
Q ss_pred CCCcCeEecccCcCccc
Q 005898 305 LPNISDLNLASNKFSGS 321 (671)
Q Consensus 305 l~~L~~L~L~~N~l~g~ 321 (671)
+++|+.|+|++|.+++.
T Consensus 158 l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 158 LSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp CTTCCEEECTTSCBCTT
T ss_pred CCCCCEEEeeCCCccCC
Confidence 77777777777776644
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.9e-19 Score=186.84 Aligned_cols=176 Identities=26% Similarity=0.249 Sum_probs=146.3
Q ss_pred CEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccC-CCCCcCEEEcccccCCCCCcccccCCCCCCEEEecc
Q 005898 145 EYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFD-SLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSK 223 (671)
Q Consensus 145 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~ 223 (671)
+.+++++|.++ .+|..+. ..++.|+|++|.|++..+..+. ++++|++|+|++|++++..|..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 68999999996 5777664 4589999999999988888887 999999999999999987778899999999999999
Q ss_pred CccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCcccc
Q 005898 224 NAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302 (671)
Q Consensus 224 N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 302 (671)
|++++..+. +..+++|+.|+|++|++++ ..|..|..+++|+.|+|++|+|++.++..+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~---------------------~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~ 156 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVV---------------------VDRNAFEDMAQLQKLYLSQNQISRFPVELI 156 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCE---------------------ECTTTTTTCTTCCEEECCSSCCCSCCGGGT
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccE---------------------ECHHHhCCcccCCEEECCCCcCCeeCHHHh
Confidence 999887664 7888999998888877653 446778889999999999999999888766
Q ss_pred ---CCCCCcCeEecccCcCcccCCcccCCCCC--ccEEECcCCcCcc
Q 005898 303 ---FSLPNISDLNLASNKFSGSLPKNLNCGGK--LVFFDISNNKLTG 344 (671)
Q Consensus 303 ---~~l~~L~~L~L~~N~l~g~~p~~~~~~~~--L~~l~ls~N~l~g 344 (671)
..+++|+.|+|++|+|++..+..+..+.. ++.|+|++|.++.
T Consensus 157 ~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp C----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred cCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 56899999999999999655566666665 4778888888864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.4e-22 Score=221.13 Aligned_cols=203 Identities=19% Similarity=0.174 Sum_probs=119.8
Q ss_pred cCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
..+++|+.|+|++|.+. .+|+++++|++|+.|++++|.....+|. .+..+.+.+.+|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 44555666666666653 4566666666666666554431000000 00000133444555555555555
Q ss_pred EE-cccc-------------cCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCc
Q 005898 195 LS-MRNN-------------KLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGL 260 (671)
Q Consensus 195 L~-L~~N-------------~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L 260 (671)
|+ ++.| .++. +|. ..|+.|+|++|.+++ +|.++.+++|+.|+|++|++
T Consensus 414 L~~l~~n~~~~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~~~~l~~L~~L~Ls~N~l----------- 475 (567)
T 1dce_A 414 VDPMRAAYLDDLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRL----------- 475 (567)
T ss_dssp HCGGGHHHHHHHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCCGGGGTTCCEEECCSSCC-----------
T ss_pred Ccchhhcccchhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcCccccccCcEeecCcccc-----------
Confidence 55 3444 3321 111 135566666666654 34455555555555555544
Q ss_pred cEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccC-CcccCCCCCccEEECcC
Q 005898 261 VMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSL-PKNLNCGGKLVFFDISN 339 (671)
Q Consensus 261 ~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~~~~L~~l~ls~ 339 (671)
+ .+|..++.+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.. |..+..+++|+.|+|++
T Consensus 476 ----------~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~ 542 (567)
T 1dce_A 476 ----------R-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542 (567)
T ss_dssp ----------C-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTT
T ss_pred ----------c-ccchhhhcCCCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecC
Confidence 4 5677788888888888888888874 4 6888888888888888888776 88888888888888888
Q ss_pred CcCcccCCCCC---CCCCCCceec
Q 005898 340 NKLTGGLPSCL---SNESDKRVVK 360 (671)
Q Consensus 340 N~l~g~~p~~~---~~~~~l~~l~ 360 (671)
|.+++.+|... ..+++|+.|+
T Consensus 543 N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 543 NSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CcCCCCccHHHHHHHHCcccCccC
Confidence 88887655321 1245565553
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.7e-18 Score=168.48 Aligned_cols=131 Identities=18% Similarity=0.263 Sum_probs=66.5
Q ss_pred CEEEcccccCCCCCc-ccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCC
Q 005898 193 TFLSMRNNKLAGPFP-SSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSF 270 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l 270 (671)
++|+|++|++++..| ..|..+++|+.|+|++|.+++..+ .+..+++|++|+|++|+++
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-------------------- 94 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-------------------- 94 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC--------------------
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccC--------------------
Confidence 344444444443322 223444444444444444444433 2444444444444444332
Q ss_pred CCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcc
Q 005898 271 SGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344 (671)
Q Consensus 271 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g 344 (671)
+..|..|..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++..|..+..+.+|+.|++++|.+++
T Consensus 95 -~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 95 -NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp -CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred -ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 2233445555555555555555555555555556666666666666665555555555666666666665554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-18 Score=169.27 Aligned_cols=132 Identities=24% Similarity=0.333 Sum_probs=57.3
Q ss_pred ccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECC
Q 005898 167 KLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLS 245 (671)
Q Consensus 167 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls 245 (671)
+|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|.++...+. +..+++|++|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 344444444444433333444444444444444444433344444444444444444444432222 2334444444444
Q ss_pred CCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCc
Q 005898 246 DNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 246 ~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
+|++++ ..|..|..+++|+.|+|++|++++.++..+..+++|+.|+|++|.+.
T Consensus 113 ~N~l~~---------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 113 ANKINC---------------------LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SSCCCC---------------------CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCE---------------------eCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 333321 22333444445555555555555555444555555555555555443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.8e-20 Score=210.91 Aligned_cols=219 Identities=20% Similarity=0.155 Sum_probs=120.1
Q ss_pred CCCCEEecccccccccCCccccCCCCCC-----EEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLE-----YLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~-----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
+.++.|+|..|.+.. +|..+.....|. .++++.|++. ..|..+..+.+|+.|+|++|.+. .+|..+.++++|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L 249 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL 249 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence 457778888888765 343332222222 2333344443 45778889999999999999988 778778889999
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG 272 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~ 272 (671)
++|+|++|.|+ .+|..|+++++|+.|+|++|.|+..++.++.|++|++|+|++|.|+
T Consensus 250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~---------------------- 306 (727)
T 4b8c_D 250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT---------------------- 306 (727)
T ss_dssp SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC----------------------
T ss_pred CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC----------------------
Confidence 99999999998 8898899999999999999999844445888888888888887664
Q ss_pred CchhhhcCCcccceeecccccccCCCccccCCCCC-cCeEecccCcCcccCCcccCCCCCccEEECcCC--------cCc
Q 005898 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPN-ISDLNLASNKFSGSLPKNLNCGGKLVFFDISNN--------KLT 343 (671)
Q Consensus 273 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N--------~l~ 343 (671)
.+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|.. |..|+++.| .++
T Consensus 307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~ 380 (727)
T 4b8c_D 307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQ 380 (727)
T ss_dssp CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------------------
T ss_pred ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCcc
Confidence 56777999999999999999999999988765432 235889999999999975 455677766 344
Q ss_pred ccCCCCCCCCCCCceeccCCCcCCC
Q 005898 344 GGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 344 g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
+..+..+.++..+....++.|.+.+
T Consensus 381 ~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 381 QSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp ---------------------CCCG
T ss_pred ccccchhhcccccceeeeecccccc
Confidence 4444444556666677788887764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=169.33 Aligned_cols=130 Identities=20% Similarity=0.246 Sum_probs=65.5
Q ss_pred cCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
+.+++|+.|++++|.+. .+| .+..+++|++|++++|.++ .++.+..+++|++|++++|.+++..|..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44555556666655554 344 4555555556665555442 2234555555555555555555544555555555555
Q ss_pred EEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCC
Q 005898 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNK 248 (671)
Q Consensus 195 L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~ 248 (671)
|++++|++++..|..+..+++|+.|++++|.+.+.+|.+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBC
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCC
Confidence 555555555444555555555555555555422223334444444444444433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.9e-18 Score=167.58 Aligned_cols=134 Identities=22% Similarity=0.257 Sum_probs=123.6
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
++|+.|+|++|.+.+..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.++...+..|..+++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 57999999999999888889999999999999999999888999999999999999999999766667899999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDS 251 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~ 251 (671)
++|++++..|..|..+++|+.|+|++|.+++..+. +..+++|+.|+|++|.+..
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99999998899999999999999999999988775 7889999999999998753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=5.2e-18 Score=167.41 Aligned_cols=134 Identities=23% Similarity=0.245 Sum_probs=121.8
Q ss_pred CCCEEecccccccccCC-ccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 119 SLRVLSLVSLGIWGSLP-DKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 119 ~L~~L~L~~n~l~g~~p-~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
.+++|+|++|.+.+..| ..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 46899999999988865 45899999999999999999888889999999999999999999888888999999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSN 252 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~ 252 (671)
++|++++..|..|..+++|+.|+|++|++++..|. +..+++|+.|+|++|.+...
T Consensus 113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99999998899999999999999999999988764 78899999999999987653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=177.06 Aligned_cols=171 Identities=22% Similarity=0.292 Sum_probs=110.2
Q ss_pred CCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
++.++..++++.|.+.+.. .+.++++|++|++++|.++ .+| .+..+++|++|+|++|.+++..| +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 3555666777777775433 4677778888888888775 345 57777777777777777775433 7777777777
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCch
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p 275 (671)
++++|++++ +|.... ++|+.|++++|.+++ ++.+..+++|+.|++++|++++ +|
T Consensus 91 ~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~~l~~l~~L~~L~Ls~N~i~~----------------------~~ 144 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKS----------------------IV 144 (263)
T ss_dssp ECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SGGGTTCTTCCEEECTTSCCCB----------------------CG
T ss_pred ECCCCccCC-cCcccc--CcccEEEccCCccCC-ChhhcCcccccEEECCCCcCCC----------------------Ch
Confidence 777777764 343222 667777777777765 3456666666666666665542 22
Q ss_pred hhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCccc
Q 005898 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321 (671)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ 321 (671)
.++.+++|+.|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 355566666666666666665 3455666666666666666543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.7e-18 Score=164.65 Aligned_cols=154 Identities=19% Similarity=0.305 Sum_probs=112.0
Q ss_pred cccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCC
Q 005898 137 KIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216 (671)
Q Consensus 137 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L 216 (671)
..+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467788899999999886 566 6888888888888888554 34577888888888888888887777778888888
Q ss_pred CEEEeccCccccccC-CCCCCCCCCEEECCCCC-CCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccc
Q 005898 217 SDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNK-LDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNAL 294 (671)
Q Consensus 217 ~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 294 (671)
+.|++++|.+++..| .+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|.+
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~----------------------~~~-~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT----------------------DIM-PLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC----------------------CCG-GGGGCSSCCEEECTTBCC
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc----------------------ccH-hhcCCCCCCEEECCCCCC
Confidence 888888888876444 36777777777777775 32 233 466677777777777777
Q ss_pred cCCCccccCCCCCcCeEecccCcCc
Q 005898 295 RGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 295 ~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
++.+ .+..+++|+.|++++|++.
T Consensus 172 ~~~~--~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 172 HDYR--GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCT--TGGGCSSCCEEEECBC---
T ss_pred cChH--HhccCCCCCEEEeeCcccC
Confidence 7654 4666777777777777664
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.8e-18 Score=172.42 Aligned_cols=171 Identities=18% Similarity=0.268 Sum_probs=128.7
Q ss_pred CCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEE
Q 005898 140 RLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDL 219 (671)
Q Consensus 140 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L 219 (671)
++.++..++++.|.+++ ++ .+..+++|++|++++|.++ .+| .+..+++|++|++++|++++. |. +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEE
Confidence 45667777888888764 33 5677788888888888777 345 577778888888888887754 33 7777788888
Q ss_pred EeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCc
Q 005898 220 DLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP 299 (671)
Q Consensus 220 ~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 299 (671)
+|++|++++ +|.+.. ++|+.|++++|+++ + +| .++.+++|+.|++++|++++.+
T Consensus 91 ~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~---------------------~-~~-~l~~l~~L~~L~Ls~N~i~~~~- 144 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIPS-ACLSRLFLDNNELR---------------------D-TD-SLIHLKNLEILSIRNNKLKSIV- 144 (263)
T ss_dssp ECCSSCCSC-CTTCCC-SSCCEEECCSSCCS---------------------B-SG-GGTTCTTCCEEECTTSCCCBCG-
T ss_pred ECCCCccCC-cCcccc-CcccEEEccCCccC---------------------C-Ch-hhcCcccccEEECCCCcCCCCh-
Confidence 888887775 333333 66666666666554 2 23 5788899999999999999874
Q ss_pred cccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCccc
Q 005898 300 PAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGG 345 (671)
Q Consensus 300 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~ 345 (671)
.+..+++|+.|+|++|++++. ..+..+++|+.|++++|.+++.
T Consensus 145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 588899999999999999876 6678888999999999998855
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-19 Score=205.94 Aligned_cols=117 Identities=15% Similarity=0.106 Sum_probs=67.7
Q ss_pred CCCcccCCCCCcCEEEcccccCCCCCc-ccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCC-----------C
Q 005898 181 TIPNWFDSLPSLTFLSMRNNKLAGPFP-SSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSD-----------N 247 (671)
Q Consensus 181 ~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~-----------N 247 (671)
.+|..+..+++|++|++++|.+++..+ ..+..+++|+.|+++++...+.++. ...+++|+.|++++ |
T Consensus 284 ~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~ 363 (592)
T 3ogk_B 284 EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEG 363 (592)
T ss_dssp TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTC
T ss_pred HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccC
Confidence 456667778889999999988765433 3357788888888873322223333 24566777777773 4
Q ss_pred CCCCC-CCC---CCCCccEEEcCCCCCCCCchhhhcC-Ccccceeecc----cccccCC
Q 005898 248 KLDSN-LPK---LPRGLVMAFLSNNSFSGEIPKQYGQ-LNQLQQLDMS----FNALRGM 297 (671)
Q Consensus 248 ~l~~~-~p~---~~~~L~~l~l~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~ 297 (671)
.++.. ++. ...+|+.++++.|.+++..+..++. +++|+.|+++ .|.+++.
T Consensus 364 ~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~ 422 (592)
T 3ogk_B 364 LVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL 422 (592)
T ss_dssp CCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC
T ss_pred ccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc
Confidence 44321 111 1245556666556665555555543 5556666664 4455543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.5e-19 Score=198.00 Aligned_cols=166 Identities=17% Similarity=0.224 Sum_probs=94.0
Q ss_pred CcchhcccCCCCCCEEeccccc-------------ccccCCccccCCCCCCEEE-cccCcCCCCCCc------cCCC--C
Q 005898 108 DSFVTTLARLTSLRVLSLVSLG-------------IWGSLPDKIHRLYSLEYLD-LSSNFLFGSVPP------KIST--M 165 (671)
Q Consensus 108 ~~~~~~l~~l~~L~~L~L~~n~-------------l~g~~p~~~~~L~~L~~L~-Ls~N~l~~~~p~------~~~~--l 165 (671)
..+|.++++|++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.. ++. .+.. .
T Consensus 362 ~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~-L~~l~l~~n~i~~l~~ 440 (567)
T 1dce_A 362 TVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD-LRSKFLLENSVLKMEY 440 (567)
T ss_dssp HHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH-HHHHHHHHHHHHHHHH
T ss_pred HhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch-hhhhhhhcccccccCc
Confidence 4789999999999999997775 5677888889999999998 66664320 000 0000 0
Q ss_pred CccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECC
Q 005898 166 VKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLS 245 (671)
Q Consensus 166 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls 245 (671)
..|+.|+|++|.+++ +|. ++++++|+.|+|++|+++ .+|..++.+++|+.|+|++|.+++ +|.++.+++|+.|+|+
T Consensus 441 ~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 441 ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLC 516 (567)
T ss_dssp TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECC
T ss_pred cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECC
Confidence 124555555555553 343 555555555555555555 445555555555555555555554 3344445555444444
Q ss_pred CCCCCCCCCCCCCCccEEEcCCCCCCCCc-hhhhcCCcccceeecccccccCCCc
Q 005898 246 DNKLDSNLPKLPRGLVMAFLSNNSFSGEI-PKQYGQLNQLQQLDMSFNALRGMPP 299 (671)
Q Consensus 246 ~N~l~~~~p~~~~~L~~l~l~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~ 299 (671)
+|+++ +.. |..++.+++|+.|+|++|.+++.+|
T Consensus 517 ~N~l~---------------------~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQ---------------------QSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCC---------------------SSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCC---------------------CCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 44332 222 4455555555555555555555544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=9.8e-17 Score=154.69 Aligned_cols=129 Identities=25% Similarity=0.300 Sum_probs=109.1
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCc-cCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPP-KISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (671)
+.+++++|++ +.+|..+.. +|++|+|++|++++..|. .|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 6788888888 567776654 889999999999766654 488899999999999999988888999999999999999
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCC
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSN 252 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~ 252 (671)
|++++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 999988888888999999999999999988775 77888899998888887653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.6e-19 Score=204.99 Aligned_cols=254 Identities=15% Similarity=0.098 Sum_probs=173.4
Q ss_pred cccCCCCCCEEeccccccccc----CCccccCCCCCCEEEcccCcCC----CCCCccCCCCCccCEEEccCCcCCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGS----LPDKIHRLYSLEYLDLSSNFLF----GSVPPKISTMVKLQTLILDDNFFNNTIPN 184 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~----~p~~~~~L~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 184 (671)
...++++|++|+|++|.+.+. ++..+.++++|++|+|++|.++ +.++..+.++++|++|+|++|.+.+ +|.
T Consensus 159 ~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~ 237 (592)
T 3ogk_B 159 IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVG 237 (592)
T ss_dssp HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHH
T ss_pred HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHH
Confidence 344677888888888877655 4445566777777788777775 2334445567777777777776654 344
Q ss_pred ccCCCC---------------------------CcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC-C-CCC
Q 005898 185 WFDSLP---------------------------SLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-D-LSS 235 (671)
Q Consensus 185 ~~~~l~---------------------------~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~-~~~ 235 (671)
.+.+++ +|+.|+++++. .+.+|..+..+++|++|+|++|.+++... . +..
T Consensus 238 ~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~ 316 (592)
T 3ogk_B 238 FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQK 316 (592)
T ss_dssp HHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTT
T ss_pred HHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHh
Confidence 444444 44444444432 34567778889999999999999765443 2 578
Q ss_pred CCCCCEEECCCCCCCCCCCCC---CCCccEEEcC-----------CCCCCCC-chhhhcCCcccceeecccccccCCCcc
Q 005898 236 LGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLS-----------NNSFSGE-IPKQYGQLNQLQQLDMSFNALRGMPPP 300 (671)
Q Consensus 236 l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~-----------~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 300 (671)
+++|+.|+++++...+.++.+ .++|+.++++ .|.+++. ++.....+++|++|+++.|++++..+.
T Consensus 317 ~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~ 396 (592)
T 3ogk_B 317 CPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396 (592)
T ss_dssp CTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHH
T ss_pred CcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHH
Confidence 999999999843222222222 3579999999 3677654 344456689999999999999987777
Q ss_pred ccCC-CCCcCeEecc----cCcCccc-----CCcccCCCCCccEEECcCC--cCcccCCCCCC-CCCCCceeccCCCcCC
Q 005898 301 AIFS-LPNISDLNLA----SNKFSGS-----LPKNLNCGGKLVFFDISNN--KLTGGLPSCLS-NESDKRVVKFRGNCLS 367 (671)
Q Consensus 301 ~~~~-l~~L~~L~L~----~N~l~g~-----~p~~~~~~~~L~~l~ls~N--~l~g~~p~~~~-~~~~l~~l~l~~N~l~ 367 (671)
.+.. +++|+.|+++ .|.+++. ++..+..+++|+.|+++++ .+++..+..+. .+++++.|++++|.++
T Consensus 397 ~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~ 476 (592)
T 3ogk_B 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES 476 (592)
T ss_dssp HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSS
T ss_pred HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCC
Confidence 7765 8999999996 6778763 3344556788888888743 36654444333 2567888888888766
Q ss_pred C
Q 005898 368 S 368 (671)
Q Consensus 368 ~ 368 (671)
+
T Consensus 477 ~ 477 (592)
T 3ogk_B 477 D 477 (592)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=7e-17 Score=151.97 Aligned_cols=135 Identities=22% Similarity=0.260 Sum_probs=121.2
Q ss_pred cCCCCCCEEeccccccc-ccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcC
Q 005898 115 ARLTSLRVLSLVSLGIW-GSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLT 193 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~-g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 193 (671)
...++|+.|+|++|.+. +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+.++++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34578999999999998 78999999999999999999999865 7899999999999999999988899888999999
Q ss_pred EEEcccccCCCCC-cccccCCCCCCEEEeccCccccccC----CCCCCCCCCEEECCCCCCCC
Q 005898 194 FLSMRNNKLAGPF-PSSIQRISTLSDLDLSKNAISGSLP----DLSSLGSLNVLNLSDNKLDS 251 (671)
Q Consensus 194 ~L~L~~N~l~g~~-p~~l~~l~~L~~L~Ls~N~l~g~~p----~~~~l~~L~~L~Ls~N~l~~ 251 (671)
+|++++|++++.. +..+..+++|+.|++++|.+++..+ .+..+++|++|++++|.+..
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 9999999998632 2789999999999999999998777 58899999999999998754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=5.1e-17 Score=149.70 Aligned_cols=129 Identities=22% Similarity=0.247 Sum_probs=116.0
Q ss_pred CCCCCCEEeccccccc-ccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 116 RLTSLRVLSLVSLGIW-GSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~-g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
..++|+.|++++|.+. +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 88999999999999999999999865 78999999999999999999888998889999999
Q ss_pred EEcccccCCCC-CcccccCCCCCCEEEeccCccccccC----CCCCCCCCCEEECCC
Q 005898 195 LSMRNNKLAGP-FPSSIQRISTLSDLDLSKNAISGSLP----DLSSLGSLNVLNLSD 246 (671)
Q Consensus 195 L~L~~N~l~g~-~p~~l~~l~~L~~L~Ls~N~l~g~~p----~~~~l~~L~~L~Ls~ 246 (671)
|++++|++++. .|..+..+++|+.|++++|.+++..+ .+..+++|+.|++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999999863 45889999999999999999998776 378899999998864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=3.9e-17 Score=157.53 Aligned_cols=113 Identities=24% Similarity=0.286 Sum_probs=106.6
Q ss_pred CCCEEecccccccccCCc-cccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 119 SLRVLSLVSLGIWGSLPD-KIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 119 ~L~~L~L~~n~l~g~~p~-~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
+|++|+|++|.+.+..|. .|+++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 799999999999877765 4999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP 231 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p 231 (671)
++|++++..|..+..+++|+.|+|++|.+++..+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 9999999999999999999999999999987654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.7e-16 Score=147.95 Aligned_cols=136 Identities=21% Similarity=0.217 Sum_probs=101.9
Q ss_pred CCCCCCEEEcccCcCC-CCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCE
Q 005898 140 RLYSLEYLDLSSNFLF-GSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218 (671)
Q Consensus 140 ~L~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~ 218 (671)
..++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|++++|++++.+|..+..+++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 3478999999999997 78888888999999999999998865 77888999999999999998778888888888888
Q ss_pred EEeccCcccccc--CCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCch---hhhcCCcccceeeccccc
Q 005898 219 LDLSKNAISGSL--PDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIP---KQYGQLNQLQQLDMSFNA 293 (671)
Q Consensus 219 L~Ls~N~l~g~~--p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~ 293 (671)
|++++|.+++.. +.+..+++|+.|++++|.+++ ..+ ..+..+++|++|+++.|.
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~---------------------~~~~~~~~~~~l~~L~~L~l~~n~ 158 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN---------------------LNDYRESVFKLLPQLTYLDGYDRE 158 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT---------------------STTHHHHHHTTCSSCCEETTEETT
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc---------------------hHHHHHHHHHhCccCcEecCCCCC
Confidence 888888887643 346666666666666665542 111 255566666666666666
Q ss_pred ccCCC
Q 005898 294 LRGMP 298 (671)
Q Consensus 294 l~~~~ 298 (671)
+...+
T Consensus 159 ~~~~~ 163 (168)
T 2ell_A 159 DQEAP 163 (168)
T ss_dssp SCBCC
T ss_pred hhhcc
Confidence 55443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.3e-16 Score=141.53 Aligned_cols=132 Identities=20% Similarity=0.166 Sum_probs=113.1
Q ss_pred CCCCCCEEEcccCcCC-CCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCE
Q 005898 140 RLYSLEYLDLSSNFLF-GSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218 (671)
Q Consensus 140 ~L~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~ 218 (671)
..++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..++.+++|++|++++|++++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3478999999999998 78999999999999999999999976 78899999999999999999889999999999999
Q ss_pred EEeccCcccccc--CCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeeccc
Q 005898 219 LDLSKNAISGSL--PDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSF 291 (671)
Q Consensus 219 L~Ls~N~l~g~~--p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 291 (671)
|++++|.+++.. +.+..+++|++|++++|++++..+ ..+..++.+++|+.||+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~------------------~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND------------------YRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT------------------HHHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH------------------HHHHHHHHCCCcccccCCC
Confidence 999999999853 568899999999999887764211 0114678888899888863
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.9e-15 Score=141.31 Aligned_cols=130 Identities=26% Similarity=0.288 Sum_probs=101.0
Q ss_pred CCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccc
Q 005898 120 LRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199 (671)
Q Consensus 120 L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (671)
.+.+++++|++. .+|..+ .++|++|++++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467778787774 455433 36788888888888876666778888888888888888876666778888888888888
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCC
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSN 252 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~ 252 (671)
|++++..+..+..+++|+.|++++|.+++.++. +..+++|++|++++|.+++.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 888876666778888888888888888876665 46788888888888877653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.4e-15 Score=143.18 Aligned_cols=126 Identities=25% Similarity=0.284 Sum_probs=98.9
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
+++++++|++. .+|..+. ++|++|+|++|+++ .+|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46777777774 5665543 57888888888886 67778888888888888888888777777888888888888888
Q ss_pred cCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCC
Q 005898 201 KLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 201 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~ 250 (671)
++++..|..|..+++|+.|+|++|.+++..+. +..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 88877777788888888888888888866664 677888888888888765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.3e-15 Score=160.64 Aligned_cols=147 Identities=12% Similarity=0.126 Sum_probs=98.5
Q ss_pred CCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch--------------hhHHHHHHHHHHHhcCCCCCcccccceee
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK--------------YTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 549 (671)
-|+....||+|+||.||+|+.++|+.||||+++.... ........++++.+...|+|+++++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3778899999999999999988999999998743210 01122233333333333444444432211
Q ss_pred cCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCC
Q 005898 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH 629 (671)
Q Consensus 550 ~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~ 629 (671)
... . .+.....+|||||+++++|...... .....++.|++.++.|+|+. +||||||||.|||++++
T Consensus 176 ~vp-~-p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVP-E-PIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp SCC-C-EEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCC-e-eeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 100 0 0001123799999999888665431 12346788999999999987 79999999999999887
Q ss_pred C----------cEEEcccCCccccc
Q 005898 630 R----------IAKLSDYGLSIVSE 644 (671)
Q Consensus 630 ~----------~~ki~DfGla~~~~ 644 (671)
+ .+.|.||+-+...+
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCcccccccccceEEEEeCCcccCC
Confidence 6 38999999876543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.4e-14 Score=139.69 Aligned_cols=128 Identities=18% Similarity=0.285 Sum_probs=108.4
Q ss_pred CEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCc
Q 005898 240 NVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 240 ~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
+.+++++|.++.....++.+++.|++++|+++ .+|..|..+++|+.|+|++|++++.++..|..+++|+.|+|++|+++
T Consensus 13 ~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~ 91 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91 (193)
T ss_dssp TEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccC
Confidence 45666666665443345566777777777776 67889999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 320 GSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 320 g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
+..|..+..+++|+.|+|++|++++..+..+..+++++.+++++|.+.+
T Consensus 92 ~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 92 CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9888899999999999999999997666678889999999999998875
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.5e-14 Score=135.71 Aligned_cols=130 Identities=16% Similarity=0.169 Sum_probs=99.3
Q ss_pred CEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCc
Q 005898 240 NVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 240 ~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
+.+++++|+++......+.+++.+++++|++++..+..|+.+++|++|++++|++++.++..+..+++|+.|+|++|+++
T Consensus 10 ~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 89 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89 (177)
T ss_dssp TEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCcc
Confidence 44555555555443344455666666666666666667788888999999999998888877888899999999999998
Q ss_pred ccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCCC
Q 005898 320 GSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSN 369 (671)
Q Consensus 320 g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~~ 369 (671)
+..+..+..+++|+.|++++|++++..+..+..+++++.+++++|.+.+.
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 77777778888899999999998865555567788888999998887753
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.1e-15 Score=141.88 Aligned_cols=132 Identities=20% Similarity=0.252 Sum_probs=112.6
Q ss_pred cccCCCCCCEEecccccccccCCccccCCC-CCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCC
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLY-SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPS 191 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 191 (671)
.+.++.+|+.|+|++|.+.. +|. +..+. +|++|+|++|.+++. +.+..+++|++|+|++|.+++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 56788999999999999974 565 55554 999999999999865 68999999999999999999765566699999
Q ss_pred cCEEEcccccCCCCCcc--cccCCCCCCEEEeccCccccccCC----CCCCCCCCEEECCCCCC
Q 005898 192 LTFLSMRNNKLAGPFPS--SIQRISTLSDLDLSKNAISGSLPD----LSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 192 L~~L~L~~N~l~g~~p~--~l~~l~~L~~L~Ls~N~l~g~~p~----~~~l~~L~~L~Ls~N~l 249 (671)
|++|++++|+++ .+|. .+..+++|+.|++++|.++...+. +..+++|+.||+++|..
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 999999999996 5776 889999999999999999855443 77899999999998865
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.3e-17 Score=159.91 Aligned_cols=133 Identities=25% Similarity=0.294 Sum_probs=91.6
Q ss_pred cccCCCCCCEEecccccccccCCc------cccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCccc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPD------KIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWF 186 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~------~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 186 (671)
.+.....++.++++.+.+.|.+|. .+.++++|++|+|++|.+++ +| .+.++++|+.|+|++|.++ .+|..+
T Consensus 13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence 356667778888888888887776 77778888888888887765 56 6777777777777777776 566666
Q ss_pred CCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC--CCCCCCCCCEEECCCCCCC
Q 005898 187 DSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP--DLSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 187 ~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~Ls~N~l~ 250 (671)
..+++|++|++++|++++ +| .+..+++|+.|++++|.+++..+ .+..+++|++|++++|.++
T Consensus 90 ~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 90 AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 666777777777777764 44 46666777777777776664322 3455555555555555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=4.4e-17 Score=157.91 Aligned_cols=154 Identities=25% Similarity=0.319 Sum_probs=92.3
Q ss_pred ccCCCCCCEEEcccCcCCCCCCc------cCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCccccc
Q 005898 138 IHRLYSLEYLDLSSNFLFGSVPP------KISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQ 211 (671)
Q Consensus 138 ~~~L~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~ 211 (671)
+.....++.++++.|.++|.+|. .+..+++|++|+|++|.+++ +| .+.++++|++|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34445566666666666666555 56666666666666666665 45 5666666666666666666 4566666
Q ss_pred CCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCch--hhhcCCcccceeec
Q 005898 212 RISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIP--KQYGQLNQLQQLDM 289 (671)
Q Consensus 212 ~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p--~~~~~l~~L~~L~L 289 (671)
.+++|+.|++++|.+++ +|.+..+++|++|++++|++++ +| ..+..+++|++|++
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N~i~~----------------------~~~~~~l~~l~~L~~L~l 147 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKITN----------------------WGEIDKLAALDKLEDLLL 147 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEEECCC----------------------HHHHHHHTTTTTCSEEEE
T ss_pred cCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCCcCCc----------------------hhHHHHHhcCCCCCEEEe
Confidence 66666666666666665 3455556666666666655431 12 34556666666666
Q ss_pred ccccccCCCccc----------cCCCCCcCeEecccCcCc
Q 005898 290 SFNALRGMPPPA----------IFSLPNISDLNLASNKFS 319 (671)
Q Consensus 290 s~N~l~~~~~~~----------~~~l~~L~~L~L~~N~l~ 319 (671)
++|.+++.+|.. +..+++|+.|| +|.++
T Consensus 148 ~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp CSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred cCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 666666654432 55566666665 44443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.52 E-value=4.9e-15 Score=155.32 Aligned_cols=101 Identities=13% Similarity=0.110 Sum_probs=61.7
Q ss_pred CCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcC-eEecccCcCcccCCcccCCCCCccEEE
Q 005898 258 RGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNIS-DLNLASNKFSGSLPKNLNCGGKLVFFD 336 (671)
Q Consensus 258 ~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~g~~p~~~~~~~~L~~l~ 336 (671)
.+|+.+++++|+++...+..|..+++|+.|+|++| ++.+.+..|.++++|+ .+++.+ .++..-+..|..+.+|+.++
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~ 303 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL 303 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence 35556666666665444455666666666666666 6666666666666666 666666 55544455666666666666
Q ss_pred CcCCcCcccCCCCCCCCCCCceec
Q 005898 337 ISNNKLTGGLPSCLSNESDKRVVK 360 (671)
Q Consensus 337 ls~N~l~g~~p~~~~~~~~l~~l~ 360 (671)
+++|+++..-+..+.++++|+.+.
T Consensus 304 l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 304 ATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred eCCCccCccchhhhcCCcchhhhc
Confidence 666666655555566666665543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-14 Score=137.12 Aligned_cols=109 Identities=21% Similarity=0.203 Sum_probs=71.4
Q ss_pred cccCCCCCCEEEcccCcCCCCCCccCCCCC-ccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCC
Q 005898 137 KIHRLYSLEYLDLSSNFLFGSVPPKISTMV-KLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215 (671)
Q Consensus 137 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~ 215 (671)
.+.++.+|++|+|++|+++. +|. +..+. +|+.|+|++|.+++. ..++.+++|++|++++|++++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 46677888888888888863 444 44444 778888888877754 56777777777777777777543344466777
Q ss_pred CCEEEeccCccccccC--CCCCCCCCCEEECCCCCC
Q 005898 216 LSDLDLSKNAISGSLP--DLSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 216 L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~Ls~N~l 249 (671)
|+.|++++|.++...+ .+..+++|+.|++++|.+
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i 125 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCC
Confidence 7777777777654332 355555666666655554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.50 E-value=4.8e-16 Score=176.23 Aligned_cols=107 Identities=8% Similarity=0.054 Sum_probs=48.6
Q ss_pred CccEEEcCCCCCCCCchhhhc-CCcccceeecc--c----ccccCCCc-----cccCCCCCcCeEecccCcCcccCCccc
Q 005898 259 GLVMAFLSNNSFSGEIPKQYG-QLNQLQQLDMS--F----NALRGMPP-----PAIFSLPNISDLNLASNKFSGSLPKNL 326 (671)
Q Consensus 259 ~L~~l~l~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~~-----~~~~~l~~L~~L~L~~N~l~g~~p~~~ 326 (671)
+|+.+.++.|.+++..+..+. .+++|+.|+++ + |.++..+. ..+..+++|+.|+|++ .+++..+..+
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l 451 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYI 451 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHH
Confidence 344444444444443333332 34555555555 2 33332221 1133445555555544 3443333333
Q ss_pred CC-CCCccEEECcCCcCcccCCCCC-CCCCCCceeccCCCcC
Q 005898 327 NC-GGKLVFFDISNNKLTGGLPSCL-SNESDKRVVKFRGNCL 366 (671)
Q Consensus 327 ~~-~~~L~~l~ls~N~l~g~~p~~~-~~~~~l~~l~l~~N~l 366 (671)
.. +++|+.|++++|.+++..+..+ ..+++|+.|++++|.+
T Consensus 452 ~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 22 4556666666666544333222 3345566666666554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-13 Score=129.36 Aligned_cols=104 Identities=22% Similarity=0.257 Sum_probs=48.7
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
+.|++++|.+.. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 445555555532 443332 44555555555555444444555555555555555554443344444444444444444
Q ss_pred cCCCCCcccccCCCCCCEEEeccCccc
Q 005898 201 KLAGPFPSSIQRISTLSDLDLSKNAIS 227 (671)
Q Consensus 201 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 227 (671)
+|++..|..|..+++|+.|+|++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 444333333444444444444444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=144.62 Aligned_cols=218 Identities=12% Similarity=0.084 Sum_probs=139.6
Q ss_pred CCCCCEEeccccccc--cc-----------------C-CccccC--------CCCCCEEEcccCcCCCCCCccCCCCCcc
Q 005898 117 LTSLRVLSLVSLGIW--GS-----------------L-PDKIHR--------LYSLEYLDLSSNFLFGSVPPKISTMVKL 168 (671)
Q Consensus 117 l~~L~~L~L~~n~l~--g~-----------------~-p~~~~~--------L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 168 (671)
+++|++|||++|.+. .. + +..|.+ +++|+.|+|+. .++..-+..|.++++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 888999999999987 11 1 223455 67777777766 5655455566777777
Q ss_pred CEEEccCCcCCCCCCcccCCCCCcCEEEcccccC----CCCCcccccCCCCCC-EEEe----------------------
Q 005898 169 QTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQRISTLS-DLDL---------------------- 221 (671)
Q Consensus 169 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~g~~p~~l~~l~~L~-~L~L---------------------- 221 (671)
+.|++++|.+....+..|..+.++..+.+..+.. ...-+..|..+..|+ .+.+
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 7777777766655555666666666555544211 111111222222332 1111
Q ss_pred ---ccCccccccCCC-CCCCCCCEEECCCCCCCCCCCCC---CCCccEEEcCCCCCCCCchhhhcCCcccc-eeeccccc
Q 005898 222 ---SKNAISGSLPDL-SSLGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLSNNSFSGEIPKQYGQLNQLQ-QLDMSFNA 293 (671)
Q Consensus 222 ---s~N~l~g~~p~~-~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~ 293 (671)
.++-.......+ ..+++|+.++|++|+++...+.. ..+|+.+++.+| ++..-+..|..+++|+ .+++.+ .
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 111000000000 12567778888777766443333 346777777777 6655567899999999 999998 8
Q ss_pred ccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEEC
Q 005898 294 LRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDI 337 (671)
Q Consensus 294 l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~l 337 (671)
++.+.+..|.++++|+.+++++|+++..-+..|..+.+|+.++.
T Consensus 285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 88888899999999999999999999777778999999998864
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=3.2e-13 Score=127.80 Aligned_cols=104 Identities=22% Similarity=0.301 Sum_probs=55.7
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
+.+++++|.+ +.+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3555555555 34554443 55666666666665555555555555555555555555443444455555555555555
Q ss_pred cCCCCCcccccCCCCCCEEEeccCccc
Q 005898 201 KLAGPFPSSIQRISTLSDLDLSKNAIS 227 (671)
Q Consensus 201 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 227 (671)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555433333555555555555555544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.44 E-value=8.2e-16 Score=174.30 Aligned_cols=246 Identities=16% Similarity=0.120 Sum_probs=130.0
Q ss_pred cCCCCCCEEecccccccccCCcccc-CCCCCCEEEcccC-cCCCC-CCccCCCCCccCEEEccCCcCCCCCCcccC----
Q 005898 115 ARLTSLRVLSLVSLGIWGSLPDKIH-RLYSLEYLDLSSN-FLFGS-VPPKISTMVKLQTLILDDNFFNNTIPNWFD---- 187 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~g~~p~~~~-~L~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---- 187 (671)
.++++|++|+|++|.+.+..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.++.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3455666666666655554444443 4556666666655 33221 233333555666666666655543333322
Q ss_pred CCCCcCEEEccccc--CCC-CCcccccCCCCCCEEEeccC-ccccccCC-CCCCCCCCEEECCCCC--------------
Q 005898 188 SLPSLTFLSMRNNK--LAG-PFPSSIQRISTLSDLDLSKN-AISGSLPD-LSSLGSLNVLNLSDNK-------------- 248 (671)
Q Consensus 188 ~l~~L~~L~L~~N~--l~g-~~p~~l~~l~~L~~L~Ls~N-~l~g~~p~-~~~l~~L~~L~Ls~N~-------------- 248 (671)
.+++|++|++++|. ++. .++..+.++++|+.|++++| .+.+ +|. +..+++|+.|+++.+.
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~ 260 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHH
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHH
Confidence 44456666666554 110 01111233456666666555 2332 221 3344445555443321
Q ss_pred ------------C----CCCCCCC---CCCccEEEcCCCCCCCCc-hhhhcCCcccceeecccccccC-CCccccCCCCC
Q 005898 249 ------------L----DSNLPKL---PRGLVMAFLSNNSFSGEI-PKQYGQLNQLQQLDMSFNALRG-MPPPAIFSLPN 307 (671)
Q Consensus 249 ------------l----~~~~p~~---~~~L~~l~l~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~ 307 (671)
+ .+.+|.+ ..+|+.|++++|.+++.. +..+..+++|+.|++++| ++. .++.....+++
T Consensus 261 l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~ 339 (594)
T 2p1m_B 261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD 339 (594)
T ss_dssp HHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT
T ss_pred HhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC
Confidence 0 1112222 357888888888876543 333567888888888887 332 22222335788
Q ss_pred cCeEecc---------cCcCcccCCcccC-CCCCccEEECcCCcCcccCCCCCC-CCCCCceeccC
Q 005898 308 ISDLNLA---------SNKFSGSLPKNLN-CGGKLVFFDISNNKLTGGLPSCLS-NESDKRVVKFR 362 (671)
Q Consensus 308 L~~L~L~---------~N~l~g~~p~~~~-~~~~L~~l~ls~N~l~g~~p~~~~-~~~~l~~l~l~ 362 (671)
|+.|+++ .|.+++.....+. .+++|+.|+++.|.+++..+..+. .+++++.++++
T Consensus 340 L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp CCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred CCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence 8888883 3455543222222 367788888888888765444443 35677888877
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=4.5e-13 Score=126.18 Aligned_cols=107 Identities=21% Similarity=0.264 Sum_probs=70.6
Q ss_pred CCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcC
Q 005898 239 LNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318 (671)
Q Consensus 239 L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 318 (671)
.+.+++++|.++.....++..++.|+|++|++++..|..|..+++|++|+|++|+|++.++..|..+++|+.|+|++|++
T Consensus 11 ~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp TTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 34566666665543333445555566666666666666777777777777777777777776667777777777777777
Q ss_pred cccCCcccCCCCCccEEECcCCcCccc
Q 005898 319 SGSLPKNLNCGGKLVFFDISNNKLTGG 345 (671)
Q Consensus 319 ~g~~p~~~~~~~~L~~l~ls~N~l~g~ 345 (671)
++..|..+..+.+|+.|+|++|.+++.
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 765555666677777777777766643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=123.58 Aligned_cols=104 Identities=22% Similarity=0.289 Sum_probs=58.5
Q ss_pred CEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCc
Q 005898 240 NVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 240 ~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
+.+++++|+++...+.++..++.|+|++|++++..|..|+.+++|++|+|++|+|++.++..+..+++|+.|+|++|+++
T Consensus 15 ~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~ 94 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK 94 (174)
T ss_dssp SEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccc
Confidence 45555555554322223344445555555555555556666666666666666666666555556666666666666666
Q ss_pred ccCCcccCCCCCccEEECcCCcCc
Q 005898 320 GSLPKNLNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 320 g~~p~~~~~~~~L~~l~ls~N~l~ 343 (671)
+..+..+..+++|+.|+|++|.+.
T Consensus 95 ~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 95 SIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCTTTTTTCTTCSEEECCSSCBC
T ss_pred eeCHHHhccccCCCEEEeCCCCcc
Confidence 444444555556666666666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=7.5e-12 Score=131.87 Aligned_cols=78 Identities=17% Similarity=0.134 Sum_probs=36.8
Q ss_pred ecccc-cccccCCccccCCCCCCEEEccc-CcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccccc
Q 005898 124 SLVSL-GIWGSLPDKIHRLYSLEYLDLSS-NFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNK 201 (671)
Q Consensus 124 ~L~~n-~l~g~~p~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 201 (671)
+++++ ++.+ +|. |..+++|++|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|++|+|++|+
T Consensus 14 ~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 44444 3432 444 55555555555543 44444444444444444444444444444444444444444444444444
Q ss_pred CC
Q 005898 202 LA 203 (671)
Q Consensus 202 l~ 203 (671)
|+
T Consensus 92 l~ 93 (347)
T 2ifg_A 92 LE 93 (347)
T ss_dssp CS
T ss_pred cc
Confidence 44
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.6e-10 Score=124.12 Aligned_cols=238 Identities=12% Similarity=0.126 Sum_probs=138.8
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
..++.+.+.+ ++...-+..|.+. +|+.++|..| ++..-...|.+ .+|+.+.+.. .+...-+..|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4555555543 2333334445553 5666666554 44334445555 3566666664 444444456666666666666
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCCC--CCCccEEEcCCCCCCCCc
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPKL--PRGLVMAFLSNNSFSGEI 274 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~L~~l~l~~N~l~~~~ 274 (671)
++|+++ .+|......++|+.+.|..| ++.... .|.++++|+.+++.+| ++..-... ..+|+.+.+. +.++..-
T Consensus 188 ~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~~i~lp-~~i~~I~ 263 (401)
T 4fdw_A 188 SKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRESGITTVKLP-NGVTNIA 263 (401)
T ss_dssp TTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTTCCCSEEEEE-TTCCEEC
T ss_pred CCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccccccccCCccEEEeC-CCccEEC
Confidence 666666 33333223566666666633 332222 2566666666666654 21111111 1356666663 3344444
Q ss_pred hhhhcCCcccceeeccccccc-----CCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCC
Q 005898 275 PKQYGQLNQLQQLDMSFNALR-----GMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSC 349 (671)
Q Consensus 275 p~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~ 349 (671)
+..|..+++|+.+++.+|.+. .+.+..|.++++|+.++|. |.++..-...|..+.+|+.+++.+| ++-.-+..
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~a 341 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSA 341 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTS
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHh
Confidence 567778888888888777765 4566677788888888887 4466444556777788888888554 55444556
Q ss_pred CCCCCCCceeccCCCcCC
Q 005898 350 LSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 350 ~~~~~~l~~l~l~~N~l~ 367 (671)
+.++ +|+.+.+.+|...
T Consensus 342 F~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 342 FNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp SSSS-CCCEEEECCSSCC
T ss_pred CCCC-CCCEEEEcCCCCc
Confidence 7777 7888888777544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=1.6e-11 Score=129.41 Aligned_cols=105 Identities=23% Similarity=0.158 Sum_probs=91.9
Q ss_pred CEEEcccC-cCCCCCCccCCCCCccCEEEccC-CcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEec
Q 005898 145 EYLDLSSN-FLFGSVPPKISTMVKLQTLILDD-NFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 145 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 222 (671)
..++++++ +|+ .+|. |..+++|++|+|++ |.|++..|..|++|++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45789988 887 4888 99999999999996 99998888899999999999999999999889999999999999999
Q ss_pred cCccccccCCCCCCCCCCEEECCCCCCCC
Q 005898 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDS 251 (671)
Q Consensus 223 ~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~ 251 (671)
+|+|++.++.......|+.|+|++|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccC
Confidence 99999877764433349999999998764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.21 E-value=4.9e-10 Score=120.28 Aligned_cols=229 Identities=9% Similarity=0.041 Sum_probs=172.8
Q ss_pred hcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCC
Q 005898 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPS 191 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 191 (671)
.+|.++ +|+.+.|..+ +...-+..|.+. +|+.++|.. .+...-+..|.++.+|+.++|+.|.++..-...|. ..+
T Consensus 130 ~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~ 204 (401)
T 4fdw_A 130 DAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG 204 (401)
T ss_dssp TTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred hhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence 356675 7999999776 655555678774 799999985 67666678899999999999999999855455565 689
Q ss_pred cCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC-CCCCCCCCCEEECCCCCCCCCCCC---CCCCccEEEcCC
Q 005898 192 LTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP-DLSSLGSLNVLNLSDNKLDSNLPK---LPRGLVMAFLSN 267 (671)
Q Consensus 192 L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~L~~l~l~~ 267 (671)
|+.+.+.++ ++..-...|..+++|+.+++..| ++..-. .|.+ ++|+.+.+.+ .++..-+. -..+|+.+.+.+
T Consensus 205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~-~i~~I~~~aF~~c~~L~~l~l~~ 280 (401)
T 4fdw_A 205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLPN-GVTNIASRAFYYCPELAEVTTYG 280 (401)
T ss_dssp CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEET-TCCEECTTTTTTCTTCCEEEEES
T ss_pred cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeCC-CccEEChhHhhCCCCCCEEEeCC
Confidence 999999855 66455567899999999999876 443322 2555 7899999954 34322222 245789999988
Q ss_pred CCCC-----CCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcC
Q 005898 268 NSFS-----GEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKL 342 (671)
Q Consensus 268 N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l 342 (671)
|.+. ..-+..|..+++|+.+++. |.++.+....|.++++|+.++|..| ++..-+..|..+ +|+.+++++|.+
T Consensus 281 ~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 281 STFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp SCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred ccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 8765 2345688999999999999 5688888889999999999999655 665556688888 999999999987
Q ss_pred cccCCCCCCC
Q 005898 343 TGGLPSCLSN 352 (671)
Q Consensus 343 ~g~~p~~~~~ 352 (671)
.-..+..+..
T Consensus 358 ~~l~~~~F~~ 367 (401)
T 4fdw_A 358 PQVFEKVWYG 367 (401)
T ss_dssp CBCCCSSCCC
T ss_pred cccccccccC
Confidence 6433333333
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=124.08 Aligned_cols=158 Identities=14% Similarity=0.089 Sum_probs=118.2
Q ss_pred HHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCc
Q 005898 479 KEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 479 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~ 557 (671)
......|+.....+.|+.+.||+.... +..+++|............+.+|+++++.++ |..+.++++++.+.+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~----- 83 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG----- 83 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-----
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC-----
Confidence 344556777778888899999998754 6889999986432222346888999998884 677888888876543
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC---------------------------
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV--------------------------- 610 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--------------------------- 610 (671)
..|+||||+++.++.+.... ..+...++.+++++++.||+..
T Consensus 84 ---~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T 3tm0_A 84 ---WSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp ---EEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred ---ceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence 67999999999998765321 1123477888999999999710
Q ss_pred -----------------------------CCCccccCCCCCceeecCCCcEEEcccCCccccccccccceee
Q 005898 611 -----------------------------IPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRL 653 (671)
Q Consensus 611 -----------------------------~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l 653 (671)
.+.++|+|+++.||+++++..+.|.||+.+...+-.|.++..+
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd~~~Dla~~~ 224 (263)
T 3tm0_A 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCV 224 (263)
T ss_dssp CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEEHHHHHHHHH
T ss_pred cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCCHHHHHHHHH
Confidence 1358999999999999876666799999998887666666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.6e-13 Score=146.01 Aligned_cols=62 Identities=19% Similarity=0.142 Sum_probs=29.1
Q ss_pred CCCCEEecccccccccCCccccC-----CCCCCEEEcccCcCCCCCCccC-CCCCccCEEEccCCcCC
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHR-----LYSLEYLDLSSNFLFGSVPPKI-STMVKLQTLILDDNFFN 179 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~-----L~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~ 179 (671)
+.|+.|+|++|.++..-...+.. .++|++|||++|.++..-...+ ..+.+|++|+|++|.++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~ 139 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG 139 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC
Confidence 45666666666664432222221 2456666666665543222111 22344555555555544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=4e-11 Score=120.46 Aligned_cols=141 Identities=15% Similarity=0.117 Sum_probs=103.5
Q ss_pred ccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCc--ccccceeecCCCCCCcccceEEEEEecC
Q 005898 492 GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL--VCLLGHCIDGGGRDDYAVNKVFLVYEFM 569 (671)
Q Consensus 492 G~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~~~~~~~~~Lv~Ey~ 569 (671)
+.|..+.||+....+|..++||..... ....+.+|+++++.+++.++ .+++++..+++ ..++||||+
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~--------~~~~v~e~i 97 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG--------RDWLLLGEV 97 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--------CEEEEEECC
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC--------CCEEEEEec
Confidence 456669999998777888999997643 22457889998888865554 45777665432 479999999
Q ss_pred CCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC---------------------------------------
Q 005898 570 SNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV--------------------------------------- 610 (671)
Q Consensus 570 ~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--------------------------------------- 610 (671)
++.++. ... .+ ...++.++++.+..||+..
T Consensus 98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998884 211 11 2356777788888888642
Q ss_pred ----------------CCCccccCCCCCceeecCCCcEEEcccCCccccccccccceeee
Q 005898 611 ----------------IPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLL 654 (671)
Q Consensus 611 ----------------~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~ 654 (671)
.+.++|+|+++.||+++++..+.|.|||.+...+..|.++..++
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~~~~Dla~~~~ 226 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATR 226 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEETHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCChHHHHHHHHh
Confidence 11389999999999998876677999999998887776666543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.3e-12 Score=139.10 Aligned_cols=87 Identities=16% Similarity=0.111 Sum_probs=45.9
Q ss_pred CCCCCEEEcccCcCCCCCCccC----C-CCCccCEEEccCCcCCCCCCccc-CCCCCcCEEEcccccCCCCCcccc----
Q 005898 141 LYSLEYLDLSSNFLFGSVPPKI----S-TMVKLQTLILDDNFFNNTIPNWF-DSLPSLTFLSMRNNKLAGPFPSSI---- 210 (671)
Q Consensus 141 L~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~g~~p~~l---- 210 (671)
+++|+.|+|++|.++......+ . ...+|++|+|++|.++..-...+ ..+++|+.|+|++|+++..-...+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3568888888888764322222 2 22567777777776653222222 234556666666666653222222
Q ss_pred -cCCCCCCEEEeccCccc
Q 005898 211 -QRISTLSDLDLSKNAIS 227 (671)
Q Consensus 211 -~~l~~L~~L~Ls~N~l~ 227 (671)
...++|+.|+|++|.++
T Consensus 151 ~~~~~~L~~L~Ls~n~l~ 168 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLT 168 (372)
T ss_dssp HSTTCCCCEEECCSSCCH
T ss_pred HhcCCccceeeCCCCCCC
Confidence 12345555555555553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.5e-09 Score=114.89 Aligned_cols=154 Identities=15% Similarity=0.248 Sum_probs=110.2
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEcc--CCc-hhhHHHHHHHHHHHhcCC--CCCcccccceeecCCCCCCcccceE
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLP--SSK-KYTVRNLKLRLDLLAKLR--HPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
.+.++.|.++.||+.+.++ ..+++|+.. ... ......+.+|.++++.++ +..+.++++++.+.+. ....
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-----~g~~ 116 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV-----IGRA 116 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-----TSSC
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-----cCCe
Confidence 5678999999999988764 578888875 332 123456888999998887 4557788888765421 1246
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC--------------------------------
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV-------------------------------- 610 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-------------------------------- 610 (671)
++||||+++..+.+... ..++..++..++.++++.|+.||...
T Consensus 117 ~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 89999999987744211 12678889999999999999999721
Q ss_pred -----------------------CCCccccCCCCCceeecCCCc--EEEcccCCcccccccccccee
Q 005898 611 -----------------------IPGFFNNRVKTNNILLNEHRI--AKLSDYGLSIVSEDINSVGVR 652 (671)
Q Consensus 611 -----------------------~~~iiHrDlk~~NiLl~~~~~--~ki~DfGla~~~~d~~s~g~~ 652 (671)
.+.++|+|+++.||++++++. +.|.||+.+...+-.+.++..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~p~~DLa~~ 258 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGHPMGDFGYH 258 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEECHHHHHHHH
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCCHHHHHHHH
Confidence 246899999999999997753 689999999887644444443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=7.6e-10 Score=116.80 Aligned_cols=14 Identities=14% Similarity=0.048 Sum_probs=7.2
Q ss_pred ccCCCCCCEEEccc
Q 005898 138 IHRLYSLEYLDLSS 151 (671)
Q Consensus 138 ~~~L~~L~~L~Ls~ 151 (671)
+.++++|+.|.+..
T Consensus 135 ~~~l~~L~~L~l~~ 148 (362)
T 2ra8_A 135 KEKFAHFEGLFWGD 148 (362)
T ss_dssp HHHHTTCSEEEECC
T ss_pred hhhcchhhheeecC
Confidence 33455555555543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.77 E-value=9.2e-10 Score=116.18 Aligned_cols=86 Identities=14% Similarity=0.122 Sum_probs=50.2
Q ss_pred chhcccCCCCCCEEecccccc---------cccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCC
Q 005898 110 FVTTLARLTSLRVLSLVSLGI---------WGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNN 180 (671)
Q Consensus 110 ~~~~l~~l~~L~~L~L~~n~l---------~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 180 (671)
++.++.++++|+.|.+..+.. .+.++..+..+++|+.|+|++|.-. .+|. +. +++|++|+|..+.++.
T Consensus 131 L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~ 207 (362)
T 2ra8_A 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPD 207 (362)
T ss_dssp HHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCH
T ss_pred HHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCCh
Confidence 344567788999999866532 1234455667778888888776311 2333 32 6677777776665543
Q ss_pred CCCcccC--CCCCcCEEEcc
Q 005898 181 TIPNWFD--SLPSLTFLSMR 198 (671)
Q Consensus 181 ~~p~~~~--~l~~L~~L~L~ 198 (671)
.....+. .+++|+.|+|+
T Consensus 208 ~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 208 SVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHHHHHHSBCTTCCEEEEE
T ss_pred HHHHHHHHccCCCCcEEEEe
Confidence 2222222 56666666664
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.64 E-value=3e-07 Score=98.35 Aligned_cols=220 Identities=13% Similarity=0.066 Sum_probs=127.7
Q ss_pred CccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCC
Q 005898 135 PDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIS 214 (671)
Q Consensus 135 p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~ 214 (671)
...|.++++|+.+++..+. ...-...|.++.+|+.+.+..| ++..-...|.++..|+.+.+..+... +.......+
T Consensus 155 ~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~ 230 (394)
T 4fs7_A 155 DEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT 230 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred hhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence 3467888888888887553 3344566778888888888766 44344456777888888777665432 233344456
Q ss_pred CCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCC--CCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccc
Q 005898 215 TLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDS--NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFN 292 (671)
Q Consensus 215 ~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 292 (671)
+|+.+.+..+.-.-.-..+..+..|+.+.+..+...- ..-.-...+..+....+.+ ....|..+.+|+.+.+..+
T Consensus 231 ~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~ 307 (394)
T 4fs7_A 231 GVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS 307 (394)
T ss_dssp CCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT
T ss_pred CCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee---ccccccccccccccccccc
Confidence 6777766543211111125566677777766553321 0111122344444433321 1234566677777777544
Q ss_pred cccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCC
Q 005898 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGN 364 (671)
Q Consensus 293 ~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N 364 (671)
++.+....|.++++|+.++|..+ ++..-...|..+.+|+.+++..| ++-.-...+.++.+|+.+.+..+
T Consensus 308 -i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 308 -VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred -cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 55555666777777777777543 44333456667777777777665 54333456666777777766543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.63 E-value=3.9e-07 Score=97.46 Aligned_cols=241 Identities=10% Similarity=0.082 Sum_probs=126.8
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCc---------------
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF--------------- 177 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~--------------- 177 (671)
+|.++++|+.+.|..+ +...-..+|.++++|+.++|..+ ++..-...|.++.+|+.+.+..+-
T Consensus 66 AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~ 143 (394)
T 4fs7_A 66 AFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKE 143 (394)
T ss_dssp TTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSE
T ss_pred HhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccc
Confidence 4555555555555432 33333344555555555555433 332223344555555544443220
Q ss_pred ------CCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccC--CCCCCCCCCEEECCCCCC
Q 005898 178 ------FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP--DLSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 178 ------l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~Ls~N~l 249 (671)
....-...|.++++|+.+.+.++..+ .-...|..+++|+.+++..| ++ .++ .+.++..|+.+.+.++..
T Consensus 144 ~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~~~~~ 220 (394)
T 4fs7_A 144 ITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEFPNSLY 220 (394)
T ss_dssp EECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCCCTTCC
T ss_pred cccCccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ce-EeCchhhccccccceeecCCCce
Confidence 01111234556666666666544321 22334556666666666554 22 111 244445555544443321
Q ss_pred C-CC------------CC-----------CCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCC
Q 005898 250 D-SN------------LP-----------KLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSL 305 (671)
Q Consensus 250 ~-~~------------~p-----------~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 305 (671)
. +. +| .-...+..+.+..+..+ .....|..+..++.+....+.+ +...+..+
T Consensus 221 ~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~ 296 (394)
T 4fs7_A 221 YLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGC 296 (394)
T ss_dssp EECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTC
T ss_pred EeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---cccccccc
Confidence 1 00 00 01123444444443221 2233455566666666555442 33467789
Q ss_pred CCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCC
Q 005898 306 PNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGN 364 (671)
Q Consensus 306 ~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N 364 (671)
.+|+.+.+..+ ++..-...|..+.+|+.+++.++ ++-.-...+.++.+|+.+.+..|
T Consensus 297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 99999999765 55444567888999999999755 65444567888899999988765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.50 E-value=3.3e-07 Score=94.32 Aligned_cols=151 Identities=16% Similarity=0.172 Sum_probs=102.1
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCc--ccccceeecCCCCCCcccceEEE
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHL--VCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~~~~~~~~~~~~~L 564 (671)
.+.++.|....||+.. ..+++|+-... .....+.+|.++|+.+. +..+ .+.+......+ .....|+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~-----~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE-----TYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS-----SCSCSCE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC-----CCCcceE
Confidence 4568999999999853 45888885432 34567899999998874 4333 23333322211 1113489
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTG----------------------------------- 609 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------------------------------- 609 (671)
||||+++.++...... .++..++..++.++++.++.||..
T Consensus 94 vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp EEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred EEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 9999999887643321 156666777777777777777741
Q ss_pred --------------------CCCCccccCCCCCceeecC--CCcEEEcccCCccccccccccceeee
Q 005898 610 --------------------VIPGFFNNRVKTNNILLNE--HRIAKLSDYGLSIVSEDINSVGVRLL 654 (671)
Q Consensus 610 --------------------~~~~iiHrDlk~~NiLl~~--~~~~ki~DfGla~~~~d~~s~g~~l~ 654 (671)
..+.++|+|+++.||++++ ...+.|.||+.+...+-.+.++..+.
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~ 235 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLME 235 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCC
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHh
Confidence 1245899999999999998 45678999999988775555555443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.49 E-value=1e-08 Score=102.81 Aligned_cols=67 Identities=24% Similarity=0.310 Sum_probs=30.8
Q ss_pred cCCCCCCEEEcccCcCCC--CCCccCCCCCccCEEEccCCcCCCCCCcccCCCC--CcCEEEcccccCCCCCc
Q 005898 139 HRLYSLEYLDLSSNFLFG--SVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLP--SLTFLSMRNNKLAGPFP 207 (671)
Q Consensus 139 ~~L~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~g~~p 207 (671)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|.|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 345555555555555554 2333444455555555555555432 1122222 44444444444444333
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=2.2e-08 Score=95.29 Aligned_cols=118 Identities=12% Similarity=0.138 Sum_probs=77.0
Q ss_pred chhcccCCCCCCEEecccc-ccccc----CCccccCCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCCcCCC
Q 005898 110 FVTTLARLTSLRVLSLVSL-GIWGS----LPDKIHRLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDNFFNN 180 (671)
Q Consensus 110 ~~~~l~~l~~L~~L~L~~n-~l~g~----~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 180 (671)
+...+...+.|++|+|++| .+... +...+...++|++|||++|.+... +...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4456777888999999988 77532 445566778888888888887532 23344555677778888777764
Q ss_pred C----CCcccCCCCCcCEEEc--ccccCCCC----CcccccCCCCCCEEEeccCccc
Q 005898 181 T----IPNWFDSLPSLTFLSM--RNNKLAGP----FPSSIQRISTLSDLDLSKNAIS 227 (671)
Q Consensus 181 ~----~p~~~~~l~~L~~L~L--~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~ 227 (671)
. +...+...++|++|+| ++|.+... +...+...++|+.|+|++|.+.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2 3445556667777777 66766532 2233444566777777666653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.37 E-value=1.7e-05 Score=84.65 Aligned_cols=131 Identities=9% Similarity=0.074 Sum_probs=73.1
Q ss_pred hcccCCCCCCEEeccccc---ccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCC
Q 005898 112 TTLARLTSLRVLSLVSLG---IWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDS 188 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n~---l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 188 (671)
.+|.++++|+.+.+..|. +...-...|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|..
T Consensus 81 ~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~ 158 (394)
T 4gt6_A 81 NAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSY 158 (394)
T ss_dssp TTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred HHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceec
Confidence 357777778877776653 43333445777777777776544 44344456777777777777643 23233445667
Q ss_pred CCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCC
Q 005898 189 LPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSD 246 (671)
Q Consensus 189 l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~ 246 (671)
+.+|+.+.+..+ ++ .+.........|+.+.+..+...-....+..+.+|.......
T Consensus 159 c~~L~~i~~~~~-~~-~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c~~l~~~~~~~ 214 (394)
T 4gt6_A 159 CYSLHTVTLPDS-VT-AIEERAFTGTALTQIHIPAKVTRIGTNAFSECFALSTITSDS 214 (394)
T ss_dssp CTTCCEEECCTT-CC-EECTTTTTTCCCSEEEECTTCCEECTTTTTTCTTCCEEEECC
T ss_pred ccccccccccce-ee-EeccccccccceeEEEECCcccccccchhhhccccceecccc
Confidence 777777777654 22 222222233566666665443321222345555555555443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.3e-06 Score=88.16 Aligned_cols=147 Identities=14% Similarity=0.094 Sum_probs=94.5
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCC---CcccccceeecCCCCCCcccceEEE
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHP---HLVCLLGHCIDGGGRDDYAVNKVFL 564 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~~~~~~~~~L 564 (671)
.+.++.|....||+. |..++||+-. .......+.+|.++|..+++. .+.+.+.++.... ...++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~-------g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD-------GNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT-------SCEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC-------CceEE
Confidence 456788999999987 5678888742 223456789999999998753 2445555554222 24689
Q ss_pred EEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005898 565 VYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT------------------------------------ 608 (671)
Q Consensus 565 v~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~------------------------------------ 608 (671)
||||+++..+...... .++..++..++.++++.|+.||+
T Consensus 91 v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 91 GYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 9999998777542110 02222333333333333333332
Q ss_pred ---------------------CCCCCccccCCCCCceeecC---CCc-EEEcccCCcccccccccccee
Q 005898 609 ---------------------GVIPGFFNNRVKTNNILLNE---HRI-AKLSDYGLSIVSEDINSVGVR 652 (671)
Q Consensus 609 ---------------------~~~~~iiHrDlk~~NiLl~~---~~~-~ki~DfGla~~~~d~~s~g~~ 652 (671)
...+.++|+|+++.||++++ ++. ..|.||+.+...+-.+.++.+
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~~Dla~~ 234 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYL 234 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGGGGGHHH
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHHHHHHHH
Confidence 12345799999999999987 455 489999999888766666654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.34 E-value=1.6e-07 Score=94.09 Aligned_cols=81 Identities=23% Similarity=0.328 Sum_probs=67.5
Q ss_pred cCCCCCCEEecccccccc--cCCccccCCCCCCEEEcccCcCCCCCCccCCCCC--ccCEEEccCCcCCCCCCc------
Q 005898 115 ARLTSLRVLSLVSLGIWG--SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMV--KLQTLILDDNFFNNTIPN------ 184 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~g--~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~------ 184 (671)
.++++|+.|+|++|.|.+ .+|+.+..+++|+.|||++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999998 6778889999999999999999865 3344444 999999999999987773
Q ss_pred -ccCCCCCcCEEEc
Q 005898 185 -WFDSLPSLTFLSM 197 (671)
Q Consensus 185 -~~~~l~~L~~L~L 197 (671)
.+..+++|+.||=
T Consensus 245 ~il~~~P~L~~LDg 258 (267)
T 3rw6_A 245 AIRERFPKLLRLDG 258 (267)
T ss_dssp HHHHHCTTCCEESS
T ss_pred HHHHHCcccCeECC
Confidence 3567788887763
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.22 E-value=1.2e-07 Score=90.12 Aligned_cols=118 Identities=13% Similarity=0.142 Sum_probs=84.9
Q ss_pred cCCccccCCCCCCEEEcccC-cCCCC----CCccCCCCCccCEEEccCCcCCCC----CCcccCCCCCcCEEEcccccCC
Q 005898 133 SLPDKIHRLYSLEYLDLSSN-FLFGS----VPPKISTMVKLQTLILDDNFFNNT----IPNWFDSLPSLTFLSMRNNKLA 203 (671)
Q Consensus 133 ~~p~~~~~L~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 203 (671)
.+...+...++|++|+|++| .+... +...+...++|++|+|++|.+... +...+...++|++|+|++|.++
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34456778899999999999 88532 345567778899999999988642 3344556678999999999887
Q ss_pred CC----CcccccCCCCCCEEEe--ccCccccccC-----CCCCCCCCCEEECCCCCCC
Q 005898 204 GP----FPSSIQRISTLSDLDL--SKNAISGSLP-----DLSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 204 g~----~p~~l~~l~~L~~L~L--s~N~l~g~~p-----~~~~l~~L~~L~Ls~N~l~ 250 (671)
.. +...+...++|+.|+| ++|.++..-. .+...++|+.|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 42 4456677788999999 7788864311 2445577888888887653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.17 E-value=7.4e-05 Score=79.59 Aligned_cols=106 Identities=12% Similarity=0.097 Sum_probs=59.9
Q ss_pred hcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCC
Q 005898 112 TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPS 191 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 191 (671)
.+|.++.+|+.+.+..+ +...-...|.++.+|+.+.+..+ +...-...|..+.+|+.+.+..+ ++..-...|. ..+
T Consensus 108 ~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~ 183 (394)
T 4gt6_A 108 QAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTA 183 (394)
T ss_dssp TTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCC
T ss_pred hhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEecccccc-ccc
Confidence 35677777877776543 33334456777888888888644 33344556777788888877654 3322223333 345
Q ss_pred cCEEEcccccCCCCCcccccCCCCCCEEEec
Q 005898 192 LTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 192 L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 222 (671)
|+.+.+..+-.. .-...+..+.+|......
T Consensus 184 l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~ 213 (394)
T 4gt6_A 184 LTQIHIPAKVTR-IGTNAFSECFALSTITSD 213 (394)
T ss_dssp CSEEEECTTCCE-ECTTTTTTCTTCCEEEEC
T ss_pred eeEEEECCcccc-cccchhhhccccceeccc
Confidence 666666543221 222344555555555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.08 E-value=0.00032 Score=74.08 Aligned_cols=239 Identities=9% Similarity=0.002 Sum_probs=119.1
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
+|.+|++|+.++|..+ +...-...|.++ +|+.+.+..+ +...-...|.. .+|+.+.+..+- ...-...|.+. +|
T Consensus 64 aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~-~~i~~~~F~~~-~l 137 (379)
T 4h09_A 64 NFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGAT-TEIGNYIFYNS-SV 137 (379)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTC-CEECTTTTTTC-CC
T ss_pred HhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcc-ccccccccccc-ee
Confidence 5778888888888654 443334456665 5777766543 43222233433 467777776542 21112223332 34
Q ss_pred CEEEcccccCCCCCcccccCCCCCCEEEeccCccccc------------------------------------cCCCCCC
Q 005898 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGS------------------------------------LPDLSSL 236 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~------------------------------------~p~~~~l 236 (671)
+.+.+..+ ++..-...+..+.+++.+.+..+..... ...+...
T Consensus 138 ~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~ 216 (379)
T 4h09_A 138 KRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYG 216 (379)
T ss_dssp CEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTC
T ss_pred eeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccccc
Confidence 44444332 2212223445555555555543322100 0012333
Q ss_pred CCCCEEECCCCCCCCCCCC---CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEec
Q 005898 237 GSLNVLNLSDNKLDSNLPK---LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNL 313 (671)
Q Consensus 237 ~~L~~L~Ls~N~l~~~~p~---~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 313 (671)
.+|+.+.+..+- ...-.. -...|..+.+..+ ++..-...|..+.+|+.+.+..+ +.......|..+++|+.+.+
T Consensus 217 ~~l~~i~~~~~~-~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSGV-TTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTTC-CEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccce-eEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 444444443321 000000 1133455555443 33223345566666777766533 55555556667777777777
Q ss_pred ccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccC
Q 005898 314 ASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362 (671)
Q Consensus 314 ~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~ 362 (671)
.++.++..-+..|..+.+|+.+++.++ ++-.-...+.++++|+.+.+.
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 766666444456666777777777544 442333455666666665554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-05 Score=80.23 Aligned_cols=144 Identities=12% Similarity=0.089 Sum_probs=92.4
Q ss_pred eeccCCce-EEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccceEEEEE
Q 005898 490 IMGEGSYG-KLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 490 ~iG~G~~g-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
.+..|..| .||+-... ++..+.+|+-... ...++.+|.+.|+.+. +--+.++++++.+.+ ..++||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--------~~~lvm 99 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--------DAWLLT 99 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--------EEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--------eEEEEE
Confidence 44555555 68987754 4667888886432 3457888998888774 333567777777653 579999
Q ss_pred ecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 005898 567 EFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLH--------------------------------------- 607 (671)
Q Consensus 567 Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------------------------------------- 607 (671)
|++++.++.+..... ...+..++.++++.|.-||
T Consensus 100 e~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp ECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999987765432210 0011122222222222222
Q ss_pred ------------CC----CCCCccccCCCCCceeecCCCcEEEcccCCccccccccccce
Q 005898 608 ------------TG----VIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGV 651 (671)
Q Consensus 608 ------------~~----~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~ 651 (671)
.. ..+.++|+|+.+.||++++++.+-|.||+.+...+-.|.++.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gdp~~Dla~ 232 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAI 232 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEETHHHHHH
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCCHHHHHHH
Confidence 21 112479999999999999877777999999998886666654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=4.3e-06 Score=87.89 Aligned_cols=161 Identities=7% Similarity=0.067 Sum_probs=94.4
Q ss_pred Ccee-ccCCceEEEEEEEc-------CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCC-C--CCcccccceeecCCC
Q 005898 488 SAIM-GEGSYGKLYKGRLE-------NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLR-H--PHLVCLLGHCIDGGG 553 (671)
Q Consensus 488 ~~~i-G~G~~g~Vy~~~~~-------~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~ 553 (671)
.+.| +.|....+|+.... ++..+++|+-.... ......+.+|+++++.++ + ..+.++++++.+.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998764 26678888865432 101245677888887774 2 245667777654320
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcC---CCCCCCCHHHHHHHHHH--------------------------------
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISEN---TPGKVLNWSERLAVLIG-------------------------------- 598 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~---~~~~~l~~~~~~~i~~~-------------------------------- 598 (671)
....++||||+++..+.+.+... .....++..++..++.+
T Consensus 105 -----~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~ 179 (357)
T 3ats_A 105 -----LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLH 179 (357)
T ss_dssp -----TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHH
T ss_pred -----cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHH
Confidence 12358999999986654321000 00000111111111111
Q ss_pred ----------------------HHHHHHHhcCCC-------CCCccccCCCCCceeecCCCcEEEcccCCcccccccccc
Q 005898 599 ----------------------VAKAVQFLHTGV-------IPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSV 649 (671)
Q Consensus 599 ----------------------ia~gl~yLH~~~-------~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~ 649 (671)
+.+.++++.+.. .+.++|+|+.+.||+++++..+.|.||+.+...+-.+.+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~g~p~~Dl 259 (357)
T 3ats_A 180 RHFNWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVALGPRELDV 259 (357)
T ss_dssp HHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEEECHHHHH
T ss_pred HHHHHHHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEcccccccCCcHHHH
Confidence 122334443221 346899999999999996545789999999888766666
Q ss_pred ceee
Q 005898 650 GVRL 653 (671)
Q Consensus 650 g~~l 653 (671)
+..+
T Consensus 260 a~~~ 263 (357)
T 3ats_A 260 AWMI 263 (357)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6544
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=2.1e-05 Score=83.90 Aligned_cols=45 Identities=20% Similarity=0.208 Sum_probs=36.3
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccccccccceeeeeee
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLILM 657 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~~~~ 657 (671)
+.++|+|+.+.||+++++ .+++.||..+...+-.+.+|..++.++
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G~p~~DLa~~l~~~~ 271 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGPIGFDVGQFIANLF 271 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEEECTHHHHHHHHHHHH
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccccCChHHhHHHHHHHHH
Confidence 478999999999999876 488999999988886666677655543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00015 Score=73.51 Aligned_cols=78 Identities=19% Similarity=0.164 Sum_probs=54.7
Q ss_pred CCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CC--CcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HP--HLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~--niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+...+.+|.|..+.||+.++.+|+.|.||+-..........|.+|.+.|+.+. .. -+.+.+++ +.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~---------- 84 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD---------- 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----------
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC----------
Confidence 44467789999999999999999999999876443333345788988888774 21 23333332 21
Q ss_pred EEEEEecCCCCCh
Q 005898 562 VFLVYEFMSNGNF 574 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL 574 (671)
-++||||++.+..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 3799999987653
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.003 Score=66.48 Aligned_cols=240 Identities=10% Similarity=0.062 Sum_probs=138.7
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
++....+|+.+.+.. +++.+-..+|.++.+|+.++|..+ ++..-...|.++ +|+.+.+..+ +...-...|.. .+|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence 455667788888864 455445567999999999999755 654455667776 7888887654 44232344544 479
Q ss_pred CEEEcccccCCCCCcc-cccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCC-------------------
Q 005898 193 TFLSMRNNKLAGPFPS-SIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSN------------------- 252 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p~-~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~------------------- 252 (671)
+.+.+..+- + .+.. .|.. .+|..+.+..+--.-....+..+.+++...+..+.....
T Consensus 116 ~~i~lp~~~-~-~i~~~~F~~-~~l~~~~~~~~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (379)
T 4h09_A 116 DDFEFPGAT-T-EIGNYIFYN-SSVKRIVIPKSVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA 192 (379)
T ss_dssp SEEECCTTC-C-EECTTTTTT-CCCCEEEECTTCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred ccccCCCcc-c-ccccccccc-ceeeeeeccceeeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence 999987653 2 2222 3333 366666665442211122366777777777665432110
Q ss_pred --------CCCC-----------CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEec
Q 005898 253 --------LPKL-----------PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNL 313 (671)
Q Consensus 253 --------~p~~-----------~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 313 (671)
+|.. ...+..+.+..+ ++..-...|..+..|+.+.+..+ ++.+....+.++.+|+.+.+
T Consensus 193 ~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 193 AKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp TCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 0000 112333333222 22122334556666777776554 55555556667777777777
Q ss_pred ccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCC
Q 005898 314 ASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRG 363 (671)
Q Consensus 314 ~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~ 363 (671)
..+ ++..-...|..+.+|+.+++.++.++-.-...+.++.+|+.+.+..
T Consensus 271 ~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 271 YAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp CCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCT
T ss_pred ccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCc
Confidence 543 4333334566677777777777766644455666677777766643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00011 Score=76.37 Aligned_cols=43 Identities=19% Similarity=0.217 Sum_probs=35.2
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccccccccceeee
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLL 654 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~ 654 (671)
+.++|+|+++.||+++.++.+.|.||+.+....-.+.++..+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~~~~Dla~~l~ 264 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDLPIRDLRKMII 264 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEECCTHHHHHHHHH
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccCChHHHHHHHHH
Confidence 5799999999999998778899999999987775555555443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.41 E-value=4.5e-05 Score=70.96 Aligned_cols=82 Identities=10% Similarity=0.086 Sum_probs=34.3
Q ss_pred CCCEEEcccCcCCCCCCccCCCCCccCEEEccCCc-CCCCCCcccCCC----CCcCEEEccccc-CCCCCcccccCCCCC
Q 005898 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF-FNNTIPNWFDSL----PSLTFLSMRNNK-LAGPFPSSIQRISTL 216 (671)
Q Consensus 143 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~g~~p~~l~~l~~L 216 (671)
+|+.|||+++.++..--..+.++++|++|+|+++. ++..--..++.+ ++|++|+|++|. ++..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 35555555544433222233444555555555442 221111122332 245555555543 432211234445555
Q ss_pred CEEEeccC
Q 005898 217 SDLDLSKN 224 (671)
Q Consensus 217 ~~L~Ls~N 224 (671)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0004 Score=74.62 Aligned_cols=44 Identities=14% Similarity=0.203 Sum_probs=36.5
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccccccccceeeeee
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLIL 656 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~~~ 656 (671)
+.++|+|+++.||+++++. ++|.||+.+...+-.+.+|..+..+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~ 275 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNL 275 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHH
Confidence 4799999999999998776 9999999999888666667765443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.12 E-value=9.1e-05 Score=68.88 Aligned_cols=84 Identities=10% Similarity=0.060 Sum_probs=62.7
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCc-CCCCCCccCCCC----CccCEEEccCCc-CCCCCCcccCCCCC
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNF-LFGSVPPKISTM----VKLQTLILDDNF-FNNTIPNWFDSLPS 191 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 191 (671)
.+|+.|||+++.++..=-..+.++++|++|+|+++. ++..-=..+..+ ++|++|+|+++. ++..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999998765433457899999999999985 554322345554 379999999974 65432245678999
Q ss_pred cCEEEccccc
Q 005898 192 LTFLSMRNNK 201 (671)
Q Consensus 192 L~~L~L~~N~ 201 (671)
|++|+++++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999985
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.002 Score=66.23 Aligned_cols=175 Identities=14% Similarity=0.151 Sum_probs=94.2
Q ss_pred cCHHHHHHHhcCCCc-----CceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCC--ccccc
Q 005898 473 FTLEELKEATNNFDM-----SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH--LVCLL 545 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~-----~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 545 (671)
++.+++......|.. .+.|+.|....+|+...++| .+++|...... ..+++..|++++..++... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555555544 23467788899999887666 57788876521 1234556777766654222 23333
Q ss_pred ceeecCCCCCCc-ccceEEEEEecCCCCChhh--------------hhhcC----C-CC----CCCCHHHHHHH------
Q 005898 546 GHCIDGGGRDDY-AVNKVFLVYEFMSNGNFRT--------------HISEN----T-PG----KVLNWSERLAV------ 595 (671)
Q Consensus 546 g~~~~~~~~~~~-~~~~~~Lv~Ey~~~GsL~~--------------~l~~~----~-~~----~~l~~~~~~~i------ 595 (671)
... ++ .... .....+++|||+++..+.. .+|.. . +. ....|.....-
T Consensus 84 ~~~-~g--~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 84 PRK-DG--ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBT-TC--CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred CCC-CC--CEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 211 11 0000 0124689999999865321 12211 0 00 01235432111
Q ss_pred ------HHHHHHHHHHhcC----CCCCCccccCCCCCceeecCCCcEEEcccCCccccccccccceee
Q 005898 596 ------LIGVAKAVQFLHT----GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRL 653 (671)
Q Consensus 596 ------~~~ia~gl~yLH~----~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l 653 (671)
...+.+.+++++. ...+.++|+|+.+.||+++++..+.|.||+.+....-.+.++..+
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g~~~~Dla~~l 228 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDLLAYDVSICL 228 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEEHHHHHHHHH
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCchhHHHHHHHH
Confidence 0113445555542 122468999999999999987666899999998776555555544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0018 Score=65.95 Aligned_cols=149 Identities=8% Similarity=0.002 Sum_probs=80.6
Q ss_pred CceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCc-ccccceeecCCCCCCcccceEEEEE
Q 005898 488 SAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL-VCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
.+.|+.|....+|+. ..+.+|+-...... ..+..+|.+.++.+....+ .++++++.+ .-++|+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~----------~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA----------TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT----------TCCEEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC----------CCEEEE
Confidence 577899999999998 45778876543211 1122456666665543233 345544322 237999
Q ss_pred ecC-CCCChhh------------------hhhcCCCC--CCCCHHHHHHHHHH---------------HHHHH----HHh
Q 005898 567 EFM-SNGNFRT------------------HISENTPG--KVLNWSERLAVLIG---------------VAKAV----QFL 606 (671)
Q Consensus 567 Ey~-~~GsL~~------------------~l~~~~~~--~~l~~~~~~~i~~~---------------ia~gl----~yL 606 (671)
||+ ++.++.. -+|..... ...+...++.-... +.+.+ +.+
T Consensus 87 e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 87 RYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp ECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred eecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 999 5433321 11221110 11111111111000 11111 122
Q ss_pred cC-CCCCCccccCCCCCceeecCCCcEEEcccCCccccccccccceee
Q 005898 607 HT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRL 653 (671)
Q Consensus 607 H~-~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l 653 (671)
.. ...+.++|+|+.+.||+ .+++.+.+.||..+...+-.+.++..+
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~~~~Dla~~~ 213 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMNDPLWDLGDLS 213 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEECTHHHHHHHH
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCCCHHHHHHHHH
Confidence 11 22345899999999999 566778999999998887666666554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.019 Score=58.63 Aligned_cols=144 Identities=11% Similarity=0.144 Sum_probs=92.1
Q ss_pred cCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC---CCCcccccceeecCCCCCCcccceEE
Q 005898 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR---HPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
..+.|+.|.+..+|+... ++..++||.-... ....+.+|.+.|+.+. ...+.++++++...+ ..+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g--------~~~ 107 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG--------HSF 107 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS--------EEE
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC--------ceE
Confidence 346789999999999875 4667888886532 3456888988887773 356777777765432 579
Q ss_pred EEEecCCCCChhh-----------hhhcCCC-C------------------CCCCHHHH-----HHHHHH----------
Q 005898 564 LVYEFMSNGNFRT-----------HISENTP-G------------------KVLNWSER-----LAVLIG---------- 598 (671)
Q Consensus 564 Lv~Ey~~~GsL~~-----------~l~~~~~-~------------------~~l~~~~~-----~~i~~~---------- 598 (671)
+||||+++..+.. .||.... . ..-+|... +.-..+
T Consensus 108 lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~ 187 (312)
T 3jr1_A 108 LLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFG 187 (312)
T ss_dssp EEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCS
T ss_pred EEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChH
Confidence 9999999876421 2332211 0 01256532 211111
Q ss_pred ----HH-HHHHHhcC-CCCCCccccCCCCCceeecCCCcEEEcccCCccccc
Q 005898 599 ----VA-KAVQFLHT-GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE 644 (671)
Q Consensus 599 ----ia-~gl~yLH~-~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~ 644 (671)
+. +..+.|.. ...|.++|+|+.+.|++++.++ +.|.||. +...+
T Consensus 188 ~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~-~~~g~ 237 (312)
T 3jr1_A 188 NIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA-CYWGD 237 (312)
T ss_dssp CHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC-CEEEC
T ss_pred HHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc-cccCC
Confidence 11 12234432 2357899999999999999887 8899984 44444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0058 Score=63.05 Aligned_cols=42 Identities=12% Similarity=0.090 Sum_probs=34.3
Q ss_pred CCccccCCCCCceeecCC----CcEEEcccCCccccccccccceee
Q 005898 612 PGFFNNRVKTNNILLNEH----RIAKLSDYGLSIVSEDINSVGVRL 653 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~----~~~ki~DfGla~~~~d~~s~g~~l 653 (671)
+.++|+|+.+.||+++++ ..+.|.||+.+...+-.+.++..+
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~~DLa~ll 228 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRAYDLVSLL 228 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTTHHHHHHH
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCHHHHHHHh
Confidence 469999999999999874 678999999998877555555543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.027 Score=57.71 Aligned_cols=157 Identities=9% Similarity=0.105 Sum_probs=86.5
Q ss_pred ceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCC--cccccceeecCCCCCCcccceEEEEE
Q 005898 489 AIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH--LVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
..++ |....||+...++|+.+++|...... ...+++..|.+++..++... +++++.. ++... ....+..++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~-~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTL-LNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSC-EEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEE-EEECCEEEEEE
Confidence 4466 77889999877778789999986321 12345667777777664222 4444443 21100 00013568899
Q ss_pred ecCCCCChhh-----------h---hhc----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHhc
Q 005898 567 EFMSNGNFRT-----------H---ISE----NT--PGKVLNWSER----LAV---------------LIGVAKAVQFLH 607 (671)
Q Consensus 567 Ey~~~GsL~~-----------~---l~~----~~--~~~~l~~~~~----~~i---------------~~~ia~gl~yLH 607 (671)
||+++..+.. . +|. .. .....++... ..+ ...+.+.++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9998754320 1 121 00 0112333211 000 001112222222
Q ss_pred C----CCCCCccccCCCCCceeecCCCcEEEcccCCcccccccccccee
Q 005898 608 T----GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVR 652 (671)
Q Consensus 608 ~----~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~ 652 (671)
. ...+.++|+|+++.||+++ + .+.|.||+.+...+-++.++..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~~~Dla~~ 233 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPAVQDLWML 233 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEECTTHHHHTT
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcHHHHHHHH
Confidence 1 1224579999999999999 4 8999999998877644444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0025 Score=68.45 Aligned_cols=155 Identities=19% Similarity=0.196 Sum_probs=91.0
Q ss_pred CceeccCCceEEEEEEEcC--------CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCc-ccccceeecCCCCCCcc
Q 005898 488 SAIMGEGSYGKLYKGRLEN--------GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL-VCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~~ 558 (671)
.+.|+.|-...||+...++ +..+.+|+..... ..+.+.+|..+++.+...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~------ 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G------ 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C------
Confidence 4567888889999998753 4788888874321 12455678888887754444 45555442 1
Q ss_pred cceEEEEEecCCCCChhh--------------h---hhcCC-C-CCCCC--HHHHHHHHH--------------------
Q 005898 559 VNKVFLVYEFMSNGNFRT--------------H---ISENT-P-GKVLN--WSERLAVLI-------------------- 597 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~--------------~---l~~~~-~-~~~l~--~~~~~~i~~-------------------- 597 (671)
.+|+||+++.++.. . +|... + ..... |....++..
T Consensus 148 ----g~v~e~l~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~~~~~~~~~i~~w~~~~~~~~~~~~~~~v~~~~~~ 223 (429)
T 1nw1_A 148 ----GRLEEYIPSRPLSCHEISLAHMSTKIAKRVAKVHQLEVPIWKEPDYLCEALQRWLKQLTGTVDAEHRFDLPEECGV 223 (429)
T ss_dssp ----EEEECCCCEEECCTTGGGSHHHHHHHHHHHHHHTTCCCSSCCSSCHHHHHHHHHHHHHHHHSCTTCCEECCGGGSC
T ss_pred ----CEEEEEeCCcccChhhcCCHHHHHHHHHHHHHHhCCccccCCCcchHHHHHHHHHHHHHhhccccccccccccccc
Confidence 48999998633321 1 12211 1 11122 322112211
Q ss_pred ------HHHHHHHHhc----C-CCCCCccccCCCCCceeecCC----------------------------CcEEEcccC
Q 005898 598 ------GVAKAVQFLH----T-GVIPGFFNNRVKTNNILLNEH----------------------------RIAKLSDYG 638 (671)
Q Consensus 598 ------~ia~gl~yLH----~-~~~~~iiHrDlk~~NiLl~~~----------------------------~~~ki~DfG 638 (671)
.+.+.++++. . ...+.++|+|+.+.||+++++ ..+.|.||.
T Consensus 224 ~~~~~~~l~~~~~~l~~~l~~~~~~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfE 303 (429)
T 1nw1_A 224 SSVNCLDLARELEFLRAHISLSKSPVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFE 303 (429)
T ss_dssp CEECHHHHHHHHHHHHHHHTTCCCCEEEECSCCCGGGEEEEC------------------------------CCEECCCT
T ss_pred ccccHHHHHHHHHHHHHhccccCCCeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecc
Confidence 1112222222 1 122358999999999999875 678999999
Q ss_pred Cccccccccccceeeeee
Q 005898 639 LSIVSEDINSVGVRLLIL 656 (671)
Q Consensus 639 la~~~~d~~s~g~~l~~~ 656 (671)
.+...+-.+.+|..+.+.
T Consensus 304 ya~~g~p~~DLA~~~~e~ 321 (429)
T 1nw1_A 304 YASYNYRAFDFANHFIEW 321 (429)
T ss_dssp TCEEEEHHHHHHHHHHHT
T ss_pred cCCcCccHHHHHHHHHHH
Confidence 999888666666655443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.38 E-value=0.00068 Score=64.19 Aligned_cols=115 Identities=17% Similarity=0.166 Sum_probs=67.8
Q ss_pred hcccCCCCCCEEecccc-cccc----cCCccccCCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCCcCCCC-
Q 005898 112 TTLARLTSLRVLSLVSL-GIWG----SLPDKIHRLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDNFFNNT- 181 (671)
Q Consensus 112 ~~l~~l~~L~~L~L~~n-~l~g----~~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~- 181 (671)
..+.+-+.|+.|+|++| .|.. .+-+.+..-+.|+.|+|++|.+... +...+..=+.|++|+|+.|.|+..
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34556678889999875 6632 2444566677888888888888532 223344456677888888877632
Q ss_pred ---CCcccCCCCCcCEEEccccc---CCC----CCcccccCCCCCCEEEeccCcc
Q 005898 182 ---IPNWFDSLPSLTFLSMRNNK---LAG----PFPSSIQRISTLSDLDLSKNAI 226 (671)
Q Consensus 182 ---~p~~~~~l~~L~~L~L~~N~---l~g----~~p~~l~~l~~L~~L~Ls~N~l 226 (671)
+-..+..-+.|+.|+|++|. +.. .+-..+..-++|+.|+++.|.+
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 22234444567777776542 221 1222334445666666666543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0073 Score=53.16 Aligned_cols=37 Identities=24% Similarity=0.451 Sum_probs=26.3
Q ss_pred ccceeecccccccCCCccccCCCCCcCeEecccCcCc
Q 005898 283 QLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFS 319 (671)
Q Consensus 283 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 319 (671)
+|+.|+|++|+|+.+++..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4667777777777777766777777777777777664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0053 Score=64.65 Aligned_cols=157 Identities=17% Similarity=0.132 Sum_probs=92.2
Q ss_pred CceeccCCceEEEEEEEc--------CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCc-ccccceeecCCCCCCcc
Q 005898 488 SAIMGEGSYGKLYKGRLE--------NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL-VCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~~~ 558 (671)
.+.+..|-...+|+.... +++.+.+|+-... ........+|.++++.+.-..+ .++++++.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-------- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-------- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence 356777888889998864 2468888886332 1234566788888877743333 455554421
Q ss_pred cceEEEEEecCCCCChhh-----------------hhhcCC--CCCCCC--HHHHHHHHHHHH-----------------
Q 005898 559 VNKVFLVYEFMSNGNFRT-----------------HISENT--PGKVLN--WSERLAVLIGVA----------------- 600 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~-----------------~l~~~~--~~~~l~--~~~~~~i~~~ia----------------- 600 (671)
.+||||+++..+.. -+|... -.+... |.+..++..++.
T Consensus 126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 39999999755431 112211 012233 333333332221
Q ss_pred --HHHHHh----cC-CCCCCccccCCCCCceeecCC----CcEEEcccCCccccccccccceeeeeee
Q 005898 601 --KAVQFL----HT-GVIPGFFNNRVKTNNILLNEH----RIAKLSDYGLSIVSEDINSVGVRLLILM 657 (671)
Q Consensus 601 --~gl~yL----H~-~~~~~iiHrDlk~~NiLl~~~----~~~ki~DfGla~~~~d~~s~g~~l~~~~ 657 (671)
+.+++| .. .....++|+|+.+.||+++++ +.+.+.||..+...+-.|.+|..+.+++
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~~~~Dla~~~~~~~ 269 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNYRGFDIGNHFCEWV 269 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEEHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCChHHHHHHHHHHHH
Confidence 122333 22 222368999999999999876 7899999999999887777787776655
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0092 Score=52.48 Aligned_cols=11 Identities=36% Similarity=0.232 Sum_probs=4.1
Q ss_pred CCEEEcccCcC
Q 005898 144 LEYLDLSSNFL 154 (671)
Q Consensus 144 L~~L~Ls~N~l 154 (671)
|++|+|++|+|
T Consensus 33 l~~L~Ls~N~l 43 (130)
T 3rfe_A 33 TTELVLTGNNL 43 (130)
T ss_dssp CSEEECTTSCC
T ss_pred CCEEECCCCcC
Confidence 33333333333
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0036 Score=65.76 Aligned_cols=44 Identities=18% Similarity=0.169 Sum_probs=35.0
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccccccccceeeeee
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLIL 656 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~~~ 656 (671)
+.++|+|+++.||+++++. +.|.||..+...+-.+.+|..+.++
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g~~~~Dla~~~~~~ 255 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGFNFLATDIANFFIET 255 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEEEEHHHHHHHHHHGG
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCCCchHHHHHHHHHHH
Confidence 3589999999999998655 8999999998887666667666554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.011 Score=63.84 Aligned_cols=74 Identities=15% Similarity=0.068 Sum_probs=45.6
Q ss_pred CceeccCCceEEEEEEEcC-CcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcc-cccceeecCCCCCCcccceEEEE
Q 005898 488 SAIMGEGSYGKLYKGRLEN-GTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV-CLLGHCIDGGGRDDYAVNKVFLV 565 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~~~~~~Lv 565 (671)
.+.|+.|-...+|+....+ +..+.+|+....... .-+-.+|..++..+...+++ ++++.+. + .+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~----------G~v 179 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N----------GRI 179 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T----------EEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C----------eEE
Confidence 3567888889999998765 477888876432211 11125778888877655554 5665542 1 359
Q ss_pred EecCCCCCh
Q 005898 566 YEFMSNGNF 574 (671)
Q Consensus 566 ~Ey~~~GsL 574 (671)
|||+++.++
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.57 E-value=0.0024 Score=60.35 Aligned_cols=88 Identities=11% Similarity=0.155 Sum_probs=50.7
Q ss_pred cccCCCCCCEEEcccC-cCCC----CCCccCCCCCccCEEEccCCcCCCC----CCcccCCCCCcCEEEcccccCCCC--
Q 005898 137 KIHRLYSLEYLDLSSN-FLFG----SVPPKISTMVKLQTLILDDNFFNNT----IPNWFDSLPSLTFLSMRNNKLAGP-- 205 (671)
Q Consensus 137 ~~~~L~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~-- 205 (671)
.+.+-+.|++|+|++| .+.. .+-..+..-+.|+.|+|++|.+... +...+..-+.|++|+|++|+|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 4556678999999885 6632 1233455556777777777776521 222333445677777777776521
Q ss_pred --CcccccCCCCCCEEEeccC
Q 005898 206 --FPSSIQRISTLSDLDLSKN 224 (671)
Q Consensus 206 --~p~~l~~l~~L~~L~Ls~N 224 (671)
+-+.+..-+.|+.|+|++|
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHhhCCceeEEECCCC
Confidence 1122333455666666643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.88 E-value=0.13 Score=53.10 Aligned_cols=42 Identities=7% Similarity=0.113 Sum_probs=34.7
Q ss_pred CCccccCCCCCceeecCCCcEEEcccCCccccccccccceee
Q 005898 612 PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRL 653 (671)
Q Consensus 612 ~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l 653 (671)
+.++|+|+.+.||++++++.+.|.||+.+...+-.+.++..+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~~~Dla~~~ 247 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKERDLMFIG 247 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEECTHHHHTTTT
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCHHHHHHHHH
Confidence 468999999999999988889999999998877555555544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.40 E-value=0.049 Score=58.06 Aligned_cols=44 Identities=18% Similarity=0.262 Sum_probs=37.5
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCccccccccccceeeeeee
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLILM 657 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~~~~ 657 (671)
.++|+|+.+.||+ ++++.+.+.||..+...+-.|.+|..+.+.+
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~~~~~Dla~~~~~~~ 306 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAINFAGADIANYFCEYI 306 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEEEHHHHHHHHHHTTT
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCcCChHHHHHHHHHHHH
Confidence 5899999999999 8888999999999998887777777665544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.84 E-value=0.068 Score=57.77 Aligned_cols=61 Identities=13% Similarity=0.103 Sum_probs=18.1
Q ss_pred cCceeccCCceEEEEEEEcC-CcEEEE------EEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeec
Q 005898 487 MSAIMGEGSYGKLYKGRLEN-GTSVAI------RCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~-g~~vAv------K~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 550 (671)
..+.+| ||.||+|.+.. ..+||| |..+... ......|.+|..++.+.+|||+++..++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999864 468999 7665432 2234568889999999999999999887643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.14 E-value=0.94 Score=47.68 Aligned_cols=44 Identities=27% Similarity=0.314 Sum_probs=35.1
Q ss_pred ccccCCCCCceee------cCCCcEEEcccCCccccccccccceeeeeee
Q 005898 614 FFNNRVKTNNILL------NEHRIAKLSDYGLSIVSEDINSVGVRLLILM 657 (671)
Q Consensus 614 iiHrDlk~~NiLl------~~~~~~ki~DfGla~~~~d~~s~g~~l~~~~ 657 (671)
++|.|+.+.||++ +++..+.+.||-+|....-.+.+|-.+.|++
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~~~fDlan~f~ew~ 295 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWM 295 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEEHHHHHHHHHHHTT
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCCchHhHHHHHHHHh
Confidence 5799999999999 4457799999999998876666676665543
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=80.50 E-value=0.39 Score=31.88 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=16.8
Q ss_pred CccceeeeehhhHHHHHHHHHHhheeeee
Q 005898 393 NVGKLVGIIVGVLVIMVLLAFGFLVVCRR 421 (671)
Q Consensus 393 ~~~~~igiivg~~v~l~l~~~~~~~~~rr 421 (671)
+.+.+.|+++++++.+.+++.+.++++||
T Consensus 9 s~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 9 TGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 45567788887776655554444444343
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 671 | ||||
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-27 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-26 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-26 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-26 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-24 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-24 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-23 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-23 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-23 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-22 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-22 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-22 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-21 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-21 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-21 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-21 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-20 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-20 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-20 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-19 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-18 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-18 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-18 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-12 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-05 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-16 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-16 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-16 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-16 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-14 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-14 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-14 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 |
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 39/176 (22%), Positives = 79/176 (44%), Gaps = 14/176 (7%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G+G +G + G G VA++C+ T + ++ +LRH +LV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
LLG ++ G +++V E+M+ G+ ++ VL L + V +A
Sbjct: 64 QLLGVIVEEKGG-------LYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEA 115
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLILMS 658
+++L F + + N+L++E +AK+SD+GL+ + G + +
Sbjct: 116 MEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA 168
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-27
Identities = 32/163 (19%), Positives = 72/163 (44%), Gaps = 14/163 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G G +G+++ G T VA++ L + +L+ +L+H LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLV 71
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L ++++ E+M NG+ + + K L ++ L + +A+
Sbjct: 72 RLYAVVTQ---------EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEG 121
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ F+ + + ++ NIL+++ K++D+GL+ + ED
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-27
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 17/171 (9%)
Query: 477 ELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLA 534
ELK+ ++F+ + +G G+ G ++K +G +A + + K +RN +R L +L
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
+ P++V G G ++ + E M G+ + + +
Sbjct: 60 ECNSPYIVGFYGAFYSDG--------EISICMEHMDGGSLDQVLKKAGR---IPEQILGK 108
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
V I V K + +L + VK +NIL+N KL D+G+S D
Sbjct: 109 VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 1e-26
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 27/190 (14%)
Query: 473 FTLEELKEATNNFDMSA---------IMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK 519
FT E+ EA F ++G G +G++ G L + VAI+ L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 520 -KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI 578
+ R+ ++ + HP+++ L G V ++ EFM NG+ + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--------TPVMIITEFMENGSLDSFL 118
Query: 579 SENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638
+N + + +L G+A +++L + + + NIL+N + + K+SD+G
Sbjct: 119 RQND--GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFG 173
Query: 639 LSIVSEDINS 648
LS ED S
Sbjct: 174 LSRFLEDDTS 183
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-26
Identities = 34/163 (20%), Positives = 64/163 (39%), Gaps = 14/163 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G G +G + G+ VAI+ + + ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLV 62
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L G C +F++ E+M+NG ++ + L + V +A
Sbjct: 63 QLYGVCTKQR--------PIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEA 112
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+++L F + + N L+N+ + K+SD+GLS D
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 36/168 (21%), Positives = 73/168 (43%), Gaps = 14/168 (8%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPH 540
+ +++ +G+G++GK+YK + E A + + + + + + + +D+LA HP+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V LL N ++++ EF + G + E + L S+ V
Sbjct: 71 IVKLLDAFYYE--------NNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTL 120
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
A+ +LH + +K NIL KL+D+G+S +
Sbjct: 121 DALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 6e-26
Identities = 30/166 (18%), Positives = 69/166 (41%), Gaps = 14/166 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G GS+G +YKG+ +V + + + ++ K + +L K RH +++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
+G+ ++ +V ++ + H+ + + + A+
Sbjct: 68 LFMGYSTA---------PQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQG 116
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ +LH + +K+NNI L+E K+ D+GL+ V +
Sbjct: 117 MDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 8e-26
Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 18/169 (10%)
Query: 485 FDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYT---VRNLKLRLDLLAKLRHPH 540
F +G GS+G +Y R + N VAI+ + S K + +++ + L KLRHP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+ G + + +LV E+ P L E AV G
Sbjct: 77 TIQYRGCYLRE--------HTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGAL 125
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSV 649
+ + +LH+ + VK NILL+E + KL D+G + + NS
Sbjct: 126 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 171
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 37/172 (21%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPH 540
++++ +G GSYG+ K R +G + + L + + L ++LL +L+HP+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGV 599
+V ID +++V E+ G+ + I++ T + L+ L V+ +
Sbjct: 65 IVRYYDRIIDRTN------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118
Query: 600 AKAVQFLH--TGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSV 649
A++ H + + +K N+ L+ + KL D+GL+ + S
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 170
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-24
Identities = 27/159 (16%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 492 GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDG 551
G+G +G++++G+ G VA++ S ++ + + + LRH +++ +
Sbjct: 12 GKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK- 68
Query: 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVI 611
D+ +++LV ++ +G+ +++ T + + + + A + LH ++
Sbjct: 69 ---DNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 612 -----PGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
P + +K+ NIL+ ++ ++D GL++ +
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 1e-24
Identities = 37/164 (22%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+ M +G G YG++Y+G + +VA++ L V ++ +++HP+L
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNL 75
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
V LLG C +++ EFM+ GN ++ E + ++ L + ++
Sbjct: 76 VQLLGVCTREP--------PFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISS 126
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
A+++L F + + N L+ E+ + K++D+GLS +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 2e-24
Identities = 33/163 (20%), Positives = 67/163 (41%), Gaps = 14/163 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ +G G +G ++ G N VAI+ + + + +++ KL HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLV 63
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L G C++ + LV+EFM +G ++ + L + + V +
Sbjct: 64 QLYGVCLEQA--------PICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEG 113
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ + + N L+ E+++ K+SD+G++ D
Sbjct: 114 ---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 4e-24
Identities = 36/163 (22%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
+ + +G+G +G+++ G T VAI+ L + ++ KLRH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLV 75
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L + +++V E+MS G+ + T GK L + + + +A
Sbjct: 76 QLYAVVSE---------EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASG 125
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ ++ + + ++ NIL+ E+ + K++D+GL+ + ED
Sbjct: 126 MAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 1e-23
Identities = 35/179 (19%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 471 RSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS---KKYTVRNL 526
R + LE +F++ +G+G +G +Y R ++ +A++ L + K L
Sbjct: 1 RQWALE-------DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 527 KLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV 586
+ +++ + LRHP+++ L G+ D +V+L+ E+ G + + +
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDA--------TRVYLILEYAPLGTVYRELQKLSK--- 102
Query: 587 LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ + +A A+ + H+ + +K N+LL K++D+G S+ +
Sbjct: 103 FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 100 bits (251), Expect = 1e-23
Identities = 35/169 (20%), Positives = 75/169 (44%), Gaps = 16/169 (9%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+++D+ +G G++G +++ G + A + + + + ++ + ++ LRHP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
V L D N++ ++YEFMS G +++ ++ E + + V K
Sbjct: 86 VNLHDAFEDD--------NEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCK 135
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHR--IAKLSDYGLSIVSEDINS 648
+ +H + + +K NI+ R KL D+GL+ + S
Sbjct: 136 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99.2 bits (246), Expect = 2e-23
Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 39/194 (20%)
Query: 475 LEELKEATNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKL 528
L L+ NN + +GEG++G++++ R E T VA++ L ++
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 529 R-LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTP---- 583
R L+A+ +P++V LLG C G + L++E+M+ G+ + +P
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVG--------KPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 584 -----------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILL 626
L+ +E+L + VA + +L F + + T N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 173
Query: 627 NEHRIAKLSDYGLS 640
E+ + K++D+GLS
Sbjct: 174 GENMVVKIADFGLS 187
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 5e-23
Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 16/168 (9%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKY-TVRNLKLRLDLLAKLRHPH 540
++D+ +GEG+YG++ +VA++ + + N+K + + L H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V GH +G N +L E+ S G I + + + +
Sbjct: 65 VVKFYGHRREG--------NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLM 113
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
V +LH G + +K N+LL+E K+SD+GL+ V N
Sbjct: 114 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 6e-23
Identities = 36/168 (21%), Positives = 74/168 (44%), Gaps = 19/168 (11%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLR 537
++ +GEG +G +++G +VAI+ + +VR L+ + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
HPH+V L+G + N V+++ E + G R+ + L+ + +
Sbjct: 67 HPHIVKLIGVITE---------NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAY 115
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
++ A+ +L + F + + N+L++ + KL D+GLS ED
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 6e-23
Identities = 37/170 (21%), Positives = 73/170 (42%), Gaps = 19/170 (11%)
Query: 476 EELKEATNNFDMSAI-MGEGSYGKLYKGRL---ENGTSVAIRCL-PSSKKYTVRNLKLRL 530
++L +N ++ I +G G++G + +G + VAI+ L ++K +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 531 DLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWS 590
++ +L +P++V L+G C + LV E G + + + S
Sbjct: 61 QIMHQLDNPYIVRLIGVCQA---------EALMLVMEMAGGGPLHKFLVGK--REEIPVS 109
Query: 591 ERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+L V+ +++L F + + N+LL AK+SD+GLS
Sbjct: 110 NVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 156
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.7 bits (245), Expect = 7e-23
Identities = 35/170 (20%), Positives = 73/170 (42%), Gaps = 21/170 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK------KYTVRNLKLRLDLLAK 535
N+F + I+G G +G++Y R + G A++CL + + N ++ L L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
P +VC+ +K+ + + M+ G+ H+S++ + ++
Sbjct: 64 GDCPFIVCMSYAFHTP--------DKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFY 112
Query: 596 LIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ ++ +H +K NILL+EH ++SD GL+
Sbjct: 113 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 1e-22
Identities = 36/174 (20%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 474 TLEELKEATNNFDMS------AIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNL 526
LE+L+ + D +G+G+ G +Y + G VAIR + ++ +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 527 KLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKV 586
+ ++ + ++P++V L + G +++++V E+++ G+ ++E
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTETCM--- 113
Query: 587 LNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + AV +A++FLH+ + +K++NILL KL+D+G
Sbjct: 114 -DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.6 bits (240), Expect = 1e-22
Identities = 32/172 (18%), Positives = 67/172 (38%), Gaps = 13/172 (7%)
Query: 476 EELKEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLL 533
++ ++ + +D ++G G++ ++ VAI+C+ + +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 534 AKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
K++HP++V L G ++L+ + +S G I E +
Sbjct: 62 HKIKHPNIVALDDIYESG--------GHLYLIMQLVSGGELFDRIVEKGF---YTERDAS 110
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
++ V AV++LH I L+E +SD+GLS + +
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 3e-22
Identities = 40/158 (25%), Positives = 65/158 (41%), Gaps = 12/158 (7%)
Query: 492 GEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHC 548
G GS+ +YKG E VA L K K + K ++L L+HP++V
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSW 77
Query: 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT 608
+ LV E M++G +T++ KV+ + + K +QFLHT
Sbjct: 78 ESTVKGKKC----IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT 130
Query: 609 GVIPGFFNNRVKTNNILLN-EHRIAKLSDYGLSIVSED 645
P + +K +NI + K+ D GL+ +
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 3e-22
Identities = 38/166 (22%), Positives = 68/166 (40%), Gaps = 18/166 (10%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSS---KKYTVRNLKLRLDLLA 534
K+ +F I+GEGS+ + R L AI+ L K+ V + D+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLA 594
+L HP V L D K++ + NG +I + + +
Sbjct: 64 RLDHPFFVKLYFTFQDD--------EKLYFGLSYAKNGELLKYIRKIGS---FDETCTRF 112
Query: 595 VLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ A+++LH I + +K NILLNE +++D+G +
Sbjct: 113 YTAEIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTA 155
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 7e-22
Identities = 41/189 (21%), Positives = 74/189 (39%), Gaps = 34/189 (17%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAK 535
N +G G++GK+ + + +VA++ L S T R + L +L+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 536 L-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN------------- 581
L H ++V LLG C GG ++ E+ G+ +
Sbjct: 83 LGNHMNIVNLLGACTIGG--------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 582 --TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
L+ + L+ VAK + FL + + + NILL RI K+ D+GL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 640 SIVSEDINS 648
+ ++ ++
Sbjct: 192 ARDIKNDSN 200
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 1e-21
Identities = 30/165 (18%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLE----NGTSVAIRCLPS---SKKYTVRNLKLRLDLLAK 535
+ + +G+GS+G + +G + SVA++CL S+ + + ++ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
L H +L+ L G + + +V E G+ + ++
Sbjct: 68 LDHRNLIRLYGVVLTP---------PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRY 116
Query: 596 LIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ VA+ + +L + F + + N+LL + K+ D+GL
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 158
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 94.7 bits (235), Expect = 1e-21
Identities = 27/166 (16%), Positives = 66/166 (39%), Gaps = 16/166 (9%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
+ +D+ +G G++G +++ G + + + +K + ++ +L HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
+ L D ++ L+ EF+S G I+ ++ +E + + +
Sbjct: 89 INLHDAFEDK--------YEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACE 138
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHR--IAKLSDYGLSIVSED 645
++ +H + +K NI+ + K+ D+GL+
Sbjct: 139 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 92.4 bits (229), Expect = 2e-21
Identities = 31/173 (17%), Positives = 68/173 (39%), Gaps = 25/173 (14%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR---------LDLL 533
N++ I+G G + + A++ + + + +++ +D+L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 534 AKLR-HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSER 592
K+ HP+++ L FLV++ M G +++E L+ E
Sbjct: 64 RKVSGHPNIIQLKDTYETN--------TFFFLVFDLMKKGELFDYLTEKVT---LSEKET 112
Query: 593 LAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
++ + + + LH + +K NILL++ KL+D+G S +
Sbjct: 113 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 8e-21
Identities = 36/186 (19%), Positives = 72/186 (38%), Gaps = 39/186 (20%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLEN------GTSVAIRCLPSSKKYTVRNLKLR-LDLLAK 535
N + ++G G++GK+ VA++ L + R + L ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 536 L-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI---------------- 578
L H ++V LLG C G ++L++E+ G+ ++
Sbjct: 97 LGSHENIVNLLGACTLSG--------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 579 ----SENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634
E VL + + L VAK ++FL + + N+L+ ++ K+
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 205
Query: 635 SDYGLS 640
D+GL+
Sbjct: 206 CDFGLA 211
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 1e-20
Identities = 35/156 (22%), Positives = 66/156 (42%), Gaps = 17/156 (10%)
Query: 490 IMGEGSYGKLYKGRLENGTS----VAIRCL-PSSKKYTVRNLKLRLDLLAKLRHPHLVCL 544
++G G +G +Y G L + A++ L + V ++ HP+++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 545 LGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQ 604
LG C+ G +V +M +G+ R I T + + + VAK ++
Sbjct: 94 LGICLRSEG-------SPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMK 144
Query: 605 FLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
FL F + + N +L+E K++D+GL+
Sbjct: 145 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 34/159 (21%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV 542
++ + ++G GS+G +Y+ +L ++G VAI+ + K++ R L++ + KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI----MRKLDHCNIV 76
Query: 543 CLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKA 602
L G + D + LV +++ +R + + L + + ++
Sbjct: 77 RLRYFFYSSGEKKDE--VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 603 VQFLHTGVIPGFFNNRVKTNNILLNEH-RIAKLSDYGLS 640
+ ++H+ G + +K N+LL+ + KL D+G +
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 2e-20
Identities = 38/169 (22%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTS-----VAIRCLPSSKKYTVRNLKLR-LDLLAKL 536
+ ++G G +G++YKG L+ + VAI+ L + R L ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 537 RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVL 596
H +++ L G + ++ E+M NG + E + + + +L
Sbjct: 67 SHHNIIRLEGVISKY--------KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGML 116
Query: 597 IGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
G+A +++L + + + NIL+N + + K+SD+GLS V ED
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 3e-20
Identities = 43/176 (24%), Positives = 81/176 (46%), Gaps = 29/176 (16%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENG---TSVAIRCL-PSSKKYTVRNLKLRLDLLAKL-R 537
N+ ++GEG++G++ K R++ AI+ + + K R+ L++L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISE-------------NTPG 584
HP+++ LLG C G ++L E+ +GN + + N+
Sbjct: 70 HPNIINLLGACEHRG--------YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
L+ + L VA+ + +L F + + NIL+ E+ +AK++D+GLS
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 174
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 4e-20
Identities = 29/165 (17%), Positives = 70/165 (42%), Gaps = 17/165 (10%)
Query: 479 KEATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR 537
KE + ++ +G G +G +++ + + + + V +K + +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIAR 59
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
H +++ L ++ +++EF+S + I+ + LN E ++ +
Sbjct: 60 HRNILHLHESFESM--------EELVMIFEFISGLDIFERINTS--AFELNEREIVSYVH 109
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR--IAKLSDYGLS 640
V +A+QFLH+ + ++ NI+ R K+ ++G +
Sbjct: 110 QVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.6 bits (219), Expect = 4e-20
Identities = 35/175 (20%), Positives = 73/175 (41%), Gaps = 31/175 (17%)
Query: 471 RSFTLEELKEATNNFDMSAIMGEGSYGKLYKGRLEN---GTSVAIRCLP--SSKKYTVRN 525
+ TLE+ + +G G++G + KG + +VA++ L ++
Sbjct: 6 KLLTLEDKE-----------LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 54
Query: 526 LKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGK 585
L +++ +L +P++V ++G C LV E G ++ +N
Sbjct: 55 LLAEANVMQQLDNPYIVRMIGICEA---------ESWMLVMEMAELGPLNKYLQQNRH-- 103
Query: 586 VLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + ++ V+ +++L F + + N+LL AK+SD+GLS
Sbjct: 104 -VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 154
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 86.7 bits (214), Expect = 2e-19
Identities = 30/163 (18%), Positives = 64/163 (39%), Gaps = 14/163 (8%)
Query: 482 TNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP---SSKKYTVRNLKLRLDLLAKLR 537
++ +++ I+G G +++ R L VA++ L + + A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
HP +V + + A ++V E++ R + P + + V+
Sbjct: 66 HPAIVAVYDTGEA----ETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIA 118
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+A+ F H G + VK NI+++ K+ D+G++
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.3 bits (215), Expect = 2e-19
Identities = 31/161 (19%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP--SSKKYTVRNLKLRLDLLAKLRHP 539
+ ++ A +G+G++G+++K R + G VA++ + + K+ + +L L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
++V L+ C + ++LV++F + + SE V+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ ++H + +K N+L+ + KL+D+GL+
Sbjct: 127 LNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 7e-19
Identities = 33/171 (19%), Positives = 68/171 (39%), Gaps = 19/171 (11%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLD----LLAKLR 537
+F + ++G+GS+GK++ + AI+ L +++ + L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
HP L + +F V E+++ G+ HI + S
Sbjct: 62 HPFLTHMFCTFQTKE--------NLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAA 110
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ +QFLH+ G +K +NILL++ K++D+G+ + ++
Sbjct: 111 EIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 9e-19
Identities = 34/171 (19%), Positives = 70/171 (40%), Gaps = 25/171 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAK 535
MS +G+GS+G +Y+G E T VAI+ + + R L ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI-------SENTPGKVLN 588
H+V LLG G ++ E M+ G+ ++++ + N +
Sbjct: 80 FNCHHVVRLLGVVSQG--------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 589 WSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
S+ + + +A + +L+ F + + N ++ E K+ D+G+
Sbjct: 132 LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 179
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 1e-18
Identities = 31/163 (19%), Positives = 65/163 (39%), Gaps = 13/163 (7%)
Query: 480 EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR-LDLLAKLR 537
+ + + +GEG+YG + N VAI+ + + T LR + +L + R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 538 HPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLI 597
H +++ + V+LV M + + L+ L
Sbjct: 65 HENIIGINDIIRAPTIEQM---KDVYLVTHLM-GADLYKLLKTQH----LSNDHICYFLY 116
Query: 598 GVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + ++++H+ + +K +N+LLN K+ D+GL+
Sbjct: 117 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 156
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (211), Expect = 1e-18
Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 17/175 (9%)
Query: 473 FTLEELKEAT----NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL--PSSKKYTVRN 525
F +E+ + + +G G+YG + G VAI+ L P + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 526 LKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGK 585
L LL +RH +++ LL DD +LV FM G + ++
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDD--FTDFYLVMPFM--GTDLGKLMKHEK-- 117
Query: 586 VLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
L ++ + K ++++H G + +K N+ +NE K+ D+GL+
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.5 bits (211), Expect = 1e-18
Identities = 34/163 (20%), Positives = 66/163 (40%), Gaps = 16/163 (9%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHC 548
++G G GK+ + A++ L K R ++L + PH+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-REVELHWRAS---QCPHIVRIVDVY 74
Query: 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT 608
+ + +V E + G + I + + E ++ + +A+Q+LH+
Sbjct: 75 ENLYAGRKC----LLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 609 GVIPGFFNNRVKTNNILLNEHR---IAKLSDYGLSIVSEDINS 648
I + VK N+L R I KL+D+G + + NS
Sbjct: 130 INIA---HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 1e-18
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 20/157 (12%)
Query: 490 IMGEGSYGKLYKGR-LENGTSVAIRCLP-----SSKKYTVRNLKLRLDLLAKLRHPHLVC 543
+GEG + +YK R VAI+ + +K R + LL +L HP+++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
LL + + LV++FM VL S A ++ + +
Sbjct: 65 LLDAFGHK--------SNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGL 113
Query: 604 QFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
++LH I + +K NN+LL+E+ + KL+D+GL+
Sbjct: 114 EYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLA 147
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 4e-18
Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 31/179 (17%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR------LENGTSVAIRCLP--SSKKYTVRNLKLRLDLLA 534
+ + +G G++G++ + +VA++ L ++ + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 535 KLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI-------------SEN 581
H ++V LLG C G + ++ EF GN T++ E+
Sbjct: 73 IGHHLNVVNLLGACTKPG-------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 582 TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
L + VAK ++FL + + + NILL+E + K+ D+GL+
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 1e-17
Identities = 33/162 (20%), Positives = 69/162 (42%), Gaps = 20/162 (12%)
Query: 485 FDMSAIMGEGSYGKLYKGRL-----ENGTSVAIRCL-PSSKKYTVRNLKLRLDLLAKLRH 538
F ++G G++G +YKG + VAI+ L ++ + + ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
PH+ LLG C+ V L+ + M G ++ E+ + L +
Sbjct: 71 PHVCRLLGICLTS---------TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQ 119
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+AK + +L + + N+L+ + K++D+GL+
Sbjct: 120 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 158
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 80.7 bits (198), Expect = 5e-17
Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPH 540
+++ + +G G Y ++++ + N V ++ L KK ++ + +L LR P+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPN 91
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
++ L D R LV+E ++N +F+ + L + + +
Sbjct: 92 IITLADIVKDPVSRTPA------LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEIL 139
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILL-NEHRIAKLSDYGLS 640
KA+ + H+ G + VK +N+++ +EHR +L D+GL+
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 6e-17
Identities = 42/256 (16%), Positives = 88/256 (34%), Gaps = 7/256 (2%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF 177
+L L + I L +L L L +N + P + +VKL+ L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 178 FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLG 237
+L L K+ + + ++ + + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 238 SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM 297
L+ + ++D + + LP L L N + LN L +L +SFN++ +
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210
Query: 298 PPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG------GLPSCLS 351
++ + P++ +L+L +NK + + + NN ++ P +
Sbjct: 211 DNGSLANTPHLRELHLNNNKLVKVPGGLADH-KYIQVVYLHNNNISAIGSNDFCPPGYNT 269
Query: 352 NESDKRVVKFRGNCLS 367
++ V N +
Sbjct: 270 KKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 66.6 bits (161), Expect = 2e-12
Identities = 42/256 (16%), Positives = 80/256 (31%), Gaps = 26/256 (10%)
Query: 133 SLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192
+P + LDL +N + + L TLIL +N + P F L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 193 TFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSN 252
L + N+L + + L + + S+ + + + L
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL---------- 131
Query: 253 LPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLN 312
+ SG + + +L + ++ + +P P++++L+
Sbjct: 132 -----------GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELH 177
Query: 313 LASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSSNVQN 372
L NK + +L L +S N ++ L+N R + N L
Sbjct: 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG 237
Query: 373 QHPESYCFEVRTERNQ 388
Y V N
Sbjct: 238 LADHKYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 24/115 (20%), Positives = 41/115 (35%)
Query: 238 SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM 297
L V+ SD L+ LP + L NN + + L L L + N + +
Sbjct: 11 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 298 PPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
P A L + L L+ N+ K +L + K+ + + L+
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 27/144 (18%), Positives = 47/144 (32%), Gaps = 11/144 (7%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLI 172
+ L + + I ++P + SL L L N + + + L L
Sbjct: 145 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 173 LDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG---- 228
L N + + P L L + NNKL P + + + L N IS
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 229 ---SLPDLSSLGSLNVLNLSDNKL 249
+ S + ++L N +
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 37/247 (14%), Positives = 83/247 (33%), Gaps = 11/247 (4%)
Query: 7 NLLLLLCLSWSLFPLGTHQLQSSQTQVLLQLR--KHLEYPKQLEIWINHGADFCYISSST 64
NL L+ ++ + + L L + E P+++ + +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 65 QVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLAR--LTSLRV 122
+ ++ N + +++ + + G +G LS D+ +TT+ + SL
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE 175
Query: 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI 182
L L I + L +L L LS N + ++ L+ + +N +
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE-LHLNNNKLVKV 234
Query: 183 PNWFDSLPSLTFLSMRNNKLAG------PFPSSIQRISTLSDLDLSKNAISGSLPDLSSL 236
P + + + NN ++ P + ++ S + L N + S+
Sbjct: 235 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
Query: 237 GSLNVLN 243
+ V
Sbjct: 295 RCVYVRA 301
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 78.8 bits (193), Expect = 9e-17
Identities = 29/160 (18%), Positives = 63/160 (39%), Gaps = 16/160 (10%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPH 540
+ +GEG+YG +YK + G + A++ + K + + +L +L+H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V L ++ LV+E + + L + L+ +
Sbjct: 62 IVKLYDVIHTK--------KRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLL 110
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ + H + +K N+L+N K++D+GL+
Sbjct: 111 NGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 1e-16
Identities = 32/189 (16%), Positives = 82/189 (43%), Gaps = 34/189 (17%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL--------ENGTSVAIRCL-PSSKKYTVRNLKLRLDLL 533
+ + +GEG++G++ T VA++ L + + + +L ++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 534 AKL-RHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHI-------------S 579
+ +H +++ LLG C ++++ E+ S GN R ++
Sbjct: 73 KMIGKHKNIINLLGACTQD--------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 580 ENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639
+ P + L+ + ++ VA+ +++L + + + N+L+ E + K++D+GL
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 640 SIVSEDINS 648
+ I+
Sbjct: 182 ARDIHHIDY 190
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.4 bits (192), Expect = 2e-16
Identities = 41/187 (21%), Positives = 75/187 (40%), Gaps = 26/187 (13%)
Query: 470 CRSFTLEELKEATNNFDMSAIMGEGSYGKLYKGR--LENGTSVAIRCLPSSK------KY 521
CR+ ++ A +GEG+YGK++K R G VA++ +
Sbjct: 3 CRA---------DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS 53
Query: 522 TVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISEN 581
T+R + + L L HP++V L C + K+ LV+E +
Sbjct: 54 TIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRE---TKLTLVFEHVDQDLTTYLDKVP 109
Query: 582 TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641
PG + ++ + + + FLH+ + +K NIL+ KL+D+GL+
Sbjct: 110 EPG--VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 164
Query: 642 VSEDINS 648
+ +
Sbjct: 165 IYSFQMA 171
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.6 bits (193), Expect = 2e-16
Identities = 30/167 (17%), Positives = 69/167 (41%), Gaps = 18/167 (10%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP---SSKKYTVRNLKLRLDLLAKLRH 538
+F + +G GS+G+++ R NG A++ L + V + +L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
P ++ + G D ++F++ +++ G + + ++ + +A
Sbjct: 64 PFIIRMWGTFQDA--------QQIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFY- 109
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
A+ L +K NILL+++ K++D+G + D
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 3e-16
Identities = 34/170 (20%), Positives = 65/170 (38%), Gaps = 18/170 (10%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRH 538
N+FD ++G+G++GK+ R G A++ L K V + +L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
P L L +++ V E+ + G H+S
Sbjct: 65 PFLTALKYAFQTH--------DRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAE 113
Query: 599 VAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ A+++LH+ +K N++L++ K++D+GL +
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 6e-16
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 484 NFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP--SSKKYTVRNLKLRLDLLAKLRHPH 540
NF +GEG+YG +YK R G VA++ + + + + LL +L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 541 LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVA 600
+V LL NK++LV+EF+ + + G + + L +
Sbjct: 63 IVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLL 112
Query: 601 KAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSED 645
+ + F H+ + + +K N+L+N KL+D+GL+
Sbjct: 113 QGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGV 154
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 76.4 bits (187), Expect = 7e-16
Identities = 28/187 (14%), Positives = 59/187 (31%), Gaps = 21/187 (11%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
++ + +GEGS+G +++G L N VAI+ P ++ L+ L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
+ + + G + LV + + G+ + +
Sbjct: 63 IPNVYYFGQEGLHN-------VLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLA 112
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNE-----HRIAKLSDYGLSIVSEDINSVGVRLLIL 656
VQ +H +K +N L+ + + D+G+ D +
Sbjct: 113 RVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 657 MSFFFGS 663
G+
Sbjct: 170 KKNLSGT 176
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 9e-16
Identities = 34/169 (20%), Positives = 66/169 (39%), Gaps = 25/169 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR------LDLLAK 535
+ +D +G G + + K R G A + + + + R R + +L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 536 LRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAV 595
++HP+++ L + V L+ E ++ G ++E L E
Sbjct: 70 IQHPNVITLHEVYENK--------TDVILILELVAGGELFDFLAEKES---LTEEEATEF 118
Query: 596 LIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEH----RIAKLSDYGLS 640
L + V +LH+ I F +K NI+L + K+ D+GL+
Sbjct: 119 LKQILNGVYYLHSLQIAHFD---LKPENIMLLDRNVPKPRIKIIDFGLA 164
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.3 bits (186), Expect = 1e-15
Identities = 74/326 (22%), Positives = 132/326 (40%), Gaps = 24/326 (7%)
Query: 29 SQTQVLLQLRKHLEYPKQLEIWINHGADFCYISSSTQVNITCQDNFITELKIIGDKPSNV 88
Q LLQ++K L P L W D C + T + + C D +
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSW-LPTTDCC---NRTWLGVLC------------DTDTQT 49
Query: 89 GNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLD 148
+ + +L + + I S + L L L + + +L +P I +L L YL
Sbjct: 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP--IPPAIAKLTQLHYLY 107
Query: 149 LSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPS 208
++ + G++P +S + L TL N + T+P SLP+L ++ N+++G P
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 209 SIQRISTLS-DLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSN 267
S S L + +S+N ++G +P + +L ++LS N L+ + L +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 268 NSFSGEIPKQYGQLNQLQQL--DMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKN 325
+ + D+ N + G P + L + LN++ N G +P+
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 326 LNCGGKLVFFDISNNKLTGG--LPSC 349
N + +NNK G LP+C
Sbjct: 288 GNL-QRFDVSAYANNKCLCGSPLPAC 312
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.6 bits (187), Expect = 2e-15
Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 14/203 (6%)
Query: 139 HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMR 198
+L +LE L ++N + P I + L L L+ N SL +LT L +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLA 249
Query: 199 NNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPR 258
NN+++ P + ++ L++L L N IS P N+ + D + +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 259 GLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKF 318
L L N+ S P L +LQ+L + N + ++ +L NI+ L+ N+
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 319 SGSLP-KNLNCGGKLVFFDISNN 340
S P NL ++ +++
Sbjct: 364 SDLTPLANLT---RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 5e-15
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 10/179 (5%)
Query: 169 QTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG 228
++LI +N ++ P +L LS+ N+L ++ ++ L+DLDL+ N IS
Sbjct: 200 ESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN 255
Query: 229 SLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288
L LS L L L L N++ N+ L + L N E L L L
Sbjct: 256 -LAPLSGLTKLTELKLGANQIS-NISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLP 347
+ FN + + P + SL + L A+NK S +L + + +N+++ P
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.2 bits (173), Expect = 8e-14
Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 14/178 (7%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF 177
T+L LSL + + L +L LDL++N + P +S + KL L L N
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 178 FNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLG 237
+N P L +LT L + N+ S I + L+ L L N IS P +SSL
Sbjct: 275 ISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP-VSSLT 329
Query: 238 SLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNA 293
L L ++NK+ S+L L + +N S P L ++ QL ++ A
Sbjct: 330 KLQRLFFANNKVSDVSSLANLTN-INWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.4 bits (145), Expect = 3e-10
Identities = 36/176 (20%), Positives = 68/176 (38%), Gaps = 27/176 (15%)
Query: 70 CQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLARLTSLRVLSLVSLG 129
+ EL + G++ ++G + N I + L+ LT L L L +
Sbjct: 216 GILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQ 274
Query: 130 IWGSLP--------------------DKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQ 169
I P I L +L YL L N + P +S++ KLQ
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332
Query: 170 TLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNA 225
L +N + + +L ++ +LS +N+++ P + ++ ++ L L+ A
Sbjct: 333 RLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 43/237 (18%), Positives = 83/237 (35%), Gaps = 15/237 (6%)
Query: 111 VTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQT 170
+ L + L LGI D + L +L ++ S+N L P + + KL
Sbjct: 37 TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230
+++++N + P + + ++ ++ L+ L+LS N IS
Sbjct: 93 ILMNNNQIADITPLANLT----NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS 148
Query: 231 PDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMS 290
+ + L L + SN +L L+ L +
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS---DISVLAKLTNLESLIAT 205
Query: 291 FNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLP 347
N + + P I N+ +L+L N+ L L D++NN+++ P
Sbjct: 206 NNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.3 bits (184), Expect = 3e-15
Identities = 33/176 (18%), Positives = 73/176 (41%), Gaps = 17/176 (9%)
Query: 472 SFTLEELK----EATNNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNL 526
+F +EL E + + +G G+YG + + G VA++ L + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 527 KLR--LDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPG 584
+ L LL ++H +++ LL +++ N V+LV M
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEF--NDVYLVTHLMGADLNNIV-----KC 115
Query: 585 KVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
+ L ++ + + ++++H+ + +K +N+ +NE K+ D+GL+
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 2e-14
Identities = 34/174 (19%), Positives = 65/174 (37%), Gaps = 25/174 (14%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLR------LDLLAK 535
+ + + ++G G +G +Y G + + VAI+ + + L + LL K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 536 LRHPH--LVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNG-NFRTHISENTPGKVLNWSER 592
+ ++ LL + L+ E + I+E L
Sbjct: 64 VSSGFSGVIRLLDWFERP--------DSFVLILERPEPVQDLFDFITERGA---LQEELA 112
Query: 593 LAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGLSIVSED 645
+ V +AV+ H G + +K NIL++ +R KL D+G + +D
Sbjct: 113 RSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (177), Expect = 2e-14
Identities = 30/161 (18%), Positives = 61/161 (37%), Gaps = 14/161 (8%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCL--PSSKKYTVRNLKLRLDLLAKLRHP 539
+ +G G+ G + +VAI+ L P + + L L+ + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
+++ LL +++ V+LV E M + E +L +
Sbjct: 77 NIISLLNVFTPQKTLEEF--QDVYLVMELMDANLCQVIQMELD------HERMSYLLYQM 128
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
++ LH+ G + +K +NI++ K+ D+GL+
Sbjct: 129 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.4 bits (174), Expect = 3e-14
Identities = 30/185 (16%), Positives = 64/185 (34%), Gaps = 19/185 (10%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHL 541
N + + +G GS+G +Y G + G VAI+ K+ L + + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 542 VCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAK 601
+ + C G + +V E + + + L + +
Sbjct: 65 IPTIRWCGAEG-------DYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMIS 114
Query: 602 AVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL---SDYGLSIVSEDINSVGVRLLILMS 658
++++H+ F + VK +N L+ + L D+GL+ D +
Sbjct: 115 RIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 659 FFFGS 663
G+
Sbjct: 172 NLTGT 176
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.5 bits (174), Expect = 4e-14
Identities = 35/161 (21%), Positives = 68/161 (42%), Gaps = 17/161 (10%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLP--SSKKYTVRNLKLRLDLLAKLRHP 539
++ +GEG+YG ++K + E VA++ + + + + LL +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 540 HLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGV 599
++V L K+ LV+EF + S N L+ + L +
Sbjct: 62 NIVRLHDVLHSD--------KKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQL 110
Query: 600 AKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640
K + F H + +K N+L+N + KL+++GL+
Sbjct: 111 LKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 71.0 bits (173), Expect = 9e-14
Identities = 31/164 (18%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 483 NNFDMSAIMGEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRL---DLLAKLRH 538
+ FD +G GS+G++ + E+G A++ L K ++ ++ L +L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 539 PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIG 598
P LV L D + +++V E+++ G +H+ +
Sbjct: 101 PFLVKLEFSFKD--------NSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQ 149
Query: 599 VAKAVQFLHT-GVIPGFFNNR-VKTNNILLNEHRIAKLSDYGLS 640
+ ++LH+ +I R +K N+L+++ +++D+G +
Sbjct: 150 IVLTFEYLHSLDLI-----YRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.0 bits (155), Expect = 2e-12
Identities = 23/165 (13%), Positives = 45/165 (27%), Gaps = 20/165 (12%)
Query: 490 IMGEGSYGKLYKGRLENGTSVAIRCLPSSK------KYTVRNLKLRLDLLAKLRHPHLVC 543
+MGEG ++ E ++ K L +LA +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 544 LLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAV 603
L YA ++ E + VL + + V
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMILEEV 116
Query: 604 QFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ I + + N+L++E I + D+ S+ +
Sbjct: 117 AKFYHRGI---VHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGW 157
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 3e-12
Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 23/175 (13%)
Query: 483 NNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLP----SSKKYTVRNLKLRLDLLA 534
NF++ ++G G+YGK++ R + G A++ L K T + + +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 535 KLRH-PHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERL 593
+R P LV L K+ L+ ++++ G TH+S+ E
Sbjct: 84 HIRQSPFLVTLHYAFQTE--------TKLHLILDYINGGELFTHLSQRER---FTEHEVQ 132
Query: 594 AVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINS 648
+ + A++ LH G +K NILL+ + L+D+GLS +
Sbjct: 133 IYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.8 bits (156), Expect = 4e-12
Identities = 46/186 (24%), Positives = 70/186 (37%), Gaps = 6/186 (3%)
Query: 114 LARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLIL 173
L L L L G+ P L +L+YL L N L + L L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160
Query: 174 DDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISG-SLPD 232
N ++ F L SL L + N++A P + + + L L L N +S
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220
Query: 233 LSSLGSLNVLNLSDNKL--DSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMS 290
L+ L +L L L+DN D L L S++ +P+ +L ++
Sbjct: 221 LAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLA 277
Query: 291 FNALRG 296
N L+G
Sbjct: 278 ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (150), Expect = 3e-11
Identities = 34/173 (19%), Positives = 58/173 (33%)
Query: 100 SLSENFSIDSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVP 159
L + L +L+ L L + D L +L +L L N +
Sbjct: 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170
Query: 160 PKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDL 219
+ L L+L N + P+ F L L L + N L+ ++ + L L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 220 DLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG 272
L+ N L S +++ +LP+ G + L+ N G
Sbjct: 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 1e-09
Identities = 56/242 (23%), Positives = 88/242 (36%), Gaps = 6/242 (2%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNF 177
+ + + L I +L L L SN L + + L+ L L DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 178 FNNTI-PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSS 235
++ P F L L L + L P + ++ L L L NA+ D
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 236 LGSLNVLNLSDNKLDSNLPKLPRG---LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFN 292
LG+L L L N++ S + RG L L N + P + L +L L + N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 293 ALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352
L +P A+ L + L L N + + L F S++++ LP L+
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 353 ES 354
Sbjct: 271 RD 272
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 3e-09
Identities = 25/103 (24%), Positives = 40/103 (38%), Gaps = 2/103 (1%)
Query: 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQY 278
L L+ ++ L L L + L+LS N+L + P L + L + + E
Sbjct: 3 LHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGV 61
Query: 279 GQLNQLQQLDMSFNALRGMPPPAIFS-LPNISDLNLASNKFSG 320
L +LQ+L + N L+ P + LNL N
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 3e-06
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 8/118 (6%)
Query: 146 YLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGP 205
L L+ L +V + ++ + L L N P +L L L +N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LE 56
Query: 206 FPSSIQRISTLSDLDLSKNAISG--SLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLV 261
+ + L +L L N + ++ L S L +LNL N L + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLA 113
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 4e-06
Identities = 27/122 (22%), Positives = 49/122 (40%), Gaps = 7/122 (5%)
Query: 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLP 254
L + + L ++++ ++ LDLS N + P L++L L VL SDN L++
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 255 KLPRGLVMAF-LSNNSF-SGEIPKQYGQLNQLQQLDMSFNALRGMP---PPAIFSLPNIS 309
+ L NN + +L L++ N+L LP++S
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
Query: 310 DL 311
+
Sbjct: 121 SI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 6e-05
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 6/120 (5%)
Query: 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNN 180
RVL L + ++ + +L + +LDLS N L +PP ++ + L+ L DN N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN 57
Query: 181 TIPNWFDSLPSLTFLSMRNNKLAG-PFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSL 239
L + NN+L + L L+L N++ L +
Sbjct: 58 VDGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.6 bits (135), Expect = 4e-09
Identities = 21/142 (14%), Positives = 50/142 (35%), Gaps = 9/142 (6%)
Query: 492 GEGSYGKLYKGR-LENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCID 550
G G + ++ + + N T VA++ + K YT + + LL ++ +
Sbjct: 22 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 551 GGGR-----DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQF 605
+ + N V +V F G + + + + + + + +
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 606 LHTGVIPGFFNNRVKTNNILLN 627
+H G + +K N+L+
Sbjct: 141 MHRR--CGIIHTDIKPENVLME 160
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 9e-09
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 8/88 (9%)
Query: 173 LDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD 232
N +N I + D PSL L++ NNKL P+ R L L S N ++ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVPE 321
Query: 233 LSSLGSLNVLNLSDNKLDSNLPKLPRGL 260
L +L L++ N L P +P +
Sbjct: 322 L--PQNLKQLHVEYNPL-REFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 21/89 (23%), Positives = 35/89 (39%), Gaps = 5/89 (5%)
Query: 197 MRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL 256
N + S +L +L++S N + LP + L L S N L + +P+L
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP--ALPPRLERLIASFNHL-AEVPEL 322
Query: 257 PRGLVMAFLSNNSFSGEIPKQYGQLNQLQ 285
P+ L + N E P + L+
Sbjct: 323 PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 1e-05
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 10/93 (10%)
Query: 262 MAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321
N+ S EI L++L++S N L +P P + L + N +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLA-E 318
Query: 322 LPKNLNCGGKLVFFDISNNKLTG--GLPSCLSN 352
+P+ L + N L +P + +
Sbjct: 319 VPELP---QNLKQLHVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 20/96 (20%), Positives = 31/96 (32%), Gaps = 10/96 (10%)
Query: 149 LSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPS 208
N + L+ L + +N +P P L L N LA P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VPE 321
Query: 209 SIQRISTLSDLDLSKNAISGSLPDL-SSLGSLNVLN 243
Q L L + N + PD+ S+ L + +
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 20/79 (25%), Positives = 32/79 (40%), Gaps = 9/79 (11%)
Query: 138 IHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197
SLE L++S+N L +P +L+ LI N +P + +L L +
Sbjct: 280 CDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHL-AEVP---ELPQNLKQLHV 331
Query: 198 RNNKLAGPFPSSIQRISTL 216
N L FP + + L
Sbjct: 332 EYNPLRE-FPDIPESVEDL 349
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 5e-08
Identities = 35/204 (17%), Positives = 62/204 (30%), Gaps = 5/204 (2%)
Query: 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDD 175
++ S ++ + +LP + + L LS N L+ + +L L LD
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 176 -NFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLS 234
+ L +L + L + + + G+L L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 235 SLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNAL 294
L L + L L L L+NN+ + L L L + N+L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 295 RGMPPPAIFSLPNISDLNLASNKF 318
+ P F + L N +
Sbjct: 185 YTI-PKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 7e-07
Identities = 34/207 (16%), Positives = 68/207 (32%), Gaps = 5/207 (2%)
Query: 137 KIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLS 196
++ ++ S ++ L ++PP + L L +N LT L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 197 MRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSD-NKLDSNLPK 255
+ +L + DL ++ L ++ ++ + L +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 256 LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLAS 315
L +L N P +L++L ++ N L +P + L N+ L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 316 NKFSGSLPKNLNCGGKLVFFDISNNKL 342
N ++PK L F + N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 46/215 (21%), Positives = 65/215 (30%), Gaps = 32/215 (14%)
Query: 58 CYISSST-QVNITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFVTTLAR 116
C +S + + C +T + D P + LSEN + TL
Sbjct: 4 CEVSKVASHLEVNCDKRNLTA--LPPDLPKDTTILH--------LSENLLYTFSLATLMP 53
Query: 117 LTSLRVLSLVSL---------------------GIWGSLPDKIHRLYSLEYLDLSSNFLF 155
T L L+L SLP L +L LD+S N L
Sbjct: 54 YTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT 113
Query: 156 GSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRIST 215
+ + +LQ L L N P P L LS+ NN L + +
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 216 LSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLD 250
L L L +N++ L L N
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 4e-05
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 118 TSLRVLSLVSLGI----WGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVK-----L 168
+ LRVL L + SL + +SL LDLS+N L + ++ V+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 169 QTLILDDNFFNNTIPNWFDSL----PSLTFLS 196
+ L+L D +++ + + +L PSL +S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 14/96 (14%), Positives = 26/96 (27%), Gaps = 10/96 (10%)
Query: 175 DNFFNNTIPNWFDSLPSLTFLSMRNNKL----AGPFPSSIQRISTLSDLDLSKNAISGSL 230
D L L + + + +++ +L +LDLS N + +
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 231 PDL------SSLGSLNVLNLSDNKLDSNLPKLPRGL 260
L L L D + + L
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 16/90 (17%), Positives = 35/90 (38%), Gaps = 10/90 (11%)
Query: 143 SLEYLDLSSNFLFGSVPPKISTMVK-LQTLILDDNFFNN----TIPNWFDSLPSLTFLSM 197
++ LD+ L + ++ +++ Q + LDD I + P+L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 198 RNNKLAGPFPSSIQRI-----STLSDLDLS 222
R+N+L + + + L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 13/92 (14%)
Query: 205 PFPSSIQRISTLSDLDLSKNAISG----SLPD-LSSLGSLNVLNLSDNKLD--------S 251
Q S L L L+ +S SL L + SL L+LS+N L
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
Query: 252 NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQ 283
++ + L L + +S E+ + L +
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 4e-05
Identities = 22/111 (19%), Positives = 36/111 (32%), Gaps = 3/111 (2%)
Query: 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSG--EIPK 276
LDL L + LN + L +P L+ LSNN ++
Sbjct: 27 LDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPE-LLSLNLSNNRLYRLDDMSS 85
Query: 277 QYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLN 327
+ L+ L++S N L+ + +L L N S +
Sbjct: 86 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.002
Identities = 23/114 (20%), Positives = 43/114 (37%), Gaps = 4/114 (3%)
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG 296
GS L+L + D +L + + +S + + + +L L++S N L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQ--NIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYR 79
Query: 297 MP--PPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPS 348
+ + PN+ LNL+ N+ + G KL + N L+
Sbjct: 80 LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 2e-04
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 4/115 (3%)
Query: 231 PDLSSLGSLNVLNLSDNKLDS---NLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQL 287
PD + L + + +LP + + + L +L+ L
Sbjct: 2 PDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 288 DMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKL 342
+ + LR + P A P +S LNL+ N SL G L +S N L
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 45/262 (17%), Positives = 95/262 (36%), Gaps = 19/262 (7%)
Query: 113 TLARLTSLRVLSLVSLGIWGSLP-DKIHRLYSLEYLDLSSNFLFGSVPPKI-STMVKLQT 170
RL S V++ + P + + ++++DLS++ + S I S KLQ
Sbjct: 16 VTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 75
Query: 171 LILDDNFFNNTIPNWFDSLPSLTFLSMR--NNKLAGPFPSSIQRISTLSDLDLSKNAISG 228
L L+ ++ I N +L L++ + + + S L +L+LS
Sbjct: 76 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 135
Query: 229 SLPDLSSLG-----------SLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQ 277
++ S NL + L + + + P + + + + ++
Sbjct: 136 EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQE 195
Query: 278 YGQLNQLQQLDMSF-NALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFD 336
+ QLN LQ L +S + + +P + L + G+L L
Sbjct: 196 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---Q 252
Query: 337 ISNNKLTGGLPSCLSNESDKRV 358
I+ + T + N+ ++ +
Sbjct: 253 INCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 6e-04
Identities = 16/98 (16%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 242 LNLSDNKLDSNLPK--LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP 299
L+L+ L ++ L +G++ + + + ++Q +D+S + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVSTL 63
Query: 300 PAIFS-LPNISDLNLASNKFSGSLPKNLNCGGKLVFFD 336
I S + +L+L + S + L LV +
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 8e-04
Identities = 15/102 (14%), Positives = 35/102 (34%), Gaps = 5/102 (4%)
Query: 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKL-DSNL 253
L + L + ++ ++ + L + S + ++LS++ + S L
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 254 PKLPRG---LVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFN 292
+ L L S I + + L +L++S
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 31/154 (20%), Positives = 57/154 (37%), Gaps = 1/154 (0%)
Query: 118 TSLRVLSLVSLGIWGSLPDKIHRLYS-LEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
L L + D + L L+L N L G P +Q L L +N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSL 236
F L L L++ +N+++ P S + +++L+ L+L+ N + +
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148
Query: 237 GSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSF 270
L +L+ P R + + L ++ F
Sbjct: 149 EWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEF 182
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 22/135 (16%), Positives = 41/135 (30%), Gaps = 8/135 (5%)
Query: 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN 176
R L L I + + L + +D S N + + +L+TL++++N
Sbjct: 17 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73
Query: 177 FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD---- 232
+LP LT L + NN L +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 233 -LSSLGSLNVLNLSD 246
+ + + VL+
Sbjct: 134 VIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.003
Identities = 20/113 (17%), Positives = 39/113 (34%), Gaps = 5/113 (4%)
Query: 214 STLSDLDLSKNAISGSLPDL-SSLGSLNVLNLSDNKLD--SNLPKLPRGLVMAFLSNNSF 270
+LDL I + +L ++L + ++ SDN++ P L R L ++NN
Sbjct: 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR-LKTLLVNNNRI 75
Query: 271 SGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLP 323
L L +L ++ N+L + + +
Sbjct: 76 CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.98 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.98 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.98 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.98 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.9 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.88 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.69 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.68 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.34 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.32 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.18 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.2 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.16 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.16 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.15 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.07 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.66 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.87 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.6e-41 Score=347.29 Aligned_cols=294 Identities=26% Similarity=0.427 Sum_probs=247.4
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCCccCCCCCCCC--CCCCCccceEeCC----CCEeEEEecCCCCCCCCCCCCcccccc
Q 005898 26 LQSSQTQVLLQLRKHLEYPKQLEIWINHGADFCY--ISSSTQVNITCQD----NFITELKIIGDKPSNVGNFDGFASANA 99 (671)
Q Consensus 26 ~~~~~~~~Ll~~k~~~~~~~~l~~W~~~~~~~C~--~~~~~~~~v~C~~----~~v~~l~l~~~~~~~~~~~~~~~~~~~ 99 (671)
|.++|++||++||+++.+|..+++|..+ +|||. |. ||+|+. .+|++|++.+....+.
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~-~d~C~~~w~-----gv~C~~~~~~~~v~~L~L~~~~l~g~----------- 65 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWL-----GVLCDTDTQTYRVNNLDLSGLNLPKP----------- 65 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTT-SCTTTTCST-----TEEECCSSSCCCEEEEEEECCCCSSC-----------
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCC-CCCCCCcCC-----CeEEeCCCCcEEEEEEECCCCCCCCC-----------
Confidence 7889999999999999998889999865 79995 64 799963 2699999987654331
Q ss_pred cCCCccCCCcchhcccCCCCCCEEeccc-ccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcC
Q 005898 100 SLSENFSIDSFVTTLARLTSLRVLSLVS-LGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFF 178 (671)
Q Consensus 100 ~l~~n~~~~~~~~~l~~l~~L~~L~L~~-n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 178 (671)
..+|+++++|++|++|+|++ |++.|.+|+.|++|++|++|||++|++.+..|..+..+.+|+.++++.|.+
T Consensus 66 --------~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~ 137 (313)
T d1ogqa_ 66 --------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137 (313)
T ss_dssp --------EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred --------CCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccc
Confidence 24677899999999999986 789999999999999999999999999988888899999999999999999
Q ss_pred CCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCC-CEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCC
Q 005898 179 NNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL-SDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKL 256 (671)
Q Consensus 179 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L-~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~ 256 (671)
.+.+|.+++++++|+.+++++|.++|.+|..+..+.++ +.++++.|++++..|. +..+ .+..+++++|
T Consensus 138 ~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l-~~~~l~l~~~--------- 207 (313)
T d1ogqa_ 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN--------- 207 (313)
T ss_dssp ESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC-CCSEEECCSS---------
T ss_pred cccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccc-cccccccccc---------
Confidence 99999999999999999999999999999988888776 8888999999888775 3333 3334555554
Q ss_pred CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEE
Q 005898 257 PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFD 336 (671)
Q Consensus 257 ~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ 336 (671)
.+.+.+|..++.+++|+.+++++|.+++.+| .+..+++|+.|+|++|+++|.+|+.+.++++|+.||
T Consensus 208 ------------~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~ 274 (313)
T d1ogqa_ 208 ------------MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274 (313)
T ss_dssp ------------EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE
T ss_pred ------------ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEE
Confidence 4455778888888899999999999988776 578889999999999999999999999999999999
Q ss_pred CcCCcCcccCCCCCCCCCCCceeccCCCc-CCC
Q 005898 337 ISNNKLTGGLPSCLSNESDKRVVKFRGNC-LSS 368 (671)
Q Consensus 337 ls~N~l~g~~p~~~~~~~~l~~l~l~~N~-l~~ 368 (671)
|++|+|+|.+|. ++++++++.+++++|+ +.|
T Consensus 275 Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 275 VSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred CcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence 999999999985 5778888889999885 454
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-37 Score=314.94 Aligned_cols=167 Identities=26% Similarity=0.485 Sum_probs=138.1
Q ss_pred CCCcCceeccCCceEEEEEEEc-CC---cEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NG---TSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.|+..++||+|+||+||+|+.. ++ ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------ 100 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST------ 100 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS------
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC------
Confidence 3455688999999999999974 33 36899998654 3445678999999999999999999999997653
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++|||||++|+|.+++.... ..++|.++.+++.|||+||+|||+. +|+||||||+|||+|+++++||+|||
T Consensus 101 --~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 101 --PVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp --SCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred --EEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcc
Confidence 6799999999999999887543 3499999999999999999999987 79999999999999999999999999
Q ss_pred Cccccc-----------------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE-----------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~-----------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+... |+||+||++|||+|+...|
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence 986421 9999999999999843333
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=314.82 Aligned_cols=170 Identities=21% Similarity=0.420 Sum_probs=148.8
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|+++|++++|||||+++|+|.+. .
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---------~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---------P 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---------S
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC---------C
Confidence 45788889999999999999999888999999997543 3457899999999999999999999988643 4
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++||||+++|+|.+++.... ...++|.++++|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence 699999999999999876432 23489999999999999999999987 89999999999999999999999999997
Q ss_pred ccc-------------------------------cccccceeeeeeehhhhcccc
Q 005898 642 VSE-------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 642 ~~~-------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
... |+||+||++|||+|+...++.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 643 999999999999997655443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-37 Score=309.18 Aligned_cols=168 Identities=23% Similarity=0.403 Sum_probs=145.3
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|+|.+.+ ..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--------~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--------PI 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--------SC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC--------ce
Confidence 4677889999999999999999888999999997643 34578999999999999999999999998653 57
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.+++.... ..++|..+..++.|||+||+|||+. +|+||||||+|||+|+++.+||+|||+|+.
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred EEEEEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhee
Confidence 99999999999999987543 3589999999999999999999997 799999999999999999999999999965
Q ss_pred cc-------------------------------cccccceeeeeeehhhhccc
Q 005898 643 SE-------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 643 ~~-------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
.. |+||+||++|||+|+...++
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 32 99999999999999655444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-37 Score=315.63 Aligned_cols=170 Identities=24% Similarity=0.474 Sum_probs=150.1
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
..++|+..+.||+|+||+||+|+.. +|+.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------- 86 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP------- 86 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-------
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCC-------
Confidence 3457888899999999999999975 689999999975433 4578999999999999999999999998653
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|||||++|+|.+++.... ...++|..+..++.|||+||+|||+. +|+||||||+|||+|+++.+||+|||+
T Consensus 87 -~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 87 -PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp -SCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred -eeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence 6799999999999999997643 34699999999999999999999987 899999999999999999999999999
Q ss_pred ccccc-------------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+... |+||+||++|||+++...+
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 97643 9999999999999965443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-37 Score=310.16 Aligned_cols=165 Identities=22% Similarity=0.433 Sum_probs=144.0
Q ss_pred hcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||+||+|+++ ..||||+++.. .....++|.+|+++|++++|||||+++|++.++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-------- 76 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-------- 76 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--------
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc--------
Confidence 457888999999999999999864 35999999643 344567899999999999999999999998643
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|||||++|+|.++++... ..++|.+++.++.|||+||+|||+. +||||||||+|||+++++.+||+|||+
T Consensus 77 -~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 77 -QLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp -SCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred -EEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccc
Confidence 4799999999999999997543 3499999999999999999999987 899999999999999999999999999
Q ss_pred ccccc-----------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+... |+||+||++|||+||...
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~P 208 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCC
Confidence 85422 999999999999997543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=307.05 Aligned_cols=167 Identities=24% Similarity=0.386 Sum_probs=145.6
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-------- 76 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-------- 76 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT--------
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--------
Confidence 56888999999999999999964 79999999996543 223467899999999999999999999998764
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..|+||||+++|+|.+++... ..+++.+...++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eeEEEEeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhh
Confidence 789999999999999999753 3499999999999999999999987 8999999999999999999999999999
Q ss_pred cccc---------------------------------cccccceeeeeeehhhhcc
Q 005898 641 IVSE---------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 641 ~~~~---------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+... |+||+||++|||++|.+..
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf 206 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence 7532 9999999999999976543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-36 Score=306.74 Aligned_cols=165 Identities=22% Similarity=0.382 Sum_probs=148.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+ .
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--------~ 91 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--------E 91 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--------E
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--------E
Confidence 4689999999999999999995 479999999997555445678999999999999999999999998764 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.|+||||+++|+|.+++.+. .+++.+...++.|++.||+|||+. +|+||||||+|||++.++++||+|||+|+
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 89999999999999988753 389999999999999999999987 89999999999999999999999999997
Q ss_pred ccc------------------------------cccccceeeeeeehhhhc
Q 005898 642 VSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
... |+||+||++|+|++|...
T Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P 215 (293)
T d1yhwa1 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (293)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCC
Confidence 542 999999999999998654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-36 Score=302.25 Aligned_cols=166 Identities=21% Similarity=0.404 Sum_probs=148.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT------ 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS------
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC------
Confidence 46888999999999999999975 78999999986432 223567899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+++|+|.+++.... .+++.....++.||++||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 80 --~~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 80 --RVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred --EEEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 7899999999999999998643 389999999999999999999987 89999999999999999999999999
Q ss_pred Cccccc----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|+..+ |+||+||++|+|++|...
T Consensus 152 ~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P 203 (263)
T d2j4za1 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203 (263)
T ss_dssp SCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence 997643 999999999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=307.81 Aligned_cols=167 Identities=23% Similarity=0.404 Sum_probs=149.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+++.+|+++|++++|||||++++++.+.+ .
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--------~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--------N 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--------E
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--------e
Confidence 46788899999999999999965 79999999997765556678999999999999999999999998764 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.++|||||++|+|.+++.+.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 899999999999999876532 3499999999999999999999997 89999999999999999999999999985
Q ss_pred ccc-----------------------------------cccccceeeeeeehhhhc
Q 005898 642 VSE-----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~~-----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
... |+||+||++|+|++|...
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P 214 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence 321 999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=298.26 Aligned_cols=169 Identities=23% Similarity=0.394 Sum_probs=149.5
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..++||+|+||+||+|+.++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+.+ ..
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~--------~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR--------PI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS--------SE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC--------ce
Confidence 57888999999999999999998888999999976543 4578999999999999999999999998653 68
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|..++.... ..++|..+.+++.|+|+||+|||+. +|+||||||+||++++++.+||+|||+|+.
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred EEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhee
Confidence 99999999999999876542 3489999999999999999999987 899999999999999999999999999964
Q ss_pred cc-------------------------------cccccceeeeeeehhhhcccc
Q 005898 643 SE-------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 643 ~~-------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
.. |+||+||++|||+|....|+.
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~ 203 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCC
Confidence 32 999999999999985454443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=313.16 Aligned_cols=169 Identities=22% Similarity=0.299 Sum_probs=148.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
.++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------- 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG------- 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-------
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-------
Confidence 467899999999999999999964 79999999996542 334578999999999999999999999998753
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|||||++|+|.+++.+.. .+++..+..++.|+++||+|||+.+ +|+||||||+|||+++++.+||+|||+
T Consensus 78 -~~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 78 -EISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp -EEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred -EEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCC
Confidence 7899999999999999997643 3899999999999999999999732 699999999999999999999999999
Q ss_pred ccccc----------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+... |+||+||++|||++|....
T Consensus 152 a~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf 203 (322)
T d1s9ja_ 152 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203 (322)
T ss_dssp CHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCS
T ss_pred ccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 97532 9999999999999986543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=301.99 Aligned_cols=163 Identities=25% Similarity=0.451 Sum_probs=141.4
Q ss_pred cCCCcCce-eccCCceEEEEEEEc---CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAI-MGEGSYGKLYKGRLE---NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~-iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|...+. ||+|+||+||+|+++ ++..||||+++... ....++|.+|+++|++++|||||+++|+|.++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence 45555664 999999999999764 35589999997543 44567899999999999999999999998653
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..|+|||||++|+|.+++.... ..++|.++.+++.|||+||+|||+. +|+||||||+||++++++.+||+||
T Consensus 82 ---~~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 82 ---ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp ---SEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred ---eEEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence 4799999999999999986532 3599999999999999999999997 8999999999999999999999999
Q ss_pred CCccccc---------------------------------cccccceeeeeeehh
Q 005898 638 GLSIVSE---------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 638 Gla~~~~---------------------------------d~~s~g~~l~~~~~~ 659 (671)
|+|+... |+||+||++|||+|.
T Consensus 154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~ 208 (285)
T d1u59a_ 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 208 (285)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhC
Confidence 9996532 999999999999984
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-36 Score=303.96 Aligned_cols=174 Identities=24% Similarity=0.388 Sum_probs=141.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~------ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN------ 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---------
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC------
Confidence 56889999999999999999864 79999999986543 3446779999999999999999999999875421
Q ss_pred ceEEEEEecCCCCChhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhcCCC--CCCccccCCCCCceeecCCCcEEEcc
Q 005898 560 NKVFLVYEFMSNGNFRTHISENT-PGKVLNWSERLAVLIGVAKAVQFLHTGV--IPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
...|+||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.. ..+|+||||||+|||+++++.+||+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 35799999999999999986421 2345999999999999999999999752 23599999999999999999999999
Q ss_pred cCCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 637 YGLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 637 fGla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
||+|+... |+||+||++|||+++...
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~P 213 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCC
Confidence 99996532 999999999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=303.17 Aligned_cols=171 Identities=23% Similarity=0.430 Sum_probs=148.3
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||+||+|+.++++.||||+++... ...++|.+|+++|++++|||||+++|+|.+. ..
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---------~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE---------PI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---------SC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecC---------Ce
Confidence 5688899999999999999999888899999997543 3457899999999999999999999998642 46
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|..++.... ...++|.+++.++.|||+||+|||+. +|+||||||+|||+|+++++||+|||+|+.
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 99999999999998887532 23499999999999999999999987 799999999999999999999999999975
Q ss_pred cc-------------------------------cccccceeeeeeehhhhcccccc
Q 005898 643 SE-------------------------------DINSVGVRLLILMSFFFGSMTSC 667 (671)
Q Consensus 643 ~~-------------------------------d~~s~g~~l~~~~~~~~~~~~~~ 667 (671)
.. |+||+||++|||+++...++..+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 32 99999999999999766555443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-35 Score=296.69 Aligned_cols=170 Identities=24% Similarity=0.368 Sum_probs=144.3
Q ss_pred CCcCceeccCCceEEEEEEEc-CCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 485 FDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 485 f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++..++||+|+||+||+|+.. +++.||||++... .....+.|.+|+++|++++|||||++++++.+... ....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~----~~~~ 86 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK----GKKC 86 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS----SCEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc----cCCE
Confidence 355678999999999999965 6889999998653 23446789999999999999999999999875321 1136
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec-CCCcEEEcccCCc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN-EHRIAKLSDYGLS 640 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~-~~~~~ki~DfGla 640 (671)
.++||||+++|+|.+++.... .+++..+..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 899999999999999997643 4899999999999999999999863 3599999999999996 5799999999999
Q ss_pred cccc---------------------------cccccceeeeeeehhhhc
Q 005898 641 IVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 641 ~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+... |+||+||++|||++|...
T Consensus 163 ~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~P 211 (270)
T d1t4ha_ 163 TLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP 211 (270)
T ss_dssp GGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred eeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCC
Confidence 7533 999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-35 Score=303.34 Aligned_cols=167 Identities=26% Similarity=0.358 Sum_probs=146.7
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
..|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++|||||++++++.+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~------ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH------ 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT------
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC------
Confidence 3488899999999999999996 478999999996543 234567999999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+|||||++|++..++.... .+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 89 --~~~iv~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 89 --TAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp --EEEEEEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred --EEEEEEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 7899999999999987766543 499999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+... |+||+||++|||++|....
T Consensus 161 ~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 161 SASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp TCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 996432 9999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=301.22 Aligned_cols=166 Identities=23% Similarity=0.374 Sum_probs=147.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE------ 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS------
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC------
Confidence 46889999999999999999974 79999999986432 223567999999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+||||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 --~~~ivmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 82 --KLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp --EEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred --EEEEEEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 7899999999999999987654 399999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc--------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE--------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~--------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|+.+. |+||+||++|+|++|...
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCC
Confidence 997532 999999999999998644
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-35 Score=296.64 Aligned_cols=156 Identities=24% Similarity=0.412 Sum_probs=136.6
Q ss_pred ceeccCCceEEEEEEEc---CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEE
Q 005898 489 AIMGEGSYGKLYKGRLE---NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVF 563 (671)
Q Consensus 489 ~~iG~G~~g~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~ 563 (671)
++||+|+||+||+|.++ +++.||||+++... ....++|.+|+++|++++|||||+++|+|.++ ..+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---------~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE---------SWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---------SEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---------CEE
Confidence 57999999999999864 35689999996432 23457899999999999999999999998653 468
Q ss_pred EEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcccc
Q 005898 564 LVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVS 643 (671)
Q Consensus 564 Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~ 643 (671)
+||||+++|+|.++++... .++|.+++.++.|||+||+|||+. +|+||||||+|||+++++.+||+|||+|+..
T Consensus 84 lvmE~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 9999999999999998643 499999999999999999999987 7999999999999999999999999999753
Q ss_pred c---------------------------------cccccceeeeeeehh
Q 005898 644 E---------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 644 ~---------------------------------d~~s~g~~l~~~~~~ 659 (671)
. |+||+||++|||+|.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~ 206 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhC
Confidence 2 999999999999984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-34 Score=304.88 Aligned_cols=168 Identities=19% Similarity=0.342 Sum_probs=149.5
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+ .
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--------~ 100 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--------E 100 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS--------E
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--------E
Confidence 5689999999999999999996 479999999998766556678899999999999999999999998653 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec--CCCcEEEcccCC
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN--EHRIAKLSDYGL 639 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~--~~~~~ki~DfGl 639 (671)
.|+|||||++|+|.+++.... ..+++.+...++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence 899999999999998876432 3499999999999999999999987 899999999999998 578999999999
Q ss_pred ccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+... |+||+||++|+|++|....
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf 228 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 228 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred ceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 97643 9999999999999987644
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-35 Score=297.18 Aligned_cols=168 Identities=23% Similarity=0.428 Sum_probs=142.3
Q ss_pred cCCCcCceeccCCceEEEEEEEcCC-----cEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENG-----TSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
+.|+..++||+|+||+||+|++++. ..||||++.... ....++|.+|+++|++++|||||+++|+|.+.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~---- 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence 3577789999999999999987532 379999996543 344567999999999999999999999998653
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++|||||.+|++.+++.... ..++|.++.+++.|||+||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 83 ----~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 83 ----PMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp ----SEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred ----ceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence 6899999999999998877543 3599999999999999999999987 799999999999999999999999
Q ss_pred cCCccccc---------------------------------cccccceeeeeeehhhhcc
Q 005898 637 YGLSIVSE---------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~~---------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
||+|+... |+||+||++|||+++...+
T Consensus 154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 99997532 9999999999999864443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-34 Score=303.72 Aligned_cols=168 Identities=24% Similarity=0.431 Sum_probs=149.7
Q ss_pred hcCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
.++|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-------- 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-------- 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT--------
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--------
Confidence 357999999999999999999964 79999999998766666778999999999999999999999998754
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec--CCCcEEEcccC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN--EHRIAKLSDYG 638 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~--~~~~~ki~DfG 638 (671)
..++|||||++|+|.+++.... ..+++..+..++.||+.||+|||+. +||||||||+|||++ .++.+||+|||
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 7899999999999999986532 3499999999999999999999997 899999999999996 46889999999
Q ss_pred Cccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|+..+ |+||+||++|+|++|...
T Consensus 172 ~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~P 224 (350)
T d1koaa2 172 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224 (350)
T ss_dssp TCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred hheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCC
Confidence 997543 999999999999998654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-35 Score=300.78 Aligned_cols=177 Identities=26% Similarity=0.452 Sum_probs=151.0
Q ss_pred HHHHHhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceee
Q 005898 477 ELKEATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCI 549 (671)
Q Consensus 477 ~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 549 (671)
+++.+.++|+..+.||+|+||+||+|+.. +++.||||++.... ....++|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34446778999999999999999999863 45789999997644 334678999999999999999999999998
Q ss_pred cCCCCCCcccceEEEEEecCCCCChhhhhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhcC
Q 005898 550 DGGGRDDYAVNKVFLVYEFMSNGNFRTHISENT---------------------PGKVLNWSERLAVLIGVAKAVQFLHT 608 (671)
Q Consensus 550 ~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~ 608 (671)
+.+ ..++||||+++|+|.++++... ....++|.+++.|+.|+|.||+|||+
T Consensus 87 ~~~--------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 87 VGK--------PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp SSS--------SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCC--------ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence 653 5799999999999999986422 12358999999999999999999998
Q ss_pred CCCCCccccCCCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeee
Q 005898 609 GVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLIL 656 (671)
Q Consensus 609 ~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~ 656 (671)
. +||||||||+|||+|.++++||+|||+|+... |+||+||++|||
T Consensus 159 ~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 159 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp T---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred C---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence 7 79999999999999999999999999986431 999999999999
Q ss_pred ehhhhccc
Q 005898 657 MSFFFGSM 664 (671)
Q Consensus 657 ~~~~~~~~ 664 (671)
+++...|+
T Consensus 236 l~~~~~p~ 243 (301)
T d1lufa_ 236 FSYGLQPY 243 (301)
T ss_dssp HTTTCCTT
T ss_pred HccCCCCC
Confidence 98754443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=302.07 Aligned_cols=168 Identities=23% Similarity=0.348 Sum_probs=149.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------ 78 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD------ 78 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS------
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc------
Confidence 5788999999999999999996 479999999996432 234577899999999999999999999998764
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+|||||++|+|.+++.... .++......++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 79 --~~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 79 --RLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred --ccccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecc
Confidence 7899999999999999998654 388889999999999999999997 89999999999999999999999999
Q ss_pred Cccccc------------------------------cccccceeeeeeehhhhccc
Q 005898 639 LSIVSE------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 639 la~~~~------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
+|+... |+||+||++|||++|.+...
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence 997532 99999999999999865443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-34 Score=297.56 Aligned_cols=166 Identities=20% Similarity=0.372 Sum_probs=147.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ------ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS------
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC------
Confidence 56888999999999999999964 79999999986432 233577999999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..|+|||||++|+|..++.... .+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 78 --~~~ivmE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 78 --QIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp --EEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred --eeeeEeeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 7899999999999999887654 378889999999999999999997 89999999999999999999999999
Q ss_pred Cccccc---------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|+... |+||+||++|+|++|...
T Consensus 150 ~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 150 FAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp SCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred cceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCC
Confidence 997643 999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-34 Score=294.21 Aligned_cols=166 Identities=22% Similarity=0.370 Sum_probs=146.7
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK------KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+++.+|+++|++++|||||++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--- 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--- 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 56889999999999999999974 79999999986432 123678999999999999999999999998753
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC----c
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR----I 631 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~----~ 631 (671)
..|+|||||++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++ .
T Consensus 87 -----~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 87 -----DVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp -----EEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred -----EEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence 7899999999999999997643 499999999999999999999987 899999999999998776 4
Q ss_pred EEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|++|||+|+..+ |+||+||++|||+++...
T Consensus 156 vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp EEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 9999999996543 999999999999998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-34 Score=297.57 Aligned_cols=166 Identities=25% Similarity=0.460 Sum_probs=137.2
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------- 80 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-------- 80 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS--------
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--------
Confidence 56888999999999999999965 78999999997543 223456889999999999999999999998753
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec---CCCcEEEccc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN---EHRIAKLSDY 637 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~---~~~~~ki~Df 637 (671)
..|+|||||++|+|.+++.... .+++.+...++.|++.||+|||+. +|+||||||+||++. +++.+||+||
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence 7899999999999999997643 499999999999999999999987 899999999999994 5789999999
Q ss_pred CCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 638 GLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+|+..+ |+||+||++|+|++|...
T Consensus 155 G~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 208 (307)
T d1a06a_ 155 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCC
Confidence 9997543 999999999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-34 Score=300.58 Aligned_cols=167 Identities=24% Similarity=0.480 Sum_probs=140.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEcC-C-----cEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLEN-G-----TSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~-g-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 553 (671)
.++|+..++||+|+||+||+|+... + ..||||++.... ....+.+.+|+.+|.++ +|||||+++++|.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 3578889999999999999998642 2 369999986543 33456789999999998 8999999999998754
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCC
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTP--------------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPG 613 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 613 (671)
..++|||||++|+|.++++.... ...++|..++.++.||++||+|||+. +
T Consensus 115 -------~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~ 184 (325)
T d1rjba_ 115 -------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---S 184 (325)
T ss_dssp -------SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred -------eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 67999999999999999975421 23589999999999999999999997 8
Q ss_pred ccccCCCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehh
Q 005898 614 FFNNRVKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 614 iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~ 659 (671)
||||||||+||+++.++.+||+|||+|+... |+||+||++|||+|.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~ 262 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence 9999999999999999999999999996532 999999999999984
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-34 Score=290.38 Aligned_cols=166 Identities=22% Similarity=0.328 Sum_probs=146.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch---------hhHHHHHHHHHHHhcCC-CCCcccccceeecC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK---------YTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDG 551 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 551 (671)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999996 4799999999865321 12346889999999997 99999999999875
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCc
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRI 631 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~ 631 (671)
+ ..|+|||||++|+|.++++... .+++.++..++.||++||+|||+. +|+||||||+||++++++.
T Consensus 83 ~--------~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 83 T--------FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp S--------EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred c--------ceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 3 7899999999999999997644 499999999999999999999987 8999999999999999999
Q ss_pred EEEcccCCccccc-----------------------------------cccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVSE-----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+++..+ |+||+||++|+|++|...
T Consensus 149 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P 214 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214 (277)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCC
Confidence 9999999996533 899999999999997643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=291.45 Aligned_cols=167 Identities=26% Similarity=0.499 Sum_probs=141.5
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
++|+..+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++|||||+++|+|.+.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-------~~~ 76 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-------GGL 76 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC---------CC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-------CcE
Confidence 46778899999999999999985 7899999997543 3578999999999999999999999997543 247
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++||||+++|+|.++++... ...++|..+++++.|||.||+|||+. +|+||||||+||+++.++.+|++|||+++.
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccccccee
Confidence 99999999999999997532 23489999999999999999999986 899999999999999999999999999976
Q ss_pred cc---------------------------cccccceeeeeeehhhhcc
Q 005898 643 SE---------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 643 ~~---------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
.. |+||+||++|||+|+...+
T Consensus 153 ~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p 200 (262)
T d1byga_ 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCC
Confidence 43 9999999999999854443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=290.60 Aligned_cols=166 Identities=25% Similarity=0.420 Sum_probs=143.3
Q ss_pred CceeccCCceEEEEEEEcC----CcEEEEEEccCC-chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 488 SAIMGEGSYGKLYKGRLEN----GTSVAIRCLPSS-KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
.++||+|+||+||+|++.+ ...||||+++.. .....++|.+|+++|++++|||||+++|+|.+.+ ...
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-------~~~ 104 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-------GSP 104 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-------TEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-------Cce
Confidence 4789999999999999743 236899999753 4455688999999999999999999999987643 268
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIV 642 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~ 642 (671)
++|||||++|+|.++++... ..++|..+++++.|+|+||.|+|+. +|+||||||+|||+|+++.+||+|||+++.
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEEEEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence 99999999999999987643 3478999999999999999999987 799999999999999999999999999975
Q ss_pred cc----------------------------------cccccceeeeeeehhhhcccc
Q 005898 643 SE----------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 643 ~~----------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
.. |+||+|+++|||+|+...+..
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 32 999999999999997665443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-33 Score=297.16 Aligned_cols=167 Identities=18% Similarity=0.326 Sum_probs=148.4
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~------ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS------ 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS------
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc------
Confidence 57899999999999999999974 79999999986432 223567899999999999999999999998753
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
..++||||+.+|+|..++.... .+++.+...++.||++||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 115 --~~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 115 --NLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred --ccccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 7899999999999999987643 389999999999999999999987 89999999999999999999999999
Q ss_pred Cccccc---------------------------cccccceeeeeeehhhhcc
Q 005898 639 LSIVSE---------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 639 la~~~~---------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
+|+... |+||+||++|+|++|....
T Consensus 187 ~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf 238 (350)
T d1rdqe_ 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp TCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC
Confidence 997643 9999999999999986543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-34 Score=287.79 Aligned_cols=168 Identities=20% Similarity=0.388 Sum_probs=138.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEcC----CcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLEN----GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.++|+..+.||+|+||+||+|+... +..||||.++... ....+.|.+|+++|++++|||||+++|+|.+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN----- 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 3568889999999999999998642 3579999986543 33467799999999999999999999998642
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++||||+++|++.+++.... ..+++.++..++.||++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 81 ----~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 81 ----PVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred ----eEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 5799999999999999876543 3589999999999999999999997 799999999999999999999999
Q ss_pred cCCccccc-------------------------------cccccceeeeeeehhhhcc
Q 005898 637 YGLSIVSE-------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 637 fGla~~~~-------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
||+|+..+ |+||+||++|||+++...|
T Consensus 152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P 209 (273)
T d1mp8a_ 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred chhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCC
Confidence 99997533 9999999999999854433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-33 Score=291.57 Aligned_cols=166 Identities=18% Similarity=0.279 Sum_probs=146.0
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||+||+|+.. +|+.||||.++.... ..+.+.+|+++|++++|||||++++++.+.+ .
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--------~ 75 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME--------E 75 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--------E
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--------E
Confidence 56888999999999999999965 789999999976543 3456889999999999999999999998754 7
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC--CCcEEEcccCC
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE--HRIAKLSDYGL 639 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~--~~~~ki~DfGl 639 (671)
.|+|||||++|+|.+++.... ..+++.+...++.||++||+|||+. +|+||||||+|||++. ...+||+|||+
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccch
Confidence 899999999999999997543 2489999999999999999999987 8999999999999984 45899999999
Q ss_pred ccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+||++|+|++|...
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~P 202 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred hhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCC
Confidence 97543 999999999999997644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=290.86 Aligned_cols=169 Identities=17% Similarity=0.371 Sum_probs=139.3
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
+.|.+.+.||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++|||||+++|+|.+.+. .....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~----~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNG----TWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS----SSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCC----cceEE
Confidence 3466778999999999999997 5889999999644321 2223345555667899999999999986532 12368
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCC-----CCCccccCCCCCceeecCCCcEEEccc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGV-----IPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
++|||||++|+|.+++++. .++|.++.+++.|+|+||+|+|+.. .++|+||||||+|||+|+++++||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999999864 3899999999999999999999742 358999999999999999999999999
Q ss_pred CCccccc----------------------------------------cccccceeeeeeehhhh
Q 005898 638 GLSIVSE----------------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 638 Gla~~~~----------------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
|+++... |+||+||++|||+|+..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~ 216 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCC
Confidence 9885421 99999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-33 Score=297.46 Aligned_cols=168 Identities=25% Similarity=0.409 Sum_probs=144.1
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHH---HHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVR---NLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
++|+..++||+|+||+||+|+.. +|+.||||++.... ..... ...+|+++++.++|||||++++++.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~--- 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD--- 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS---
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC---
Confidence 57889999999999999999965 79999999985432 11122 3344577888899999999999998753
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..|+|||||++|+|.+++.... .+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 81 -----~~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 81 -----KLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp -----EEEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred -----EEEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence 7899999999999999997643 388999999999999999999997 89999999999999999999999
Q ss_pred ccCCccccc-----------------------------cccccceeeeeeehhhhccc
Q 005898 636 DYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 636 DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|||+|+... |+||+||++|||++|.....
T Consensus 150 DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 150 DLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp CCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 999997543 99999999999999876543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-33 Score=292.40 Aligned_cols=171 Identities=29% Similarity=0.536 Sum_probs=145.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc--EEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT--SVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..++||+|+||+||+|++. +|. .||||++.... ....++|.+|+++|.++ +|||||+++|+|.+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence 56888899999999999999975 454 57889886443 33456899999999998 7999999999998764
Q ss_pred ccceEEEEEecCCCCChhhhhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCce
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISEN-------------TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNI 624 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~Ni 624 (671)
..++||||+++|+|.++++.. .....++|.++.+++.|||+||.|+|+. +|+||||||+||
T Consensus 85 ---~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NI 158 (309)
T d1fvra_ 85 ---YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 158 (309)
T ss_dssp ---EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred ---eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceE
Confidence 789999999999999999753 2235699999999999999999999997 899999999999
Q ss_pred eecCCCcEEEcccCCccccc-----------------------------cccccceeeeeeehhhhccc
Q 005898 625 LLNEHRIAKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 625 Ll~~~~~~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|+++++.+||+|||+|+... |+||+||++|||+++...++
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence 99999999999999986533 99999999999998755443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.6e-33 Score=292.44 Aligned_cols=168 Identities=24% Similarity=0.429 Sum_probs=142.8
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCc----EEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGT----SVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDD 556 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~ 556 (671)
.+|+..++||+|+||+||+|+.. +|+ .||||+++... ....++|.+|+++|++++|||||+++|+|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 35888999999999999999864 454 58999886533 34567899999999999999999999999864
Q ss_pred cccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcc
Q 005898 557 YAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSD 636 (671)
Q Consensus 557 ~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~D 636 (671)
..++++||+.+|+|.+++.... ..++|..+++++.|||+||+|||+. +|+||||||+||++++++.+||+|
T Consensus 84 ----~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 84 ----TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp ----SEEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred ----CeeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence 4689999999999999887643 3599999999999999999999997 799999999999999999999999
Q ss_pred cCCccccc--------------------------------cccccceeeeeeehhhhccc
Q 005898 637 YGLSIVSE--------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 637 fGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
||+|+... |+||+||++|||+|+...|+
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 99986532 99999999999998544443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.7e-33 Score=289.35 Aligned_cols=173 Identities=20% Similarity=0.336 Sum_probs=148.3
Q ss_pred hcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 554 (671)
.++|+..+.||+|+||+||+|++. +++.||||+++... ......|.+|++++++++|||||+++|+|...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-- 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-- 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--
Confidence 467888899999999999999863 35789999997543 344567999999999999999999999997653
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISEN-------TPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN 627 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~ 627 (671)
..++|||||++|+|.++++.. .....++|.++.+++.|+|+||.|||+. +|+||||||+|||+|
T Consensus 97 ------~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 97 ------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 167 (308)
T ss_dssp ------SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred ------ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeec
Confidence 579999999999999988632 2224589999999999999999999997 799999999999999
Q ss_pred CCCcEEEcccCCccccc--------------------------------cccccceeeeeeehhhhcccc
Q 005898 628 EHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFGSMT 665 (671)
Q Consensus 628 ~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~~~ 665 (671)
+++++||+|||+|+... |+||+||++|||+|+...++.
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 99999999999997542 999999999999998655443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1e-33 Score=291.63 Aligned_cols=174 Identities=25% Similarity=0.414 Sum_probs=138.3
Q ss_pred HhcCCCcCceeccCCceEEEEEEEc------CCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCC
Q 005898 481 ATNNFDMSAIMGEGSYGKLYKGRLE------NGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGG 552 (671)
Q Consensus 481 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 552 (671)
..++|+..+.||+|+||+||+|+.. +++.||||+++... ....+++.+|++.+.++ +|+|||.+++++.+.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 4467889999999999999999853 34689999997543 34456788888888776 6899999999887653
Q ss_pred CCCCcccceEEEEEecCCCCChhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCC
Q 005898 553 GRDDYAVNKVFLVYEFMSNGNFRTHISENT-------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRV 619 (671)
Q Consensus 553 ~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl 619 (671)
...++|||||++|+|.++++... ....++|.++..++.|||+||+|||+. +|+||||
T Consensus 91 -------~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 91 -------GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp -------SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred -------CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 25799999999999999997532 123589999999999999999999987 7999999
Q ss_pred CCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehhhhccc
Q 005898 620 KTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 620 k~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
||+|||+++++++||+|||+|+... |+||+||++|||+|+...++
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence 9999999999999999999996432 99999999999998765444
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-33 Score=286.93 Aligned_cols=163 Identities=21% Similarity=0.419 Sum_probs=134.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc--CC--cEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE--NG--TSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRD 555 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~--~g--~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 555 (671)
++|+..+.||+|+||+||+|++. ++ ..||||+++... ....++|.+|+++|++++|||||+++|+|.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 45888899999999999999863 33 378999986532 33457899999999999999999999999753
Q ss_pred CcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEc
Q 005898 556 DYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLS 635 (671)
Q Consensus 556 ~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~ 635 (671)
..++||||+++|++.+++.... ..++|..++.++.|+|+||+|||+. +|+||||||+||+++.++++||+
T Consensus 84 -----~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 84 -----PMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred -----chheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence 4689999999999998876532 3499999999999999999999986 89999999999999999999999
Q ss_pred ccCCccccc---------------------------------cccccceeeeeeehh
Q 005898 636 DYGLSIVSE---------------------------------DINSVGVRLLILMSF 659 (671)
Q Consensus 636 DfGla~~~~---------------------------------d~~s~g~~l~~~~~~ 659 (671)
|||+++... |+||+||++|||+|+
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~ 210 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhC
Confidence 999987532 999999999999984
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.2e-33 Score=289.82 Aligned_cols=166 Identities=23% Similarity=0.392 Sum_probs=144.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc---hhhHHHHHHHHHHHh-cCCCCCcccccceeecCCCCCCc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK---KYTVRNLKLRLDLLA-KLRHPHLVCLLGHCIDGGGRDDY 557 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~~~ 557 (671)
++|+..++||+|+||+||+|+.. +|+.||||+++... ....+.+..|+.++. .++|||||++++++.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~----- 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----- 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----
Confidence 57888999999999999999965 79999999996432 233456777777665 689999999999998764
Q ss_pred ccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEccc
Q 005898 558 AVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDY 637 (671)
Q Consensus 558 ~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~Df 637 (671)
..|+|||||++|+|.+++.... .++..+...++.||+.||+|||+. +|+||||||+|||+++++.+|++||
T Consensus 77 ---~~yivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 ---NLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ---ceeEEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 7899999999999999998643 388999999999999999999997 7999999999999999999999999
Q ss_pred CCccccc------------------------------cccccceeeeeeehhhhc
Q 005898 638 GLSIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 638 Gla~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+|+... |+||+||++|+|++|...
T Consensus 148 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred chhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC
Confidence 9997532 999999999999997543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-33 Score=287.25 Aligned_cols=161 Identities=27% Similarity=0.376 Sum_probs=135.9
Q ss_pred CceeccCCceEEEEEEEc-CCcEEEEEEccCCchhh-----HHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 488 SAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYT-----VRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
.++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|+++|++++|||||++++++.+.+ .
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--------~ 74 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--------N 74 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--------C
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--------c
Confidence 478999999999999964 79999999996543211 246889999999999999999999998754 6
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCcc
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLSI 641 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~ 641 (671)
.|+||||+++|++....... ..+++.++..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+
T Consensus 75 ~~ivmE~~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp CEEEEECCSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eeehhhhhcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence 89999999998776665432 3488889999999999999999997 79999999999999999999999999996
Q ss_pred ccc-------------------------------cccccceeeeeeehhhhc
Q 005898 642 VSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
... |+||+||++|||++|...
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 200 (299)
T d1ua2a_ 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200 (299)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence 532 999999999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.2e-33 Score=285.47 Aligned_cols=167 Identities=25% Similarity=0.400 Sum_probs=141.3
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+++|++++|||||++++++.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~------- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN------- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-------
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-------
Confidence 5788999999999999999996 5799999999964432 23567999999999999999999999998764
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..|+||||+.++ +..++.... ...+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 75 -~~~iv~e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 75 -KLYLVFEFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp -EEEEEEECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred -ceeEEEeecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 789999999764 444443322 23599999999999999999999997 799999999999999999999999999
Q ss_pred ccccc-------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+... |+||+||++|+|++|...
T Consensus 149 a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~P 202 (298)
T d1gz8a_ 149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202 (298)
T ss_dssp HHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCC
Confidence 96532 999999999999997643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=1.3e-32 Score=280.11 Aligned_cols=170 Identities=19% Similarity=0.299 Sum_probs=147.3
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK---KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
+.|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.|.+|+++|++++|||||++++++.+.+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~----~ 82 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP----A 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS----S
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC----C
Confidence 5688899999999999999996 479999999996532 2335679999999999999999999999876431 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....|+||||+++|+|.+++.... .+++.+...++.||+.||+|||+. +|+||||||+||+++.++..+++|||
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred CceEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence 135799999999999999887643 499999999999999999999987 89999999999999999999999999
Q ss_pred Cccccc---------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE---------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~---------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
.++... |+||+||++|+|+||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCC
Confidence 875422 999999999999998654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-32 Score=284.91 Aligned_cols=172 Identities=27% Similarity=0.440 Sum_probs=147.5
Q ss_pred hcCCCcCceeccCCceEEEEEEE------cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL------ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDGGG 553 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 553 (671)
.++|+..++||+|+||.||+|++ .+++.||||+++... .....+|.+|+.++.++ +|||||+++|+|.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 46788889999999999999985 246789999997543 34566799999999999 6999999999998753
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENT---------------PGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
..++|||||++|+|.++++... ....+++.++.+++.|||+||+|||+. +|+|||
T Consensus 101 -------~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrD 170 (311)
T d1t46a_ 101 -------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (311)
T ss_dssp -------SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred -------EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 5799999999999999987532 123589999999999999999999997 799999
Q ss_pred CCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehhhhccc
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|||+||+++.++.+|++|||+++... |+||+||++|||+|+-..++
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999999999997543 99999999999998544433
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=1.1e-32 Score=281.84 Aligned_cols=165 Identities=21% Similarity=0.308 Sum_probs=144.8
Q ss_pred cCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCch--hhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK--YTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..++||+|+||+||+|+.++|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-------- 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-------- 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--------
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--------
Confidence 57888999999999999999998999999999965432 23578999999999999999999999998764
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..+++|||+.++.+..+.... ..++..+...++.||+.||+|||+. +|+||||||+|||+++++.+|++|||.|
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred ceeEEEEeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccc
Confidence 689999999887776665543 3499999999999999999999987 7999999999999999999999999998
Q ss_pred cccc-------------------------------cccccceeeeeeehhhh
Q 005898 641 IVSE-------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~~-------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
.... |+||+||++|||++|..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~ 199 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCC
Confidence 5432 99999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=281.26 Aligned_cols=172 Identities=22% Similarity=0.455 Sum_probs=141.9
Q ss_pred hcCCCcCceeccCCceEEEEEEEcC--------CcEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCCCcccccceeecC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRLEN--------GTSVAIRCLPSSK-KYTVRNLKLRLDLLAKL-RHPHLVCLLGHCIDG 551 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 551 (671)
.++|+..+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578888999999999999998532 2479999997644 34467889999998888 899999999999875
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccC
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTP-------------GKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNR 618 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrD 618 (671)
+ ..++|||||++|+|.+++..... ...++|.++++++.|+|.||+|||+. +|||||
T Consensus 92 ~--------~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrD 160 (299)
T d1fgka_ 92 G--------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 160 (299)
T ss_dssp S--------SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred C--------eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeee
Confidence 3 68999999999999999975431 24589999999999999999999997 799999
Q ss_pred CCCCceeecCCCcEEEcccCCccccc--------------------------------cccccceeeeeeehhhhccc
Q 005898 619 VKTNNILLNEHRIAKLSDYGLSIVSE--------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 619 lk~~NiLl~~~~~~ki~DfGla~~~~--------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|||+|||++.++.+||+|||+++... |+||+||++|||+++...++
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 99999999999999999999997543 99999999999998644443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-32 Score=284.34 Aligned_cols=169 Identities=20% Similarity=0.356 Sum_probs=141.0
Q ss_pred hcCCCcC-ceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhc-CCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMS-AIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAK-LRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~-~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+.. ++||+|+||+||+|+. .+|+.||||+++.. +.+.+|++++.+ .+|||||++++++.+... .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~----~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA----G 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET----T
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc----C
Confidence 3567765 4699999999999996 57999999998643 346789988655 589999999999865211 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC---CCcEEEc
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE---HRIAKLS 635 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~---~~~~ki~ 635 (671)
....|+|||||++|+|.+++.... ...+++.+...++.|++.||+|||+. +|+||||||+|||+++ ++.+||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 136899999999999999998542 34599999999999999999999987 8999999999999985 4679999
Q ss_pred ccCCccccc-----------------------------cccccceeeeeeehhhhcc
Q 005898 636 DYGLSIVSE-----------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 636 DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|||+|+... |+||+||++|+|+||....
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 999997532 9999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.2e-32 Score=283.43 Aligned_cols=170 Identities=22% Similarity=0.322 Sum_probs=138.3
Q ss_pred CCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceE
Q 005898 484 NFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKV 562 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~ 562 (671)
.|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|||||+++++|......+ ....+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~--~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK--DEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC--SCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccC--CceEE
Confidence 4777889999999999999975 799999999975432 2357999999999999999999987643211 12357
Q ss_pred EEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEcccCCcc
Q 005898 563 FLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGLSI 641 (671)
Q Consensus 563 ~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~DfGla~ 641 (671)
++|||||++|.+....+.......+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 89999998765444333222344599999999999999999999987 899999999999999775 89999999996
Q ss_pred ccc------------------------------cccccceeeeeeehhhhc
Q 005898 642 VSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 642 ~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
... |+||+||++|||++|...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~p 222 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCC
Confidence 532 999999999999998643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-32 Score=276.40 Aligned_cols=166 Identities=20% Similarity=0.315 Sum_probs=141.4
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCch------hhHHHHHHHHHHHhcCC--CCCcccccceeecCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKK------YTVRNLKLRLDLLAKLR--HPHLVCLLGHCIDGGG 553 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 553 (671)
++|+..++||+|+||+||+|+. .+|+.||||++..... ...+++.+|+++|++++ |||||++++++.+++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~- 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence 4688899999999999999996 4799999999864321 11234678999999986 899999999998764
Q ss_pred CCCcccceEEEEEecCCC-CChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-CCc
Q 005898 554 RDDYAVNKVFLVYEFMSN-GNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-HRI 631 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~-GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-~~~ 631 (671)
..++||||+.+ +++.+++.... .+++.+...++.|+++||+|||+. +|+||||||+||+++. ++.
T Consensus 83 -------~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 83 -------SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp -------EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred -------eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence 78999999976 67888876543 489999999999999999999987 8999999999999985 479
Q ss_pred EEEcccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 632 AKLSDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 632 ~ki~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+||+|||+|+... |+||+||++|+|++|...
T Consensus 150 vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp EEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence 9999999997533 999999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.9e-31 Score=272.14 Aligned_cols=167 Identities=23% Similarity=0.295 Sum_probs=147.3
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+.+|++++|||||+++++|.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK------- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-------
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-------
Confidence 4688899999999999999996 478999999986432 334678999999999999999999999998764
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
..++|+||+.++++..++.... .+.+..+..++.|+++||+|||+. +|+||||||+|||++.++.+|++|||.
T Consensus 75 -~~~iv~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 75 -KLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp -EEEEEEECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred -ceeEEeeecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 6899999999999988776543 488999999999999999999997 899999999999999999999999999
Q ss_pred ccccc-------------------------------cccccceeeeeeehhhhcc
Q 005898 640 SIVSE-------------------------------DINSVGVRLLILMSFFFGS 663 (671)
Q Consensus 640 a~~~~-------------------------------d~~s~g~~l~~~~~~~~~~ 663 (671)
|+... |+||+||++|||+++....
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred hhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 97533 9999999999999986653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.8e-31 Score=276.31 Aligned_cols=168 Identities=20% Similarity=0.284 Sum_probs=139.6
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK-KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
+.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++....- ...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~----~~~ 83 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI----EQM 83 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST----TTC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc----ccc
Confidence 4688899999999999999985 489999999997543 3446688999999999999999999999876431 111
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCCc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGLS 640 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla 640 (671)
..+.++||+.+|+|.+++... .+++.....++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 234555667799999999753 389999999999999999999987 8999999999999999999999999998
Q ss_pred cccc----------------------------------cccccceeeeeeehhhh
Q 005898 641 IVSE----------------------------------DINSVGVRLLILMSFFF 661 (671)
Q Consensus 641 ~~~~----------------------------------d~~s~g~~l~~~~~~~~ 661 (671)
+... |+||+||++|+|++|..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~ 211 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCC
Confidence 6432 99999999999999854
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-30 Score=274.25 Aligned_cols=171 Identities=22% Similarity=0.320 Sum_probs=139.6
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCC--chhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSS--KKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.+.|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+.. ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~--~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL--DD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST--TT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc--cc
Confidence 35688899999999999999996 47999999999753 234466789999999999999999999999865421 11
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++||||+ +++|..+.+.. .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 23579999999 55787776543 399999999999999999999997 89999999999999999999999999
Q ss_pred Cccccc----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|+..+ |+||+||++|+|++|.+.
T Consensus 167 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p 218 (346)
T d1cm8a_ 167 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218 (346)
T ss_dssp TCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence 997643 999999999999998543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-31 Score=275.77 Aligned_cols=166 Identities=27% Similarity=0.408 Sum_probs=143.8
Q ss_pred cCCCcCceeccCCceEEEEEEE----cCCcEEEEEEccCCc----hhhHHHHHHHHHHHhcCCC-CCcccccceeecCCC
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL----ENGTSVAIRCLPSSK----KYTVRNLKLRLDLLAKLRH-PHLVCLLGHCIDGGG 553 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 553 (671)
++|+..++||+|+||+||+|+. .+|+.||||.++... ....+.+.+|+++|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 5699999999999999999984 258899999986432 2234568899999999977 89999999988764
Q ss_pred CCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEE
Q 005898 554 RDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAK 633 (671)
Q Consensus 554 ~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~k 633 (671)
..++|||||++|+|.+++..... +.......++.|++.||+|+|+. +|+||||||+||+++.++.+|
T Consensus 103 -------~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 103 -------KLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp -------EEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred -------ceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence 78999999999999999976543 67788889999999999999997 799999999999999999999
Q ss_pred EcccCCccccc---------------------------------cccccceeeeeeehhhhc
Q 005898 634 LSDYGLSIVSE---------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 634 i~DfGla~~~~---------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+|||+|+... |+||+||++|+|++|...
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P 231 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999996532 999999999999998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-30 Score=270.44 Aligned_cols=175 Identities=18% Similarity=0.314 Sum_probs=140.5
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++||||+++++++......-...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36789999999999999999996 479999999985432 233567889999999999999999999987643110111
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++||||++++.+..+.... ..+.......++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 24689999999988776554432 3478888999999999999999987 89999999999999999999999999
Q ss_pred Cccccc-----------------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE-----------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~-----------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+++..+ |+||+||++|||++|.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p 221 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC
Confidence 985322 999999999999998544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=2.4e-30 Score=269.84 Aligned_cols=162 Identities=22% Similarity=0.389 Sum_probs=140.7
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|.+++ ||||+++++++..... .
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~------~ 105 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVS------R 105 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT------C
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC------C
Confidence 5799999999999999999996 479999999997543 457889999999995 9999999999875431 3
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-cEEEcccCC
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR-IAKLSDYGL 639 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~-~~ki~DfGl 639 (671)
..++||||+++|+|..+.+ .++......++.||+.||+|||++ +|+||||||+|||++.++ .+|++|||+
T Consensus 106 ~~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp SEEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred ceeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 6899999999999977643 388999999999999999999997 899999999999998654 699999999
Q ss_pred ccccc------------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE------------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~------------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
|+... |+||+||++|+|+++...
T Consensus 177 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~p 229 (328)
T d3bqca1 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229 (328)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCC
Confidence 96543 999999999999997643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-30 Score=268.62 Aligned_cols=173 Identities=23% Similarity=0.323 Sum_probs=138.4
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cC-CcEEEEEEccCCc--hhhHHHHHHHHHHHhc---CCCCCcccccceeecCCCC
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-EN-GTSVAIRCLPSSK--KYTVRNLKLRLDLLAK---LRHPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~-g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~---l~H~niv~l~g~~~~~~~~ 554 (671)
.++|+..+.||+|+||+||+|+. .+ ++.||||+++... .....++.+|+++|+. .+|||||+++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 6789999985432 1122345567666555 4899999999998643211
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEE
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKL 634 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki 634 (671)
.....+++|||+++|.+....... ...+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||
T Consensus 86 ---~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 ---RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp ---SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ---cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 124689999999988775444432 23489999999999999999999997 7999999999999999999999
Q ss_pred cccCCccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 635 SDYGLSIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 635 ~DfGla~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
+|||+++... |+||+||++|||++|...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~p 214 (305)
T d1blxa_ 158 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214 (305)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCC
Confidence 9999987543 999999999999998654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.7e-30 Score=269.86 Aligned_cols=171 Identities=18% Similarity=0.268 Sum_probs=142.2
Q ss_pred hcCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcc
Q 005898 482 TNNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYA 558 (671)
Q Consensus 482 ~~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~ 558 (671)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++|||||++++++...... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~---~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL---E 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST---T
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc---c
Confidence 45688899999999999999995 579999999997542 33456789999999999999999999998754311 1
Q ss_pred cceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccC
Q 005898 559 VNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYG 638 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfG 638 (671)
....++++||+.+|+|.+++... .+++.+...++.||+.||+|||+. +|+||||||+|||++.++.+|++|||
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred cCceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 12346778888999999998643 499999999999999999999987 89999999999999999999999999
Q ss_pred Cccccc----------------------------cccccceeeeeeehhhhc
Q 005898 639 LSIVSE----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 639 la~~~~----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++.... |+||+||++|+|++|...
T Consensus 167 ~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p 218 (348)
T d2gfsa1 167 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218 (348)
T ss_dssp ---CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence 986543 999999999999998654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=5.2e-29 Score=257.79 Aligned_cols=230 Identities=27% Similarity=0.455 Sum_probs=205.0
Q ss_pred CCCEEecccccccc--cCCccccCCCCCCEEEccc-CcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 119 SLRVLSLVSLGIWG--SLPDKIHRLYSLEYLDLSS-NFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 119 ~L~~L~L~~n~l~g--~~p~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
+++.|+|++|++.| .+|+++++|++|++|||++ |+++|.+|+.|++|++|++|+|++|++.+..|..+..+++|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 57889999999988 5899999999999999986 89999999999999999999999999999999999999999999
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCC-CEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCC
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSL-NVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L-~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~ 273 (671)
++++|++.+.+|..+.+++.|+.+++++|.++|.+|. +..+..+ +.+++++|++ ++.
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l---------------------~~~ 189 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL---------------------TGK 189 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE---------------------EEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccc---------------------ccc
Confidence 9999999999999999999999999999999998885 5566554 5666665554 456
Q ss_pred chhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCC
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNE 353 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~ 353 (671)
.|..++.+..+ .+++++|.+.+.+|..+..+++++.+++++|.+++.+| .+..+++|+.|||++|+++|.+|.+++++
T Consensus 190 ~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L 267 (313)
T d1ogqa_ 190 IPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267 (313)
T ss_dssp CCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGC
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCC
Confidence 67777777554 79999999999999999999999999999999998876 57888999999999999999999999999
Q ss_pred CCCceeccCCCcCCCCcC
Q 005898 354 SDKRVVKFRGNCLSSNVQ 371 (671)
Q Consensus 354 ~~l~~l~l~~N~l~~~~~ 371 (671)
++|+.|++++|.++|.+|
T Consensus 268 ~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 268 KFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp TTCCEEECCSSEEEEECC
T ss_pred CCCCEEECcCCcccccCC
Confidence 999999999999997654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=4.9e-29 Score=255.30 Aligned_cols=166 Identities=16% Similarity=0.252 Sum_probs=140.3
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCchhhHHHHHHHHHHHhcCCC-CCcccccceeecCCCCCCcccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRH-PHLVCLLGHCIDGGGRDDYAVN 560 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~~~~~~ 560 (671)
++|+..+.||+|+||+||+|+.. +|+.||||++..... .+++.+|++.++.++| +|++.+++++.+..
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-------- 74 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-------- 74 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--------
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--------
Confidence 46888999999999999999964 799999999865432 2457788888988875 89999998887653
Q ss_pred eEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC-----CCcEEEc
Q 005898 561 KVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE-----HRIAKLS 635 (671)
Q Consensus 561 ~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~-----~~~~ki~ 635 (671)
..++||||+ +|+|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence 679999999 689999887643 3589999999999999999999997 8999999999999974 5789999
Q ss_pred ccCCccccc-------------------------------------cccccceeeeeeehhhhccc
Q 005898 636 DYGLSIVSE-------------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 636 DfGla~~~~-------------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
|||+|+... |+||+||++|||++|.....
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 999996421 99999999999999765543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.9e-29 Score=260.93 Aligned_cols=169 Identities=21% Similarity=0.265 Sum_probs=137.9
Q ss_pred cCCCcCceeccCCceEEEEEEEc-CCcEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCccc
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRLE-NGTSVAIRCLPSSK--KYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAV 559 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~ 559 (671)
++|+..++||+|+||+||+|+.. +|+.||||++.... ....+++.+|+.++++++|||||++++++...+.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~--~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL--EEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST--TTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc--ccC
Confidence 56888999999999999999965 79999999997542 33456789999999999999999999999764311 123
Q ss_pred ceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCCcEEEcccCC
Q 005898 560 NKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHRIAKLSDYGL 639 (671)
Q Consensus 560 ~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~~~ki~DfGl 639 (671)
...|+||||+.+|.+ +.+.. .+++.....++.||+.||+|||+. +|+||||||+|||++.++..|++|||+
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 578999999976544 44432 388999999999999999999997 899999999999999999999999998
Q ss_pred ccccc-----------------------------cccccceeeeeeehhhhc
Q 005898 640 SIVSE-----------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 640 a~~~~-----------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
++... |+||+||++|+|++|.+.
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~p 217 (355)
T d2b1pa1 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCC
Confidence 76533 999999999999998653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=6.7e-29 Score=255.28 Aligned_cols=167 Identities=19% Similarity=0.326 Sum_probs=137.0
Q ss_pred cCCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccce
Q 005898 483 NNFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNK 561 (671)
Q Consensus 483 ~~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~ 561 (671)
++|+..+.||+|+||+||+|+. .+|+.||||++..... .+++.+|++++++++|+|+|..++.|...+ +.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-------~~ 77 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG-------DY 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET-------TE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC-------CE
Confidence 4588899999999999999996 4789999999865432 245889999999999988887777665433 36
Q ss_pred EEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeec---CCCcEEEcccC
Q 005898 562 VFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLN---EHRIAKLSDYG 638 (671)
Q Consensus 562 ~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~---~~~~~ki~DfG 638 (671)
.++||||+. |++...+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ .+..+|++|||
T Consensus 78 ~~ivme~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 78 NVMVMELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEEEECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 899999995 56666655432 3599999999999999999999997 899999999999875 45679999999
Q ss_pred Cccccc-------------------------------------cccccceeeeeeehhhhccc
Q 005898 639 LSIVSE-------------------------------------DINSVGVRLLILMSFFFGSM 664 (671)
Q Consensus 639 la~~~~-------------------------------------d~~s~g~~l~~~~~~~~~~~ 664 (671)
+|+... |+||+||++|||++|.....
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 996431 99999999999999755443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=7e-24 Score=217.95 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=212.7
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
+++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|++++|+++ .+|..+ ...|..|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhc
Confidence 57899999999997766678999999999999999999888889999999999999999998 466543 468999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccC---CCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCc
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLP---DLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI 274 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~ 274 (671)
.+|.+.+..+..+.....+..++...|....... .+..+++|+.+++++|.++......+.+++.+++++|..++..
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~ 187 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD 187 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEEC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCC
Confidence 9999997777778888899999999886543322 3677899999999999988655556789999999999999999
Q ss_pred hhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCC-----
Q 005898 275 PKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSC----- 349 (671)
Q Consensus 275 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~----- 349 (671)
+..|..++.++.|++++|.+++.++..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++..-...
T Consensus 188 ~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~ 266 (305)
T d1xkua_ 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266 (305)
T ss_dssp TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS
T ss_pred hhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcc
Confidence 999999999999999999999999999999999999999999998 67889999999999999999998432222
Q ss_pred -CCCCCCCceeccCCCcCC
Q 005898 350 -LSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 350 -~~~~~~l~~l~l~~N~l~ 367 (671)
......++.+++++|.+.
T Consensus 267 ~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 267 YNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCTTSCCCSEEECCSSSSC
T ss_pred hhcccCCCCEEECCCCcCc
Confidence 234567889999999875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.8e-24 Score=218.68 Aligned_cols=247 Identities=22% Similarity=0.227 Sum_probs=192.4
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEcc-CCcCCCCCCcccCCCCCcCEEE
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILD-DNFFNNTIPNWFDSLPSLTFLS 196 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~ 196 (671)
+.+++|+|++|.|++..+..|.++++|++||+++|++.+..+..+..+..+..+... .|.++...|..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 467999999999987777789999999999999999998888888999999998765 5666666688899999999999
Q ss_pred cccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCC---CCCccEEEcCCCCCCC
Q 005898 197 MRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLSNNSFSG 272 (671)
Q Consensus 197 L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~~N~l~~ 272 (671)
+++|.+....+..+..+++|+.+++++|++++.++. +..+++|+.|++++|++++..+.. ..+|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 999999877777888899999999999999977664 778899999999999987765544 3467778888888887
Q ss_pred CchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCC
Q 005898 273 EIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSN 352 (671)
Q Consensus 273 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~ 352 (671)
..|..|..+++|++||+++|++.+.++..+..+++|+.|+|++|.+.+.-+.. .-...++.+....+++++..|..+..
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~l~~~l~~~~~~~~~~~C~~p~~l~g 270 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch-HHHHHHHhCcCCCCceEeCCchHHcC
Confidence 77888888888888888888888888878888888888888888877543211 01122444555666677666665542
Q ss_pred CCCCceeccCCCcCCC
Q 005898 353 ESDKRVVKFRGNCLSS 368 (671)
Q Consensus 353 ~~~l~~l~l~~N~l~~ 368 (671)
....+++.+.++|
T Consensus 271 ---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 271 ---RDLKRLAANDLQG 283 (284)
T ss_dssp ---CBGGGSCGGGSCC
T ss_pred ---CccccCCHHHCCC
Confidence 3445555555543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.90 E-value=9.5e-25 Score=230.17 Aligned_cols=170 Identities=19% Similarity=0.256 Sum_probs=134.6
Q ss_pred CCCcCceeccCCceEEEEEEE-cCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-----------CCCcccccceeecC
Q 005898 484 NFDMSAIMGEGSYGKLYKGRL-ENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-----------HPHLVCLLGHCIDG 551 (671)
Q Consensus 484 ~f~~~~~iG~G~~g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~ 551 (671)
.|+..++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.++++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 388899999999999999996 5799999999976533 3457788888888775 57899999888653
Q ss_pred CCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecCCC-
Q 005898 552 GGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNEHR- 630 (671)
Q Consensus 552 ~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~~~- 630 (671)
.. ...+++|+++..+..............+++.....++.||+.||+|||+.. +|+||||||+|||++.++
T Consensus 93 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 93 GP------NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp ET------TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred cc------cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCc
Confidence 21 356788887776654433333333445888999999999999999999742 799999999999998654
Q ss_pred -----cEEEcccCCccccc---------------------------cccccceeeeeeehhhhc
Q 005898 631 -----IAKLSDYGLSIVSE---------------------------DINSVGVRLLILMSFFFG 662 (671)
Q Consensus 631 -----~~ki~DfGla~~~~---------------------------d~~s~g~~l~~~~~~~~~ 662 (671)
.+|++|||.|+... |+||+||++++|++|...
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 228 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred ccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence 39999999986432 999999999999997653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=5.6e-23 Score=208.98 Aligned_cols=222 Identities=20% Similarity=0.243 Sum_probs=175.2
Q ss_pred EecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcc-ccc
Q 005898 123 LSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMR-NNK 201 (671)
Q Consensus 123 L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~ 201 (671)
++.+++++. .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....+..+..++.+..++.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 344555554 5666543 568999999999987666789999999999999999998888888889999998775 566
Q ss_pred CCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcC
Q 005898 202 LAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQ 280 (671)
Q Consensus 202 l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~ 280 (671)
++...|..+.++++|++|++++|.+....+. +...++|+.+++++|++++ ..+..|..
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~---------------------i~~~~f~~ 151 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA---------------------LPDDTFRD 151 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------------------CCTTTTTT
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccc---------------------cChhHhcc
Confidence 6666677889999999999999988765553 5667788888887776653 33455667
Q ss_pred CcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceec
Q 005898 281 LNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVK 360 (671)
Q Consensus 281 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~ 360 (671)
+++|+.|++++|++++.++..+..+++|+.+++++|++++..|..|..+++|+.||+++|++++..|..+..+.+++.++
T Consensus 152 ~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~ 231 (284)
T d1ozna_ 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLR 231 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEE
T ss_pred ccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEE
Confidence 77888888888888888888888888888888888888887788888888888888888888877777777788888888
Q ss_pred cCCCcCCC
Q 005898 361 FRGNCLSS 368 (671)
Q Consensus 361 l~~N~l~~ 368 (671)
+++|.+.+
T Consensus 232 l~~N~l~C 239 (284)
T d1ozna_ 232 LNDNPWVC 239 (284)
T ss_dssp CCSSCEEC
T ss_pred ecCCCCCC
Confidence 88887764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.7e-22 Score=203.28 Aligned_cols=198 Identities=23% Similarity=0.240 Sum_probs=97.3
Q ss_pred CCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEec
Q 005898 143 SLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLS 222 (671)
Q Consensus 143 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 222 (671)
.+.+.|.+++.|+ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+| .++.+++|+.|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence 3334444444443 2343332 24445555555544433344555555555555555554 222 23445555555555
Q ss_pred cCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCcccc
Q 005898 223 KNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAI 302 (671)
Q Consensus 223 ~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 302 (671)
+|++++..+.+..+++|+.|++++|.+.+ ..+..+..+.+++.|++++|.++..++..+
T Consensus 86 ~N~l~~~~~~~~~l~~L~~L~l~~~~~~~---------------------~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~ 144 (266)
T d1p9ag_ 86 HNQLQSLPLLGQTLPALTVLDVSFNRLTS---------------------LPLGALRGLGELQELYLKGNELKTLPPGLL 144 (266)
T ss_dssp SSCCSSCCCCTTTCTTCCEEECCSSCCCC---------------------CCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred cccccccccccccccccccccccccccce---------------------eeccccccccccccccccccccceeccccc
Confidence 55555444445555555555555554432 122233344445555555555555555444
Q ss_pred CCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCC
Q 005898 303 FSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 303 ~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
..+++|+.|++++|++++..|..+..+.+|+.|||++|+|+ .+|..+..++.++.+++++|.+.
T Consensus 145 ~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 55555555555555555444444555555555555555555 45555555555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.6e-22 Score=203.60 Aligned_cols=202 Identities=24% Similarity=0.306 Sum_probs=163.8
Q ss_pred cCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
.+.+.+...+.++++++ .+|+.+. ++|++|||++|+|++..+..|.++++|++|+|++|+++. +| .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 34556677788888887 4676664 578999999999987666789999999999999999984 44 3578999999
Q ss_pred EEcccccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCC
Q 005898 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 195 L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~ 273 (671)
|+|++|++++ +|..+..+++|+.|++++|.+.+..+. +..+.+++.|++++|.++. .
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~---------------------l 139 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT---------------------L 139 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC---------------------C
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccce---------------------e
Confidence 9999999984 677889999999999999998876554 6778888888888776653 3
Q ss_pred chhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcc
Q 005898 274 IPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344 (671)
Q Consensus 274 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g 344 (671)
.+..+..+++|+.|++++|++++.++..+..+++|+.|+|++|+|+ .+|+.+..+.+|+.|+|++|.+..
T Consensus 140 ~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 3455667788888888888888888888888888888888888888 788888788888888888888763
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=7.9e-22 Score=208.46 Aligned_cols=188 Identities=26% Similarity=0.386 Sum_probs=113.2
Q ss_pred CCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEE
Q 005898 164 TMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLN 243 (671)
Q Consensus 164 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~ 243 (671)
.+++++.|++++|.+++..| +..+++|++|++++|+++. + +.+..+++|+.|++++|.+++.. .+..+++|+.|+
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~ 269 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELK 269 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEE
T ss_pred cccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC-cccccccCCEee
Confidence 33445555555555554332 2344556666666665552 2 24555666666666666665433 355566666666
Q ss_pred CCCCCCCCCCCC-CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCcccC
Q 005898 244 LSDNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSL 322 (671)
Q Consensus 244 Ls~N~l~~~~p~-~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~ 322 (671)
+++|++++..+- -...+..+.+..|.+++ +..+..+++++.|++++|++++.++ +..+++|+.|++++|++++ +
T Consensus 270 l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l 344 (384)
T d2omza2 270 LGANQISNISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-V 344 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-C
T ss_pred ccCcccCCCCcccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-C
Confidence 666666543221 12345566666666654 2345666777777777777776643 6667777777777777764 3
Q ss_pred CcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCC
Q 005898 323 PKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGN 364 (671)
Q Consensus 323 p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N 364 (671)
| .+..+++|+.|++++|++++..| +.++++|+.|++++|
T Consensus 345 ~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 345 S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 3 46667777777777777776544 666777777777766
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.88 E-value=1.9e-21 Score=199.59 Aligned_cols=260 Identities=22% Similarity=0.226 Sum_probs=207.5
Q ss_pred ceEeCCCCEeEEEecCCCCCCCCCCCCcccccccCCCccCCCcch-hcccCCCCCCEEecccccccccCCccccCCCCCC
Q 005898 67 NITCQDNFITELKIIGDKPSNVGNFDGFASANASLSENFSIDSFV-TTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLE 145 (671)
Q Consensus 67 ~v~C~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~-~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~ 145 (671)
+|.|.+..++++ +...++... .+++++|.. ..+| ..|.++++|++|++++|.+....|..|.++++|+
T Consensus 14 ~~~C~~~~L~~l--P~~l~~~l~--------~L~Ls~N~i-~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~ 82 (305)
T d1xkua_ 14 VVQCSDLGLEKV--PKDLPPDTA--------LLDLQNNKI-TEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82 (305)
T ss_dssp EEECTTSCCCSC--CCSCCTTCC--------EEECCSSCC-CCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred EEEecCCCCCcc--CCCCCCCCC--------EEECcCCcC-CCcChhHhhccccccccccccccccccchhhhhCCCccC
Confidence 589976655533 222222211 224566543 4455 4799999999999999999988899999999999
Q ss_pred EEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCC--CCCcccccCCCCCCEEEecc
Q 005898 146 YLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA--GPFPSSIQRISTLSDLDLSK 223 (671)
Q Consensus 146 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--g~~p~~l~~l~~L~~L~Ls~ 223 (671)
+|++++|+++ .+|..+ ...|+.|++.+|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++
T Consensus 83 ~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~ 159 (305)
T d1xkua_ 83 RLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159 (305)
T ss_dssp EEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred EecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCcccccc
Confidence 9999999997 466544 357899999999999877777888899999999888643 45566788999999999999
Q ss_pred CccccccCCCCCCCCCCEEECCCCCCCCCCCCC---CCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCcc
Q 005898 224 NAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKL---PRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPP 300 (671)
Q Consensus 224 N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 300 (671)
|.++.. |. ..+++|+.|++++|..++..+.. ...+..+++++|.+++..|..+..+++|++|+|++|+|+..+ .
T Consensus 160 n~l~~l-~~-~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp-~ 236 (305)
T d1xkua_ 160 TNITTI-PQ-GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-G 236 (305)
T ss_dssp SCCCSC-CS-SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC-T
T ss_pred CCcccc-Cc-ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccc-c
Confidence 998754 32 23689999999999998776653 356889999999999888999999999999999999999764 5
Q ss_pred ccCCCCCcCeEecccCcCcccCCcc------cCCCCCccEEECcCCcCc
Q 005898 301 AIFSLPNISDLNLASNKFSGSLPKN------LNCGGKLVFFDISNNKLT 343 (671)
Q Consensus 301 ~~~~l~~L~~L~L~~N~l~g~~p~~------~~~~~~L~~l~ls~N~l~ 343 (671)
.+..+++|+.|+|++|+++..-... .....+|+.|++++|.++
T Consensus 237 ~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 8999999999999999998543223 345678999999999985
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=6.8e-21 Score=201.17 Aligned_cols=241 Identities=22% Similarity=0.263 Sum_probs=188.6
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCC----------
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTI---------- 182 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~---------- 182 (671)
.+..|++|++|+|++|++++. | .++++++|++|++++|++.+. + .++++++|+.|++++|.+++..
T Consensus 61 gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~ 136 (384)
T d2omza2 61 GVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136 (384)
T ss_dssp TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSE
T ss_pred ccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccc-c-cccccccccccccccccccccccccccccccc
Confidence 356778888888888888654 3 288888888888888888653 3 3778888888888877665311
Q ss_pred -----------------------------------------------------CcccCCCCCcCEEEcccccCCCCCccc
Q 005898 183 -----------------------------------------------------PNWFDSLPSLTFLSMRNNKLAGPFPSS 209 (671)
Q Consensus 183 -----------------------------------------------------p~~~~~l~~L~~L~L~~N~l~g~~p~~ 209 (671)
+..+..+++++.+++++|.+++..|
T Consensus 137 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-- 214 (384)
T d2omza2 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-- 214 (384)
T ss_dssp EEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc--
Confidence 1234566788888999998886544
Q ss_pred ccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCC-CCCCccEEEcCCCCCCCCchhhhcCCcccceee
Q 005898 210 IQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLD 288 (671)
Q Consensus 210 l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~ 288 (671)
+..+++|+.|++++|.++. ++.+..+++|+.|++++|.+++..+- ....|+.+++++|.+++.. .+..+..++.++
T Consensus 215 ~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~ 291 (384)
T d2omza2 215 LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLE 291 (384)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred ccccCCCCEEECCCCCCCC-cchhhcccccchhccccCccCCCCcccccccCCEeeccCcccCCCC--cccccccccccc
Confidence 4667889999999998875 56678888999999999988875442 2467889999999988644 367888899999
Q ss_pred cccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 289 MSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 289 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
++.|.+++.. .+..+++++.|++++|++++..| +..+++|+.|++++|++++ +| .+..+++|+.+++++|.+++
T Consensus 292 ~~~n~l~~~~--~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 292 LNENQLEDIS--PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp CCSSCCSCCG--GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCB
T ss_pred cccccccccc--ccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCC
Confidence 9999998753 47788999999999999997543 7788999999999999985 44 58889999999999999885
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5.4e-22 Score=189.23 Aligned_cols=132 Identities=14% Similarity=0.178 Sum_probs=103.8
Q ss_pred cCceeccCCceEEEEEEEcCCcEEEEEEccCCch------------------hhHHHHHHHHHHHhcCCCCCccccccee
Q 005898 487 MSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKK------------------YTVRNLKLRLDLLAKLRHPHLVCLLGHC 548 (671)
Q Consensus 487 ~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~ 548 (671)
..++||+|+||+||+|+..+|+.||||+++.... .......+|.+.+.+++|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4688999999999999988899999998642110 1123456788899999999999876543
Q ss_pred ecCCCCCCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCCccccCCCCCceeecC
Q 005898 549 IDGGGRDDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHTGVIPGFFNNRVKTNNILLNE 628 (671)
Q Consensus 549 ~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk~~NiLl~~ 628 (671)
..++||||++++.+.+ +.......++.|++++++|||+. +|+||||||+|||+++
T Consensus 84 ------------~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~ 138 (191)
T d1zara2 84 ------------GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSE 138 (191)
T ss_dssp ------------TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEET
T ss_pred ------------CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeC
Confidence 1279999999865533 22334567899999999999997 8999999999999996
Q ss_pred CCcEEEcccCCccccc
Q 005898 629 HRIAKLSDYGLSIVSE 644 (671)
Q Consensus 629 ~~~~ki~DfGla~~~~ 644 (671)
+ .+++.|||.|+..+
T Consensus 139 ~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 139 E-GIWIIDFPQSVEVG 153 (191)
T ss_dssp T-EEEECCCTTCEETT
T ss_pred C-CEEEEECCCcccCC
Confidence 5 58899999997654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=3.4e-18 Score=167.19 Aligned_cols=187 Identities=23% Similarity=0.322 Sum_probs=95.3
Q ss_pred cCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCE
Q 005898 139 HRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSD 218 (671)
Q Consensus 139 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~ 218 (671)
..|.+|++|++++|.++. ++ .+..+++|++|++++|.+++..| +..+++|+++++++|.++ .++ .+..+++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccc
Confidence 445555555555555542 32 35555555555555555554322 555555555555555554 222 3455555555
Q ss_pred EEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCC-CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCC
Q 005898 219 LDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM 297 (671)
Q Consensus 219 L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 297 (671)
++++.+...+. +.+...+.+..+.++++.+....+- ...+++.+++++|.++... .++.+++|+.|++++|++++.
T Consensus 112 l~l~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l 188 (227)
T d1h6ua2 112 LDLTSTQITDV-TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI 188 (227)
T ss_dssp EECTTSCCCCC-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred ccccccccccc-chhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCC
Confidence 55555555432 2234445555555555544322110 1223334444444443221 255666666666666666654
Q ss_pred CccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECc
Q 005898 298 PPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDIS 338 (671)
Q Consensus 298 ~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls 338 (671)
++ +..+++|+.|+|++|++++. | .+.++++|+.|+++
T Consensus 189 ~~--l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 189 SP--LASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp GG--GGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred hh--hcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 32 55666666666666666643 2 25556666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=3.7e-18 Score=168.45 Aligned_cols=212 Identities=17% Similarity=0.116 Sum_probs=108.4
Q ss_pred EEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCC-cccCCCCCcCEEEccc-
Q 005898 122 VLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIP-NWFDSLPSLTFLSMRN- 199 (671)
Q Consensus 122 ~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~- 199 (671)
+++.++.+++ .+|+.+. +++++|||++|+++...+..|.++++|++|+|++|.+...+| ..|.++++++++.+..
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4444444443 4444332 355666666666654333455666666666666665554333 3455566666665543
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccC--CCCCCCCCCEEECCCCCCCCCCCC----CCCCccEEEcCCCCCCCC
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLP--DLSSLGSLNVLNLSDNKLDSNLPK----LPRGLVMAFLSNNSFSGE 273 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~L~~l~l~~N~l~~~ 273 (671)
|++....|..|..+++|+.|++++|.+....+ .+..+..+..+..+++.+....+. ....+..+++++|+++..
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i 168 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence 45554555556666666666666666553222 123334444444444444322111 123444555555555532
Q ss_pred chhhhcCCcccc-eeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEEC
Q 005898 274 IPKQYGQLNQLQ-QLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDI 337 (671)
Q Consensus 274 ~p~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~l 337 (671)
.+..+ ...+++ .+++++|+++..++..|..+++|+.|+|++|+++...+..+.++.+|+.+++
T Consensus 169 ~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 169 HNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp CTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 22222 333333 3345666666666666666677777777777766433334555555554444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=8e-18 Score=162.45 Aligned_cols=179 Identities=22% Similarity=0.340 Sum_probs=108.4
Q ss_pred ecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCC
Q 005898 124 SLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLA 203 (671)
Q Consensus 124 ~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 203 (671)
++..+.+.+.++. ..+.+|++|++++|.++. ++ .+..+++|++|+|++|++++. + .++.+++|++|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccc
Confidence 3444455444432 245567777777777653 22 366677777777777777653 3 2566777777777777776
Q ss_pred CCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcc
Q 005898 204 GPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQ 283 (671)
Q Consensus 204 g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~ 283 (671)
+ +| .+..+++|+.|++++|.+. .++.+..+++|+.+++++|.+++ +..+..+++
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~-~~~~l~~l~~l~~l~~~~n~l~~-----------------------~~~~~~l~~ 157 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITD-----------------------ITVLSRLTK 157 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCC-CCGGGGGCTTCCEEECCSSCCCC-----------------------CGGGGGCTT
T ss_pred c-cc-ccccccccccccccccccc-ccccccccccccccccccccccc-----------------------ccccccccc
Confidence 3 44 4666777777777777665 34456666677777666665532 123445566
Q ss_pred cceeecccccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECc
Q 005898 284 LQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDIS 338 (671)
Q Consensus 284 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls 338 (671)
|+.+++++|++++.++ +.++++|+.|+|++|+++. +| .+..+++|+.|+|+
T Consensus 158 L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 158 LDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccccccccccccccc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 6666666666665432 5566666666666666653 33 35566666666664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1.4e-17 Score=162.61 Aligned_cols=207 Identities=19% Similarity=0.299 Sum_probs=169.7
Q ss_pred CCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEE
Q 005898 141 LYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLD 220 (671)
Q Consensus 141 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~ 220 (671)
|.++..++++.+++++.+ .+..+.+|+.|++.+|.++. ++ .+..+++|++|++++|++++..| +..+++|+.++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence 334455677777777643 45678899999999999985 54 58999999999999999986443 89999999999
Q ss_pred eccCccccccCCCCCCCCCCEEECCCCCCCCCCCC-CCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCc
Q 005898 221 LSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPK-LPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP 299 (671)
Q Consensus 221 Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 299 (671)
+++|.++ .++.+..+++|+.+++++|...+..+- ....+..+.++++.+.... .+..+++|+.|++++|.++...+
T Consensus 92 ~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~ 168 (227)
T d1h6ua2 92 LSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP 168 (227)
T ss_dssp CCSCCCS-CCGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG
T ss_pred ccccccc-ccccccccccccccccccccccccchhccccchhhhhchhhhhchhh--hhccccccccccccccccccchh
Confidence 9999987 567788999999999999988765442 2456788899999887543 46788999999999999987654
Q ss_pred cccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccC
Q 005898 300 PAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362 (671)
Q Consensus 300 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~ 362 (671)
+.++++|+.|+|++|++++ +|. +..+++|+.|++++|+++. +| .+.++++|+.++++
T Consensus 169 --l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 --LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp --GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred --hcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence 8899999999999999986 443 7888999999999999995 44 37788999998875
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.6e-17 Score=157.92 Aligned_cols=127 Identities=24% Similarity=0.289 Sum_probs=95.2
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCC-CccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSV-PPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRN 199 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 199 (671)
+.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 46777777775 5665543 57888888888887644 45567788888888888888877777888888888888888
Q ss_pred ccCCCCCcccccCCCCCCEEEeccCccccccCC-CCCCCCCCEEECCCCCCC
Q 005898 200 NKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-LSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 200 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~Ls~N~l~ 250 (671)
|+++...|..|.++++|++|+|++|+|++..|. |..+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 888866667778888888888888888776664 667777777777777664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=7e-17 Score=155.73 Aligned_cols=166 Identities=27% Similarity=0.353 Sum_probs=138.2
Q ss_pred CCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 116 RLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
.+.+|+.|++++|.+... + .+..+++|++|+|++|++++ ++ .++.+++|+.|++++|+++. +| .+..+++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccc
Confidence 467899999999998653 3 38899999999999999986 44 37899999999999999985 45 58999999999
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCch
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIP 275 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p 275 (671)
++++|.+.. ...+..++.|+.+++++|.+++ ++.+..+++|+.+++++|++++ ++
T Consensus 118 ~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~-~~~~~~l~~L~~l~l~~n~l~~----------------------i~ 172 (210)
T d1h6ta2 118 SLEHNGISD--INGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISD----------------------IV 172 (210)
T ss_dssp ECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCC----------------------CG
T ss_pred ccccccccc--cccccccccccccccccccccc-cccccccccccccccccccccc----------------------cc
Confidence 999999863 3468899999999999999985 4456788899999988887652 22
Q ss_pred hhhcCCcccceeecccccccCCCccccCCCCCcCeEeccc
Q 005898 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLAS 315 (671)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 315 (671)
.++++++|+.|+|++|+++..+ .+..+++|+.|+|++
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFS 209 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEE
T ss_pred -cccCCCCCCEEECCCCCCCCCh--hhcCCCCCCEEEccC
Confidence 2778889999999999998753 588899999999874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=4.9e-18 Score=161.53 Aligned_cols=113 Identities=23% Similarity=0.269 Sum_probs=104.6
Q ss_pred CCCCEEecccccccccC-CccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEE
Q 005898 118 TSLRVLSLVSLGIWGSL-PDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLS 196 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~-p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 196 (671)
+++++|+|++|.|++.+ +..|.++++|++|+|++|++.+..+..|..+++|++|+|++|+++...|..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 57899999999998755 56789999999999999999999999999999999999999999988889999999999999
Q ss_pred cccccCCCCCcccccCCCCCCEEEeccCcccccc
Q 005898 197 MRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSL 230 (671)
Q Consensus 197 L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~ 230 (671)
|++|+|++..|..|..+++|++|+|++|.+....
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cCCccccccCHHHhcCCccccccccccccccccc
Confidence 9999999888888999999999999999987644
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1e-16 Score=153.12 Aligned_cols=103 Identities=23% Similarity=0.366 Sum_probs=52.9
Q ss_pred CCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEE
Q 005898 140 RLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDL 219 (671)
Q Consensus 140 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L 219 (671)
.+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..| ++++++|++|++++|.+.. +| .+..++.|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 44555556665555542 22 34555555555555555554222 5555555555555555542 22 25555555555
Q ss_pred EeccCccccccCCCCCCCCCCEEECCCCCC
Q 005898 220 DLSKNAISGSLPDLSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 220 ~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l 249 (671)
++++|.+.. ++.+..+++|+.|++++|++
T Consensus 112 ~l~~~~~~~-~~~~~~l~~L~~L~l~~n~l 140 (199)
T d2omxa2 112 TLFNNQITD-IDPLKNLTNLNRLELSSNTI 140 (199)
T ss_dssp ECCSSCCCC-CGGGTTCTTCSEEECCSSCC
T ss_pred ccccccccc-ccccchhhhhHHhhhhhhhh
Confidence 555555543 23344555555555555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=1.2e-16 Score=152.74 Aligned_cols=163 Identities=28% Similarity=0.457 Sum_probs=133.4
Q ss_pred cCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCE
Q 005898 115 ARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTF 194 (671)
Q Consensus 115 ~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 194 (671)
..+.+|++|++++|++.. ++ .+..+++|++|+|++|++++..| +.++++|++|++++|.+.. +| .+.++++|+.
T Consensus 37 ~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~ 110 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTG 110 (199)
T ss_dssp HHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred HHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccc
Confidence 457889999999999864 43 48899999999999999986433 8999999999999999874 44 4889999999
Q ss_pred EEcccccCCCCCcccccCCCCCCEEEeccCccccccCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCc
Q 005898 195 LSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEI 274 (671)
Q Consensus 195 L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~ 274 (671)
|++++|.+... ..+..+++|+.|++++|++.. ++.+..+++|+.|++++|++++ +
T Consensus 111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~----------------------l 165 (199)
T d2omxa2 111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTD----------------------L 165 (199)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC----------------------C
T ss_pred ccccccccccc--cccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccC----------------------C
Confidence 99999998753 458889999999999999974 5678889999999998887653 2
Q ss_pred hhhhcCCcccceeecccccccCCCccccCCCCCcCeE
Q 005898 275 PKQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDL 311 (671)
Q Consensus 275 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 311 (671)
+ .++++++|+.|++++|+++..+ .+..+++|+.|
T Consensus 166 ~-~l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~L 199 (199)
T d2omxa2 166 K-PLANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199 (199)
T ss_dssp G-GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSEE
T ss_pred c-cccCCCCCCEEECCCCCCCCCc--cccCCCCCCcC
Confidence 2 3677888888888888888753 46777777765
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.69 E-value=1.2e-15 Score=157.95 Aligned_cols=235 Identities=23% Similarity=0.277 Sum_probs=144.3
Q ss_pred CcchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccC
Q 005898 108 DSFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFD 187 (671)
Q Consensus 108 ~~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 187 (671)
..+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .++|++|++++|.+. .+|. ++
T Consensus 51 ~~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~ 117 (353)
T d1jl5a_ 51 SSLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQ 117 (353)
T ss_dssp SCCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CT
T ss_pred CCCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hh
Confidence 345542 457788888888875 567543 46777788888775 33321 135788888888877 4554 56
Q ss_pred CCCCcCEEEcccccCCCCCc------------------ccccCCCCCCEEEeccCccccc-------------------c
Q 005898 188 SLPSLTFLSMRNNKLAGPFP------------------SSIQRISTLSDLDLSKNAISGS-------------------L 230 (671)
Q Consensus 188 ~l~~L~~L~L~~N~l~g~~p------------------~~l~~l~~L~~L~Ls~N~l~g~-------------------~ 230 (671)
.+++|++|++++|.+....+ ..+..++.++.++++.|.+... +
T Consensus 118 ~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~ 197 (353)
T d1jl5a_ 118 NSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEEL 197 (353)
T ss_dssp TCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSC
T ss_pred hhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccccccccccccccccccccccc
Confidence 78888888888777653211 2234456667777766655431 2
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeecccccccC--------------
Q 005898 231 PDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRG-------------- 296 (671)
Q Consensus 231 p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-------------- 296 (671)
+.+..++.|+.+++++|.... +|.....+..+.+..|.+... +.. ...+...++..|.+.+
T Consensus 198 ~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~-~~~---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~ 272 (353)
T d1jl5a_ 198 PELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSGLSELPPNLYYLNAS 272 (353)
T ss_dssp CCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSEESCCCTTCCEEECC
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccc-ccc---cccccccccccccccccccccchhcccccc
Confidence 224456677777777776543 444455566666666655432 111 1222333332222221
Q ss_pred --CCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 297 --MPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 297 --~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
.++.....+++|++|+|++|+++ .+|.. +++|+.|++++|+++ .+|.. .++++.|++++|.++.
T Consensus 273 ~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp SSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS
T ss_pred cCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC
Confidence 11112233578999999999998 67754 467889999999998 67764 3468889999998873
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=2e-16 Score=155.81 Aligned_cols=215 Identities=13% Similarity=0.110 Sum_probs=165.0
Q ss_pred CCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCc-ccccCCCCCCEEEec
Q 005898 144 LEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFP-SSIQRISTLSDLDLS 222 (671)
Q Consensus 144 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~l~~l~~L~~L~Ls 222 (671)
.+.++.+++.++ .+|+.+. +++++|+|++|+++...+..|.++++|++|++++|.+...+| ..|..+++++++++.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 368888888887 6887664 589999999999986656679999999999999999987654 468899999999986
Q ss_pred c-CccccccCC-CCCCCCCCEEECCCCCCCCCCCC-C---CCCccEEEcCCCCCCCCchhhhcCCc-ccceeeccccccc
Q 005898 223 K-NAISGSLPD-LSSLGSLNVLNLSDNKLDSNLPK-L---PRGLVMAFLSNNSFSGEIPKQYGQLN-QLQQLDMSFNALR 295 (671)
Q Consensus 223 ~-N~l~g~~p~-~~~l~~L~~L~Ls~N~l~~~~p~-~---~~~L~~l~l~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 295 (671)
. |.+....+. +.++++|+.+++++|++....+. . .+.+......++.+....+..|..+. .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4 677766665 68899999999999998754332 1 23455566777787765566666664 7889999999999
Q ss_pred CCCccccCCCCCcCeE-ecccCcCcccCCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccC
Q 005898 296 GMPPPAIFSLPNISDL-NLASNKFSGSLPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFR 362 (671)
Q Consensus 296 ~~~~~~~~~l~~L~~L-~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~ 362 (671)
...+..+ ..+++..+ ++++|+++...+..|..+++|+.||+++|+++...+..+.+++.|+.+++.
T Consensus 167 ~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 167 EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 8776544 45565554 678888885445568889999999999999995444456666666666553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.57 E-value=9.7e-14 Score=143.29 Aligned_cols=230 Identities=27% Similarity=0.338 Sum_probs=148.1
Q ss_pred CCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEc
Q 005898 118 TSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSM 197 (671)
Q Consensus 118 ~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 197 (671)
.+|++|||++|+++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 47899999999996 58864 578999999999997 678764 57899999999987 34432 146999999
Q ss_pred ccccCCCCCcccccCCCCCCEEEeccCccccccCC-------------------CCCCCCCCEEECCCCCCCCCCCCCCC
Q 005898 198 RNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPD-------------------LSSLGSLNVLNLSDNKLDSNLPKLPR 258 (671)
Q Consensus 198 ~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~-------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~ 258 (671)
++|.++ .+|. ++.+++|+.|++++|.++...+. +..++.++.+++++|.+... +....
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~-~~~~~ 182 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKL-PDLPL 182 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-CCCCT
T ss_pred cccccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccc-ccccc
Confidence 999998 5674 68899999999999988654321 34566778888888776542 22222
Q ss_pred CccEEEcCCCCCCCCchhhhcCCcccceeecccccccCCCccc----------------cCCCCCcCeEecccCcCccc-
Q 005898 259 GLVMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPPPA----------------IFSLPNISDLNLASNKFSGS- 321 (671)
Q Consensus 259 ~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----------------~~~l~~L~~L~L~~N~l~g~- 321 (671)
....+...++.+. .+| .+..++.|+.+++++|.....+... .....++...++..|.+.+.
T Consensus 183 ~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 260 (353)
T d1jl5a_ 183 SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260 (353)
T ss_dssp TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEES
T ss_pred ccccccccccccc-ccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2223333333322 122 2334455555555555444322100 00122333344443333221
Q ss_pred ---------------CCcccCCCCCccEEECcCCcCcccCCCCCCCCCCCceeccCCCcCCC
Q 005898 322 ---------------LPKNLNCGGKLVFFDISNNKLTGGLPSCLSNESDKRVVKFRGNCLSS 368 (671)
Q Consensus 322 ---------------~p~~~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~l~~l~l~~N~l~~ 368 (671)
++......++|+.|++++|+++ .+|..+ ++++.|++++|.++.
T Consensus 261 ~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~L~~N~L~~ 318 (353)
T d1jl5a_ 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAE 318 (353)
T ss_dssp CCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSC
T ss_pred cccchhcccccccCccccccccCCCCCEEECCCCccC-cccccc---CCCCEEECCCCcCCc
Confidence 1111223468999999999998 678654 578899999999874
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.6e-14 Score=123.38 Aligned_cols=104 Identities=29% Similarity=0.366 Sum_probs=84.6
Q ss_pred CEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccc
Q 005898 121 RVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNN 200 (671)
Q Consensus 121 ~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 200 (671)
|+|+|++|+++ .+| .+.++++|++||+++|+++ .+|+.++.+++|+.|++++|.++. +| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 67899999986 445 4888999999999999986 577788889999999999999885 44 4888999999999999
Q ss_pred cCCCCC-cccccCCCCCCEEEeccCccccc
Q 005898 201 KLAGPF-PSSIQRISTLSDLDLSKNAISGS 229 (671)
Q Consensus 201 ~l~g~~-p~~l~~l~~L~~L~Ls~N~l~g~ 229 (671)
+++... +..+..+++|+.|++++|.++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 987432 25678888999999999888753
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=2e-14 Score=132.06 Aligned_cols=127 Identities=20% Similarity=0.236 Sum_probs=104.1
Q ss_pred cccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCc
Q 005898 113 TLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSL 192 (671)
Q Consensus 113 ~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 192 (671)
.+.++.+|++|+|++|+|+. +|..+..+++|++|||++|.++. ++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 46788899999999999965 47777889999999999999974 43 58899999999999999987666667789999
Q ss_pred CEEEcccccCCCCCc--ccccCCCCCCEEEeccCccccccC----CCCCCCCCCEEE
Q 005898 193 TFLSMRNNKLAGPFP--SSIQRISTLSDLDLSKNAISGSLP----DLSSLGSLNVLN 243 (671)
Q Consensus 193 ~~L~L~~N~l~g~~p--~~l~~l~~L~~L~Ls~N~l~g~~p----~~~~l~~L~~L~ 243 (671)
++|++++|+++. ++ ..+..+++|+.|++++|.++.... .+..+++|++||
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999999999974 44 367889999999999998875432 156788888886
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=1.6e-15 Score=162.72 Aligned_cols=133 Identities=16% Similarity=0.162 Sum_probs=76.2
Q ss_pred CCCCCCEEECCCCCCCCCCCC-------CCCCccEEEcCCCCCCCCchhhh-----cCCcccceeecccccccCCCcccc
Q 005898 235 SLGSLNVLNLSDNKLDSNLPK-------LPRGLVMAFLSNNSFSGEIPKQY-----GQLNQLQQLDMSFNALRGMPPPAI 302 (671)
Q Consensus 235 ~l~~L~~L~Ls~N~l~~~~p~-------~~~~L~~l~l~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~~~~~ 302 (671)
....++.+++++|.+...... ....+..+++++|.++......+ .....|+.+++++|.++......+
T Consensus 253 ~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l 332 (460)
T d1z7xw1 253 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF 332 (460)
T ss_dssp TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhc
Confidence 345677777777766432110 12456677777777653222221 123467777777777665433222
Q ss_pred ----CCCCCcCeEecccCcCccc----CCcccC-CCCCccEEECcCCcCccc----CCCCCCCCCCCceeccCCCcCC
Q 005898 303 ----FSLPNISDLNLASNKFSGS----LPKNLN-CGGKLVFFDISNNKLTGG----LPSCLSNESDKRVVKFRGNCLS 367 (671)
Q Consensus 303 ----~~l~~L~~L~L~~N~l~g~----~p~~~~-~~~~L~~l~ls~N~l~g~----~p~~~~~~~~l~~l~l~~N~l~ 367 (671)
...++|+.|+|++|+++.. +++.+. ....|+.|+|++|+++.. ++..+...++++.|++++|+++
T Consensus 333 ~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 333 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred ccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 3445677777777777532 233332 345677777777777632 3334445566777777777765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=1.4e-13 Score=120.17 Aligned_cols=100 Identities=25% Similarity=0.329 Sum_probs=55.3
Q ss_pred CEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccC
Q 005898 145 EYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKN 224 (671)
Q Consensus 145 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N 224 (671)
|+|||++|+++ .+| .+..+++|++|++++|.++ .+|+.++.+++|++|++++|++++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 45666666665 333 3566666666666666665 345556666666666666666653 33 3555555666666555
Q ss_pred cccccc--CCCCCCCCCCEEECCCCCC
Q 005898 225 AISGSL--PDLSSLGSLNVLNLSDNKL 249 (671)
Q Consensus 225 ~l~g~~--p~~~~l~~L~~L~Ls~N~l 249 (671)
+++... ..+..+++|+.|++++|++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 555322 1244445555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=9.1e-14 Score=127.51 Aligned_cols=132 Identities=21% Similarity=0.182 Sum_probs=105.5
Q ss_pred cccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCC
Q 005898 137 KIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTL 216 (671)
Q Consensus 137 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L 216 (671)
.+.++.+|++|||++|+|+ .+|..+..+++|+.|+|++|.++. ++ .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4678889999999999997 467777889999999999999984 44 58899999999999999996555567789999
Q ss_pred CEEEeccCccccc--cCCCCCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCCchhhhcCCcccceeec
Q 005898 217 SDLDLSKNAISGS--LPDLSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGEIPKQYGQLNQLQQLDM 289 (671)
Q Consensus 217 ~~L~Ls~N~l~g~--~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~~p~~~~~l~~L~~L~L 289 (671)
+.|++++|+++.. +..+..+++|++|++++|.++.. .+.-+..+..+++|+.||-
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~------------------~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK------------------KHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGS------------------TTHHHHHHHHCTTCSEETT
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccc------------------cchHHHHHHHCCCcCeeCC
Confidence 9999999999753 23577889999999999887531 0111335667777887774
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=2.4e-14 Score=144.36 Aligned_cols=175 Identities=20% Similarity=0.226 Sum_probs=86.3
Q ss_pred CccCEEEccCCcCCCC-CCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccC-ccccc-cCC-CCCCCCCCE
Q 005898 166 VKLQTLILDDNFFNNT-IPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKN-AISGS-LPD-LSSLGSLNV 241 (671)
Q Consensus 166 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N-~l~g~-~p~-~~~l~~L~~ 241 (671)
.+|++|+|+++.++.. ++..+..+++|++|+|++|.+++..+..++++++|+.|+++++ .++.. +.. ..++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 3444444444444322 1223344444444444444444444444444444444444442 23210 111 123444555
Q ss_pred EECCCC-CCCCC-----CCCCCCCccEEEcCCC--CCCC-CchhhhcCCcccceeecccc-cccCCCccccCCCCCcCeE
Q 005898 242 LNLSDN-KLDSN-----LPKLPRGLVMAFLSNN--SFSG-EIPKQYGQLNQLQQLDMSFN-ALRGMPPPAIFSLPNISDL 311 (671)
Q Consensus 242 L~Ls~N-~l~~~-----~p~~~~~L~~l~l~~N--~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L 311 (671)
|+++++ .++.. +......|+.++++++ .++. .+......+++|++|++++| .+++.....+..+++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 555443 12110 0011233444444432 2222 13334456777778888764 4666666667777778888
Q ss_pred eccc-CcCcccCCcccCCCCCccEEECcCC
Q 005898 312 NLAS-NKFSGSLPKNLNCGGKLVFFDISNN 340 (671)
Q Consensus 312 ~L~~-N~l~g~~p~~~~~~~~L~~l~ls~N 340 (671)
+|++ +.++......+..+++|+.|+++++
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 8877 4566555556667777777877765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=3.8e-14 Score=142.86 Aligned_cols=215 Identities=18% Similarity=0.164 Sum_probs=120.8
Q ss_pred CCCCCCEEeccccccccc-CCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCC-cCCCC-CCcccCCCCCc
Q 005898 116 RLTSLRVLSLVSLGIWGS-LPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN-FFNNT-IPNWFDSLPSL 192 (671)
Q Consensus 116 ~l~~L~~L~L~~n~l~g~-~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L 192 (671)
...+|++|||+++.+... ++..+.++++|++|+|+++.+++..+..+..+++|++|+|+++ .++.. +...+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 344666666666665433 3444566666666666666666555556666666666666663 33311 11123345666
Q ss_pred CEEEcccc-cCCC-CCcccccC-CCCCCEEEeccC--cccc-ccCC-CCCCCCCCEEECCCCCCCCCCCCCCCCccEEEc
Q 005898 193 TFLSMRNN-KLAG-PFPSSIQR-ISTLSDLDLSKN--AISG-SLPD-LSSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFL 265 (671)
Q Consensus 193 ~~L~L~~N-~l~g-~~p~~l~~-l~~L~~L~Ls~N--~l~g-~~p~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l 265 (671)
++|+++++ .++. .++..+.. .++|+.|++++. .++. .+.. ..++++|+.|++++|.
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~----------------- 186 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV----------------- 186 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT-----------------
T ss_pred cccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccccc-----------------
Confidence 66666654 2321 11112222 345666666543 2221 1111 2334555665555432
Q ss_pred CCCCCCCCchhhhcCCcccceeeccc-ccccCCCccccCCCCCcCeEecccCcCcccCCcccCCCCCccEEECcCCcCcc
Q 005898 266 SNNSFSGEIPKQYGQLNQLQQLDMSF-NALRGMPPPAIFSLPNISDLNLASNKFSGSLPKNLNCGGKLVFFDISNNKLTG 344 (671)
Q Consensus 266 ~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~~~~L~~l~ls~N~l~g 344 (671)
.+++..+..+.++++|++|++++ +.++......+..+++|+.|+++++--.+.++.....++. |++..++++.
T Consensus 187 ---~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~ 260 (284)
T d2astb2 187 ---MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTT 260 (284)
T ss_dssp ---TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTT---SEESCCCSCC
T ss_pred ---CCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcc---ccccCccCCC
Confidence 35556667788899999999998 4677666667888999999999887222222222223344 4456777776
Q ss_pred cCCCCCCCC
Q 005898 345 GLPSCLSNE 353 (671)
Q Consensus 345 ~~p~~~~~~ 353 (671)
..++.+++.
T Consensus 261 ~~~~~~~~~ 269 (284)
T d2astb2 261 IARPTIGNK 269 (284)
T ss_dssp TTCSSCSST
T ss_pred CCCCccCcc
Confidence 666665543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.34 E-value=6.2e-14 Score=145.27 Aligned_cols=238 Identities=20% Similarity=0.233 Sum_probs=134.1
Q ss_pred chhcccCCCCCCEEeccccccccc----CCccccCCCCCCEEEcccCcCCCC----------CCccCCCCCccCEEEccC
Q 005898 110 FVTTLARLTSLRVLSLVSLGIWGS----LPDKIHRLYSLEYLDLSSNFLFGS----------VPPKISTMVKLQTLILDD 175 (671)
Q Consensus 110 ~~~~l~~l~~L~~L~L~~n~l~g~----~p~~~~~L~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~L~~ 175 (671)
+...+...+.|+.|+|++|.+... +-..+...++|+.|+++++..... +...+...++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 345667777888888888876432 334456677788888876654211 112234456666666666
Q ss_pred CcCCCC----CCcccCCCCCcCEEEcccccCCCCCccc-------------ccCCCCCCEEEeccCcccccc----C-CC
Q 005898 176 NFFNNT----IPNWFDSLPSLTFLSMRNNKLAGPFPSS-------------IQRISTLSDLDLSKNAISGSL----P-DL 233 (671)
Q Consensus 176 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~-------------l~~l~~L~~L~Ls~N~l~g~~----p-~~ 233 (671)
|.++.. +...+...++|+.|++++|.+...-... ....+.|+.+++++|.++..- . .+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 665543 2223334556666666666553110000 122344555555555443110 0 02
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCccEEEcCCCCCCCC-----chhhhcCCcccceeecccccccCC----CccccCC
Q 005898 234 SSLGSLNVLNLSDNKLDSNLPKLPRGLVMAFLSNNSFSGE-----IPKQYGQLNQLQQLDMSFNALRGM----PPPAIFS 304 (671)
Q Consensus 234 ~~l~~L~~L~Ls~N~l~~~~p~~~~~L~~l~l~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~ 304 (671)
...+.|+.|+|++ |.++.. +...+..+++|+.|+|++|.++.. +...+..
T Consensus 183 ~~~~~L~~L~L~~---------------------n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~ 241 (344)
T d2ca6a1 183 QSHRLLHTVKMVQ---------------------NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241 (344)
T ss_dssp HHCTTCCEEECCS---------------------SCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred hhhhhhccccccc---------------------ccccccccccchhhhhcchhhhcccccccccccccccccccccccc
Confidence 2334455555544 444321 233456677888888888887543 2344567
Q ss_pred CCCcCeEecccCcCcccCCcc----cC--CCCCccEEECcCCcCccc----CCCCCC-CCCCCceeccCCCcCCC
Q 005898 305 LPNISDLNLASNKFSGSLPKN----LN--CGGKLVFFDISNNKLTGG----LPSCLS-NESDKRVVKFRGNCLSS 368 (671)
Q Consensus 305 l~~L~~L~L~~N~l~g~~p~~----~~--~~~~L~~l~ls~N~l~g~----~p~~~~-~~~~l~~l~l~~N~l~~ 368 (671)
+++|+.|+|++|.+++.-... +. ....|+.||+++|+++.. +...+. +.+.++.+++++|+++.
T Consensus 242 ~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred cccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 788888888888887542222 21 235688899999887642 222232 45678889999988863
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.32 E-value=7.1e-14 Score=144.81 Aligned_cols=218 Identities=16% Similarity=0.169 Sum_probs=150.6
Q ss_pred cCCccccCCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCCcCCCCC----------CcccCCCCCcCEEEcc
Q 005898 133 SLPDKIHRLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDNFFNNTI----------PNWFDSLPSLTFLSMR 198 (671)
Q Consensus 133 ~~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----------p~~~~~l~~L~~L~L~ 198 (671)
.+...+.+..+|+.|+|++|.+... +...+...++|+.|+++++...... ...+...++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3455677889999999999988532 3455778899999999987654221 1234567889999999
Q ss_pred cccCCCC----CcccccCCCCCCEEEeccCcccccc--------CC------CCCCCCCCEEECCCCCCCCCCCCCCCCc
Q 005898 199 NNKLAGP----FPSSIQRISTLSDLDLSKNAISGSL--------PD------LSSLGSLNVLNLSDNKLDSNLPKLPRGL 260 (671)
Q Consensus 199 ~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~g~~--------p~------~~~l~~L~~L~Ls~N~l~~~~p~~~~~L 260 (671)
+|.++.. +...+...++|+.|++++|.++..- .. ....+.|+.+++++|+++..
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~-------- 173 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG-------- 173 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG--------
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccc--------
Confidence 9988754 3334556788888888888764210 00 12445677777766655310
Q ss_pred cEEEcCCCCCCCCchhhhcCCcccceeecccccccCC-----CccccCCCCCcCeEecccCcCccc----CCcccCCCCC
Q 005898 261 VMAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGM-----PPPAIFSLPNISDLNLASNKFSGS----LPKNLNCGGK 331 (671)
Q Consensus 261 ~~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~~~~ 331 (671)
. ...+...+...+.|+.|+|++|.++.. ....+..+++|+.|+|++|.++.. +...+..+++
T Consensus 174 --------~-~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~ 244 (344)
T d2ca6a1 174 --------S-MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244 (344)
T ss_dssp --------G-HHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred --------c-cccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccccccccc
Confidence 0 012344566788999999999998642 233466789999999999998643 4455677899
Q ss_pred ccEEECcCCcCcccCCCCC------CCCCCCceeccCCCcCC
Q 005898 332 LVFFDISNNKLTGGLPSCL------SNESDKRVVKFRGNCLS 367 (671)
Q Consensus 332 L~~l~ls~N~l~g~~p~~~------~~~~~l~~l~l~~N~l~ 367 (671)
|+.|++++|.+++.-...+ .....++.+++++|.++
T Consensus 245 L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred chhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 9999999999875321111 12356899999999875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=2e-14 Score=153.95 Aligned_cols=259 Identities=22% Similarity=0.229 Sum_probs=175.1
Q ss_pred chhcccCCCCCCEEecccccccc----cCCccccCCCCCCEEEcccCcCCCC----CCccCC-CCCccCEEEccCCcCCC
Q 005898 110 FVTTLARLTSLRVLSLVSLGIWG----SLPDKIHRLYSLEYLDLSSNFLFGS----VPPKIS-TMVKLQTLILDDNFFNN 180 (671)
Q Consensus 110 ~~~~l~~l~~L~~L~L~~n~l~g----~~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~ 180 (671)
+..-+..+++|++|+|++|+++. .++..+..+++|++|||++|.++.. +...+. ...+|++|+|++|.++.
T Consensus 19 ~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~ 98 (460)
T d1z7xw1 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98 (460)
T ss_dssp HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBG
T ss_pred HHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccc
Confidence 34556778899999999998862 4566778999999999999988521 223332 34579999999999875
Q ss_pred C----CCcccCCCCCcCEEEcccccCCCCCc---------------------------------ccccCCCCCCEEEecc
Q 005898 181 T----IPNWFDSLPSLTFLSMRNNKLAGPFP---------------------------------SSIQRISTLSDLDLSK 223 (671)
Q Consensus 181 ~----~p~~~~~l~~L~~L~L~~N~l~g~~p---------------------------------~~l~~l~~L~~L~Ls~ 223 (671)
. ++..+..+++|++|++++|.++..-. ..+.....++.++++.
T Consensus 99 ~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~ 178 (460)
T d1z7xw1 99 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 178 (460)
T ss_dssp GGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCS
T ss_pred cccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccccc
Confidence 3 45667889999999999998652100 0012235677777776
Q ss_pred Cccccc-----------cC-----------------------CCCCCCCCCEEECCCCCCCCC--------CCCCCCCcc
Q 005898 224 NAISGS-----------LP-----------------------DLSSLGSLNVLNLSDNKLDSN--------LPKLPRGLV 261 (671)
Q Consensus 224 N~l~g~-----------~p-----------------------~~~~l~~L~~L~Ls~N~l~~~--------~p~~~~~L~ 261 (671)
+..... .+ .+...+.++.+++++|++... .......+.
T Consensus 179 ~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~ 258 (460)
T d1z7xw1 179 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 258 (460)
T ss_dssp SBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCC
T ss_pred cccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccc
Confidence 544210 00 011245677777777765321 112345788
Q ss_pred EEEcCCCCCCCC----chhhhcCCcccceeecccccccCCCcccc-----CCCCCcCeEecccCcCcccCCc----ccCC
Q 005898 262 MAFLSNNSFSGE----IPKQYGQLNQLQQLDMSFNALRGMPPPAI-----FSLPNISDLNLASNKFSGSLPK----NLNC 328 (671)
Q Consensus 262 ~l~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~g~~p~----~~~~ 328 (671)
.+++++|.+... ....+...+.++.+++++|.++......+ ...+.|+.+++++|.++..-.. .+..
T Consensus 259 ~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~ 338 (460)
T d1z7xw1 259 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 338 (460)
T ss_dssp EEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccccccc
Confidence 999999988743 23345678899999999999865332222 2346899999999998754322 2334
Q ss_pred CCCccEEECcCCcCccc----CCCCCC-CCCCCceeccCCCcCCC
Q 005898 329 GGKLVFFDISNNKLTGG----LPSCLS-NESDKRVVKFRGNCLSS 368 (671)
Q Consensus 329 ~~~L~~l~ls~N~l~g~----~p~~~~-~~~~l~~l~l~~N~l~~ 368 (671)
..+|+.|||++|+++.. ++..+. ..+.|+.|++++|.++.
T Consensus 339 ~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 339 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred ccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 56899999999999752 333332 35678999999998873
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=5.1e-14 Score=133.83 Aligned_cols=129 Identities=22% Similarity=0.313 Sum_probs=105.3
Q ss_pred cchhcccCCCCCCEEecccccccccCCccccCCCCCCEEEcccCcCCCCCCccCCCCCccCEEEccCCcCCCCCCcccCC
Q 005898 109 SFVTTLARLTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDS 188 (671)
Q Consensus 109 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 188 (671)
.++.++..+++|+.|+|++|.|. .++ .+.++++|++|+|++|.++ .+|..+..+++|+.|++++|.++. + +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 45667899999999999999996 455 5889999999999999996 567666667789999999999985 3 34788
Q ss_pred CCCcCEEEcccccCCCCCc--ccccCCCCCCEEEeccCccccccCC-----------CCCCCCCCEEE
Q 005898 189 LPSLTFLSMRNNKLAGPFP--SSIQRISTLSDLDLSKNAISGSLPD-----------LSSLGSLNVLN 243 (671)
Q Consensus 189 l~~L~~L~L~~N~l~g~~p--~~l~~l~~L~~L~Ls~N~l~g~~p~-----------~~~l~~L~~L~ 243 (671)
+++|++|++++|+++. ++ ..+..+++|+.|+|++|.+....+. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999999999999974 44 4688999999999999998765553 34578888876
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.24 E-value=9.4e-14 Score=131.94 Aligned_cols=115 Identities=23% Similarity=0.309 Sum_probs=59.9
Q ss_pred CcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEEeccCccccccCCC-CCCCCCCEEECCCCCCCCCCCCCCCCcc
Q 005898 183 PNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLDLSKNAISGSLPDL-SSLGSLNVLNLSDNKLDSNLPKLPRGLV 261 (671)
Q Consensus 183 p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~L~ 261 (671)
|..+..|++|++|+|++|+++ .++ .+..+++|+.|+|++|.++. +|.+ ..+++|+.|++++|+++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~----------- 106 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA----------- 106 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECC-----------
T ss_pred hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccc-cccccccccccccccccccccc-----------
Confidence 344455555555555555554 232 35555555555555555542 2221 22234445544444432
Q ss_pred EEEcCCCCCCCCchhhhcCCcccceeecccccccCCCc-cccCCCCCcCeEecccCcCcccCC
Q 005898 262 MAFLSNNSFSGEIPKQYGQLNQLQQLDMSFNALRGMPP-PAIFSLPNISDLNLASNKFSGSLP 323 (671)
Q Consensus 262 ~l~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~g~~p 323 (671)
.+ +.+..+++|+.|++++|+++.... ..+..+++|+.|+|++|+++...+
T Consensus 107 -----------~l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 107 -----------SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp -----------CH-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred -----------cc-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 12 235556667777777776665432 345666777777777776654433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=2.6e-11 Score=109.97 Aligned_cols=108 Identities=20% Similarity=0.121 Sum_probs=71.2
Q ss_pred CCCCEEEcccCcCCCCCCccCCCCCccCEEEccCC-cCCCCCCcccCCCCCcCEEEcccccCCCCCcccccCCCCCCEEE
Q 005898 142 YSLEYLDLSSNFLFGSVPPKISTMVKLQTLILDDN-FFNNTIPNWFDSLPSLTFLSMRNNKLAGPFPSSIQRISTLSDLD 220 (671)
Q Consensus 142 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~ 220 (671)
...+.++.+++.+. ..|..+..+++|++|++++| .++..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34455666666664 45666666777777777654 36655556677777777777777777765566677777777777
Q ss_pred eccCccccccCCCCCCCCCCEEECCCCCCC
Q 005898 221 LSKNAISGSLPDLSSLGSLNVLNLSDNKLD 250 (671)
Q Consensus 221 Ls~N~l~g~~p~~~~l~~L~~L~Ls~N~l~ 250 (671)
|++|+++...+......+|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccccccccccCCCccc
Confidence 777777755555444446777777777653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=4.3e-11 Score=108.55 Aligned_cols=109 Identities=17% Similarity=0.120 Sum_probs=82.6
Q ss_pred CCCCCEEecccccccccCCccccCCCCCCEEEcccCc-CCCCCCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEE
Q 005898 117 LTSLRVLSLVSLGIWGSLPDKIHRLYSLEYLDLSSNF-LFGSVPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFL 195 (671)
Q Consensus 117 l~~L~~L~L~~n~l~g~~p~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 195 (671)
+.....++.+++++. .+|..+..+++|++|++++|+ ++...+..|.++++|+.|+|++|+++...|..|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 334456777777764 456677888888888887664 766556778888888888888888887777888888888888
Q ss_pred EcccccCCCCCcccccCCCCCCEEEeccCccc
Q 005898 196 SMRNNKLAGPFPSSIQRISTLSDLDLSKNAIS 227 (671)
Q Consensus 196 ~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 227 (671)
+|++|+|+ .+|.......+|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred eccCCCCc-ccChhhhccccccccccCCCccc
Confidence 88888888 55555444557888999888774
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.20 E-value=6.9e-07 Score=87.12 Aligned_cols=161 Identities=14% Similarity=0.113 Sum_probs=97.3
Q ss_pred HHHHHHhcCCCcCceeccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCC-CCCcccccceeecCCCC
Q 005898 476 EELKEATNNFDMSAIMGEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLR-HPHLVCLLGHCIDGGGR 554 (671)
Q Consensus 476 ~~~~~~~~~f~~~~~iG~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 554 (671)
.++......|...+..+-++-..||+... +++.+.||+..........++.+|.+.+..+. +--+.+++.++.+++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~-- 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG-- 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT--
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC--
Confidence 34555555665444433334468998764 45667888876544434445777888776653 333556666665442
Q ss_pred CCcccceEEEEEecCCCCChhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhcC--------------------------
Q 005898 555 DDYAVNKVFLVYEFMSNGNFRTHISENTPGKVLNWSERLAVLIGVAKAVQFLHT-------------------------- 608 (671)
Q Consensus 555 ~~~~~~~~~Lv~Ey~~~GsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------- 608 (671)
..++|||++++.++.+..... - ++.+++.++++.++.||+
T Consensus 84 ------~~~lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T d1j7la_ 84 ------WSNLLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp ------EEEEEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred ------ceEEEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence 579999999987764332110 0 011122222333333332
Q ss_pred ---------------------------C---CCCCccccCCCCCceeecCCCcEEEcccCCccccccccccceee
Q 005898 609 ---------------------------G---VIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRL 653 (671)
Q Consensus 609 ---------------------------~---~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l 653 (671)
. ..+.++|+|+.+.||+++++...-|.||+.+...+-.|.++..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~~~~Dla~~~ 224 (263)
T d1j7la_ 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCV 224 (263)
T ss_dssp CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEEHHHHHHHHH
T ss_pred hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCCHHHHHHHHH
Confidence 1 11237899999999999987767799999999887555555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=7.5e-08 Score=87.17 Aligned_cols=46 Identities=20% Similarity=0.174 Sum_probs=23.6
Q ss_pred hhhcCCcccceeecccccccCCCccccCCCCCcCeEecccCcCccc
Q 005898 276 KQYGQLNQLQQLDMSFNALRGMPPPAIFSLPNISDLNLASNKFSGS 321 (671)
Q Consensus 276 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~g~ 321 (671)
..+..+++|+.|+|++|.++...+-......+|+.|++++|.++..
T Consensus 85 ~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 85 SIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp THHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence 3344555555555555555554443333334455566666655543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=4.3e-08 Score=88.83 Aligned_cols=68 Identities=21% Similarity=0.096 Sum_probs=31.7
Q ss_pred cccCCCCCCEEEcccCcCCCC--CCccCCCCCccCEEEccCCcCCCCCCcccCCCCCcCEEEcccccCCC
Q 005898 137 KIHRLYSLEYLDLSSNFLFGS--VPPKISTMVKLQTLILDDNFFNNTIPNWFDSLPSLTFLSMRNNKLAG 204 (671)
Q Consensus 137 ~~~~L~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 204 (671)
.+.++++|++|||++|+|+.. ++..+..+++|+.|+|++|.++..-+-.+....+|+.|++++|.++.
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 334555566666666665432 12233445555555555555543222122223345555555555543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.42 E-value=2.1e-05 Score=70.91 Aligned_cols=110 Identities=15% Similarity=0.136 Sum_probs=60.4
Q ss_pred cCCCCCCEEecccc-ccccc----CCccccCCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCCcCCCC----
Q 005898 115 ARLTSLRVLSLVSL-GIWGS----LPDKIHRLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDNFFNNT---- 181 (671)
Q Consensus 115 ~~l~~L~~L~L~~n-~l~g~----~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~---- 181 (671)
.+.+.|+.|+|+++ .+... +-..+...++|++|+|++|.+... +...+...+.|++|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34577888888764 34321 223456667788888888877522 222334456677777777766532
Q ss_pred CCcccCCCCCcCEEEcccccCCCC-------CcccccCCCCCCEEEeccC
Q 005898 182 IPNWFDSLPSLTFLSMRNNKLAGP-------FPSSIQRISTLSDLDLSKN 224 (671)
Q Consensus 182 ~p~~~~~l~~L~~L~L~~N~l~g~-------~p~~l~~l~~L~~L~Ls~N 224 (671)
+-..+..-++|++|++++|.+... +...+..-++|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 112344556666666666654311 1222333455555555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.38 E-value=0.00029 Score=67.34 Aligned_cols=152 Identities=11% Similarity=0.073 Sum_probs=87.4
Q ss_pred eeccCCc-eEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCC--CCcccccceeecCCCCCCcccceEEEEE
Q 005898 490 IMGEGSY-GKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRH--PHLVCLLGHCIDGGGRDDYAVNKVFLVY 566 (671)
Q Consensus 490 ~iG~G~~-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~~~~~~~~Lv~ 566 (671)
.+..|.. ..||+...+++..+.+|.-..... .++.+|++.++.+.. --+.++++++.+++ ..++||
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~--------~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAG--------RDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--------CEEEEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccccc--------ceEEEE
Confidence 3444443 578998888788888888654332 345667766665533 33455666655432 579999
Q ss_pred ecCCCCChhh--------------h---hhcCC-CCCC--CCHHHHHHHHH--------------------HHHHHHHHh
Q 005898 567 EFMSNGNFRT--------------H---ISENT-PGKV--LNWSERLAVLI--------------------GVAKAVQFL 606 (671)
Q Consensus 567 Ey~~~GsL~~--------------~---l~~~~-~~~~--l~~~~~~~i~~--------------------~ia~gl~yL 606 (671)
||+++.++.+ . ||... .... -.+..+..-.. .....+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 9998765432 1 11100 0000 11111111100 112223333
Q ss_pred cCC----CCCCccccCCCCCceeecCCCcEEEcccCCcccccccccccee
Q 005898 607 HTG----VIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVR 652 (671)
Q Consensus 607 H~~----~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~ 652 (671)
... ..+.++|+|+.+.||+++++..+-|.||+.+...+-.+.++..
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g~~~~Dla~~ 215 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALA 215 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEETHHHHHHH
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccCCHHHHHHHH
Confidence 321 1234799999999999998766789999999887755555543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.15 E-value=0.00032 Score=72.00 Aligned_cols=43 Identities=21% Similarity=0.233 Sum_probs=35.3
Q ss_pred CccccCCCCCceeecCCCcEEEcccCCccccccccccceeeeee
Q 005898 613 GFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLIL 656 (671)
Q Consensus 613 ~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~~~ 656 (671)
.++|+|+.+.||+++++. ++|.||-.+...+-.+.+|..+..+
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~~~~Dlg~~~~~~ 266 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYGPIGFDVGQFIANL 266 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEECTHHHHHHHHHHH
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccCCHHHHHHHHHHHH
Confidence 589999999999998764 8999999998888666667766543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.07 E-value=6.1e-05 Score=67.67 Aligned_cols=88 Identities=10% Similarity=0.155 Sum_probs=49.1
Q ss_pred cCCCCCCEEEcccC-cCCCC----CCccCCCCCccCEEEccCCcCCCC----CCcccCCCCCcCEEEcccccCCCC----
Q 005898 139 HRLYSLEYLDLSSN-FLFGS----VPPKISTMVKLQTLILDDNFFNNT----IPNWFDSLPSLTFLSMRNNKLAGP---- 205 (671)
Q Consensus 139 ~~L~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~---- 205 (671)
.+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.++.. +...+...+.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34577888888764 34321 223355666777777777766521 122334456677777777766531
Q ss_pred CcccccCCCCCCEEEeccCcc
Q 005898 206 FPSSIQRISTLSDLDLSKNAI 226 (671)
Q Consensus 206 ~p~~l~~l~~L~~L~Ls~N~l 226 (671)
+-..+...++|++|++++|.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSS
T ss_pred HHHHHHhCCcCCEEECCCCcC
Confidence 112344455666666666644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.55 E-value=0.00013 Score=65.25 Aligned_cols=113 Identities=12% Similarity=0.145 Sum_probs=66.1
Q ss_pred ccCCCCCCEEeccc-cccccc----CCccccCCCCCCEEEcccCcCCCC----CCccCCCCCccCEEEccCCcCCCC---
Q 005898 114 LARLTSLRVLSLVS-LGIWGS----LPDKIHRLYSLEYLDLSSNFLFGS----VPPKISTMVKLQTLILDDNFFNNT--- 181 (671)
Q Consensus 114 l~~l~~L~~L~L~~-n~l~g~----~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~--- 181 (671)
..+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++.. +-..+...+.|+.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 45667888888886 445321 333455778888888888877532 222345566777777777766532
Q ss_pred -CCcccCCCCCcCEEEc--ccccCCC----CCcccccCCCCCCEEEeccCcc
Q 005898 182 -IPNWFDSLPSLTFLSM--RNNKLAG----PFPSSIQRISTLSDLDLSKNAI 226 (671)
Q Consensus 182 -~p~~~~~l~~L~~L~L--~~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l 226 (671)
+-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+..
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2234455666766444 3455532 2233344566666666665543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.52 E-value=0.0044 Score=61.38 Aligned_cols=147 Identities=11% Similarity=0.135 Sum_probs=80.3
Q ss_pred eEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccceeecCCCCCCcccceEEEEEecCCCCChhh
Q 005898 497 GKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGHCIDGGGRDDYAVNKVFLVYEFMSNGNFRT 576 (671)
Q Consensus 497 g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~~~~~~~~Lv~Ey~~~GsL~~ 576 (671)
-.||+.+.++|..|++|.-.... .+.+++..|.+.|..+....+.-.......++ .-.......+.+++|+++..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~-~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQ-TLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTB-SCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCC-eeeeeeeEEEEEEeecCCcCCCC
Confidence 47999999999999999875432 24567788888887775433321111111111 10112246788999997643210
Q ss_pred -----------h---hhc----CC--CCCCCCHHH-------------------HHHHHHHHHHHHHHh----cCCCCCC
Q 005898 577 -----------H---ISE----NT--PGKVLNWSE-------------------RLAVLIGVAKAVQFL----HTGVIPG 613 (671)
Q Consensus 577 -----------~---l~~----~~--~~~~l~~~~-------------------~~~i~~~ia~gl~yL----H~~~~~~ 613 (671)
. +|. .. .....++.. +-.+...+.+.++.+ .......
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 111 10 011222211 111111122223332 2222346
Q ss_pred ccccCCCCCceeecCCCcEEEcccCCccccc---ccc
Q 005898 614 FFNNRVKTNNILLNEHRIAKLSDYGLSIVSE---DIN 647 (671)
Q Consensus 614 iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~---d~~ 647 (671)
+||+|+.+.||+++++ ..+.||+-+.... |+|
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g~~~~DLa 228 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARNGPAVQDLW 228 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCEECTTHHHH
T ss_pred eecCCCCcccEEEeCC--ceEEechhcccCcHHHHHH
Confidence 8999999999999754 4588999887654 655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.66 E-value=0.0096 Score=58.39 Aligned_cols=181 Identities=13% Similarity=0.106 Sum_probs=92.7
Q ss_pred cCHHHHHHHhcCCCcCcee-----ccCCceEEEEEEEcCCcEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcccccce
Q 005898 473 FTLEELKEATNNFDMSAIM-----GEGSYGKLYKGRLENGTSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLVCLLGH 547 (671)
Q Consensus 473 ~~~~~~~~~~~~f~~~~~i-----G~G~~g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 547 (671)
.+.+|+.....+|...+.. ..|---+.|+.+.++|+ +++|+..... ..++...|+++|..+...++.-..-.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4567777777888765443 35555788998877665 8888875432 22345556667766644333211111
Q ss_pred eecCCCCCC-cccceEEEEEecCCCCChhh--------------hhhc----CC---CCCCCCH-HH-------------
Q 005898 548 CIDGGGRDD-YAVNKVFLVYEFMSNGNFRT--------------HISE----NT---PGKVLNW-SE------------- 591 (671)
Q Consensus 548 ~~~~~~~~~-~~~~~~~Lv~Ey~~~GsL~~--------------~l~~----~~---~~~~l~~-~~------------- 591 (671)
...++... ......+.++.+..+..... .++. .. ......| ..
T Consensus 80 -~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 80 -PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp -CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred -eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11111100 01234567777776543211 0110 00 0000111 10
Q ss_pred ---HHHHHHHHHHHHHHhcCC-CCCCccccCCCCCceeecCCCcEEEcccCCccccccccccceeeeeee
Q 005898 592 ---RLAVLIGVAKAVQFLHTG-VIPGFFNNRVKTNNILLNEHRIAKLSDYGLSIVSEDINSVGVRLLILM 657 (671)
Q Consensus 592 ---~~~i~~~ia~gl~yLH~~-~~~~iiHrDlk~~NiLl~~~~~~ki~DfGla~~~~d~~s~g~~l~~~~ 657 (671)
....+..+...+.-.+.. -..++||+|+.+.||+++++...-|-||+.+....-++.+++.+..++
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~~~~~DLAi~~~~~~ 228 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDLLAYDVSICLNAWC 228 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEEHHHHHHHHHHHHS
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccccchhhhhHHHHHHHHh
Confidence 111111222222222221 223689999999999999887778999999977654444566555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.30 E-value=0.0028 Score=56.10 Aligned_cols=17 Identities=12% Similarity=0.200 Sum_probs=8.6
Q ss_pred hhcCCcccceeeccccc
Q 005898 277 QYGQLNQLQQLDMSFNA 293 (671)
Q Consensus 277 ~~~~l~~L~~L~Ls~N~ 293 (671)
.+...++|+.|+++.+.
T Consensus 127 ~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 127 MLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHCSSCCEEECCCSS
T ss_pred HHHhCCCcCEEeCcCCC
Confidence 34445555555555443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.87 E-value=0.019 Score=58.25 Aligned_cols=73 Identities=19% Similarity=0.180 Sum_probs=46.6
Q ss_pred CceeccCCceEEEEEEEcCC--------cEEEEEEccCCchhhHHHHHHHHHHHhcCCCCCcc-cccceeecCCCCCCcc
Q 005898 488 SAIMGEGSYGKLYKGRLENG--------TSVAIRCLPSSKKYTVRNLKLRLDLLAKLRHPHLV-CLLGHCIDGGGRDDYA 558 (671)
Q Consensus 488 ~~~iG~G~~g~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~~~ 558 (671)
.+.|+-|-.-.+|+...+++ +.|.+++..... ...+..+|..+++.+.-.+++ ++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence 35678888899999986542 456666654322 223456788787777433454 56666531
Q ss_pred cceEEEEEecCCCCCh
Q 005898 559 VNKVFLVYEFMSNGNF 574 (671)
Q Consensus 559 ~~~~~Lv~Ey~~~GsL 574 (671)
.+|+||+++-.+
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 689999986443
|